<SEC-DOCUMENT>0001162194-22-000055.txt : 20220509
<SEC-HEADER>0001162194-22-000055.hdr.sgml : 20220509
<ACCEPTANCE-DATETIME>20220509142145
ACCESSION NUMBER:		0001162194-22-000055
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		88
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220509
DATE AS OF CHANGE:		20220509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STANDARD BIOTOOLS INC.
		CENTRAL INDEX KEY:			0001162194
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				770513190
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34180
		FILM NUMBER:		22904398

	BUSINESS ADDRESS:	
		STREET 1:		2 TOWER PLACE
		STREET 2:		SUITE 2000
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		6502666000

	MAIL ADDRESS:	
		STREET 1:		2 TOWER PLACE
		STREET 2:		SUITE 2000
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FLUIDIGM CORP
		DATE OF NAME CHANGE:	20011113
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>fldm-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:3567094e-7943-4bac-b9e5-feece94f0a52,g:ecd4ac27-903f-4673-9e8a-4f46fd5b8bd9,d:3f52f78858b0473b983a2153293d04e0--><html xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:fldm="http://fluidigm.com/20220331" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>fldm-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80L2ZyYWc6YzBiYzc2NmMyZDI3NGQ2OWJmZjM2MzNiNjk1NjEyNDEvdGFibGU6ZTI1NGYzMmU1M2ZkNGMzMGIxNWFlYzBmOTdjYmQ0MzIvdGFibGVyYW5nZTplMjU0ZjMyZTUzZmQ0YzMwYjE1YWVjMGY5N2NiZDQzMl8zLTEtMS0xLTUzMzU1_05379bb8-84ed-41ca-8d8d-b53de6c2dc42">false</ix:nonNumeric><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80L2ZyYWc6YzBiYzc2NmMyZDI3NGQ2OWJmZjM2MzNiNjk1NjEyNDEvdGFibGU6ZTI1NGYzMmU1M2ZkNGMzMGIxNWFlYzBmOTdjYmQ0MzIvdGFibGVyYW5nZTplMjU0ZjMyZTUzZmQ0YzMwYjE1YWVjMGY5N2NiZDQzMl80LTEtMS0xLTUzMzU1_6e0211d9-e4cd-4a0b-811e-b49d6beabe17">2022</ix:nonNumeric><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80L2ZyYWc6YzBiYzc2NmMyZDI3NGQ2OWJmZjM2MzNiNjk1NjEyNDEvdGFibGU6ZTI1NGYzMmU1M2ZkNGMzMGIxNWFlYzBmOTdjYmQ0MzIvdGFibGVyYW5nZTplMjU0ZjMyZTUzZmQ0YzMwYjE1YWVjMGY5N2NiZDQzMl81LTEtMS0xLTUzMzU1_0c063146-b317-4c2d-9b8d-2d679d9f0180">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80L2ZyYWc6YzBiYzc2NmMyZDI3NGQ2OWJmZjM2MzNiNjk1NjEyNDEvdGFibGU6ZTI1NGYzMmU1M2ZkNGMzMGIxNWFlYzBmOTdjYmQ0MzIvdGFibGVyYW5nZTplMjU0ZjMyZTUzZmQ0YzMwYjE1YWVjMGY5N2NiZDQzMl82LTEtMS0xLTUzMzU1_c8273f03-2859-4017-aeca-21a11d66f7c8">0001162194</ix:nonNumeric><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80L2ZyYWc6YzBiYzc2NmMyZDI3NGQ2OWJmZjM2MzNiNjk1NjEyNDEvdGFibGU6ZTI1NGYzMmU1M2ZkNGMzMGIxNWFlYzBmOTdjYmQ0MzIvdGFibGVyYW5nZTplMjU0ZjMyZTUzZmQ0YzMwYjE1YWVjMGY5N2NiZDQzMl83LTEtMS0xLTUzMzU1_0e95d181-d52e-4494-9f98-591fecebdc3a">--12-31</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="icbc9e7ab23954ae68df17a0ee7ed1b6f_D20220325-20220325" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMjQ1L2ZyYWc6NWQyZTQ0MWE3MmRlNDlmNTk0ZDAzMzA1OWFkOWIyZTkvdGV4dHJlZ2lvbjo1ZDJlNDQxYTcyZGU0OWY1OTRkMDMzMDU5YWQ5YjJlOV8xMzE5NDEzOTUzMzUwMQ_4148616a-a732-4a4a-ba06-d429f97bfd2d">0.3521126</ix:nonFraction><ix:nonNumeric contextRef="i335933a56ca64d3d94f51a90d798f76c_I20220331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80OS9mcmFnOmQ0YmNjM2RmYzE1OTQyODY4ODY0ODJmMDgyNDVjNGUxL3RhYmxlOjc3NTI1NDUyOGNmYjRkYTQ4ZGQ3NzRlZjYzZDJkNjUzL3RhYmxlcmFuZ2U6Nzc1MjU0NTI4Y2ZiNGRhNDhkZDc3NGVmNjNkMmQ2NTNfMS0xLTEtMS01MzM1NQ_76a2a275-ed22-4cda-9695-52b86777e69c">9</ix:nonNumeric><ix:nonNumeric contextRef="i3bcb2e193d7c4e4ba7f7c804e5ec66cd_I20220331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80OS9mcmFnOmQ0YmNjM2RmYzE1OTQyODY4ODY0ODJmMDgyNDVjNGUxL3RhYmxlOjc3NTI1NDUyOGNmYjRkYTQ4ZGQ3NzRlZjYzZDJkNjUzL3RhYmxlcmFuZ2U6Nzc1MjU0NTI4Y2ZiNGRhNDhkZDc3NGVmNjNkMmQ2NTNfMi0xLTEtMS01MzM1NQ_99a50dc1-526a-4cd0-9e5f-3b7a3d8a45bc">1</ix:nonNumeric><ix:nonNumeric contextRef="ibbe253446f1d4da380bb648d1169a573_I20220331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80OS9mcmFnOmQ0YmNjM2RmYzE1OTQyODY4ODY0ODJmMDgyNDVjNGUxL3RhYmxlOjc3NTI1NDUyOGNmYjRkYTQ4ZGQ3NzRlZjYzZDJkNjUzL3RhYmxlcmFuZ2U6Nzc1MjU0NTI4Y2ZiNGRhNDhkZDc3NGVmNjNkMmQ2NTNfMy0xLTEtMS01MzM1NQ_1804b613-9221-4991-8d9e-6b2afcff636b">1</ix:nonNumeric><ix:nonNumeric contextRef="i48119219acbf471d93f5816373e96a28_I20220331" xsi:nil="true" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80OS9mcmFnOmQ0YmNjM2RmYzE1OTQyODY4ODY0ODJmMDgyNDVjNGUxL3RhYmxlOjc3NTI1NDUyOGNmYjRkYTQ4ZGQ3NzRlZjYzZDJkNjUzL3RhYmxlcmFuZ2U6Nzc1MjU0NTI4Y2ZiNGRhNDhkZDc3NGVmNjNkMmQ2NTNfNC0xLTEtMS01MzM1NQ_1fdf1408-ebbe-4590-98a7-0140cc981f17"></ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="ia6dab1bdeec84907af3edc92f528486f_D20191101-20191130" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82MS9mcmFnOmEyMGQxNDk0N2I3ODRkMTliNTE5YmQ2ZGRlMGRiY2M5L3RhYmxlOmE3ZWFmMWVkOTRmYTRlMTliNGNjNDU0MDQ5OTVhYzFlL3RhYmxlcmFuZ2U6YTdlYWYxZWQ5NGZhNGUxOWI0Y2M0NTQwNDk5NWFjMWVfMS0yLTEtMS01MzM1NQ_d1d32980-0465-4bec-9d1f-5202cc3870bd">0.3448276</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="fldm-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8129f3bfc4ec41c9aa6d162ae2eba76a_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i464bfcf84ef44fa0b0e68af70cc3988f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab920cccfecf44528e9ce52d935fa63a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96de28bb25374cbaa71d471a786e1db3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6c770a450054cda9c777968afb1bca3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a25af0ec36e425db27350cae34291e2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50ef3b1943a5459d80af3119e547f1cc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f969efefbfa43cab57d0b0dbba8b692_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37fe6c7bd98449ef8909d4137b4673a2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67531e388c0e40cdb02f90448ebfc132_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0e22c724c524303bf88f4ed321cc50d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife53191c83774d009455b6219ab8d213_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id512bd02ff5c466b83c1a85dc87fe1ef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3062eea440bb4b8abee952bb6d8f666f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia01ee6541d314637a0cf139b7a3517a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ee876a5d6724fc3baf62a71ac362565_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3160813ed6ea47239b8b14f10a6a132f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i743f2be8661c4d49bf0e11f2fd7672c6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief97f0f005454a3ebb73d10c8a6fc288_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3d0b28316714637ae16364f010efcb3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i671f9af2f29c4f1f929a61c12aba4b42_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaeae6add4f148cd8e2a749b602bcc59_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7108a12ba20140bf8ddbbf0bd06e0086_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7edfc49d39cd47138bdc5064597c073b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id77c72e5a5f841e093b9ab6998fcfc1f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87fc908e2306474ca6061592bbd313c0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4e40eb27af64de29a8412568ad4b140_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id803a63fc74c495aa4dd5311fbcac8b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i569592ee5f454ea69635943e7f236859_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e3525e6da4a471bbb0a4a59a5d15773_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic26f34b391524936ad12d32af015e7a6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic05a8c6dfa64446bad2c73b3c7882945_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47472db137014a838484b58ca7ec54b1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdac09bb73da4bc698146a2f6d7842a5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cd95ac79ec64220ae66aaf7e20ff229_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28b9b63dddca4cf59ed8ad13d8b810aa_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id618e4076c984ee2b69327451b1b9e70_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26bb80925b7243dd86ac47e3aa792a15_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6927dcea8afc4590868e910c711eb950_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32573a3e0127457ab8cd1f21b8706b01_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7cbdf74105f4c63acc93bf88685787f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bf7ca99df7546ac8f6f641356b6669f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb59364bf80942a7b409ac934e71fc8d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4590fb02726433eac6b072086045564_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0922be352f994b20b3f553c5fd67b357_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1870e9c226e845e4aed6768f8701a354_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:BridgeLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27af03e024e04f15ba5f16d8c26d2c92_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:BridgeLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6548c4721969408e92076ddc5ec286a8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i033e8053b42848b5b5fc39a8d349706c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1a5805104194441bb995ef05eee862f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2fc67f467ba494384ae37dc00e28c5f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02bbc839aff04cb6b76120a51050ad62_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib249f81dacbc44039cd73fb307a2440a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i969516905a714099b6f6cbab3a226bb5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndFourteenConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia023da1bf6d94cddb5bfc0acd240aef6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndFourteenConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i886c80d6b2014617accd5fb486b0da62_I20220123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a6c6bdfb4274d13b3f7a97a1f9a2bcd_D20220404-20220404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-04</xbrli:startDate><xbrli:endDate>2022-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56ff172b378c40bfa9fb091517220986_D20220404-20220404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:CasdinMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fldm:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-04</xbrli:startDate><xbrli:endDate>2022-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb221a8d5f7b4664a321c4333783b5a8_I20220404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:CasdinMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fldm:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie16dc5fbce7344098cb3d3224ce907b0_D20220404-20220404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fldm:SeriesB2ConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:VikingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-04</xbrli:startDate><xbrli:endDate>2022-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2c825e393d44392a0cdda4dde9c896c_I20220404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fldm:SeriesB2ConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:VikingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3c3e7b51c6f444eb205479e022d6700_I20220404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic68aad560626482181eb728c71653aff_I20220403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77616e0764104572bb6724b63bf8ab85_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="fldm:DebtCovenantPeriodAxis">fldm:DebtCovenantPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i2f4791be67494f768846d8731311ee82_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="fldm:DebtCovenantPeriodAxis">fldm:DebtCovenantPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib91f694990c84e7b80102a9d2003a94f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="fldm:DebtCovenantPeriodAxis">fldm:DebtCovenantPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8289410ad96c48e9a79c0ea4d1093e35_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="fldm:DebtCovenantPeriodAxis">fldm:DebtCovenantPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe298cbdde5842d1abc79d95ddf9275c_I20220123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0ed4fcc32994c51a64df27a56bebe58_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdfcd99ed0d44886aa6f217791a9b7b2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17f98442bfed4b7c9e994c9fd18a4bc3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedc9287f43ef4070913785190e868b4a_D20220123-20220123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-23</xbrli:startDate><xbrli:endDate>2022-01-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cc0a83a704c446185dfcd2f538f5b2e_D20220123-20220123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-23</xbrli:startDate><xbrli:endDate>2022-01-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2127000202e94f0988bb0ca0fe40e66b_I20220123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="ib0ec30bb1300459287d9f22d16790089_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbc9e7ab23954ae68df17a0ee7ed1b6f_D20220325-20220325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-25</xbrli:startDate><xbrli:endDate>2022-03-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia846fcc54289492ea9f2caf7da738fb2_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:UndisclosedCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafdb8ef4ee9b4330a1afed79e1a6adab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:UndisclosedCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c64b4d5135043b2bf9e4a910f74a574_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:UndisclosedCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f8e6499d1bf4299a4a07cd4f748586b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286841fd19da443ead3fbf7f94d46b19_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i072ebd8279c8453f8cd2f1cb832d29fd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87071d29b432475bb23956adf7514f92_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f17be2ff1a047ea95cdaeba288d236a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24e8ea78bbff495b800d3ede81174994_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a58b69e2fd947c19feffcbbf475f7fb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5517c1a9f7d46acb4b2910a6e65a460_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e1af6815ea14d86990d3949065312c1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dbaa6754bf146218a79d666b5fbe97b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefe32db1cf564d38b50cdb165fc5cb80_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0afc35aeae144b7e896655ac0045040f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd77101528ad4efaa4764f0e88507854_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d2106e31ca44f2b930bd540e5346338_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i335933a56ca64d3d94f51a90d798f76c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bcb2e193d7c4e4ba7f7c804e5ec66cd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbe253446f1d4da380bb648d1169a573_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48119219acbf471d93f5816373e96a28_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i553dcb7ee7ea4ac9a75e92d924b88f3e_I20140228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:DVSSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i830df8f0fc5846878354fcf3361da7fb_D20140201-20140228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:DVSSciencesInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-02-01</xbrli:startDate><xbrli:endDate>2014-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib03343990d404ba9a12387dbb99c7af4_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i78a77be6f4bb47ae9b4e1a70ef8aba45_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd0ea5bfa71e4a248571cf351b4fbc02_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic84a49a6264541b9a2ad518751a09a27_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3ccc2277618429ba4dd1bf8f8ac9415_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c9074a6857a429c8182e81cbd9e260b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4debd5fa9102490ba7555a1193ce7701_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20d31a7327ed4de3a49655170f642acc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fa8acd9c9d642edad45d44d1963e783_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc22933a248246149e4c0d789e039050_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bf82049acf4414db15019056a8b4a4d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i090e27ef0a04457484fad8f0a7075dd1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57628b9b4d1948008ccba2dcd4ef1952_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7f4a8245b6143b2953ff1fa9ffa2409_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:LaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68ab04d53d1948088109f492c3fb4362_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:LaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f99c36bb724482982e5d8102ceeecd7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0863696f8964c36a94715de8e0f295d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie84a730a5b8e43089afed4061de374a5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i367f8eaf66e547ca84a65357249c487a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i160268d0fa1b4d38bd5ea84554f1559f_I20140228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7a77d2cffbb466495dfbdb0f232de97_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib879a74c7d314a99bfe67a83c5ae025a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07369311ad5b4af1a043b008ade3c4e7_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6fc6a3e6a134443b3035ae7eef72da4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ccaab30a9344f92a4d5d4f061f686d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i918712e2e4c4473592c78603409a2035_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i633deee677b14f20aedd746e431d49ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9170739660ea4bfc8eb6c551e60b2612_D20140201-20140228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-02-01</xbrli:startDate><xbrli:endDate>2014-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b39964a5e6c4c19b88ad79540049976_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29e7a7788ad04a3d8770310cb3706589_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa7db0e7f6e64bc38b954e286cf01912_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b2bc86d58a540e1859dd280a7ab24e4_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie91e1a9f5d3646f68aebba6fd62e9508_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i908b5614888049f28cbb80e7a6178f8e_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i812e59424f52454887fd27588f8469d3_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5874eb1b19274365b89e4f16ba6865fc_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4690c6ae02014999bb14d18dc8b565b2_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i736e4e930c62488998bc7af6f80cb9a5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40c95c830e9346709b9e8f6f68d3ca08_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3bcdcd73f1c405f8f2d59a089c890f3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7290240890949c08edf84cb715e251f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7138e77d1b41464ba17008df0fb4ab55_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6637980e82554f3da6571c3ff1c70650_D20180801-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id87ce5c4623f4d3b9b99a89129d283c5_I20210802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c05f390be1e4fba9543e3eef05cd18a_I20210802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-08-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea73508f9d1047c38f6efe4f293e882e_D20210802-20210802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-02</xbrli:startDate><xbrli:endDate>2021-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71f15dd92cc34cc88d928463e4fdea0d_D20180801-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9ff2eebee8640b1845873f7c8306421_D20180801-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5c8dc8c1e56417a96b944b97cd01027_D20180801-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-01</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43f34e3da8064d94ba11bd59638ffba3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ceba926b97e4336840e0087ebe96841_D20210802-20210802"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-02</xbrli:startDate><xbrli:endDate>2021-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="monthly_installment"><xbrli:measure>fldm:monthly_installment</xbrli:measure></xbrli:unit><xbrli:context id="ia6dab1bdeec84907af3edc92f528486f_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2946e1733f13418ea3b80b32b99bb663_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9401f96d3b934202bdd9b43f3164dc99_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6d96d54873a406f8857760fcb97e6dc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dd1c0dbe46d4ab4b631cf79d9b0e5f0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8bf776768964321b47a464ab18406e1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4d100cb233e46569570b3a9160fffaf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb02155ee72947fe93b3c7c9297367dd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ab4b34b0e7949c0853287c6a741b50c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09c9b9a0eec74f1eb1b5c7f46fce7ad2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">fldm:CashAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cbe9fcdac0241f08b13a6f1500deafa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">fldm:RestrictedCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2106d7d27e2429382ccfccea124e2d2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia410cf951ff442a7af6415951fac5467_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">fldm:CashAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7656b92dc6c44155b55eebf7f72273b9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">fldm:RestrictedCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53f8932dab17405f952c3ec80f549c94_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacd8238416414b529e9c11e81b3cb3ea_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66a0e027243e4b7e8de45f9fb688f73d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i192f9657493242a29365f3d839d90d10_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35de4e7e785e4aa7b55659c0991572df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75ab6b689aa54665b3fe1c022f4f383e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i719deb7dffa9447ea8e3e92416972180_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ec07d32c39e41fc8f6fae982f6ddbb1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0057b63c6d1d42858acd5f470ced781d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b6e6c6f6d6d40c09000d22bf80671b7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2947c7abf7fa4f2691d0ca9cde5d6514_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94d6459171cf40a6843977458759b899_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25222c4b0d624dc4bd5bea0e9e94cbe1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90ccecdd5e034b9e8b3a73afd56dd029_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5621449148c64e2998b4cfe5304b2265_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d3d07f8af4b4470897c2977833f9255_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53271b8cc303430b9324caf250af4723_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d08369cf4e743e1980090e6f9bd90e3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i744122bb17644424b7a8fd06cb0c7128_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i430bde457f8b49c297f4b7eb59db0e6c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if48c5a23863e4cd8bbe66e032efb7a3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a2855f667ed4c72a5b8a3fca49072e7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58112e5c277c4b30a89447743fc62c04_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bcb085019064514a3ff3a7b73e42196_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c3dfe2aada444b685f4219ae06fcd20_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b63c6fe97894fe5a0d2c4975b4da0fe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf2d9ac881dc4deea1d8989f49ab808d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c347987f267431784a940da9799e057_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77951f80ba15446c8cd2f0e9ef5ba4f1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d2a998f16924d858cf125d7c1d814bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88a9b5eeb2b441ca8c84ceb94e14ff84_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d77114634a0476587c0c6e236131dd4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61c25a145cf849d690fe64971fb1219b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7e1d70fc37c4900b64ff49301b03fd4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2385c7f15ba43f4afc1f5f66be141ae_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndTenEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03880c5036734260b46d06727e442f92_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndTenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42f0b198127148778a174350609491d0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndTenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie87e1842c50e4d569dca108ae8ad47ff_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndSeventeenInducementAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1145f4ff09c84a6790d15188392833e4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndSeventeenInducementAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i058640ba016f4fb396b722f5d98c4df8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndSeventeenInducementAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03c0001f48254fe3bdfc3606ca7946d0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96a7681635b84887bcccedb27f5cffe1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec8080f040c148cd9a55c99e106e20ca_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad71c918ee434181ba0fff19eced37d5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45fe81b2edc14e8283a89efd8ec7b239_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbc7c42ab7c948dbb536b605def058fd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id07ffabfcd0b42608b10129b2e59ffd5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida95b698f6f541feb12d26c1e08f3545_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9af5c9a4df634b10aa18bac8dd63496d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f2f332657784dd188961528d24aadfb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i227d5a5fe544411ea37d71f144593da9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12d6eaf877364d5dbf2a9fe63b59e9aa_D20190601-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanTwentyElevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icefddd7e6aa7456685103922b493fb0b_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b311a9055cd4350a32fbf48c1d51dcf_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanTwentyElevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b27a08b375d4bd6a7bdb7050cb92f97_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fa095588fa743319343a18e9698ac0e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41bfbc4f8008465d885af193c5915937_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b42cfc93e2b4c79b0b5d4699ce58cae_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib321b7bc2a2347bda69869d595adc12e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i357950952be44c25a149476baf5f1338_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic924218fbf5a4d91b76fd02ad51f0368_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63b45dc8c7f84841a01e93bde43297e1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fldm:CertainEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i976dac4ee8d24a6b9937b433c337665a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f8238e8d8694c059385a480dcb687e1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9291755db0804b7e971901deb2d9a94a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45dc092a669a4531bc189ae9f0583e68_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f805e7f1d6c46a69b33311aa284f9dd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id192327cb55c41259f9faa5f5322725c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>fldm:segment</xbrli:measure></xbrli:unit><xbrli:context id="i890754c6557847938cb71a04d83d4e22_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6825599028a44895afeda749b0c6a2be_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd04707bc427433aa0a24baf6c191f0c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i448c3bd9337e456095cdb94a8fa30336_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3dda181cdd645f793c5612b9ec9660b_D20220404-20220404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-04</xbrli:startDate><xbrli:endDate>2022-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib980c3b074f94dd4a574cde692cff868_I20220404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:A2022InducementEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b39f3273ab44415baf1d8b96c519c44_D20220404-20220404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:A2022InducementEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-04</xbrli:startDate><xbrli:endDate>2022-04-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5320ad3429740cc9ae7dfdcc463a85f_D20220404-20220404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001162194</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:A2022InducementEquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-04</xbrli:startDate><xbrli:endDate>2022-04-04</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3f52f78858b0473b983a2153293d04e0_1"></div><div style="min-height:36pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzA0_f98e7f03-c8e7-4bb3-ad70-921950185f8d">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzA5_af649969-23f4-48d6-a0e2-646bac97d9bd">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yNTk_e8a06938-920d-49df-81fd-0b5793c41a61">March 31, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">or</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzEw_92b97755-4c88-4bb1-a90a-4294b9d7c5cb">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION&#160;13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">_____________________________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzA1_2c74769f-5d51-4754-98a6-3e445856c5a0">001-34180</ix:nonNumeric> </span></div><div style="text-align:center"><img src="fldm-20220331_g1.jpg" alt="fldm-20220331_g1.jpg" style="height:100px;margin-bottom:5pt;vertical-align:text-bottom;width:130px"/></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzAx_849b3d2c-7eda-4278-8196-59f3efce4cd5">STANDARD BIOTOOLS INC.</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.759%"><tr><td style="width:1.0%"></td><td style="width:23.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ODY4YjBiNDlkYjdhNGFmNzgyMzBkN2QyZWRlN2Y0YmQvdGFibGVyYW5nZTo4NjhiMGI0OWRiN2E0YWY3ODIzMGQ3ZDJlZGU3ZjRiZF8wLTAtMS0xLTUzMzU1_2da19030-bd7d-4e58-9584-8d58f3e68cf9">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ODY4YjBiNDlkYjdhNGFmNzgyMzBkN2QyZWRlN2Y0YmQvdGFibGVyYW5nZTo4NjhiMGI0OWRiN2E0YWY3ODIzMGQ3ZDJlZGU3ZjRiZF8wLTQtMS0xLTUzMzU1_cb016959-1313-4e6f-a223-78480b687678">77-0513190</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State or other jurisdiction of incorporation or organization</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">I.R.S. Employer Identification No.</span></td></tr><tr style="height:6pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ODY4YjBiNDlkYjdhNGFmNzgyMzBkN2QyZWRlN2Y0YmQvdGFibGVyYW5nZTo4NjhiMGI0OWRiN2E0YWY3ODIzMGQ3ZDJlZGU3ZjRiZF8zLTAtMS0xLTUzMzU1_49febf12-5130-4f04-8c6a-261f16327c8c">2 Tower Place, Ste 2000</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ODY4YjBiNDlkYjdhNGFmNzgyMzBkN2QyZWRlN2Y0YmQvdGFibGVyYW5nZTo4NjhiMGI0OWRiN2E0YWY3ODIzMGQ3ZDJlZGU3ZjRiZF8zLTEtMS0xLTUzMzU1_a7b923bc-9263-4f1c-9f40-45e7158c3a15">South San Francisco,</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ODY4YjBiNDlkYjdhNGFmNzgyMzBkN2QyZWRlN2Y0YmQvdGFibGVyYW5nZTo4NjhiMGI0OWRiN2E0YWY3ODIzMGQ3ZDJlZGU3ZjRiZF8zLTItMS0xLTUzMzU1_363ddc09-57b5-48bf-bb82-03b6cf87ccec">CA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ODY4YjBiNDlkYjdhNGFmNzgyMzBkN2QyZWRlN2Y0YmQvdGFibGVyYW5nZTo4NjhiMGI0OWRiN2E0YWY3ODIzMGQ3ZDJlZGU3ZjRiZF8zLTQtMS0xLTUzMzU1_a0c65c87-2e82-4d07-94b7-1bc60ffd2f06">94080</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Address of principal executive offices</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Zip Code</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzEx_6563d650-0185-4c5b-834c-00bf13dd0596">650</ix:nonNumeric>) <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzAy_83341a07-180b-4966-b4ee-c19264c22d3c">266-6000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.224%"><tr><td style="width:1.0%"></td><td style="width:39.651%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ZTI2Mjg3NDIxMTIxNGVmYmE0ZmQzMjJmNDNkNDczYzIvdGFibGVyYW5nZTplMjYyODc0MjExMjE0ZWZiYTRmZDMyMmY0M2Q0NzNjMl8xLTAtMS0xLTUzMzU1_e10ca631-4730-4f41-9526-9bba1d3859f2">Common Stock, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ZTI2Mjg3NDIxMTIxNGVmYmE0ZmQzMjJmNDNkNDczYzIvdGFibGVyYW5nZTplMjYyODc0MjExMjE0ZWZiYTRmZDMyMmY0M2Q0NzNjMl8xLTEtMS0xLTUzMzU1_54bb0105-d726-4ad2-b032-d871b517227b">LAB</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ZTI2Mjg3NDIxMTIxNGVmYmE0ZmQzMjJmNDNkNDczYzIvdGFibGVyYW5nZTplMjYyODc0MjExMjE0ZWZiYTRmZDMyMmY0M2Q0NzNjMl8xLTItMS0xLTUzMzU1_5db3ec14-5f55-4e7d-a4d8-0c422bb6d8c8">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:2pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzA2_a3a144a7-e75a-4be2-8816-4594652d6655">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt;margin-top:2pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;&#160;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzAz_129edd63-70e2-4554-a80a-46163f8cb2dd">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt;margin-top:2pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ct.           </span></div><div style="margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.825%"><tr><td style="width:1.0%"></td><td style="width:28.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.579%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.950%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.192%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.229%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6NmIxZTI2YmNmZWY4NGYwODk4NTg1NjA3NzExNTI1N2YvdGFibGVyYW5nZTo2YjFlMjZiY2ZlZjg0ZjA4OTg1ODU2MDc3MTE1MjU3Zl8wLTUtMS0xLTUzMzU1_85a5136c-6fe4-4f65-b624-92ebde5b83a7">Accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated&#160;filer  </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company  </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6NmIxZTI2YmNmZWY4NGYwODk4NTg1NjA3NzExNTI1N2YvdGFibGVyYW5nZTo2YjFlMjZiY2ZlZjg0ZjA4OTg1ODU2MDc3MTE1MjU3Zl8xLTctMS0xLTUzMzU1_034fe74a-925d-4c00-8e0a-6c5c90f5a988">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company  </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6NmIxZTI2YmNmZWY4NGYwODk4NTg1NjA3NzExNTI1N2YvdGFibGVyYW5nZTo2YjFlMjZiY2ZlZjg0ZjA4OTg1ODU2MDc3MTE1MjU3Zl8yLTctMS0xLTUzMzU1_2bbeb246-1669-415d-a7a3-a0e5c1aa433f">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzA3_8da2605b-dd51-4b41-890b-7df93584fc71">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April 30, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i8129f3bfc4ec41c9aa6d162ae2eba76a_I20220430" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF81NDk3NTU4MTQxMzQ1_c71e289b-105c-4dad-bf36-217f9612a4d9">77,252,135</ix:nonFraction> shares of the registrant&#8217;s common stock, $0.001 par value per share, outstanding.</span></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STANDARD BIOTOOLS INC.</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(formerly known as FLUIDIGM CORPORATION)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART&#160;I.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">FINANCIAL INFORMATION</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_13">Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_13">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_16">Condensed Consolidated Balance Sheets as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_16">March 31</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_16">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_16">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_16"> and December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_16">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_16"> </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_16">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_19">Condensed Consolidated Statements of Operations for the three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_19"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_19">months </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_19">ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_19">March 31</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_19">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_19">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_19"> and 202</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_19">2</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_22">Condensed Consolidated Statements of Comprehensive Loss for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_22">months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_22">March 31, 2022</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_22"> and 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_22">1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_22">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_25">Condensed Consolidated Statements of Stockholders&#8217; Equity for the three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_25"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_25">months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_25">Mar</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_25">ch 31, 2022</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_25"> and 202</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_25">4</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_28">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_28">three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_28">months ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_28">March 31, 2022 </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_28">and 202</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_28">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_31">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_85">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_85">25</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_109">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_109">37</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_112">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_112">37</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART&#160;II.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">OTHER INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_118">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_118">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_121">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_121">39</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_307">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_307">70</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_310">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_310">70</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_313">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_313">70</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_316">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_316">70</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_319">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_319">71</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_319">EXHIBIT LIST</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_319">71</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_322">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i3f52f78858b0473b983a2153293d04e0_322">73</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i3f52f78858b0473b983a2153293d04e0_13"></div><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Financial Statements</span></div><div id="i3f52f78858b0473b983a2153293d04e0_16"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STANDARD BIOTOOLS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(formerly known as FLUIDIGM CORPORATION)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNC0yLTEtMS01MzM1NQ_a9e7d4f0-1310-4ebe-8718-b1129f92b6cb">29,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNC00LTEtMS01MzM1NQ_7145249b-e16e-4970-8a4d-5b082a25ec9a">28,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable (net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNi0wLTEtMS01MzM1NS90ZXh0cmVnaW9uOjllMjM3ODhkYWE2ZTQ2NTNiY2IxNDBkNjNmOTdjY2Y3XzQ1_058abbed-4f6f-4e32-b994-450ab9aa081a"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNi0wLTEtMS01MzM1NS90ZXh0cmVnaW9uOjllMjM3ODhkYWE2ZTQ2NTNiY2IxNDBkNjNmOTdjY2Y3XzQ1_60e0c7fd-01c4-4039-8449-f0be3993f770">356</ix:nonFraction></ix:nonFraction> at each of March 31, 2022 and December&#160;31, 2021)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNi0yLTEtMS01MzM1NQ_d6f7b83b-2bc8-4586-b3b1-3f578cce5f63">15,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNi00LTEtMS01MzM1NQ_c3818781-9027-4e6d-a197-893b858ac990">18,320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfOC0yLTEtMS01MzM1NQ_fbe43f6a-fe09-4d93-b1ed-bb1a8fa131d2">23,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfOC00LTEtMS01MzM1NQ_a885a7cc-4ca7-4688-b63c-3df403f2472d">20,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfOS0yLTEtMS01MzM1NQ_68f2cd22-81b0-4784-bb14-55de392ef384">4,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfOS00LTEtMS01MzM1NQ_f42045a7-2619-4711-80c5-7c275fb4606a">4,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTAtMi0xLTEtNTMzNTU_60f5af3c-052e-471d-b7c5-d8f688fd7725">73,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTAtNC0xLTEtNTMzNTU_573a2be7-341a-4945-a1b1-d12886cfa268">72,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTItMi0xLTEtNTMzNTU_d7ed667b-7af2-4890-ae70-7feeb6c9df55">27,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTItNC0xLTEtNTMzNTU_293173c1-d325-46c2-93d2-981e51d4176b">28,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTMtMi0xLTEtNTMzNTU_3a0a283c-f452-4144-9b78-3789ffec30e6">36,389</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTMtNC0xLTEtNTMzNTU_09170b64-816c-4aed-8fcd-16b99c348bdd">37,119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTQtMi0xLTEtNTMzNTU_43d2792b-c927-4ee2-b912-fb462242937c">3,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTQtNC0xLTEtNTMzNTU_68b0e367-3a0a-4785-9cfd-c2dcafd35b9c">3,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTUtMi0xLTEtNTMzNTU_009f180d-da14-49fa-8b9d-235190bcb856">24,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTUtNC0xLTEtNTMzNTU_8a46c399-2ad7-4861-93c5-f29dbc8499cf">27,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTYtMi0xLTEtNTMzNTU_cc15951c-747a-4c38-bf53-0e1e03ac6958">106,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTYtNC0xLTEtNTMzNTU_c1ab8ca6-d256-4ea8-931f-1f77cd1ef9e4">106,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTctMi0xLTEtNTMzNTU_a4c818e9-33da-42bc-94e5-9348bccb47ae">271,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTctNC0xLTEtNTMzNTU_5da018f4-26f2-4d61-9c1a-236220e6568e">275,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjAtMi0xLTEtNTMzNTU_bbfcd97d-6114-4ee2-bcf9-01e63ff548d5">12,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjAtNC0xLTEtNTMzNTU_61571711-916c-49ea-9d2e-59afc39a9edd">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjEtMi0xLTEtNTMzNTU_ac446e97-a789-4ef5-88f6-085381cfdef9">7,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjEtNC0xLTEtNTMzNTU_e2a2527f-f9c3-45b8-bafc-8db5430f48c2">4,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjItMi0xLTEtNTMzNTU_c64c47e0-7077-4bc0-83d4-f910b1f0317b">3,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjItNC0xLTEtNTMzNTU_f44a55c5-9249-4936-8e78-0613900c8115">3,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt 0 19pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjMtMi0xLTEtNTQyNjI_01060e84-42d0-47d1-98ec-a0aa9c555ba6">12,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjMtNC0xLTEtNTQyNjI_93fc477d-1112-471f-9e05-1f0c5ef70b4f">11,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant income, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 19pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:DeferredGrantRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjQtMi0xLTEtNTMzNTU_8f565241-cb45-4dbc-a2e1-d0fbf70a8229">3,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:DeferredGrantRevenueCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjQtNC0xLTEtNTMzNTU_53c54be8-c986-4af3-a991-7d66084614a8">3,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjUtMi0xLTEtNTM4Nzg_e0a15c53-2aef-4bf5-84d6-745a27472443">7,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjUtNC0xLTEtNTM4Nzg_14d0d84f-09a4-4242-9d3e-24dc35a59c66">8,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances under revolving credit agreement, current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjYtMi0xLTEtNTM4Nzg_14ae1987-5a04-4245-9a69-0c53f1fb6f32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjYtNC0xLTEtNTM4Nzg_5e5a6638-442f-4c22-b3ba-f3115b982e07">6,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjYtMi0xLTEtNTMzNTU_0ce610e8-1452-4d13-a271-a5446ac2f87c">47,173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjYtNC0xLTEtNTMzNTU_9cffff07-115c-4558-946c-3d655b6ff11d">49,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridge loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjgtMi0xLTEtNjk4MzQ_28f2a956-7dfd-4730-aec5-fd132fa5aa1e">35,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjgtNC0xLTEtNjk4MzQ_4a130cf8-492b-42d6-ab4b-99613a059ce0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible notes, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:ConvertibleLongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjktMi0xLTEtNjQ2ODI_13b2ef12-f2eb-4d0c-b6fe-572ac93657ac">54,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:ConvertibleLongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjktNC0xLTEtNjQ2ODI_4b2f83d9-612a-4d89-a2e3-9f5ae2f1edbc">54,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjctMi0xLTEtNTMzNTU_caea2f8d-60f0-4991-a8f4-11527a7cee29">10,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjctNC0xLTEtNTMzNTU_4d109aa4-9afd-4f5f-8c0c-cacaf47bcb36">10,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjktMi0xLTEtNTMzNTU_90c0252d-3b8f-4c7b-be75-582b526cbfa3">3,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjktNC0xLTEtNTMzNTU_3fb28373-2b91-4b9e-bac6-cb86b6b968ed">4,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzAtMi0xLTEtNTMzNTU_d2d092f8-bcd8-4628-b10b-1f3143218de9">36,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzAtNC0xLTEtNTMzNTU_4ef367fe-3b6c-4859-9d8c-81ad8ec3e3ee">37,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, non-current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzEtMi0xLTEtNTMzNTU_8ffb6c53-aaac-4dd1-81d9-aa465e49e285">5,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzEtNC0xLTEtNTMzNTU_0c224988-4e8d-4488-977a-db35480e38ac">5,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant income, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:DeferredGrantRevenueNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzItMi0xLTEtNTMzNTU_9133fed0-a5ba-42d0-9e27-bce8c31e5ca2">17,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:DeferredGrantRevenueNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzItNC0xLTEtNTMzNTU_4f0c5188-97ed-4955-a275-f32046a3d4f2">18,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Obligation for Series B Preferred Stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:StockRepurchaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzUtMi0xLTEtNzE3MDk_c248df7a-0c1d-4676-9a35-76726b92c674">37,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:StockRepurchaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzUtNC0xLTEtNzE3MDk_af20bbd9-5eca-45ed-b483-fefe74bbaeae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzMtMi0xLTEtNTMzNTU_e5d9490a-1c8d-4efc-9468-4a9bfe5b75d6">1,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzMtNC0xLTEtNTMzNTU_0d069cd3-bb49-4ea4-abfb-ef1bc01b58c6">882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzQtMi0xLTEtNTMzNTU_dec6eb04-cdc3-47d3-bdfa-2791c6b14a10">249,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzQtNC0xLTEtNTMzNTU_39796a92-cad7-44b6-8ad7-968f257effa0">180,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzUtMi0xLTEtNTMzNTU_a68864a4-876c-47b9-87df-51faa9b23e94"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzUtNC0xLTEtNTMzNTU_270bfdd7-f8c0-4c8b-b773-bf36e22cc9f1"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M18yMQ_2a9a81de-9b1e-4e9c-81db-a54091470adc"><ix:nonFraction unitRef="usdPerShare" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M18yMQ_602d5241-76fa-451e-8122-ad57c581b4e3">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M18zNQ_2fb81257-fbea-4290-bf52-58d307d0a386"><ix:nonFraction unitRef="shares" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M18zNQ_bbbfdfdf-2fb7-4c41-8c75-2b4978b620b3">10,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M181Nw_4d3ff3f0-a598-44d9-a1dd-28e1fb96690f"><ix:nonFraction unitRef="shares" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M181Nw_940a6441-c03a-4a88-bfa3-24d889d88d1d"><ix:nonFraction unitRef="shares" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M181Nw_b00c5ed2-67be-4c0e-bc3d-fcc61a01ac8b"><ix:nonFraction unitRef="shares" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M181Nw_cd419518-91f9-40be-8746-146097d345e5">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at either March&#160;31, 2022 or December 31, 2021</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMi0xLTEtNTMzNTU_41b9179e-c064-4731-b8fc-05d59307fef9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctNC0xLTEtNTMzNTU_fd4a73c6-c6a6-45cf-a781-9026d61348a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock: $<ix:nonFraction unitRef="usdPerShare" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl8xOA_679f6b3a-2c9f-430e-8411-53e9c6ae52b3"><ix:nonFraction unitRef="usdPerShare" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl8xOA_e827f0c4-e8ee-4d1c-8364-260bfcd9bf14">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl8zMg_1d65f7c1-c0b9-42b1-adbb-2e07200a9cb2"><ix:nonFraction unitRef="shares" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl8zMg_2949ee37-8cb5-4728-af66-b366ecb502a5">200,000</ix:nonFraction></ix:nonFraction> shares authorized at March&#160;31, 2022 and December&#160;31, 2021; <ix:nonFraction unitRef="shares" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl84Mg_020383e5-fda4-4e81-9909-076958f26e02"><ix:nonFraction unitRef="shares" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl84Mg_1d64a7c4-14d6-4e2b-9fb7-94088c588721">77,199</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl84OQ_a354d478-18af-48a2-a910-b0ca1d788417"><ix:nonFraction unitRef="shares" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl84OQ_d459342b-3731-43b0-b237-bae0f8b1a8e5">76,919</ix:nonFraction></ix:nonFraction> shares issued and outstanding at March&#160;31, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMi0xLTEtNTMzNTU_166ec526-5a7b-4206-bb8d-4c24e7b1ffac">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtNC0xLTEtNTMzNTU_4ca0dc6b-6e98-483c-bc0e-3ea986dafbdb">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzktMi0xLTEtNTMzNTU_bc5fb6e9-3c05-489f-bec9-3b7aa0b3c7bb">835,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzktNC0xLTEtNTMzNTU_3d41b3e8-a8db-4a9d-b046-208aa84fedae">831,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDAtMi0xLTEtNTMzNTU_ab53a020-9f03-447b-b541-9f6ba9f8f0be">1,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDAtNC0xLTEtNTMzNTU_a182b23c-1a6e-467e-860f-0b20ec9fada1">907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDEtMi0xLTEtNTMzNTU_169e8215-4df0-4222-9c4c-4f1fa6983b2d">812,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDEtNC0xLTEtNTMzNTU_c89c1c35-ede2-4708-9538-73938f449933">735,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDItMi0xLTEtNTMzNTU_b6f2be07-1588-4fe9-ba5e-0feae0e7553a">22,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDItNC0xLTEtNTMzNTU_6479f00f-60d9-40ea-b00d-60dac5b69118">94,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDMtMi0xLTEtNTMzNTU_b6078411-f6b0-4977-a731-399c57636bc8">271,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDMtNC0xLTEtNTMzNTU_f4db8ba0-8098-4520-87e2-8736c685dc70">275,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STANDARD BIOTOOLS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(formerly known as FLUIDIGM CORPORATION)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i464bfcf84ef44fa0b0e68af70cc3988f_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMy0xLTEtMS01MzM1NQ_0101f40a-0511-45fc-8d39-68046d6369dc">20,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab920cccfecf44528e9ce52d935fa63a_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMy0zLTEtMS01MzM1NQ_81107398-991a-42b4-b104-54676523ac23">24,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96de28bb25374cbaa71d471a786e1db3_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNC0xLTEtMS01MzM1NQ_f8a274b2-bd3f-4c41-8fe2-9387b2ad315c">6,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6c770a450054cda9c777968afb1bca3_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNC0zLTEtMS01MzM1NQ_3cef8098-7a39-48a6-8b84-e37481c00777">6,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a25af0ec36e425db27350cae34291e2_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNS0xLTEtMS01MzM1NQ_d64fa7a4-3018-4885-90f6-1c692640741f">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50ef3b1943a5459d80af3119e547f1cc_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNS0zLTEtMS01MzM1NQ_1d4853c4-8034-452c-a3b3-a7e4be03d908">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f969efefbfa43cab57d0b0dbba8b692_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNi0xLTEtMS01MzM1NQ_225947fa-10c8-4b24-b27d-8b78dfc257db">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37fe6c7bd98449ef8909d4137b4673a2_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNi0zLTEtMS01MzM1NQ_fc1db5c2-0a35-484b-b1a7-90d6df197d6d">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNy0xLTEtMS01MzM1NQ_b8f78f4a-af95-4d0c-8e9a-af7cacd9bc54">26,504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNy0zLTEtMS01MzM1NQ_ffd2b899-cc90-44f7-b093-a510d7cf3ab5">32,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i464bfcf84ef44fa0b0e68af70cc3988f_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfOS0xLTEtMS01MzM1NQ_bc17701a-11a8-47be-9802-fa3f9158e2b9">12,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab920cccfecf44528e9ce52d935fa63a_D20210101-20210331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfOS0zLTEtMS01MzM1NQ_65bcbf6c-a005-4239-a8e0-a1c834006b46">11,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96de28bb25374cbaa71d471a786e1db3_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTAtMS0xLTEtNTMzNTU_371beb6e-3156-467f-89de-0473b81f30bd">1,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6c770a450054cda9c777968afb1bca3_D20210101-20210331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTAtMy0xLTEtNTMzNTU_996c5d00-f174-46b7-9c15-f3819d07c676">2,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTEtMS0xLTEtNTMzNTU_b0d2d151-0de3-4d2f-a765-b3bf26c933ad">8,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTEtMy0xLTEtNTMzNTU_b3b606cf-4a34-4abf-b0f6-c44a140af6b5">10,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTItMS0xLTEtNTMzNTU_7caead2d-bb09-4b86-80a6-b5450660cf79">30,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTItMy0xLTEtNTMzNTU_19a78c6f-d0e1-421b-a7d0-71610b21c79c">27,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTMtMS0xLTEtNTMzNTU_c3a6473a-8c91-4407-924f-e908db63fa29">54,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTMtMy0xLTEtNTMzNTU_e3e53020-bf71-4a43-97b6-83b586e23fbd">52,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTQtMS0xLTEtNTMzNTU_0c0bff42-a7e2-46b4-8dce-1804979a4b62">27,503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTQtMy0xLTEtNTMzNTU_a1ccdf85-3db0-46cb-8102-e845536e4215">19,320</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTUtMS0xLTEtNTMzNTU_0a5caf12-0827-4d67-abc6-db6923c3039e">1,030</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTUtMy0xLTEtNTMzNTU_38e7bdcc-2f71-4466-a1de-482faee082c5">887</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on forward sale of Series B Preferred Stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67531e388c0e40cdb02f90448ebfc132_D20220101-20220331" decimals="-3" name="fldm:LossOnForwardSaleOfStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTYtMS0xLTEtNjk4ODI_6c385e16-00e1-43c8-a667-37c2680fae5b">37,792</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e22c724c524303bf88f4ed321cc50d_D20210101-20210331" decimals="-3" name="fldm:LossOnForwardSaleOfStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTYtMy0xLTEtNjk4ODI_81895315-6dc0-499a-8595-cf9593d0ed6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on bridge loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTYtMS0xLTEtNTMzNTU_3d371e39-bc89-4d33-b6bd-42cf3fd477f6">10,655</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:DebtSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTYtMy0xLTEtNTMzNTU_cd00f9c3-8ccb-4849-b087-8306204bcbd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTctMS0xLTEtNTMzNTU_9ffb1855-8eb7-4c58-8d20-37c69d681e0f">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTctMy0xLTEtNTMzNTU_fbf0071f-7f32-46fd-b163-1e9a967725c6">285</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTgtMS0xLTEtNTMzNTU_bfbd386b-dc40-48b1-bdb5-abbdcff68b34">76,862</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTgtMy0xLTEtNTMzNTU_6e234df0-2459-4ac7-9f1d-33a83e6d91fb">20,492</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTktMS0xLTEtNTMzNTU_e0dcaf5b-27c2-408d-acba-17c9b2609da3">574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTktMy0xLTEtNTMzNTU_1c1d48f1-3716-4798-bf1d-0c65998fd6aa">1,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjAtMS0xLTEtNTMzNTU_9b63fcfc-0056-42b0-a6fa-1c0ef58816f4">76,288</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjAtMy0xLTEtNTMzNTU_d2bd70b1-b34a-46d0-8862-59461e71b377">18,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjEtMS0xLTEtNTMzNTU_7fdd9ad7-09f6-4a1f-a2b8-47decff4de7a"><ix:nonFraction unitRef="usdPerShare" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjEtMS0xLTEtNTMzNTU_a4cfe893-1cf9-4f65-bdda-30291909f1b8">0.99</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjEtMy0xLTEtNTMzNTU_0e5533db-0678-4cbe-97bb-baf0f6f0f0d7"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjEtMy0xLTEtNTMzNTU_1d459f6b-d79b-43a9-9664-ad82f28c3002">0.25</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing net loss per share, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjItMS0xLTEtNTMzNTU_8aa31e36-b66d-4c67-9948-418ff911cb14"><ix:nonFraction unitRef="shares" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjItMS0xLTEtNTMzNTU_f3b84bbe-18f9-4dcf-a372-af9637db6322">77,031</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjItMy0xLTEtNTMzNTU_e39ad405-a36c-493f-bced-789fba8fe2bc"><ix:nonFraction unitRef="shares" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjItMy0xLTEtNTMzNTU_eac785e3-a9ff-4551-85bd-294556458c4b">74,707</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STANDARD BIOTOOLS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(formerly known as FLUIDIGM CORPORATION)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.268%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMi9mcmFnOjYyN2VkNjk2OTJiYTQyMmFiMzlkNWFjY2Q2NTBjNDRlL3RhYmxlOmIzMmZhNGM5NWJkMDQ3MWE5ZTc1MzY1NjViNGQ4ZjJiL3RhYmxlcmFuZ2U6YjMyZmE0Yzk1YmQwNDcxYTllNzUzNjU2NWI0ZDhmMmJfMi0xLTEtMS01MzM1NQ_99fe2176-8447-4e5e-b6dd-7bf4044b0eda">76,288</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMi9mcmFnOjYyN2VkNjk2OTJiYTQyMmFiMzlkNWFjY2Q2NTBjNDRlL3RhYmxlOmIzMmZhNGM5NWJkMDQ3MWE5ZTc1MzY1NjViNGQ4ZjJiL3RhYmxlcmFuZ2U6YjMyZmE0Yzk1YmQwNDcxYTllNzUzNjU2NWI0ZDhmMmJfMi0zLTEtMS01MzM1NQ_ede6a6a6-069b-46d9-8954-5afc40e17d95">18,821</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMi9mcmFnOjYyN2VkNjk2OTJiYTQyMmFiMzlkNWFjY2Q2NTBjNDRlL3RhYmxlOmIzMmZhNGM5NWJkMDQ3MWE5ZTc1MzY1NjViNGQ4ZjJiL3RhYmxlcmFuZ2U6YjMyZmE0Yzk1YmQwNDcxYTllNzUzNjU2NWI0ZDhmMmJfNC0xLTEtMS01MzM1NQ_c44ac59f-fcf5-4235-b57d-ed825b067b72">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMi9mcmFnOjYyN2VkNjk2OTJiYTQyMmFiMzlkNWFjY2Q2NTBjNDRlL3RhYmxlOmIzMmZhNGM5NWJkMDQ3MWE5ZTc1MzY1NjViNGQ4ZjJiL3RhYmxlcmFuZ2U6YjMyZmE0Yzk1YmQwNDcxYTllNzUzNjU2NWI0ZDhmMmJfNC0zLTEtMS01MzM1NQ_df716eb2-7ea3-493c-b2b6-b4ed8cf4dd64">443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMi9mcmFnOjYyN2VkNjk2OTJiYTQyMmFiMzlkNWFjY2Q2NTBjNDRlL3RhYmxlOmIzMmZhNGM5NWJkMDQ3MWE5ZTc1MzY1NjViNGQ4ZjJiL3RhYmxlcmFuZ2U6YjMyZmE0Yzk1YmQwNDcxYTllNzUzNjU2NWI0ZDhmMmJfNy0xLTEtMS01MzM1NQ_18a04ceb-aa85-4d91-b9f2-d18e97615433">76,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMi9mcmFnOjYyN2VkNjk2OTJiYTQyMmFiMzlkNWFjY2Q2NTBjNDRlL3RhYmxlOmIzMmZhNGM5NWJkMDQ3MWE5ZTc1MzY1NjViNGQ4ZjJiL3RhYmxlcmFuZ2U6YjMyZmE0Yzk1YmQwNDcxYTllNzUzNjU2NWI0ZDhmMmJfNy0zLTEtMS01MzM1NQ_5fc571da-2c8c-499b-9344-5841bbe6d550">19,264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STANDARD BIOTOOLS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(formerly known as FLUIDIGM CORPORATION)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.434%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.560%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.966%"></td><td style="width:0.1%"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.2pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife53191c83774d009455b6219ab8d213_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMi0yLTEtMS01MzM1NQ_672070ce-159f-4441-b984-bca7ca1952a2">76,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife53191c83774d009455b6219ab8d213_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMi00LTEtMS01MzM1NQ_53f11ad0-2eb4-4d19-afc7-1db311298990">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id512bd02ff5c466b83c1a85dc87fe1ef_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMi02LTEtMS01MzM1NQ_55e53f5a-8fad-4bdd-8f48-4620793cfe73">831,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3062eea440bb4b8abee952bb6d8f666f_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMi04LTEtMS01MzM1NQ_1f1b0413-d48e-448a-a73d-ed0e1f74e573">907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia01ee6541d314637a0cf139b7a3517a8_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMi0xMC0xLTEtNTMzNTU_233466b4-9e55-4f73-9c31-3f5c454e178d">735,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMi0xMi0xLTEtNTMzNTU_e3504f71-4381-4bce-a255-14a230dbc132">94,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of shares withheld for taxes, and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ee876a5d6724fc3baf62a71ac362565_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMy0yLTEtMS01MzM1NQ_b86792fa-2c7e-4892-bd30-1b203e04b0f6">280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3160813ed6ea47239b8b14f10a6a132f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMy02LTEtMS01MzM1NQ_24d3b8dc-a61e-4fa3-b51c-b5ed40d4a6db">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMy0xMi0xLTEtNTMzNTU_ebcd1b53-837b-401b-b474-9c39d315ddb9">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3160813ed6ea47239b8b14f10a6a132f_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfNS02LTEtMS01MzM1NQ_77ec8587-0af8-45cf-9c1b-b20d88e6d158">4,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfNS0xMi0xLTEtNTMzNTU_babf39c4-9a37-40d6-965c-ae8c8d7e5072">4,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i743f2be8661c4d49bf0e11f2fd7672c6_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfNi0xMC0xLTEtNTMzNTU_040055ec-a2fa-4431-a942-b51bd012f03b">76,288</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfNi0xMi0xLTEtNTMzNTU_61c66ad6-6b47-4b07-a7da-ff4bb4d77969">76,288</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief97f0f005454a3ebb73d10c8a6fc288_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfNy04LTEtMS01MzM1NQ_98383a40-43c6-4bc0-b2fd-6faa10e05506">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfNy0xMi0xLTEtNTMzNTU_9c028da8-085d-4ca1-8615-39b0a7727621">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic3d0b28316714637ae16364f010efcb3_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfOC0yLTEtMS01MzM1NQ_05fef2f7-af63-495d-a96d-7aa2a62e3a32">77,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3d0b28316714637ae16364f010efcb3_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfOC00LTEtMS01MzM1NQ_8eb8b36b-d478-481e-9794-7a867b3c2ed1">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671f9af2f29c4f1f929a61c12aba4b42_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfOC02LTEtMS01MzM1NQ_775e589e-a65b-4e89-9e06-f54911d9bbd1">835,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieaeae6add4f148cd8e2a749b602bcc59_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfOC04LTEtMS01MzM1NQ_201dd665-977c-44b4-9046-35668b1805e2">1,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7108a12ba20140bf8ddbbf0bd06e0086_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfOC0xMC0xLTEtNTMzNTU_ac767018-5ef8-40e8-badc-1ac487e00100">812,286</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfOC0xMi0xLTEtNTMzNTU_3e494922-f64e-4a49-b171-2494e1a3b1f5">22,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.2pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7edfc49d39cd47138bdc5064597c073b_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjgtMi0xLTEtNTQxMTk_6792f3ba-0016-46c4-aa22-8be5a212f740">74,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7edfc49d39cd47138bdc5064597c073b_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjgtNC0xLTEtNTQxMTk_690060e5-2c04-4ddf-b538-b03c5cc6f176">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id77c72e5a5f841e093b9ab6998fcfc1f_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjgtNi0xLTEtNTQxMTk_e9866cf8-1a52-4a15-9dad-5cb97bcdf72c">815,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87fc908e2306474ca6061592bbd313c0_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjgtOC0xLTEtNTQxMTk_a37c4d55-6fb3-4893-8aaa-08a351546307">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if4e40eb27af64de29a8412568ad4b140_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjgtMTAtMS0xLTU0MTE5_49ef7259-c4e2-438d-b6e9-a3eb9e9177ea">676,761</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id803a63fc74c495aa4dd5311fbcac8b6_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjgtMTItMS0xLTU0MTE5_06516b9e-dd42-4a6e-8bc8-4088cec25eaf">139,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of shares withheld for taxes, and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i569592ee5f454ea69635943e7f236859_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjktMi0xLTEtNTQxMTk_91a15c4f-e3c7-481f-a64b-3502c6a4fb0d">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e3525e6da4a471bbb0a4a59a5d15773_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjktNi0xLTEtNTQxMTk_a702d9df-a90b-42d4-8960-2fff82095465">525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjktMTItMS0xLTU0MTE5_7f5075f0-c9c7-4580-abda-12277afdf4bb">525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3525e6da4a471bbb0a4a59a5d15773_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzEtNi0xLTEtNTQxMTk_6a011026-dae7-45c4-b021-36be63160ef5">3,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzEtMTItMS0xLTU0MTE5_f9215cdb-af16-48c1-919b-2c05bd19d586">3,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic26f34b391524936ad12d32af015e7a6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzItMTAtMS0xLTU0MTE5_8446d1ed-2bce-4174-af5b-bbd620682c95">18,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzItMTItMS0xLTU0MTE5_3b5e8368-09d4-4d62-bc74-f565dbe8297c">18,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss, net of tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic05a8c6dfa64446bad2c73b3c7882945_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzMtOC0xLTEtNTQxMTk_853557db-2bc0-49a8-85d1-d48a4c3aa12d">443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzMtMTItMS0xLTU0MTE5_842153be-d697-4a2a-8396-c953aaecfd1f">443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47472db137014a838484b58ca7ec54b1_I20210331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzQtMi0xLTEtNTQxMTk_4db958eb-4594-457f-8332-66c51a74892b">74,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47472db137014a838484b58ca7ec54b1_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzQtNC0xLTEtNTQxMTk_9055e11b-5123-4475-abf5-50d24b12bffc">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdac09bb73da4bc698146a2f6d7842a5_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzQtNi0xLTEtNTQxMTk_01a13126-8a36-4d06-b23f-796987dd467d">818,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6cd95ac79ec64220ae66aaf7e20ff229_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzQtOC0xLTEtNTQxMTk_eade47ef-5140-4881-9d17-21e16111a59c">331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28b9b63dddca4cf59ed8ad13d8b810aa_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzQtMTAtMS0xLTU0MTE5_eb081cbb-c130-4479-a101-01fefc527666">695,582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id618e4076c984ee2b69327451b1b9e70_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzQtMTItMS0xLTU0MTE5_caec5b7d-e04c-497e-a8ce-b6f4c16b5db1">122,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STANDARD BIOTOOLS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(formerly known as FLUIDIGM CORPORATION)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMy0yLTEtMS01MzM1NQ_17a8ceb1-56bc-4f81-8e9b-6705547eb3fb">76,288</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMy00LTEtMS01MzM1NQ_18f223c3-6b6b-48b1-b208-83aff39e91a3">18,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loss on forward sale of Series B Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="fldm:LossOnForwardSaleOfStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNS0yLTEtMS02OTk2NQ_98d3be75-2f27-45a2-8f78-75566eceac28">37,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="fldm:LossOnForwardSaleOfStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNS00LTEtMS02OTk2NQ_c54ca4bf-02e3-446a-84cf-46a86f2f4afe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized loss on bridge loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNi0yLTEtMS02OTk2NQ_6d686153-ff2e-4ff9-bec9-b61ac9684130">10,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:DebtSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNi00LTEtMS02OTk2NQ_3d455f0d-0977-40bd-9d41-a9a5f309524d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNS0yLTEtMS01MzM1NQ_f65bd8db-2ff3-44cc-b119-d48a46f44151">4,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNS00LTEtMS01MzM1NQ_05fee469-b37e-453f-858b-c420957fbc2b">3,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of developed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNi0yLTEtMS01MzM1NQ_b60d7e29-2cd1-4e9d-a250-414112f07b7d">2,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNi00LTEtMS01MzM1NQ_cdb5252f-e15b-4102-94f4-6e43d14520e4">2,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationAmortizationAndAccretionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNy0yLTEtMS01MzM1NQ_a28fa57a-2022-4505-9836-5b1f6b8ba0e8">1,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNy00LTEtMS01MzM1NQ_74e2b6f7-f93a-4f9c-9178-7f29146c2997">934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for excess and obsolete inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfOC0yLTEtMS01NDMzMQ_f57492c6-f634-4f5f-8fe0-ae96609b3d48">851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfOC00LTEtMS01NDMzMQ_bf1c1dde-e29b-46ce-92a5-203e49f59a2b">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of debt discounts, premiums and issuance costs </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfOC0yLTEtMS01MzM1NQ_7846ded3-4b30-4410-b293-7ac57c43d0c6">211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfOC00LTEtMS01MzM1NQ_568c08f9-cd89-43e2-baf2-321b95ae3d37">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTQtMi0xLTEtNTMzNTU_a88b7ea2-04d7-40ce-aca6-68b791f757d7">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTQtNC0xLTEtNTMzNTU_43afe1c6-63d9-4619-a20e-467edb93a3cd">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTYtMi0xLTEtNTMzNTU_7c815811-642a-4ecc-8bff-e8e3046b18f1">2,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTYtNC0xLTEtNTMzNTU_6c9806e5-3c4b-4d60-acbc-a608f04afa26">9,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTctMi0xLTEtNTMzNTU_d999175c-0244-4bf3-8ebb-9fd4f31a3028">3,558</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTctNC0xLTEtNTMzNTU_50537e7f-dadd-48bd-a591-33165dcf465b">2,896</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTgtMi0xLTEtNTMzNTU_caf027f2-b9c9-4bbb-ab9e-b409bbf76c93">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTgtNC0xLTEtNTMzNTU_1e24040f-5b52-44a2-b134-1d0d1637d3ad">2,763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTktMi0xLTEtNTMzNTU_700ad20f-303f-4bde-9752-3c005105a399">1,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTktNC0xLTEtNTMzNTU_1e2526d3-2e65-4fb3-a905-b670f6fee8d9">3,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued compensation and related benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjEtMi0xLTEtNTMzNTU_e1fa8a05-6427-42ee-a568-28ca1994ecb5">3,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjEtNC0xLTEtNTMzNTU_5d46a6b5-1b63-4b4a-853b-e502e4470ad7">5,020</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 19pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjItMi0xLTEtNTQzOTk_ae43b29e-bd06-42af-aab7-9e4e3718ead3">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjItNC0xLTEtNTQzOTk_fbaacc43-6dc5-4fa8-b9a1-ae489c2c2415">156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjItMi0xLTEtNTMzNTU_e4204fb9-ddf0-4648-9511-61572651083b">1,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjItNC0xLTEtNTMzNTU_7e6f531d-e64d-4975-98b8-0d757929c377">4,967</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjMtMi0xLTEtNTMzNTU_482b1a44-5ba2-49ce-85c4-4b85e19f1e34">15,590</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjMtNC0xLTEtNTMzNTU_c88f69d0-1fc7-463c-8cfe-7ff547573dce">12,901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from NIH Contract</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="fldm:ProceedsFromResearchAndDevelopmentGrant" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjctMi0xLTEtNTMzNTU_7580c7d1-2dba-46b2-8621-a45425104ffa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="fldm:ProceedsFromResearchAndDevelopmentGrant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjctNC0xLTEtNTMzNTU_5e0f2bfe-0158-4ddb-9733-ba2671609be1">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzAtMi0xLTEtNTMzNTU_68b2972a-de62-47f0-bc5b-973f47ce396d">868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzAtNC0xLTEtNTMzNTU_05400ac8-973e-4439-a79e-bdc65bd2ab9c">6,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzEtMi0xLTEtNTMzNTU_c34c5a0b-1bf7-411a-8a85-39c5041fcdc3">868</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzEtNC0xLTEtNTMzNTU_ce4a7e0b-0e87-4fd0-9c39-8bfcd0f009f5">4,923</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from bridge loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjktMi0xLTEtNjQ2ODg_17a6346a-fbac-4c94-99f6-cae83f918843">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjktNC0xLTEtNjQ2ODg_b43b7736-7ad9-4bb2-b50b-e842f9bbbf4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of advances under credit agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjktMi0xLTEtNjQyNjU_1369a4d6-4b27-45c8-aece-82e4ab285fb2">6,838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjktNC0xLTEtNjQyNjU_d71bfda9-d53c-4c85-a0e1-40bb791b11da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzItMi0xLTEtNjkwOTk_c6bd4b71-e073-4b9e-9cb3-a1e8339781ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzItNC0xLTEtNjkwOTk_acd1e263-d21c-4ebe-9966-5a0e074aa66b">501</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments for taxes related to net share settlement of equity awards and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzgtMi0xLTEtNTMzNTU_edb1ffff-ecc4-4273-9121-5bf5d251d3b9">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzgtNC0xLTEtNTMzNTU_679181ad-78a3-4eaa-a70f-c719cfb88066">525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDItMi0xLTEtNTMzNTU_67bc1e2b-8eb4-445f-8bc7-0e3350bca0b6">18,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDItNC0xLTEtNTMzNTU_ab8e003e-b4be-469e-afd2-ed33f43b2a8c">1,026</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of foreign exchange rate fluctuations on cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDMtMi0xLTEtNTMzNTU_82580248-1b08-4915-99e0-49ead4f87d91">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDMtNC0xLTEtNTMzNTU_aa076e40-9f6a-4e8d-95f3-b7ee7b86d2be">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDQtMi0xLTEtNTMzNTU_9539c778-4cf4-4ed9-89bd-0aac4b84a978">1,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDQtNC0xLTEtNTMzNTU_fc77fd62-b7bb-48bf-aee6-fdb6c74be710">18,776</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDUtMi0xLTEtNTMzNTU_acb33f4f-55ab-4ea3-8039-b0a5135c9ecc">29,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id803a63fc74c495aa4dd5311fbcac8b6_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDUtNC0xLTEtNTMzNTU_1a52c606-4ef6-40b4-94f6-e8e2b0988c21">69,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDYtMi0xLTEtNTMzNTU_7d50ef3a-6926-4a81-b5aa-14e74d8d8fdf">30,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id618e4076c984ee2b69327451b1b9e70_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDYtNC0xLTEtNTMzNTU_d3c26ceb-e23f-4355-8f9e-c79e2aa99d31">50,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosures of cash flow information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDktMi0xLTEtNTMzNTU_1b81b9a0-189e-43c5-ab16-34f900271405">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDktNC0xLTEtNTMzNTU_944eb9e7-97fe-4cdd-a05c-6fe8bcb78785">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash paid for income taxes, net of refunds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNTAtMi0xLTEtNTMzNTU_b8d71798-28a5-45c2-b9d4-12de49539c71">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNTAtNC0xLTEtNTMzNTU_9168be48-77f7-4f28-8c1a-b41be3561318">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-cash right-of-use assets and lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="fldm:NonCashRightOfUseAssetsAndLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNTEtMi0xLTEtNTMzNTU_5e1d18d3-3f4e-4c01-a656-6a3926e35307">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="fldm:NonCashRightOfUseAssetsAndLeaseLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNTEtNC0xLTEtNTMzNTU_14a4fa7a-b87a-456c-8974-0baf77f4e469">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Asset retirement obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="fldm:AssetRetirementObligationsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNTMtMi0xLTEtNTMzNTU_e023fdb8-8e35-4afe-a2da-fe0dd71b7a95">722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="fldm:AssetRetirementObligationsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNTMtNC0xLTEtNTMzNTU_71222623-d11f-46e3-9924-397b29008f74">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STANDARD BIOTOOLS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(formerly known as FLUIDIGM CORPORATION)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2022</span></div><div id="i3f52f78858b0473b983a2153293d04e0_34"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNC9mcmFnOmJlNDMxODJlM2ExZjRkNGQ5OTRkYzczNDhlZDQyMmRkL3RleHRyZWdpb246YmU0MzE4MmUzYTFmNGQ0ZDk5NGRjNzM0OGVkNDIyZGRfODk2_a14828b8-9066-4174-a95f-1703c3035720" continuedAt="i376814c38f3748648d2172867821fdc6" escape="true">Description of Business</ix:nonNumeric></span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i376814c38f3748648d2172867821fdc6" continuedAt="i936a8e68f6a94721b027a92f93b087a4">Standard BioTools Inc. (Standard BioTools, the Company, we, our or us), previously known as Fluidigm Corporation, is driven by a bold vision &#8211; unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, we provide reliable and repeatable insights in health and disease using our proprietary mass cytometry and microfluidics technologies that help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. </ix:continuation></span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i936a8e68f6a94721b027a92f93b087a4">The Company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022, in connection with the completion of the private placement issuance discussed in Note 3. The Company was founded in 1999 and is headquartered in South San Francisco, California.</ix:continuation> </span></div><div id="i3f52f78858b0473b983a2153293d04e0_37"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcxMjQ_d59e8608-5da4-4ea6-835d-080e98512cd7" continuedAt="i3658886831c94234a289c74f7c0f7d6c" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i3658886831c94234a289c74f7c0f7d6c" continuedAt="if386d37227a640aaa2cbc6c2a9a697c1"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcwNjM_db2c8e9c-8c3d-414c-8056-c1d421ac7654" continuedAt="i6d9b298a1ea14613959bb9251a46745a" escape="true"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of March&#160;31, 2022, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, Italy, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;text-indent:18pt"><ix:continuation id="i6d9b298a1ea14613959bb9251a46745a" continuedAt="i3322d759a8de478bb0b48a3b19cbb0de"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the audited financial statements and the related notes for the year ended December&#160;31, 2021 included in our annual report on Form 10-K, filed with the SEC on</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March 8, 2022, we disclosed that we had performed an assessment to determine whether there were conditions or events, considered in the aggregate, that raised substantial doubt about our ability to continue as a going concern for at least the twelve-month period following the date the financial statements were issued. We believed that our then-current level of cash and cash equivalents, together with committed financing facilities, were not sufficient to fund ongoing operations for at least the twelve-month period after the financial statements are issued. Since then, we have closed the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-6" name="us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMzg0ODI5MDc3MTcyMA_aab068cd-08a6-42ea-9f44-f04ef82b107f">225</ix:nonFraction> million Series B Preferred Equity Financing, as defined in Note 3, </span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3322d759a8de478bb0b48a3b19cbb0de">that was previously disclosed in Note 18 to our audited financial statements for the year ended December 31, 2021 as contingent on stockholder approval. The completion of this financing has eliminated the doubt about the Company&#8217;s ability to continue as a going concern.</ix:continuation> See Note 3 and Note 17 for further discussion. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcwNjE_760bf02f-a4ab-4207-afee-55a0ba4ea27e" escape="true">Certain prior period amounts in the condensed consolidated financial statements were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders&#8217; equity, total revenue, total costs and expenses, loss from operations or net loss.</ix:nonNumeric></span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Interim Financial Information</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim condensed consolidated financial statements and related disclosures are unaudited, have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the results of operations for the periods presented.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year-end condensed consolidated balance sheet was derived from audited financial statements, but does not include all </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disclosures required by U.S. GAAP. The condensed consolidated results of operations for the three months ended March&#160;31, 2022 are not necessarily indicative of the results to be expected for the full year or for any other year or interim period. The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements and the related notes for the year ended December&#160;31, 2021 included in our annual report on Form 10-K, filed with the SEC on March&#160;8, 2022.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if386d37227a640aaa2cbc6c2a9a697c1" continuedAt="i63fae3691cdd4b2ab2ba3a1efc0716ce"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcwMzM_6eccfffa-84c0-421e-8611-3167f8480622" escape="true"><div style="margin-bottom:8pt;margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information, including the unknown impact of COVID-19 and the war in Ukraine. Accounting matters that rely on forecasted financial information included, but were not limited to, our inventory, and related reserves, and the carrying value of goodwill and other long-lived assets and liabilities. Actual results could differ materially from these estimates and could have a material adverse effect on our condensed consolidated financial statements. We also use significant judgment in determining the fair value of financial instruments, including the Bridge Loans, forward contracts on Series B Preferred Stock and other debt and equity instruments.</span></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcwOTg_987755de-5d90-46e1-bf8c-eced01fcd3ca" continuedAt="i8dbf0d344a5541198153f58dfbe7a7f7" escape="true">Foreign Currency</ix:nonNumeric></span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8dbf0d344a5541198153f58dfbe7a7f7">Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. Income and expense accounts are translated at monthly average exchange rates during the year. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders&#8217; equity.</ix:continuation> </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Private Placement Issuance </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">See Note 3 for a detailed discussion of the transactions, including the accounting treatment, and additional information.</span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcxMjk_3dec69da-645a-4576-93e5-7d45f7fc5558" escape="true"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Loss </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) generally consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcxMjA_577b9c12-77c3-44d9-b3a1-8c0d522339b5" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The component of accumulated other comprehensive loss, net of tax, for the three months ended March&#160;31, 2022 is as follows (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at December 31, 2021</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26bb80925b7243dd86ac47e3aa792a15_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMS0yLTEtMS01MzM1NQ_5bba66e1-8adc-4bbb-899a-d74235d65ff2">907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6927dcea8afc4590868e910c711eb950_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMS00LTEtMS01MzM1NQ_43d5e1ae-12dd-4639-8aa3-09da425822f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3062eea440bb4b8abee952bb6d8f666f_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMS02LTEtMS01MzM1NQ_50ece547-fbcb-4e87-b21e-8981cd149d2c">907</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32573a3e0127457ab8cd1f21b8706b01_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMi0yLTEtMS01MzM1NQ_7bcca162-c83f-4309-a4d2-206509c8f6bc">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7cbdf74105f4c63acc93bf88685787f_D20220101-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMi00LTEtMS01MzM1NQ_5fdf373d-abd7-4e3b-ae0b-bb1521c9d351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMi02LTEtMS01MzM1NQ_b2117c5d-61ff-49bd-b646-caf595cc5470">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at March 31, 2022</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bf7ca99df7546ac8f6f641356b6669f_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMy0yLTEtMS01MzM1NQ_d9b68cf6-7134-4a9e-a1a6-42a440083b8a">1,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb59364bf80942a7b409ac934e71fc8d_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMy00LTEtMS01MzM1NQ_746c391b-80b6-4461-9c6c-0e41cae5e04e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieaeae6add4f148cd8e2a749b602bcc59_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMy02LTEtMS01MzM1NQ_f5489075-c5e5-469c-a46b-4b8d2d7f2344">1,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcwNzY_52690d15-1bee-4025-81c3-9396b307033c" escape="true"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss per Share </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i63fae3691cdd4b2ab2ba3a1efc0716ce" continuedAt="i95b2a1b3c1f94f8994b66287a0db40c9"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcwNTI_afe1f39d-849a-4100-9635-88126e9887c6" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options, restricted stock units and performance awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4590fb02726433eac6b072086045564_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfMi0yLTEtMS01MzM1NQ_d9abd94b-3f2f-4d54-9f22-9120a46476a5">7,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0922be352f994b20b3f553c5fd67b357_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfMi00LTEtMS01MzM1NQ_11787f76-88f6-450a-99fb-f52178441b77">6,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridge Loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1870e9c226e845e4aed6768f8701a354_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfMy0yLTEtMS02OTU0Mg_5737ee90-f7de-4aeb-9482-9f24792868aa">8,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27af03e024e04f15ba5f16d8c26d2c92_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfMy00LTEtMS02OTU0Mg_86daf7ac-4f04-4e27-89d2-a56de01fc688">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Convertible Preferred Stock Purchase Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6548c4721969408e92076ddc5ec286a8_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNC0yLTEtMS03ODQ3OQ_c6ac96dd-a348-4e67-aaca-d7b628bf22ea">66,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i033e8053b42848b5b5fc39a8d349706c_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNC00LTEtMS03ODQ3OQ_36f35aa3-614b-457a-9afd-606d49b232d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1a5805104194441bb995ef05eee862f_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfMy0yLTEtMS01MzM1NQ_fd26ae0c-fe8f-427a-9543-ae41242d93d2">18,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic2fc67f467ba494384ae37dc00e28c5f_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfMy00LTEtMS01MzM1NQ_4568986f-60e0-4b86-8033-3d70dda6ca7f">18,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Convertible Notes potential make-whole shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02bbc839aff04cb6b76120a51050ad62_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNC0yLTEtMS01MzM1NQ_c9504e7b-30b0-4de5-a38a-cfa765a41348">1,775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib249f81dacbc44039cd73fb307a2440a_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNC00LTEtMS01MzM1NQ_1f61151d-ee6a-4992-8f26-b52981822fe0">1,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i969516905a714099b6f6cbab3a226bb5_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNS0yLTEtMS01MzM1NQ_c00c42c4-a482-41bb-97c1-7b08487256bb">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia023da1bf6d94cddb5bfc0acd240aef6_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNS00LTEtMS01MzM1NQ_01a06216-c250-4292-a370-2ace7e7b600c">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNi0yLTEtMS01MzM1NQ_5942e087-9c38-4cff-ad16-fa1bc038a2b2">103,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNi00LTEtMS01MzM1NQ_f90910d0-dcd1-4b9f-875a-be156b6c897a">27,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Potentially dilutive securities in the above table include the impact of the Bridge Loans and the Series B Convertible Preferred Stock Purchase Agreements, defined in Note 3.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See Note 3 for further discussion.</span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcxMDU_e7dc588a-839d-4267-b3f5-bb2494f498fc" continuedAt="i3b603c2d78f04b8bb9614c7423581af4" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Changes and Accounti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ng Pronouncements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Guidance </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2020, the FASB issued ASU 2020-06 Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. The amendment to this ASU reduces the number of accounting models for convertible instruments and allows more contracts to qualify for equity classification, which is expected to result in more convertible instruments being accounted for as a single unit, rather than being bifurcated between debt and equity. The new guidance is effective for fiscal years beginning after December 15, 2021. The Company adopted ASU 2020-06 effective January 1, 2022. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The adoption of ASU 2020-06 did not have an impact on the Company&#8217;s 2014 and 2019 Convertible Notes.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2021, the FASB issued ASU 2021-10 Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. The amendment is effective for annual periods beginning after December 15, 2021. The amendment establishes financial disclosure requirements for business entities that receive government assistance that the entities account for by analogizing to a grant or contribution model because there is no specific authoritative guidance under U.S. GAAP that applies to the transaction. Entities that receive this type of assistance should include the following information in their annual report: (1) the nature of the transaction, (2) the significant terms and conditions, (3) the accounting treatment, (4) the line items on the balance sheet and income statement that are affected along with (5) the respective amounts that have been recorded. The Company adopted ASU 2021-10 effective January 1, 2022. The adoption of ASU 2021-10 did not have a material impact on the Company&#8217;s financial statements. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3b603c2d78f04b8bb9614c7423581af4"><ix:continuation id="i95b2a1b3c1f94f8994b66287a0db40c9">None</ix:continuation>.</ix:continuation></span></div><div id="i3f52f78858b0473b983a2153293d04e0_2193"></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="fldm:DebtAndEquityIssuanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM18xMjA5NDYyODAyMjQ3Ng_0937c14b-c83f-4831-ad4f-bddb5a5b1a36" continuedAt="i6073fa170b824315a3edc822d555655e" escape="true">Private Placement Issuance</ix:nonNumeric></span></div><ix:continuation id="i6073fa170b824315a3edc822d555655e" continuedAt="i327f7d051d774efead5e60a8e2d8907f"><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Transactions </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 23, 2022, we entered into (i) a Loan Agreement (the Casdin Bridge Loan Agreement) with Casdin Private Growth Equity Fund II, L.P. and Casdin Partners Master Fund, L.P. (collectively, Casdin) and (ii) a Loan Agreement (the Viking Bridge Loan Agreement, and together with the Casdin Bridge Loan Agreement, the Bridge Loan Agreements) with Viking Global Opportunities Illiquid Investments Sub-Master LP and Viking Global Opportunities Drawdown (Aggregator) LP (collectively, Viking and, together with Casdin, the Purchasers and each, a Purchaser). Each Bridge Loan Agreement provided for a $<ix:nonFraction unitRef="usd" contextRef="i886c80d6b2014617accd5fb486b0da62_I20220123" decimals="INF" name="fldm:DebtInstrumentFaceAmountPerInstrument" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjAz_b9c2ef5c-b61c-45ef-9138-c355f8bffaea">12.5</ix:nonFraction>&#160;million term loan (the Bridge Loans) to the Company. The Bridge Loans were fully drawn on January 24, 2022. The Bridge Loans automatically converted into Series B Preferred Stock, defined below, upon the completion of the Preferred Equity Financ</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ing, defined below.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also on January 23, 2022, we entered into separate Series B Convertible Preferred Stock Purchase Agreements (the Purchase Agreements) with each of Casdin and Viking pursuant to which at the closing of the transactions contemplated thereby, and on the terms and subject to the conditions set forth therein, including the approval of our stockholders, we issued and sold an aggregate of $<ix:nonFraction unitRef="usd" contextRef="i5a6c6bdfb4274d13b3f7a97a1f9a2bcd_D20220404-20220404" decimals="-6" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjEz_b58b9cb7-0f9a-423e-b710-a21395a2f52a">225</ix:nonFraction> million of convertible preferred stock on April 4, 2022, consisting of: (i) <ix:nonFraction unitRef="shares" contextRef="i56ff172b378c40bfa9fb091517220986_D20220404-20220404" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjIx_b4248fc0-fbda-4d97-9531-0bdbdc26ae09">112,500</ix:nonFraction> shares of the Company&#8217;s Series B-1 Convertible Preferred Stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ifb221a8d5f7b4664a321c4333783b5a8_I20220404" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjI1_08404dca-6c4f-499d-ab48-af4fe4da43f1">0.001</ix:nonFraction> per share (the Series B-1 Preferred Stock), at a purchase </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i327f7d051d774efead5e60a8e2d8907f" continuedAt="i07c748ae90ff4ebca39902aa523336d9"><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ifb221a8d5f7b4664a321c4333783b5a8_I20220404" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjMx_997e62eb-af97-4774-80bc-8860533680c8">1,000</ix:nonFraction> per share to Casdin; and (ii) <ix:nonFraction unitRef="shares" contextRef="ie16dc5fbce7344098cb3d3224ce907b0_D20220404-20220404" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjM1_25c5b8ae-e068-4a8c-b44a-0abcbfc14379">112,500</ix:nonFraction> shares of the Company&#8217;s Series B-2 Convertible Preferred Stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ib2c825e393d44392a0cdda4dde9c896c_I20220404" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjQ0_938cff01-2adf-41ac-8860-c47ad6831765">0.001</ix:nonFraction> per share (the Series B-2 Preferred Stock, and together with the Series B-1 Preferred Stock, the Series B Preferred Stock) at a purchase price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib2c825e393d44392a0cdda4dde9c896c_I20220404" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjQ4_bfdf3dbe-b2ea-427e-9415-6f82d13f465b">1,000</ix:nonFraction> per share to Viking (the Preferred Equity Financing, and together with the issuance of shares of Series B Preferred Stock in connection with the conversion of the Bridge Loans, the Private Placement Issuance). </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, preferences and privileges of the Series B Preferred Stock are set forth in the Series B-1 Certificate of Designations and Series B-2 Certificate of Designations (collectively, the Series B Certificates of Designations), each as defined in the respective Purchase Agreements. The Series B Preferred Stock ranks senior to our common stock with respect to dividend rights, redemption rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. The holders of Series B Preferred Stock are entitled to participate in all dividends declared on our common stock on an as-converted basis, on the terms and subject to the conditions set forth in the Series B </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certificates of Designations.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors (the Board) called a meeting (Special Meeting) to ask our stockholders to consider, vote upon and approve (i) a proposal to amend the Company&#8217;s Eighth Amended and Restated Certificate of Incorporation (the Charter) to, among other things, increase the number of shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ib3c3e7b51c6f444eb205479e022d6700_I20220404" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjUx_e8c18c38-923d-4e9b-81ab-2a16a39a79b3">0.001</ix:nonFraction> per share, that we are authorized to issue from two hundred million (<ix:nonFraction unitRef="shares" contextRef="ic68aad560626482181eb728c71653aff_I20220403" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjU2_50729308-8560-4787-baf6-2e36867755c0">200,000,000</ix:nonFraction>) shares to four hundred million (<ix:nonFraction unitRef="shares" contextRef="ib3c3e7b51c6f444eb205479e022d6700_I20220404" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjYw_308ee6a1-e52e-4543-866d-92e31a7fcc29">400,000,000</ix:nonFraction>) shares and to change the Company&#8217;s name to Standard BioTools Inc. (the Charter Amendment Proposal); (ii) a proposal to approve, in accordance with Nasdaq Listing Rule 5635, the issuance of (A) the Series B-1 Preferred Stock and the Series B-2 Preferred Stock pursuant to the Purchase Agreements, (B) the Series B-1 Preferred Stock and the Series B-2 Preferred Stock issuable pursuant to the terms of the Bridge Loan Agreements and (C) the common stock issuable upon the conversion of the Series B Preferred Stock (the Private Placement Issuance Proposal); and (iii) a proposal to adjourn the Special Meeting if the Special Meeting were convened and a quorum were present, but there were not sufficient votes to approve the Charter Amendment Proposal and the Private Placement Issuance Proposal (the Adjournment Proposal, and, together with the Private Placement Issuance Proposal and the Charter Amendment Proposal, the Stockholder Proposals). Each of the Private Placement Issuance Proposal and Charter Amendment Proposal were conditioned on the approval of the other proposal, and neither proposal would take effect unless both were approved by our stockholders. Our stockholders approved the Charter Amendment Proposal and Private Placement Issuance Proposal on April 1, 2022. The Private Placement Issuance closed on April 4, 2022. The proceeds of the Private Placement Issuance have been and will be used to fund expenses related to the Private Placement Issuance, as well as working capital, general corporate purposes and potential future merger and acquisition opportunities that we may identify from time to time. </span></div><div style="margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bridge Loans</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to their conversion, the Bridge Loans bore interest (i) from and including the effective date of the Bridge Loan Agreements to but excluding March 1, 2022, at <ix:nonFraction unitRef="number" contextRef="i77616e0764104572bb6724b63bf8ab85_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjY0_ff7a0bc5-c511-42d5-aa5f-1361264a5ec8">10</ix:nonFraction>%, (ii) from and including March 1, 2022 to but excluding June 1, 2022, at <ix:nonFraction unitRef="number" contextRef="i2f4791be67494f768846d8731311ee82_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjY3_116d5a35-1c86-4f2b-856b-f3d734bbc304">12</ix:nonFraction>%, (iii) from and including June 1, 2022 to but excluding September 1, 2022, at <ix:nonFraction unitRef="number" contextRef="ib91f694990c84e7b80102a9d2003a94f_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjcx_a61ffeda-5810-472b-b4c9-77fe747b607d">14</ix:nonFraction>%, and (iv) from and including September 1, 2022 and thereafter, at <ix:nonFraction unitRef="number" contextRef="i8289410ad96c48e9a79c0ea4d1093e35_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjc2_1f88b102-7c00-4c45-beca-174a2a852b8d">16</ix:nonFraction>%. Interest accrued daily and was payable in kind by adding the accrued interest to the outstanding principal amount. Unless earlier converted, the outstanding principal amount of the Bridge Loans (inclusive of principal and accrued and unpaid interest) was due and payable in cash on the maturity date.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Bridge Loans automatically converted into Series B Preferred Stock upon the issuance of the shares of Series B Preferred Stock pursuant to the Purchase Agreements, in accordance with the terms of the Bridge Loan Agreements. The Bridge Loans converted into a number of shares of Series B Preferred Stock equal to (i) the then outstanding principal amount of the applicable Bridge Loan (including any interest added to the original principal amount thereof) plus accrued and unpaid interest (together, the Conversion Amount) on the Bridge Loans divided by $<ix:nonFraction unitRef="usd" contextRef="i886c80d6b2014617accd5fb486b0da62_I20220123" decimals="INF" name="fldm:DebtInstrumentConvertibleCalculationToDetermineSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjg2_b485df41-db0d-45f1-bc94-b3f2ef669b79">1,000</ix:nonFraction> multiplied by (ii) the Conversion Price (as defined in the Series B Certificates of Designations) divided by $<ix:nonFraction unitRef="number" contextRef="i886c80d6b2014617accd5fb486b0da62_I20220123" decimals="2" name="fldm:DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMzAw_0ecc4594-25cd-43ec-8683-ae69b42b224c">2.84</ix:nonFraction>. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Series B Preferred Stock had not been approved for issuance by our stockholders, or the Purchase Agreements were terminated, then the Bridge Loans would have become convertible, at each lender&#8217;s option, into common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ibe298cbdde5842d1abc79d95ddf9275c_I20220123" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMzA0_54452627-7737-4687-aaa0-b47250f4f19a">0.001</ix:nonFraction> per share, of the Company at an initial conversion rate of 352.1126 shares of common stock per $1,000 of the Conversion Amount, subject to the cap set forth in the Bridge Loan Agreements. Unless earlier converted, the Bridge Loans, inclusive of principal and accrued and unpaid interest, would have become due and payable in cash on the maturity date. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity date of the Bridge Loans was 91 days after the maturity date of the Term Loan Facility as defined in Note 9. The latest possible maturity date of the Bridge Loans was September 30, 2025. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion rate was subject to customary adjustments as set forth in the Bridge Loan Agreements. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i07c748ae90ff4ebca39902aa523336d9" continuedAt="i6d30d5bfd6d34b46b7b778686c288f65"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM18xMjA5NDYyODAyMjQyMA_3fde1789-3aab-4953-8faf-d6570ef9ebaf" escape="true"><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Bridge Loans is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl8xLTItMS0xLTc1OTM1_19613c2f-1ad1-4d68-9e39-f3212a3ea041">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ed4fcc32994c51a64df27a56bebe58_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl8xLTQtMS0xLTc1OTM1_bb959255-462f-4b3e-b944-8e698d54054e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and unpaid interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331" decimals="-3" name="us-gaap:InterestPayableCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl8yLTItMS0xLTc1OTM1_82f2832b-b3c2-4e69-bca5-4524e0844fa2">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ed4fcc32994c51a64df27a56bebe58_I20211231" decimals="-3" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl8yLTQtMS0xLTc1OTM1_3f07f1a7-54cf-4bbc-843f-7d772a7d1ab0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdfcd99ed0d44886aa6f217791a9b7b2_D20220101-20220331" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl8zLTItMS0xLTc1OTM1_92b020ac-f8e2-4351-a5e0-7168900d0a8b">25,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f98442bfed4b7c9e994c9fd18a4bc3_D20210101-20211231" decimals="-3" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl8zLTQtMS0xLTc1OTM1_f1657939-1a9e-4ffd-97a8-90fd2ba54b49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on Bridge Loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdfcd99ed0d44886aa6f217791a9b7b2_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl80LTItMS0xLTc1OTM1_ed8e4809-eb07-40ac-82fd-999618905b88">10,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f98442bfed4b7c9e994c9fd18a4bc3_D20210101-20211231" decimals="-3" name="us-gaap:DebtSecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl80LTQtMS0xLTc1OTM1_a2a77826-4347-409b-b8e1-98f895e071fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of Bridge Loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl81LTItMS0xLTc1OTM1_9ba819c2-4e1f-4e80-a826-db1b40316543">35,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ed4fcc32994c51a64df27a56bebe58_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl81LTQtMS0xLTc1OTM1_f48d6830-1949-4bf6-b22b-6c71226be24d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Applying the guidance in ASC 825, we elected to record the Bridge Loans at their fair value. The change in fair value of the Bridge Loans from $<ix:nonFraction unitRef="usd" contextRef="i886c80d6b2014617accd5fb486b0da62_I20220123" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgzMTE3_ff36dc8b-9694-4d75-aa41-6a95b103e12d">25.0</ix:nonFraction> million at inception to $<ix:nonFraction unitRef="usd" contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNTEy_7c0f6df6-a551-46c8-a634-79eb311e7103">35.7</ix:nonFraction> million as of March&#160;31, 2022, including the portion attributable to accrued interest, is reflected as a non-operating unrealized loss on the Bridge Loans in the accompanying consolidated statement of operations. In addition, as required under the fair value option, issuance costs associated with the debt of $<ix:nonFraction unitRef="usd" contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM18zODQ4MjkwODMxMTMz_2372fd06-17a8-49f7-abdc-b10e660d98c7">0.2</ix:nonFraction> million were recognized in selling, general and administrative expenses in the first quarter of 2022.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unrealized loss on the Bridge Loans was largely driven by an increase in the price of our common stock from $<ix:nonFraction unitRef="usdPerShare" contextRef="ibe298cbdde5842d1abc79d95ddf9275c_I20220123" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMzQ0_3d7ce022-0d7b-48dd-8d4c-dcf480fb7721">2.84</ix:nonFraction> per share at inception to $<ix:nonFraction unitRef="usdPerShare" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMzUy_da53dc0a-7304-4288-a4c5-ab5100605b6f">3.59</ix:nonFraction> per share as of March&#160;31, 2022, and, to a lesser extent, to the change in value of the various conversion options under the Approval Scenario, discussed below. We employed a probability&#8208;weighted expected return method in our valuation analysis of the Bridge Loans. Specifically, our analysis contemplated two scenarios: 1) our stockholders approve the transaction (Approval Scenario) and 2) our stockholders do not approve the transaction (Disapproval Scenario). To estimate the fair value of the Bridge Loans pursuant to the Approval Scenario, we employed a Monte Carlo Simulation (MCS) analysis based on the underlying Series B Preferred Stock into which the Bridge Loans were convertible. Given the convertibility of the Series B Preferred Stock into cash or our common stock, our MCS analysis simulated the value of the Series B Preferred Stock using a random&#8208;walk process that incorporated the various provisions of the Series B Preferred Stock discussed below.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Series B Convertible Preferred Stock Purchase Agreements</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Purchase Agreements for the issuance of <ix:nonFraction unitRef="shares" contextRef="iedc9287f43ef4070913785190e868b4a_D20220123-20220123" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMzYx_c488a0f4-48f8-4c61-9f32-c34d61d3d1bb">225,000</ix:nonFraction> shares of Series B Preferred Stock for $<ix:nonFraction unitRef="usd" contextRef="i4cc0a83a704c446185dfcd2f538f5b2e_D20220123-20220123" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMzY2_61ec8612-56e3-4a55-8a9a-f4a896551de1">225</ix:nonFraction> million at a future date, have been accounted for as forward sales contracts at fair value in accordance with ASC 480 because the Series B Preferred Stock includes certain contingent redemption features which create an obligation for the Company to repurchase its shares. The fair values of the forward sales contracts were determined using the MCS analysis discussed above. As noted above, given the convertibility of the Series B Preferred Stock into cash or our common stock under several scenarios, the MCS analysis simulated the value of our common stock and the resulting impact on the value of Series B Preferred Stock, given the various provisions discussed below. The fair value of <ix:nonFraction unitRef="shares" contextRef="iedc9287f43ef4070913785190e868b4a_D20220123-20220123" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDM5_6d529e01-af7e-4d7b-a6da-d336adaf51b1">225,000</ix:nonFraction> shares of Series B Preferred Stock was determined to be $<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-5" name="fldm:PreferredStockFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDU5_04a7ab21-6272-41fb-abf2-e60101a24316">262.8</ix:nonFraction> million as of March&#160;31, 2022. The $<ix:nonFraction unitRef="usd" contextRef="i2127000202e94f0988bb0ca0fe40e66b_I20220123" decimals="-5" name="fldm:StockRepurchaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDg2MjAx_9dd2c49a-4353-4547-8dfb-2c17dcb85352">37.8</ix:nonFraction> million difference between the fair value of the Series B Preferred Stock of $<ix:nonFraction unitRef="usd" contextRef="i2127000202e94f0988bb0ca0fe40e66b_I20220123" decimals="-5" name="fldm:PreferredStockFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDQz_852d5015-bcd4-4e56-a57e-27d26c93a966">262.8</ix:nonFraction> million and the par value of $<ix:nonFraction unitRef="usd" contextRef="i4cc0a83a704c446185dfcd2f538f5b2e_D20220123-20220123" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDMw_9e2e0cbb-5219-4c04-a496-4a4eee13c9bd">225</ix:nonFraction> million represents the value of the forward sales contracts and is recorded on the condensed consolidated balance sheet in non-current liabilities, while the change in the fair value of the forward sales contracts is</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in non-operating income in the condensed consolidated statement of operations for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March&#160;31, 2022. The increase in the fair value of the Series B Preferred Stock from January 23, 2022 to March 31, 2022 reflects the increase in the price of our common stock since the inception of the contracts through March 31, 2022, and the value of the various conversion rights and key provisions discussed below.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Certificates of Designations contain several conversion rights and other key provisions described below. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Holder Voluntary Conversion Rights </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock is convertible at the option of the holders thereof at any time into a number of shares of common stock equal to the Conversion Rate (as defined in the Series B Certificates of Designations), which is initially <ix:nonFraction unitRef="number" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="INF" name="us-gaap:PreferredStockConvertibleConversionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDc0_f542136f-6f4a-456d-9e37-1082c0a9092a">294.1176</ix:nonFraction> shares of common stock per share of Series B Preferred Stock, in each case subject to certain adjustments and certain limitations on conversion. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuer Call Provision</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any time after the fifth anniversary of the closing of the Private Placement Issuance, if the last reported sale price of the common stock is greater than <ix:nonFraction unitRef="number" contextRef="i67531e388c0e40cdb02f90448ebfc132_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDg1_3fe2ce94-4908-454f-a840-0d3395b3c1d3">250</ix:nonFraction>% of the Conversion Price (as defined in the Series B Certificates of Designations) as of such time for at least <ix:nonFraction unitRef="d" contextRef="i67531e388c0e40cdb02f90448ebfc132_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM18xMjA5NDYyODAyMjM1NQ_bc283f98-2514-429e-9c0a-4f4f1ee83b58">20</ix:nonFraction> consecutive trading days, we may elect to convert all of the outstanding shares of Series B Preferred Stock into shares of common stock. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6d30d5bfd6d34b46b7b778686c288f65" continuedAt="i0fba335513b2407d9c639a4735905fa2"><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuer Redemption Provision</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the seventh anniversary of the closing of the Private Placement Issuance, subject to certain conditions, we may, at our option, redeem all of the outstanding shares of Series B Preferred Stock at a redemption price per share of Series B Preferred Stock, payable in cash, equal to the Liquidation Preference (as defined in the Series B Certificates of Designations). </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change of Control Provisions</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo certain change of control transactions, each holder of outstanding shares of Series B Preferred Stock will have the option, subject to the holder&#8217;s right to convert all or a portion of the shares of Series B Preferred Stock held by such holder into common stock, to require us to purchase all or a portion of such holder&#8217;s outstanding shares of Series B Preferred Stock that have not been converted into common stock at a purchase price per share of Series B Preferred Stock, payable in cash, equal to the greater of (A) the Liquidation Preference of such share of Series B Preferred Stock, and (B) the amount of cash and/or other assets that such holder would have been entitled to receive if such holder had converted such share of Series B Preferred Stock into common stock immediately prior to the change of control transaction (Change of Control Put).</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a change of control in which we are not expected to be the surviving corporation or if the common stock will no longer be listed on a U.S. national securities exchange, we will have a right to redeem, subject to the holder&#8217;s right to convert into common stock prior to such redemption, all of such holder&#8217;s shares of Series B Preferred Stock, or if a holder exercises the Change of Control Put in part, the remainder of such holder&#8217;s shares of Series B Preferred Stock, at a redemption price per share payable in cash, equal to the greater of (A) the Liquidation Preference of such share of Series B Preferred Stock, and (B) the amount of cash and/or other assets that the holder would have received if such holder had converted such share of Series B Preferred Stock into common stock immediately prior to the change of control transaction. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidation Rights </span></div></ix:continuation><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0fba335513b2407d9c639a4735905fa2">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the Series B Preferred Stock has a liquidation preference equal to the greater of (i) the Liquidation Preference (as defined in the Series B Certificates of Designations, currently $<ix:nonFraction unitRef="usdPerShare" contextRef="ib0ec30bb1300459287d9f22d16790089_I20220331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDcw_0a4a1796-dde6-4f59-8d99-4ff686c0238a">3.40</ix:nonFraction>) and (ii) the amount per share of Series B Preferred Stock that such holder would have received had all holders of Series B Preferred Stock, immediately prior to such voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, converted all shares of Series B Preferred Stock into common stock pursuant to the terms of the Series B Certificates of Designations (without regard to any limitations on conversion contained therein).</ix:continuation> </span></div><div id="i3f52f78858b0473b983a2153293d04e0_40"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfMjc4MA_2581e0c7-1b0a-4845-ae6d-81b582b49634" continuedAt="i0621a453b0fd46cd8cde6b918ffada4d" escape="true">NIH Contract</ix:nonNumeric></span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0621a453b0fd46cd8cde6b918ffada4d" continuedAt="i2ddfa8f667cf4a6b9c59d0da5d3cd148">In 2020, we were awarded the NIH Contract under the RADx program to support the expansion of our production capacity and throughput capabilities for COVID-19 testing with our microfluidics technology. We completed the required milestones in 2021 and received the total NIH Contract value of $<ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-5" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfNjA0NzMxMzk2MTEzMA_3087972f-a2e3-4baf-acfb-bde3a57f23ad">34.0</ix:nonFraction> million. Proceeds from the NIH Contract have been used primarily for capital expenditures to expand production capacity and, to a lesser extent, to offset applicable operating costs. Grant proceeds that exceed the cost of the capital expenditures and expenses that have been and are expected to be incurred are recorded in other non-operating income.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i2ddfa8f667cf4a6b9c59d0da5d3cd148"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfMjc4MQ_e55ce74a-d0cf-4205-adda-42a2abeb614b" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity under the NIH Contract as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts from milestones achieved</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMS0yLTEtMS01MzM1NQ_234f4e52-039c-45f2-85d1-a7e72a220212">34,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMS00LTEtMS01MzM1NQ_dabb5258-73c8-4aea-b14d-e067cfc43bf1">34,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative amounts applied against operating costs (excluding depreciation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMi0yLTEtMS01MzM1NQ_a8022c13-a49c-4365-8cb0-4cc6c65e7979">4,526</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMi00LTEtMS01MzM1NQ_a503763f-d06e-4e7d-9d21-ac7c10a92b88">4,522</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative amounts applied against depreciation expense for assets placed in service</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMy0yLTEtMS01MzM1NQ_b6dcf9ec-4d50-4c0d-b6d1-96719a139866">1,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMy00LTEtMS01MzM1NQ_bac775ec-2288-4b80-a148-96e80ca58749">703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative amounts recognized as non-operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfNC0yLTEtMS01MzM1NQ_9760cf29-cd76-40a2-9d23-3ec52e053c61">7,140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfNC00LTEtMS01MzM1NQ_f856d0f3-9d12-4c85-b33e-d7b8ea9b2107">7,140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:DeferredGrantRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfNS0yLTEtMS01NDkwNg_b41ded73-3437-4216-bf9a-7b0cc750fed4">20,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:DeferredGrantRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfNS00LTEtMS01NDkwNg_960ac113-daa9-4bed-b216-e4c39f441d7a">21,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets placed in service, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfNy0yLTEtMS01MzM1NQ_34739668-bf4d-4de1-bb5a-e638e91a7b8f">20,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfNy00LTEtMS01MzM1NQ_63a28e80-b5b6-4c34-b124-8182a6cdf367">16,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfOC0yLTEtMS01MzM1NQ_8edf502d-5ef1-4318-86ac-cdf2b3ead824">937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfOC00LTEtMS01MzM1NQ_cd7a8617-05cd-4f10-b086-d010dc5b2fd5">3,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative amounts applied against depreciation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfOS0yLTEtMS01MzM1NQ_066df34c-b62e-431a-b80d-fac65eaf5bc7">1,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfOS00LTEtMS01MzM1NQ_b481f602-c5bd-4c41-b3aa-4da20b5c814c">703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTEtMi0xLTEtNTQ5NDA_8971fb18-2edc-43f3-bdd9-66cc330cf7b5">19,852</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTEtNC0xLTEtNTQ5NDA_7a807740-32f4-4cea-9899-c1da5c4ddca4">20,096</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated future capital expenditures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTMtMi0xLTEtNTQ5NDA_d861ade6-fe70-4b93-97ce-6f2232df7d31">988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTMtNC0xLTEtNTQ5NDA_7bd65fe6-b1e1-440b-96c8-c69a90f4ce39">1,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:DeferredGrantRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTQtMi0xLTEtNTQ5NDA_341cd3f0-5dec-4f2d-a3da-792431163de2">20,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:DeferredGrantRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTQtNC0xLTEtNTQ5NDA_bfc60530-fbe5-48fe-9ff9-89a22b97f3e8">21,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant income, current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:DeferredGrantIncomeCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTItMi0xLTEtNTMzNTU_14f218b5-d168-4dc2-a6ad-22a08f0414dc">3,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:DeferredGrantIncomeCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTItNC0xLTEtNTMzNTU_d0ef1480-6584-4f23-a8c4-93369038e262">3,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant income, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:DeferredGrantIncomeNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTMtMi0xLTEtNTMzNTU_1e745691-9b05-408d-91d1-9813884c10c4">17,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:DeferredGrantIncomeNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTMtNC0xLTEtNTMzNTU_1042096d-6276-4759-98fe-9ffe1ab88b91">18,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:DeferredGrantRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTQtMi0xLTEtNTMzNTU_ea8f72e1-2b0c-44ff-9ae7-6380e087aa71">20,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:DeferredGrantRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTQtNC0xLTEtNTMzNTU_915defe0-88c0-4e0a-b97a-6277a632ec70">21,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred grant income, current on the condensed consolidated balance sheet represents amounts expected to be offset against depreciation expense over the next twelve months. Deferred grant income, non-current includes amounts expected to be offset against depreciation expense in later periods. </span></div><div style="margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to spend </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-5" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfMTY0OTI2NzQ0ODQwOA_7d81b745-0a0c-47da-8b97-81b6190cb011">22.4</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on capital expenditures associated with the NIH Contract. We have incurred $<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-5" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfMTY0OTI2NzQ0ODQwMA_87d5d659-2c47-49d8-8148-e66f54462476">21.4</ix:nonFraction> million of capital expenditures th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rough March&#160;31, 2022, of which $<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-5" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfMTY0OTI2NzQ0ODM4MQ_dcad5b56-953b-4093-abfc-271756293d82">20.4</ix:nonFraction> million has been placed in service, while the remaining $<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-5" name="fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfMTY0OTI2NzQ0ODM5MQ_0a9aa288-80e1-4552-bb31-ffbb2307e27d">0.9</ix:nonFraction> million is included in construction-in-progress (See Note 8). We expect to place the remaining equipment in service by the end of the first half of 2022.</span></div></ix:continuation><div id="i3f52f78858b0473b983a2153293d04e0_43"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80My9mcmFnOjhmZGY3ZGZmZDdiOTQ0MTc5MWM5YTcxM2M3MjdlMjg2L3RleHRyZWdpb246OGZkZjdkZmZkN2I5NDQxNzkxYzlhNzEzYzcyN2UyODZfNzIz_8ccdcacd-f535-46f1-87fb-18e5d77e13ac" continuedAt="i28f034781e1b4546a25b3d82ad277512" escape="true">Development Agreement</ix:nonNumeric></span></div><div style="margin-bottom:8pt;text-indent:18pt"><ix:continuation id="i28f034781e1b4546a25b3d82ad277512"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective March 31, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, we signed an OEM Supply and Development Agreement (Development Agreement) with a customer. Under the Development Agreement, we developed products based on our microfluidics technology. The Development Agreement provided for up-front and periodic milestone payments during the development stage, which was completed in the third quarter of 2021, and on-going annual payments of $<ix:nonFraction unitRef="usd" contextRef="ia846fcc54289492ea9f2caf7da738fb2_I20210930" decimals="-5" name="fldm:CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80My9mcmFnOjhmZGY3ZGZmZDdiOTQ0MTc5MWM5YTcxM2M3MjdlMjg2L3RleHRyZWdpb246OGZkZjdkZmZkN2I5NDQxNzkxYzlhNzEzYzcyN2UyODZfNjA0NzMxMzk1NDMyNw_a95b27e0-8830-4dc9-9e99-25ba67857c41">0.4</ix:nonFraction>&#160;million for sustaining efforts. We recognized $<ix:nonFraction unitRef="usd" contextRef="iafdb8ef4ee9b4330a1afed79e1a6adab_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80My9mcmFnOjhmZGY3ZGZmZDdiOTQ0MTc5MWM5YTcxM2M3MjdlMjg2L3RleHRyZWdpb246OGZkZjdkZmZkN2I5NDQxNzkxYzlhNzEzYzcyN2UyODZfNDgw_33986b1a-c008-4df2-bbba-99f898341a15">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3c64b4d5135043b2bf9e4a910f74a574_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80My9mcmFnOjhmZGY3ZGZmZDdiOTQ0MTc5MWM5YTcxM2M3MjdlMjg2L3RleHRyZWdpb246OGZkZjdkZmZkN2I5NDQxNzkxYzlhNzEzYzcyN2UyODZfMTY0OTI2NzQ0MjUyOQ_d00251d2-bbbf-40f2-94c8-97a5699f104a">1.5</ix:nonFraction> million of development revenue from this agreement during the three months ended March&#160;31, 2022 and March&#160;31, 2021, respectively.</span></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_46"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfMTMwOQ_3b5e07cd-7979-4e98-9f2b-95aaf39addb9" continuedAt="ic8019d4f30f64d979526550fb96e9330" escape="true">Revenue</ix:nonNumeric></span></div><ix:continuation id="ic8019d4f30f64d979526550fb96e9330"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfMTMwNg_6818afed-69ef-4f5a-a416-82a738004b87" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our revenue for the three months ended March&#160;31, 2022 and 2021 based upon geographic area and source in thousands:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Markets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f8e6499d1bf4299a4a07cd4f748586b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfMy0xLTEtMS01MzM1NQ_5f00690d-69e0-41fe-b05d-1c1d00a71a0a">12,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286841fd19da443ead3fbf7f94d46b19_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfMy0zLTEtMS01MzM1NQ_004b38dd-6e05-4d8e-b354-0c307a5151ef">18,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i072ebd8279c8453f8cd2f1cb832d29fd_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfNC0xLTEtMS01MzM1NQ_86b60756-311e-4e89-b8de-b0954f066893">8,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87071d29b432475bb23956adf7514f92_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfNC0zLTEtMS01MzM1NQ_51354593-f186-4dbc-9b19-5d28c385e882">9,142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f17be2ff1a047ea95cdaeba288d236a_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfNS0xLTEtMS01MzM1NQ_69f43870-b5c8-47be-913e-71c97b4227e5">4,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24e8ea78bbff495b800d3ede81174994_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfNS0zLTEtMS01MzM1NQ_5844f0e8-2bf0-4464-9001-b8eafa5407e3">5,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfNi0xLTEtMS01MzM1NQ_9108577a-c265-47af-8889-215deb8c9934">26,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfNi0zLTEtMS01MzM1NQ_ab6deab1-4922-489c-a8fc-a832beb1d03b">32,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Source:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a58b69e2fd947c19feffcbbf475f7fb_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNC0xLTEtMS01MzM1NQ_d44bf5dc-ddc3-4005-96ce-44c1508b58d1">7,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5517c1a9f7d46acb4b2910a6e65a460_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNC0zLTEtMS01MzM1NQ_dd39fd10-c231-4327-a93d-bc959fc6a687">7,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e1af6815ea14d86990d3949065312c1_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNS0xLTEtMS01MzM1NQ_7dbb35ad-881f-4418-9e61-957ea2f07488">12,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dbaa6754bf146218a79d666b5fbe97b_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNS0zLTEtMS01MzM1NQ_dceff6f4-0096-409e-8d56-b5b40de2c564">17,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i464bfcf84ef44fa0b0e68af70cc3988f_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNi0xLTEtMS01MzM1NQ_e20140b4-63cc-4e80-aa0c-d744d7c42740">20,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab920cccfecf44528e9ce52d935fa63a_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNi0zLTEtMS01MzM1NQ_da20f0ba-19ed-49f0-8b17-93bb0db59c16">24,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96de28bb25374cbaa71d471a786e1db3_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNy0xLTEtMS01MzM1NQ_4373b148-cfec-41ad-aee0-c1ecc898dcb6">6,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6c770a450054cda9c777968afb1bca3_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNy0zLTEtMS01MzM1NQ_dc4b6eba-c11f-464d-91c7-502adc1f7859">6,286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a25af0ec36e425db27350cae34291e2_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfOC0xLTEtMS01MzM1NQ_6c7de91c-2dc3-4d68-8c60-d2632fb6fc2a">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50ef3b1943a5459d80af3119e547f1cc_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfOC0zLTEtMS01MzM1NQ_b58b0b5f-dd80-4ad9-9f3c-78ff0e6ab107">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;License and royalty revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefe32db1cf564d38b50cdb165fc5cb80_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTAtMS0xLTEtNTMzNTU_b6710110-dec8-4cf1-85cb-fff40f968c45">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0afc35aeae144b7e896655ac0045040f_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTAtMy0xLTEtNTMzNTU_b05dedf9-14d9-462d-a873-7fddcddab08a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd77101528ad4efaa4764f0e88507854_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTEtMS0xLTEtNTMzNTU_c142075b-7a5e-477b-ab1e-6995da8b1fcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d2106e31ca44f2b930bd540e5346338_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTEtMy0xLTEtNTMzNTU_3b240da1-eecf-45dc-8dcf-388039de9871">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f969efefbfa43cab57d0b0dbba8b692_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTItMS0xLTEtNTMzNTU_219edf27-8bea-414e-a093-64ebdab1736d">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37fe6c7bd98449ef8909d4137b4673a2_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTItMy0xLTEtNTMzNTU_77d6d738-e5c8-40a5-9d0b-a8ee5f0118c5">300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTMtMS0xLTEtNTMzNTU_932e5c37-cb20-4d60-8651-b5c559c49984">26,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTMtMy0xLTEtNTMzNTU_4deb165a-c722-48af-8755-7f0a1d21cb8c">32,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unfulfilled Performance Obligations</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reported $<ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfMjEw_081b4b37-d3bb-44e0-b3fa-e11ce067ed34">17.9</ix:nonFraction> million of deferred revenue on our December&#160;31, 2021 consolidated balance sheet. During the three months ended March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfMjg5_d251ac50-0dac-4406-a570-7779cb1fa718">4.1</ix:nonFraction> million of the opening balance was recognized as revenue and $<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-5" name="fldm:ContractWithCustomerLiabilityIncreaseFromCashReceipts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfMzQ1_3db03207-5e23-425d-b144-37f02a3ae8a4">4.3</ix:nonFraction> million of net additional advance payments were received from customers, primarily associated with instrument service contracts. At March&#160;31, 2022, we reported $<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfNDg4_6d3bee36-5588-41ba-baee-bc5b308a1529">18.1</ix:nonFraction>&#160;million of deferred revenue. </span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfMTMwNw_4c903dc5-7815-4eeb-903e-2b4b6ebac149" escape="true"><div style="margin-top:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed as of March&#160;31, 2022 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expected Revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 remainder of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i335933a56ca64d3d94f51a90d798f76c_I20220331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjlhNjdhM2U4ODNkNTRjYjk4NWRkNTM4OTU2MzlkZTJhL3RhYmxlcmFuZ2U6OWE2N2EzZTg4M2Q1NGNiOTg1ZGQ1Mzg5NTYzOWRlMmFfMS0yLTEtMS01MzM1NQ_67f3d950-f82c-48d8-b7a6-c90fc565b0c1">10,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bcb2e193d7c4e4ba7f7c804e5ec66cd_I20220331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjlhNjdhM2U4ODNkNTRjYjk4NWRkNTM4OTU2MzlkZTJhL3RhYmxlcmFuZ2U6OWE2N2EzZTg4M2Q1NGNiOTg1ZGQ1Mzg5NTYzOWRlMmFfMi0yLTEtMS01MzM1NQ_8bb9e701-4b1e-4adc-b602-5f6b800a0627">7,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe253446f1d4da380bb648d1169a573_I20220331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjlhNjdhM2U4ODNkNTRjYjk4NWRkNTM4OTU2MzlkZTJhL3RhYmxlcmFuZ2U6OWE2N2EzZTg4M2Q1NGNiOTg1ZGQ1Mzg5NTYzOWRlMmFfMy0yLTEtMS01MzM1NQ_522ace0e-b3d7-4300-a253-56ba105d2494">3,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48119219acbf471d93f5816373e96a28_I20220331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjlhNjdhM2U4ODNkNTRjYjk4NWRkNTM4OTU2MzlkZTJhL3RhYmxlcmFuZ2U6OWE2N2EzZTg4M2Q1NGNiOTg1ZGQ1Mzg5NTYzOWRlMmFfNC0yLTEtMS01MzM1NQ_83368405-cc7c-46bf-a1be-a0207e9150fd">2,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjlhNjdhM2U4ODNkNTRjYjk4NWRkNTM4OTU2MzlkZTJhL3RhYmxlcmFuZ2U6OWE2N2EzZTg4M2Q1NGNiOTg1ZGQ1Mzg5NTYzOWRlMmFfNS0yLTEtMS01MzM1NQ_b8545828-e10c-447c-85b9-09a0c6f815ae">23,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.</span></div></ix:nonNumeric><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the practical expedient that permits us not to disclose information about unsatisfied performance obligations for service contracts with an expected term of one year or less.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:18pt"><span><br/></span></div><div id="i3f52f78858b0473b983a2153293d04e0_52"></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjAyMg_6a371415-72f6-4fd9-97f7-c1d4be5252dd" continuedAt="i71d127ddb2ea4c618ed096d6bb53af9d" escape="true">Goodwill and Intangible Assets, net</ix:nonNumeric></span></div><ix:continuation id="i71d127ddb2ea4c618ed096d6bb53af9d"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our acquisition of DVS in February 2014, we recognized goodwill of $<ix:nonFraction unitRef="usd" contextRef="i553dcb7ee7ea4ac9a75e92d924b88f3e_I20140228" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMTI3_052b98aa-7cea-4845-afd3-a3f0206bd12c">104.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i830df8f0fc5846878354fcf3361da7fb_D20140201-20140228" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMTQ2_e1de7618-8d86-4a8b-a702-87184d15eaaa">112.0</ix:nonFraction> million of developed technology. In the first quarter of 2020, we recognized $<ix:nonFraction unitRef="usd" contextRef="ib03343990d404ba9a12387dbb99c7af4_I20200331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjUz_9ee7a0ec-ca22-4fd3-b274-572c017aec3b">2.2</ix:nonFraction> million (Euro <ix:nonFraction unitRef="eur" contextRef="ib03343990d404ba9a12387dbb99c7af4_I20200331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjYy_125714ec-dc27-4c3d-b5de-c92a647a0a6a">2.0</ix:nonFraction> million) of goodwill from the InstruNor acquisition and $<ix:nonFraction unitRef="usd" contextRef="i78a77be6f4bb47ae9b4e1a70ef8aba45_D20200101-20200331" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjgy_f19e1ea4-1e3d-4288-b7f6-4d054a03fbef">5.4</ix:nonFraction> million (Euro <ix:nonFraction unitRef="eur" contextRef="i78a77be6f4bb47ae9b4e1a70ef8aba45_D20200101-20200331" decimals="-5" name="us-gaap:FinitelivedIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjkx_e6ec9ffb-d33d-45fc-b3af-323bf85418b9">4.9</ix:nonFraction> million) of developed technology. As the goodwill and developed technology from the InstruNor acquisition are recorded in the functional currency of our European operations, which is the Euro, these balances are revalued each period and the U.S. dollar value of these assets will fluctuate as foreign exchange rates change. We are amortizing InstruNor developed technology over <ix:nonNumeric contextRef="icd0ea5bfa71e4a248571cf351b4fbc02_D20220101-20220331" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMTY0OTI2NzQ0NDU5OQ_4161c267-334f-428f-bb69-f6601bab9083">8</ix:nonNumeric> years.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Qualitative assessment includes assessing significant events and circumstances such as our current results, assumptions regarding future performance, strategic initiatives and overall economic factors, including the ongoing global COVID-19 pandemic and macroeconomic developments to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of our reporting unit or intangible assets is less than their carrying value. If indicators of impairment are identified, a quantitative impairment test is performed.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There have been no indicators of impairment during the three months ended March&#160;31, 2022.</span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjAxMw_7f7f5aac-1d2e-41bc-9b9a-2a6a91a001e7" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets also include other patents and licenses, which are included in other non-current assets. Intangibl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e assets, net, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMi0yLTEtMS01MzM1NQ_88e69133-641a-4132-b314-7925af843a38">117,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMi00LTEtMS01MzM1NQ_2aee1674-cba3-406f-a056-79b9f357e00d">92,517</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMi02LTEtMS01MzM1NQ_efd61c05-dc0f-440d-b3fc-c3a9e8ab9ce2">24,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic3ccc2277618429ba4dd1bf8f8ac9415_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMi04LTEtMS01MzM1NQ_07487f3b-3a48-466a-8462-a7b671ac179a">9.9</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licenses</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMy0yLTEtMS01MzM1NQ_7248b528-61c8-4b37-988d-5010ded3ad95">11,259</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMy00LTEtMS01MzM1NQ_211b7ab5-be5b-4e5a-a8c9-252af7c1aab0">10,171</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMy02LTEtMS01MzM1NQ_09534a26-faee-4cf3-9a6b-b89d29248514">1,088</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4debd5fa9102490ba7555a1193ce7701_D20220101-20220331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMy04LTEtMS01MzM1NQ_11e03150-7fee-4d45-8f77-c17cf5c11ac4">7.0</ix:nonNumeric> years</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.020%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20d31a7327ed4de3a49655170f642acc_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfMy0yLTEtMS01MzM1NQ_3140b93d-244a-48af-b608-79cad77ec4df">117,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20d31a7327ed4de3a49655170f642acc_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfMy00LTEtMS01MzM1NQ_d66024fb-3e77-4733-989a-e6588a398837">89,576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20d31a7327ed4de3a49655170f642acc_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfMy02LTEtMS01MzM1NQ_22409cbc-ea0e-4ac2-ac59-d0c3a2ccd020">27,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6fa8acd9c9d642edad45d44d1963e783_D20210101-20210331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfMy04LTEtMS01MzM1NQ_b36f1d48-5ce3-4784-a2ff-f9aa6e1b1eed">9.9</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licenses</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc22933a248246149e4c0d789e039050_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfNC0yLTEtMS01MzM1NQ_bb9cb650-a4bb-457d-a97a-2218c4c2847c">11,257</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc22933a248246149e4c0d789e039050_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfNC00LTEtMS01MzM1NQ_84632a15-228d-4b2a-81c5-e4d50c724801">10,000</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc22933a248246149e4c0d789e039050_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfNC02LTEtMS01MzM1NQ_5e6b8cd7-7d4c-4cd7-89da-6e079ec050f6">1,257</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3bf82049acf4414db15019056a8b4a4d_D20210101-20210331" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfNC04LTEtMS01MzM1NQ_24d529ee-32bc-4e0e-bf08-bca5e288aab7">7.0</ix:nonNumeric> years</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:7pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization expense for the three months ended March&#160;31, 2022 and 2021 was $<ix:nonFraction unitRef="usd" contextRef="ic3ccc2277618429ba4dd1bf8f8ac9415_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMTc2Mg_9ed23460-5c6e-43b1-bad9-896976f9f884">3.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6fa8acd9c9d642edad45d44d1963e783_D20210101-20210331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMTc3MA_b028e871-05e2-4977-b3dc-2a7f83726511">3.2</ix:nonFraction> million, respectively. </span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjAxNg_974bdd05-d15a-4af1-b1db-66d90c2f6229" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the carrying value of intangible assets as of&#160;March&#160;31, 2022, the amortization expense is expected to be as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Technology Amortization Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patents and Licenses Amortization Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 remainder of the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMS0xLTEtMS01MzM1NQ_3c7307a7-8667-45f8-a015-2b5464c843e4">8,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMS0zLTEtMS01MzM1NQ_f26600c1-af5f-419c-9c17-d5a7fc5b64e0">508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMS01LTEtMS01MzM1NQ_67191475-e8a4-40cf-bedc-f6861e7007f0">9,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMi0xLTEtMS01MzM1NQ_91591982-a29d-4b3d-b7c3-1ca49f316af0">11,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMi0zLTEtMS01MzM1NQ_5d6679c6-000c-4abf-8543-d2f2dcdaf113">572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMi01LTEtMS01MzM1NQ_0e76d79c-2f4e-4597-b0b1-da71be716365">12,446</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMy0xLTEtMS01MzM1NQ_4945bfdc-ba8e-4714-a82c-7b22ed70b59b">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMy0zLTEtMS01MzM1NQ_e6618f06-7023-4a6a-9f56-51a2806f7b1d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMy01LTEtMS01MzM1NQ_5190605e-3f3f-4189-ba5e-e88ae2e0d5f9">2,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNC0xLTEtMS01MzM1NQ_eb7360ed-848a-424b-8598-4d8def06ea10">674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNC0zLTEtMS01MzM1NQ_77af218c-343a-4087-b59d-884f37b7c3ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNC01LTEtMS01MzM1NQ_b9fbeab9-1578-4249-babd-9d4bf2387baa">674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNS0xLTEtMS01MzM1NQ_059a3dfa-cfa1-43d1-b5a2-5392da5b7021">674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNS0zLTEtMS01MzM1NQ_3aa95fda-5fca-418a-ba7b-dd487a85957c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNS01LTEtMS01MzM1NQ_cc95bee7-b37a-45b8-8dff-b75a7b55a12e">674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331" decimals="-3" name="fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNi0xLTEtMS01MzM1NQ_135757d9-dd69-4179-a044-1c5321979384">674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331" decimals="-3" name="fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNi0zLTEtMS01MzM1NQ_bdfd4cca-249c-4620-b631-3eaf8dec22bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNi01LTEtMS01MzM1NQ_faee61db-70a5-4f79-8dc0-17c41c5a5aea">674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNy0xLTEtMS01MzM1NQ_afedbb2c-4a98-4b64-8712-b4e8992b1d0b">24,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNy0zLTEtMS01MzM1NQ_8973c99b-421d-4d6a-91af-e9bc3cd9cf66">1,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNy01LTEtMS01MzM1NQ_1625bc2e-adf8-46d5-9763-f9059153b238">25,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTExNQ_776b39a7-c363-41d8-8870-a8a3f9cf6874" continuedAt="i923f50f0696e4cf0bac28ccc2ca019ea" escape="true">Balance Sheet Details</ix:nonNumeric></span></div><ix:continuation id="i923f50f0696e4cf0bac28ccc2ca019ea" continuedAt="i9271b0fa04484fb6b511778255187684"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash </span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTA5Mw_85037dc6-1be4-4857-8591-294f2f956e4a" escape="true"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTEyMw_00e76941-7e7b-47bf-aeba-86c930ea3d07" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjY0NDg5MmRmYTEwZDQwYWI5ZjNiNTNlYmM1MTYzOTQ3L3RhYmxlcmFuZ2U6NjQ0ODkyZGZhMTBkNDBhYjlmM2I1M2ViYzUxNjM5NDdfMS0yLTEtMS01MzM1NQ_0fa65923-a902-4a2a-88f2-32c26717a47e">29,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjY0NDg5MmRmYTEwZDQwYWI5ZjNiNTNlYmM1MTYzOTQ3L3RhYmxlcmFuZ2U6NjQ0ODkyZGZhMTBkNDBhYjlmM2I1M2ViYzUxNjM5NDdfMS00LTEtMS01MzM1NQ_74bbd9cf-f99d-4279-b214-7b22789c764d">28,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjY0NDg5MmRmYTEwZDQwYWI5ZjNiNTNlYmM1MTYzOTQ3L3RhYmxlcmFuZ2U6NjQ0ODkyZGZhMTBkNDBhYjlmM2I1M2ViYzUxNjM5NDdfMi0yLTEtMS01MzM1NQ_6c1b9048-5047-44da-8cf4-1448a8ae2906">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjY0NDg5MmRmYTEwZDQwYWI5ZjNiNTNlYmM1MTYzOTQ3L3RhYmxlcmFuZ2U6NjQ0ODkyZGZhMTBkNDBhYjlmM2I1M2ViYzUxNjM5NDdfMi00LTEtMS01MzM1NQ_792485c2-6e86-491a-9a95-dd9711e088e3">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjY0NDg5MmRmYTEwZDQwYWI5ZjNiNTNlYmM1MTYzOTQ3L3RhYmxlcmFuZ2U6NjQ0ODkyZGZhMTBkNDBhYjlmM2I1M2ViYzUxNjM5NDdfMy0yLTEtMS01MzM1NQ_abc5b23a-404e-4c6a-baff-62d283edb84a">30,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjY0NDg5MmRmYTEwZDQwYWI5ZjNiNTNlYmM1MTYzOTQ3L3RhYmxlcmFuZ2U6NjQ0ODkyZGZhMTBkNDBhYjlmM2I1M2ViYzUxNjM5NDdfMy00LTEtMS01MzM1NQ_b9d061ef-43bf-4a32-bbf9-0e4eedfeb90b">29,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term restricted cash of approximately $<ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfNjA0NzMxMzk1NTc5MQ_22f5b484-f8a4-445d-9f67-ffed0b10599c"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfNjA0NzMxMzk1NTc5MQ_53b41a96-eefd-4ad2-85a1-2c33016dff71">16</ix:nonFraction></ix:nonFraction>&#160;thousand is included in prepaid expenses and other current assets and $<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-5" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfNjA0NzMxMzk1NTgwMw_13b24f7b-bf31-47de-83fb-94645e9a53e2"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-5" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfNjA0NzMxMzk1NTgwMw_d4963a8d-74d0-4ea8-acf2-2d566d105c84">1.0</ix:nonFraction></ix:nonFraction>&#160;million of non-current restricted cash is included in other non-current assets in the condensed consolidated balance sheet as of March&#160;31, 2022 and December&#160;31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories, net</span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTEwMg_ab375fb8-d696-4575-a430-ff281ad30839" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfMS0yLTEtMS01MzM1NQ_c55f9006-7e83-4d71-9784-039e28204a98">12,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfMS00LTEtMS01MzM1NQ_aeb60940-56a3-4474-8762-3e6d2dd6121d">9,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfMi0yLTEtMS01MzM1NQ_f02aaec9-9465-4098-b291-4e6bfd6b083a">994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfMi00LTEtMS01MzM1NQ_d777118d-0a23-48a9-8b2f-d9ef8ea29b8e">867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfMy0yLTEtMS01MzM1NQ_11d4cbbe-008c-40db-951f-c215b745a479">9,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfMy00LTEtMS01MzM1NQ_58920f1d-df84-488b-97a6-51343c8780db">10,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfNC0yLTEtMS01MzM1NQ_c8b12a37-dc94-496d-98ea-c603c726e7f5">23,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfNC00LTEtMS01MzM1NQ_3b0bb705-4073-4af1-b2ab-be3d96db3f9e">20,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment, net </span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTExMQ_ee9c7d8e-0951-4763-ba7a-cdd8378f9511" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i090e27ef0a04457484fad8f0a7075dd1_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfMS0yLTEtMS01MzM1NQ_94a59e22-07f2-4781-a8a9-b1f366d233ba">5,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57628b9b4d1948008ccba2dcd4ef1952_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfMS00LTEtMS01MzM1NQ_1e682ab0-544b-4d3f-b045-ecb1e69024ec">5,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and manufacturing equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7f4a8245b6143b2953ff1fa9ffa2409_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfMi0yLTEtMS01MzM1NQ_0530abcd-c186-41b0-8e15-647ca6938cb8">33,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ab04d53d1948088109f492c3fb4362_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfMi00LTEtMS01MzM1NQ_9e8910b6-0c97-46c8-977b-8ae7934cc5e1">30,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f99c36bb724482982e5d8102ceeecd7_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfMy0yLTEtMS01MzM1NQ_cf266293-0e6a-4f7a-b48e-b7b799dcac42">12,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0863696f8964c36a94715de8e0f295d_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfMy00LTEtMS01MzM1NQ_05e79067-9d4e-4b93-84d2-9ac21aea1682">12,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie84a730a5b8e43089afed4061de374a5_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNC0yLTEtMS01MzM1NQ_d41b89f1-b1f7-4f5c-b226-c6f65d2dc188">2,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i367f8eaf66e547ca84a65357249c487a_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNC00LTEtMS01MzM1NQ_a43b005f-a61b-48cf-91b0-abeaf51c981e">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNS0yLTEtMS01MzM1NQ_3ac8f005-0e59-409a-b1a3-950a4cbb6553">54,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNS00LTEtMS01MzM1NQ_6afbd6d3-e923-4710-989a-0f1be9573c35">50,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNi0yLTEtMS01MzM1NQ_c5b698c4-7937-43a8-bf7b-0e76d860e748">28,151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNi00LTEtMS01MzM1NQ_e4a89fc7-97d3-4655-8983-81c1e83ea4ad">26,703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNy0yLTEtMS01MzM1NQ_8ef571eb-1e2c-4a68-88f2-ed171891dedb">1,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNy00LTEtMS01MzM1NQ_aaa52e56-a31f-49be-a12c-99dc42ac1cd0">4,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfOC0yLTEtMS01MzM1NQ_e87a2c91-fd02-4156-a754-a41fac7371b9">27,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfOC00LTEtMS01MzM1NQ_5eb0889c-2d37-4de4-b0e9-c8bc84650641">28,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the amounts included in construction-in-progress are related to the NIH Contract (see Note 4).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Compensation and Related Benefits</span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTA5Ng_0ab9f70a-267f-4095-952d-1f3902007150" continuedAt="i18cf4628195442a09e9cfdefda929b42" escape="true"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation and related benefits, which is included in current liabilities on the condensed consolidated balance sheet consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued incentive compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:WorkersCompensationLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfMS0yLTEtMS01MzM1NQ_59fd2465-6d73-48e9-bc51-9142575ae136">1,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfMS00LTEtMS01MzM1NQ_0a9b3b25-2b34-4cc6-83ae-dfd552b56efb">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued vacation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:AccruedVacationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfMi0yLTEtMS01MzM1NQ_80eeaaae-52ac-4fcd-a995-6fb8d29b5a58">3,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:AccruedVacationCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfMi00LTEtMS01MzM1NQ_4a488f00-9978-4b4b-8111-436dba375416">3,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll taxes and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:AccruedPayrollTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfMy0yLTEtMS01MzM1NQ_729a6005-64f7-4028-bec4-633d022ba41c">1,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:AccruedPayrollTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfMy00LTEtMS01MzM1NQ_94fb30ee-84d9-4d83-8230-511dba58cdc5">1,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued severance and retention bonuses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:AccruedBonusesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfNC0yLTEtMS02NzA0OQ_14538a59-367e-42bb-a318-49b2f01a48c6">901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:AccruedBonusesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfNC00LTEtMS02NzA0OQ_de7c9054-58d6-4ae1-98c7-df418a23d0ac">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfNC0yLTEtMS01MzM1NQ_9864035c-45ec-4a00-a46f-1548d54266dc">7,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfNC00LTEtMS01MzM1NQ_5f4a3c57-34e7-41af-87ff-cdf72114ce18">4,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9271b0fa04484fb6b511778255187684"><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i18cf4628195442a09e9cfdefda929b42">Long-term accrued s</ix:continuation>everance and retention bonuses of approximately $<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-5" name="fldm:AccruedBonusesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfNjA0NzMxMzk1NDY0OA_fde721ac-96ba-4dd1-a615-f639b69deec4">0.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-5" name="fldm:AccruedBonusesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfNjA0NzMxMzk1NDcxMA_dbbc8800-83d6-4272-ab1e-5439f0e1ce8f">0.1</ix:nonFraction>&#160;million are included in non-current other liabilities on our condensed consolidated balance sheet as of March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-bottom:8pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warranties</span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTEwNw_6f879c57-9970-4e63-9eef-0e5c0663f5d3" escape="true"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued warranty is included in other current liabilities on our condensed consolidated balance sheet. Activity for our warranty accrual for the three months ended March&#160;31, 2022&#160;and 2021 is summarized below (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:ProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfMi0yLTEtMS01MzM1NQ_7233dbee-7c96-4a72-bf35-0b0ba3a16a98">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id803a63fc74c495aa4dd5311fbcac8b6_I20201231" decimals="-3" name="us-gaap:ProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfMi00LTEtMS01MzM1NQ_628adbc4-d941-41b7-b5f9-e2187a04e1a1">1,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual (release) for current period warranties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:ProductWarrantyAccrualPreexistingIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfMy0yLTEtMS01MzM1NQ_c1f5b677-45ff-442d-90d5-e6cd58ff9a35">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:ProductWarrantyAccrualPreexistingIncreaseDecrease" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfMy00LTEtMS01MzM1NQ_3921280e-88f0-43ae-8586-4ebbe890cf0c">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty costs incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:ProductWarrantyAccrualPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfNC0yLTEtMS01MzM1NQ_92221b8a-913a-406d-8387-1597df3c5cb0">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:ProductWarrantyAccrualPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfNC00LTEtMS01MzM1NQ_2ce4887b-fa73-422f-ace7-46987b4dad74">236</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:ProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfNS0yLTEtMS01MzM1NQ_ef9b0f7f-bba0-4979-ab82-4f732422746c">1,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id618e4076c984ee2b69327451b1b9e70_I20210331" decimals="-3" name="us-gaap:ProductWarrantyAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfNS00LTEtMS01MzM1NQ_39ae3c0b-e519-4577-990c-3b44934587a6">1,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i3f52f78858b0473b983a2153293d04e0_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">9. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfODM3NA_f8b61600-a63a-4453-8b33-d05ee54a6efe" continuedAt="ie4fd5a47aaf4447ebb24290252807fc3" escape="true">Debt</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%"><br/><ix:continuation id="ie4fd5a47aaf4447ebb24290252807fc3" continuedAt="i5ae69ac6eb54491fae60b74c4de363e3">Bridge Loans </ix:continuation></span></div><ix:continuation id="i5ae69ac6eb54491fae60b74c4de363e3" continuedAt="i670f52c445c34c00b3df6cab5a0e041a"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3 for a discussion of the $<ix:nonFraction unitRef="usd" contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMzg0ODI5MDc1NDc2MA_e8f55ea5-6fd3-41c8-8486-4c14cdc62fea">35.7</ix:nonFraction> million Bridge Loans outstanding as of March&#160;31, 2022 as part of the Private Placement Issuance.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2014 Senior Convertible Notes (2014 Notes) and 2019 Senior Convertible Notes (2019 Notes)</span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMTMxOTQxMzk1OTIzODQ_a67f8666-0757-4cdc-a2bd-bcafde576020" continuedAt="i816da84a7a354f28bb6cdd4a84e9b28c" escape="true"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the components of the 2014 Notes and 2019 Notes are as follows (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;<ix:nonFraction unitRef="number" contextRef="i160268d0fa1b4d38bd5ea84554f1559f_I20140228" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMS0wLTEtMS02NDc0OS90ZXh0cmVnaW9uOjMwNmY4NmYwMjViZTRlNjliN2QyNmFlMDE3OWQ2YjBjXzY_5341d8f7-0957-401d-b3c8-892e7eca8510">2.75</ix:nonFraction>% 2014 Notes due 2034   </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a77d2cffbb466495dfbdb0f232de97_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMi0yLTEtMS02NDc0OQ_54485400-e6ea-40e9-bd81-45dc9b126e49">578</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib879a74c7d314a99bfe67a83c5ae025a_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMi00LTEtMS02NDc0OQ_edc5988d-d57f-4153-bee7-79a92115064e">578</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7a77d2cffbb466495dfbdb0f232de97_I20220331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMy0yLTEtMS02NDc0OQ_9d11666b-01f6-4534-9bbb-f73f7d01ffa5">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib879a74c7d314a99bfe67a83c5ae025a_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMy00LTEtMS02NDc0OQ_6e7f152e-ec2a-424b-a061-93b81495545e">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7a77d2cffbb466495dfbdb0f232de97_I20220331" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfNC0yLTEtMS02NDc0OQ_91e46533-338b-4d44-ad94-8af33a80b3c6">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib879a74c7d314a99bfe67a83c5ae025a_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfNC00LTEtMS02NDc0OQ_3b0b64a2-b79b-48fb-bdbb-0dab55df34e4">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of 2014 Notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a77d2cffbb466495dfbdb0f232de97_I20220331" decimals="-3" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfNS0yLTEtMS03NjIzMQ_7b0298e2-5b10-4608-b68c-b5478a12ead5">568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib879a74c7d314a99bfe67a83c5ae025a_I20211231" decimals="-3" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfNS00LTEtMS03NjIzMQ_a01c0b79-e54a-4b2b-9d44-f0b2d3ee5af3">568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;<ix:nonFraction unitRef="number" contextRef="i07369311ad5b4af1a043b008ade3c4e7_I20191130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfNy0wLTEtMS02NDc0OS90ZXh0cmVnaW9uOmEyM2U2ZmRhNmZiYTRkNjM5MWI4ZGUyNGIyZDQwY2JhXzY_1988f466-e82c-4ffe-8194-70db45614724">5.25</ix:nonFraction>% 2019 Notes due 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6fc6a3e6a134443b3035ae7eef72da4_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfOC0yLTEtMS02NDc0OQ_6813bd18-72c0-4a15-a60a-01dbf8dee5ce">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ccaab30a9344f92a4d5d4f061f686d2_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfOC00LTEtMS02NDc0OQ_9029736e-7322-4f3c-8023-6c49604d6a7f">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6fc6a3e6a134443b3035ae7eef72da4_I20220331" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfOS0yLTEtMS02NDc0OQ_28be45d5-ca5a-499f-baa1-26079412e22c">1,297</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ccaab30a9344f92a4d5d4f061f686d2_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfOS00LTEtMS02NDc0OQ_7d3ec033-1626-461e-8936-d57cb586af0e">1,408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of 2019 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6fc6a3e6a134443b3035ae7eef72da4_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMTAtMi0xLTEtNzYyMzQ_5114cca7-1e92-4bf8-b053-66d7f7d4c141">53,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ccaab30a9344f92a4d5d4f061f686d2_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMTAtNC0xLTEtNjQ3NDk_6b6de0c5-f801-4b64-a46c-75ebd5e7b059">53,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of all Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i918712e2e4c4473592c78603409a2035_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMTEtMi0xLTEtNjQ3NDk_017bf6de-c8d6-41c5-99d2-e3bedbd93c12">54,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i633deee677b14f20aedd746e431d49ed_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMTEtNC0xLTEtNjQ3NDk_069ed106-e29c-4a9d-a77c-362a1e1928fe">54,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2014 Senior Convertible Notes (2014 Notes) </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2014, we closed an underwritten public offering of 2014 Notes. In 2019, the outstanding 2014 Notes were largely refinanced with the 2019 Notes, discussed below. The effective interest rate on the 2014 Notes, reflecting the impact of debt discounts and issuance costs, is approximately <ix:nonFraction unitRef="number" contextRef="i160268d0fa1b4d38bd5ea84554f1559f_I20140228" decimals="2" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjA0NzMxNDAxMTkyMQ_c6ff3c0a-e1a6-44dd-833b-202745fb710d">3</ix:nonFraction>%. The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. Holders may require us to repurchase all or a portion of their 2014 Notes on each of February 6, 2024 and February 6, 2029, at a repurchase price in cash equal to <ix:nonFraction unitRef="number" contextRef="i9170739660ea4bfc8eb6c551e60b2612_D20140201-20140228" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfOTk0_e93068ae-18a6-42fd-85cf-2684477c868f">100</ix:nonFraction>% of the principal amount of the 2014 Notes plus accrued and unpaid interest. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As provided by the indenture governing the 2014 Notes, in February 2021, holders of $<ix:nonFraction unitRef="usd" contextRef="i2b39964a5e6c4c19b88ad79540049976_I20210228" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMTY0OTI2NzQ1MjIwNA_46b8b336-c59b-469e-8e93-b046627402ed">0.5</ix:nonFraction> million of the 2014 Notes required us to repurchase their notes at <ix:nonFraction unitRef="number" contextRef="i29e7a7788ad04a3d8770310cb3706589_D20210201-20210228" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMTY0OTI2NzQ1MDg5Ng_14717dfd-dc7e-4f80-8724-362593d24e61">100</ix:nonFraction>% of the principal amount plus accrued and unpaid interest. We recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="ifa7db0e7f6e64bc38b954e286cf01912_D20210201-20210228" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMTY0OTI2NzQ1MjIxMg_c93bcec8-06c7-473e-a548-942b73cc833e">9</ix:nonFraction> thousand on the extinguishment of those notes, representing the difference between the price paid to extinguish the 2014 Notes and their carrying value, including unamortized debt issuance costs. As of March&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="id7a77d2cffbb466495dfbdb0f232de97_I20220331" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMTY0OTI2NzQ1MjIzOA_b0ca9b49-f959-4be1-aadc-7bfc0069ccec">0.6</ix:nonFraction> million aggregate principal of the 2014 Notes outstanding.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i670f52c445c34c00b3df6cab5a0e041a" continuedAt="i363b1cf1672b4735a8dfb74f90ee40b4"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Senior Convertible Notes (2019 Notes)</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we issued $<ix:nonFraction unitRef="usd" contextRef="i07369311ad5b4af1a043b008ade3c4e7_I20191130" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMjM2OQ_e6242e6e-18e1-42b7-985b-abce04f4a871">55.0</ix:nonFraction> million aggregate principal amount of 2019 Notes. Net proceeds of the 2019 Notes issuance were $<ix:nonFraction unitRef="usd" contextRef="i3b2bc86d58a540e1859dd280a7ab24e4_D20191101-20191130" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMjQ3NQ_ab3f0c6c-170c-453e-9399-85beb90759bb">52.7</ix:nonFraction> million, after deductions for commissions and other debt issuance costs. $<ix:nonFraction unitRef="usd" contextRef="ie91e1a9f5d3646f68aebba6fd62e9508_D20191101-20191130" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMjU2Mw_181745f7-d918-4d0e-bc85-0ad9cddb86ba">51.8</ix:nonFraction> million of the proceeds of the 2019 Notes were used to retire $<ix:nonFraction unitRef="usd" contextRef="i3b2bc86d58a540e1859dd280a7ab24e4_D20191101-20191130" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMjYyMA_6a403d9f-ca94-40c9-82ed-f111efb0b606">50.2</ix:nonFraction> million aggregate principal amount of our 2014 Notes, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">leaving $<ix:nonFraction unitRef="usd" contextRef="i908b5614888049f28cbb80e7a6178f8e_I20191130" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjA0NzMxNDAxMTc0MQ_61db0d1b-bcae-4419-9090-c1fa3b01ce3b">1.1</ix:nonFraction> million of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aggregate principal value of 2014 Notes then outstanding. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Notes bear interest at <ix:nonFraction unitRef="number" contextRef="i07369311ad5b4af1a043b008ade3c4e7_I20191130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMjc3NA_1988f466-e82c-4ffe-8194-70db45614724">5.25</ix:nonFraction>% per annum, payable semiannually on June 1 and December 1 of each year, beginning on June 1, 2020. The 2019 Notes will mature on December 1, 2024, unless earlier repurchased or converted pursuant to their terms. The 2019 Notes will be convertible at the option of the holder at any point prior to the close of business on the second scheduled trading day preceding the maturity date. The initial conversion rate of the 2019 Notes is 344.8276 shares of our common stock per $1,000 principal amount of 2019 Notes (which is equivalent to an initial conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i812e59424f52454887fd27588f8469d3_I20191130" decimals="2" name="fldm:InitialConversionPriceOfStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMzM3MQ_63e16a60-4038-4cf4-8c87-6be14fb120c4">2.90</ix:nonFraction> per share). The conversion rate is subject to adjustment upon the occurrence of certain specified events. Those certain specified events include voluntary conversion of the 2019 Notes prior to our exercise of the Issuer&#8217;s Conversion Option or in connection with a make-whole fundamental change, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2019 Notes. The conversion rate will not be adjusted for any accrued and unpaid interest. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Notes will also be convertible at our option upon certain conditions in accordance with the terms of the indenture governing the 2019 Notes. On or after December 1, 2021 to December 1, 2022, if the price of our common stock has equaled or exceeded <ix:nonFraction unitRef="number" contextRef="i5874eb1b19274365b89e4f16ba6865fc_D20191101-20191130" decimals="INF" name="fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNDI0MA_ffa35cf3-df89-4dbf-9b3f-21a282ab7b10">150</ix:nonFraction>% of the Conversion Price (as defined in the indenture) then in effect for a specified number of days (Issuer&#8217;s Conversion Option), we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of common stock of the Company, determined in accordance with the terms of the indenture. On or after December 1, 2022, if the price of our common stock has equaled or exceeded <ix:nonFraction unitRef="number" contextRef="i4690c6ae02014999bb14d18dc8b565b2_D20191101-20191130" decimals="INF" name="fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNDYwNg_0e671d5a-2c2c-4b15-9d86-56c1e603cc53">130</ix:nonFraction>% of the Conversion Price then in effect for a specified number of days, we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of common stock of the Company, determined in accordance with the terms of the indenture. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering-related costs for the 2019 Notes were capitalized as debt issuance costs and are recorded as an offset to the carrying value of the 2019 Notes. The effective rate on the 2019 Notes is <ix:nonFraction unitRef="number" contextRef="i07369311ad5b4af1a043b008ade3c4e7_I20191130" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNTIxNw_b03f70b5-8b4f-4f9e-a5c6-10e2cfe33adf">6.2</ix:nonFraction>%.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revolving Credit Facility and Term Loan, net</span></div><ix:continuation id="i816da84a7a354f28bb6cdd4a84e9b28c" continuedAt="i85ca9833061e481f8a2da01523fecbeb"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of our term loan and advances under the Credit Facility, and the maximum amount available under the Credit Facility are as follows (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfMi0yLTEtMS02NDc3OA_6e788a87-a849-4e66-af22-4c5938bbda27">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c95c830e9346709b9e8f6f68d3ca08_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfMi00LTEtMS02NDc3OA_dc7e00a7-75ca-45f3-8218-1e971f6e266f">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of term fee accretion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331" decimals="-3" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfMy0yLTEtMS02NDc3OA_2c2728b4-24ab-4b82-86d9-8b72ea1da73d">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c95c830e9346709b9e8f6f68d3ca08_I20211231" decimals="-3" sign="-" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfMy00LTEtMS02NDc3OA_f17e5f2a-043f-4139-be87-141355f5b68f">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfNC0yLTEtMS02NDc3OA_6293c08e-4196-4ac9-b396-61df07786f9a">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i40c95c830e9346709b9e8f6f68d3ca08_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfNC00LTEtMS02NDc3OA_2ebf043c-ab54-4502-94de-864bb3817169">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfNS0yLTEtMS03NjIzNw_be5bd232-c725-42ee-a356-d79a3465a73c">10,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c95c830e9346709b9e8f6f68d3ca08_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfNS00LTEtMS03NjIzNw_579de0e6-88c6-4541-b218-0445977d8c9b">10,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of advances under credit agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3bcdcd73f1c405f8f2d59a089c890f3_I20220331" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfOS0yLTEtMS02NDc3OA_aa88b235-df65-4e32-9f1b-a73d755e01dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7290240890949c08edf84cb715e251f_I20211231" decimals="-3" name="us-gaap:LineOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfOS00LTEtMS02NDc3OA_4d4f25f7-7e60-454b-8e5e-5fb4ddd31dfd">6,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we entered into a revolving credit facility with Silicon Valley Bank (as amended, the Revolving Credit Facility) in an aggregate principal amount of up to the lesser of (i) $<ix:nonFraction unitRef="usd" contextRef="i7138e77d1b41464ba17008df0fb4ab55_I20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNTU2OQ_f11b5c9e-7ad1-477b-bb25-4a92814a5eba">15.0</ix:nonFraction> million (Maximum Amount) or (ii) the sum of (a) <ix:nonFraction unitRef="number" contextRef="i6637980e82554f3da6571c3ff1c70650_D20180801-20180831" decimals="INF" name="fldm:LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNTYxMw_cd832a4a-f0e9-4368-8b83-12e60d7072d5">85</ix:nonFraction>% of our eligible receivables and (b) <ix:nonFraction unitRef="number" contextRef="i6637980e82554f3da6571c3ff1c70650_D20180801-20180831" decimals="INF" name="fldm:LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNTY1Mg_435a42d6-143c-455a-bc78-200fc83b90ef">50</ix:nonFraction>% of our eligible inventory, in each case, subject to certain limitations (Borrowing Base), provided that the amount of eligible inventory that may be counted towards the Borrowing Base shall be subject to a cap as set forth in the Revolving Credit Facility. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2021, we amended our Revolving Credit Facility to extend the maturity date to August 2, 2023 and to provide for a new $<ix:nonFraction unitRef="usd" contextRef="id87ce5c4623f4d3b9b99a89129d283c5_I20210802" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjE5Mw_64f49d45-cb8c-4509-8b3f-d4dc7f460c22">10.0</ix:nonFraction>&#160;million Term Loan Facility (the Term Loan Facility and, together with the Revolving Credit Facility, the Credit Facility). The stated maturity of the Term Loan Facility is July 1, 2025.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, if the principal amount of our convertible debt exceeds </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i6c05f390be1e4fba9543e3eef05cd18a_I20210802" decimals="-5" name="fldm:DebtInstrumentCovenantConvertibleDebtThreshold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjQ0NQ_ee5eccd2-19a7-4043-b6cb-30cd92f08dbc">0.6</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as of June 1, 2024 or if the maturity of our 2019 Notes has not been extended beyond January 1, 2026 by June 1, 2024, then the maturity date of the Term Loan Facility will be June 1, 2024. The Credit Facility is </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i363b1cf1672b4735a8dfb74f90ee40b4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">collateralized by substantially all our property, other than intellectual property. The Credit Facility also includes a financial covenant that requires us to maintain a minimum Adjusted Quick Ratio, as defined in the agreement, of at least <ix:nonFraction unitRef="number" contextRef="iea73508f9d1047c38f6efe4f293e882e_D20210802-20210802" decimals="2" name="fldm:DebtInstrumentCovenantMinimumAdjustedQuickRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjkwNg_3c901c17-3442-4eba-9149-6582caee91cf">1.25</ix:nonFraction> to 1.00.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The interest rate on advances made under the Revolving Credit Facility is the greater of (i) prime rate plus <ix:nonFraction unitRef="number" contextRef="i71f15dd92cc34cc88d928463e4fdea0d_D20180801-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNzAyOQ_882d9979-fbdd-47b4-8a84-e1c1626a40dd">0.50</ix:nonFraction>% or (ii) <ix:nonFraction unitRef="number" contextRef="ia9ff2eebee8640b1845873f7c8306421_D20180801-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNzA0MA_65809ec3-beb7-4cb9-b8a6-8d84b2550909">5.25</ix:nonFraction>%. Interest on any outstanding amounts is due and payable monthly and the principal balance is due at maturity, though loans can be prepaid at any time without penalty. Fees for the Revolving Credit Facility include an annual commitment fee of $<ix:nonFraction unitRef="usd" contextRef="ia5c8dc8c1e56417a96b944b97cd01027_D20180801-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeeAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNzI4NQ_75f3a7f7-ef80-42dc-ae85-41427dd4c27e">112,500</ix:nonFraction> and a quarterly unused line fee based on the Borrowing Base. Total availability under the Revolving Credit Facility as of March&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="id3bcdcd73f1c405f8f2d59a089c890f3_I20220331" decimals="-5" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjA0NzMxNDAwNzg5OQ_239dcb28-8a31-4e71-ab70-4a29771bcf7d">8.4</ix:nonFraction> million. There were <ix:nonFraction unitRef="usd" contextRef="id3bcdcd73f1c405f8f2d59a089c890f3_I20220331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjA0NzMxNDAwNzQxMg_85e70b9b-19ee-460b-8859-abb933c2a8fe">no</ix:nonFraction> borrowings outstanding under the Revolving Credit Facility at</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> March&#160;31, 2022.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March&#160;31, 2022, the Term Loan Facility was fully drawn. The interest rate on the Term Loan Facility is the greater of <ix:nonFraction unitRef="number" contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNzYzMw_d0ee623c-ca33-49e7-ac76-f6edb3e3ae53">4.0</ix:nonFraction>% or a floating per annum rate equal to three quarters of one percentage point (<ix:nonFraction unitRef="number" contextRef="i43f34e3da8064d94ba11bd59638ffba3_D20220101-20220331" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNzcxMw_fed061be-e41e-4c43-887a-3bfeb2ebf3ee">0.75</ix:nonFraction>%) above the prime rate. Interest on any outstanding term loan advances is due and payable monthly. In addition to the monthly interest payments, a final payment equal to <ix:nonFraction unitRef="number" contextRef="iea73508f9d1047c38f6efe4f293e882e_D20210802-20210802" decimals="3" name="fldm:DebtInstrumentIncrementalPaymentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNzg4Ng_d230fdd7-1a7a-4562-a8dc-e6cfced1f0d4">6.5</ix:nonFraction>% of the original principal amount of each advance is due on the earlier of the maturity date or the date the advance is repaid. Principal balances are required to be repaid in <ix:nonFraction unitRef="monthly_installment" contextRef="i1ceba926b97e4336840e0087ebe96841_D20210802-20210802" decimals="INF" name="fldm:DebtInstrumentPeriodicPaymentNumberOfInstallments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfODA2NQ_03cc9120-3824-49d9-b5d6-22589078c1cb">twenty-four</ix:nonFraction> equal installments beginning on August 1, 2023. The effective interest rate on the Term Loan Facility, reflecting the impact of debt issuance costs, the end-of-term fee and expected timing of principal repayment was <ix:nonFraction unitRef="number" contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfODI5MQ_2becd6d8-c490-4797-832d-b48801c068ec">6.3</ix:nonFraction>% as of March&#160;31, 2022.</span></div></ix:continuation><div id="i3f52f78858b0473b983a2153293d04e0_64"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RleHRyZWdpb246MDA3Zjk2ZTZlZWE4NGIyZWI0MjAxYzEyMDNhOWY1YTBfMzg4_7be4ba21-37f7-4907-a673-e7ecd597fc43" continuedAt="ib22606c1b78448298ef105b66c912e60" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="ib22606c1b78448298ef105b66c912e60"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating leases for buildings, equipment and vehicles. Existing leases have remaining terms of less than <ix:nonNumeric contextRef="i2946e1733f13418ea3b80b32b99bb663_D20220101-20220331" name="fldm:LesseeOperatingLeaseRemainingTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RleHRyZWdpb246MDA3Zjk2ZTZlZWE4NGIyZWI0MjAxYzEyMDNhOWY1YTBfMTI5_45f8daa6-ad9f-4247-b299-1eae5cafa6fe">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="i9401f96d3b934202bdd9b43f3164dc99_D20220101-20220331" name="fldm:LesseeOperatingLeaseRemainingTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RleHRyZWdpb246MDA3Zjk2ZTZlZWE4NGIyZWI0MjAxYzEyMDNhOWY1YTBfNjA0NzMxMzk1MzQyNQ_27e39251-35c2-473c-b65e-8452d31fe5f3">eight years</ix:nonNumeric>. Some leases contain options to extend the lease, usually for up to <ix:nonNumeric contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RleHRyZWdpb246MDA3Zjk2ZTZlZWE4NGIyZWI0MjAxYzEyMDNhOWY1YTBfMjA2_a1b04643-f3ef-4d81-919e-0628186f0450">five years</ix:nonNumeric>, and termination options.</span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="fldm:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RleHRyZWdpb246MDA3Zjk2ZTZlZWE4NGIyZWI0MjAxYzEyMDNhOWY1YTBfMzg0_0d910c7e-e9bf-4418-bf56-0b2d4b49330d" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands, except for discount rate and lease term):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.636%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use buildings</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6d96d54873a406f8857760fcb97e6dc_I20220331" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMS0yLTEtMS01MzM1NQ_ea4ebbbc-342d-4171-a258-675564c5a377">43,595</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd1c0dbe46d4ab4b631cf79d9b0e5f0_I20211231" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMS00LTEtMS01MzM1NQ_d7fa786b-aef1-47a3-8da4-b35232e934a4">43,457</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use equipment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8bf776768964321b47a464ab18406e1_I20220331" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMi0yLTEtMS01MzM1NQ_6fc0e685-34fc-4351-927e-5f042490c4cb">82</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4d100cb233e46569570b3a9160fffaf_I20211231" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMi00LTEtMS01MzM1NQ_6f7def4e-86e3-4a8e-91c3-a45709a771ae">84</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use vehicles</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb02155ee72947fe93b3c7c9297367dd_I20220331" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMy0yLTEtMS01MzM1NQ_45d4e9b9-4424-472b-8e47-79d22dab91af">609</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ab4b34b0e7949c0853287c6a741b50c_I20211231" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMy00LTEtMS01MzM1NQ_5851c021-b517-45ea-8147-70d5561b4985">676</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets, gross</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfNC0yLTEtMS01MzM1NQ_7b75c4c2-f9f8-42d9-b198-8766a1fdeffc">44,286</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfNC00LTEtMS01MzM1NQ_952beecd-d3bb-4a72-9524-d4cf796a2829">44,217</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfNS0yLTEtMS01MzM1NQ_38457eda-238a-422b-b2e7-57500dbfb630">7,897</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="fldm:OperatingLeaseRightOfUseAssetAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfNS00LTEtMS01MzM1NQ_d1d59f39-691d-466b-937a-e52db5581f27">7,098</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets, net</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfNi0yLTEtMS01MzM1NQ_2ab299a1-91bb-4265-bca5-2cb8aa70edce">36,389</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfNi00LTEtMS01MzM1NQ_975f9625-98a8-4106-bb7b-9ea8150dd63c">37,119</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfOC0yLTEtMS01MzM1NQ_866ceb4e-4bac-4c18-b10b-f6a10e9088fa">3,209</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfOC00LTEtMS01MzM1NQ_243a2e2e-d3b2-4f88-9e0d-f8f3eca575f2">3,053</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfOS0yLTEtMS01MzM1NQ_640d4e95-b152-4cd0-ae4a-635417913cca">36,760</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfOS00LTEtMS01MzM1NQ_e1e7b1de-8310-499d-ad7e-35cdeec97a2b">37,548</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMTAtMi0xLTEtNTMzNTU_fbf11e96-9cf9-4e54-876d-50b3d0baa3f3">39,969</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMTAtNC0xLTEtNTMzNTU_9b16904a-f41d-4234-96f1-98c925afbde4">40,601</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMTItMi0xLTEtNTMzNTU_10f662a3-eb08-4fed-907d-9f273da9c453">7.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMTItNC0xLTEtNTMzNTU_554eff6a-959d-4abb-bfb8-69238b5917ff">7.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate per annum</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMTMtMi0xLTEtNTMzNTU_9eee4e64-dbfb-4798-932b-799165bc23b4">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMTMtNC0xLTEtNTMzNTU_8fd0273e-b0cf-44c6-bcef-370a0259b4f0">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.328%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RleHRyZWdpb246MTFjMjdiNTNjYzQxNDJkYTg0ZDU0MGFmYWQ3MDlkN2ZfMTQwMQ_2d1ec7d1-f2ee-4b7d-8ab4-7555c4a3c71a" continuedAt="ifa51cb8eb40342fab9fc4663ba7de649" escape="true">Fair Value of Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="ifa51cb8eb40342fab9fc4663ba7de649" continuedAt="i67685624eca4402d87dd31abb7adab49"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RleHRyZWdpb246MTFjMjdiNTNjYzQxNDJkYTg0ZDU0MGFmYWQ3MDlkN2ZfMTQwOA_b2a81c33-d476-4525-a637-2523a266f238" escape="true"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.825%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash- Restricted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09c9b9a0eec74f1eb1b5c7f46fce7ad2_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMy0xLTEtMS01MzM1NQ_07f899c6-056f-4cbb-8fbd-3c7d743955ad">29,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09c9b9a0eec74f1eb1b5c7f46fce7ad2_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMy03LTEtMS01MzM1NQ_4ec14213-7cbb-4231-b486-a526bd56f4f3">29,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09c9b9a0eec74f1eb1b5c7f46fce7ad2_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMy05LTEtMS01MzM1NQ_fa1fe87d-44f8-40e0-be33-b169dbc03c94">29,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-restricted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cbe9fcdac0241f08b13a6f1500deafa_I20220331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNC0xLTEtMS01MzM1NQ_8ae41e6b-4a99-412e-a85f-70fee4c110df">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cbe9fcdac0241f08b13a6f1500deafa_I20220331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNC03LTEtMS01MzM1NQ_3b128788-7bff-4046-a4bd-a5ee751c7559">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cbe9fcdac0241f08b13a6f1500deafa_I20220331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNC0xMy0xLTEtNTMzNTU_6b409aca-9eb0-4adf-b4fb-11ff9d37c656">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2106d7d27e2429382ccfccea124e2d2_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNS0xLTEtMS01MzM1NQ_48e52a07-65ad-4d8f-8136-8de3488c2cad">30,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2106d7d27e2429382ccfccea124e2d2_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNS03LTEtMS01MzM1NQ_be9d990e-7a40-4696-8f58-3b1f58e52489">30,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2106d7d27e2429382ccfccea124e2d2_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNS05LTEtMS01MzM1NQ_3d8b2e98-7656-4a03-abaf-e6a78f7c6cc1">29,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2106d7d27e2429382ccfccea124e2d2_I20220331" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNS0xMy0xLTEtNTMzNTU_89472ef6-ca53-4e41-b02b-759eef035c6d">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash- Restricted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia410cf951ff442a7af6415951fac5467_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTYtMS0xLTEtNTMzNTU_86558552-9c84-420d-8c4c-7073064e2ef3">28,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia410cf951ff442a7af6415951fac5467_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTYtNy0xLTEtNTMzNTU_6c3a0311-d77d-4221-866d-0c7ac2594b89">28,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia410cf951ff442a7af6415951fac5467_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTYtOS0xLTEtNTMzNTU_acc949d7-840d-4356-b221-990a8110ed9b">28,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-restricted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7656b92dc6c44155b55eebf7f72273b9_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTctMS0xLTEtNTMzNTU_c16b108a-666b-4dcb-860d-d8ab636f1736">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7656b92dc6c44155b55eebf7f72273b9_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTctNy0xLTEtNTMzNTU_83df4c2f-c190-459a-9c7f-a35213b82102">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7656b92dc6c44155b55eebf7f72273b9_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTctMTMtMS0xLTUzMzU1_52d588dc-6f4b-4d2b-8425-7b5d94e5a062">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f8932dab17405f952c3ec80f549c94_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTgtMS0xLTEtNTMzNTU_98f2a114-e9cd-4bcd-9f4f-cd9ac7ee090d">29,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f8932dab17405f952c3ec80f549c94_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTgtNy0xLTEtNTMzNTU_75655199-e900-4a15-ae8f-c45e3825068c">29,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f8932dab17405f952c3ec80f549c94_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTgtOS0xLTEtNTMzNTU_3305047f-a7ad-4be3-a4e5-eb676181f19d">28,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53f8932dab17405f952c3ec80f549c94_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTgtMTMtMS0xLTUzMzU1_e8c81e85-e8d2-4654-ba92-27cc781eb781">1,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are Level I measurements. There were no transfers between Level I and Level II measurements, and no changes in the valuation techniques used during the three months ended March&#160;31, 2022.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record our Bridge Loans and forward contracts on our Series B Preferred Equity Financing at their fair market values. See Note 3 for a discussion of these transactions and the determination of their fair market value.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our convertible notes, Bridge Loans, and forward sales contracts are not regularly traded and it is difficult to estimate a reliable and accurate market price for these securities. The estimated fair values for these securities represent Level III valuations since a fair value for these securities cannot be determined by using readily observable inputs or measures, such as market prices. Fair values were estimated using pricing models and risk-adjusted value ranges. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our term loan also represents a Level III valuation since the value cannot be determined by using readily observable inputs or measures, such as market prices. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our term loan was estimated using a discounted cash flows approach and current market interest rate data for similar loans.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i85ca9833061e481f8a2da01523fecbeb"><ix:continuation id="i67685624eca4402d87dd31abb7adab49"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the par value, carrying value and the estimated fair value of our debt as of March&#160;31, 2022 and December&#160;31, 2021, respectively (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridge Loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi0yLTEtMS02NjU2Ng_765199df-3fda-4075-88c5-37a0b9ad1fcb">25,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacd8238416414b529e9c11e81b3cb3ea_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi00LTEtMS02NjU2Ng_9333e56f-815f-41da-8468-8822769639a7">35,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66a0e027243e4b7e8de45f9fb688f73d_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi02LTEtMS02NjU2Ng_de1af30b-0af3-45bd-92c4-041d739fcd3c">35,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0ed4fcc32994c51a64df27a56bebe58_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi04LTEtMS02NjU2Ng_5ceb96f5-eea6-4984-81a9-d2c4c2dfc4d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i192f9657493242a29365f3d839d90d10_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi0xMC0xLTEtNjY1NjY_d87a7533-7b07-4184-8e37-10ca18dd9d6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35de4e7e785e4aa7b55659c0991572df_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi0xMi0xLTEtNjY1NjY_1ef36019-16a8-488a-8447-c615f7c16284">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a77d2cffbb466495dfbdb0f232de97_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi0xLTEtMS01MzM1NQ_dd9d67e1-9417-4606-a8b6-f96df9aed8eb">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75ab6b689aa54665b3fe1c022f4f383e_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi0zLTEtMS01MzM1NQ_6d204c49-bb44-4cc5-9337-e085f8c6fff1">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i719deb7dffa9447ea8e3e92416972180_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi01LTEtMS01MzM1NQ_ee7d0b5f-c192-4092-be3c-d4fb1fdc8afd">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib879a74c7d314a99bfe67a83c5ae025a_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi03LTEtMS01MzM1NQ_e713c4ff-c67e-4446-80c9-727764dabbbf">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec07d32c39e41fc8f6fae982f6ddbb1_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi05LTEtMS01MzM1NQ_94229e0c-71b9-4d06-9d96-d43f0e3d5bbb">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0057b63c6d1d42858acd5f470ced781d_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi0xMS0xLTEtNTMzNTU_6930e9aa-8a27-4d52-9d3c-6cda97ec13f8">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6fc6a3e6a134443b3035ae7eef72da4_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMy0xLTEtMS01MzM1NQ_36b75906-6c9b-4519-ba36-42c86dae4cc4">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b6e6c6f6d6d40c09000d22bf80671b7_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMy0zLTEtMS01MzM1NQ_437ae7f0-87d1-48a0-8286-3dee3e76d0e5">53,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2947c7abf7fa4f2691d0ca9cde5d6514_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMy01LTEtMS01MzM1NQ_7e114ca5-ef42-44b9-a29b-09210ee4d2da">74,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ccaab30a9344f92a4d5d4f061f686d2_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMy03LTEtMS01MzM1NQ_d12c591f-e184-4b17-bdde-2ea52bca19ff">55,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d6459171cf40a6843977458759b899_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMy05LTEtMS01MzM1NQ_0c5a68d9-df3d-4cc7-8f5b-ca1f1aaab322">53,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25222c4b0d624dc4bd5bea0e9e94cbe1_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMy0xMS0xLTEtNTMzNTU_1acf7536-0fdd-4da4-a6e5-67bbc61ad1c7">81,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i918712e2e4c4473592c78603409a2035_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNC0xLTEtMS01MzM1NQ_6c36ff99-05a3-41b9-8289-eedf96421003">55,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90ccecdd5e034b9e8b3a73afd56dd029_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNC0zLTEtMS01MzM1NQ_d4ea0ab2-695c-4497-aa05-64427dab6cc3">54,271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5621449148c64e2998b4cfe5304b2265_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNC01LTEtMS01MzM1NQ_e3d532cb-103d-428a-80e3-45cb7acdc66a">75,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i633deee677b14f20aedd746e431d49ed_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNC03LTEtMS01MzM1NQ_d36851ac-6876-431f-82a0-21210fdb529a">55,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d3d07f8af4b4470897c2977833f9255_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNC05LTEtMS01MzM1NQ_12c9f426-c768-4ec3-9253-7df65fed64db">54,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53271b8cc303430b9324caf250af4723_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNC0xMS0xLTEtNTMzNTU_0470fdaa-855e-4c69-a633-d24952aacada">82,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNi0xLTEtMS01MzM1NQ_95545c38-7441-4244-9707-f8c99ec2369f">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d08369cf4e743e1980090e6f9bd90e3_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNi0zLTEtMS01MzM1NQ_f9f063a6-816d-4040-b2ce-b96da4e9177e">10,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i744122bb17644424b7a8fd06cb0c7128_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNi01LTEtMS01MzM1NQ_44988edb-05e2-4d20-b4c7-65c1a190a6cf">9,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40c95c830e9346709b9e8f6f68d3ca08_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNi03LTEtMS01MzM1NQ_ed935bda-9748-4854-a202-44b1a610b1f5">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i430bde457f8b49c297f4b7eb59db0e6c_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNi05LTEtMS01MzM1NQ_5b78b9ae-f31b-4c36-9a00-4efe8ddfaad1">10,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if48c5a23863e4cd8bbe66e032efb7a3c_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNi0xMS0xLTEtNTMzNTU_eaa4bf00-2a41-431d-ada3-1ac750bfc68c">10,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances under revolving credit agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2855f667ed4c72a5b8a3fca49072e7_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfOC0xLTEtMS01NTUwMA_59d517ed-450b-43e1-914a-6199b9bcedaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58112e5c277c4b30a89447743fc62c04_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfOC0zLTEtMS01NTUwMA_48ec6030-acea-4cea-8ad4-13a68b908f4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bcb085019064514a3ff3a7b73e42196_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfOC01LTEtMS01NTUwMA_9f9c9d64-c38f-4d18-b3ff-2cc273835106">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c3dfe2aada444b685f4219ae06fcd20_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfOC03LTEtMS01NTUwMA_12a4325f-281f-4957-8f9f-ecb9e2cc1f91">6,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b63c6fe97894fe5a0d2c4975b4da0fe_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfOC05LTEtMS01NTUwMA_7c6c130d-852f-4e0f-a538-00bcd267bde2">6,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf2d9ac881dc4deea1d8989f49ab808d_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfOC0xMS0xLTEtNTU1MDA_1bbfbf15-289f-4e2c-b283-2ad8ffb45d9a">6,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMTMtMi0xLTEtNzU3NDg_e98bfab6-2e96-4afa-8a40-cd4e7f4bf1c6">90,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c347987f267431784a940da9799e057_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMTMtNC0xLTEtNzU3NDg_3e2e23ee-f83d-4928-9792-67a3bbbebc0a">100,032</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77951f80ba15446c8cd2f0e9ef5ba4f1_I20220331" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMTMtNi0xLTEtNzU3NDg_9226f442-6c89-40a4-ba18-b7360d2cfedf">121,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMTMtOC0xLTEtNzU3NDg_f829a41e-5744-4e62-bf35-9bca336cbabf">72,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d2a998f16924d858cf125d7c1d814bb_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMTMtMTAtMS0xLTc1NzQ4_cff3b7b6-6eca-4a04-be9a-e5caf83a90ee">71,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a9b5eeb2b441ca8c84ceb94e14ff84_I20211231" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMTMtMTItMS0xLTc1NzQ4_bf2497f5-8643-4052-84bc-c9ac8170b22b">99,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i3f52f78858b0473b983a2153293d04e0_70"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RleHRyZWdpb246YzFmZDg5N2RjMmE3NDBhZmI0Y2JjNTcwNzI5M2I2NTdfMTI5Ng_67d0946f-8416-4219-a194-71474adca138" continuedAt="i5cd9c1f3b24c41db9c4c046f863f57b3" escape="true">Shareholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="i5cd9c1f3b24c41db9c4c046f863f57b3"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Shares Reserved </span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RleHRyZWdpb246YzFmZDg5N2RjMmE3NDBhZmI0Y2JjNTcwNzI5M2I2NTdfMTI5Mg_c1292410-6955-464e-88e9-425b2fd00d3d" continuedAt="i2014d530a0a74e47a8fdc3bed6241437" escape="true"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had reserved shares of common</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stock for future issuance under equity compensation plans as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">In thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Exercise Of Options </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units at Maximum</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number Of Remaining Securities Available For Future Issuance </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2011 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d77114634a0476587c0c6e236131dd4_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfMi0yLTEtMS01MzM1NQ_1b6ce137-f106-4530-90a2-28be5eea1d6d">1,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61c25a145cf849d690fe64971fb1219b_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfMi00LTEtMS01MzM1NQ_5829b2fc-08be-4791-aadc-a9f42f816d47">7,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7e1d70fc37c4900b64ff49301b03fd4_I20220331" decimals="-3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfMi02LTEtMS01MzM1NQ_b6113e83-48d6-4478-8840-9e510fa2deb1">3,561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVS Sciences Inc. 2010 Equity Incentive Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2385c7f15ba43f4afc1f5f66be141ae_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfMy0yLTEtMS01MzM1NQ_5ed18f08-eeed-4557-b51d-2e56e29e3d20">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03880c5036734260b46d06727e442f92_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfMy00LTEtMS01MzM1NQ_c46e1c8b-7155-47fd-b877-102da96f3c2d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42f0b198127148778a174350609491d0_I20220331" decimals="-3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfMy02LTEtMS01MzM1NQ_f7f5f3f7-0324-4a9d-9d89-a38342b3af1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Inducement Award Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie87e1842c50e4d569dca108ae8ad47ff_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNC0yLTEtMS01MzM1NQ_cb9eb51d-4065-42c8-840d-58e60c5c1c12">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1145f4ff09c84a6790d15188392833e4_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNC00LTEtMS01MzM1NQ_23669f88-ac49-49b3-a010-11d387f23de4">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i058640ba016f4fb396b722f5d98c4df8_I20220331" decimals="-3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNC02LTEtMS01MzM1NQ_be633458-1068-448f-9330-36a797072dde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Employee Stock Purchase Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i03c0001f48254fe3bdfc3606ca7946d0_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNS0yLTEtMS01MzM1NQ_02b9bcf4-37cf-4a30-9d0a-0824b6dd1f76">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96a7681635b84887bcccedb27f5cffe1_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNS00LTEtMS01MzM1NQ_0d0590a3-08e3-4f42-9563-dd99a2ee536b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iec8080f040c148cd9a55c99e106e20ca_I20220331" decimals="-3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNS02LTEtMS01MzM1NQ_508c6af9-8f6d-49d1-be0a-a5bd311db9ab">2,633</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad71c918ee434181ba0fff19eced37d5_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNi0yLTEtMS01MzM1NQ_a63ea090-529b-49f4-bca1-68b107582b78">1,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i45fe81b2edc14e8283a89efd8ec7b239_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNi00LTEtMS01MzM1NQ_77a86a0c-f263-4b74-915e-20ca498a161f">7,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNi02LTEtMS01MzM1NQ_f0becac1-629d-41b3-9540-a21f4ff36ee6">6,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the securities to be issued upon release of RSUs and PSUs are the maximum number of shares that could be issued for performance share unit awards, which can vest at <ix:nonFraction unitRef="number" contextRef="ifbc7c42ab7c948dbb536b605def058fd_D20220101-20220331" decimals="INF" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RleHRyZWdpb246YzFmZDg5N2RjMmE3NDBhZmI0Y2JjNTcwNzI5M2I2NTdfNjU5NzA2OTc2OTQwNA_6d0775b3-cc60-43ea-90e4-cfaccb8ceb44">0</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="id07ffabfcd0b42608b10129b2e59ffd5_D20220101-20220331" decimals="INF" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RleHRyZWdpb246YzFmZDg5N2RjMmE3NDBhZmI0Y2JjNTcwNzI5M2I2NTdfNjU5NzA2OTc2OTQwOA_f89f4749-b202-4746-b7f1-78a907d80185">200</ix:nonFraction>% of the number of awards granted. The number of shares available for future issuance also reflects PSU awards granted at the maximum number of shares that could be issued under these awards.</span></div></ix:continuation><div id="i3f52f78858b0473b983a2153293d04e0_73"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk1OQ_cdaa3385-cb11-49f9-b5b4-f16e40514b25" continuedAt="i6d10d738843a40be812a0c8dbfc5dd8a" escape="true">Stock-Based Plans</ix:nonNumeric></span></div><ix:continuation id="i6d10d738843a40be812a0c8dbfc5dd8a" continuedAt="i125339c1512a470c8d759c83a101238f"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors sets the terms, conditions, and restrictions related to our 2017 Employee Stock Purchase Plan (ESPP) and the grant of stock options, restricted stock units (RSUs) and performance-based awards under our equity incentive plans. Our board of directors determines the number of awards to grant and also sets vesting criteria. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, RSUs vest on a quarterly basis over a period of <ix:nonNumeric contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNDMz_1f3a5c61-81e1-4faa-adbe-a7e0ce5f80f1">four years</ix:nonNumeric> from the date of grant at a rate of <ix:nonFraction unitRef="number" contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNDc5_85241f0e-ca4a-4ca7-9d66-033be5071999">25</ix:nonFraction>% on the first anniversary of the grant date and ratably each quarter over the remaining 12 quarters, or ratably over 16 quarters, subject to the employees&#8217; continued employment. We may grant RSUs with different vesting terms from time to time. In the first quarter of 2022, we granted <ix:nonFraction unitRef="shares" contextRef="ida95b698f6f541feb12d26c1e08f3545_D20220101-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNjA0NzMxMzk2NDQzNQ_89270ba7-e109-4303-b5e7-b3838b0117d9">0.8</ix:nonFraction>&#160;million of retention RSUs which vest within <ix:nonNumeric contextRef="ida95b698f6f541feb12d26c1e08f3545_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTQ5NzU1ODE1MTAxOA_e4cc5da0-38be-4c69-8c26-d1097bbbf8ac">one year</ix:nonNumeric>.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i125339c1512a470c8d759c83a101238f" continuedAt="i983957dabe94406790ee0176b8f5d32a"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incentive stock options and non-statutory stock options granted under our 2011 Equity Incentive Plan (2011 Plan) have a term of no more than <ix:nonNumeric contextRef="i9af5c9a4df634b10aa18bac8dd63496d_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfODEz_ed0d6b30-a194-4f9c-95b4-061c9b60fded">ten years</ix:nonNumeric> from the date of grant and an exercise price of at least <ix:nonFraction unitRef="number" contextRef="i9af5c9a4df634b10aa18bac8dd63496d_D20220101-20220331" decimals="INF" name="fldm:StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfODcz_1a2a0fb7-3f5d-4a99-a77e-645d21827611">100</ix:nonFraction>% of the fair market value of the underlying common stock on the date of grant. Generally, options vest at a rate of either <ix:nonFraction unitRef="number" contextRef="ida95b698f6f541feb12d26c1e08f3545_D20220101-20220331" decimals="INF" name="fldm:PortionOfStockOptionsVestOnFirstAnniversary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfOTk4_9fe0b265-a5d4-4491-9f73-f11d5c8037d6">25</ix:nonFraction>% on the first anniversary of the option grant date and ratably each month over the remaining period of <ix:nonNumeric contextRef="i1f2f332657784dd188961528d24aadfb_D20220101-20220331" name="fldm:NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMTEwMw_03406cda-c77a-4ea5-8465-0ddef1bb7b2b">36</ix:nonNumeric> months, or ratably each month over <ix:nonNumeric contextRef="i227d5a5fe544411ea37d71f144593da9_D20220101-20220331" name="fldm:NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMTEzNA_7634646c-230b-4f0c-8b02-81b47e53fcf0">48</ix:nonNumeric> months. We may grant options with different vesting terms from time to time. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For performance-based share awards, our board of directors sets the performance objectives and other vesting provisions in determining the number of shares or value of performance units and performance shares that will be paid out. Such payout will be a function of the extent to which performance objectives or other vesting provisions have been achieved.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2011 Equity Incentive Plan</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January&#160;2011, our board of directors adopted the 2011 Plan under which incentive stock options, non-statutory stock options, RSUs, stock appreciation rights, performance stock units (PSUs), and performance shares may be granted to our employees, directors, and consultants. In April 2019, our board of directors authorized, and in June 2019, our stockholders approved an amendment and restatement of the 2011 Plan to make various changes, including increasing the number of shares reserved for issuance by approximately <ix:nonFraction unitRef="shares" contextRef="i12d6eaf877364d5dbf2a9fe63b59e9aa_D20190601-20190630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMjExNQ_7cb56aec-fa0f-4847-9b3d-e8a4a70d8174">5.0</ix:nonFraction> million shares and extending the term of the 2011 Plan until April 2029. In May 2020, our board of directors authorized, and in June 2020, our stockholders approved, an increase of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="icefddd7e6aa7456685103922b493fb0b_D20200601-20200630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNjA0NzMxMzk2NDQ0Ng_f32e11bd-facb-48ff-a242-f11b3a4d67ee">1.4</ix:nonFraction>&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares reserved for issuance under the 2011 Plan. In April 2021, our board of directors authorized, and in May 2021, our stockholders approved, an additional increase of <ix:nonFraction unitRef="shares" contextRef="i8b311a9055cd4350a32fbf48c1d51dcf_D20210501-20210531" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMjQ4MQ_17cc7a13-96dc-43c9-85f1-518fd799f994">4.1</ix:nonFraction>&#160;million shares reserved for issuance under the 2011 Plan.</span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTkzOA_d1b1b964-5d0a-41fd-86b3-91aca1089035" escape="true"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the various plans was as follows:</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units<br/>&#160;(in 000s)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1b27a08b375d4bd6a7bdb7050cb92f97_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfMS0yLTEtMS01MzM1NQ_75276d1b-101e-4628-bc4d-732d457d7934">5,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b27a08b375d4bd6a7bdb7050cb92f97_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfMS00LTEtMS01MzM1NQ_2e8564f1-e522-42c1-9695-93d0678a9b15">5.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfMi0yLTEtMS01MzM1NQ_42e4c7d0-a2ba-4195-b8a7-21e786b804c4">808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfMi00LTEtMS01MzM1NQ_3e93d85f-de24-42af-ab6f-b191ed90f77b">3.62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU released</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfMy0yLTEtMS01MzM1NQ_62bddf8e-1f99-48f1-84c2-c5214c840074">302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfMy00LTEtMS01MzM1NQ_3580f983-f89c-4477-9e06-874e5f18ebe0">5.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfNC0yLTEtMS01MzM1NQ_e52bcfa3-fbc9-4865-b768-ea389175f383">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfNC00LTEtMS01MzM1NQ_a46618cb-3222-4d86-a604-8d70529e03aa">5.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3fa095588fa743319343a18e9698ac0e_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfNS0yLTEtMS01MzM1NQ_fa784271-bbd4-46af-8713-3e3149a41e12">5,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3fa095588fa743319343a18e9698ac0e_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfNS00LTEtMS01MzM1NQ_55c478e3-c7d8-40b8-b0df-808b62f75c97">4.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the unrecognized compensation costs related to outstanding unvested RSUs under our equity incentive plans were $<ix:nonFraction unitRef="usd" contextRef="i3fa095588fa743319343a18e9698ac0e_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMjc0Nw_7e276688-7de8-41f7-9616-10b45e85ad8f">21.8</ix:nonFraction> million. We expect to recognize those costs over a weighted average period of <ix:nonNumeric contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk1MQ_f3798e83-8778-44e5-9d15-6b1f101bf47d">2.2</ix:nonNumeric> years.</span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk0NA_2ad0bd13-1034-4c94-9140-301983e64b9e" continuedAt="i3c5091b5090e464aaed299ddb3120b38" escape="true"><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">: </span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Options (000s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price<br/>per Option</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average Remaining Contractual Life (in Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> in (000s)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMS0yLTEtMS01MzM1NQ_eb435a80-5fce-4bf3-8b96-a53d3991f2c4">1,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMS00LTEtMS01MzM1NQ_595c0c67-ba46-4fb3-b7a1-1fcd9b039ae4">7.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i41bfbc4f8008465d885af193c5915937_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMS02LTEtMS01MzM1NQ_6a44efeb-2a7a-4b04-b4df-3594122db64b">5.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMS04LTEtMS01MzM1NQ_a77e0ca3-6d4f-406a-af6e-1cec033dc35e">82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMi0yLTEtMS01MzM1NQ_53460431-2ebf-444f-bd89-9a80edbe398d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMi00LTEtMS01MzM1NQ_f5116cb3-b99f-4b88-92f1-93d0918cc89e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMy0yLTEtMS01MzM1NQ_2a964858-7b2c-4646-9af2-98b32d31413a">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMy00LTEtMS01MzM1NQ_bee33e38-3624-491a-96a3-0975376e7d8c">2.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMy04LTEtMS01MzM1NQ_eb415284-8ea6-4955-8005-ad0ad9629d96">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNC0yLTEtMS01MzM1NQ_d81a098e-8311-4f5e-8e61-bfb3c1ea6fdd">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNC00LTEtMS01MzM1NQ_ac7525e9-8d07-4234-9315-413e07593e96">14.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNS0yLTEtMS01MzM1NQ_78cf5763-539a-4f71-bb1a-bad8acd825cd">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNS00LTEtMS01MzM1NQ_7be4b6a1-085f-4ac1-ae79-22d9666789ad">6.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNS02LTEtMS01MzM1NQ_d4e2e74c-e938-44f1-a88e-62555661b995">5.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNS04LTEtMS01MzM1NQ_fe6a5719-9908-44b2-96c8-c7553c8892c0">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNi0yLTEtMS01MzM1NQ_789bd27e-efb2-4906-b6f4-63c6514bdea8">1,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="2" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNi00LTEtMS01MzM1NQ_54aeed53-df7e-41db-8fdd-ec2303ca1dda">6.89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNi02LTEtMS01MzM1NQ_1fc87896-931a-4c64-b9a7-03e259cc47e7">5.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNi04LTEtMS01MzM1NQ_f91f8772-6e0c-4053-a1c0-861525a985c7">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested awards at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNy0yLTEtMS01MzM1NQ_162b42f3-d1e6-4d0c-b893-d80384e81e4d">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="2" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNy00LTEtMS01MzM1NQ_e5134bc0-bf0c-4a38-a750-e90d8d9a959a">6.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNy02LTEtMS01MzM1NQ_3e64867c-961e-43a0-82ba-22897de96a19">8.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="-3" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNy04LTEtMS01MzM1NQ_fc4c8437-5116-4c2d-a320-5ca0f22c7ac7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div></ix:nonNumeric><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3c5091b5090e464aaed299ddb3120b38" continuedAt="i5f6847b10e964094b79793bc598385e9">(1)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"><ix:continuation id="i5f6847b10e964094b79793bc598385e9">Aggregate intrinsic value as of March&#160;31, 2022 was calculated as the difference between the closing price per share of our common stock on the last trading day of March&#160;31, 2022, which was $<ix:nonFraction unitRef="usdPerShare" contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMzAyMg_ed22d8ec-e707-4b87-b0a3-803463b486cf">3.59</ix:nonFraction>, and the exercise price of the options, multiplied by the number of in-the-money options.</ix:continuation> </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the unrecognized compensation costs related to outstanding unvested options under our equity incentive plans were $<ix:nonFraction unitRef="usd" contextRef="i1b42cfc93e2b4c79b0b5d4699ce58cae_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMzI0MA_decebf7a-5248-4462-835c-f14f4c6fa067">0.1</ix:nonFraction> million. We expect to recognize those costs over a weighted average period of <ix:nonNumeric contextRef="ib321b7bc2a2347bda69869d595adc12e_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk1NQ_e8ef4238-54d2-4f48-b379-ad1e2d176597">0.5</ix:nonNumeric> years. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i983957dabe94406790ee0176b8f5d32a"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-based Awards:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Stock Units with Market Condition</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted PSU awards to certain executive officers and senior level employees. The number of PSUs ultimately earned under these awards is calculated based on the Total Shareholder Return (TSR) of our common stock as compared to the TSR of a defined group of peer companies during the applicable <ix:nonNumeric contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk0MA_6796fdb8-2886-4c9b-ab2d-973ffc54f352">three-year</ix:nonNumeric> performance period. The percentage of PSUs that vest will depend on our relative position at the end of the performance period and can range from <ix:nonFraction unitRef="number" contextRef="ifbc7c42ab7c948dbb536b605def058fd_D20220101-20220331" decimals="INF" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMzg1MQ_21481c74-7e2b-410d-a730-31ed4255d97d">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="id07ffabfcd0b42608b10129b2e59ffd5_D20220101-20220331" decimals="INF" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMzg1Nw_0fbffbb9-ecd6-468d-8e6e-e06fb1bb2803">200</ix:nonFraction>% of the number of units granted.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the performance of our stock relative to our defined group of peer companies, none of the PSUs awarded in 2019 for the 2019-2021 measurement period were vested. The performance adjustment in the table below reflects that <ix:nonFraction unitRef="shares" contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt-sec:numwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMTIwOTQ2Mjc5MTc2MjQ_c76c9075-d3d5-4efc-9d2e-ee131d7ff9b7">no</ix:nonFraction> shares were issued upon vesting of the 2019 PSU awards. </span></div><ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk1Mw_21935f03-ff02-4c36-b926-8fec074b41b0" escape="true"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the TSR-based PSUs is as follows: </span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units <br/>(in 000s)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i357950952be44c25a149476baf5f1338_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfMS0yLTEtMS01MzM1NQ_2169eb3f-6253-4061-b08a-659ff433099c">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i357950952be44c25a149476baf5f1338_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfMS00LTEtMS01MzM1NQ_6fab7dee-0afc-428d-8ebd-660e021d93f6">10.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfMi0yLTEtMS01MzM1NQ_07480a36-e5cb-47e0-b385-01f82788e2e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfMi00LTEtMS01MzM1NQ_88f256b7-779f-43f0-b247-c45721a1a186">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance adjustment for 2019 awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331" decimals="-3" sign="-" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfMy0yLTEtMS01MzM1NQ_8c8ce813-7a79-4fa1-a28d-6f50757caa49">341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331" decimals="2" name="fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfMy00LTEtMS01MzM1NQ_8813ecb9-edcd-42ee-8701-5f1f63119801">16.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU released</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfNC0yLTEtMS01MzM1NQ_1d83cb8b-5c3b-4604-accd-037787055be6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfNC00LTEtMS01MzM1NQ_2e9be8bd-6b3c-4e6f-a962-3162d386f8a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfNS0yLTEtMS01MzM1NQ_eb8f2efa-d62a-4b83-ada2-c095c1e85c53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfNS00LTEtMS01MzM1NQ_5b3ca31b-04a4-4335-a9d4-02a7f6974f30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic924218fbf5a4d91b76fd02ad51f0368_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfNi0yLTEtMS01MzM1NQ_a2eb51e1-2fd9-41aa-9301-33ce26121aef">869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic924218fbf5a4d91b76fd02ad51f0368_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfNi00LTEtMS01MzM1NQ_2a72f24d-1554-4745-9660-2ec8a0cb354f">7.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:8pt;margin-top:3pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of&#160;March&#160;31, 2022, the unrecognized compensation costs related to these awards were $<ix:nonFraction unitRef="usd" contextRef="ic924218fbf5a4d91b76fd02ad51f0368_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNDYxMQ_670fa4da-13fc-4936-8da8-2055712e3038">3.2</ix:nonFraction> million. We expect to recognize those costs over a weighted average period of <ix:nonNumeric contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk0Ng_b1ba583b-4f8d-4d62-a58b-c8944a230453">1.6</ix:nonNumeric> years. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Stock Units with Performance Conditions</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we granted performance stock units to an employee. The number of performance stock units that ultimately vested under these awards was dependent on the employee achieving certain discrete operational milestones, the last of which was measured at December 31, 2021. In early 2022, it was determined that the operational milestones were not met and the <ix:nonFraction unitRef="shares" contextRef="i63b45dc8c7f84841a01e93bde43297e1_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMTIwOTQ2Mjc5MTcxMDM_5f936d9f-e594-4066-9ffa-fec752729510">29</ix:nonFraction>&#160;thousand awards that were outstanding on December 31, 2021 were cancelled.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2017 Employee Stock Purchase Plan (ESPP)</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ESPP offers U.S. and some non-U.S. employees the right to purchase shares of our common stock. Our ESPP program has a <ix:nonNumeric contextRef="i976dac4ee8d24a6b9937b433c337665a_D20220101-20220331" name="fldm:EmployeeStockPurchasePlanOfferingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk0Nw_d2068f8f-42ce-4949-b071-ee80a827ce2b">six-month</ix:nonNumeric> offering period, with a new period commencing on the first trading day on or after May 31 and November 30 of each year. Employees are eligible to participate through payroll deductions of up to <ix:nonFraction unitRef="number" contextRef="i6f8238e8d8694c059385a480dcb687e1_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTUxMQ_ce9e7477-5b48-4925-b8f9-e8ff6d008094">10</ix:nonFraction>% of their compensation. Employees may not purchase more than $<ix:nonFraction unitRef="usd" contextRef="i976dac4ee8d24a6b9937b433c337665a_D20220101-20220331" decimals="INF" name="fldm:SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTU3NA_bbd3b2ce-918d-423a-9e03-b2ebea4c38a4">25</ix:nonFraction> thousand of stock for any calendar year. The purchase price at which shares are sold under the ESPP is <ix:nonFraction unitRef="number" contextRef="i976dac4ee8d24a6b9937b433c337665a_D20220101-20220331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTY3MQ_8de4fbcf-f71f-441e-b2ca-34bf32e1eaa9">85</ix:nonFraction>% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based Compensation Expense</span></div><ix:continuation id="i2014d530a0a74e47a8fdc3bed6241437"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units, stock options and performance share units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9291755db0804b7e971901deb2d9a94a_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjA0ZjM5ZDk5ODA3ZDQzMTc4YzU4N2M1ODJlNWM0Njk1L3RhYmxlcmFuZ2U6MDRmMzlkOTk4MDdkNDMxNzhjNTg3YzU4MmU1YzQ2OTVfMi0yLTEtMS01MzM1NQ_040c1b1f-ccae-49ab-8a16-902ae6743c05">3,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45dc092a669a4531bc189ae9f0583e68_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjA0ZjM5ZDk5ODA3ZDQzMTc4YzU4N2M1ODJlNWM0Njk1L3RhYmxlcmFuZ2U6MDRmMzlkOTk4MDdkNDMxNzhjNTg3YzU4MmU1YzQ2OTVfMi00LTEtMS01MzM1NQ_15c0b969-7009-41e0-b60b-dd1e1f18dfeb">3,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f805e7f1d6c46a69b33311aa284f9dd_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjA0ZjM5ZDk5ODA3ZDQzMTc4YzU4N2M1ODJlNWM0Njk1L3RhYmxlcmFuZ2U6MDRmMzlkOTk4MDdkNDMxNzhjNTg3YzU4MmU1YzQ2OTVfMy0yLTEtMS01MzM1NQ_ce91b095-4a5a-4254-86f4-d5c123a67d32">100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id192327cb55c41259f9faa5f5322725c_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjA0ZjM5ZDk5ODA3ZDQzMTc4YzU4N2M1ODJlNWM0Njk1L3RhYmxlcmFuZ2U6MDRmMzlkOTk4MDdkNDMxNzhjNTg3YzU4MmU1YzQ2OTVfMy00LTEtMS01MzM1NQ_f5f6d7b7-fcc7-4d01-8113-3f329a24bcb1">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjA0ZjM5ZDk5ODA3ZDQzMTc4YzU4N2M1ODJlNWM0Njk1L3RhYmxlcmFuZ2U6MDRmMzlkOTk4MDdkNDMxNzhjNTg3YzU4MmU1YzQ2OTVfNC0yLTEtMS01MzM1NQ_f389de9d-e31e-4071-b52c-2fa538fbc85f">4,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjA0ZjM5ZDk5ODA3ZDQzMTc4YzU4N2M1ODJlNWM0Njk1L3RhYmxlcmFuZ2U6MDRmMzlkOTk4MDdkNDMxNzhjNTg3YzU4MmU1YzQ2OTVfNC00LTEtMS01MzM1NQ_653a5bde-c022-4743-8bc0-f7858437d6df">3,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83Ni9mcmFnOjFjMmJkM2UwYjc5MjQ3YzQ5NjAzNTM0MDZmYmEyYzNkL3RleHRyZWdpb246MWMyYmQzZTBiNzkyNDdjNDk2MDM1MzQwNmZiYTJjM2RfMjgwOQ_5342c03b-5d91-4617-acd8-5420afadbe5f" continuedAt="i97c56875309240c99eb754e9ac9cd24b" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i97c56875309240c99eb754e9ac9cd24b" continuedAt="i1c86f36fb37e46a8951fc914b816c34f"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly provision for income taxes is based on an estimated effective annual income tax rate. Our quarterly provision for income taxes also includes discrete items, such as changes in valuation allowances or adjustments upon finalization of tax returns as well as infrequently occurring items, if any, such as the effects of changes in tax laws or rates, in the interim period in which they occur.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83Ni9mcmFnOjFjMmJkM2UwYjc5MjQ3YzQ5NjAzNTM0MDZmYmEyYzNkL3RleHRyZWdpb246MWMyYmQzZTBiNzkyNDdjNDk2MDM1MzQwNmZiYTJjM2RfNDU1_7e2027ed-782d-4793-9f16-93d681766a66">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83Ni9mcmFnOjFjMmJkM2UwYjc5MjQ3YzQ5NjAzNTM0MDZmYmEyYzNkL3RleHRyZWdpb246MWMyYmQzZTBiNzkyNDdjNDk2MDM1MzQwNmZiYTJjM2RfNDYy_7068966b-3211-4c9a-96b0-0e963e2ab20e">1.7</ix:nonFraction>&#160;million for the three months ended March&#160;31, 2022 and 2021, respectively. Lower losses in our foreign operations in the quarter ended March&#160;31, 2022 compared to the quarter ended March&#160;31, 2021 resulted in a lower tax benefit for our foreign operations for the three months ended March&#160;31, 2022 compared to the prior year period.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax benefit for the periods presented in this report differs from the 21% U.S. Federal statutory rate principally because we maintain a valuation allowance for our domestic deferred tax assets, which primarily consist of net-operating loss carryforwards.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recording deferred tax assets is appropriate when realization of these assets is more likely than not. Assessing the realizability of deferred tax assets is dependent upon several factors including historical financial results and future expected financial results. Domestic deferred tax assets have been offset by valuation allowances. Any release of valuation allowances could have the effect of decreasing the income tax provision in the period the valuation allowance is released. We continue to assess the likelihood that we will be able to recover our deferred tax assets, including those for which a valuation allowance is recorded. There can be no assurance that we will generate profits in the future periods enabling us to fully realize our deferred tax assets. The timing of recording a valuation allowance or the reversal of such valuation allowance is subject to objective and subjective factors that cannot be readily predicted in advance.</span></div></ix:continuation><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1c86f36fb37e46a8951fc914b816c34f">Our tax positions are subject to audits by multiple tax jurisdictions. We believe that we have provided adequate reserves for uncertain tax positions for all tax years still open for assessment. For the three months ended March&#160;31, 2022&#160;and 2021, respectively, we did&#160;not recognize any material interest or penalties related to uncertain tax positions.</ix:continuation> </span></div><div id="i3f52f78858b0473b983a2153293d04e0_79"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTYwNg_f5ed101e-db53-4327-9c89-a7953cba92a2" continuedAt="if6cceb8c53fc48e1818873785221877f" escape="true">Information About Geographic Areas</ix:nonNumeric></span></div><ix:continuation id="if6cceb8c53fc48e1818873785221877f"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in <ix:nonFraction unitRef="segment" contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfNTg_9f7c5ec9-b026-48a0-9a20-837a4fb9027d">one</ix:nonFraction> reporting segment that develops, manufactures and commercializes tools for life science research. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. For purposes of allocating resources and evaluating regional financial performance, our chief executive officer reviews separate sales information for the different regions of the world. Our general and administrative expenses and our research and development expenses are not allocated to any specific region. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary table of our revenue by geographic areas of our customers and by product and services for the three months ended March&#160;31, 2022 and 2021 is included in Note 6 to the condensed consolidated financial statements. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from customers in the United States represented $<ix:nonFraction unitRef="usd" contextRef="i890754c6557847938cb71a04d83d4e22_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfOTc3_e02b2b7d-ba53-49de-9300-f87014b809f5">11.8</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="i890754c6557847938cb71a04d83d4e22_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfOTg0_5212f1de-1f1b-4d24-b1e2-97449d24cf15">45</ix:nonFraction>% of total revenues, and $<ix:nonFraction unitRef="usd" contextRef="i6825599028a44895afeda749b0c6a2be_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTAxMA_c65c3a3e-9d1f-458d-b041-01764f00258f">18.1</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="i6825599028a44895afeda749b0c6a2be_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTAxNw_af2452f8-74b6-433a-8c06-a30fb029b3e3">55</ix:nonFraction>% of total revenues, for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from customers in China represented $<ix:nonFraction unitRef="usd" contextRef="icd04707bc427433aa0a24baf6c191f0c_D20220101-20220331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTI2Mw_acd5e346-6d1a-4670-9872-661b9ae8d96a">2.8</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="icd04707bc427433aa0a24baf6c191f0c_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTI3MA_9113905c-4d97-4111-afa5-1d36fec03a38">11</ix:nonFraction>% of total revenues, and $<ix:nonFraction unitRef="usd" contextRef="i448c3bd9337e456095cdb94a8fa30336_D20210101-20210331" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTI5Nw_e7e97918-fbd2-43af-94d2-dbb2cf842b8d">3.0</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="i448c3bd9337e456095cdb94a8fa30336_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTMwNA_7fff89d7-b571-4f39-a3d5-791868c53739">9</ix:nonFraction>% of total revenues, for the three months ended March&#160;31, 2022 and 2021, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of China for the three months ended March&#160;31, 2022, no foreign country had revenue in excess of 10% of total revenues during any of the periods presented in this report.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i3f52f78858b0473b983a2153293d04e0_82"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF84Mi9mcmFnOmU3YjdjODI5ZDI2YjQxMzJiZDgxMzAxNTY4ZWZhNDg5L3RleHRyZWdpb246ZTdiN2M4MjlkMjZiNDEzMmJkODEzMDE1NjhlZmE0ODlfMzM3MA_f9ce0d0e-6cbb-4da0-ba54-fa8cb7559ffa" continuedAt="ib504199f9f4f435fbae270529fb64e10" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="ib504199f9f4f435fbae270529fb64e10" continuedAt="ic9d9f01714554a1f8ff8abc858a67263"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we have entered into indemnification provisions under certain of our agreements in the ordinary course of business, typically with business partners, customers, and suppliers. Pursuant to these agreements, we may indemnify, hold harmless, and agree to reimburse the indemnified parties on a case-by-case basis for losses suffered or incurred by the indemnified parties in connection with any patent or other intellectual property infringement claim by any third party with respect to our products. The term of these indemnification provisions is generally perpetual from the time of the execution of the agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is typically not limited to a specific amount. In addition, we have entered into indemnification agreements with our officers, directors, and certain other employees. With certain exceptions, these agreements provide for indemnification for </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic9d9f01714554a1f8ff8abc858a67263"><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related expenses including, among others, attorneys&#8217; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, a putative class action complaint alleging violations of the federal securities laws was filed against the Company (also naming our now-former Chief Executive Officer and our Chief Financial Officer as defendants) in the U.S. District Court for the Northern District of California (Reena Saintjermain, et al. v. Fluidigm Corporation, et al). The Court appointed a lead plaintiff and lead counsel in December 2020, and an amended complaint was filed on February 19, 2021. The complaint, as amended, seeks unspecified damages on behalf of a purported class of persons and entities who acquired our common stock between February 7, 2019 and November 5, 2019 and alleges securities laws violations based on statements and alleged omissions made by the Company during such period. The Company filed a motion to dismiss the complaint on April 5, 2021 and, on August 4, 2021, the Court granted defendants&#8217; motion to dismiss with leave to amend. A second amended complaint was filed on September 14, 2021. The Company filed a motion to dismiss the second amended complaint on October 29, 2021 and, on February 14, 2022, the Court granted defendants&#8217; motion and dismissed the second amended complaint with prejudice. On March 15, 2022, plaintiff filed a Notice of Appeal to the U.S. Court of Appeals for the Ninth Circuit. We believe the claims alleged in the complaint lack merit and we intend to defend this action vigorously. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law, tax, regulatory, distribution arrangements, employee relations and other matters. Periodically, we review the status of each matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we continue to reassess the potential liability related to pending claims and litigation and may revise estimates.</span></div></ix:continuation><div id="i3f52f78858b0473b983a2153293d04e0_2178"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMjA5NDYyNzkxMjk2Mw_cb5149e1-2db3-4f9a-886f-cfb660507371" continuedAt="i2655752adafb4ab1aa7695e381916570" escape="true">Subsequent Event</ix:nonNumeric></span></div><ix:continuation id="i2655752adafb4ab1aa7695e381916570"><div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, our</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stockholders approved the Charter Amendment Proposal and Private Placement Issuance Proposal discussed in Note 3. The Private Placement Issuance closed on April 4, 2022. On April 4, 2022, we received $<ix:nonFraction unitRef="usd" contextRef="ic3dda181cdd645f793c5612b9ec9660b_D20220404-20220404" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDc0Mg_ff195f61-1068-4b38-87bf-0dd7a3715a4f">225</ix:nonFraction>&#160;million, before expenses, and issued <ix:nonFraction unitRef="shares" contextRef="ic3dda181cdd645f793c5612b9ec9660b_D20220404-20220404" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDc1Ng_36121433-9867-427f-8d07-d70221b5dcf8">225,000</ix:nonFraction> shares of Series B Preferred Stock pursuant to the Purchase Agreements. The Bridge Loans converted into <ix:nonFraction unitRef="shares" contextRef="ic3dda181cdd645f793c5612b9ec9660b_D20220404-20220404" decimals="INF" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDc2NQ_c1c48069-d1e4-4fb6-ba01-72791867fe17">30,559</ix:nonFraction> shares of Series B Preferred Stock based on a Conversion Amount, as described in Note 3, of $<ix:nonFraction unitRef="usd" contextRef="ic3dda181cdd645f793c5612b9ec9660b_D20220404-20220404" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDc3Mw_5d3690f6-f8cd-40c1-9f49-20bec00b2da9">25.5</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following stockholder approval of the Charter Amendment Proposal and the Private Placement Issuance Proposal, our name was changed to Standard BioTools Inc. Shortly after the closing of the Private Placement Issuance, we also changed the ticker symbol for our common stock to LAB. Upon the closing of the Private Placement Issuance, Dr. Michael Egholm was appointed as the Company&#8217;s President and Chief Executive Officer and as a member of the Board of Directors. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the closing, we adopted the 2022 Inducement Equity Incentive Plan with an initial reserve of approximately <ix:nonFraction unitRef="shares" contextRef="ib980c3b074f94dd4a574cde692cff868_I20220404" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDc4Nw_65acb1e4-2997-40ab-88d8-46d2943b47e7">9.5</ix:nonFraction>&#160;million shares. Effective April 4, 2022, we awarded options for <ix:nonFraction unitRef="shares" contextRef="i9b39f3273ab44415baf1d8b96c519c44_D20220404-20220404" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDgwMA_5ac1dd38-d7e6-4d05-aa7a-2b9345886a8c">8.1</ix:nonFraction>&#160;million shares of our common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9b39f3273ab44415baf1d8b96c519c44_D20220404-20220404" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDgxMw_e3d3ddee-5354-4bf5-9d8b-9c91bacf9de2">3.99</ix:nonFraction> per share and <ix:nonFraction unitRef="shares" contextRef="ic5320ad3429740cc9ae7dfdcc463a85f_D20220404-20220404" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDgyMA_afeefc0e-dda6-4b53-971b-581c78fa0591">1.4</ix:nonFraction>&#160;million restricted stock units to members of our management team, including Dr. Egholm under the 2022 Inducement Equity Incentive Plan. These awards vest over <ix:nonNumeric contextRef="i9b39f3273ab44415baf1d8b96c519c44_D20220404-20220404" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDg0Ng_baa605dc-c1cc-4fb8-ac89-ca74ed333e99">four years</ix:nonNumeric>.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i3f52f78858b0473b983a2153293d04e0_88"></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (MD&amp;A) is intended to help the reader understand the results of operations and financial condition of Standard BioTools Inc. MD&amp;A is provided as a supplement to, and should be read together with our condensed consolidated financial statements and the notes to those statements included elsewhere in this Form&#160;10-Q. This Form&#160;10-Q contains forward-looking statements </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">within </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">the meaning of Section&#160;27A of the Securities Act of 1933, as amended (the Securities Act), and Section&#160;21E of the Securities Exchange Act of 1934, as amended, or Exchange Act, that are based on our management&#8217;s beliefs and assumptions and on information currently available to our management. The forward-looking statements are contained principally in the section entitled &#8220;Risk Factors&#8221; and this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations. Forward-looking statements include information concerning our possible or assumed future cash flow, revenue, sources of revenue and results of operations, cost of product revenue and product margin, operating and other income and expenses, unit sales and the selling prices of our products, business strategies, financing plans, expansion of our business, competitive position, industry environment, potential growth opportunities, market growth expectations, and the effects of competition and public health crises (including the COVID-19 pandemic) on our business, the global supply chain, and our customers, suppliers, and other business partners. Forward-looking statements include statements that are not historical facts and can be identified by terms such as &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;could,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or similar expressions and the negatives of those terms.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in Part II, Item&#160;1A, &#8220;Risk Factors,&#8221; located elsewhere in this quarterly report on Form&#160;10-Q, and in our annual report on Form 10-K filed with the Securities and Exchange Commission (SEC). Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management&#8217;s beliefs and assumptions only as of the date of this Form&#160;10-Q.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. You should read this Form&#160;10-Q completely and with the understanding that our actual future results may be materially different from what we expect.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Standard BioTools&#8482;, the Standard BioTools logo, Fluidigm&#174;, the Fluidigm logo, Access Array&#8482;, Acculift&#8482;, Advanta&#8482;, Atlas&#8482;, Biomark&#8482;, Bringing new insights to life&#8482;, C1&#8482;, Callisto&#8482;, Cell-ID&#8482;, CyTOF&#174;, CyTOF XT&#8482;, CyTOF XT logo, D3&#8482;, Delta Gene&#8482;, Direct&#8482;, Digital Array&#8482;, Dynamic Array&#8482;, EP1&#8482;, EQ&#8482;, FC1&#8482;, Flex Six&#8482;, Flow Conductor&#8482;, GeckoGrip&#8482;, Helios&#8482;, High-Precision 96.96 Genotyping&#8482;, HTI&#8482;, Hyperion&#8482;, IMC&#8482;, Imaging Mass Cytometry&#8482;, Immune Profiling Assay&#8482;, Juno&#8482;, Maxpar&#174;, MCD&#8482;, MSL&#174;, Nanoflex&#8482;, Open App&#8482;, Pathsetter&#8482;, Polaris&#8482;, qdPCR 37K&#8482;, Script Builder&#8482;, Script Hub&#8482;, Singular&#8482;, SNP Trace&#8482;, and SNP Type&#8482; are trademarks or registered trademarks of Standard BioTools Inc. Other service marks, trademarks and trade names referred to in this quarterly report on Form&#160;10-Q are the property of their respective owners.</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">___________________________</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this Form&#160;10-Q to &#8220;Standard BioTools&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Standard BioTools Inc. and its subsidiaries.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our MD&amp;A is organized in the following sections: </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Overview </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Recent Developments</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Critical Accounting Policies, Significant Judgments and Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Recent Accounting Changes and Accounting Pronouncements</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Results of Operations</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Liquidity and Capital Resources </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standard BioTools Inc., previously known as Fluidigm Corporation, is driven by a bold vision &#8211; unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, we provide reliable and repeatable insights in health and disease using our proprietary mass cytometry and microfluidics technologies that help transform scientific discoveries into better patient outcomes. We work with leading academic, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We distribute our systems through our direct sales force and support organizations located in North America, Europe, and Asia-Pacific, and through distributors or sales agents in several European, Latin American, Middle Eastern, and Asia-Pacific countries. Our manufacturing operations are located in Singapore and Canada.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Our facility in Singapore manufactures our integrated fluidic circuits (IFCs) as well as our microfluidics instruments, which are assembled by our contract manufacturer located within our Singapore facility. Our mass cytometry instruments, assays and reagents are manufactured at our facility in Canada.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total revenue for the three months ended March&#160;31, 2022 was $26.5 million and $32.8 million for the three months ended March&#160;31, 2021. We have incurred significant net losses since our inception in 1999 and, as of March&#160;31, 2022, our accumulated deficit was $812.3 million.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement Issuance</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 23, 2022, we entered into (i) a Loan Agreement (the Casdin Bridge Loan Agreement) with Casdin Private Growth Equity Fund II, L.P. and Casdin Partners Master Fund, L.P. (collectively, Casdin) and (ii) a Loan Agreement (the Viking Bridge Loan Agreement, and together with the Casdin Bridge Loan Agreement, the Bridge Loan Agreements) and each a Bridge Loan) with Viking Global Opportunities Illiquid Investments Sub-Master LP and Viking Global Opportunities Drawdown (Aggregator) LP (collectively, Viking and, together with Casdin, the Purchasers and each, a Purchaser). Each Bridge Loan Agreement provided for a $12.5 million term loan to the Company. The Bridge Loans were fully drawn on January 24, 2022. The Bridge Loans automatically converted into Series B Preferred Stock, defined below, upon the completion of the Preferred Equity Financing, defined below. The proceeds of the Bridge Loans may be used for working capital and general corporate purposes.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also on January 23, 2022, we entered into separate Series B Convertible Preferred Stock Purchase Agreements (the Purchase Agreements) with each of the Purchasers pursuant to which, among other things, at the closing of the transactions contemplated thereby, and on the terms and subject to the conditions set forth therein, including the approval of our stockholders, we issued and sold an aggregate of $225 million of convertible preferred stock on April 4, 2022, consisting of: (i) 112,500 shares of the Company&#8217;s Series B-1 Convertible Preferred Stock, par value $0.001 per share (the Series B-1 Preferred Stock), at a purchase price of $1,000 per share to Casdin; and (ii) 112,500 shares of the Company&#8217;s Series B-2 Convertible Preferred Stock, par value $0.001 per share (the Series B-2 Preferred Stock, and together with the Series B-1 Preferred Stock, the Series B Preferred Stock) at a purchase price of $1,000 per share to Viking (the Preferred Equity Financing, and together with the issuance of shares of Series B Preferred Stock in connection with the conversion of the Bridge Loans, the Private Placement Issuance). The proceeds of the Preferred Equity Financing will be used for expenses related to the Private Placement Issuance, as well as working capital, general corporate purposes and potential future merger and acquisition opportunities that we may identify from time to time.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors (the Board) called a meeting (Special Meeting) to ask our stockholders to consider, vote upon and approve (i) a proposal to amend the Company&#8217;s Eighth Amended and Restated Certificate of Incorporation (the Charter) to, among other things, increase the number of shares of common stock, par value $0.001 per share, (Common Stock) of the Company that we are authorized to issue from two hundred million (200,000,000) shares to four hundred million (400,000,000) shares and to change our name to Standard BioTools Inc. (the Charter Amendment Proposal); (ii) a proposal to approve, in accordance with Nasdaq Listing Rule 5635, the issuance of (A) the Series B-1 Preferred Stock and the Series B-2 Preferred Stock pursuant to the Purchase Agreements, (B) the Series B-1 Preferred Stock and the Series B-2 Preferred Stock issuable pursuant to the terms of the Bridge Loan Agreements and (C) the Common Stock issuable upon the conversion of the Series B Preferred Stock (the Private Placement Issuance Proposal); and (iii) a proposal to adjourn the Special Meeting if the Special Meeting were convened and a quorum were present, but there were not sufficient votes to approve the Charter Amendment Proposal and the Private Placement Issuance Proposal (the Adjournment Proposal, and, together with the Private Placement Issuance Proposal and the Charter Amendment Proposal, the Stockholder Proposals). Each of the Private Placement Issuance Proposal and Charter Amendment Proposal were conditioned on the approval of the other proposal, and neither proposal would take effect unless both were approved by our stockholders. Our stockholders approved the Charter Amendment Proposal and Private Placement Issuance Proposal on April 1, 2022. The Private Placement Issuance closed on April 4, 2022.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;1, 2022, the Company filed with the Secretary of State of the State of Delaware (i)&#160;the Charter Amendment, (ii) the Series&#160;B-1&#160;Preferred Stock Certificate of Designations to establish the preferences, limitations and relative rights of the Series&#160;B-1&#160;Preferred Stock and (iii)&#160;the Series&#160;B-2&#160;Preferred Stock Certificate of Designations to establish the preferences, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">limitations and relative rights of the Series&#160;B-2&#160;Preferred Stock. The Charter Amendment, Series&#160;B-1&#160;Certificate of Designations and Series B-2 Certificate of Designations became effective upon filing.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 4, 2022, following stockholder approval of the Charter Amendment Proposal and the Private Placement Issuance Proposal, we received $225 million, before expenses, and issued 225,000 shares of Series B Preferred Stock, pursuant to the Purchase Agreements. The Bridge Loans converted into 30,559 shares of Series B Preferred Stock. With the approval of the proposals, our name was changed to Standard BioTools Inc. Shortly after the closing of the Private Placement Issuance we also changed our ticker symbol for our common stock to LAB. Upon the closing of the Private Placement Issuance, Dr. Michael Egholm was appointed as the Company&#8217;s President and Chief Executive Officer and as a member of the Board of Directors. </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Update </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The capital from the Private Placement Issuance is expected to help fuel a realization of identified growth and cost opportunities and allow for new growth drivers as we pursue and consolidate complementary technologies across the life science ecosystem. </span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Achieving significantly greater breadth and scale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With a strong platform and deeply experienced management team, we will strive to accelerate growth both organically and, importantly, inorganically to deliver breadth and scale to the Company. </span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Optimizing the cost structure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As we work toward our goal of being sustainably cash flow positive, we intend to have a leaner general and administrative expense structure and a sales and marketing spend that is better aligned to support high-growth areas. </span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Leveraging a larger menu to expanding customer base. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to direct sales and marketing towards expanding our relationships deeper into the life science ecosystem, including large biopharma, emerging biotech, and diagnostic companies and the broader contract research organization and contract manufacturing organization service provider network.</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Accelerating growth in mass cytometry</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With particular emphasis on expanding our CyTOF and Imaging Mass Cytometry&#8482; platforms to further support translational and clinical research, we intend to simplify the design and execution of deep cell profiling, standardize sample analysis with reproducible workflows and automation, and significantly advance capabilities for novel therapeutic development. </span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Realizing and rationalizing opportunities in targeted high-profit areas within microfluidics</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We plan to focus on targeted end-applications (e.g., proteomics, biomarker analysis) and key partnerships (e.g., Olink&#174; Bioscience) while rationalizing business processes and execution</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the audited consolidated financial statements and the related notes for the year ended December&#160;31, 2021 included in our annual report on Form 10-K, filed with the SEC on</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> March 8, 2022, we disclosed that we had performed an assessment to determine whether there were conditions or events, considered in the aggregate, that raised substantial doubt about our ability to continue as a going concern for at least the twelve-month period following the date the financial statements were issued. We believed that our then-current level of cash and cash equivalents, together with committed financing facilities, were not sufficient to fund ongoing operations for at least the twelve-month period after the financial statements were issued. Since then, we have closed the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$225 million Series B Preferred Equity Financing, as discussed in Note 3. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The financing, which was contingent upon stockholder approval, was previously disclosed in Note 18 to our audited financial statements included in our 2021 annual report on Form 10-K. The completion of this investment has eliminated the doubt about the Company&#8217;s ability to continue as a going concern. See Note 3 and Note 17 for additional discussion.  </span></div><div id="i3f52f78858b0473b983a2153293d04e0_91"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies, Significant Judgments and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimates</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements and the related notes included elsewhere in this Form 10-Q are prepared in accordance with accounting principles generally accepted in the United States. The preparation of these condensed financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. We also assessed certain accounting matters that generally require consideration of forecasted financial information, including the unknown impact of the COVID-19 pandemic and the war in Ukraine. Accounting matters that rely on forecasted financial information included, but were not limited to, our inventory, and related reserves, and the carrying value of goodwill and other long-lived assets and liabilities. Actual results could differ materially from these estimates and could have a material adverse effect on our condensed consolidated financial statements. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We also use significant judgment in determining the fair value of financial instruments, including debt and equity instruments.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Changes and Accounting Pronouncements</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Guidance</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06 Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. The amendment to this ASU reduces the number of accounting models for convertible instruments and allows more contracts to qualify for equity classification, which is expected to result in more convertible instruments being accounted for as a single unit, rather than being bifurcated between debt and equity. The new guidance is effective for fiscal years beginning after December 15, 2021. We adopted ASU 2020-06 effective January 1, 2022.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The adoption of ASU 2020-06 did not have an impact on our 2014 and 2019 Convertible Notes.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2021, the FASB issued ASU 2021-10 Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. The amendment is effective for annual periods beginning after December 15, 2021. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The amendment establishes financial disclosure requirements for business entities that receive government assistance that they account for by analogizing to a grant or contribution model because there is no specific authoritative guidance under U.S. GAAP that applies to the transaction. Entities that receive this type of assistance should include the following information in their annual report: (1) the nature of the transaction, (2) the significant terms and conditions, (3) the accounting treatment, (4) the line items on the balance sheet and income statement that are affected along with (5) the respective amounts that have been recorded. We adopted ASU 2021-10 effective January 1, 2022. The adoption of ASU 2021-10 did not have a material impact on our financial statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our historical condensed consolidated statements of operations data for the three months ended March&#160;31, 2022 and 2021, and as a percentage of total revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:63.974%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.855%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.914%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.855%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.918%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,504&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,503)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,320)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(887)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on forward sale of Series B Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,792)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on bridge loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,655)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,862)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,492)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,288)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,821)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from sales of our products and services, and by entering into product development agreements, license and royalty agreements, and grants. Our product revenue consists of sales of instruments and consumables. Consumables revenue is largely driven by the size of our installed base of instruments and the annual level of pull-through per instrument. Service revenue is linked to the sales and active installed base of our instruments as our service revenue primarily consists of post-warranty service contracts, preventive maintenance plans, instrument parts, installation and training. We sell our products to leading academic and government laboratories, as well as pharmaceutical, biotechnology, clinical, plant and animal research organizations and clinical laboratories worldwide. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Development Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. On March 31, 2020, we entered into an OEM Supply and Development Agreement (Development Agreement) with a customer to develop products based on our microfluidics technology. The Development Agreement provided for up-front and periodic milestone payments during its development stage, which was completed in the third quarter of 2021, and for on-going annual payments of $0.4&#160;million for sustaining efforts. During the three months ended March&#160;31, 2022, we recognized $0.1 million of development revenue associated with these fees. During the three months ended March&#160;31, 2021, we recognized $1.5 million of revenue from the project. Costs associated with the Development Agreement were recorded in research and development expense in the condensed consolidated statement of operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Grant Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the three months ended March&#160;31, 2021, we recognized $0.3 million of grant revenue by providing research and development services under a contractual arrangement we entered into in the second half of 2019. The contract was completed during the third quarter of 2021. Costs associated with the agreement were recorded in research and development expense in the condensed consolidated statement of operations. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">License Revenue</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We recognize revenue from license agreements when the license is transferred to the customer and the customer is able to use and benefit from the license. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">three months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> March&#160;31, 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">we entered into an agreement to settle intellectual property infringement claims and received a </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$0.3 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> payment in exchange for a license to certain of our intellectual property.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single customer represented more than 10% of our total revenue for the three months ended March&#160;31, 2022. Revenue from one customer exceeded 10% of total revenue for the three months ended March&#160;31, 2021. Revenue from our five largest customers represented 21% and 27% of total revenue for the three months ended March&#160;31, 2022 and 2021, respectively. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our revenue disaggregated by source for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.780%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Instruments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Consumables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,004&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product and service revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,014&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,504&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,794&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:14pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our total revenue by geographic area for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.195%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,930&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,523&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,504&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,794&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;text-indent:18pt"><span><br/></span></div><div id="i3f52f78858b0473b983a2153293d04e0_97"></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue decreased by $6.3 million, or 19%, for the three months ended March&#160;31, 2022 compared to the three months ended March&#160;31, 2021 primarily driven by a decline in consumables revenue and development revenue. A weaker dollar negatively impacted Company total revenues by 1.1 percentage points</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Americas revenue decreased by $5.6 million, or 30%, for the three months ended March&#160;31, 2022 compared to th</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e three months ended March&#160;31, 2021. The decline is primarily attributable to a reduction in product revenue driven by</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the sharp decline in the demand for COVID-19 testing products and by a $1.4&#160;million decline in development revenue. EMEA revenue decreased by $0.5&#160;million driven by a decline in mass cytometry instruments, and partially offset by an increase in microfluidics instruments revenue primarily from products launched in the second half of 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A weaker dollar contributed 4.0 percentage points of the 5.8 percentage point decrease in EMEA revenue. In</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Asia-Pacific, revenue decreased by $0.2&#160;million, or 3.2%, primarily due to a decline in consumables revenue, which was largely offset by an increase in instruments revenue.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product and Service Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the split of product and service revenue between mass cytometry and microfluidics product categories and as a percentage of the respective category&#8217;s total product and service revenue for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"></td><td style="width:325.75pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:40.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:25.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:37.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:25.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:30.25pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year-Over-Year Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mass cytometry:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,540&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,482&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product and service revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,530&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Microfluidics:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,153&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,445&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,868&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,188&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total product and service revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,618&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,992&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mass cytometry revenue decreased by $0.5 million, or 4%, during the three months ended March&#160;31, 2022 compared to the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021. The year-over-year decrease was primarily attributable to an overall decrease in legacy mass cytometry instruments revenue, partially offset by an increase in revenue from CyTOF XT instruments, which were released in May 2021. The decline in microfluidics revenue of $4.4 million, or 26%, during the three months ended March&#160;31, 2022 compared to the three months ended March&#160;31, 2021 is directly attributable to reduced demand for our COVID-19 testing products, partially offset by revenues from new BioMark O and BioMark X instruments, which were both released in the second half of 2021.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect the average selling prices of our products to fluctuate over time based on market conditions, product mix, and currency fluctuations. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product and Service Cost, Product and Service Gross Profit and Product and Service Margin </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of product revenue includes manufacturing costs incurred in the production process, including component materials, labor and overhead, installation, packaging, and delivery costs. In addition, cost of product revenue includes amortization of developed technology and intangibles,&#160;royalty costs for licensed technologies included in our products, warranty, provisions for slow-moving and obsolete inventory, and stock-based compensation expense. Our cost of product revenue and related product margin may fluctuate depending on the capacity utilization of our manufacturing facilities in response to market conditions and the demand for our products. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of service revenue includes direct labor hours, overhead, and instrument parts. Our cost of service revenue and related service margin may fluctuate depending on the variability in material and labor costs of servicing instruments.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our product and service cost, product and service gross profit, and product and service margin for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:63.416%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.861%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product and service revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,267&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product and service gross profit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product and service margin</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ppt</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product and service margin decreased by 10.3 percentage points for the three months ended March&#160;31, 2022 compared to the three months ended March&#160;31, 2021. Products introduced in the second half of 2021, which have lower average gross margins, reduced product and service margins by 2.4 percentage points for the three months ended March&#160;31, 2022 compared to the three months ended March&#160;31, 2021. Higher inventory reserves and warranty costs contributed 2.2 percentage points and 1.7 percentage points, respectively, to the decline in product and service margins. Fixed depreciation and amortization costs on a lower revenue base contributed 2.4 percentage points to the decline in product and service margins for the three months ended March&#160;31, 2022 compared to the three months ended March&#160;31, 2021. Other factors, including unfavorable product mix from lower COVID-19 consumables sales in the three months ended March&#160;31, 2022 compared to the three months ended March&#160;31, 2021, coupled with the impact of lower plant utilization for mass cytometry products account for the majority of the remaining decline in product and service gross margins for the three months ended March&#160;31, 2022 compared to the three months ended March&#160;31, 2021. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our operating expenses for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.653%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,865&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,753&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,740&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,361&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense consists primarily of compensation-related costs, product development and material expenses, and other allocated facilities and information technology expenses. Our research and development efforts have focused primarily on enhancing our technologies and supporting development and commercialization of new and existing products and services. Research and development expense also includes costs incurred in conjunction with research grants and development arrangements. We have made substantial investments in research and development since our inception and expect to continue to do so.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense decreased by $1.9 million, or 18%, for the three months ended March&#160;31, 2022 compared to the three months ended March&#160;31, 2021 as the year-ago period includes development costs related to products that were launched in the second half of 2021.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense consists primarily of personnel costs for our sales and marketing, business development, finance, legal, human resources, information technology, and general management, as well as professional services, such as legal and accounting services.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense increased by $3.3 million, or 12%, for the three months ended March&#160;31, 2022 compared to the three months ended March&#160;31, 2021. The increase was primarily due to $3.4 million of costs associated with the Private Placement Issuance, and $1.2 million of severance costs for our former CEO. Litigation costs decreased by $1.1 million due to the resolution of patent infringement claims.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses for the rest of 2022 will be negatively impacted by costs associated with approximately $5.0 million of cash retention bonuses and approximately $2.9 million of stock-based compensation that will pay out over the next year through the first quarter of 2023.</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense and Other Non-Operating Items</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents these items for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.653%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year-over-Year Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,030)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(887)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on forward sale of Series B Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,792)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on bridge loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,655)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NA</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,359)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,172)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterest expense i</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s comprised primarily of interest on our convertible debt and Term Loan Facility. The increase in interest expense for the three months ended March&#160;31, 2022 compared to the three months ended March&#160;31, 2021 is due primarily to our Term Loan Facility. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Purchase Agreements, which promised to exchange 225,000 shares of Series B Preferred Stock for $225 million at a future date, accounted for as forward sales contracts at fair value in accordance with ASC 480 because the Series B Preferred Stock includes certain contingent redemption features which created an obligation for the Company to repurchase its shares. The fair value of the forward sales contracts was determined using a Monte Carlo Simulation (MCS) analysis. Given the convertibility of the Series B Preferred Stock into cash or our common stock under several scenarios, the MCS analysis simulated the value of the Series B Preferred Stock under numerous scenarios, reflecting the impact of the various conversion and redemption provisions of the Series B Preferred Stock. The fair value of 225,000 shares of Series B Preferred Stock was $262.8 million as of March 31, 2022. The increase in the fair value of the Series B Preferred Stock from January 23, 2022 to March&#160;31, 2022 reflects the increase in the price of our common stock price since the inception of the contracts and the change in the value of the various conversion rights and key provisions discussed below. The loss of $37.8 million on the forward sale of the Series B Preferred Stock represents the difference between the fair value of the Series B Preferred Stock</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $262.8 million and the $225.0 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of cash to be received.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applying the guidance in ASC 825 to the Bridge Loans, we have elected to record the Bridge Loans at their fair value, given the short period of time in which the Bridge Loans were expected to be outstanding. The Unrealized Loss on the Bridge Loans reflects the entire change in the value of the Bridge Loans as a single line item on the condensed consolidated statement of operations, including the portion attributable to accrued interest. Accordingly, we have recognized no interest expense on the Bridge Loans for the three months ended March&#160;31, 2022.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Bridge Loans is largely driven by the value of our common stock and the value of the Series B Preferred Stock into which they were converted. The Unrealized Loss on the Bridge Loans of $10.7 million was largely driven by an increase in the value in the price of our common stock from $2.84 per share at inception to $3.59 per share as of March&#160;31, 2022 and, to a lesser extent, by the impact of the change in value of the various conversion options of the Series B Preferred Stock. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Benefit</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax provision is generally driven by three components: (i) tax provision from our foreign operations, (ii) tax benefits from the amortization of acquisition-related intangible assets, and (iii) discrete items, such as changes in valuation allowances or adjustments upon finalization of tax returns. Depending on the relative value of these components, we can have either a tax benefit or expense for any given period.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a tax benefit of&#160;$0.6 million, or an effective tax rate of 0.7%, for the three months ended March&#160;31, 2022. In the three months ended March&#160;31, 2021, we recorded a tax benefit of $1.7&#160;million, or an effective tax rate of 8.2%. Lower losses in certain of our foreign operations in the quarter ended March&#160;31, 2022 compared to the quarter ended March&#160;31, 2021 resulted in a lower tax benefit for our foreign operations for the three months ended March&#160;31, 2022.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div style="text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, our principal sources of liquidity consisted of $30.0 million of cash and cash equivalents, as well as $1.0 million of restricted cash and $8.4 million of availability under the Revolving Credit Facility. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our cash flow summary for the three months ended March&#160;31, 2022 and 2021 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flow summary:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,590)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(868)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,923)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,026)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign exchange rate fluctuations on cash and cash equivalents</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,532&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,776)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase obligations consist of contractual and legally binding commitments to purchase goods and services. The majority of our contracts are cancellable with little or no notice or penalty. However, once a vendor has incurred costs to fulfill a contract with us, and which costs cannot be otherwise deployed, we are liable for those costs upon cancellation. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have additional obligations as part of our ordinary course of business, beyond those committed for capital expenditures and other purchase obligations and commitments for purchases of goods and services. For example, see Note 3 and Note 9 within our condensed consolidated financial statements for information about our short-term and long-term debt obligations and the Private Placement Issuance. See Note 10 within our condensed consolidated financial statements for information about our lease obligations, and see Note 16 within our condensed consolidated financial statements included elsewhere in this Form 10-Q for information about our various contractual and legally binding purchase commitments to purchase goods and services. Other than as disclosed above, there have been no material changes during the three months ended March&#160;31, 2022 to our contractual obligations disclosed in our &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our annual report on Form 10-K for the year ended December&#160;31, 2021. The expected timing of payments of our obligations is estimated based on current information. Timing of payments and actual amounts paid may be different, depending on the timing of receipt of goods or services, or changes to agreed-upon amounts for some obligations. In addition, some of our purchasing requirements are not current obligations and are therefore not included in the amounts above. For example, some of these requirements are not handled through binding contracts or are fulfilled by vendors on a purchase order basis within short time horizons.</span></div><div style="margin-bottom:8pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Used in Operating Activities</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive cash flows from operations primarily from cash collected from the sale of our products and services, license agreements and grants. Our cash flows from operating activities are also significantly influenced by our use of cash for operating expenses and working capital to support the business. We have historically experienced negative cash flows from operating activities as we have expanded our business and built our infrastructure domestically and internationally.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities for the three months ended March&#160;31, 2022 was $15.6 million and consisted of net loss of $76.3 million, less non-cash items of $57.6 million and cash provided by assets and liabilities, net, of $3.1 million. Non-cash items included a loss on forward sale of Series B Preferred Stock of $37.8 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an unrealized loss on the Bridge Loans of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$10.7 million, st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ock-based compensation expense of $4.0 million, amortization of developed technology of $3.0 million, depreciation and amortization of $1.0 million, provision for excess and obsolete inventory of $0.9 million, and a variety of smaller items.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net decrease in assets and liabilities was primarily attributable to a $3.0 million increase of accrued compensation and related benefits due to an increase in severance and retention bonuses, a reduction of accounts receivable, net of $2.9 million, and an increase of accounts payable of $1.9 million. These decreases were partially offset by an increase in inventories, net of $3.6 million, and a decrease of other liabilities of $1.3 million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Used in Investing Activities</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary investing activities consist of purchases, sales, and maturities of ou</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r short-term investments and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">capital expenditures for manufacturing, laboratory, computer equipment and software to support our infrastructure and workforce. We expect to continue to incur costs for capital expenditures to improve manufacturing efficiencies and strengthen information technology and network security. However, we may choose to decrease or defer certain capital expenditures and development activities, while further optimizing our organization.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the three months ended March&#160;31, 2022 was $0.9 million. Capital expenditures of $0.9&#160;million were incurred primarily to expand our microfluidics IFC production capacity in Singapore related to the NIH Contract. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Provided by (Used in) Financing Activities</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net cash provided by financing activities totaled $18.1 million during the three months ended March&#160;31, 2022. The principal source of cash was proceeds from the $25.0 million Bridge Loans, which occurred as part of the Private Placement Issuance. This was partially offset by repayments of $6.8 million of advances under the Revolving Credit Facility.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Resources</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2022 and December&#160;31, 2021, our working capital, excluding deferred revenues, current and deferred grant income, current, and restricted cash, was $41.9 million and $38.0 million, respectively, including cash and cash equivalents of $30.0 million and $28.5 million, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no investments as of March&#160;31, 2022 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2014, we closed an underwritten public offering of our 2014 Notes. Pursuant to the Indenture governing the 2014 Notes, holders of the 2014 Notes have the right, subject to certain conditions specified in such indenture, to require us to repurchase all or a portion of their 2014 Notes on each of February 6, 2024 and February 6, 2029, at a repurchase price in cash equal to 100% of the principal amount of the 2014 Notes plus accrued and unpaid interest. On February 6, 2021, holders of $0.5&#160;million of the 2014 Notes caused us to repurchase their notes in accordance with this provision leaving $0.6&#160;million of 2014 Notes outstanding as of March&#160;31, 2022.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we closed a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of $55.0 million aggregate principal amount of our 2019 Notes. The 2019 Notes bear interest at 5.25% per annum, payable semiannually on June 1 and December 1 of each year, beginning on June 1, 2020. The 2019 Notes will mature on December 1, 2024, unless earlier repurchased or converted pursuant to their terms. The 2019 Notes will be convertible at the option of the holder at any point prior to close of business on the second scheduled trading day preceding the maturity date. The initial conversion rate of the 2019 Notes is 344.8276 shares of the Company&#8217;s common stock per $1,000 principal amount of 2019 Notes (which is equivalent to an initial conversion price of $2.90 per share). The conversion rate will be subject to adjustment upon the occurrence of certain specified events but will not be adjusted for any accrued and unpaid interest. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Notes will also be convertible at our option upon certain conditions in accordance with the terms of the indenture governing the 2019 Notes. On or after December 1, 2021 to December 1, 2022, if the price of the Company&#8217;s common stock has equaled or exceeded 150% of the Conversion Price (as defined in the indenture, currently $2.90, subject to adjustment) for a specified number of days (Issuer&#8217;s Conversion Option), we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture. On or after December 1, 2022, if the price of the Company&#8217;s common stock has equaled or exceeded 130% of the Conversion Price then in effect for a specified number of days, we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of the Company, determined in accordance with the terms of the indenture.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing summaries of the 2014 Notes and the 2019 Notes are not complete and are qualified in their entirety by the applicable indentures, forms of global notes, and other agreements and documents filed with the SEC. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2018, we entered into a Loan and Security Agreement with&#160;SVB (the Credit Agreement) for our Revolving Credit Facility, which provides for secured revolving loans in an aggregate amount of up to $15.0 million, In August 2021, we amended our Revolving Credit Facility to extend the maturity date to August 2, 2023 and to provide for a new $10.0 million Term Loan Facility (the Term Loan Facility and, together with the Revolving Credit Facility, the Credit Facility). The Credit Facility is collateralized by substantially all our property, other than intellectual property.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity date of the Term Loan Facility is July 1, 2025, subject to the following condition: in the event the principal amount of our convertible debt exceeds $0.6&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f June 1, 2024 or if the maturity date of our 2019 Notes has not been extended beyond January 1, 2026 by that date, then the maturity date of the Term Loan Facility will be June 1, 2024.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the balance outstanding on the Term Loan Facility was $10.1 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Interest on the term loan accrues on the outstanding principal amount thereof at the greater of (i) a floating per annum rate equal to three quarters of one percentage point (0.75%) above the prime rate (as customarily defined), or 4% with a final payment equal to 6.5% of the aggregate original principal amounts of each term loan advance due on the earlier of the maturity date of the Term Loan Facility, the acceleration of the term loan advances or any prepayment of a term loan advance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest is payable monthly. The principal amount of the term loan advances is repayable beginning on August 1, 2023, in twenty-four equal monthly installments of principal plus monthly payments of accrued interest. The Amendment also added a financial covenant to the Credit </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facility, requiring us to maintain a minimum Adjusted Quick Ratio (as defined) of at least 1.25 to 1.00. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, tota</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">l availability under the Revolving Credit Facility was $8.4 million. We currently have no outstanding debt under the Revolving Credit Facility, and we are in compliance with all the terms and conditions of the Revolving Credit Facility as of March&#160;31, 2022. See Note 9 to our condensed consolidated financial statements for more information about the Revolving Credit Facility and Term Loan Facility.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 23, 2022, we entered into $25 million of Bridge Loans Agreements with Casdin and Viking. On April 4, 2022, we completed the Private Placement Issuance, receiving $225 million of funding in exchange for the issuance of 225,000 shares of Series B Preferred Stock. The Bridge Loans also automatically converted into 30,559 shares of Series B Preferred Stock on April 4, 2022.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, preferences and privileges of the Series B Preferred Stock are set forth in the Series B-1 Certificate of Designations and Series B-2 Certificate of Designations. The Series B Preferred Stock ranks senior to our common stock with respect to dividend rights, redemption rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. The holders of Series B Preferred Stock will be entitled to participate in all dividends declared on our common stock on an as-converted basis, on the terms and subject to the conditions set forth in the Series B Certificates of Designations. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a brief summary of the conversion rights and other key provisions of the Series B Preferred Stock:</span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Holder Voluntary Conversion Rights </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock is convertible at the option of the holders thereof at any time into a number of shares of Common Stock equal to the Conversion Rate (as defined in the Series B Certificates of Designations), which is initially  294.1176 shares of common stock per share of Series B Preferred Stock, in each case subject to certain adjustments and limitations on conversion. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuer Call Provision</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any time after the fifth anniversary of the closing of the Private Placement Issuance, if the last reported sale price of the Common Stock is greater than 250% of the Conversion Price (as defined in the Series B Certificates of Designations) as of such time for at least 20 consecutive trading days immediately preceding the date of the notice of mandatory conversion, we may elect to convert all of the outstanding shares of Series B Preferred Stock into shares of common stock. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuer Redemption Provision</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the seventh anniversary of the closing of the Private Placement Issuance, subject to certain conditions, we may, at our option, redeem all of the outstanding shares of Series B Preferred Stock at a redemption price per share of Series B Preferred Stock, payable in cash, equal to the Liquidation Preference. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change of Control Provisions</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo certain change of control transactions, each holder of outstanding shares of Series B Preferred Stock will have the option, subject to the holder&#8217;s right to convert all or a portion of the shares of Series B Preferred Stock held by such holder into Common Stock prior to such redemption, to require us to purchase all or a portion of such holder&#8217;s outstanding shares of Series B Preferred Stock that have not been converted into Common Stock at a purchase price per share of Series B Preferred Stock, payable in cash, equal to the greater of (A) the Liquidation Preference of such share of Series B Preferred Stock, and (B) the amount of cash and/or other assets that such holder would have been entitled to receive if such holder had converted such share of Series B Preferred Stock into Common Stock immediately prior to the change of control transaction (Change of Control Put). </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a change of control in which we are anticipated to merge with another person and will not be the surviving corporation or if the Common Stock will no longer be listed on a U.S. national securities exchange, we will have a right to redeem, subject to the holder&#8217;s right to convert into Common Stock prior to such redemption, all of such holder&#8217;s shares of Series B Preferred Stock, or if a holder exercises the Change of Control Put in part, the remainder of such holder&#8217;s shares of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Series B Preferred Stock, at a redemption price per share payable in cash, equal to the greater of (A) the Liquidation Preference of such share of Series B Preferred Stock, and (B) the amount of cash and/or other assets that the holder would have received if such holder had converted such share of Series B Preferred Stock into Common Stock immediately prior to the change of control transaction. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidation Rights </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the Series B Preferred Stock has a liquidation preference equal to the greater of (i) the Liquidation Preference (as defined in the Certificate of Designations, currently $3.40) and (ii) the amount per share of Series B Preferred Stock that such holder would have </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">received had all holders of Series B Preferred Stock, immediately prior to such voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, converted all shares of Series B Preferred Stock into Common Stock pursuant to the terms of the Series B Certificates of Designations (without regard to any limitations on conversion contained therein). </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our existing cash, cash equivalents, and investments, along with funding available from Private Placement Issuance and the Revolving Credit Facility, will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. </span></div><div id="i3f52f78858b0473b983a2153293d04e0_109"></div><div style="margin-bottom:8pt;margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. Quantitative and Qualitative Disclosures about Market Risk </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates and interest rates. We do not hold or issue financial instruments for trading purposes.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we expand internationally our results of operations and cash flows will become increasingly subject to fluctuations due to changes in foreign currency exchange rates. Our revenue is generally denominated in the local currency of the contracting party. Historically, the majority of our revenue has been denominated in U.S. dollars. Our expenses are generally denominated in the currencies in which our operations are located, which is primarily in the United States, with a portion of expenses incurred in Singapore and Canada where our manufacturing facilities are located. Our results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates. The volatility of exchange rates depends on many factors that we cannot forecast with reliable accuracy. We have experienced and will continue to experience fluctuations in our net income or loss as a result of transaction gains or losses related to revaluing certain current asset and current liability balances that are denominated in currencies other than the functional currency of the entities in which they are recorded. For the three months ended March&#160;31, 2022, we had a foreign currency gain of $0.1 million compared to a foreign currency loss of $0.4 million in the prior year for the same period. To date, we have not entered into any foreign currency hedging contracts although we may do so in the future. As our international operations grow, we will continue to reassess our approach to manage our risk relating to fluctuations in currency rates. If foreign currency exchange rates had changed by 10% during the periods presented, it would not have had a material impact on our financial position or results of operations.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Sensitivity</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had cash and cash equivalents of $30.0 million as of March&#160;31, 2022. These amounts were held primarily in cash on deposit with banks and money market funds which are short-term. We held</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> no investments in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> treasury securities at March&#160;31, 2022. Cash, cash equivalents and investments are held for working capital purposes. We believe that we do not have any material exposure to changes in the fair value of our money market portfolio as a result of changes in interest rates. Declines in interest rates, however, will reduce future investment income. If overall interest rates had decreased by 10% during the periods presented, our interest income would not have been materially affected.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have material exposure to market risk with respect to investments. We do not use derivative financial instruments for speculative or trading purposes. We may adopt specific hedging strategies in the future.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_112"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. Controls and Procedures</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of March&#160;31, 2022. The term &#8220;disclosure controls and procedures,&#8221; as </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of March&#160;31, 2022, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the three months ended March&#160;31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitations on the Effectiveness of Controls</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Control systems, no matter how well conceived and operated, are designed to provide a reasonable, but not an absolute, level of assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Because of the inherent limitations in any control system, misstatements due to error or fraud may occur and not be detected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART&#160;II. OTHER INFORMATION</span></div><div id="i3f52f78858b0473b983a2153293d04e0_118"></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, a putative class action complaint alleging violations of the federal securities laws was filed against the Company (also naming our now-former Chief Executive Officer and our Chief Financial Officer as defendants) in the U.S. District Court for the Northern District of California (Reena Saintjermain, et al. v. Fluidigm Corporation, et al). The Court appointed a lead plaintiff and lead counsel in December 2020, and an amended complaint was filed on February 19, 2021. The complaint, as amended, seeks unspecified damages on behalf of a purported class of persons and entities who acquired our common stock between February 7, 2019 and November 5, 2019 and alleges securities laws violations based on statements and alleged omissions made by the Company during such period. The Company filed a motion to dismiss the complaint on April 5, 2021 and, on August 4, 2021, the Court granted defendants&#8217; motion to dismiss with leave to amend. A second amended complaint was filed on September 14, 2021. The Company filed a motion to dismiss the second amended complaint on October 29, 2021 and, on February 14, 2022, the Court granted defendants&#8217; motion and dismissed the second amended complaint with prejudice. On March 15, 2022, plaintiff filed a Notice of Appeal to the U.S. Court of Appeals for the Ninth Circuit. We believe the claims alleged in the complaint lack merit and we intend to defend this action vigorously. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are from time to time involved in legal proceedings or potential legal proceedings, including matters involving employment, intellectual property, or others. Although the results of litigation and claims cannot be predicted with certainty, we currently believe that the final outcome of any currently pending matters would not have a material adverse effect on our business, operating results, financial condition, or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_121"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We operate in a rapidly changing environment that involves numerous uncertainties and risks. The following risks and uncertainties may have a material and adverse effect on our business, financial condition, or results of operations. You should consider these risks and uncertainties carefully, together with all of the other information included or incorporated by reference in this quarterly report on Form 10-Q. The risks described below are not the only ones we face. Our business is also subject to the risks that affect many other companies, such as employment relations, general economic conditions, global sociopolitical events and international operations. Further, additional risks not currently known to us or that we currently believe are immaterial may in the future materially and adversely affect our business, operations, liquidity and stock price. If any of these risks occur, our business, results of operations, or financial condition could suffer, the trading price of our securities could decline, and you may lose all or part of your investment.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_124"></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Risk Factors</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Business, Industry, and Strategy</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The COVID-19 pandemic has significantly affected our business operations.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our financial results and revenue growth rates have varied significantly from quarter-to-quarter and year-to-year, and may not be consistent with expectations.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have incurred losses since inception, and we may continue to incur substantial losses for the foreseeable future.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The life science markets are highly competitive and subject to rapid technological change.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our research and product development efforts do not result in commercially viable products within anticipated timelines, if at all, our business and results of operations will be adversely affected.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our future success is dependent upon our ability to expand our customer base and introduce new applications.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our products fail to achieve and sustain sufficient market acceptance, our revenue will be adversely affected.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business growth strategy involves the potential for significant acquisitions.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our efficiency and cost-savings initiatives could be disruptive to our operations.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Implementation of a company-wide enterprise resource planning (ERP) system could adversely affect our business.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Operations and Reliance on Third Parties</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may experience development or manufacturing problems or delays.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business depends on research and development spending levels of our customers.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruption of our manufacturing facilities or other operations, or in the operations of our customers or business partners, could result in cancellation of orders, delays in deliveries or other business activities, or loss of customers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely on single and sole source suppliers for some of the components and materials used in our products.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any disruption or delay in the shipping or off-loading of our products may have an adverse effect on our financial condition and results of operations.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business operations depend upon the continuing efforts of our management team and other key employees.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our distribution capabilities and direct sales, field support, and marketing forces must be sufficient to meet our customers&#8217; needs.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">To use our analytical systems, customers typically need to purchase specialized reagents. </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Security breaches, loss of data, cyberattacks, and other IT failures could adversely affect our business.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Quality and the Regulatory Environment</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our products could have defects or errors.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Although the FDA granted Emergency Use Authorization (EUA) for our Advanta Dx SARS-CoV-2 RT-PCR Assay in August 2020 and an update to our EUA for use of the AZOVA COVID-19 Test Collection Kit in February 2021, among other updates, these authorizations are only valid during the COVID-19 public health emergency.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">To the extent we elect to label and promote any of our non-EUA products as medical devices, we would be required to obtain prior approval or clearance by the FDA or comparable foreign regulatory authority.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Compliance or the failure to comply with current and future regulations affecting our products and business operations worldwide could cause us significant expense and adversely impact our business.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Economic Conditions and Operating a Global Business</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We generate a substantial portion of our revenue internationally.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adverse conditions in the global economy may significantly harm our revenue, profitability, and results of operations.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to fluctuations in the exchange rate of the U.S. dollar and foreign currencies.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial, Tax, and Accounting Risks</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our future capital needs are uncertain and we may need to raise additional funds in the future.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any failure to maintain effective internal control over financial reporting could adversely affect our business.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not realize the value of our goodwill or other intangible assets.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to comply with the covenants and other obligations under our debt facilities, the lenders may be able to accelerate amounts owed under the facilities and, in the case of our Credit Facility (as defined herein), may foreclose upon the assets securing our obligations.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to risks related to taxation in multiple jurisdictions.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have a significant amount of outstanding indebtedness.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to protect our intellectual property and proprietary technology is uncertain.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be involved in lawsuits to protect or enforce our patents and proprietary rights.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be subject to damages resulting from claims that we or our employees have wrongfully used or disclosed alleged trade secrets.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We depend on certain technologies that are licensed to us.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to certain manufacturing restrictions related to licensed technologies that were developed with the financial assistance of U.S. governmental grants.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to certain obligations and restrictions relating to technologies developed in cooperation with Canadian government agencies.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our stock price is volatile.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Future sales of our common stock in the public market could cause our stock price to fall.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If securities or industry analysts publish unfavorable research about us or cease to cover our business, our stock price and/or trading volume could decline.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any conversions of our 2014 Notes or 2019 Notes will dilute the ownership interest of our existing stockholders.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Capital Structure </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Purchasers own a significant portion of our total outstanding voting securities and may prevent other stockholders from influencing material corporate decisions.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The market value of our Common Stock could decline if the holders of our Series B Preferred Stock sell their shares when transfer restrictions expire.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The holders of Series B-1 Preferred Stock and Series B-2 Preferred Stock may exercise influence over us, including through their ability to each designate a member of our board of directors.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_127"></div><div style="margin-top:16pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR BUSINESS, INDUSTRY, AND STRATEGY</span></div><div id="i3f52f78858b0473b983a2153293d04e0_130"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The global COVID-19 pandemic has significantly affected our business operations and could continue to adversely impact our financial position and cash flows to an extent that is unknown and difficult to predict. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic and international public health emergency caused by SARS-CoV-2, the novel strain of coronavirus that causes the disease commonly known as COVID-19, has adversely affected all the countries in which we and our customers, suppliers, and other business partners operate, disrupting supply chains, causing significant volatility in global financial markets, and raising the prospect of an extended global recession. Public health problems resulting from COVID-19 and precautionary measures instituted by governments and businesses to mitigate its spread and resurgence, including travel restrictions and quarantines, could continue to contribute to a general slowdown in the global economy, cause increasingly adverse impacts on our customers, suppliers, and other business partners, and further disrupt our operations. Changes in our operations as a result of the COVID-19 pandemic have resulted in inefficiencies and delays, including in sales and product development efforts, and additional costs related to business continuity initiatives that cannot be fully mitigated through succession planning, employees working remotely, or teleconferencing technologies. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic and related governmental and societal reactions have had, and may continue to have, a negative impact on our business, liquidity, results of operations, and stock price due to the occurrence of some or all of the following events or circumstances among others:</span></div><div style="margin-bottom:5pt;margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced demand for some of our products and services due to the impact of COVID-19 on our customers, including in the global academic research community;</span></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the negative impact of ongoing travel restrictions and social distancing policies on our sales operations, marketing efforts, and customer field support;</span></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diminished business productivity due to inefficiencies in employees working from home or increasing physical distancing and other pandemic response protocols in our production facilities;</span></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased voluntary turnover, together with impaired ability to hire and effectively train new personnel due to labor shortages, travel restrictions, and physical distancing protocols; </span></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased susceptibility to the risk of information technology security breaches and other disruptions due to increased volumes of remote access to our information systems from our employees working at home;</span></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased operating costs if one of our facilities were to experience a COVID-19 outbreak;</span></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruption of the operations of our contract manufacturers, suppliers, and other business partners;</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">shortages or delays in the supply of components and materials used in our products; and</span></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased volatility in our stock price due to financial market instability.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to its negative impact on some aspects of our business, the COVID-19 pandemic has been a source of opportunity for our diagnostics business, opening up external funding sources to support innovation and product development and resulting in increased revenues due to sales of our Advanta Dx SARS-CoV-2 RT-PCR test and related sales of our microfluidics instruments. However, as vaccines </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and alternative testing options </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the coronavirus have become available and the perceived threat of the pandemic has receded, the demand for our COVID-19 testing products has slowed, resulting in a corresponding decline in related revenue.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, factors such as supply chain constraints, China trade restrictions, and the ongoing slowdown in the Asia-Pacific region caused our overall revenues to decline more than expected. The extent to which the COVID-19 pandemic will continue to impact our business and financial results will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the continued spread and resurgences of the coronavirus; the emergence of new strains of the disease, such as the Delta and Omicron variants; the availability, efficacy, and acceptance of COVID-19 vaccines; the scope and duration of the public health emergency; and COVID-19 mitigation measures such as travel bans and restrictions, social </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">distancing, quarantines, and business shutdowns and closures. Additionally, in response to rising COVID-19 infections in 2022, China has imposed lockdowns in certain parts of the country, which have and continue to negatively impact manufacturing and/or supply chains, as well as demand for our products.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the severity, magnitude, and duration of the COVID-19 pandemic and its economic consequences are uncertain, we are unable to predict the impact of COVID-19 on our operations, our financial performance, and our ability to successfully execute our business strategies and initiatives. The ultimate impact of the COVID-19 pandemic on our operations and financial performance depends on many factors that are not within our control, including, but not limited, to: governmental, business, and individual actions that have been and continue to be taken in response to the pandemic (including restrictions on travel, transport and workforce pressures); the impact of the pandemic and actions taken in response on global and regional economies, travel, and economic activity; the availability of federal, state, local or non-U.S. funding programs; general economic uncertainty in key global markets and financial market volatility; global economic conditions and levels of economic growth; labor and materials shortages; supply chain difficulties, including disruption of logistics, shipping, and other distribution operations; and the pace of recovery when the threat of COVID-19 subsides.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the COVID-19 pandemic continues to affect our operating and financial results, it may also have the effect of heightening many of the other risks described in our other risk factors below. COVID-19 may also affect our operating and financial results in a manner that is not presently known to us or that we currently do not expect to present significant risks to our operations or financial results, particularly if the pandemic and its associated impacts reoccur in the coming months. </span></div><div id="i3f52f78858b0473b983a2153293d04e0_133"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our financial results and revenue growth rates have varied significantly from quarter-to-quarter and year-to-year due to a number of factors, and a significant variance in our operating results or rates of growth from our financial guidance or market expectations, if any, could lead to substantial volatility in our stock price.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue, results of operations, and revenue growth rates have varied in the past and may continue to vary significantly from quarter-to-quarter or year-to-year. We may experience substantial variability in our product mix from period-to-period as revenue from sales of our instruments relative to sales of our consumables may fluctuate or deviate significantly from expectations. Although our revenue increased year-over-year in 2020 compared to 2019 and in 2019 compared to 2018, we experienced a year-over-year decline in revenue in 2021 compared to 2020, and we may be similarly unable to achieve revenue growth in future periods. Variability in our quarterly or annual results of operations, mix of product revenue, including any decline in our revenue related to the COVID-19 pandemic, or variability in rates of revenue growth, if any, may lead to volatility in our stock price as research analysts and investors respond to these fluctuations. These fluctuations are due to numerous factors that are difficult to forecast, including: </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in demand for our products; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in customer budget cycles, capital spending, and the availability of VAT and import tax exemptions; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seasonal variations in customer operations; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">tendencies among some customers to defer purchase decisions to the end of the quarter; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the large unit value of our systems, particularly our proteomics systems; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our pricing and sales policies or the pricing and sales policies of our competitors; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to design, manufacture, market, sell, and deliver products to our customers in a timely and cost-effective manner; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to timely obtain adequate quantities of the materials or components used in our products, which in certain cases are purchased through sole and single source suppliers; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">staffing shortages, lack of skilled labor, increased turnover, and competitive job markets;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations or reductions in revenue from sales of legacy instruments that may have contributed significant revenue in prior periods; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">quality control or yield problems in our manufacturing operations; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new product introductions and enhancements by us and our competitors; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated increases in costs or expenses; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our complex, variable and, at times, lengthy sales cycle; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trade restrictions and government protectionism;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">global economic conditions; and </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in foreign currency exchange rates. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we have certain customers who have historically placed large orders in multiple quarters during a calendar year. A significant reduction in orders from one or more of these customers could adversely affect our revenue and operating results, and if these customers defer or cancel purchases or otherwise alter their purchasing patterns, our financial results and actual results of operations could be significantly impacted. Other unknown or unpredictable factors also could harm our results.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, inflationary pressure, including as a result of supply shortages, could adversely impact our financial results. Our operating costs have increased, and may continue to increase, due to the recent growth in inflation. We may not fully offset these cost increases by raising prices for our products and services, which could result in downward pressure on our margins. Further, our customers may choose to reduce their business with us if we increase our pricing.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing factors, as well as other factors, could materially and adversely affect our quarterly and annual results of operations and rates of revenue growth, if any. We have experienced significant revenue growth in the past but we may not achieve similar growth rates in future periods. You should not rely on our operating results for any prior quarterly or annual period as an indication of our future operating performance. If we are unable to achieve adequate revenue growth, our operating results could suffer and our stock price could decline. In addition, a significant amount of our operating expenses are relatively fixed due to our manufacturing, research and development, and sales and general administrative efforts. Any failure to adjust spending quickly enough to compensate for a shortfall relative to our anticipated revenue could magnify the adverse impact of such shortfalls on our results of operations. We expect that our sales will continue to fluctuate on an annual and quarterly basis and that our financial results for some periods may be below those projected by securities analysts, which could significantly decrease the price of our common stock.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_136"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We have incurred losses since inception, and we may continue to incur substantial losses for the foreseeable future.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant losses in each fiscal year since our inception, including net losses of $59.2 million, $53.0&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and $64.8&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the years 2021, 2020, and 2019, respectively. As of March&#160;31, 2022, we had an accumulated deficit of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$812.3 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These losses have resulted principally from costs incurred in our research and development programs, and from our manufacturing costs and selling, general, and administrative expenses. To date, we have funded our operations primarily through equity offerings, the issuance of debt instruments, and from sales of our products. Until we are able to generate additional revenue to support our level of operating expenses, we will continue to incur operating and net losses and negative cash flow from operations.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, inflationary pressure, including as a result of supply shortages, could adversely impact our financial results. Our operating costs have increased, and may continue to increase, due to the recent growth in inflation. We may not fully offset these cost increases by raising prices for our products and services, which could result in downward pressure on our margins. Further, our customers may choose to reduce their business with us if we increase our pricing.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our continued investment in research and development, sales, and marketing is essential to our long-term competitive position and future revenue growth and, as a result, we may incur operating losses for the foreseeable future and may never achieve profitability.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_145"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market opportunities may not develop as quickly as we expect, limiting our ability to successfully sell our products, or our product development and strategic plans may change and our entry into certain markets may be delayed, if it occurs at all. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The application of our technologies to high-throughput genomics, single-cell genomics and, particularly, mass cytometry applications are in many cases emerging market opportunities. We believe these opportunities will take several years to develop or mature and we cannot be certain that these market opportunities will develop as we expect. The future growth of our markets and the success of our products depend on many factors beyond our control, including recognition and acceptance by the scientific community, and the growth, prevalence, and costs of competing methods of genetic and protein analysis. Additionally, our success depends on the ability of our sales organization to successfully sell our products into these new markets. If we are not able to successfully market and sell our products, or to achieve the revenue or margins we expect, our operating results may be harmed and we may not recover our product development and marketing expenditures. In addition, our product development and strategic plans may change, which could delay or impede our entry into these markets.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_139"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The life science markets are highly competitive and subject to rapid technological change, and we may not be able to successfully compete.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The markets for our products are characterized by rapidly changing technology, evolving industry standards, changes in customer needs, emerging competition, new product introductions, and strong price competition. We compete with both established and development stage life science research companies that design, manufacture, and market instruments and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consumables for gene expression analysis, single-cell targeted gene expression and protein expression analysis, SNP genotyping, quantitative polymerase chain reaction (qPCR), digital PCR, flow cytometry, tissue imaging, and additional applications using well established laboratory techniques, as well as newer technologies such as bead encoded arrays, microfluidics, next-generation DNA sequencing (NGS), microdroplets, spatial protein expression, and photolithographic arrays. Most of our current competitors have significantly greater name recognition, greater financial and human resources, broader product lines and product packages, larger sales forces, larger existing installed bases, larger intellectual property portfolios, and greater experience and scale in research and development, manufacturing, and marketing than we do. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider Agilent Technologies, Inc., Thermo Fisher Scientific Inc. (Thermo), Bio-Rad Laboratories, Inc., NanoString Technologies, Inc. (NanoString), and Agena Bioscience, Inc. to be our principal competitors in the microfluidics space. We believe that Cytek Biosciences, Inc. and Becton, Dickinson and Company are currently our principal competitors for our mass cytometry market share, and that IonPath Inc., Akoya Biosciences, Inc., NanoString, and 10x Genomics, Inc. are our principal competitors for our Imaging Mass Cytometry&#8482; market share. While the aforementioned principal competitors are the largest and most prevalent in their representative technology areas, the combined markets in which we compete have an additional 10 to 20 smaller competitors with competing approaches and technologies that we routinely face in selling situations.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors may be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards, or customer requirements. In light of these advantages, even if our technology is more effective than the product or service offerings of our competitors, current or potential customers might accept competitive products and services in lieu of purchasing our technology. We anticipate that we will continue to face increased competition in the future as existing companies and competitors develop new or improved products and as new companies enter the market with new technologies. Increased competition is likely to result in pricing pressures, which could reduce our profit margins and increase our sales and marketing expenses. In addition, mergers, consolidations, or other strategic transactions between two or more of our competitors, or between our competitor and one of our key customers, could change the competitive landscape and weaken our competitive position, adversely affecting our business.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_142"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If our research and product development efforts do not result in commercially viable products within anticipated timelines, if at all, our business and results of operations will be adversely affected.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is dependent on the improvement of our existing products, our development of new products to serve existing markets, and our development of new products to create new markets and applications that were previously not practical with existing systems. We intend to devote significant personnel and financial resources to research and development activities designed to advance the capabilities of our technology. We have developed design rules for the implementation of our technology that are frequently revised to reflect new insights we have gained about the technology. In addition, we have discovered that biological or chemical reactions sometimes behave differently when implemented on our systems rather than in a standard laboratory environment. Furthermore, many such reactions take place within the confines of single cells, which have also demonstrated unexpected behavior when grown and manipulated within microfluidic environments. As a result, research and development efforts may be required to transfer certain reactions and cell handling techniques to our systems. In the past, product development projects have been significantly delayed when we encountered unanticipated difficulties in implementing a process on our systems. We may have similar delays in the future, and we may not obtain any benefits from our research and development activities. Any delay or failure by us to develop and release new products or product enhancements would have a substantial adverse effect on our business and results of operations. </span></div><div id="i3f52f78858b0473b983a2153293d04e0_148"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our future success is dependent upon our ability to expand our customer base and introduce new applications. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customer base is primarily composed of academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, biopharmaceutical, biotechnology, and plant and animal research companies, and contract research organizations that perform analyses for research and commercial purposes. Our success will depend, in part, upon our ability to increase our market share among these customers, attract additional customers outside of these markets, and market new applications to existing and new customers as we develop such applications. Attracting new customers and introducing new applications require substantial time and expense. For example, it may be difficult to identify, engage, and market to customers who are unfamiliar with the current applications of our systems. Any failure to expand our existing customer base or launch new applications would adversely affect our ability to increase our revenue.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_151"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If our products fail to achieve and sustain sufficient market acceptance, our revenue will be adversely affected.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on our ability to develop and market products that are recognized and accepted as reliable, enabling and cost-effective. Most of our potential customers already use expensive research systems in their laboratories and may be reluctant to replace those systems. Market acceptance of our systems will depend on many factors, including our ability to convince potential customers that our systems are an attractive alternative to existing technologies. Compared to some </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">competing technologies, our technology is relatively new, and most potential customers have limited knowledge of, or experience with, our products. Prior to adopting our systems, some potential customers may need to devote time and effort to testing and validating our systems. Any failure of our systems to meet these customer benchmarks could result in customers choosing to retain their existing systems or to purchase systems other than ours, and revenue from the sale of legacy instruments that may have contributed significant revenue in prior periods may decrease.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, it is important that our systems be perceived as accurate and reliable by the scientific and medical research community as a whole. Historically, a significant part of our sales and marketing efforts has been directed at convincing industry leaders of the advantages of our systems and encouraging such leaders to publish or present the results of their evaluation of our system. If we are unable to continue to induce leading researchers to use our systems, or if such researchers are unable to achieve and publish or present significant experimental results using our systems, acceptance and adoption of our systems will be slowed and our ability to increase our revenue would be adversely affected.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_154"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not be able to develop new products or enhance the capabilities of our existing systems to keep pace with rapidly changing technology and customer requirements, which could have a material adverse effect on our business, revenue, financial condition, and operating results.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on our ability to develop new products and applications for our technology in existing and new markets, while improving the performance and cost-effectiveness of our systems. New technologies, techniques, or products could emerge that might offer better combinations of price and performance than our current or future product lines and systems. Existing markets for our products, including high-throughput genomics, single-cell genomics and mass cytometry, as well as potential markets for our products such as high-throughput NGS and molecular applications, are characterized by rapid technological change and innovation. It is critical to our success for us to anticipate changes in technology and customer requirements and to successfully introduce new, enhanced, and competitive technology to meet our customers&#8217; and prospective customers&#8217; needs on a timely and cost-effective basis. Developing and implementing new technologies will require us to incur substantial development costs and we may not have adequate resources available to be able to successfully introduce new applications of, or enhancements to, our systems. We cannot guarantee that we will be able to maintain technological advantages over emerging technologies in the future. While we typically plan improvements to our systems, we may not be able to successfully implement these improvements. If we fail to keep pace with emerging technologies, demand for our systems will not grow and may decline, and our business, revenue, financial condition, and operating results could suffer materially. In addition, if we introduce enhanced systems but fail to manage product transitions effectively, customers may delay or forgo purchases of our systems and our operating results may be adversely affected by product obsolescence and excess inventory. Even if we successfully implement some or all of these planned improvements, we cannot guarantee that our current and potential customers will find our enhanced systems to be an attractive alternative to existing technologies, including our current products.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_157"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our efficiency and cost-savings initiatives could be disruptive to our operations and adversely affect our results of operations and financial condition.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we have implemented efficiency and cost-savings initiatives intended to stabilize our business operations. These efficiency initiatives have included targeted workforce reductions, optimizing our facilities, and reducing excess space. In 2020, in response to the uncertainty arising from the COVID-19 pandemic, we initiated a range of additional actions aimed at temporarily reducing our operating expenses and preserving liquidity, including implementing temporary enterprise-wide salary reductions of 20% for employees at or above the &#8216;director&#8217; level and 10% for all others, temporarily reducing our board members&#8217; cash retainers by 20%, and constraining hiring. Although we discontinued our hiring constraints and pandemic-related pay reductions in 2020, we regularly review other possible actions to preserve liquidity and optimize our organization. For example, we may need to decrease or defer capital expenditures and development activities or implement further operating expense reduction measures. The implementation of these and other efficiency and cost-savings initiatives could impair our ability to invest in developing, marketing and selling new and existing products, be disruptive to our operations, make it difficult to attract or retain employees, result in higher than anticipated charges, divert the attention of management, result in a loss of accumulated knowledge, impact our customer and supplier relationships, and otherwise adversely affect our results of operations and financial condition. </span></div><div id="i3f52f78858b0473b983a2153293d04e0_160"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we seek to implement a company-wide enterprise resource planning (ERP) system, such implementation could adversely affect our business and results of operations or the effectiveness of internal control over financial reporting.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are considering implementing a company-wide ERP system to handle the business and financial processes within our operations and corporate functions. ERP implementations are complex and time-consuming projects that involve substantial expenditures on system software and implementation activities that can continue for several years. ERP implementations also require transformation of business and financial processes in order to reap the benefits of the ERP system. If we decide to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">implement a company-wide ERP system, our business and results of operations could be adversely affected if we experience operating problems and/or cost overruns during the ERP implementation process, or if the ERP system and the associated process changes do not give rise to the benefits that we expect. If we do not effectively implement the ERP system as planned or if the system does not operate as intended, our business, results of operations, and internal controls over financial reporting could be adversely affected. </span></div><div id="i3f52f78858b0473b983a2153293d04e0_163"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business growth strategy involves the potential for significant acquisitions, and our operating results and prospects could be harmed if we are unable to integrate future acquisitions successfully.</span></div><div style="margin-bottom:6pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may acquire other businesses to improve our product offerings or expand into new markets. Our future acquisition strategy will depend on our ability to identify, negotiate, complete, and integrate acquisitions and, if necessary, to obtain satisfactory debt or equity financing to fund those acquisitions. Mergers and acquisitions are inherently risky, and any transaction we complete may not be successful. Any merger or acquisition we may pursue would involve numerous risks, including but not limited to the following:</span></div><div style="margin-bottom:5pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in integrating and managing the operations, technologies, and products of the companies we acquire;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of our management&#8217;s attention from normal daily operation of our business;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to maintain the key business relationships and the reputations of the businesses we acquire;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to retain key personnel of the acquired company;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainty of entry into markets in which we have limited or no prior experience and in which competitors have stronger market positions;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dependence on unfamiliar affiliates and customers of the companies we acquire;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">insufficient revenue to offset our increased expenses associated with acquisitions;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our responsibility for the liabilities of the businesses we acquire, including those which we may not anticipate; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possibility that we may not realize the value of acquired assets recorded as goodwill or intangible assets, and would be required to incur material charges relating to the impairment of those assets; and</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to maintain internal standards, controls, procedures, and policies.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be unable to secure the equity or debt funding necessary to finance future acquisitions on terms that are acceptable to us. If we finance acquisitions by issuing equity or convertible debt securities, our existing stockholders will likely experience dilution, and if we finance future acquisitions with debt funding, we will incur interest expense and may have to comply with financial covenants and secure that debt obligation with our assets.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_166"></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OPERATIONS AND RELIANCE ON THIRD PARTIES</span></div><div id="i3f52f78858b0473b983a2153293d04e0_169"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may experience development or manufacturing problems or delays that could limit the potential growth of our revenue or increase our losses. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may encounter unforeseen situations in the manufacturing and assembly of our products that would result in delays or shortfalls in our production. For example, our production processes and assembly methods may have to change to accommodate any significant future expansion of our manufacturing capacity, which may increase our manufacturing costs, delay production of our products, reduce our product margin, and adversely impact our business. Conversely, if demand for our products shifts such that a manufacturing facility is operated below its capacity for an extended period, we may adjust our manufacturing operations to reduce fixed costs, which could lead to uncertainty and delays in manufacturing times and quality during any transition period.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, all of our integrated fluidic circuits (IFCs) for commercial sale are manufactured at our facility in Singapore. Production of the elastomeric block that is at the core of our IFCs is a complex process requiring advanced clean rooms, sophisticated equipment, and strict adherence to procedures. Any contamination of the clean room, equipment malfunction, or failure to strictly follow procedures can significantly reduce our yield in one or more batches. We have in the past experienced variations in yields due to such factors. A drop in yield can increase our cost to manufacture our IFCs or, in more severe cases, require us to halt the manufacture of our IFCs until the problem is resolved. Identifying and resolving the cause of a drop in yield can require substantial time and resources. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, developing an IFC for a new application may require developing a specific production process for that type of IFC. While all of our IFCs are produced using the same basic processes, significant variations may be required to ensure </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adequate yield of any particular type of IFC. Developing such a process can be time consuming, and any unexpected difficulty in doing so can delay the introduction of a product.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our manufacturing activities are adversely impacted, or if we are otherwise unable to keep up with demand for our products by successfully manufacturing, assembling, testing, and shipping our products in a timely manner, our revenue could be impaired, market acceptance for our products could be adversely affected and our customers might instead purchase our competitors&#8217; products.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_172"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business depends on research and development spending levels of our customers, a reduction in which could limit our ability to sell our products and adversely affect our business.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our revenue in the foreseeable future will continue to be derived primarily from sales of our systems, IFCs, assays, and reagents to academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories biopharmaceutical, biotechnology, and plant and animal research companies, and contract research organizations worldwide. Our success will depend upon their demand for and use of our products. Accordingly, the spending policies and practices of these customers&#8212;which have been impacted by the COVID-19 pandemic and may additionally be impacted by other factors&#8212;have had and will continue to have a significant effect on the demand for our technology. These policies may be based on a wide variety of factors, including concerns regarding any future federal government budget sequestrations, the availability of resources to make purchases, the spending priorities among various types of equipment, policies regarding spending during recessionary periods, tariffs and trade restrictions, and changes in the political climate. In addition, academic, governmental, and other research institutions that fund research and development activities may be subject to stringent budgetary constraints that could result in spending reductions, reduced allocations, or budget cutbacks, which could jeopardize the ability of these customers to purchase our products. Our operating results have fluctuated and may continue to fluctuate substantially due to reductions and delays in research and development expenditures by our customers. For example, reductions in operating expenditures by global academic research facilities because of the COVID-19 pandemic have resulted in lower than expected sales of our mass cytometry instruments. Additionally, the imposition of tariffs and delays in issuing VAT and import tax exemptions have adversely affected the sales of our products in China. Similar reductions and delays in customer spending have resulted and may continue to result from other factors that are not within our control, such as:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in economic conditions;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">natural disasters or public health crises;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in government programs that provide funding to research institutions and companies;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">macroeconomic conditions and the political climate; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">governmental protectionism, the escalation of tariffs and other trade barriers;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of tax permits and incentives, including VAT and import tax exemptions;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the regulatory environment affecting life science and plant and animal research companies engaged in research and commercial activities;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our customers&#8217; research priorities;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differences in budget cycles across various geographies and industries;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">personnel shortages among our customers;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market-driven pressures on companies to consolidate operations and reduce costs;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mergers and acquisitions in the life science and plant and animal research industries; and</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other factors affecting research and development spending.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any decrease in our customers&#8217; budgets or expenditures or in the size, scope, or frequency of capital or operating expenditures, as well as any increase in local tariffs could materially and adversely affect our operations or financial condition.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_175"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If one or more of our manufacturing facilities become unavailable or inoperable, we will be unable to continue manufacturing our instruments, IFCs, assays and/or reagents and, as a result, our business will be harmed until we are able to secure a new facility.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture our microfluidics analytical and preparatory instruments and IFCs for commercial sale at our facility in Singapore and our mass cytometry instruments, assays, and reagents for commercial sale at our facility in Canada. No other manufacturing facilities are currently available to us, particularly facilities of the size and scope of our Singapore and Canada operations. Our facilities and the equipment we use to manufacture our instruments, IFCs, assays, and reagents would be costly to replace and could require substantial lead times to repair or replace. Our facilities may be harmed or rendered inoperable by </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">natural or man-made disasters, which may render it difficult or impossible for us to manufacture our products for some period of time. If any of our facilities become unavailable to us, we cannot provide assurances that we will be able to secure a new manufacturing facility on acceptable terms, if at all. The inability to manufacture our products, combined with our limited inventory of manufactured supplies, may result in the loss of customers or harm our reputation, and we may be unable to reestablish relationships with those customers in the future. Although we possess insurance for damage to our property and the disruption of our business, this insurance may not be sufficient to cover all of our potential losses and may not continue to be available to us on acceptable terms, or at all. If our manufacturing capabilities are impaired, we may not be able to manufacture and ship our products in a timely manner, which would adversely impact our business. </span></div><div id="i3f52f78858b0473b983a2153293d04e0_178"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disruption of our manufacturing facilities or other operations, or in the operations of our customers or business partners, due to earthquake, flood, other natural catastrophic events, public health crises, or terrorism could result in cancellation of orders, delays in deliveries or other business activities, or loss of customers and could seriously harm our business.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant manufacturing operations in Singapore and Canada and operations in the United States. In addition, our business is international in nature, with our sales, service and administrative personnel and our customers located in numerous countries throughout the world. Operations at our manufacturing facilities and our subcontractors, as well as our other operations and those of our customers, are subject to disruption for a variety of reasons, including work stoppages, acts of war, terrorism, public health crises (including the ongoing COVID-19 pandemic), fire, earthquake, volcanic eruptions, energy shortages, flooding, or other natural disasters. Such disruption could cause delays in, among other things, shipments of products to our customers, our ability to perform services requested by our customers, or the installation of our products at customer sites. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot provide any assurance that alternate means of conducting our operations (whether through alternate production capacity or service providers or otherwise) would be available if a major disruption were to occur or that, if such alternate means were available, they could be obtained on favorable terms.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_181"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We rely on a limited number of third-party suppliers for some of the components and materials used in our products, and the loss of any of these suppliers, or delays or problems in the supply of components and materials could harm our business.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a limited number of third-party suppliers for certain components and materials used in our products, including single and sole source suppliers. Additionally, several of our instruments are assembled at the facilities of contract manufacturers in Singapore. We do not have long-term contracts with our suppliers of these components and materials or our assembly service providers. The loss of a single or sole source supplier of any of the following components and/or materials would require significant time and effort to locate and qualify an alternative source of supply, if at all: </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The IFCs used in our microfluidic systems are fabricated using a specialized polymer, and other specialized materials, that are available from a limited number of sources. In the past, we have encountered quality issues that have reduced our manufacturing yield or required the use of additional manufacturing processes.</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The electron multiplier detector included in the Hyperion/CyTOF systems and certain metal isotopes used with the Hyperion/CyTOF systems are purchased from sole source suppliers.</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The raw materials for our Delta Gene and SNP Type assays and Access Array target-specific primers are available from a limited number of sources.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reliance on single and sole source suppliers and assembly service providers also subjects us to other risks that could harm our business, including the following: </span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be subject to increased component or assembly costs and</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be able to obtain adequate supply or services in a timely manner or on commercially reasonable terms.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the global supply chain disruptions following the onset of the COVID-19 pandemic, we have experienced and are continuing to experience problems with some of our suppliers. In the third quarter of 2021, shortages of certain components caused a backlog and we were unable to fulfill all of the demand for our products during the quarter. We have in the past experienced supply issues, as well as quality control problems such as manufacturing errors, with some of our suppliers, and may again experience problems in the future. We may not be able to quickly establish additional or replacement suppliers, particularly for our single source components, or assembly service providers. Any continued or future interruption or delay in the supply of components or materials or assembly of our instruments, or our inability to obtain components, materials, or assembly services from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders or switch to competitive products, which would harm our business. In </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">response to rising COVID-19 infections, China has imposed lockdowns in certain parts of the country, which may negatively impact manufacturing and/or supply chains.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_184"></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not be able to convert our orders in backlog into revenue.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our backlog represents product orders from our customers that we have confirmed but have not been able to fulfill, and, accordingly, for which we have not yet recognized revenue. We may not receive revenue from these orders, and any order backlog we report may not be indicative of our future revenue.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many events can cause an order to be delayed or not completed at all, some of which may be out of our control, including the potential impacts from the COVID-19 pandemic and our suppliers not being able to provide us with products or components. If we delay fulfilling customer orders or if customers reconsider their orders, those customers may seek to cancel or modify their orders with us. Customers may otherwise seek to cancel or delay their orders even if we are prepared to fulfill them. If our orders in backlog do not result in sales, our operating results may suffer.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_187"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Any disruption or delay in the shipping or off-loading of our products, whether domestically or internationally, may have an adverse effect on our financial condition and results of operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on shipping providers to deliver products to our customers globally. Labor, tariff, or World Trade Organization-related disputes, piracy, physical damage to shipping facilities or equipment caused by severe weather or terrorist incidents, congestion at shipping facilities, complications related to public health crises (including the ongoing COVID-19 pandemic), inadequate equipment to load, dock, and offload our products, energy-related tie-ups, or other factors could disrupt or delay shipping or off-loading of our products domestically and internationally. Such disruptions or delays may have an adverse effect on our financial condition and results of operations.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_190"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business operations depend upon the continuing efforts of our management team and other skilled and experienced personnel, and if we are unable to retain them or to recruit and train new key executives, scientists, and technical support personnel, we may be unable to achieve our goals.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends largely on the skills, experience, and performance of our management team and scientific and technical support personnel. The loss of the services of certain members of our management team or our scientific or technical support staff might significantly delay or prevent the development of our products or achievement of other business objectives by diverting management&#8217;s attention to transition matters and identification of suitable replacements, and staffing shortages could also negatively impact our ability to expand and scale functions that are needed to support the development of our products and the growth of our business. Our research and product development efforts could also be delayed or curtailed if we are unable to attract, train, and retain highly skilled employees, particularly, senior scientists and engineers. Competition for qualified senior management and key employees in our industry is intense. This competition has become exacerbated by the increase in employee resignations currently taking place throughout the United States as a result of the COVID-19 pandemic. The loss of qualified employees, or an inability to attract, retain, and motivate employees could prevent us from pursuing collaborations and materially and adversely affect our support of existing products, product development and introductions, business growth prospects, results of operations and financial condition. We have experienced increased turnover at all levels since the start of the COVID-19 pandemic and general labor shortages in various areas of our business, all of which could have a material adverse impact on our business. We may need to increase employee wages and benefits in order to attract and retain the personnel necessary to achieve our goals, and our business, operations, and financial results may suffer if we are unable to do so. We do not maintain significant key person life insurance with any of our employees and all our employees, including our management team, may terminate employment without notice and without cause or good reason.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, to expand our research and product development efforts, we need to retain and recruit scientists skilled in areas such as molecular and cellular biology, assay development, engineering physics, and manufacturing. We also need highly trained technical support personnel with the necessary scientific background and ability to understand our systems at a technical level to effectively support potential new customers and the expanding needs of current customers. Competition for these people is intense and we may face challenges in retaining and recruiting such individuals if, for example, our stock price declines, reducing the retention value of equity awards, or our business or technology is no longer perceived as leading in our field. Because of the complex and technical nature of our systems and the dynamic market in which we compete, any failure to attract and retain a sufficient number of qualified employees could materially harm our ability to develop and commercialize our technology.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_193"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we are unable to expand our direct sales, field support, and marketing forces or distribution capabilities to adequately address our customers&#8217; needs, our business will be adversely affected.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to market, sell, and, distribute our products effectively enough to support our planned growth. We sell our products primarily through our own sales force and through distributors in certain territories. Our future sales will depend in large part on our ability to continue to increase the scope of our marketing efforts and develop and substantially expand our direct sales force and field application specialist and service engineer teams. Our products are technically complex and used for highly specialized applications. As a result, we believe it is necessary to continue to develop a direct sales force that includes people with specific scientific backgrounds and expertise, and a marketing group with technical sophistication. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past year, we have experienced significant changes and increased turnover in our sales and marketing organizations, and we face considerable challenges in recruiting and training qualified replacements. Our future success will depend largely on our ability to recruit, retain, and motivate the skilled sales and marketing force necessary to support our business activities, and any failure to maintain competitive levels of compensation will negatively impact our ability to so. Because competition for such employees is intense, we can provide no assurance that we will be able to retain them on favorable or commercially reasonable terms, if at all. Failure to attract and retain our current personnel or to build an efficient and effective sales and marketing force would negatively impact sales of our products and reduce our revenue and profitability.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may continue to enlist one or more sales representatives and distributors to assist with sales, distribution, and customer support globally or in certain regions of the world. If we do seek to enter into such arrangements, we may not be successful in attracting desirable sales representatives and distributors, or we may not be able to enter into such arrangements on favorable terms. If our sales and marketing efforts, or those of any third-party sales representatives and distributors, are not successful, our technologies and products may not gain market acceptance, which would materially and adversely impact our business operations.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_196"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To use our products&#8212;our Biomark, EP1, CyTOF, and Hyperion systems in particular&#8212;customers typically need to purchase specialized reagents. Any interruption in the availability of these reagents for use in our products could limit our ability to market our products.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products, our Biomark, EP1, CyTOF, and Hyperion systems in particular, must be used in conjunction with one or more reagents designed to produce or facilitate the particular biological or chemical reaction desired by the user. Many of these reagents are highly specialized and available to the user only from a single supplier or a limited number of suppliers. Although we sell reagents for use with certain of our products, our customers may purchase these reagents directly from third-party suppliers, and we have no control over the supply of those materials. In addition, our products are designed to work with these reagents as they are currently formulated. We have no control over the formulation of reagents sold by third-party suppliers, and the performance of our products might be adversely affected if the formulation of these reagents is changed. If one or more of these reagents were to become unavailable or were reformulated, our ability to market and sell our products could be materially and adversely affected.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the use of a reagent for a particular process may be covered by one or more patents relating to the reagent itself, the use of the reagent for the particular process, the performance of that process, or the equipment required to perform the process. Typically, reagent suppliers, who are either the patent holders or their authorized licensees, sell the reagents along with a license or covenant not to sue with respect to such patents. The license accompanying the sale of a reagent often purports to restrict the purposes for which the reagent may be used. If a patent holder or authorized licensee were to assert against us or our customers that the license or covenant relating to a reagent precluded its use with our systems, our ability to sell and market our products could be materially and adversely affected. For example, our Biomark system involves real-time quantitative polymerase chain reaction (qPCR) technology. Leading suppliers of reagents for real-time qPCR reactions include Life Technologies Corporation (now part of Thermo) and Roche Diagnostics Corporation, who are our direct competitors, and their licensees. These real-time qPCR reagents are typically sold pursuant to limited licenses or covenants not to sue with respect to patents held by these companies. We do not have any contractual supply agreements for these real-time qPCR reagents, and we cannot assure you that these reagents will continue to be available to our customers for use with our systems, or that these patent holders will not seek to enforce their patents against us, our customers, or suppliers.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_199"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security breaches, loss of data, cyberattacks, and other information technology failures could disrupt our operations, damage our reputation, and adversely affect our business, operations, and financial results.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent upon our data and information technology systems for the effective operation of our business and for the secure maintenance and storage of confidential data relating to our business and third-party businesses. Our information technology systems may be damaged, disrupted or shut down due to attacks by experienced programmers or hackers who may be able to penetrate our security controls and deploy computer viruses, cyberattacks, phishing schemes, or other malicious software programs, or due to employee error or malfeasance, power outages, hardware failures, telecommunication or utility </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">failures, catastrophes or other unforeseen events, and our system redundancy and other disaster recovery planning may be ineffective or inadequate in preventing or responding to any of these circumstances. Any such compromise of our information technology systems could result in the unauthorized publication of our confidential business or proprietary information and unauthorized release of customer, supplier or employee data, any of which could expose us to a risk of legal claims or proceedings, liability under privacy or other laws, disruption of our operations and damage to our reputation, which could divert our management&#8217;s attention from the operation of our business and materially and adversely affect our business, revenues and competitive position. In addition, our liability insurance may not be sufficient in type or amount to cover us against claims related to security breaches, cyberattacks and other related breaches. The cost and operational consequences of implementing further data protection measures, either as a response to specific breaches or as a result of evolving risks, could be significant. In addition, our inability to use or access our information systems at critical points in time could adversely affect the timely and efficient operation of our business. Any delayed sales, significant costs or lost customers resulting from these technology failures could adversely affect our business, operations, and financial results. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented security controls to protect our information technology infrastructure but, due to the ever-evolving nature of information security threats, we are not fully insulated from technology disruptions that could adversely impact us. For example, in early 2019, we experienced a ransomware attack that infiltrated and encrypted certain of our information technology systems, including systems containing critical business data. Immediately following the attack, actions were taken to recover the compromised systems and we were able to restore their operation without significant loss of business data within weeks. Based on the nature of the attack and its impact on our systems, we believe no confidential data was lost or disclosed. If, however, confidential data were determined to have been released in the course of any future event, it is possible that we could be the subject of actions by governmental authorities or claims from persons alleging they suffered damages from such a release. We believe our mitigation measures and expanded information security program have reduced, but cannot eliminate, the risk of a similar attack, and we anticipate additional work and expense in the future as we continuously improve our security processes and initiatives in response to ever-changing information security challenges.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to risks affecting our own systems, we could also be negatively impacted by a data breach or cyber incident happening to a third party&#8217;s network and affecting us. Third parties with which we conduct business have access to certain portions of our sensitive data, including information pertaining to our customers and employees. In the event that these third parties do not adequately safeguard our data, security breaches could result and negatively impact our business, operations, and financial results.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the COVID-19 pandemic, we have an increased number of employees working remotely. As a result, we may have increased cyber security and data security risks, due to increased use of home wi-fi networks and virtual private networks, as well as increased disbursement of physical machines. While we have implemented security controls, updated our policies, and augmented our information security training program to reduce the risk of cyberattacks and security breaches, there is no guarantee that these measures will be adequate to safeguard all systems with the increased number of employees working remotely.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_202"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO QUALITY AND THE REGULATORY ENVIRONMENT</span></div><div id="i3f52f78858b0473b983a2153293d04e0_205"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our products could have defects or errors, which may give rise to claims against us, adversely affect market adoption of our systems, and adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our systems utilize novel and complex technology and such systems may develop or contain undetected defects or errors. We cannot assure you that material performance problems, defects, or errors will not arise, and as we increase the density and integration of our systems, these risks may increase. We generally provide warranties that our systems will meet performance expectations and will be free from defects. The costs incurred in correcting any defects or errors may be substantial and could adversely affect our operating margins. For example, we have experienced a performance issue with respect to certain IFCs used in our C1 systems due to the presence of more than one cell in an IFC chamber. Although we have redesigned such C1 IFCs, we may experience additional unexpected product defects or errors that could affect our ability to adequately address these performance issues. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In manufacturing our products, including our systems, IFCs, and assays, we depend upon third parties for the supply of various components, many of which require a significant degree of technical expertise to produce. In addition, we purchase certain products from third-party suppliers for resale. If our suppliers fail to produce components to specification or provide defective products to us for resale and our quality control tests and procedures fail to detect such errors or defects, or if we or our suppliers use defective materials or workmanship in the manufacturing process, the reliability and performance of our products will be compromised.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our products contain defects, we may experience:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a failure to achieve market acceptance or expansion of our product sales;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of customer orders and delay in order fulfillment;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">damage to our brand reputation;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased cost of our warranty program due to product repair or replacement;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product recalls or replacements;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inability to attract new customers;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of resources from our manufacturing and research and development departments into our service department; and</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">legal claims against us, including product liability claims, which could be costly and time consuming to defend and result in substantial damages.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain of our products are marketed for use with products sold by third parties. For example, certain of our systems are marketed as compatible with major NGS instruments. If such third-party products are not produced to specification, are produced in accordance with modified specifications, or are defective, they may not be compatible with our products. In such case, the reliability and performance of our products may be compromised.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any one or more of the foregoing could negatively affect our business, financial condition, and results of operations.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_208"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Although the FDA granted Emergency Use Authorization (EUA) for our Advanta Dx SARS-CoV-2 RT-PCR Assay in August 2020 (which was updated for use with the AZOVA COVID-19 Test Collection Kit in February 2021, among other updates) and our Advanta Dx COVID-19 EASE Assay in February 2022, these authorizations are only valid during the COVID-19 public health emergency, and when the federally declared public health emergency ends, we will be required to stop commercial distribution of our assay and the collection kit immediately in the United States unless we comply with FDA requirements, which may include obtaining FDA clearance or approval for our assay under a traditional regulatory pathway for in vitro diagnostics, which is lengthy and expensive.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under section 564 of the Federal Food, Drug, and Cosmetic Act (FD&amp;C Act), the FDA has authority to allow certain unapproved medical products or unapproved uses of approved medical products to be used during a public health emergency under an EUA. In issuing an EUA, the FDA will consider the totality of scientific evidence available to the FDA regarding safety, efficacy and known and potential risks of such products and availability of alternatives to the emergency use products, among others. EUAs issued by the FDA will specify the scope of authorization and conditions of authorization, including limitations on distribution and conditions related to product advertising and promotion. Once granted, an EUA is effective until the declaration that circumstances exist justifying the authorization of the emergency use is terminated under Section 564(b)(2) of the FD&amp;C Act or the EUA is revoked under Section 564(g) of the FD&amp;C Act, after which the product must be cleared or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approved by the FDA under a traditional pathway as defined by the FDA and we must comply with the FDA quality system regulations in order to remain on the market or to continue commercialization of the product. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FDA granted EUA for our Advanta Dx SARS-CoV-2 RT-PCR Assay for qualitative detection of nucleic acid from SARS-CoV-2 in saliva specimens from individuals suspected by their healthcare providers of having COVID-19, with the use of the assay limited to CLIA high complexity laboratories. Four supplements have been submitted and authorized as follows: S001 for addition of the FDA Reference Panel Results, S002 for software updates and labeling changes, S003 for addition of alternative source of targets and labeling updates, and S004 for addition of AZOVA home collection kit. In February 2021, the FDA updated that EUA for our Advanta Dx SARS-CoV-2 RT-PCR Assay for use with the AZOVA COVID-19 Test Collection Kit, which is authorized for self-collection of saliva specimens at home. In February 2022, we were granted EUA for our the Advanta Dx COVID-19 EASE Assay, which is authorized for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swab, oropharyngeal swab, mid-turbinate nasal swab, and anterior nasal swab specimens from individuals suspected of COVID-19 by their healthcare provider. As set forth in each EUA, we are required to comply with the conditions of authorization, including certain requirements pertaining to FDA notification, distribution, printed materials, advertising and promotion. If we, our distributors, or authorized laboratories do not comply with the EUA requirements, our business, financial condition and results of operations may be adversely impacted, and we may be subject to regulatory or enforcement actions, including recall of our products and the issuance of an untitled letter, a warning letter, penalties, or fines, among other adverse actions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA&#8217;s policies and guidance change unexpectedly and/or materially or if we misinterpret them, potential sales of Advanta Dx SARS-CoV-2 RT-PCR and the AZOVA COVID-19 Test Collection Kit could be adversely impacted. In addition, the FDA will revoke an EUA where it is determined that the underlying public health emergency no longer exists or warrants such authorization, or if new evidence becomes available that indicates the test does not meet the conditions of authorization or perform as provided in the EUA application. We cannot predict how long this EUA will remain effective. The termination or revocation of the EUA and changing policies and regulatory requirements could adversely impact our business, financial condition and results of operations. The demand for our product and our profitability may decline or be adversely impacted by the federal government&#8217;s implementation of a national COVID-19 testing strategy. Given the uncertain nature of the COVID-19 pandemic and future legislation and regulation in this space, we can provide no assurance with respect to our ability to achieve or sustain profitability on a quarterly or annual basis.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_2217"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The healthcare industry is highly regulated and if we fail to comply with applicable healthcare laws and regulations, we could suffer fines and penalties or be required to make significant changes to our operations which could have a significant adverse effect on the results of our business operations.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete in markets in which we or our customers must comply with federal, state, local and foreign regulations, such as healthcare fraud and abuse, data privacy and medical product laws and regulations. The healthcare industry is subject to extensive and frequently changing international and United States federal, state and local laws and regulations. In addition, federal and state enforcement agencies have substantial powers and remedies to pursue suspected violations under broad laws and regulations relating to healthcare fraud and abuse, interactions and financial arrangements with healthcare professionals or entities, data privacy and misconduct involving government programs or contracts. If we, our employees, collaborators or contractors fail to comply with applicable laws and regulations, we could suffer civil and criminal damages, fines and penalties, exclusion from participation in governmental healthcare programs, and the loss of various licenses and authorizations necessary to operate our business, as well as incur liabilities from third-party claims, all of which could have a significant adverse effect on our business.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_211"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our contract with the National Institutes of Health (NIH) could expose us to unique risks and costs as an entity contracting with the federal government.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The NIH launched the Rapid Acceleration of Diagnostics (RADx) program to expedite development, commercialization, and implementation of technologies for COVID-19 testing to help increase testing in the United States. In July 2020, we entered into a letter contract with the NIH for a project under the RADx program. The letter contract provided access to approximately $12.2 million of the total proposed funding for the project prior to execution of a further definitive contract for the project. In September 2020, we executed a definitive contract with the NIH as an amendment to the letter contract (collectively, the NIH Contract) to expand production capacity and throughput capabilities for COVID-19 testing with our microfluidics technology. Pursuant to the terms of the NIH Contract, the funding for the project was increased by approximately $22.0 million, for a total contract value of up to approximately $34.0 million. Release of funding under the NIH Contract is based on the achievement of milestones, including expansion of our manufacturing facilities, addition of production lines, and achieving full production capacity. As of December 31, 2021, all milestones have been achieved and accepted by NIH.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must prioritize among many different opportunities, and we may expend our limited resources on programs that do not yield a successful or profitable product candidate and may forego other more profitable opportunities. Further, the Bayh-Dole Act applies to all NIH research and development funding granted to for-profit organizations, which requires the government to be provided a nonexclusive, nontransferable, irrevocable, paid-up license to practice or have practiced for or on behalf of the United States any subject invention throughout the world. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NIH Contract includes certain provisions from the Federal Acquisition Regulations, some of which are customary or legally required, that give the U.S. government substantial rights and remedies, many of which are not typically found in commercial contracts. For example, the NIH Contract contains provisions permitting unilateral termination or modification, in whole or in part, at the convenience of the U.S. government. Under general principles of government contracting law, if the U.S. government terminates a contract for convenience, the government contractor may recover only its incurred or committed costs, settlement expenses and profit on work completed prior to the termination. If the U.S. government terminates a contract for default, the government contractor is entitled to recover costs incurred and associated profits on accepted items only and may be liable for excess costs incurred by the government in procuring undelivered items from another source. In addition, government contracts normally contain additional requirements that may increase our costs of doing business, reduce our profits, and expose us to liability for failure to comply with these terms and conditions. These requirements include, for example, mandatory internal control systems and policies, mandatory socioeconomic compliance requirements, including labor standards, non-discrimination and affirmative action programs and environmental compliance requirements and public disclosures of certain contract information, which may enable competitors to gain insights into our research program. If we fail to maintain compliance with these requirements, we may be subject to potential contract or False Claims Act liability and to termination of our NIH Contract.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other examples of rights and remedies under the NIH Contract include provisions that allow NIH to:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">terminate the NIH Contract, in whole or in part, for any reason or no reason;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unilaterally reduce or modify the U.S. government&#8217;s obligations under the NIH Contract, without our consent, including by imposing price adjustments;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">claim rights, including intellectual property rights, in or to (i) products, (ii) data, and (iii) facilities, in each case developed under the NIH Contract;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">under certain circumstances involving public health and safety, license inventions made under such agreements to third parties;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend us from receiving new contracts pending resolution of alleged violations of procurement laws or regulations;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impose U.S. manufacturing requirements for products that embody inventions conceived or first reduced to practice under the NIH Contract;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend or debar us from doing future business with the government;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">change the course of a development program in a manner that differs from the NIH Contract&#8217;s original terms or from our desired development plan, including decisions regarding our partners in the program;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pursue civil or criminal remedies under the False Claims Act and False Statements Act; and</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">control or prohibit the export of products.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, we may be required to enter into agreements and subcontracts with third parties, including suppliers, consultants and other third-party contractors in order to satisfy our contractual obligations pursuant to our agreements with the U.S. government. Negotiating and entering into such arrangements can be time-consuming and we may not be able to reach agreement with such third parties. Any such agreement must also be compliant with the terms of the NIH Contract. Any delay or inability to enter into such arrangements or entering into such arrangements in a manner that is non-compliant with the terms of our contract, may result in violations of our contract.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies routinely audit and investigate government contractors and recipients of federal grants and contracts, even after performance has been completed. These agencies review a contractor&#8217;s performance under its contracts, cost structure and compliance with applicable laws, regulations and standards. The audit may also include review of the adequacy of, and a contractor&#8217;s compliance with, its internal control systems and policies, including the contractor&#8217;s accounting, purchasing, property, estimating, compensation and management information systems. If an audit uncovers improper or illegal activities, we may be subject to civil and criminal penalties and administrative sanctions. In addition, we could suffer serious reputational harm if allegations of impropriety were made against us, which could cause our stock price to decrease.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_214"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To the extent we elect to label and promote any of our non-EUA products as medical devices, we would be required to obtain prior approval or clearance by the FDA or comparable foreign regulatory authority, which could take significant time and expense and could fail to result in a marketing authorization for the intended uses we believe are commercially attractive. Obtaining marketing authorization in one jurisdiction does not mean that we will be successful in obtaining marketing authorization in other jurisdictions where we conduct business.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for the Advanta Dx SARS-CoV-2 RT-PCR Assay and the AZOVA COVID-19 Test Collection Kit authorized by the FDA under an EUA granted in August 2020 and updated in February 2021, among other updates, and our Advanta Dx COVID-19 EASE Assay authorized by the FDA under an EUA granted in February 2022, our other products are currently labeled, promoted and sold to academic research institutions, translational research and medicine centers, cancer centers, clinical research laboratories, contract research organizations, and biopharmaceutical, biotechnology, and plant and animal research companies as &#8220;research use only&#8221; (RUO), and are not designed, or intended to be used, for clinical diagnostic tests or as medical devices as currently marketed. If we elect to label and market our products for use as, or in the performance of, clinical diagnostics in the United States, thereby subjecting them to FDA regulation as medical devices, we would be required to obtain premarket 510(k) clearance or premarket approval from the FDA, unless an exception applies. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently registered with the FDA as a medical device manufacturer, with the reagents for the Advanta Dx SARS-CoV-2 RT-PCR Assay listed as our sole medical device product. As noted in the issued EUA for the Advanta Dx SARS-CoV-2 RT-PCR Assay (including the EUA update for use with the AZOVA COVID-19 Test Collection Kit, among other updates) and the issued EUA for the Advanta Dx COVID-19 EASE Assay, the FDA has waived certain quality system requirements under 21 CFR Part 820 for the duration of each EUA. We may in the future list some of our other products with the FDA pursuant to an FDA Class I listing for general purpose laboratory equipment if we pursue clinical applications for such equipment. While this regulatory classification is generally exempt from certain FDA requirements, such as the need to submit a premarket notification commonly known as a 510(k), and some of the requirements of the FDA&#8217;s Quality System Regulations (QSRs), we would be subject to ongoing FDA &#8220;general controls,&#8221; which include compliance with FDA regulations for labeling, inspections by the FDA, complaint evaluation, corrections and removals reporting, promotional restrictions, reporting adverse events or malfunctions for our products, and general prohibitions against misbranding and adulteration. If we do not comply with all the requirements of the EUA or the normal regulatory requirements for any of our medical device products, including additional regulatory requirements that would apply to the Advanta Dx SARS-CoV-2 RT-PCR Assay and the AZOVA COVID-19 Test Collection Kit after the expiration or termination of the EUA, we may be subject to regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, penalties, or fines, among other adverse actions, any of which may adversely impact our business, financial condition and results of operations. Compliance with additional or changing regulatory requirements can be time-consuming and costly.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may in the future submit 510(k) premarket notifications to the FDA to obtain FDA clearance of certain of our products on a selected basis. It is possible, in the event we elect to submit 510(k) applications for certain of our products, that the FDA would take the position that a more burdensome premarket application, such as a premarket approval application or a de novo application is required for some of our products. If such applications were required, greater time and investment would be required to obtain FDA approval. Even if the FDA agreed that a 510(k) was appropriate, FDA clearance can be expensive and time consuming. It generally takes a significant amount of time to prepare a 510(k), including conducting appropriate testing on our products, and several months to years for the FDA to review a submission. Notwithstanding the effort and expense, FDA clearance or approval could be denied for some or all of our products. Even if we were to seek and obtain regulatory approval or clearance, it may not be for the intended uses we believe are important or commercially attractive.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we sought and received regulatory clearance or approval for certain of our products, we would be subject to ongoing FDA obligations and continued regulatory oversight and review, including the general controls listed above and the FDA&#8217;s QSRs for our development and manufacturing operations. In addition, we would be required to obtain a new 510(k) clearance before we could introduce subsequent material modifications or improvements to such products. We could also be subject to additional FDA post-marketing obligations for such products, any or all of which would increase our costs and divert resources away from other projects. If we sought and received regulatory clearance or approval and are not able to maintain regulatory compliance with applicable laws, we could be prohibited from marketing our products for use as, or in the performance of, clinical diagnostics and/or could be subject to enforcement actions, including warning letters and adverse publicity, fines, injunctions, and civil penalties; recall or seizure of products; operating restrictions; and criminal prosecution.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to the extent we decide to seek regulatory marketing authorization for certain of our products in countries outside of the United States, we or our partners, or collaborators, will need to obtain regulatory marketing authorization for our products for the intended use in the jurisdiction where such products will be marketed. Regulatory clearance or approval in one jurisdiction does not mean that we will be successful in obtaining regulatory marketing authorization in other jurisdictions where we conduct business. Sales of such products outside the United States will likely be subject to foreign regulatory requirements, which can vary greatly from country to country. As a result, the time required to obtain clearances or approvals </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">outside the United States may differ from that required to obtain FDA clearance or approval and we may not be able to obtain foreign regulatory approvals on a timely basis or at all. In Europe, we need to comply with the In Vitro Diagnostic Directive 98/79/EC and transition to the In Vitro Diagnostic Regulation 2017/746, which became effective May 26, 2017, with an application date of May 26, 2022. This will increase the difficulty of regulatory approvals in Europe in the future. In addition, the FDA regulates exports of medical devices. Failure to comply with these regulatory requirements or obtain and maintain required approvals, clearances and certifications could impair our ability to commercialize our products for diagnostic use outside of the United States.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, we announced a supply and distribution agreement to market our CyTOF technology, panels, and reagents to clinical labs in China.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the agreement, we are working to seek National Medical Products Administration (NMPA) approval for our CyTOF instrument for diagnostic use in China.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we increase our operations outside of the United States, our compliance and operational costs will increase, and we will be exposed to greater liability under additional laws and regulations.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_217"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our products could become subject to regulation as medical devices by the FDA or other regulatory agencies even if we do not elect to seek regulatory clearance or approval to market our products for diagnostic purposes, which would adversely impact our ability to market and sell our products and harm our business.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As products that are currently labeled, promoted and intended as RUO, our products are not currently subject to regulation as medical devices by the FDA or comparable agencies of other countries. However, the FDA or comparable agencies of other countries could disagree with our conclusion that our products are currently intended for research use only or deem our current sales, marketing and promotional efforts as being inconsistent with research use only products. For example, our customers may independently elect to use our research use only labeled products in their own laboratory developed tests (LDTs) for clinical diagnostic use. The FDA has historically exercised enforcement discretion in not enforcing the medical device regulations against laboratories offering LDTs. However, on October 3, 2014, the FDA issued two draft guidance documents that set forth the FDA&#8217;s proposed risk-based framework for regulating LDTs, which are designed, manufactured, and used within a single laboratory. The draft guidance documents provide the anticipated details through which the FDA would propose to establish an LDT oversight framework, including premarket review for higher-risk LDTs, such as those that have the same intended use as FDA-approved or cleared companion diagnostic tests currently on the market. In January 2017, the FDA announced that it would not issue final guidance on the oversight of LDTs and manufacturers of products used for LDTs, but would seek further public discussion on an appropriate oversight approach, and give Congress an opportunity to develop a legislative solution. More recently, the FDA has issued warning letters to certain genomics labs for illegally marketing genetic tests that claim to predict patients&#8217; responses to specific medications, noting that the FDA has not created a legal &#8220;carve-out&#8221; for LDTs and retains discretion to take action when appropriate, such as when certain genomic tests raise significant public health concerns. As manufacturers develop more complex genetic tests and diagnostic software, the FDA may increase its regulation of LDTs. Any future legislative or administrative rule making or oversight of LDTs, if and when finalized, may impact the sales of our products and how customers use our products, and may require us to change our business model in order to maintain compliance with these laws. We cannot predict how these various efforts will be resolved, how Congress or the FDA will regulate LDTs in the future, or how that regulatory system will impact our business.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on November&#160;25, 2013, the FDA issued Final Guidance &#8220;Distribution of In Vitro Diagnostic Products Labeled for Research Use Only.&#8221; The guidance emphasizes that the FDA will review the totality of the circumstances when it comes to evaluating whether equipment and testing components are properly labeled as RUO. The final guidance states that merely including a labeling statement that the product is for research purposes only will not necessarily render the device exempt from the FDA&#8217;s clearance, approval, and other regulatory requirements if the circumstances surrounding the distribution, marketing and promotional practices indicate that the manufacturer knows its products are, or intends for its products to be, used for clinical diagnostic purposes. These circumstances may include written or verbal sales and marketing claims or links to articles regarding a product&#8217;s performance in clinical applications and a manufacturer&#8217;s provision of technical support for clinical applications. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, as part of the U.S. government&#8217;s efforts to combat COVID-19 and consistent with the direction in Executive Orders 13771 and 13924, the Department of Health and Human Services (HHS) announced rescission of guidances and other informal issuances of the FDA regarding premarket review of LDTs absent notice-and-comment rulemaking, stating that, absent notice-and-comment rulemaking, those seeking approval or clearance of, or an emergency use authorization, for an LDT may nonetheless voluntarily submit a premarket approval application, premarket notification or an EUA request, respectively, but are not required to do so. However, laboratories opting to use LDTs without FDA premarket review or authorization would not be eligible for liability protection under the Public Readiness and Emergency Preparedness Act, or the PREP Act. In November 2021, HHS under the Biden administration issued a statement that withdrew the August 2020 policy announcement, stating that HHS does not have a policy on LDTs that is separate from FDA&#8217;s longstanding approach. The FDA also issued a revised version of its COVID-19 test policy that states the FDA expects newly offered COVID-19 tests, including </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LDTs, to have an EUA, or traditional marketing authorization such as a granted De Novo or cleared 510(k), prior to clinical use. Further, in June 2021, Congress introduced an updated legislation called the Verifying Accurate, Leading-edge IVCT Development Act (VALID Act), which, if enacted, will establish a new risk-based regulatory framework for in vitro clinical tests (IVCTs), which include IVDs, LDTs, collection devices, and instruments used with such tests, and a technology certification program, among other proposals. The adoption of new restrictions on IVDs, LDTs, or RUOs, whether by the FDA or Congress, could adversely affect our ability to commercialize our products and the demand for our specialized reagents and instruments. Further, we could be required to obtain premarket clearance or approval from the FDA before we can sell our products to certain customers.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA determines our products or related applications should be subject to additional regulation as in vitro diagnostic devices based upon customers&#8217; use of our products for clinical diagnostic or therapeutic decision-making purposes, our ability to market and sell our products could be impeded and our business, prospects, results of operations and financial condition may be adversely affected. In addition, the FDA could consider our products to be misbranded or adulterated under the Federal Food, Drug, and Cosmetic Act and subject to recall and/or other enforcement action.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_220"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compliance or the failure to comply with current and future regulations affecting our products and business operations worldwide, such as environmental regulations enacted in the European Union, could cause us significant expense and adversely impact our business. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to many federal, state, local, and foreign regulations relating to various aspects of our business operations. Governmental entities at all levels are continuously enacting new regulations, and it is difficult to identify all applicable regulations and anticipate how such regulations will be implemented and enforced. We continue to evaluate the necessary steps for compliance with applicable regulations. To comply with applicable regulations, we have and will continue to incur significant expense and allocate valuable internal resources to manage compliance-related issues. In addition, such regulations could restrict our ability to expand or equip our facilities, or could require us to acquire costly equipment or to incur other significant expenses to comply with the regulations. For example, the Restriction on the Use of Certain Hazardous Substances in Electrical and Electronic Equipment Directive (RoHS) and the Waste Electrical and Electronic Equipment Directive (WEEE), both enacted in the European Union, regulate the use of certain hazardous substances in, and require the collection, reuse, and recycling of waste from, products we manufacture. Certain of our products sold in these countries are subject to WEEE and RoHS. These and similar regulations that have been or are in the process of being enacted in other countries may require us to redesign our products, use different types of materials in certain components, or source alternative components to ensure compliance with applicable standards, and may reduce the availability of parts and components used in our products by negatively impacting our suppliers&#8217; ability to source parts and components in a timely and cost-effective manner.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation (EC) No. 1907/206 is the European Union&#8217;s regulation on chemicals and their safe use. The list of chemicals has been updated and some of the updates affect chemicals used in our products. We will request a research exception, but if not granted, we will need to reduce the concentration of some of the chemicals in our products, which will require significant research and development and operations efforts. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any such redesigns, required use of alternative materials, or limited availability of parts and components used in our products may detrimentally impact the performance of our products, add greater testing lead times for product introductions, reduce our product margins, or limit the markets for our products, and if we fail to comply with any present and future regulations, we could be subject to future fines, penalties, and restrictions, such as the suspension of manufacturing of our products or a prohibition on the sale of products we manufacture. Any of the foregoing could adversely affect our business, financial condition, or results of operations. </span></div><div id="i3f52f78858b0473b983a2153293d04e0_223"></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO ECONOMIC CONDITIONS AND OPERATING A GLOBAL BUSINESS</span></div><div id="i3f52f78858b0473b983a2153293d04e0_226"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We generate a substantial portion of our revenue internationally and our international business exposes us to business, regulatory, political, operational, financial, and economic risks associated with doing business outside of the United States.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years 2021, 2020, and 2019, approximately</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 56%, 54%, and 63% respec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tively, of our product and service revenue was generated from sales to customers located outside of the United States. We believe that a significant percentage of our future revenue will continue to come from international sources as we expand our international operations and develop opportunities in other countries. Engaging in international business inherently involves a number of difficulties and risks, including:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required compliance with existing and changing foreign regulatory requirements and laws that are or may be applicable to our business in the future, such as the European Union&#8217;s General Data Protection Regulation, the California Consumer Privacy Act, and other data privacy requirements, labor and employment regulations, anticompetition regulations, the U.K. Bribery Act of 2010 and other anticorruption laws, and the RoHS and WEEE directives and REACH regulation, which regulate the use and importation of certain hazardous substances in, and require the collection, reuse, and recycling of waste from, products we manufacture;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required compliance with U.S. laws such as the Foreign Corrupt Practices Act, and other U.S. federal laws and regulations established by the Office of Foreign Assets Control;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">export requirements and import or trade restrictions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws and business practices favoring local companies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">longer payment cycles and difficulties in enforcing agreements and collecting receivables through certain foreign legal systems;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in social, economic, and political conditions or in laws, regulations and policies governing foreign trade, manufacturing, development, and investment both domestically as well as in the other countries and jurisdictions in which we operate and into which we sell our products, including as a result of the separation of the United Kingdom from the European Union (Brexit) or the Russian invasion of Ukraine;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business interruptions and travel restrictions resulting from global sociopolitical events, including war and terrorism, public health crises (including the ongoing COVID-19 pandemic), and natural disasters including earthquakes, typhoons, floods and fires;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potentially adverse tax consequences, tariffs, customs charges, bureaucratic requirements, and other trade barriers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties and costs of staffing and managing foreign operations; and</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties protecting or procuring intellectual property rights.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the beginning of the COVID-19 pandemic, travel restrictions have caused significant slowdowns in China, Japan, and other parts of the Asia-Pacific region. These slowdowns, in addition to shipment delays in China due to delays in obtaining VAT and import tax exemptions for our products, have caused our financial results to suffer. If these situations continue, or if other risks occur, we could be forced to dedicate significant resources to their resolution, and if we are unsuccessful in finding a solution, our financial condition and results will suffer.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, political instability, civil unrest, the deterioration of the political situation in a country in which we have significant sales or operations, or the breakdown of trade relations between the United States and a foreign country in which we have significant operations, could adversely affect our business, financial condition, and results of operations. For example, a change in trade status between the United States and a foreign country could result in a substantial increase in the import duty of products manufactured in that foreign country and imported into the United States. The United States has commenced certain trade actions, including imposing increased tariffs on certain goods imported into the United States from China, which has resulted in retaliatory tariffs by China. In addition, the United States has commenced certain trade actions as a result of the Russian invasion of Ukraine, which are widely expected to result in retaliatory measures or actions, including tariffs, by Russia. Any increased trade barriers or restrictions on global trade imposed by the United States, or further retaliatory trade measures taken by China, Russia, or other countries in response, could adversely affect our business, financial condition, and results of operations.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_2224"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business is subject to a variety of new U.S. and foreign export controls and economic sanctions regulations that were issued in response to Russia&#8217;s invasion of Ukraine; our failure to comply with these laws and regulations could harm our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to recent regulations, U.S. companies can no longer provide or receive services or conduct any business with, including selling, shipping, or otherwise transferring any U.S.-controlled products to, the Donetsk People&#8217;s Republic (DNR) and Luhansk People&#8217;s Republic (LNR) regions of Ukraine. Additionally, existing U.S. sanctions continue to extend these prohibitions to the Crimea region of Ukraine. Our business is also subject to the expansion of previously existing sanctions imposed by the Treasury Department&#8217;s Office of Foreign Assets Controls that now cover a significant number of individuals and entities located in Russia, Belarus, and surrounding regions as well as new U.S. export controls imposed by the U.S. Department of Commerce&#8217;s Export Administration Regulations on exports to Russia. These laws and regulations cover U.S. persons as well as U.S.-controlled products, software, and technologies wherever located. Failure to comply with U.S. and foreign export control and economic sanctions laws and regulations can result in criminal sanctions, civil fines, debarment from government contracting, the loss of export privileges, and, in some cases, imprisonment. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently implementing new measures to reduce our exposure to this liability. The implementation of these measures may require us to expend substantial resources or to discontinue certain products or services, which would negatively affect our business, financial condition, and operating results. In addition, the increased attention focused upon liability issues as a result of lawsuits, regulatory proceedings, and legislative proposals could damage our brand or otherwise impact the growth of our business. Finally, our ability to receive payment from these regions has been significantly impacted. Any costs incurred or loss of business that occurs as a result of compliance or other liabilities under these laws or regulations could harm our business and operating results.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_229"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adverse conditions in the global economy and disruption of financial markets may significantly harm our revenue, profitability, and results of operations.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Adverse economic conditions in the U.S. and international markets, including the worldwide economic disruption related to the COVID-19 pandemic and related slowdowns in China, Japan, and elsewhere in the Asia-Pacific region, have negatively affected our revenues and operating results and may continue to do so. Even before the current public health crisis took hold, the global credit and financial markets had been experiencing volatility and disruptions, including diminished liquidity and credit availability, increased concerns about inflation and deflation, and the downgrade of U.S. debt and exposure risks on other sovereign debts, decreased consumer confidence, lower economic growth, volatile energy costs, increased unemployment rates, and uncertainty about economic stability. Geopolitical events including the COVID-19 pandemic, the Russian invasion of Ukraine, including any resulting adoption and expansion of trade restrictions by the United States, Russia, and/or China, and Brexit have caused significant economic, market, political and regulatory uncertainty in some of our markets. Volatility and disruption of financial markets could limit our customers&#8217; ability to obtain adequate financing or credit to purchase and pay for our products in a timely manner or to maintain operations, which could result in a decrease in sales volume that could harm our results of operations. General concerns about the fundamental soundness of domestic and international economies may also cause our customers to reduce their purchases. Changes in governmental banking, monetary, and fiscal policies to address liquidity and increase credit availability may not be effective. Significant government investment and allocation of resources to assist the economic recovery of sectors that do not include our customers may reduce the resources available for government grants and related funding for life science, plant and animal research, and clinical research and development. Continuation or further deterioration of these financial and macroeconomic conditions could significantly harm our sales, profitability, and results of operations.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_232"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to fluctuations in the exchange rate of the U.S. dollar and foreign currencies. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of our product sales are currently denominated in U.S. dollars and fluctuations in the value of the U.S. dollar relative to foreign currencies could decrease demand for our products and adversely impact our financial performance. For example, if the value of the U.S. dollar increases relative to foreign currencies, our products could become more costly to the international consumer and therefore less competitive in international markets, or if the value of the U.S. dollar decreases relative to the Singapore dollar or the Canadian dollar, it would become more costly in U.S. dollars for us to manufacture our products in Singapore and/or in Canada. Additionally, our expenses are generally denominated in the currencies of the countries in which our operations are located, which is primarily in the United States, with a portion of expenses incurred in Singapore and Canada where a significant portion of our manufacturing operations are located. Our results of operations and cash flows are, therefore, subject to fluctuations due to changes in foreign currency exchange rates. The volatility of exchange rates depends on many factors that we cannot forecast with reliable accuracy. We have experienced and will continue to experience fluctuations in our net income or loss as a result of transaction gains or losses related to revaluing certain current asset and current liability balances that are denominated in currencies other than the functional currency of the entities in which they are recorded. Fluctuations in currency exchange rates could have an adverse impact on our financial results in the future.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_235"></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">FINANCIAL, TAX, AND ACCOUNTING RISKS</span></div><div id="i3f52f78858b0473b983a2153293d04e0_238"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our future capital needs are uncertain and we may need to raise additional funds in the future, which may cause dilution to stockholders or may be upon terms that are not favorable to us.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our existing cash, cash equivalents, and investments, along with funding available from the Private Placement Issuance and the Revolving Credit Facility, will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. However, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we have continued to experience losses and, if that trend continues, we may need to seek additional sources of financing. In addition, we may need to raise substantial additional capital for various purposes, including:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">funding our operations;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expanding the commercialization of our products;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">furthering our research and development; and</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquiring other businesses or assets and licensing technologies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future funding requirements will depend on many factors, including:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market acceptance of our products;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of our research and development activities;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of filing and prosecuting patent applications;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of defending any litigation including intellectual property, employment, contractual or other litigation;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of regulatory clearances or approvals, if any;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of establishing additional sales, marketing, and distribution capabilities;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of establishing additional technical support capabilities;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in cash demands (e.g., due to interest or principal payments or payouts under existing cash compensation plans);</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">variability in sales and timing of related cash collections;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effectiveness of our efficiency and cost-savings initiatives; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of any natural disasters or public health crises (including the COVID-19 pandemic);</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of competing technological and market developments; and</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we acquire or invest in businesses, products, and technologies, although we currently have no commitments or agreements relating to any of these types of transactions.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent we draw on our Credit Facility or otherwise incur additional indebtedness, the risks described above could increase. Further, if we increase our indebtedness, our actual cash requirements in the future may be greater than expected. Our cash flow from operations may not be sufficient to repay all of the outstanding debt as it becomes due, and we cannot assure you that we will be able to obtain additional funds on acceptable terms, or at all. The ongoing COVID-19 pandemic has led to significant disruption and volatility in the global capital markets, increasing the cost of&#8212;and adversely impacting access to&#8212;capital. We entered into an Open Market Sale Agreement (Sale Agreement) with Jefferies LLC (Jefferies) to sell shares of our common stock having aggregate sales proceeds of up to $50 million, from time to time, through an at-the-market (ATM) equity offering program under which Jefferies acts as sales agent. During the third quarter of 2020, we sold approximately 2.5 million shares of our common stock pursuant to the Sale Agreement, for aggregate gross proceeds of $20.9 million. Our net proceeds were approximately $20.1 million, after deducting related expenses, including commissions of approximately $0.6 million and issuance costs of approximately $0.2 million. If we raise additional funds by issuing equity securities, either under the ATM program or otherwise, our stockholders will experience dilution. Debt financing in addition to the Credit Facility, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt or equity financing that we raise may contain terms that are not favorable to us or our stockholders, and our ability to raise additional capital may be adversely impacted by the impact of the COVID-19 pandemic on the economy. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we raise additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish some rights to our technologies or our products, or grant licenses on terms that are not favorable to us. If we do not have or are unable to raise adequate funds, we may have to liquidate some or all of our assets, delay development or commercialization of our products, or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce marketing, customer support, research and development, or other resources devoted to our products, or cease operations. Any of these factors could harm our operating results.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_241"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to maintain effective internal control over financial reporting in the future, the accuracy and timing of our financial reporting may be impaired, which could adversely affect our business and our stock price.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sarbanes-Oxley Act requires, among other things, that we maintain effective internal control over financial reporting and disclosure controls and procedures. In particular, we must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting, as required by Section&#160;404 of the Sarbanes-Oxley Act. Our testing may reveal deficiencies in our internal control over financial reporting that are deemed to be material weaknesses. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compliance with Section&#160;404 requires that we incur substantial accounting expense and expend significant management time on compliance-related issues. We currently do not have an internal audit group, and we continue to evaluate our need for additional accounting and financial staff with appropriate public company experience and technical accounting knowledge. Moreover, if we do not comply with the requirements of Section&#160;404, or if we or our independent registered public accounting firm identify deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the market price of our stock could decline and we could be subject to sanctions or investigations by The Nasdaq Stock Market LLC, the SEC, or other regulatory authorities, which would require additional financial and management resources.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_244"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not realize the value of our goodwill or other intangible assets, which would be reflected in an impairment charge.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business acquisitions typically result in goodwill and other intangible assets, which affect the amount of future period amortization expense and possible impairment expense. We make estimates and assumptions in valuing such intangible assets that affect our condensed consolidated financial statements. As of March 31, 2022, we had approximately $132.3 million of goodwill and net intangible assets, including approximately $106.3 million of goodwill and $26.0 million of net intangible assets. These assets represent a significant portion of the assets recorded on our condensed consolidated balance sheet and relate primarily to our acquisition of DVS Sciences, Inc. (DVS) in February 2014 and InstruNor in 2020. In addition, if in the future we acquire additional businesses, technologies, or other intangible assets, a substantial portion of the value of such assets may be recorded as goodwill or intangible assets. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the realizability of goodwill and indefinite-lived intangible assets annually as well as whenever events or changes in circumstances indicate that these assets may be impaired. We assess the realizability of definite-lived intangible assets whenever events or changes in circumstances indicate that these assets may be impaired. These events or circumstances would generally include operating losses or a significant decline in earnings associated with the acquired business or asset. Our ability to realize the value of the goodwill and intangible assets will depend on the future cash flows of these businesses. These cash flows in turn depend in part on how well we have integrated these businesses. If we are not able to realize the value of the goodwill and intangible assets, we may be required to incur material charges relating to the impairment of those assets.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_247"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If we fail to comply with the covenants and other obligations under our Credit Facility, the lenders may be able to accelerate amounts owed under the facilities and may foreclose upon the assets securing our obligations.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we amended our Revolving Credit Facility, which provides for secured revolving loans in an aggregate amount of up to $15.0 million, to extend the maturity date to August 2, 2023 and to provide for a new $10.0 million term loan facility (the Term Loan Facility and, together with the Revolving Credit Facility, the Credit Facility). The Credit Facility is secured by substantially all of our assets, other than intellectual property. The</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Credit Facility contains customary affirmative and negative covenants which, unless waived by the bank, limit our ability to, among other things, incur additional indebtedness, grant liens, make investments, repurchase stock, pay dividends, transfer assets, enter into affiliate transactions, undergo a change of control, or engage in merger and acquisition activity, including merging or consolidating with a third party. Additionally, we are required to maintain a minimum Adjusted Quick Ratio (as defined in the amendment) of at least 1.25 to 1.00. If we fail to comply with the covenants and our other obligations under the Credit Facility, the lenders would be able to accelerate the required repayment of amounts due under the Credit Facility and, if they are not repaid, could foreclose upon the assets securing our obligations under the Credit Facility.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_250"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our ability to use net operating loss carryforwards to offset future taxable income for U.S. federal income tax purposes and other tax benefits may be limited.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 382 of the Internal Revenue Code of 1986, as amended (the Code), imposes an annual limitation on the amount of taxable income that may be offset by net operating loss carryforwards (NOLs) if a corporation experiences an &#8220;ownership change.&#8221; As provided in Section 382 of the Code, an &#8220;ownership change&#8221; occurs when a company&#8217;s &#8220;five-percent shareholders&#8221; collectively increase their ownership in the company by more than 50 percentage points (by value) over a rolling three-year period. Various states also have limitations on the use of state NOLs following an ownership change.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future changes in our stock ownership, some of which are outside our control, could result in an ownership change under Section 382 of the Code. If we experience an ownership change, our ability to use our NOLs or other tax benefits could be substantially limited, which could significantly impair their value.&#160; There is no assurance that we will be able to fully utilize our NOLs or other tax benefits, which could adversely impact our results of operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that these tax benefits are a valuable asset for us and we monitor our stock ownership to determine whether our NOLs are at material risk of limitation based on an ownership change pursuant to Section 382. If our board of directors determines a potential risk exists that our NOLs could be limited, it could elect to adopt a tax benefit preservation plan in an effort to protect our tax benefits. Adoption of a tax benefit preservation plan could make it more difficult for a third party to </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acquire, or could discourage a third party from acquiring, us or a large block of our common stock.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_253"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to risks related to taxation in multiple jurisdictions and our effective income tax rate could be adversely affected and we could have additional tax liability if existing tax laws or regulations change or if taxing authorities disagree with our interpretations of tax laws or regulations. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in both the United States and certain foreign jurisdictions. Significant judgments based on interpretations of existing tax laws or regulations are required in determining the provision for income taxes. For example, we have made certain interpretations of existing tax laws or regulations based upon the operations of our business internationally and we have implemented intercompany agreements based upon these interpretations and related transfer pricing analyses. If the U.S. Internal Revenue Service or other taxing authorities disagree with the positions, our effective income tax rate could be adversely affected and we could have additional tax liability, including interest and penalties. From time to time, we may review our corporate structure and tax positions in the various international jurisdictions in which we operate and such review may result in changes to how we structure our international business operations, which may adversely impact our effective income tax rate. Our effective income tax rate could also be adversely affected by changes in the mix of earnings in tax jurisdictions with different statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in existing tax laws or tax rates, changes in the level of non-deductible expenses (including share-based compensation), changes in our future levels of research and development spending, mergers and acquisitions, or the result of examinations by various tax authorities. Payment of additional amounts as a result of changes in applicable tax law or upon final adjudication of any disputes could have a material impact on our results of operations and financial position.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_256"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in accounting principles, or interpretations thereof, could have a significant impact on our financial position and results of operations. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). These principles are subject to interpretation by the SEC and various bodies formed to interpret and create appropriate accounting principles. A change in these principles can have a significant effect on our reported results and may even retroactively affect previously reported transactions. Additionally, the adoption of new or revised accounting principles may require that we make significant changes to our systems, processes and controls.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is not clear if or when potential changes in accounting principles may become effective, whether we have the proper systems and controls in place to accommodate such changes and the impact that any such changes may have on our financial position and results of operations.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_259"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We have a significant amount of outstanding indebtedness, and our financial condition and results of operations could be adversely affected if we do not efficiently manage our liabilities.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have significant outstanding convertible debt. As of March 31, 2022, we had outstanding $0.6 million aggregate principal amount of our 2.75% Senior Convertible Notes due 2034 (2014 Notes) and $55.0 million aggregate principal amount of our 5.25% convertible senior notes due 2024 (2019 Notes).&#160;The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. Pursuant to the terms of the indenture governing the 2014 Notes (2014 Notes Indenture), holders of the 2014 Notes may require us to repurchase all or a portion of the 2014 Notes at a repurchase price in cash equal to 100% of the principal amount of such 2014 Notes plus accrued and unpaid interest thereon, on each of February 6, 2024 and February 6, 2029. The 2019 Notes will mature on December 1, 2024, unless earlier converted, or repurchased in accordance with the terms of the 2019 Notes. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo a fundamental change (as defined in the 2014 Notes Indenture or the indenture governing the 2019 Notes, as applicable (collectively, the Convertible Notes)), holders of the applicable series of Convertible Notes may require us to repurchase such Convertible Notes in whole or in part for cash at a repurchase price equal to 100% of the principal amount of the applicable series of Convertible Notes plus accrued and unpaid interest. If we refinance all or any portion of the Convertible Notes, we may issue additional convertible notes or other debt, which could include additional company obligations and represent more dilution to existing stockholders and noteholders.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This significant amount of debt has important risks to us and our investors, including:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requiring a portion of our cash flow from operations to make interest payments on this debt;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing our vulnerability to general adverse economic and industry conditions;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reducing the cash flow available to fund capital expenditures and other corporate purposes and to grow our business;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our flexibility in planning for, or reacting to, changes in our business and the industry; and</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our ability to borrow additional funds as needed or take advantage of business opportunities as they arise.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to the extent we draw on our Revolving Credit Facility or otherwise incur additional indebtedness, the risks described above could increase. Further, if we increase our indebtedness, our actual cash requirements in the future may be greater than expected. Our cash flow from operations may not be sufficient to repay all of the outstanding debt as it becomes due, and we may not be able to borrow money, sell assets or otherwise raise funds on acceptable terms, or at all, to refinance our debt.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_262"></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">RISKS RELATED TO INTELLECTUAL PROPERTY</span></div><div id="i3f52f78858b0473b983a2153293d04e0_265"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our ability to protect our intellectual property and proprietary technology through patents and other means is uncertain.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends in part on our ability to protect our intellectual property and proprietary technologies. We rely on patent protection, where appropriate and available, as well as a combination of copyright, trade secret, and trademark laws, and nondisclosure, confidentiality, and other contractual restrictions to protect our proprietary technology. However, these legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep any competitive advantage. We apply for patents covering our products and technologies and uses thereof, as we deem appropriate. However, we may fail to apply for patents on important products and technologies in a timely fashion or at all. Our pending U.S. and foreign patent applications may not issue as patents or may not issue in a form that will be sufficient to protect our proprietary technology and gain or keep our competitive advantage. Any patents we have obtained or do obtain may be subject to re-examination, reissue, opposition, or other administrative proceeding, or may be challenged in litigation, and such challenges could result in a determination that the patent is invalid or unenforceable. In addition, competitors may be able to design alternative methods or devices that avoid infringement of our patents. Both the patent application process and the process of managing patent disputes can be time consuming and expensive.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the laws of some foreign countries may not protect our intellectual property rights to the same extent as do the laws of the United States, and many companies have encountered significant problems in protecting and defending such rights in foreign jurisdictions. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business. Changes in either the patent laws or in interpretations of patent laws in the United States or other countries may diminish the value of our intellectual property. We cannot predict the breadth of claims that may be allowed or enforced in our patents or in third-party patents. For example:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we might not have been the first to make the inventions covered by each of our pending patent applications;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we might not have been the first to file patent applications for these inventions;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the patents of others may have an adverse effect on our business; and</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others may independently develop similar or alternative products and technologies or duplicate any of our products and technologies.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent our intellectual property, including licensed intellectual property, offers inadequate protection, or is found to be invalid or unenforceable, our competitive position and our business could be adversely affected.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_268"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be involved in lawsuits to protect or enforce our patents and proprietary rights, to determine the scope, coverage and validity of others&#8217; proprietary rights, or to defend against third-party claims of intellectual property infringement, any of which could be time-intensive and costly and may adversely impact our business or stock price.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation may be necessary for us to enforce our patent and proprietary rights, determine the scope, coverage, and validity of others&#8217; proprietary rights, and/or defend against third-party claims of intellectual property infringement against us as well as against our suppliers, distributors, customers, and other entities with which we do business. Litigation could result in substantial legal fees and could adversely affect the scope of our patent protection. The outcome of any litigation or other proceeding is inherently uncertain and might not be favorable to us, and we might not be able to obtain licenses to technology that we require. Even if such licenses are obtainable, they may not be available at a reasonable cost. We could therefore incur substantial costs related to royalty payments for licenses obtained from third parties, which could negatively affect our product margins or financial position. Further, we could encounter delays in product introductions, or interruptions in product sales, as we develop alternative methods or products. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we move into new markets and applications for our products, incumbent participants in such markets may assert their patents and other proprietary rights against us as a means of impeding our entry into such markets or as a means to extract substantial license and royalty payments from us. Our commercial success may depend in part on our non-infringement of the patents or proprietary rights of third parties. Numerous significant intellectual property issues have been litigated, and will likely continue to be litigated, between existing and new participants in our existing and targeted markets. For example, some of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our products provide for the testing and analysis of genetic material, and patent rights relating to genetic materials remain a developing area of patent law. A recent U.S. Supreme Court decision held, among other things, that claims to isolated genomic DNA occurring in nature are not patent eligible, while claims relating to synthetic DNA may be patent eligible. We expect the ruling will result in additional litigation in our industry. In addition, third parties may assert that we are employing their proprietary technology without authorization, and if they are successful in making such claims, we may be forced to enter into license agreements, pay additional royalties or license fees, or enter into settlements that include monetary obligations or restrictions on our business.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers have been sued for various claims of intellectual property infringement in the past, and we expect that our customers will be involved in additional litigation in the future. In particular, our customers may become subject to lawsuits claiming that their use of our products infringes third-party patent rights, and we could become subject to claims that we contributed to or induced our customer&#8217;s infringement. In addition, our agreements with some of our suppliers, distributors, customers, and other entities with which we do business may require us to defend or indemnify these parties to the extent they become involved in infringement claims against us, including the claims described above. We could also voluntarily agree to defend or indemnify third parties in instances where we are not obligated to do so if we determine it would be important to our business relationships. If we are required or agree to defend or indemnify any of these third parties in connection with any infringement claims, we could incur significant costs and expenses that could adversely affect our business, operating results, or financial condition.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_271"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be subject to damages resulting from claims that we or our employees have wrongfully used or disclosed alleged trade secrets of our employees&#8217; former employers or other institutions or third parties with which such employees may have been previously affiliated.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our employees were previously employed at universities or other life science or plant and animal research companies, including our competitors or potential competitors. In the future, we may become subject to claims that our employees, or we, have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers or other third parties or institutions with which our employees may have been previously affiliated. Litigation may be necessary to defend against these claims. A resulting loss of key research personnel work product could hamper or prevent our ability to commercialize certain potential products or a loss of or inability to hire key marketing, sales or research and development personnel could adversely affect our future product development, sales and revenues, any of which could severely harm our business. Even if we are successful in defending against any such claims, litigation could result in substantial costs and be a distraction to management.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_274"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We depend on certain technologies that are licensed to us. We do not control these technologies and any loss of our rights to them could prevent us from selling our products, which would have an adverse effect on our business.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on licenses in order to be able to use various proprietary technologies that are material to our business, including our core IFC, multi-layer soft lithography, and mass cytometry technologies. In some cases, we do not control the prosecution, maintenance, or filing of the patents to which we hold licenses, or the enforcement of these patents against third parties. Additionally, our business and product development plans anticipate and may substantially depend on future in-license agreements with additional third parties, some of which are currently in the early discussion phase. For example, Fluidigm Canada Inc. (Fluidigm Canada), an Ontario corporation and wholly owned subsidiary of Fluidigm Sciences, was party to an interim license agreement, now expired, with Nodality, Inc., or Nodality, under which Nodality granted Fluidigm Canada a worldwide, non-exclusive, research use only, royalty bearing license to certain cytometric reagents, instruments, and other products. While we were able to secure a license under a new license agreement with Nodality, we cannot provide assurances that we will always be able to obtain suitable license rights to technologies or intellectual property of other third parties on acceptable terms, if at all.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-licensed intellectual property rights that are fundamental to our business being operated present numerous risks and limitations. For example, all or a portion of the license rights granted may be limited for research use only, and in the event we attempt to expand into diagnostic applications, we would be required to negotiate additional rights, which may not be available to us on commercially reasonable terms, if at all.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our rights to use the technology we license are also subject to the negotiation and continuation of those licenses. Certain of our licenses contain provisions that allow the licensor to terminate the license upon specific conditions. Our rights under the licenses are subject to our continued compliance with the terms of the license, including the payment of royalties due under the license. Because of the complexity of our products and the patents we have licensed, determining the scope of the license and related royalty obligation can be difficult and can lead to disputes between us and the licensor. An unfavorable resolution of such a dispute could lead to an increase in the royalties payable pursuant to the license. If a licensor believed we were not paying the royalties due under the license or were otherwise not in compliance with the terms of the license, the licensor might </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">attempt to revoke the license. If such an attempt were successful and the license is terminated, we might be barred from marketing, producing, and selling some or all of our products, which would have an adverse effect on our business. Potential disputes between us and one of our existing licensors concerning the terms or conditions of the applicable license agreement could result, among other risks, in substantial management distraction; increased expenses associated with litigation or efforts to resolve disputes; substantial customer uncertainty concerning the direction of our product lines; potential infringement claims against us and/or our customers, which could include efforts by a licensor to enjoin sales of our products; customer requests for indemnification by us; and, in the event of an adverse determination, our inability to operate our business as currently operated. Termination of material license agreements could prevent us from manufacturing and selling our products unless we can negotiate new license terms or develop or acquire alternative intellectual property rights that cover or enable similar functionality. Any of these factors would be expected to have a material adverse effect on our business, operating results, and financial condition and could result in a substantial decline in our stock price.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_277"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to certain manufacturing restrictions related to licensed technologies that were developed with the financial assistance of U.S. governmental grants.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to certain U.S. government regulations because we have licensed technologies that were developed with U.S. government grants. In accordance with these regulations, these licenses provide that products embodying the technologies are subject to domestic manufacturing requirements. If this domestic manufacturing requirement is not met, the government agency that funded the relevant grant is entitled to exercise specified rights, referred to as &#8220;march-in rights,&#8221; which if exercised would allow the government agency to require the licensors or us to grant a non-exclusive, partially exclusive, or exclusive license in any field of use to a third party designated by such agency. All of our microfluidic systems revenue is dependent upon the availability of our IFCs, which incorporate technology developed with U.S. government grants. Our genomics instruments, including microfluidic systems and IFCs, are manufactured at our facility in Singapore. The federal regulations allow the funding government agency to grant, at the request of the licensors of such technology, a waiver of the domestic manufacturing requirement. Waivers may be requested prior to any government notification. We have assisted the licensors of these technologies with the analysis of the domestic manufacturing requirement, and, in December 2008, the sole licensor subject to the requirement applied for a waiver of the domestic manufacturing requirement with respect to the relevant patents licensed to us by this licensor. In July 2009, the funding government agency granted the requested waiver of the domestic manufacturing requirement for a three-year period commencing in July 2009. In June 2012, the licensor requested a continued waiver of the domestic manufacturing requirement with respect to the relevant patents, but the government agency has not yet taken any action in response to this request. If the government agency does not grant the requested waiver or the government fails to grant additional waivers of such requirement that may be sought in the future, then the U.S. government could exercise its march-in rights with respect to the relevant patents licensed to us. In addition, the license agreement under which the relevant patents are licensed to us contains provisions that obligate us to comply with this domestic manufacturing requirement. We are not currently manufacturing instruments and IFCs in the United States that incorporate the relevant licensed technology. If our lack of compliance with this provision constituted a material breach of the license agreement, the license of the relevant patents could be terminated or we could be compelled to relocate our manufacturing of microfluidic systems and IFCs to the United States to avoid or cure a material breach of the license agreement. Any of the exercise of march-in rights, the termination of our license of the relevant patents or the relocation of our manufacturing of microfluidic systems and IFCs to the United States could materially adversely affect our business, operations and financial condition.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_280"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to certain obligations and restrictions relating to technologies developed in cooperation with Canadian government agencies. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our Canadian research and development is funded in part through government grants and by government agencies. The intellectual property developed through these projects is subject to rights and restrictions in favor of government agencies and Canadians generally. In most cases the government agency retains the right to use intellectual property developed through the project for non-commercial purposes and to publish the results of research conducted in connection with the project. This may increase the risk of public disclosure of information relating to our intellectual property, including confidential information, and may reduce its competitive advantage in commercializing intellectual property developed through these projects. In certain projects, we have also agreed to use commercially reasonable efforts to commercialize intellectual property in Canada, or more specifically in the province of Ontario, for the economic benefit of Canada and the province of Ontario. These restrictions will limit our choice of business and manufacturing locations, business partners and corporate structure and may, in certain circumstances, restrict our ability to achieve maximum profitability and cost efficiency from the intellectual property generated by these projects. In one instance, a dispute with the applicable government funded entity may require mediation, which could lead to unanticipated delays in our commercialization efforts to that project. One of our Canadian government funded projects is also subject to certain limited &#8220;march-in&#8221; rights in favor of the government of the Province of Ontario, under which we may be required to grant a license to our intellectual property, including background intellectual property developed outside the scope of the project, to a responsible applicant on reasonable terms in circumstances where the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">government determines that such a license is necessary in order to alleviate emergency or extraordinary health or safety needs or for public use. In addition, we must provide reasonable assistance to the government in obtaining similar licenses from third parties required in connection with the use of its intellectual property. Instances in which the government of the Province of Ontario has exercised similar &#8220;march-in&#8221; rights are rare; however, the exercise of such rights could materially adversely affect our business, operations and financial condition.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_283"></div><div style="margin-top:15pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">RISKS RELATED TO OUR COMMON STOCK</span></div><div id="i3f52f78858b0473b983a2153293d04e0_286"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our stock price is volatile. </span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock is currently traded on the Nasdaq Global Select Market (Nasdaq), but we can provide no assurance that we will be able to maintain an active trading market on Nasdaq or any other exchange in the future.&#160;The trading volume of our stock tends to be low relative to our total outstanding shares, and we have several stockholders who hold substantial blocks of our stock.&#160;As of December 31, 2021, we had 76,919,287 shares of common stock outstanding, and stockholders holding at least 5% of our stock, individually or with affiliated persons or entities, collectively beneficially owned or controlled approximately 51% of such shares.&#160;Sales of large numbers of shares by any of our large stockholders could adversely affect our trading price, particularly given our relatively small historic trading volumes.&#160;If stockholders holding shares of our common stock sell, indicate an intention to sell, or if it is perceived that they will sell, substantial amounts of their common stock in the public market, the trading price of our common stock could decline. Moreover, if there is no active trading market or if the volume of trading is limited, holders of our common stock may have difficulty selling their shares. In addition, the concentration of ownership of our outstanding common stock (approximately 51% held by our top seven stockholders as of December 31, 2021) means that a relatively small number of stockholders have significant control over the outcomes of stockholder voting. </span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our common stock is highly volatile and subject to wide fluctuations in response to various factors, some of which are beyond our control. These factors include:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of public health crises, including the COVID-19 pandemic, on global financial markets;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated quarterly variation in our results of operations or the results of our competitors;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to achieve performance consistent with our financial guidance and/or market expectations;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements or communications by us or our competitors relating to, among other things, new commercial products, technological advances, significant contracts, commercial relationships, capital commitments, acquisitions or sales of businesses, and/or misperceptions in or speculation by the market regarding such announcements or communications;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issuance of new or changed securities analysts&#8217; reports or recommendations for our stock;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments or disputes concerning our intellectual property or other proprietary rights;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">commencement of, or our involvement in, litigation;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market conditions in the life science, plant and animal research, and contract research organization sectors;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to complete significant sales;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacturing disruptions that could occur if we are unable to successfully expand our production in our current or an alternative facility;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supply chain disruptions;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any future sales of our common stock or other securities in connection with raising additional capital or otherwise;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any major change to the composition of our board of directors or management; </span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general market conditions and other factors unrelated to our operating performance or the operating performance of our competitors, including deteriorating market conditions due to investor concerns regarding inflation and hostilities between Russia and Ukraine; and</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic conditions and slow or negative growth of our markets.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock market in general, and market prices for the securities of technology-based companies like ours in particular, have from time to time experienced volatility that often has been unrelated to the operating performance of the underlying companies. These broad market and industry fluctuations may adversely affect the market price of our common stock regardless of our operating performance. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In several recent situations where the market price of a stock has been volatile, holders of that stock have instituted securities class action litigation against the company that issued the stock. As discussed in the Legal Proceedings section of this </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">quarterly report on Form 10-Q, a class action securities lawsuit against us is currently pending. While we are continuing to defend such action vigorously, the defense of this action and any additional actions can be costly, divert the time and attention of our management, and harm our operating results, and any judgment against us or any future stockholder litigation could result in substantial costs.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_289"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future sales of our common stock in the public market could cause our stock price to fall.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our stock price could decline as a result of sales of a large number of shares of our common stock or the perception that these sales could occur. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in the future, we may issue additional shares of common stock or other equity or debt securities convertible into common stock in connection with a financing, acquisition, litigation settlement, employee arrangements or otherwise. Any such future issuance, including any issuances pursuant to our ATM equity offering program under our Sale Agreement with Jefferies, could result in substantial dilution to our existing stockholders and could cause our stock price to decline.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_292"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We will have broad discretion over the use of the proceeds to us from our ATM equity offering program and may apply the proceeds to uses that do not improve our operating results or the value of your securities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will have broad discretion to use the net proceeds to us from our ATM equity offering program, and investors will be relying solely on the judgment of our board of directors and management regarding the application of these proceeds. Investors will not have the opportunity, as part of their investment decision, to assess whether the proceeds are being used appropriately. Our use of the proceeds may not improve our operating results or increase the value of the securities offered pursuant to the ATM equity offering program.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_295"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">If securities or industry analysts publish unfavorable research about us or cease to cover our business, our stock price and/or trading volume could decline.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common stock may rely, in part, on the research and reports that equity research analysts publish about us and our business. We do not have any control of the analysts or the content and opinions included in their reports. The price of our stock could decline if one or more equity research analysts downgrade our stock or issue other unfavorable commentary or research. If one or more equity research analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which in turn could cause our stock price or trading volume to decline. </span></div><div id="i3f52f78858b0473b983a2153293d04e0_298"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management and limit the market price of our common stock.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions in our certificate of incorporation and bylaws may have the effect of delaying or preventing a change of control or changes in our management, including provisions that:</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorize our board of directors to issue, without further action by the stockholders, up to 10,000,000 shares of undesignated preferred stock;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require that any action to be taken by our stockholders be effected at a duly called annual or special meeting and not by written consent;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specify that special meetings of our stockholders can be called only by our board of directors, the chairman of the board, the chief executive officer or the president;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our board of directors;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish that our board of directors is divided into three classes, Class I, Class II, and Class III, with each class serving staggered three-year terms;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that our directors may be removed only for cause;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that vacancies on our board of directors may be filled only by a majority of directors then in office, even though less than a quorum;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specify that no stockholder is permitted to cumulate votes at any election of directors; and</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require a super-majority of votes to amend certain of the above-mentioned provisions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors, which is responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section&#160;203 of the Delaware General Corporation Law (DGCL), which limits the ability of stockholders owning in excess of 15% of our outstanding voting stock to merge or combine with us.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_301"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The forum selection provision in our bylaws could limit the ability of our stockholders to bring a claim in a judicial forum viewed by the stockholders as more favorable for disputes with us or our directors, officers or other employees.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our bylaws provide that the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another State court in Delaware or the federal district court for the District of Delaware) is the exclusive forum for the following (except for any claim as to which such court determines that there is an indispensable party not subject to the jurisdiction of such court (and the indispensable party does not consent to the personal jurisdiction of such court within 10 days following such determination), which is vested in the exclusive jurisdiction of a court or forum other than such court or for which such court does not have subject matter jurisdiction):</span></div><div style="margin-top:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any derivative action or proceeding brought on our behalf;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim of breach of fiduciary duty;</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim against us arising under the DGCL, our certificate of incorporation or our bylaws; and</span></div><div style="margin-top:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim against us that is governed by the internal-affairs doctrine.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision does not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our bylaws further provide that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These exclusive-forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees. Any person or entity purchasing or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to these provisions. There is uncertainty as to whether a court would enforce such provisions, and the enforceability of similar choice of forum provisions in other companies&#8217; charter documents has been challenged in legal proceedings.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that a court could find these types of provisions to be inapplicable or unenforceable, and if a court were to find either exclusive-forum provision in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving the dispute in other jurisdictions, which could seriously harm our business.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_304"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Any conversions of the 2014 Notes or 2019 Notes will dilute the ownership interest of our existing stockholders and may otherwise depress the price of our common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any conversion of some or all of the 2014 Notes or 2019 Notes will dilute the ownership interests of our existing stockholders. Any sales in the public market of our common stock issuable upon such conversion could also adversely affect prevailing market prices of our common stock.  In addition, holders of the 2014 Notes or 2019 Notes may hedge their position in such Convertible Notes by entering into short positions with respect to the underlying common stock. As a result, any anticipated conversion of the 2014 Notes or 2019 Notes could depress the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities. </span></div><div id="i3f52f78858b0473b983a2153293d04e0_2253"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKS RELATED TO OUR CAPITAL STRUCTURE</span></div><div id="i3f52f78858b0473b983a2153293d04e0_2261"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As a result of the Private Placement Issuance, the Purchasers own a significant portion of our total outstanding voting securities and may prevent other stockholders from influencing material corporate decisions, and the Purchasers&#8217; interests may conflict with those of our other stockholders.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock is initially convertible into up to approximately 75,164,397 shares of our common stock (without giving effect to limitations associated with any conversion cap). On an as-converted basis, this collectively represents approximately 49.4% of our issued and outstanding common stock (equating to approximately 24.7% per Purchaser) based on the number of shares of common stock outstanding as of April 30, 2022, but assuming full conversion of all Series B Preferred Stock (without giving effect to limitations associated with any conversion cap). As a result, the Purchasers are our largest stockholders. This concentration of ownership, together with the voting rights, director designation rights and consent rights granted to the Purchasers as part of the Private Placement Issuance, may be perceived negatively by other investors and, as a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">result, may adversely affect the market price of our common stock. The Purchasers, if they acted together, could significantly influence all matters requiring approval by our stockholders, including the election of directors and the approval of mergers or other business combination transactions. The interests of the Purchasers may not always coincide with our interests or the interests of other stockholders.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_2267"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The market value of our common stock could decline if the Purchasers sell their Series B Preferred Stock or common stock after certain transfer restrictions expire or if our current stockholders sell large amounts of common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Registration Rights Agreement that we entered into on January 23, 2022 with the Purchasers, we agreed to certain customary registration rights with respect to shares issuable under the Bridge Loan Agreements and the Purchase Agreements, including (i) any shares of common stock acquired by any Purchaser pursuant to the conversion of the Series B Preferred Stock in accordance with the Series B Certificates of Designations, and (ii) any shares of common stock acquired by any Purchaser pursuant to preemptive rights under the Purchase Agreements, which means that such shares would become eligible for resale in the public markets following the expiration of any applicable transfer restrictions. Any sale of such shares, or the anticipation of the possibility of such sales, could create downward pressure on the market price of our common stock. Furthermore, our current stockholders may decide to reduce their investment in us due to the changes to our investment profile as a result of the Private Placement Issuance, and may sell large amounts of common stock. Such sales of our common stock could have the effect of depressing the market price of our common stock.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_2282"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Series B Preferred Stock has rights, preferences and privileges that are not held by, and are preferential to, the rights of our common stockholders, which could adversely affect our liquidity and financial condition, result in the interests of holders of our Series B Preferred Stock differing from those of our common stockholders and make an acquisition of us more difficult.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of our Series B preferred stock have (i) a liquidation preference (ii) rights to dividends, which are senior to all of our other equity securities, (iii) the right to require us to repurchase any or all of their Series B Preferred Stock in connection with certain change of control events, and (iv) conversion price adjustments upon the occurrence of certain events, each subject to the terms, conditions and exceptions contained in the Certificate of Designations for the Series B-1 and Series B-2 Preferred Stock. These dividend and other rights and obligations could impact our liquidity and reduce the amount of cash flows available for working capital, capital expenditures, growth opportunities, acquisitions, and other general corporate purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of our Series B Preferred Stock could also limit our ability to obtain additional financing or increase our borrowing costs, which could have an adverse effect on our financial condition. The preferential rights could also result in divergent interests between the Purchasers and holders of our common stock. Furthermore, a sale of our Company, as a change of control event, may require us to repurchase Series B Preferred Stock, which could have the effect of making an acquisition of our Company more expensive and potentially deterring proposed transactions that may otherwise be beneficial to our stockholders.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_2274"></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The holders of Series B Preferred Stock are entitled to vote with the holders of common stock with voting power measured in a manner related to the conversion ratio of the shares of Series B Preferred Stock and the holders of Series B Preferred Stock have rights to approve certain actions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The holders of Series B Preferred Stock may exercise influence over us, including through the ability of each of the holders of the Series B-1 Preferred Stock and the holders of the Series B-2 Preferred Stock to designate a member of our board of directors.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of Series B Preferred Stock are generally entitled to vote with the holders of the shares of common stock on all matters submitted for a vote of holders of shares of common stock (voting together with the holders of shares of common stock as one class) with voting power measured in a manner related to the conversion ratio of the shares of Series B Preferred Stock, subject to certain voting limitations as described in the Series B Certificates of Designations. Additionally, the consent of the holders of at least 60% of the shares of Series B Preferred Stock is required for, among other things, (i) amendments to our Certificate of Incorporation or Bylaws that have an adverse effect on the rights, preferences, privileges or voting powers of the Series B Preferred Stock and (ii) issuances by us of securities that are senior to, or equal in priority with, the Series B Preferred Stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, pursuant to the Series B Certificates of Designations, the Purchasers each have the right to nominate and elect one member to our board of directors at each annual meeting of the stockholders of the Company or at any special meeting called for the purpose of electing directors, for so long as the Casdin Preferred Percentage or Viking Preferred Percentage, as applicable, is equal to or greater than 7.5%. The director designated by each of the Purchasers is entitled to serve on committees of our board of directors, subject to applicable law and Nasdaq rules. Notwithstanding the fact that all directors will be subject to fiduciary duties to us and to applicable law, the interests of the directors designated by the Purchasers may differ from the interests of our security holders as a whole or of our other directors.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These significant stockholders may be able to determine or significantly influence matters requiring stockholder approval. The interests of significant stockholders may not always coincide with our interests or the interests of other stockholders. The Series B-1 Director and the Series B-2 Director are not subject to the classified board of directors provisions of our Charter. The director designated by the holders of the Series B -1 Preferred Stock and Series B-2 Preferred Stock will also be entitled to serve on committees of our board of directors, subject to applicable law and stock exchange rules. In addition, the Series B Certificates of Designations also provide that for so long as the Casdin Ownership Percentage and the Viking Ownership Percentage (each as defined in the applicable Certificate of Designations) continue to be met or exceeded for such series of Series B Preferred Stock, the Series B-1 Director and Series B-2 Director will have certain consent rights over, among other things: (i) any increase in the number of directors on the Board beyond seven; (ii) the hiring, promotion, demotion, or termination of the Company&#8217;s Chief Executive Officer; (iii) entering into or modifying (including by waiver) any transaction, agreement or arrangement with any Related Person (as such term is defined in the Series B Certificates of Designations), subject to certain exceptions; (iv) any voluntary petition under any applicable federal or state bankruptcy or insolvency law effected by the Company; (v) any change in the principal business of the Company or entry by the Company into any material new line of business; and (vi) for a period of three years after the Closing, (A) any acquisition (including by merger, consolidation or acquisition of stock or assets) of any assets, securities or property of any other person or (B) any sale, lease, license, transfer or other disposition of any assets of the Company or any of its subsidiaries, in each case, other than acquisitions or disposition of inventory or equipment in the ordinary course of business consistent with past practice, for consideration in excess of $50,000,000 in the aggregate in any six month period.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, the holders of Series B Preferred Stock have the ability to influence the outcome of certain matters affecting our governance and capitalization. Our obligations to the holders of Series B Preferred Stock could also limit our ability to obtain additional financing or increase our borrowing costs, which could have an adverse effect on our financial condition.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_307"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, at the Special Meeting, the stockholders of the Company approved the issuance of the Series B Preferred Stock pursuant to the Purchase Agreements and the Bridge Loan Agreements. Accordingly, on April 4, 2022, the Company issued an aggregate of 127,780 shares of Series B-1 Preferred Stock to Casdin and an aggregate of 127,779 shares of Series B-2 Preferred Stock to Viking pursuant to the terms of the Purchase Agreements and Bridge Loan Agreements.</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The securities of the Company that were issued as part of the Private Placement Issuance were not registered under the Securities Act of 1933, as amended (Securities Act), in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act. The investors represented to the Company in the Purchase Agreements and the Loan Agreements that they are &#8220;accredited investors&#8221; within the meaning of Regulation D of the Securities Act.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_310"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_313"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-top:8pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i3f52f78858b0473b983a2153293d04e0_316"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-bottom:8pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_319"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. Exhibits</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The documents listed in the Exhibit List, which follows below, are incorporated by reference or are filed with this quarterly report on Form 10-Q, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K).</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT LIST</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.152%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated<br/>by&#160;Reference<br/>From Form</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated<br/>by&#160;Reference<br/>From&#160;Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date&#160;Filed</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312511078412/dex31.htm">Eighth Amended and Restated Certificate of Incorporation filed on February 15, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312511078412/dex31.htm">2011.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/28/2011</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522093794/d300506dex48.htm">Amended and Restated Bylaws of Standard BioTools Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522093794/d300506dex43.htm">Certificate of Amendment to the Eighth Amended and Restated Certificate of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522093794/d300506dex43.htm">Incorporation.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312516774501/d294669dex31.htm">Certificate of Designation of Rights, Preferences and Privileges of Series A Participating Preferred Stock</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312516774501/d294669dex31.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11/22/2016</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000114420417039703/v471897_ex3-1.htm">Certificate of Elimination of Series A Participating Preferred </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000114420417039703/v471897_ex3-1.htm">Stock.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/2/2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522096290/d314141dex36.htm">Certificate of Designations of Rights, Preferences and Privileges of Series B-1 Convertible Preferred </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522096290/d314141dex36.htm">Stock.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/5/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522096290/d314141dex37.htm">Certificate of Designations of Rights, Preferences and Privileges of Series B-2 Convertible Preferred </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522096290/d314141dex37.htm">Stock.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/5/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522036985/d307863dex101.htm">Series B-1 Loan Agreement, dated as of January 23, 2022, by and among Fluidigm Corporation, Casdin Partners Master Fund, L.P., and Casdin Private Growth Equity Fund II, L.P.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/11/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/d243622dex102.htm">Series B-2 Loan Agreement, dated as of January 23, 2022, by and among Fluidigm Corporation, Viking Global Opportunities Illiquid Investments Sub-Master LP, and Viking Global Opportunities Drawdown (Aggregator) LP.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/24/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522052230/d263023ddef14a.htm">Series B-1 Convertible Preferred Stock Purchase Agreement, dated as of January 23, 2022, by and among Fluidigm Corporation, Casdin Private Growth Equity Fund II, L.P., and Casdin Partners Master Fund, L.P.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEF 14A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anx. B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/24/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522052230/d263023ddef14a.htm">Series B-2 Convertible Preferred Stock Purchase Agreement, dated as of January 23, 2022, by and among Fluidigm Corporation, Viking Global Opportunities Illiquid Investments Sub-Master LP, and Viking Global Opportunities Drawdown (Aggregator) LP.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEF 14A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anx. C</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/24/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/d243622dex105.htm">Registration Rights Agreement, dated as of January 23, 2022, by and between Fluidigm Corporation, Casdin Private Growth Equity Fund II, L.P., Casdin Partners Master Fund, L.P., Viking Global Opportunities Illiquid Investments Sub-Master LP, and Viking Global Opportunities Drawdown (Aggregator) LP.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/24/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/d243622dex106.htm">Stephen Christopher Linthwaite Transition Agreement and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/d243622dex106.htm">Release.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/24/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/d243622dex107.htm">Michael Egholm Offer Letter</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/d243622dex107.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/24/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/d243622dex108.htm">Indemnification Agreement, dated January 23, 2022, by and between the Company and Michael Egholm.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/24/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/d243622dex109.htm">Hanjoon Alex Kim Offer Letter</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/d243622dex109.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/24/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522093794/d300506dex49.htm">Standard BioTools 2022 Inducement Equity Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522093794/d300506dex49.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522093794/d300506dex991.htm">Form of Notice of Stock Option Grant and Stock Option Agreement under the 2022 Inducement Equity Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522093794/d300506dex991.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522093794/d300506dex992.htm">Form of Notice of Restricted Stock Unit Grant and Restricted Stock Unit Agreement under the 2022 Inducement Equity Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522093794/d300506dex992.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/1/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/d243622dex1010.htm">Form of Retention </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522016151/d243622dex1010.htm">Letter.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/24/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000116219422000021/exhibit1019fdefaultwaivera.htm">Default Waiver and Consent to Loan and Security Agreement, dated March 4, 2022, between the Company and Silicon Valley Bank.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19F</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/8/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522085854/d302500dex101.htm">Letter Agreement dated March 25, 2022</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522085854/d302500dex101.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/28/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522087550/d325093dex101.htm">Support Agreement, dated March 29, 2022, by and among Fluidigm Corporation and Caligan Partners LP and certain of its affiliates</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1162194/000119312522087550/d325093dex101.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/29/2022</span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.152%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated<br/>by&#160;Reference<br/>From Form</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated<br/>by&#160;Reference<br/>From&#160;Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date&#160;Filed</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31110q1q2022.htm">Certification Pursuant to 18 U.S.C. Section&#160;1350, as Adopted Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 of Chief Executive Officer.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31210q1q2022.htm">Certification Pursuant to 18 U.S.C. Section&#160;1350, as Adopted Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32110q1q2022.htm">Certification Pursuant to 18 U.S.C. Section&#160;1350, as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 of Chief Executive Officer.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32210q1q2022.htm">Certification Pursuant to 18 U.S.C. Section&#160;1350, as Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 of Chief Financial Officer.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document&#160;- the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Portions of this exhibit have been redacted in compliance with Regulation S-K Item 601(b)(10)(iv).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">+&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicates management contract or compensatory plan, contract, or arrangement.</span></div><div style="margin-top:6pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(1) In accordance with Item&#160;601(b)(32)(ii) of Regulation&#160;S-K and SEC Release No.&#160;33-8238 and 34-47986, Final Rule: Management&#8217;s Reports on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished in Exhibits 32.1 and 32.2 hereto are deemed to accompany this Form&#160;10-Q and will not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange Act. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><div id="i3f52f78858b0473b983a2153293d04e0_322"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div style="margin-top:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:15pt;margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.794%"><tr><td style="width:1.0%"></td><td style="width:30.025%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">STANDARD BIOTOOLS INC.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: May 9, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael Egholm</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Egholm</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and President</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: May 9, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Vikram Jog</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vikram Jog</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit31110q1q2022.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i20ce780660764e92b496058d667176cb_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF THE PRESIDENT AND CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECURITIES EXCHANGE ACT RULES 13a-14(a)&#160;AND 15d-14(a),</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael Egholm, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this quarterly report on Form 10-Q of Standard BioTools Inc.&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:37.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  May 9, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Egholm</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Egholm</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer (Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit31210q1q2022.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i231e4fbdae2e4737b9c0719b3dcb9b07_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF THE CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECURITIES EXCHANGE ACT RULES 13a-14(a)&#160;AND 15d-14(a),</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Vikram Jog, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">I have reviewed this quarterly report on Form 10-Q of Standard BioTools Inc.&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:37.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.884%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  May 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Vikram Jog</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vikram Jog</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit32110q1q2022.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4a86ed4f63cb49128491928fab60f040_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Michael Egholm, the chief executive officer of Standard BioTools Inc. (the &#8220;Company&#8221;), certify for the purposes of 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,</font></div><div style="margin-top:9pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 (the &#8220;Report&#8221;), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-bottom:3pt;margin-top:9pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"></td><td style="width:57.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.197%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  May 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Michael Egholm</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Egholm</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-top:9pt;text-indent:24.75pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit32210q1q2022.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4fa4235e33394b4c9eaa8e61e70734d3_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.2</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Vikram Jog, the chief financial officer of Standard BioTools Inc. (the &#8220;Company&#8221;), certify for the purposes of 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge,</font></div><div style="margin-top:9pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">the Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022 (the &#8220;Report&#8221;), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-bottom:3pt;margin-top:9pt;padding-left:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.619%"><tr><td style="width:1.0%"></td><td style="width:57.138%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.095%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;  May 9, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Vikram Jog</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vikram Jog</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>fldm-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3567094e-7943-4bac-b9e5-feece94f0a52,g:ecd4ac27-903f-4673-9e8a-4f46fd5b8bd9-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:fldm="http://fluidigm.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://fluidigm.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fldm-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fldm-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fldm-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fldm-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://fluidigm.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://fluidigm.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquity" roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusiness" roleURI="http://fluidigm.com/role/DescriptionofBusiness">
        <link:definition>2101101 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2102102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails">
        <link:definition>2406402 - Disclosure - Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails">
        <link:definition>2407403 - Disclosure - Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrivatePlacementIssuance" roleURI="http://fluidigm.com/role/PrivatePlacementIssuance">
        <link:definition>2108103 - Disclosure - Private Placement Issuance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrivatePlacementIssuanceTables" roleURI="http://fluidigm.com/role/PrivatePlacementIssuanceTables">
        <link:definition>2309302 - Disclosure - Private Placement Issuance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrivatePlacementIssuanceNarrativeDetails" roleURI="http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails">
        <link:definition>2410404 - Disclosure - Private Placement Issuance - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails" roleURI="http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails">
        <link:definition>2411405 - Disclosure - Private Placement Issuance - Schedule of Carrying Value of the Bridge Loans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NIHContract" roleURI="http://fluidigm.com/role/NIHContract">
        <link:definition>2112104 - Disclosure - NIH Contract</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NIHContractTables" roleURI="http://fluidigm.com/role/NIHContractTables">
        <link:definition>2313303 - Disclosure - NIH Contract (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NIHContractNarrativeDetails" roleURI="http://fluidigm.com/role/NIHContractNarrativeDetails">
        <link:definition>2414406 - Disclosure - NIH Contract - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NIHContractDetails" roleURI="http://fluidigm.com/role/NIHContractDetails">
        <link:definition>2415407 - Disclosure - NIH Contract (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentAgreement" roleURI="http://fluidigm.com/role/DevelopmentAgreement">
        <link:definition>2116105 - Disclosure - Development Agreement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentAgreementDetails" roleURI="http://fluidigm.com/role/DevelopmentAgreementDetails">
        <link:definition>2417408 - Disclosure - Development Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://fluidigm.com/role/Revenue">
        <link:definition>2118106 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://fluidigm.com/role/RevenueTables">
        <link:definition>2319304 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueScheduleofDisaggregationofRevenueDetails" roleURI="http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails">
        <link:definition>2420409 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://fluidigm.com/role/RevenueNarrativeDetails">
        <link:definition>2421410 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuePerformanceObligationsDetails" roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails">
        <link:definition>2422411 - Disclosure - Revenue - Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuePerformanceObligationsDetails_1" roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails_1">
        <link:definition>2422411 - Disclosure - Revenue - Performance Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnet" roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnet">
        <link:definition>2123107 - Disclosure - Goodwill and Intangible Assets, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetTables" roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables">
        <link:definition>2324305 - Disclosure - Goodwill and Intangible Assets, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetNarrativeDetails" roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails">
        <link:definition>2425412 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails">
        <link:definition>2426413 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails">
        <link:definition>2427414 - Disclosure - Goodwill and Intangible Assets, net - Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetails" roleURI="http://fluidigm.com/role/BalanceSheetDetails">
        <link:definition>2128108 - Disclosure - Balance Sheet Details</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsTables" roleURI="http://fluidigm.com/role/BalanceSheetDetailsTables">
        <link:definition>2329306 - Disclosure - Balance Sheet Details (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" roleURI="http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails">
        <link:definition>2430415 - Disclosure - Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsInventoriesDetails" roleURI="http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails">
        <link:definition>2431416 - Disclosure - Balance Sheet Details - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsPropertyandEquipmentDetails" roleURI="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails">
        <link:definition>2432417 - Disclosure - Balance Sheet Details - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails" roleURI="http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails">
        <link:definition>2433418 - Disclosure - Balance Sheet Details - Accrued Compensation and Related Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsWarrantyAccrualDetails" roleURI="http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails">
        <link:definition>2434419 - Disclosure - Balance Sheet Details - Warranty Accrual (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://fluidigm.com/role/Debt">
        <link:definition>2135109 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://fluidigm.com/role/DebtTables">
        <link:definition>2336307 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://fluidigm.com/role/DebtNarrativeDetails">
        <link:definition>2437420 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofDebtDetails" roleURI="http://fluidigm.com/role/DebtScheduleofDebtDetails">
        <link:definition>2438421 - Disclosure - Debt - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://fluidigm.com/role/Leases">
        <link:definition>2139110 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://fluidigm.com/role/LeasesTables">
        <link:definition>2340308 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://fluidigm.com/role/LeasesNarrativeDetails">
        <link:definition>2441422 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalancesheetDetails" roleURI="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails">
        <link:definition>2442423 - Disclosure - Leases - Supplemental Balance sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstruments" roleURI="http://fluidigm.com/role/FairValueofFinancialInstruments">
        <link:definition>2143111 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsTables" roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsTables">
        <link:definition>2344309 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails">
        <link:definition>2445424 - Disclosure - Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsScheduleofDebtDetails" roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails">
        <link:definition>2446425 - Disclosure - Fair Value of Financial Instruments - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://fluidigm.com/role/ShareholdersEquity">
        <link:definition>2147112 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://fluidigm.com/role/ShareholdersEquityTables">
        <link:definition>2348310 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNarrativeDetails" roleURI="http://fluidigm.com/role/ShareholdersEquityNarrativeDetails">
        <link:definition>2449426 - Disclosure - Shareholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityScheduleofStockOptionsDetails" roleURI="http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails">
        <link:definition>2450427 - Disclosure - Shareholders' Equity - Schedule of Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedPlans" roleURI="http://fluidigm.com/role/StockBasedPlans">
        <link:definition>2151113 - Disclosure - Stock-Based Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedPlansTables" roleURI="http://fluidigm.com/role/StockBasedPlansTables">
        <link:definition>2352311 - Disclosure - Stock-Based Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedPlansNarrativeDetails" roleURI="http://fluidigm.com/role/StockBasedPlansNarrativeDetails">
        <link:definition>2453428 - Disclosure - Stock-Based Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedPlansRestrictedandPerformanceStockUnitsDetails" roleURI="http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails">
        <link:definition>2454429 - Disclosure - Stock-Based Plans - Restricted and Performance Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedPlansStockOptionActivityDetails" roleURI="http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails">
        <link:definition>2455430 - Disclosure - Stock-Based Plans - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedPlansStockBasedCompensationExpenseDetails" roleURI="http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails">
        <link:definition>2456431 - Disclosure - Stock-Based Plans - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://fluidigm.com/role/IncomeTaxes">
        <link:definition>2157114 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://fluidigm.com/role/IncomeTaxesDetails">
        <link:definition>2458432 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InformationAboutGeographicAreas" roleURI="http://fluidigm.com/role/InformationAboutGeographicAreas">
        <link:definition>2159115 - Disclosure - Information About Geographic Areas</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InformationAboutGeographicAreasDetails" roleURI="http://fluidigm.com/role/InformationAboutGeographicAreasDetails">
        <link:definition>2460433 - Disclosure - Information About Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://fluidigm.com/role/CommitmentsandContingencies">
        <link:definition>2161116 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvent" roleURI="http://fluidigm.com/role/SubsequentEvent">
        <link:definition>2162117 - Disclosure - Subsequent Event</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://fluidigm.com/role/SubsequentEventsDetails">
        <link:definition>2463434 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="fldm_InstruNorASMember" abstract="true" name="InstruNorASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ProceedsFromResearchAndDevelopmentGrant" abstract="false" name="ProceedsFromResearchAndDevelopmentGrant" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_DeferredGrantRevenueCurrent" abstract="false" name="DeferredGrantRevenueCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_LossOnForwardSaleOfStock" abstract="false" name="LossOnForwardSaleOfStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_A2022InducementEquityIncentivePlanMember" abstract="true" name="A2022InducementEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" abstract="false" name="NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_DVSSciencesInc.Member" abstract="true" name="DVSSciencesInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_DebtCovenantPeriodAxis" abstract="true" name="DebtCovenantPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="fldm_DeferredGrantIncomeNoncurrent" abstract="false" name="DeferredGrantIncomeNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_RestrictedCashAndCashEquivalentsMember" abstract="true" name="RestrictedCashAndCashEquivalentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" abstract="true" name="TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_DebtCovenantPeriodFourMember" abstract="true" name="DebtCovenantPeriodFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_CashAndMoneyMarketFundsMember" abstract="true" name="CashAndMoneyMarketFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_StockRepurchaseLiability" abstract="false" name="StockRepurchaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor" abstract="false" name="DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="fldm_PortionOfStockOptionsVestOnFirstAnniversary" abstract="false" name="PortionOfStockOptionsVestOnFirstAnniversary" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" abstract="false" name="ContractWithCustomerLiabilityIncreaseFromCashReceipts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_RestrictedStockAndPerformanceShareUnitsMember" abstract="true" name="RestrictedStockAndPerformanceShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_DebtAndEquityIssuanceTextBlock" abstract="false" name="DebtAndEquityIssuanceTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="fldm_LaboratoryAndManufacturingEquipmentMember" abstract="true" name="LaboratoryAndManufacturingEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_LesseeOperatingLeaseRemainingTermOfContract" abstract="false" name="LesseeOperatingLeaseRemainingTermOfContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="fldm_AccruedBonusesNoncurrent" abstract="false" name="AccruedBonusesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_TwoThousandAndSeventeenInducementAwardPlanMember" abstract="true" name="TwoThousandAndSeventeenInducementAwardPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_BridgeLoansMember" abstract="true" name="BridgeLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_PatentsandLicenseAgreementsMember" abstract="true" name="PatentsandLicenseAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_DeferredGrantRevenue" abstract="false" name="DeferredGrantRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_PreferredStockFairValueDisclosure" abstract="false" name="PreferredStockFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_SeriesB1ConvertiblePreferredStockMember" abstract="true" name="SeriesB1ConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="fldm_UndisclosedCustomerMember" abstract="true" name="UndisclosedCustomerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio" abstract="false" name="DebtInstrumentCovenantMinimumAdjustedQuickRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="fldm_CollaborationRevenueMember" abstract="true" name="CollaborationRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_ShareholdersEquityLineItems" abstract="true" name="ShareholdersEquityLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" abstract="true" name="OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_AssetRetirementObligationsIncurredButNotYetPaid" abstract="false" name="AssetRetirementObligationsIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_DebtCovenantPeriodThreeMember" abstract="true" name="DebtCovenantPeriodThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_TwoThousandAndTenEquityIncentivePlanMember" abstract="true" name="TwoThousandAndTenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_EquityIncentivePlanTwentyElevenMember" abstract="true" name="EquityIncentivePlanTwentyElevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" abstract="false" name="OperatingLeaseRightOfUseAssetAccumulatedAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_InstrumentsMember" abstract="true" name="InstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" abstract="true" name="TwoThousandSeventeenEmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_EmployeeStockPurchasePlanOfferingPeriod" abstract="false" name="EmployeeStockPurchasePlanOfferingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments" abstract="false" name="DebtInstrumentPeriodicPaymentNumberOfInstallments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_SeniorConvertibleNotesdue2034Member" abstract="true" name="SeniorConvertibleNotesdue2034Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_DebtCovenantPeriodTwoMember" abstract="true" name="DebtCovenantPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_ExchangeConvertibleSeniorNotesDue2034Member" abstract="true" name="ExchangeConvertibleSeniorNotesDue2034Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement" abstract="false" name="CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_TwoThousandAndFourteenConvertibleNotesMember" abstract="true" name="TwoThousandAndFourteenConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_CasdinMember" abstract="true" name="CasdinMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_DebtCovenantPeriodOneMember" abstract="true" name="DebtCovenantPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_OperatingLeaseRightOfUseAssetGross" abstract="false" name="OperatingLeaseRightOfUseAssetGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_DeferredGrantRevenueNoncurrent" abstract="false" name="DeferredGrantRevenueNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" abstract="false" name="StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="fldm_TwoThousandAndNineteenConvertibleNotesMember" abstract="true" name="TwoThousandAndNineteenConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_CertainEmployeeMember" abstract="true" name="CertainEmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_InitialConversionPriceOfStock" abstract="false" name="InitialConversionPriceOfStock" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="fldm_DebtInstrumentIncrementalPaymentPercent" abstract="false" name="DebtInstrumentIncrementalPaymentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="fldm_DebtCovenantPeriodDomain" abstract="true" name="DebtCovenantPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_SeriesB2ConvertiblePreferredStockMember" abstract="true" name="SeriesB2ConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="fldm_TwoThousandAndElevenEquityIncentivePlanMember" abstract="true" name="TwoThousandAndElevenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="fldm_DebtInstrumentFaceAmountPerInstrument" abstract="false" name="DebtInstrumentFaceAmountPerInstrument" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="fldm_ShareholdersEquityTable" abstract="true" name="ShareholdersEquityTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued" abstract="false" name="DebtInstrumentConvertibleCalculationToDetermineSharesIssued" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_VikingMember" abstract="true" name="VikingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_SeniorConvertibleNotesDue2024Member" abstract="true" name="SeniorConvertibleNotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_NonCashRightOfUseAssetsAndLeaseLiabilities" abstract="false" name="NonCashRightOfUseAssetsAndLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_EquityIncentivePlanMember" abstract="true" name="EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_ComputerEquipmentAndSoftwareMember" abstract="true" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross" abstract="false" name="ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="fldm_DebtInstrumentCovenantConvertibleDebtThreshold" abstract="false" name="DebtInstrumentCovenantConvertibleDebtThreshold" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_DeferredGrantIncomeCurrent" abstract="false" name="DeferredGrantIncomeCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" abstract="false" name="DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>fldm-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3567094e-7943-4bac-b9e5-feece94f0a52,g:ecd4ac27-903f-4673-9e8a-4f46fd5b8bd9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="fldm-20220331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_10638233-3463-4954-af32-524e8390a046" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_60b56aae-4032-4d5d-8754-ec843fc0914b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10638233-3463-4954-af32-524e8390a046" xlink:to="loc_us-gaap_LiabilitiesCurrent_60b56aae-4032-4d5d-8754-ec843fc0914b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenueNoncurrent_03bd6e8e-3a05-4748-8f9b-b562435d870f" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantRevenueNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10638233-3463-4954-af32-524e8390a046" xlink:to="loc_fldm_DeferredGrantRevenueNoncurrent_03bd6e8e-3a05-4748-8f9b-b562435d870f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_49599810-5fdc-4410-97d3-651aae998773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10638233-3463-4954-af32-524e8390a046" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_49599810-5fdc-4410-97d3-651aae998773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9556182c-2af2-4d50-a78c-47de0d4c5b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10638233-3463-4954-af32-524e8390a046" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9556182c-2af2-4d50-a78c-47de0d4c5b84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_37175082-4423-44db-b90e-f39fb89b6228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10638233-3463-4954-af32-524e8390a046" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_37175082-4423-44db-b90e-f39fb89b6228" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_5a7858f5-77ca-4962-9432-5b708b4bae6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10638233-3463-4954-af32-524e8390a046" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_5a7858f5-77ca-4962-9432-5b708b4bae6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d57008a1-2b6d-4cda-8f36-2c8c4a824007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10638233-3463-4954-af32-524e8390a046" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_d57008a1-2b6d-4cda-8f36-2c8c4a824007" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_StockRepurchaseLiability_ba7f037a-5aa2-495e-a714-34cb361c1777" xlink:href="fldm-20220331.xsd#fldm_StockRepurchaseLiability"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10638233-3463-4954-af32-524e8390a046" xlink:to="loc_fldm_StockRepurchaseLiability_ba7f037a-5aa2-495e-a714-34cb361c1777" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_5d7a69e8-8b17-4d00-9452-ed650902d92c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10638233-3463-4954-af32-524e8390a046" xlink:to="loc_us-gaap_SecuredDebt_5d7a69e8-8b17-4d00-9452-ed650902d92c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c7bdc8e5-81e5-4982-9892-62a8d6c51acc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_10638233-3463-4954-af32-524e8390a046" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c7bdc8e5-81e5-4982-9892-62a8d6c51acc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3b67632b-5694-489c-8a76-1ab62733c44f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_419e493e-8add-4bf8-b25c-a4ab3389a29f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b67632b-5694-489c-8a76-1ab62733c44f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_419e493e-8add-4bf8-b25c-a4ab3389a29f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f1bcb9dd-f0ff-4ff1-9908-7a116d434642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b67632b-5694-489c-8a76-1ab62733c44f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f1bcb9dd-f0ff-4ff1-9908-7a116d434642" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8ffdbaa8-9d0f-4571-accf-21bce0b7bfc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b67632b-5694-489c-8a76-1ab62733c44f" xlink:to="loc_us-gaap_InventoryNet_8ffdbaa8-9d0f-4571-accf-21bce0b7bfc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8a732b50-f7d6-4e5f-83f4-35036b9aecb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_3b67632b-5694-489c-8a76-1ab62733c44f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8a732b50-f7d6-4e5f-83f4-35036b9aecb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cb636cec-4cc8-4589-a3c9-4e56e8ffb854" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_0eeff80e-834f-46ca-8223-00d2a06cdfdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cb636cec-4cc8-4589-a3c9-4e56e8ffb854" xlink:to="loc_us-gaap_LinesOfCreditCurrent_0eeff80e-834f-46ca-8223-00d2a06cdfdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2cbf8be2-011e-4e38-a5f7-faa1827e214b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cb636cec-4cc8-4589-a3c9-4e56e8ffb854" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2cbf8be2-011e-4e38-a5f7-faa1827e214b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3de6e3bf-435d-4039-82e2-6397143f6479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cb636cec-4cc8-4589-a3c9-4e56e8ffb854" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3de6e3bf-435d-4039-82e2-6397143f6479" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ef3aec9b-68d0-4a11-9e66-57f782653ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cb636cec-4cc8-4589-a3c9-4e56e8ffb854" xlink:to="loc_us-gaap_AccountsPayableCurrent_ef3aec9b-68d0-4a11-9e66-57f782653ed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a39cd596-6eb4-4c37-87db-d07cae04e02b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cb636cec-4cc8-4589-a3c9-4e56e8ffb854" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a39cd596-6eb4-4c37-87db-d07cae04e02b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1114c387-ab02-4bad-a085-e3a9ffdf68d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cb636cec-4cc8-4589-a3c9-4e56e8ffb854" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1114c387-ab02-4bad-a085-e3a9ffdf68d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenueCurrent_9cd51079-5d5a-47d0-a5ae-68a4a4c124c5" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantRevenueCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_cb636cec-4cc8-4589-a3c9-4e56e8ffb854" xlink:to="loc_fldm_DeferredGrantRevenueCurrent_9cd51079-5d5a-47d0-a5ae-68a4a4c124c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7ecf9b5f-6745-4370-9f50-f3faee50f56a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_801ba755-7d4e-4da5-9082-98918d635ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7ecf9b5f-6745-4370-9f50-f3faee50f56a" xlink:to="loc_us-gaap_Liabilities_801ba755-7d4e-4da5-9082-98918d635ad4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2e8f8259-84b4-4e43-b439-92f005cee30a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7ecf9b5f-6745-4370-9f50-f3faee50f56a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2e8f8259-84b4-4e43-b439-92f005cee30a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8c77cf7c-6d85-4ca9-bcaa-f192e12af6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7ecf9b5f-6745-4370-9f50-f3faee50f56a" xlink:to="loc_us-gaap_StockholdersEquity_8c77cf7c-6d85-4ca9-bcaa-f192e12af6c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6a15585d-7b12-47e8-b0fa-12530315a516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0a2b42a5-f643-4d4a-b218-5737b9123dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6a15585d-7b12-47e8-b0fa-12530315a516" xlink:to="loc_us-gaap_AssetsCurrent_0a2b42a5-f643-4d4a-b218-5737b9123dd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_35dfb6f2-b793-4ef5-9753-1acb51d71313" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6a15585d-7b12-47e8-b0fa-12530315a516" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_35dfb6f2-b793-4ef5-9753-1acb51d71313" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7d81d4ea-f3a1-4b11-af64-5024f17d2617" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6a15585d-7b12-47e8-b0fa-12530315a516" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7d81d4ea-f3a1-4b11-af64-5024f17d2617" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_99212650-da2a-41c9-81f4-d295e43a4aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6a15585d-7b12-47e8-b0fa-12530315a516" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_99212650-da2a-41c9-81f4-d295e43a4aa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4896f32d-d64e-4b05-a324-301f2fefb65f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6a15585d-7b12-47e8-b0fa-12530315a516" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4896f32d-d64e-4b05-a324-301f2fefb65f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_22652d3c-88a8-420f-83d2-111679e7bbde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6a15585d-7b12-47e8-b0fa-12530315a516" xlink:to="loc_us-gaap_Goodwill_22652d3c-88a8-420f-83d2-111679e7bbde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_295657a9-e363-4aba-ad03-cbdf339a2563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_7cae57c4-6cc3-44b0-a822-a3cf7766fdaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_295657a9-e363-4aba-ad03-cbdf339a2563" xlink:to="loc_us-gaap_PreferredStockValue_7cae57c4-6cc3-44b0-a822-a3cf7766fdaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_75ab8cfe-ca39-451a-b42d-35e38b89fbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_295657a9-e363-4aba-ad03-cbdf339a2563" xlink:to="loc_us-gaap_CommonStockValue_75ab8cfe-ca39-451a-b42d-35e38b89fbd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1fcb246c-d172-4ee7-b306-8c609b22c27f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_295657a9-e363-4aba-ad03-cbdf339a2563" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1fcb246c-d172-4ee7-b306-8c609b22c27f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6238599b-106f-4b08-b99f-9a4a3163d8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_295657a9-e363-4aba-ad03-cbdf339a2563" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6238599b-106f-4b08-b99f-9a4a3163d8fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_18e53f48-204b-44cc-b087-159bc0bc6788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_295657a9-e363-4aba-ad03-cbdf339a2563" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_18e53f48-204b-44cc-b087-159bc0bc6788" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="fldm-20220331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_56628d59-670c-4c64-aaf8-9236b1d6b76b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_dcff9f8d-8fcb-4940-905f-c1e271116550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_56628d59-670c-4c64-aaf8-9236b1d6b76b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_dcff9f8d-8fcb-4940-905f-c1e271116550" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0e823b92-db5f-4aaf-be4a-923319e19bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_56628d59-670c-4c64-aaf8-9236b1d6b76b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_0e823b92-db5f-4aaf-be4a-923319e19bcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ef61306c-3abb-4e7d-a9bd-2ff05edad9e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_56628d59-670c-4c64-aaf8-9236b1d6b76b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ef61306c-3abb-4e7d-a9bd-2ff05edad9e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a76f2026-8df3-4003-a646-1b71be1a5286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6cb0abd1-47a8-45a0-bace-a8148c3a9fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a76f2026-8df3-4003-a646-1b71be1a5286" xlink:to="loc_us-gaap_OperatingIncomeLoss_6cb0abd1-47a8-45a0-bace-a8148c3a9fdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_418417d6-228c-4b9f-8014-7e21b96f4924" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a76f2026-8df3-4003-a646-1b71be1a5286" xlink:to="loc_us-gaap_InterestExpense_418417d6-228c-4b9f-8014-7e21b96f4924" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_f42facae-c478-412e-9419-d2bb9f1f06e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesUnrealizedGainLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a76f2026-8df3-4003-a646-1b71be1a5286" xlink:to="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_f42facae-c478-412e-9419-d2bb9f1f06e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1090d71c-0291-438a-92c6-e71e124ca4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a76f2026-8df3-4003-a646-1b71be1a5286" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1090d71c-0291-438a-92c6-e71e124ca4ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LossOnForwardSaleOfStock_ebd2b06e-5122-4969-9fcf-b89de1bef69b" xlink:href="fldm-20220331.xsd#fldm_LossOnForwardSaleOfStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a76f2026-8df3-4003-a646-1b71be1a5286" xlink:to="loc_fldm_LossOnForwardSaleOfStock_ebd2b06e-5122-4969-9fcf-b89de1bef69b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3259d44e-95d5-4463-83e7-d7a439aa16a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9f4ed90e-b537-402e-bcf0-cd21d0b68b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3259d44e-95d5-4463-83e7-d7a439aa16a9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9f4ed90e-b537-402e-bcf0-cd21d0b68b4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8fd2944b-e360-48b5-941a-789cab8bda74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3259d44e-95d5-4463-83e7-d7a439aa16a9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8fd2944b-e360-48b5-941a-789cab8bda74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_759b12e6-1d5e-410e-80a0-cd8f0df11ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_222e5be1-c6d3-4ddc-b4da-c67b72994aec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_759b12e6-1d5e-410e-80a0-cd8f0df11ea8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_222e5be1-c6d3-4ddc-b4da-c67b72994aec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_82e4b9d4-0a70-4a83-a4a1-cedbee0e8b58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_759b12e6-1d5e-410e-80a0-cd8f0df11ea8" xlink:to="loc_us-gaap_OperatingExpenses_82e4b9d4-0a70-4a83-a4a1-cedbee0e8b58" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="fldm-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7cb57c82-bc8f-4d96-bd65-3ee6167b635c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_07712483-d907-4dfd-8827-0c8e5ae3c759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7cb57c82-bc8f-4d96-bd65-3ee6167b635c" xlink:to="loc_us-gaap_NetIncomeLoss_07712483-d907-4dfd-8827-0c8e5ae3c759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_31140cdf-b5c9-4131-9edd-a4fce8bc7155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_7cb57c82-bc8f-4d96-bd65-3ee6167b635c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_31140cdf-b5c9-4131-9edd-a4fce8bc7155" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="fldm-20220331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_35616120-a3b7-4491-90e0-e1de07836939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesUnrealizedGainLoss"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_35616120-a3b7-4491-90e0-e1de07836939" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_d74c598b-ba3e-4b19-ba45-438c8c408c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_d74c598b-ba3e-4b19-ba45-438c8c408c91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_cc070427-8113-4447-9684-cdd68c0be8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_cc070427-8113-4447-9684-cdd68c0be8e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5df6c4f7-2526-435f-b7a7-449ac78957c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5df6c4f7-2526-435f-b7a7-449ac78957c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LossOnForwardSaleOfStock_34be4ed1-1269-4aa8-b7ab-70e686b7cee4" xlink:href="fldm-20220331.xsd#fldm_LossOnForwardSaleOfStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_fldm_LossOnForwardSaleOfStock_34be4ed1-1269-4aa8-b7ab-70e686b7cee4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_319b0bdd-7230-40fc-aedf-eed92fddbbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_ShareBasedCompensation_319b0bdd-7230-40fc-aedf-eed92fddbbc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2ca414d1-3ab6-4c7f-a435-04583f134217" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2ca414d1-3ab6-4c7f-a435-04583f134217" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_25ac929a-2385-4f49-8dd7-aeee24d3b232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_25ac929a-2385-4f49-8dd7-aeee24d3b232" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_187f6969-6b00-4604-90a7-f1fbc3aaabd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_187f6969-6b00-4604-90a7-f1fbc3aaabd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c69f9d3a-cc7a-41cb-b871-28823d8448b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_NetIncomeLoss_c69f9d3a-cc7a-41cb-b871-28823d8448b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_fc2c0de8-2ced-414c-b558-8e9f937c7928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_fc2c0de8-2ced-414c-b558-8e9f937c7928" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_adeb8b8c-05cc-47a5-bf1d-961505994c9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_adeb8b8c-05cc-47a5-bf1d-961505994c9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_d02b0faf-d423-4f3f-a432-c183fedaea21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_d02b0faf-d423-4f3f-a432-c183fedaea21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f0c672dd-bb31-42e6-af7a-fdc4edc9df85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f0c672dd-bb31-42e6-af7a-fdc4edc9df85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_6932c029-b709-4e72-ad84-f896188715a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_6932c029-b709-4e72-ad84-f896188715a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0d874602-2300-41c1-bc25-7c30591307bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_92e36e95-ce66-47ec-99b1-c5e97535db32" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0d874602-2300-41c1-bc25-7c30591307bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3d18b824-eba2-43df-befc-c04e2d8d7b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e55809b0-9d44-41b6-9f5b-b797f51a65ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3d18b824-eba2-43df-befc-c04e2d8d7b59" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e55809b0-9d44-41b6-9f5b-b797f51a65ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a62ae8fd-9322-4024-aabc-9c92fa364850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3d18b824-eba2-43df-befc-c04e2d8d7b59" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a62ae8fd-9322-4024-aabc-9c92fa364850" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5742afe2-643a-41bd-a30e-c8bd7a224d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3d18b824-eba2-43df-befc-c04e2d8d7b59" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5742afe2-643a-41bd-a30e-c8bd7a224d7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d06c9847-9136-438e-b684-444cebca03f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3d18b824-eba2-43df-befc-c04e2d8d7b59" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d06c9847-9136-438e-b684-444cebca03f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47d34b5c-a25f-47c7-9282-a2575875f3be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_54b9dcea-7eff-4d32-aa71-da1f754895d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47d34b5c-a25f-47c7-9282-a2575875f3be" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_54b9dcea-7eff-4d32-aa71-da1f754895d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_172a7a04-880a-48a7-ae51-ffb38f14eee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47d34b5c-a25f-47c7-9282-a2575875f3be" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_172a7a04-880a-48a7-ae51-ffb38f14eee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_3fbfdd0e-285a-4be0-8911-f5f1d2caab7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47d34b5c-a25f-47c7-9282-a2575875f3be" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_3fbfdd0e-285a-4be0-8911-f5f1d2caab7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_f2213b9c-318d-49d2-9af6-ff713bc06fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_47d34b5c-a25f-47c7-9282-a2575875f3be" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_f2213b9c-318d-49d2-9af6-ff713bc06fd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6dc5ae89-0aef-4b84-9702-ddde2078d182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ProceedsFromResearchAndDevelopmentGrant_ca094329-befb-4951-8623-eb1c227e6394" xlink:href="fldm-20220331.xsd#fldm_ProceedsFromResearchAndDevelopmentGrant"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6dc5ae89-0aef-4b84-9702-ddde2078d182" xlink:to="loc_fldm_ProceedsFromResearchAndDevelopmentGrant_ca094329-befb-4951-8623-eb1c227e6394" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dadb937e-23cb-4d87-9517-9de1931ff189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6dc5ae89-0aef-4b84-9702-ddde2078d182" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_dadb937e-23cb-4d87-9517-9de1931ff189" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/NIHContractDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#NIHContractDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/NIHContractDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenue_90cc5de2-b822-4c40-bfb4-f313c99ebb65" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantRevenue"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantIncomeCurrent_1887467b-42ff-473f-a6a0-8e837afb1869" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantIncomeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fldm_DeferredGrantRevenue_90cc5de2-b822-4c40-bfb4-f313c99ebb65" xlink:to="loc_fldm_DeferredGrantIncomeCurrent_1887467b-42ff-473f-a6a0-8e837afb1869" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantIncomeNoncurrent_55af4c04-cd6c-48a0-a5e6-f99a21071a23" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantIncomeNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fldm_DeferredGrantRevenue_90cc5de2-b822-4c40-bfb4-f313c99ebb65" xlink:to="loc_fldm_DeferredGrantIncomeNoncurrent_55af4c04-cd6c-48a0-a5e6-f99a21071a23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet_e0573066-b07b-43b3-a98a-7898edd21404" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross_6d33fb2e-ce88-4115-8c03-f518b5839a76" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet_e0573066-b07b-43b3-a98a-7898edd21404" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross_6d33fb2e-ce88-4115-8c03-f518b5839a76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross_a4ca369d-e79b-46a8-8133-e79bcc6230ec" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet_e0573066-b07b-43b3-a98a-7898edd21404" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross_a4ca369d-e79b-46a8-8133-e79bcc6230ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses_ebd89b6d-03d9-42f9-8493-ccb1b1f60e06" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet_e0573066-b07b-43b3-a98a-7898edd21404" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses_ebd89b6d-03d9-42f9-8493-ccb1b1f60e06" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_39dd9dae-d277-43e8-bdcb-89f647359683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0d3050a3-2a7c-44a2-b9de-1bb011c3ee38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_39dd9dae-d277-43e8-bdcb-89f647359683" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0d3050a3-2a7c-44a2-b9de-1bb011c3ee38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_512538b7-fbb3-4510-8c99-96a8033ae3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_39dd9dae-d277-43e8-bdcb-89f647359683" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_512538b7-fbb3-4510-8c99-96a8033ae3cb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f285dad3-dd59-443a-9424-615bde90f716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0ddeec15-4acd-4118-b3df-508f01b25adb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f285dad3-dd59-443a-9424-615bde90f716" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0ddeec15-4acd-4118-b3df-508f01b25adb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_034396da-053b-47d8-afe3-0d359132851b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f285dad3-dd59-443a-9424-615bde90f716" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_034396da-053b-47d8-afe3-0d359132851b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0511926a-2b4b-4814-ac78-7c15f846b0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f285dad3-dd59-443a-9424-615bde90f716" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0511926a-2b4b-4814-ac78-7c15f846b0a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e3a3cb33-b560-4f9c-8330-b87d5d2fcf62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f285dad3-dd59-443a-9424-615bde90f716" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e3a3cb33-b560-4f9c-8330-b87d5d2fcf62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d17ffce8-91c6-448d-b072-9b3dca8693be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f285dad3-dd59-443a-9424-615bde90f716" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d17ffce8-91c6-448d-b072-9b3dca8693be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_37c45bc1-ab0e-4eee-a687-8bbc3514e834" xlink:href="fldm-20220331.xsd#fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f285dad3-dd59-443a-9424-615bde90f716" xlink:to="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_37c45bc1-ab0e-4eee-a687-8bbc3514e834" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ef17e9e-41b7-4cf1-ba17-d147ea699e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bb5ab6d0-48d5-4bfb-99e0-b3edbccae8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ef17e9e-41b7-4cf1-ba17-d147ea699e5e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bb5ab6d0-48d5-4bfb-99e0-b3edbccae8d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_bcb575bb-1d5c-4c34-8d2d-289e101d1e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ef17e9e-41b7-4cf1-ba17-d147ea699e5e" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_bcb575bb-1d5c-4c34-8d2d-289e101d1e04" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#BalanceSheetDetailsInventoriesDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0832cde7-dad1-4e0c-b31a-ac988efc69e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_2d81b995-1c55-4f16-9766-0923a3711c82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0832cde7-dad1-4e0c-b31a-ac988efc69e9" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_2d81b995-1c55-4f16-9766-0923a3711c82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_92bb46f6-9f19-4a84-92ce-252c66ed670d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0832cde7-dad1-4e0c-b31a-ac988efc69e9" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_92bb46f6-9f19-4a84-92ce-252c66ed670d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_65c7d8c0-5666-4d45-8729-cc7b17955770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0832cde7-dad1-4e0c-b31a-ac988efc69e9" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_65c7d8c0-5666-4d45-8729-cc7b17955770" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#BalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_246bf28e-4fea-4de6-8ded-821315037574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8572673e-7f52-41ec-8f3c-5ef269f99475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_246bf28e-4fea-4de6-8ded-821315037574" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8572673e-7f52-41ec-8f3c-5ef269f99475" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c91cdd13-3808-4ddb-97d8-17d8b59abfe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_246bf28e-4fea-4de6-8ded-821315037574" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c91cdd13-3808-4ddb-97d8-17d8b59abfe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_98825584-615e-434d-95e4-059a2ac69fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_246bf28e-4fea-4de6-8ded-821315037574" xlink:to="loc_us-gaap_ConstructionInProgressGross_98825584-615e-434d-95e4-059a2ac69fb3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_54764e96-728b-4060-a16e-4d00f4a39615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent_7534a5f9-9fe0-4fc7-b80e-3c47a66ea9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_54764e96-728b-4060-a16e-4d00f4a39615" xlink:to="loc_us-gaap_AccruedBonusesCurrent_7534a5f9-9fe0-4fc7-b80e-3c47a66ea9b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_969c06c7-10b3-48ec-943e-49f6556fabda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_54764e96-728b-4060-a16e-4d00f4a39615" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_969c06c7-10b3-48ec-943e-49f6556fabda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent_bd45d2e6-4402-4922-9ddc-e9fb2a0a6e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_54764e96-728b-4060-a16e-4d00f4a39615" xlink:to="loc_us-gaap_AccruedVacationCurrent_bd45d2e6-4402-4922-9ddc-e9fb2a0a6e3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent_a6c10972-11fb-4d71-b695-c78ba744e554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_54764e96-728b-4060-a16e-4d00f4a39615" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrent_a6c10972-11fb-4d71-b695-c78ba744e554" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#DebtScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/DebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_202cc787-a346-4036-9028-97aede40226e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_1fcb929e-ff12-4796-b8df-2eaa882eb581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_202cc787-a346-4036-9028-97aede40226e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_1fcb929e-ff12-4796-b8df-2eaa882eb581" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_32321026-66d4-4ed9-a8ba-82783cef55f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_202cc787-a346-4036-9028-97aede40226e" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_32321026-66d4-4ed9-a8ba-82783cef55f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1843d764-2ef1-44a1-9175-2b0d298656e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_202cc787-a346-4036-9028-97aede40226e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1843d764-2ef1-44a1-9175-2b0d298656e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_a1d09c22-a882-432f-a74d-9df5ba9d0e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_202cc787-a346-4036-9028-97aede40226e" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_a1d09c22-a882-432f-a74d-9df5ba9d0e0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_253982cc-8ee8-48e0-af34-78fbd9af3710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_202cc787-a346-4036-9028-97aede40226e" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_253982cc-8ee8-48e0-af34-78fbd9af3710" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#LeasesSupplementalBalancesheetDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1c50539e-856b-4565-a5c3-b6ac253d97c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetGross_79ec8a5b-4d1c-481f-8ddf-b191fe20edb0" xlink:href="fldm-20220331.xsd#fldm_OperatingLeaseRightOfUseAssetGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_1c50539e-856b-4565-a5c3-b6ac253d97c7" xlink:to="loc_fldm_OperatingLeaseRightOfUseAssetGross_79ec8a5b-4d1c-481f-8ddf-b191fe20edb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_f800b1f6-33ae-45cc-8783-1e20c2236f6f" xlink:href="fldm-20220331.xsd#fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_1c50539e-856b-4565-a5c3-b6ac253d97c7" xlink:to="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_f800b1f6-33ae-45cc-8783-1e20c2236f6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_2ed7c9dd-f0b2-41d2-a910-8d3d1c6a3b73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb18cfc3-5956-49bf-9d91-449e124f5a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_2ed7c9dd-f0b2-41d2-a910-8d3d1c6a3b73" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bb18cfc3-5956-49bf-9d91-449e124f5a9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9b6ce923-7bf6-405e-a452-938fa1ee0dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_2ed7c9dd-f0b2-41d2-a910-8d3d1c6a3b73" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9b6ce923-7bf6-405e-a452-938fa1ee0dac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"/>
  <link:calculationLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_49d1b75c-bc39-4eb4-934f-0aa04bf371ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cad029cc-ed67-46c0-898a-11327e88e371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_49d1b75c-bc39-4eb4-934f-0aa04bf371ab" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cad029cc-ed67-46c0-898a-11327e88e371" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_2a724783-4b7c-4b46-9878-485bca4754b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_49d1b75c-bc39-4eb4-934f-0aa04bf371ab" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_2a724783-4b7c-4b46-9878-485bca4754b6" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>fldm-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3567094e-7943-4bac-b9e5-feece94f0a52,g:ecd4ac27-903f-4673-9e8a-4f46fd5b8bd9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="fldm-20220331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended" id="i938aa4442325489d984aea5bb1cbff4b_CondensedConsolidatedStatementsofOperations">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_9f7dd129-094e-4d96-9f01-3fc6707e93c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_RevenuesAbstract_9f7dd129-094e-4d96-9f01-3fc6707e93c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_39beba89-e14f-4cb8-88fb-1b6bcc900ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_9f7dd129-094e-4d96-9f01-3fc6707e93c0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_39beba89-e14f-4cb8-88fb-1b6bcc900ebb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_2b5fe8e1-5a61-4b41-872f-d2d341a93097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_2b5fe8e1-5a61-4b41-872f-d2d341a93097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_631c1382-763b-45e7-b2c9-617007e83e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2b5fe8e1-5a61-4b41-872f-d2d341a93097" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_631c1382-763b-45e7-b2c9-617007e83e7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3c32cb08-c877-4d04-9996-805a49ffdb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2b5fe8e1-5a61-4b41-872f-d2d341a93097" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3c32cb08-c877-4d04-9996-805a49ffdb2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_752a8d14-0141-4d6e-ba96-150e8930c097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2b5fe8e1-5a61-4b41-872f-d2d341a93097" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_752a8d14-0141-4d6e-ba96-150e8930c097" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b30bdf21-fbdb-4d7c-a685-5254004610fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2b5fe8e1-5a61-4b41-872f-d2d341a93097" xlink:to="loc_us-gaap_OperatingExpenses_b30bdf21-fbdb-4d7c-a685-5254004610fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3ec68f50-6a1a-4bbb-8209-12c40f582910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_OperatingIncomeLoss_3ec68f50-6a1a-4bbb-8209-12c40f582910" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_dd22aa5d-ff73-408b-8f58-11b26209b27a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_InterestExpense_dd22aa5d-ff73-408b-8f58-11b26209b27a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LossOnForwardSaleOfStock_94f75f02-4740-4402-9c74-849c8cd645de" xlink:href="fldm-20220331.xsd#fldm_LossOnForwardSaleOfStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_fldm_LossOnForwardSaleOfStock_94f75f02-4740-4402-9c74-849c8cd645de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_3713c787-5722-4660-81bf-ba6eb26d8bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_3713c787-5722-4660-81bf-ba6eb26d8bb8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ef362548-cf2f-441e-91a2-5527c368afc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ef362548-cf2f-441e-91a2-5527c368afc4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1b20265e-8910-43e9-afac-88f601666fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1b20265e-8910-43e9-afac-88f601666fba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b8b74e93-df53-4b30-95dd-d9c232f7b813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b8b74e93-df53-4b30-95dd-d9c232f7b813" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2d9d6114-04ce-4da2-963f-b4c4f78e863c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_NetIncomeLoss_2d9d6114-04ce-4da2-963f-b4c4f78e863c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1a6b2107-e5aa-425f-a59f-4af0de51ae0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_EarningsPerShareBasic_1a6b2107-e5aa-425f-a59f-4af0de51ae0a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c46908cc-d088-4e0e-bad7-5c07a4838414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c46908cc-d088-4e0e-bad7-5c07a4838414" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f95759a9-cc1e-4f00-b063-d8407d7b13d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f95759a9-cc1e-4f00-b063-d8407d7b13d9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_757214a4-0291-4375-b6ae-e61f6d65ab9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_757214a4-0291-4375-b6ae-e61f6d65ab9f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_292fb449-9104-470a-8d77-f911d476f6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_StatementTable_292fb449-9104-470a-8d77-f911d476f6e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_70b1daef-ed0b-4918-bedb-88358ded9b13" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_292fb449-9104-470a-8d77-f911d476f6e3" xlink:to="loc_srt_ProductOrServiceAxis_70b1daef-ed0b-4918-bedb-88358ded9b13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_70b1daef-ed0b-4918-bedb-88358ded9b13_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_70b1daef-ed0b-4918-bedb-88358ded9b13" xlink:to="loc_srt_ProductsAndServicesDomain_70b1daef-ed0b-4918-bedb-88358ded9b13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b9458039-6a62-4e58-9396-7f86973c2f23" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_70b1daef-ed0b-4918-bedb-88358ded9b13" xlink:to="loc_srt_ProductsAndServicesDomain_b9458039-6a62-4e58-9396-7f86973c2f23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_251e752e-b4de-4ef5-a737-3f4bbe4e98e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b9458039-6a62-4e58-9396-7f86973c2f23" xlink:to="loc_us-gaap_ProductMember_251e752e-b4de-4ef5-a737-3f4bbe4e98e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_6adc7fc1-190b-411f-98a4-80d351386fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b9458039-6a62-4e58-9396-7f86973c2f23" xlink:to="loc_us-gaap_ServiceMember_6adc7fc1-190b-411f-98a4-80d351386fca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember_2cbcbdce-f6f5-44f5-8d52-806dd2424e31" xlink:href="fldm-20220331.xsd#fldm_CollaborationRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b9458039-6a62-4e58-9396-7f86973c2f23" xlink:to="loc_fldm_CollaborationRevenueMember_2cbcbdce-f6f5-44f5-8d52-806dd2424e31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_a2ee5384-ce84-402e-9083-06fd7adcf22b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b9458039-6a62-4e58-9396-7f86973c2f23" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_a2ee5384-ce84-402e-9083-06fd7adcf22b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cb519662-457a-4f84-95f8-b60807a91ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_292fb449-9104-470a-8d77-f911d476f6e3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cb519662-457a-4f84-95f8-b60807a91ef1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cb519662-457a-4f84-95f8-b60807a91ef1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cb519662-457a-4f84-95f8-b60807a91ef1" xlink:to="loc_us-gaap_ClassOfStockDomain_cb519662-457a-4f84-95f8-b60807a91ef1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4576310b-7db9-4b87-a583-1f949960b79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cb519662-457a-4f84-95f8-b60807a91ef1" xlink:to="loc_us-gaap_ClassOfStockDomain_4576310b-7db9-4b87-a583-1f949960b79c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_a55e2fad-f327-4b6f-a2ba-51de17c804d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4576310b-7db9-4b87-a583-1f949960b79c" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_a55e2fad-f327-4b6f-a2ba-51de17c804d5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="fldm-20220331.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i82dad6415ecd45efa1dd6bf50bf51136_CondensedConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1d283a01-8f66-489b-b978-0375afc95677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d283a01-8f66-489b-b978-0375afc95677" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3781315c-aff5-4189-ac4e-b5ee96511c51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3781315c-aff5-4189-ac4e-b5ee96511c51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7cc9b334-fb2d-41be-bc7c-e774bc1e241d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_StockholdersEquity_7cc9b334-fb2d-41be-bc7c-e774bc1e241d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_64c47a52-8ae9-4029-a998-7bdfec1b6ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_64c47a52-8ae9-4029-a998-7bdfec1b6ce1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_9dcdb83e-cf94-4e15-b8ba-55511a5ad631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_9dcdb83e-cf94-4e15-b8ba-55511a5ad631" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_94886493-8b89-4fcf-9a64-b7eeacef15fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_94886493-8b89-4fcf-9a64-b7eeacef15fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b1ad875a-2ef5-47cc-9c33-125513b5c1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_NetIncomeLoss_b1ad875a-2ef5-47cc-9c33-125513b5c1ff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e1390ab7-3044-412f-9fc4-e37917e36a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e1390ab7-3044-412f-9fc4-e37917e36a01" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e04af5f9-0110-4d3f-ac01-6a8b86e82764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2cb16c6a-9bd8-43c4-acc5-0805c2c9f8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d7960dc0-f64b-40e2-a795-e8237f823089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1d283a01-8f66-489b-b978-0375afc95677" xlink:to="loc_us-gaap_StatementTable_d7960dc0-f64b-40e2-a795-e8237f823089" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_11fab00f-be82-4f2f-aece-618beb944577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d7960dc0-f64b-40e2-a795-e8237f823089" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_11fab00f-be82-4f2f-aece-618beb944577" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_11fab00f-be82-4f2f-aece-618beb944577_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_11fab00f-be82-4f2f-aece-618beb944577" xlink:to="loc_us-gaap_EquityComponentDomain_11fab00f-be82-4f2f-aece-618beb944577_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_39c13469-4821-4dbf-8f3b-609799cfd46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_11fab00f-be82-4f2f-aece-618beb944577" xlink:to="loc_us-gaap_EquityComponentDomain_39c13469-4821-4dbf-8f3b-609799cfd46b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_dcb6cc49-69da-44c9-968a-a8f03401d8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_39c13469-4821-4dbf-8f3b-609799cfd46b" xlink:to="loc_us-gaap_CommonStockMember_dcb6cc49-69da-44c9-968a-a8f03401d8d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_24012558-0554-420a-b188-48bd7ffcd761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_39c13469-4821-4dbf-8f3b-609799cfd46b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_24012558-0554-420a-b188-48bd7ffcd761" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8d88393a-3c23-415e-8f6f-523ef9ffecac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_39c13469-4821-4dbf-8f3b-609799cfd46b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8d88393a-3c23-415e-8f6f-523ef9ffecac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_848648d2-b22c-4c0d-8133-a55f7053ed87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_39c13469-4821-4dbf-8f3b-609799cfd46b" xlink:to="loc_us-gaap_RetainedEarningsMember_848648d2-b22c-4c0d-8133-a55f7053ed87" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" xlink:type="extended" id="id516be4d3d8749f3b83a6a995931236e_SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_04db14e4-7fb0-41e5-ad18-8a5355a109fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_725b66c0-d5d0-435d-a65b-cc8a06eec9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_04db14e4-7fb0-41e5-ad18-8a5355a109fb" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_725b66c0-d5d0-435d-a65b-cc8a06eec9ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e00b9b66-d3e6-46d4-8f2e-d88ce01d4a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_725b66c0-d5d0-435d-a65b-cc8a06eec9ed" xlink:to="loc_us-gaap_StockholdersEquity_e00b9b66-d3e6-46d4-8f2e-d88ce01d4a99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2bf19e63-cebc-4ad1-8a3f-d62da0852212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_725b66c0-d5d0-435d-a65b-cc8a06eec9ed" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2bf19e63-cebc-4ad1-8a3f-d62da0852212" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7f6f2dd4-7dd4-4515-b252-83d8fcf5991b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_462ea976-d8c5-4155-8972-c79b92052090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_04db14e4-7fb0-41e5-ad18-8a5355a109fb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_462ea976-d8c5-4155-8972-c79b92052090" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d033e7bc-a195-48dd-a005-9b30d1ffabe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_462ea976-d8c5-4155-8972-c79b92052090" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d033e7bc-a195-48dd-a005-9b30d1ffabe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d033e7bc-a195-48dd-a005-9b30d1ffabe0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d033e7bc-a195-48dd-a005-9b30d1ffabe0" xlink:to="loc_us-gaap_EquityComponentDomain_d033e7bc-a195-48dd-a005-9b30d1ffabe0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_295e1225-f502-4eb1-9f9e-ce285c5afc82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d033e7bc-a195-48dd-a005-9b30d1ffabe0" xlink:to="loc_us-gaap_EquityComponentDomain_295e1225-f502-4eb1-9f9e-ce285c5afc82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_29ffa908-647b-480f-9594-63a5a0db6e13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_295e1225-f502-4eb1-9f9e-ce285c5afc82" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_29ffa908-647b-480f-9594-63a5a0db6e13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_83dfb1b8-9d1c-481e-92ab-331e7f761576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_295e1225-f502-4eb1-9f9e-ce285c5afc82" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_83dfb1b8-9d1c-481e-92ab-331e7f761576" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1494ca3a-2c60-479c-a8da-07baad4aead8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_295e1225-f502-4eb1-9f9e-ce285c5afc82" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1494ca3a-2c60-479c-a8da-07baad4aead8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" xlink:type="extended" id="iab3451fbe7d14d5791aba2e553b4f09f_SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_03665b31-cbb5-4a95-822c-01866c14a027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_223fdc72-9f6e-47da-93c7-6dd1ced680da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_03665b31-cbb5-4a95-822c-01866c14a027" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_223fdc72-9f6e-47da-93c7-6dd1ced680da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9cf921a3-45fd-476f-844e-eef4c71b3b33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_03665b31-cbb5-4a95-822c-01866c14a027" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9cf921a3-45fd-476f-844e-eef4c71b3b33" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_56e44c49-b73b-4220-96a1-fc05cbc13e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9cf921a3-45fd-476f-844e-eef4c71b3b33" xlink:to="loc_us-gaap_DebtInstrumentAxis_56e44c49-b73b-4220-96a1-fc05cbc13e0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_56e44c49-b73b-4220-96a1-fc05cbc13e0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_56e44c49-b73b-4220-96a1-fc05cbc13e0e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_56e44c49-b73b-4220-96a1-fc05cbc13e0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_46fd4681-be2d-4974-976b-5db0f942fd72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_56e44c49-b73b-4220-96a1-fc05cbc13e0e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_46fd4681-be2d-4974-976b-5db0f942fd72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_BridgeLoansMember_b8c33f1e-75ac-43be-aa14-1fac36dda29e" xlink:href="fldm-20220331.xsd#fldm_BridgeLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_46fd4681-be2d-4974-976b-5db0f942fd72" xlink:to="loc_fldm_BridgeLoansMember_b8c33f1e-75ac-43be-aa14-1fac36dda29e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineteenConvertibleNotesMember_f70eaa92-be34-468b-a602-ad13489e6e90" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndNineteenConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_46fd4681-be2d-4974-976b-5db0f942fd72" xlink:to="loc_fldm_TwoThousandAndNineteenConvertibleNotesMember_f70eaa92-be34-468b-a602-ad13489e6e90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_50459d72-b856-42d1-b002-382d35c4ff1d" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_46fd4681-be2d-4974-976b-5db0f942fd72" xlink:to="loc_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_50459d72-b856-42d1-b002-382d35c4ff1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndFourteenConvertibleNotesMember_942ecadb-745c-48f2-81aa-8f57ddcad388" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndFourteenConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_46fd4681-be2d-4974-976b-5db0f942fd72" xlink:to="loc_fldm_TwoThousandAndFourteenConvertibleNotesMember_942ecadb-745c-48f2-81aa-8f57ddcad388" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_473fffb4-05b0-46bc-9c16-e60fb3e703e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9cf921a3-45fd-476f-844e-eef4c71b3b33" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_473fffb4-05b0-46bc-9c16-e60fb3e703e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_473fffb4-05b0-46bc-9c16-e60fb3e703e3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_473fffb4-05b0-46bc-9c16-e60fb3e703e3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_473fffb4-05b0-46bc-9c16-e60fb3e703e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0d0177b4-da01-47bb-9cad-7516254e0027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_473fffb4-05b0-46bc-9c16-e60fb3e703e3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0d0177b4-da01-47bb-9cad-7516254e0027" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_9cd2dced-65d2-4d45-8093-a4fcd16187a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0d0177b4-da01-47bb-9cad-7516254e0027" xlink:to="loc_us-gaap_StockCompensationPlanMember_9cd2dced-65d2-4d45-8093-a4fcd16187a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_7bc4c30e-3615-49ca-98bb-42d1015e6f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BridgeLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0d0177b4-da01-47bb-9cad-7516254e0027" xlink:to="loc_us-gaap_BridgeLoanMember_7bc4c30e-3615-49ca-98bb-42d1015e6f3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_9dfaea47-cce6-4a5b-b1cb-d416eb581fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0d0177b4-da01-47bb-9cad-7516254e0027" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_9dfaea47-cce6-4a5b-b1cb-d416eb581fd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_e6c89a42-830f-41eb-a63a-14d59249ffd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0d0177b4-da01-47bb-9cad-7516254e0027" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_e6c89a42-830f-41eb-a63a-14d59249ffd4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#PrivatePlacementIssuanceNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails" xlink:type="extended" id="i33123eeec5c04ffd9f527e04720f2c5c_PrivatePlacementIssuanceNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentFaceAmountPerInstrument_280455c0-f787-4d19-a02b-f7ad50800a1b" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentFaceAmountPerInstrument"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_fldm_DebtInstrumentFaceAmountPerInstrument_280455c0-f787-4d19-a02b-f7ad50800a1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c3ec5948-5357-4394-8d3b-6576cce2c98c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c3ec5948-5357-4394-8d3b-6576cce2c98c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_cea982f3-00c4-480c-b0ab-eb2b69ca1c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_cea982f3-00c4-480c-b0ab-eb2b69ca1c4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a6fdc20d-a233-43d1-9d13-df796ed4f27b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a6fdc20d-a233-43d1-9d13-df796ed4f27b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_f114105d-726d-424b-b95b-321f4e94eb89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_f114105d-726d-424b-b95b-321f4e94eb89" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3d3ad89b-6ec5-472b-9e0d-295200979638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3d3ad89b-6ec5-472b-9e0d-295200979638" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_430200e2-48fd-4017-bea7-0117b9f413bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_430200e2-48fd-4017-bea7-0117b9f413bc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3af056d2-c70a-4800-8274-9272a9c42d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3af056d2-c70a-4800-8274-9272a9c42d58" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued_3828e052-61be-4e99-a65e-adf48bc617a6" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued_3828e052-61be-4e99-a65e-adf48bc617a6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor_7298d871-865e-419d-950a-f0af33b84e9d" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor_7298d871-865e-419d-950a-f0af33b84e9d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_483cb89d-d4e8-40e5-a05d-7bfe5cefbae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_SharePrice_483cb89d-d4e8-40e5-a05d-7bfe5cefbae6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_999766bb-94ff-4424-9fdf-34b5c46b690d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_DebtInstrumentFairValue_999766bb-94ff-4424-9fdf-34b5c46b690d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_3f111ba9-64dc-4496-9c43-f9de4d80a962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_3f111ba9-64dc-4496-9c43-f9de4d80a962" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PreferredStockFairValueDisclosure_8d2750e6-1677-4b9c-b19c-6a488b3d6e84" xlink:href="fldm-20220331.xsd#fldm_PreferredStockFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_fldm_PreferredStockFairValueDisclosure_8d2750e6-1677-4b9c-b19c-6a488b3d6e84" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_StockRepurchaseLiability_f687c2d4-8577-4c67-b724-b1ef910cc80d" xlink:href="fldm-20220331.xsd#fldm_StockRepurchaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_fldm_StockRepurchaseLiability_f687c2d4-8577-4c67-b724-b1ef910cc80d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_9d68f19d-2ca4-4876-a939-21207fab9344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_9d68f19d-2ca4-4876-a939-21207fab9344" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6dfb06bc-9a55-4668-a921-b436598773a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6dfb06bc-9a55-4668-a921-b436598773a6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_68522b0c-25d4-4ba4-8f4e-19cd88c5c149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_68522b0c-25d4-4ba4-8f4e-19cd88c5c149" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare_ea52768f-6059-4b6f-820e-f126b573ebb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare_ea52768f-6059-4b6f-820e-f126b573ebb7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_71c2ea2b-701e-4c06-9ef9-68d02eced810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_71c2ea2b-701e-4c06-9ef9-68d02eced810" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_78cbb2d8-51ca-4c0f-a542-c222d59140ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_78cbb2d8-51ca-4c0f-a542-c222d59140ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_78cbb2d8-51ca-4c0f-a542-c222d59140ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_78cbb2d8-51ca-4c0f-a542-c222d59140ed" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_78cbb2d8-51ca-4c0f-a542-c222d59140ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_78331069-3f88-438d-a779-49429b66fc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_78cbb2d8-51ca-4c0f-a542-c222d59140ed" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_78331069-3f88-438d-a779-49429b66fc74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_79fba416-18d0-41c8-a46d-d86d280ae8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BridgeLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_78331069-3f88-438d-a779-49429b66fc74" xlink:to="loc_us-gaap_BridgeLoanMember_79fba416-18d0-41c8-a46d-d86d280ae8c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c078506f-9c0e-4c15-8eca-49fffe87d2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c078506f-9c0e-4c15-8eca-49fffe87d2ec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c078506f-9c0e-4c15-8eca-49fffe87d2ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c078506f-9c0e-4c15-8eca-49fffe87d2ec" xlink:to="loc_us-gaap_ClassOfStockDomain_c078506f-9c0e-4c15-8eca-49fffe87d2ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8d0a5d0d-937a-4f26-80ff-682056d2932d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c078506f-9c0e-4c15-8eca-49fffe87d2ec" xlink:to="loc_us-gaap_ClassOfStockDomain_8d0a5d0d-937a-4f26-80ff-682056d2932d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_021ce81d-33c6-4d15-88af-eb72161534e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8d0a5d0d-937a-4f26-80ff-682056d2932d" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_021ce81d-33c6-4d15-88af-eb72161534e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_8fc0288a-1468-495c-a412-bde1e2468348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8d0a5d0d-937a-4f26-80ff-682056d2932d" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_8fc0288a-1468-495c-a412-bde1e2468348" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeriesB1ConvertiblePreferredStockMember_a4df7f8a-757f-47be-8a46-0b2200d97a28" xlink:href="fldm-20220331.xsd#fldm_SeriesB1ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeriesBPreferredStockMember_8fc0288a-1468-495c-a412-bde1e2468348" xlink:to="loc_fldm_SeriesB1ConvertiblePreferredStockMember_a4df7f8a-757f-47be-8a46-0b2200d97a28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeriesB2ConvertiblePreferredStockMember_3a7de038-81ff-4106-ad7b-b63159c09997" xlink:href="fldm-20220331.xsd#fldm_SeriesB2ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeriesBPreferredStockMember_8fc0288a-1468-495c-a412-bde1e2468348" xlink:to="loc_fldm_SeriesB2ConvertiblePreferredStockMember_3a7de038-81ff-4106-ad7b-b63159c09997" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_75853c9e-edd0-458f-b394-746b0b476128" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:to="loc_srt_CounterpartyNameAxis_75853c9e-edd0-458f-b394-746b0b476128" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_75853c9e-edd0-458f-b394-746b0b476128_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_75853c9e-edd0-458f-b394-746b0b476128" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_75853c9e-edd0-458f-b394-746b0b476128_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_20f6b34e-dcf0-404b-b07c-ad6e7d5a6b75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_75853c9e-edd0-458f-b394-746b0b476128" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_20f6b34e-dcf0-404b-b07c-ad6e7d5a6b75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CasdinMember_c9349f51-b9e1-4a39-bf68-59119942642d" xlink:href="fldm-20220331.xsd#fldm_CasdinMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_20f6b34e-dcf0-404b-b07c-ad6e7d5a6b75" xlink:to="loc_fldm_CasdinMember_c9349f51-b9e1-4a39-bf68-59119942642d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_VikingMember_1e83fb51-8160-43f4-bec0-7d597f078810" xlink:href="fldm-20220331.xsd#fldm_VikingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_20f6b34e-dcf0-404b-b07c-ad6e7d5a6b75" xlink:to="loc_fldm_VikingMember_1e83fb51-8160-43f4-bec0-7d597f078810" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodAxis_29e8e44d-aad5-4652-981e-e68dd102ad27" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:to="loc_fldm_DebtCovenantPeriodAxis_29e8e44d-aad5-4652-981e-e68dd102ad27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodDomain_29e8e44d-aad5-4652-981e-e68dd102ad27_default" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_fldm_DebtCovenantPeriodAxis_29e8e44d-aad5-4652-981e-e68dd102ad27" xlink:to="loc_fldm_DebtCovenantPeriodDomain_29e8e44d-aad5-4652-981e-e68dd102ad27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodDomain_2275e6d6-8b72-4745-b418-36725f39229b" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_fldm_DebtCovenantPeriodAxis_29e8e44d-aad5-4652-981e-e68dd102ad27" xlink:to="loc_fldm_DebtCovenantPeriodDomain_2275e6d6-8b72-4745-b418-36725f39229b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodOneMember_592e47e9-a1e1-4357-b903-ee609432b997" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_DebtCovenantPeriodDomain_2275e6d6-8b72-4745-b418-36725f39229b" xlink:to="loc_fldm_DebtCovenantPeriodOneMember_592e47e9-a1e1-4357-b903-ee609432b997" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodTwoMember_316ec36a-6b37-4429-9536-37b9c20044ad" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_DebtCovenantPeriodDomain_2275e6d6-8b72-4745-b418-36725f39229b" xlink:to="loc_fldm_DebtCovenantPeriodTwoMember_316ec36a-6b37-4429-9536-37b9c20044ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodThreeMember_a23d56d5-7be0-4a82-b5cb-901fa466e52f" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_DebtCovenantPeriodDomain_2275e6d6-8b72-4745-b418-36725f39229b" xlink:to="loc_fldm_DebtCovenantPeriodThreeMember_a23d56d5-7be0-4a82-b5cb-901fa466e52f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodFourMember_91a1dde7-99f0-4718-950c-79cb1d149069" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_DebtCovenantPeriodDomain_2275e6d6-8b72-4745-b418-36725f39229b" xlink:to="loc_fldm_DebtCovenantPeriodFourMember_91a1dde7-99f0-4718-950c-79cb1d149069" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_aa3d8550-af51-41d9-8451-e04278f6bb66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_aa3d8550-af51-41d9-8451-e04278f6bb66" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_aa3d8550-af51-41d9-8451-e04278f6bb66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_aa3d8550-af51-41d9-8451-e04278f6bb66" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_aa3d8550-af51-41d9-8451-e04278f6bb66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f70f3b47-533a-4b0a-83c7-f16d27ce8172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_aa3d8550-af51-41d9-8451-e04278f6bb66" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f70f3b47-533a-4b0a-83c7-f16d27ce8172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_7088fac3-3232-4a30-bc77-119cb09179ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f70f3b47-533a-4b0a-83c7-f16d27ce8172" xlink:to="loc_us-gaap_SubsequentEventMember_7088fac3-3232-4a30-bc77-119cb09179ca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails" xlink:type="extended" id="i934acecbb1a14a078b6d1b43ebf3cd4f_PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_cc0e54d7-4c0d-4314-819f-3caa98e2684f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_cc0e54d7-4c0d-4314-819f-3caa98e2684f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_b8ac6177-d04d-409e-9752-f7b07325fc84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_b8ac6177-d04d-409e-9752-f7b07325fc84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_5b9dde9f-439c-45ff-97ef-c130d9e4d168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_5b9dde9f-439c-45ff-97ef-c130d9e4d168" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_cec54c23-f570-40d4-aafe-7facc79b9aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:to="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_cec54c23-f570-40d4-aafe-7facc79b9aaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_60c65df2-1438-4b54-96c0-be3a02d974d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:to="loc_us-gaap_DebtInstrumentFairValue_60c65df2-1438-4b54-96c0-be3a02d974d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c29a8a59-b11e-4937-bac1-026bead9c1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:to="loc_us-gaap_DebtInstrumentTable_c29a8a59-b11e-4937-bac1-026bead9c1f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_591a4ff9-3789-4709-86e9-a88db16108a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c29a8a59-b11e-4937-bac1-026bead9c1f2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_591a4ff9-3789-4709-86e9-a88db16108a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_591a4ff9-3789-4709-86e9-a88db16108a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_591a4ff9-3789-4709-86e9-a88db16108a7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_591a4ff9-3789-4709-86e9-a88db16108a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8fed9d35-790a-4860-9d86-1b70163a17df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_591a4ff9-3789-4709-86e9-a88db16108a7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8fed9d35-790a-4860-9d86-1b70163a17df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_4baa74d5-e6a3-4b2b-90bf-4071e63bb283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BridgeLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8fed9d35-790a-4860-9d86-1b70163a17df" xlink:to="loc_us-gaap_BridgeLoanMember_4baa74d5-e6a3-4b2b-90bf-4071e63bb283" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DevelopmentAgreementDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#DevelopmentAgreementDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/DevelopmentAgreementDetails" xlink:type="extended" id="i702e6fc272b94f50a1c0f0151308c50d_DevelopmentAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1605f0f6-d070-470d-a885-a9923e5d8256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement_6fc3d426-07eb-4889-a52c-4581d5e427f7" xlink:href="fldm-20220331.xsd#fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1605f0f6-d070-470d-a885-a9923e5d8256" xlink:to="loc_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement_6fc3d426-07eb-4889-a52c-4581d5e427f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_36804349-98fe-4b68-bdbb-aff86e24d6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1605f0f6-d070-470d-a885-a9923e5d8256" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_36804349-98fe-4b68-bdbb-aff86e24d6b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ac35d96f-dfca-4424-aebb-a745670394ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1605f0f6-d070-470d-a885-a9923e5d8256" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ac35d96f-dfca-4424-aebb-a745670394ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5442171a-ef1d-4adf-b3a4-158ce8abc2ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ac35d96f-dfca-4424-aebb-a745670394ce" xlink:to="loc_srt_ProductOrServiceAxis_5442171a-ef1d-4adf-b3a4-158ce8abc2ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5442171a-ef1d-4adf-b3a4-158ce8abc2ee_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5442171a-ef1d-4adf-b3a4-158ce8abc2ee" xlink:to="loc_srt_ProductsAndServicesDomain_5442171a-ef1d-4adf-b3a4-158ce8abc2ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7888a9af-5715-4aac-bc5c-0e3393c32a94" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5442171a-ef1d-4adf-b3a4-158ce8abc2ee" xlink:to="loc_srt_ProductsAndServicesDomain_7888a9af-5715-4aac-bc5c-0e3393c32a94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember_93037097-8abb-4e05-8198-14347b731042" xlink:href="fldm-20220331.xsd#fldm_CollaborationRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7888a9af-5715-4aac-bc5c-0e3393c32a94" xlink:to="loc_fldm_CollaborationRevenueMember_93037097-8abb-4e05-8198-14347b731042" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d2e54cd4-8416-48ca-8e51-c4b4b5a2d12d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ac35d96f-dfca-4424-aebb-a745670394ce" xlink:to="loc_srt_CounterpartyNameAxis_d2e54cd4-8416-48ca-8e51-c4b4b5a2d12d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d2e54cd4-8416-48ca-8e51-c4b4b5a2d12d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d2e54cd4-8416-48ca-8e51-c4b4b5a2d12d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d2e54cd4-8416-48ca-8e51-c4b4b5a2d12d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_97cdbbe7-53f2-4287-84cb-921bbf447576" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d2e54cd4-8416-48ca-8e51-c4b4b5a2d12d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_97cdbbe7-53f2-4287-84cb-921bbf447576" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_UndisclosedCustomerMember_f3b5fc7e-3607-4225-b7e4-2b1b7fe22b37" xlink:href="fldm-20220331.xsd#fldm_UndisclosedCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_97cdbbe7-53f2-4287-84cb-921bbf447576" xlink:to="loc_fldm_UndisclosedCustomerMember_f3b5fc7e-3607-4225-b7e4-2b1b7fe22b37" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#RevenueScheduleofDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" xlink:type="extended" id="if17e0d4eab1b4086966789bd642ed5fb_RevenueScheduleofDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6a6b67ed-b6bf-4ed7-8565-0b17e72283d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0980989a-eeb5-48ba-a4ce-51e4e1eab263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6a6b67ed-b6bf-4ed7-8565-0b17e72283d9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0980989a-eeb5-48ba-a4ce-51e4e1eab263" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0f36008f-6731-465c-96c6-d7c14ef58a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6a6b67ed-b6bf-4ed7-8565-0b17e72283d9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0f36008f-6731-465c-96c6-d7c14ef58a01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a0add2be-5b23-4db6-91b6-f06898647137" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0f36008f-6731-465c-96c6-d7c14ef58a01" xlink:to="loc_srt_StatementGeographicalAxis_a0add2be-5b23-4db6-91b6-f06898647137" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a0add2be-5b23-4db6-91b6-f06898647137_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a0add2be-5b23-4db6-91b6-f06898647137" xlink:to="loc_srt_SegmentGeographicalDomain_a0add2be-5b23-4db6-91b6-f06898647137_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f60ef74d-8d73-4148-96ca-87785e264a67" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a0add2be-5b23-4db6-91b6-f06898647137" xlink:to="loc_srt_SegmentGeographicalDomain_f60ef74d-8d73-4148-96ca-87785e264a67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_2158db7e-4eda-44c2-8223-aa887f775f2b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f60ef74d-8d73-4148-96ca-87785e264a67" xlink:to="loc_srt_AmericasMember_2158db7e-4eda-44c2-8223-aa887f775f2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_1db9ffa3-c95b-439f-8fbc-e794335cfd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f60ef74d-8d73-4148-96ca-87785e264a67" xlink:to="loc_us-gaap_EMEAMember_1db9ffa3-c95b-439f-8fbc-e794335cfd3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_57bc9e32-a812-4750-8acb-a8bb7dc339e6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f60ef74d-8d73-4148-96ca-87785e264a67" xlink:to="loc_srt_AsiaPacificMember_57bc9e32-a812-4750-8acb-a8bb7dc339e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b913d50c-0c13-4988-a429-dead110c2f95" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0f36008f-6731-465c-96c6-d7c14ef58a01" xlink:to="loc_srt_ProductOrServiceAxis_b913d50c-0c13-4988-a429-dead110c2f95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b913d50c-0c13-4988-a429-dead110c2f95_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b913d50c-0c13-4988-a429-dead110c2f95" xlink:to="loc_srt_ProductsAndServicesDomain_b913d50c-0c13-4988-a429-dead110c2f95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b913d50c-0c13-4988-a429-dead110c2f95" xlink:to="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstrumentsMember_6834f658-89d7-4d24-8b75-f78801cb88d4" xlink:href="fldm-20220331.xsd#fldm_InstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_fldm_InstrumentsMember_6834f658-89d7-4d24-8b75-f78801cb88d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ConsumablesMember_7f5a8123-f59c-4ff5-9591-1aef01805209" xlink:href="fldm-20220331.xsd#fldm_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_fldm_ConsumablesMember_7f5a8123-f59c-4ff5-9591-1aef01805209" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_65ad2a27-af59-448c-9940-66d18f52ad26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_us-gaap_ProductMember_65ad2a27-af59-448c-9940-66d18f52ad26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_49095d3c-1523-4dc8-844c-d1f7c6e8c9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_us-gaap_ServiceMember_49095d3c-1523-4dc8-844c-d1f7c6e8c9f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember_02e3a1fe-7239-45ce-a24e-5b52b92dc065" xlink:href="fldm-20220331.xsd#fldm_CollaborationRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_fldm_CollaborationRevenueMember_02e3a1fe-7239-45ce-a24e-5b52b92dc065" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_7be950d4-1a57-499d-9530-e492459a344b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_us-gaap_LicenseMember_7be950d4-1a57-499d-9530-e492459a344b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_3a12c567-3649-49bd-87c1-156ae1672ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_us-gaap_GrantMember_3a12c567-3649-49bd-87c1-156ae1672ddf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_540f8d6d-124e-4140-93d0-a978cb0f9965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_540f8d6d-124e-4140-93d0-a978cb0f9965" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#RevenuePerformanceObligationsDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/RevenuePerformanceObligationsDetails" xlink:type="extended" id="i6ee09e7acb7f4506947ec57c18cd7bd9_RevenuePerformanceObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1e12abd0-0c4c-4fe4-b89f-411344e0c634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_4c44e27f-4530-42f9-8103-5ae09a7c9be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1e12abd0-0c4c-4fe4-b89f-411344e0c634" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_4c44e27f-4530-42f9-8103-5ae09a7c9be6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_20b8b4a7-a7e2-4727-b085-70f2da069de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1e12abd0-0c4c-4fe4-b89f-411344e0c634" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_20b8b4a7-a7e2-4727-b085-70f2da069de3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f678a352-3bea-4104-beaf-73156840828a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1e12abd0-0c4c-4fe4-b89f-411344e0c634" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f678a352-3bea-4104-beaf-73156840828a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_3d753c43-c811-43c1-a818-fd20e32812c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f678a352-3bea-4104-beaf-73156840828a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_3d753c43-c811-43c1-a818-fd20e32812c9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails_1" xlink:type="simple" xlink:href="fldm-20220331.xsd#RevenuePerformanceObligationsDetails_1"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/RevenuePerformanceObligationsDetails_1" xlink:type="extended" id="i06bcda0a45824eaeb70bfab97fccbac9_RevenuePerformanceObligationsDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1e12abd0-0c4c-4fe4-b89f-411344e0c634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_4c44e27f-4530-42f9-8103-5ae09a7c9be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1e12abd0-0c4c-4fe4-b89f-411344e0c634" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_4c44e27f-4530-42f9-8103-5ae09a7c9be6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_20b8b4a7-a7e2-4727-b085-70f2da069de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1e12abd0-0c4c-4fe4-b89f-411344e0c634" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_20b8b4a7-a7e2-4727-b085-70f2da069de3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f678a352-3bea-4104-beaf-73156840828a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1e12abd0-0c4c-4fe4-b89f-411344e0c634" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f678a352-3bea-4104-beaf-73156840828a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#GoodwillandIntangibleAssetsnetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="extended" id="if28969f6e43e451697226e2d4a7a9e98_GoodwillandIntangibleAssetsnetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_94f37339-f3e4-4b72-9eda-829b063ba08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_04a91dc5-a53c-4989-b7b1-088bfc3cc074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_94f37339-f3e4-4b72-9eda-829b063ba08b" xlink:to="loc_us-gaap_Goodwill_04a91dc5-a53c-4989-b7b1-088bfc3cc074" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_40fd4b4f-57f8-468a-92ed-4ec896173e46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_94f37339-f3e4-4b72-9eda-829b063ba08b" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_40fd4b4f-57f8-468a-92ed-4ec896173e46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f418b309-01a5-4a26-a991-e5378a9ef176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_94f37339-f3e4-4b72-9eda-829b063ba08b" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f418b309-01a5-4a26-a991-e5378a9ef176" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_14424def-de67-4f95-9669-e292d1055b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_94f37339-f3e4-4b72-9eda-829b063ba08b" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_14424def-de67-4f95-9669-e292d1055b6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9dd1243f-678b-4fbe-95a0-ddb22d1fb3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_94f37339-f3e4-4b72-9eda-829b063ba08b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9dd1243f-678b-4fbe-95a0-ddb22d1fb3ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6d47cc83-2a9c-4abf-b3ba-a7edee4b6b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9dd1243f-678b-4fbe-95a0-ddb22d1fb3ed" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6d47cc83-2a9c-4abf-b3ba-a7edee4b6b17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6d47cc83-2a9c-4abf-b3ba-a7edee4b6b17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6d47cc83-2a9c-4abf-b3ba-a7edee4b6b17" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6d47cc83-2a9c-4abf-b3ba-a7edee4b6b17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a3c3cc9-cb34-44fe-8feb-8ef7cbeec18d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6d47cc83-2a9c-4abf-b3ba-a7edee4b6b17" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a3c3cc9-cb34-44fe-8feb-8ef7cbeec18d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DVSSciencesInc.Member_7ccaeac2-8548-402e-b31d-62a920a1ca34" xlink:href="fldm-20220331.xsd#fldm_DVSSciencesInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a3c3cc9-cb34-44fe-8feb-8ef7cbeec18d" xlink:to="loc_fldm_DVSSciencesInc.Member_7ccaeac2-8548-402e-b31d-62a920a1ca34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember_2c439303-c014-44f9-af73-bd4a5fd8f57c" xlink:href="fldm-20220331.xsd#fldm_InstruNorASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a3c3cc9-cb34-44fe-8feb-8ef7cbeec18d" xlink:to="loc_fldm_InstruNorASMember_2c439303-c014-44f9-af73-bd4a5fd8f57c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f0c2dd71-d252-4908-a205-c05f30ea3c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9dd1243f-678b-4fbe-95a0-ddb22d1fb3ed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f0c2dd71-d252-4908-a205-c05f30ea3c38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f0c2dd71-d252-4908-a205-c05f30ea3c38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f0c2dd71-d252-4908-a205-c05f30ea3c38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f0c2dd71-d252-4908-a205-c05f30ea3c38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c45bdc98-70ed-42f6-986e-6dffb58e18ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f0c2dd71-d252-4908-a205-c05f30ea3c38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c45bdc98-70ed-42f6-986e-6dffb58e18ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3dc9a0c8-dc94-4b17-bbfc-0eb0b56eb9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c45bdc98-70ed-42f6-986e-6dffb58e18ff" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3dc9a0c8-dc94-4b17-bbfc-0eb0b56eb9ad" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="extended" id="if5170bce0486452db0f104352ca456cd_GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d321c4f2-71a2-4ef4-b62d-ddba03a36a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5560428f-8e28-4c46-8ac1-1531785239d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d321c4f2-71a2-4ef4-b62d-ddba03a36a1a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5560428f-8e28-4c46-8ac1-1531785239d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_02a4b27a-deac-46b3-a03c-c75294ef9e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d321c4f2-71a2-4ef4-b62d-ddba03a36a1a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_02a4b27a-deac-46b3-a03c-c75294ef9e6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_22295ae3-ec7b-4715-9759-8a9079171dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d321c4f2-71a2-4ef4-b62d-ddba03a36a1a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_22295ae3-ec7b-4715-9759-8a9079171dfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_5156cf76-21c6-4a0b-b47e-663438a40501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d321c4f2-71a2-4ef4-b62d-ddba03a36a1a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_5156cf76-21c6-4a0b-b47e-663438a40501" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c99c8fa5-305f-4d54-8003-a76413fede81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d321c4f2-71a2-4ef4-b62d-ddba03a36a1a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c99c8fa5-305f-4d54-8003-a76413fede81" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1b40003b-b85f-4058-92a8-ef485d31ae44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c99c8fa5-305f-4d54-8003-a76413fede81" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1b40003b-b85f-4058-92a8-ef485d31ae44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b40003b-b85f-4058-92a8-ef485d31ae44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1b40003b-b85f-4058-92a8-ef485d31ae44" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1b40003b-b85f-4058-92a8-ef485d31ae44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21850ba6-2cac-45dd-8da0-20272f678156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1b40003b-b85f-4058-92a8-ef485d31ae44" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21850ba6-2cac-45dd-8da0-20272f678156" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_ae5fcae1-f0b4-4459-9745-3633a96b341f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21850ba6-2cac-45dd-8da0-20272f678156" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_ae5fcae1-f0b4-4459-9745-3633a96b341f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PatentsandLicenseAgreementsMember_3ee08e92-d939-42d3-bd71-bd9f2fd512be" xlink:href="fldm-20220331.xsd#fldm_PatentsandLicenseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21850ba6-2cac-45dd-8da0-20272f678156" xlink:to="loc_fldm_PatentsandLicenseAgreementsMember_3ee08e92-d939-42d3-bd71-bd9f2fd512be" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" xlink:type="extended" id="i0d9ce28f3a624ce999cb6e1c860b6c5e_GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_954f7698-b792-46de-8e34-c8702e0c38ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_954f7698-b792-46de-8e34-c8702e0c38ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b0c609f9-4de2-4c49-a6c2-2fa8c7d23d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b0c609f9-4de2-4c49-a6c2-2fa8c7d23d1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2ae11cc6-0b83-4013-a161-78477f9887de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2ae11cc6-0b83-4013-a161-78477f9887de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_390f30c9-6395-49fc-a2a5-9a37028194e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_390f30c9-6395-49fc-a2a5-9a37028194e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_aaaa2a84-b090-410f-8c4b-b163f9e7ceaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_aaaa2a84-b090-410f-8c4b-b163f9e7ceaa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_5c1422c1-1e6d-481d-8ef0-1b456b8b5372" xlink:href="fldm-20220331.xsd#fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_5c1422c1-1e6d-481d-8ef0-1b456b8b5372" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_59036526-8ce8-40cd-bdb6-8d024f64bc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_59036526-8ce8-40cd-bdb6-8d024f64bc83" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8395be46-da20-4ef0-82bd-85d77d88694a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8395be46-da20-4ef0-82bd-85d77d88694a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d0256f37-559e-4030-9b33-21a39ae7555a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8395be46-da20-4ef0-82bd-85d77d88694a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d0256f37-559e-4030-9b33-21a39ae7555a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d0256f37-559e-4030-9b33-21a39ae7555a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d0256f37-559e-4030-9b33-21a39ae7555a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d0256f37-559e-4030-9b33-21a39ae7555a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4402a817-e9f4-49a8-bb27-05395997ef4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d0256f37-559e-4030-9b33-21a39ae7555a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4402a817-e9f4-49a8-bb27-05395997ef4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_81abd028-72d2-4060-8a7f-38601ccf7b90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4402a817-e9f4-49a8-bb27-05395997ef4d" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_81abd028-72d2-4060-8a7f-38601ccf7b90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PatentsandLicenseAgreementsMember_1da24183-4c44-4bf3-acae-dd2294db5f8d" xlink:href="fldm-20220331.xsd#fldm_PatentsandLicenseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4402a817-e9f4-49a8-bb27-05395997ef4d" xlink:to="loc_fldm_PatentsandLicenseAgreementsMember_1da24183-4c44-4bf3-acae-dd2294db5f8d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#BalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended" id="ib88babe721144d6cb2a067d127658a6a_BalanceSheetDetailsPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e1791753-a788-4dc7-89d5-55fc52671caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a0f7a7fc-f8bc-43b3-8b17-673443074173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e1791753-a788-4dc7-89d5-55fc52671caa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a0f7a7fc-f8bc-43b3-8b17-673443074173" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b76eff15-04b3-4372-a28d-0c09424e2f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e1791753-a788-4dc7-89d5-55fc52671caa" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b76eff15-04b3-4372-a28d-0c09424e2f18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_61e902aa-925d-4843-8e85-14a320b6e7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e1791753-a788-4dc7-89d5-55fc52671caa" xlink:to="loc_us-gaap_ConstructionInProgressGross_61e902aa-925d-4843-8e85-14a320b6e7cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_55168b7e-ae31-4b12-b986-08fc5d0e8d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e1791753-a788-4dc7-89d5-55fc52671caa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_55168b7e-ae31-4b12-b986-08fc5d0e8d7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4ff21fb7-02d0-4d5d-82bc-1b0e92cf3da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e1791753-a788-4dc7-89d5-55fc52671caa" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4ff21fb7-02d0-4d5d-82bc-1b0e92cf3da9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_353c7cc2-1b74-43be-b4c1-825328be6270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4ff21fb7-02d0-4d5d-82bc-1b0e92cf3da9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_353c7cc2-1b74-43be-b4c1-825328be6270" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_353c7cc2-1b74-43be-b4c1-825328be6270_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_353c7cc2-1b74-43be-b4c1-825328be6270" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_353c7cc2-1b74-43be-b4c1-825328be6270_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca9de6fe-f21b-483c-aa9c-145c37976bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_353c7cc2-1b74-43be-b4c1-825328be6270" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca9de6fe-f21b-483c-aa9c-145c37976bb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ComputerEquipmentAndSoftwareMember_e62d8b36-e453-4cf8-8fa2-ab9ba7b992c7" xlink:href="fldm-20220331.xsd#fldm_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca9de6fe-f21b-483c-aa9c-145c37976bb7" xlink:to="loc_fldm_ComputerEquipmentAndSoftwareMember_e62d8b36-e453-4cf8-8fa2-ab9ba7b992c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LaboratoryAndManufacturingEquipmentMember_e7229db2-5d17-48ef-9bbd-3c6dd4ace4ba" xlink:href="fldm-20220331.xsd#fldm_LaboratoryAndManufacturingEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca9de6fe-f21b-483c-aa9c-145c37976bb7" xlink:to="loc_fldm_LaboratoryAndManufacturingEquipmentMember_e7229db2-5d17-48ef-9bbd-3c6dd4ace4ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_84535e91-5b3e-4365-a79c-6080b3ea0e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca9de6fe-f21b-483c-aa9c-145c37976bb7" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_84535e91-5b3e-4365-a79c-6080b3ea0e52" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_ecde8eae-e4a4-45bb-8cfa-f3e945db6e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca9de6fe-f21b-483c-aa9c-145c37976bb7" xlink:to="loc_us-gaap_OfficeEquipmentMember_ecde8eae-e4a4-45bb-8cfa-f3e945db6e5c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/DebtNarrativeDetails" xlink:type="extended" id="i7a02ed9625f94d3f8cd5272481d2ac39_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_17cf57a5-e2ea-4a83-bd24-c56e259000e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_LongTermDebt_17cf57a5-e2ea-4a83-bd24-c56e259000e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_84d74bdc-56ff-4cf9-aa39-3f34abf20ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_84d74bdc-56ff-4cf9-aa39-3f34abf20ab4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_273d3b7d-740f-438c-8e1e-ca31055a71b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_273d3b7d-740f-438c-8e1e-ca31055a71b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_956b5703-5d01-4cdc-9932-76e40abb10e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_956b5703-5d01-4cdc-9932-76e40abb10e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d3c8d52e-478f-4ac8-811a-2490c5aa4c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d3c8d52e-478f-4ac8-811a-2490c5aa4c9f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b3608f55-fb0f-4819-b856-9eaaa629a063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b3608f55-fb0f-4819-b856-9eaaa629a063" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_61569052-0754-417c-b369-853220ac6d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_61569052-0754-417c-b369-853220ac6d28" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_8bbd039a-1ac2-48a3-ad8b-b6268e199a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_8bbd039a-1ac2-48a3-ad8b-b6268e199a6c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4ca5f3ae-cb9b-40b3-890a-161cee1aff41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4ca5f3ae-cb9b-40b3-890a-161cee1aff41" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_3853abf8-cda1-4d6d-9bdf-1e5ffdf93c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_3853abf8-cda1-4d6d-9bdf-1e5ffdf93c37" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InitialConversionPriceOfStock_013c2e70-7f65-4667-beca-e2da2b36bde1" xlink:href="fldm-20220331.xsd#fldm_InitialConversionPriceOfStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_InitialConversionPriceOfStock_013c2e70-7f65-4667-beca-e2da2b36bde1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_9142205c-2ad1-4fa8-b7db-a7ea22e47512" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_9142205c-2ad1-4fa8-b7db-a7ea22e47512" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_50b573de-58cf-4dc8-935e-3821d118811d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_50b573de-58cf-4dc8-935e-3821d118811d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_2b574886-77d5-44b1-9259-17e2b6d5089e" xlink:href="fldm-20220331.xsd#fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_2b574886-77d5-44b1-9259-17e2b6d5089e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_26f7f83e-397e-48ac-ad62-8cef782b884e" xlink:href="fldm-20220331.xsd#fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_26f7f83e-397e-48ac-ad62-8cef782b884e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentCovenantConvertibleDebtThreshold_fe467b0c-d787-418f-8f94-e2cb7d508a31" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentCovenantConvertibleDebtThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_DebtInstrumentCovenantConvertibleDebtThreshold_fe467b0c-d787-418f-8f94-e2cb7d508a31" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio_5bdfb6a0-e0b8-419d-b875-cd6918e97e0c" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio_5bdfb6a0-e0b8-419d-b875-cd6918e97e0c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2764a874-545e-453a-96df-2154fb1a0935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2764a874-545e-453a-96df-2154fb1a0935" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_afba4730-dbf5-45b1-9335-65d6c5e1d66e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_afba4730-dbf5-45b1-9335-65d6c5e1d66e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_fcf11dfc-8a0b-407f-8ae2-75b6ebf6cf88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_fcf11dfc-8a0b-407f-8ae2-75b6ebf6cf88" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b5452a1f-c1fe-4d8a-ba2f-8d415b38fd33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_LineOfCredit_b5452a1f-c1fe-4d8a-ba2f-8d415b38fd33" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentIncrementalPaymentPercent_16cc6a77-1d9d-4aac-95d1-4c8ba73f83dd" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentIncrementalPaymentPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_DebtInstrumentIncrementalPaymentPercent_16cc6a77-1d9d-4aac-95d1-4c8ba73f83dd" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments_729d5ea1-2fc8-407a-804c-25c814d9c6e8" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments_729d5ea1-2fc8-407a-804c-25c814d9c6e8" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b6c4f662-d5d3-49cc-b8e0-dd82cea615ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:to="loc_us-gaap_DebtInstrumentAxis_b6c4f662-d5d3-49cc-b8e0-dd82cea615ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b6c4f662-d5d3-49cc-b8e0-dd82cea615ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b6c4f662-d5d3-49cc-b8e0-dd82cea615ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b6c4f662-d5d3-49cc-b8e0-dd82cea615ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f098521a-19b9-40b8-bd1e-3a446a8d327d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b6c4f662-d5d3-49cc-b8e0-dd82cea615ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f098521a-19b9-40b8-bd1e-3a446a8d327d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_bd0dbdcb-ca26-49fe-9dbf-cab76df86694" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f098521a-19b9-40b8-bd1e-3a446a8d327d" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_bd0dbdcb-ca26-49fe-9dbf-cab76df86694" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member_8cbe563f-5ab2-445d-bc1e-e946ad2415c9" xlink:href="fldm-20220331.xsd#fldm_ExchangeConvertibleSeniorNotesDue2034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f098521a-19b9-40b8-bd1e-3a446a8d327d" xlink:to="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member_8cbe563f-5ab2-445d-bc1e-e946ad2415c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_261c2fe5-2508-49f6-8e43-a8d5ebfcf555" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f098521a-19b9-40b8-bd1e-3a446a8d327d" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_261c2fe5-2508-49f6-8e43-a8d5ebfcf555" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_65504c83-9644-44f6-a504-98e16471d45c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_65504c83-9644-44f6-a504-98e16471d45c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_65504c83-9644-44f6-a504-98e16471d45c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_65504c83-9644-44f6-a504-98e16471d45c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_65504c83-9644-44f6-a504-98e16471d45c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_97f35a79-589f-49d4-a8f4-805f4dd40950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_65504c83-9644-44f6-a504-98e16471d45c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_97f35a79-589f-49d4-a8f4-805f4dd40950" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_cc9d090f-bbc6-47e8-bdda-9e544cae6269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BridgeLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_97f35a79-589f-49d4-a8f4-805f4dd40950" xlink:to="loc_us-gaap_BridgeLoanMember_cc9d090f-bbc6-47e8-bdda-9e544cae6269" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_39c442ac-a9a4-49b6-8565-a07b71bd3de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_97f35a79-589f-49d4-a8f4-805f4dd40950" xlink:to="loc_us-gaap_ConvertibleDebtMember_39c442ac-a9a4-49b6-8565-a07b71bd3de7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_673dcde6-0703-40c8-9413-4510c7592bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_97f35a79-589f-49d4-a8f4-805f4dd40950" xlink:to="loc_us-gaap_LineOfCreditMember_673dcde6-0703-40c8-9413-4510c7592bd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_5767566b-85ac-45a2-b78f-b8e770ea75f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_97f35a79-589f-49d4-a8f4-805f4dd40950" xlink:to="loc_us-gaap_SecuredDebtMember_5767566b-85ac-45a2-b78f-b8e770ea75f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3de648df-82ed-4302-a289-bd4a4c57a2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3de648df-82ed-4302-a289-bd4a4c57a2f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3de648df-82ed-4302-a289-bd4a4c57a2f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3de648df-82ed-4302-a289-bd4a4c57a2f9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_3de648df-82ed-4302-a289-bd4a4c57a2f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_7b89eb88-3525-4d19-a27b-610309402e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3de648df-82ed-4302-a289-bd4a4c57a2f9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_7b89eb88-3525-4d19-a27b-610309402e3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_0e133b52-a5ca-46f1-a7b3-41c09a2eb956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_7b89eb88-3525-4d19-a27b-610309402e3b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_0e133b52-a5ca-46f1-a7b3-41c09a2eb956" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_d88aa92d-6ff2-44b8-9ebf-a6d6405c9dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_7b89eb88-3525-4d19-a27b-610309402e3b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_d88aa92d-6ff2-44b8-9ebf-a6d6405c9dd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_11bca256-39d0-4c8d-8ad5-232bb320fe96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_7b89eb88-3525-4d19-a27b-610309402e3b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_11bca256-39d0-4c8d-8ad5-232bb320fe96" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b248ceb0-90ff-4cac-9f20-35a2c8c5f7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:to="loc_us-gaap_CreditFacilityAxis_b248ceb0-90ff-4cac-9f20-35a2c8c5f7f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b248ceb0-90ff-4cac-9f20-35a2c8c5f7f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b248ceb0-90ff-4cac-9f20-35a2c8c5f7f7" xlink:to="loc_us-gaap_CreditFacilityDomain_b248ceb0-90ff-4cac-9f20-35a2c8c5f7f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_75da6168-9c5b-432c-8fac-de4c63bca989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b248ceb0-90ff-4cac-9f20-35a2c8c5f7f7" xlink:to="loc_us-gaap_CreditFacilityDomain_75da6168-9c5b-432c-8fac-de4c63bca989" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_dc22b72f-9e6d-40b0-a569-0ac5109bba06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_75da6168-9c5b-432c-8fac-de4c63bca989" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_dc22b72f-9e6d-40b0-a569-0ac5109bba06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b603e254-b889-4fab-994a-1914e3d734e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:to="loc_srt_RangeAxis_b603e254-b889-4fab-994a-1914e3d734e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b603e254-b889-4fab-994a-1914e3d734e7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b603e254-b889-4fab-994a-1914e3d734e7" xlink:to="loc_srt_RangeMember_b603e254-b889-4fab-994a-1914e3d734e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d1da3ee7-bd1c-487e-b22b-dd11e2d874d5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b603e254-b889-4fab-994a-1914e3d734e7" xlink:to="loc_srt_RangeMember_d1da3ee7-bd1c-487e-b22b-dd11e2d874d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8f2f60ae-fd30-47e0-a7e1-8f579eb04ef2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d1da3ee7-bd1c-487e-b22b-dd11e2d874d5" xlink:to="loc_srt_MinimumMember_8f2f60ae-fd30-47e0-a7e1-8f579eb04ef2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7dbb2907-46ee-4c97-9105-73cbfef3a61a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d1da3ee7-bd1c-487e-b22b-dd11e2d874d5" xlink:to="loc_srt_MaximumMember_7dbb2907-46ee-4c97-9105-73cbfef3a61a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_917c2cf5-0f4f-499f-b15e-4760b7db5b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:to="loc_us-gaap_VariableRateAxis_917c2cf5-0f4f-499f-b15e-4760b7db5b94" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_917c2cf5-0f4f-499f-b15e-4760b7db5b94_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_917c2cf5-0f4f-499f-b15e-4760b7db5b94" xlink:to="loc_us-gaap_VariableRateDomain_917c2cf5-0f4f-499f-b15e-4760b7db5b94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_fe2fbb38-281e-4619-9692-e66b6806d815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_917c2cf5-0f4f-499f-b15e-4760b7db5b94" xlink:to="loc_us-gaap_VariableRateDomain_fe2fbb38-281e-4619-9692-e66b6806d815" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_137cd5b4-51b9-445c-9c22-1e7de007a5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_fe2fbb38-281e-4619-9692-e66b6806d815" xlink:to="loc_us-gaap_PrimeRateMember_137cd5b4-51b9-445c-9c22-1e7de007a5ab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#DebtScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/DebtScheduleofDebtDetails" xlink:type="extended" id="i277ce83213d7429e8d4d28787b3023cc_DebtScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e03fe8b0-e8dc-4088-991c-7d74489e7e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e03fe8b0-e8dc-4088-991c-7d74489e7e8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_0303e9e4-204e-407c-a9c7-181228465624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_0303e9e4-204e-407c-a9c7-181228465624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_46daad78-581b-49ba-8d4d-e799619959be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_46daad78-581b-49ba-8d4d-e799619959be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_da1daf65-c1d8-4e33-bbe3-ee969aa5ab77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_da1daf65-c1d8-4e33-bbe3-ee969aa5ab77" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9354128e-9dd4-4256-94dc-eef61a60c7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_9354128e-9dd4-4256-94dc-eef61a60c7a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a1a02e8d-4f0f-434f-b09c-c75eb4e1573a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_LongTermDebt_a1a02e8d-4f0f-434f-b09c-c75eb4e1573a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_541a3aa0-795f-439c-9738-2bbb5d15ab66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_LineOfCredit_541a3aa0-795f-439c-9738-2bbb5d15ab66" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_338eb3a3-884a-4aff-8624-6acdb2f1a1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_DebtInstrumentTable_338eb3a3-884a-4aff-8624-6acdb2f1a1c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dfb0ec54-1d2c-40c5-b4ae-3240e6c4c72e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_338eb3a3-884a-4aff-8624-6acdb2f1a1c3" xlink:to="loc_us-gaap_DebtInstrumentAxis_dfb0ec54-1d2c-40c5-b4ae-3240e6c4c72e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dfb0ec54-1d2c-40c5-b4ae-3240e6c4c72e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_dfb0ec54-1d2c-40c5-b4ae-3240e6c4c72e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dfb0ec54-1d2c-40c5-b4ae-3240e6c4c72e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d72f7cfd-e187-4a2e-b02b-47a38323a04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_dfb0ec54-1d2c-40c5-b4ae-3240e6c4c72e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d72f7cfd-e187-4a2e-b02b-47a38323a04b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_cf6c7d95-835d-4f37-9471-4a94cb2fee79" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72f7cfd-e187-4a2e-b02b-47a38323a04b" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_cf6c7d95-835d-4f37-9471-4a94cb2fee79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_f0ab369f-ca6b-41c8-a03c-e64edad0c480" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72f7cfd-e187-4a2e-b02b-47a38323a04b" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_f0ab369f-ca6b-41c8-a03c-e64edad0c480" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fca324e9-bdf9-4d09-adff-798ec71b7175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_338eb3a3-884a-4aff-8624-6acdb2f1a1c3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fca324e9-bdf9-4d09-adff-798ec71b7175" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fca324e9-bdf9-4d09-adff-798ec71b7175_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fca324e9-bdf9-4d09-adff-798ec71b7175" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fca324e9-bdf9-4d09-adff-798ec71b7175_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0a383b69-d8d2-40c1-98ed-5a35b6a734e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fca324e9-bdf9-4d09-adff-798ec71b7175" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0a383b69-d8d2-40c1-98ed-5a35b6a734e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_13e40f48-1e85-4e30-8fcf-5ebfb3bd51d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0a383b69-d8d2-40c1-98ed-5a35b6a734e9" xlink:to="loc_us-gaap_ConvertibleDebtMember_13e40f48-1e85-4e30-8fcf-5ebfb3bd51d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c4ac015a-67b5-42c1-8887-a30a65ad1c70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0a383b69-d8d2-40c1-98ed-5a35b6a734e9" xlink:to="loc_us-gaap_SecuredDebtMember_c4ac015a-67b5-42c1-8887-a30a65ad1c70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_bee134ce-d728-4286-af02-fad0e30477ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0a383b69-d8d2-40c1-98ed-5a35b6a734e9" xlink:to="loc_us-gaap_LineOfCreditMember_bee134ce-d728-4286-af02-fad0e30477ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c6afd699-17b4-45a2-8cfe-4b268c373025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_338eb3a3-884a-4aff-8624-6acdb2f1a1c3" xlink:to="loc_us-gaap_CreditFacilityAxis_c6afd699-17b4-45a2-8cfe-4b268c373025" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c6afd699-17b4-45a2-8cfe-4b268c373025_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c6afd699-17b4-45a2-8cfe-4b268c373025" xlink:to="loc_us-gaap_CreditFacilityDomain_c6afd699-17b4-45a2-8cfe-4b268c373025_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d26f5734-ce5d-4ee2-8fd1-4628b49a4114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c6afd699-17b4-45a2-8cfe-4b268c373025" xlink:to="loc_us-gaap_CreditFacilityDomain_d26f5734-ce5d-4ee2-8fd1-4628b49a4114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3441e2f1-dfc8-490a-a505-99ee38af0838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d26f5734-ce5d-4ee2-8fd1-4628b49a4114" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3441e2f1-dfc8-490a-a505-99ee38af0838" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/LeasesNarrativeDetails" xlink:type="extended" id="ia27b130897794d12a798cc122f548866_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_a9cd09a2-da38-4021-a1fe-781d4f7f74f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LesseeOperatingLeaseRemainingTermOfContract_a5c501bd-f53d-4972-abcd-438d369d09f6" xlink:href="fldm-20220331.xsd#fldm_LesseeOperatingLeaseRemainingTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_a9cd09a2-da38-4021-a1fe-781d4f7f74f3" xlink:to="loc_fldm_LesseeOperatingLeaseRemainingTermOfContract_a5c501bd-f53d-4972-abcd-438d369d09f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_8a54e9b1-f033-4847-9524-fa6d68c08c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_a9cd09a2-da38-4021-a1fe-781d4f7f74f3" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_8a54e9b1-f033-4847-9524-fa6d68c08c46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4fca82c7-d5ad-4f16-b7df-8916315ff638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_a9cd09a2-da38-4021-a1fe-781d4f7f74f3" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4fca82c7-d5ad-4f16-b7df-8916315ff638" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_580028d7-fab4-4d99-9e6f-419d27264f79" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4fca82c7-d5ad-4f16-b7df-8916315ff638" xlink:to="loc_srt_RangeAxis_580028d7-fab4-4d99-9e6f-419d27264f79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_580028d7-fab4-4d99-9e6f-419d27264f79_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_580028d7-fab4-4d99-9e6f-419d27264f79" xlink:to="loc_srt_RangeMember_580028d7-fab4-4d99-9e6f-419d27264f79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7dec1bdc-f72f-4aa1-81a5-b7ecdcd7187d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_580028d7-fab4-4d99-9e6f-419d27264f79" xlink:to="loc_srt_RangeMember_7dec1bdc-f72f-4aa1-81a5-b7ecdcd7187d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7bca25da-78d4-4b0e-8bda-99fa64e00890" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7dec1bdc-f72f-4aa1-81a5-b7ecdcd7187d" xlink:to="loc_srt_MinimumMember_7bca25da-78d4-4b0e-8bda-99fa64e00890" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a171d405-68c0-40f1-af7d-43629a6dc7ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7dec1bdc-f72f-4aa1-81a5-b7ecdcd7187d" xlink:to="loc_srt_MaximumMember_a171d405-68c0-40f1-af7d-43629a6dc7ae" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#LeasesSupplementalBalancesheetDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" xlink:type="extended" id="icbe51e2a2ff34d5c9b211dd11807cbf2_LeasesSupplementalBalancesheetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetGross_76a9fc34-deb7-4fbe-bac9-5c6387c92618" xlink:href="fldm-20220331.xsd#fldm_OperatingLeaseRightOfUseAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_fldm_OperatingLeaseRightOfUseAssetGross_76a9fc34-deb7-4fbe-bac9-5c6387c92618" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_e0a36c43-b61b-4f44-abce-824459ebe985" xlink:href="fldm-20220331.xsd#fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_e0a36c43-b61b-4f44-abce-824459ebe985" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ebee5ab2-20be-42fb-a1cb-5fb5ad581d76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ebee5ab2-20be-42fb-a1cb-5fb5ad581d76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1491fdbe-980d-498e-8163-84be0298bf38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1491fdbe-980d-498e-8163-84be0298bf38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_68e9668a-0aaa-452e-bebd-19971efb8be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_68e9668a-0aaa-452e-bebd-19971efb8be0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4e93c1bc-2176-412c-bae9-87c23bf3f606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_us-gaap_OperatingLeaseLiability_4e93c1bc-2176-412c-bae9-87c23bf3f606" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0c4a9c91-a151-46dd-9c1d-835ded7b30e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0c4a9c91-a151-46dd-9c1d-835ded7b30e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1206bcf7-d8a4-4352-85fa-a3a75cea8f60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1206bcf7-d8a4-4352-85fa-a3a75cea8f60" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b94d6e89-8eb7-4d58-aa05-93da92b66587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b94d6e89-8eb7-4d58-aa05-93da92b66587" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de47d5f8-5333-49d9-ab15-6ddf69728fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b94d6e89-8eb7-4d58-aa05-93da92b66587" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de47d5f8-5333-49d9-ab15-6ddf69728fa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de47d5f8-5333-49d9-ab15-6ddf69728fa5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de47d5f8-5333-49d9-ab15-6ddf69728fa5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_de47d5f8-5333-49d9-ab15-6ddf69728fa5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f8cc0d4b-1f1f-4255-8b95-9111d1479f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de47d5f8-5333-49d9-ab15-6ddf69728fa5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f8cc0d4b-1f1f-4255-8b95-9111d1479f10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_bfcd50ae-26db-45b0-bd7b-8d9cbf88d222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f8cc0d4b-1f1f-4255-8b95-9111d1479f10" xlink:to="loc_us-gaap_BuildingMember_bfcd50ae-26db-45b0-bd7b-8d9cbf88d222" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_3f860d42-f3ed-42fc-acc3-ba1b3950e870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f8cc0d4b-1f1f-4255-8b95-9111d1479f10" xlink:to="loc_us-gaap_EquipmentMember_3f860d42-f3ed-42fc-acc3-ba1b3950e870" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_337ad446-5d8e-4728-b48c-9828ba51d2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f8cc0d4b-1f1f-4255-8b95-9111d1479f10" xlink:to="loc_us-gaap_VehiclesMember_337ad446-5d8e-4728-b48c-9828ba51d2d8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" xlink:type="extended" id="i1d85efc2339f47dab05ed1fecd5c2986_FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_0900cf51-ddca-467c-b8cc-e92941f6018b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_07bbbcc7-f9a0-4e0f-9f5d-783134631d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_0900cf51-ddca-467c-b8cc-e92941f6018b" xlink:to="loc_us-gaap_AssetsAbstract_07bbbcc7-f9a0-4e0f-9f5d-783134631d20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6839405f-ef44-4f72-b25a-472f6f239958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_07bbbcc7-f9a0-4e0f-9f5d-783134631d20" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6839405f-ef44-4f72-b25a-472f6f239958" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_72c5c34a-8626-4dc4-afbc-6056ae15c8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_07bbbcc7-f9a0-4e0f-9f5d-783134631d20" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_72c5c34a-8626-4dc4-afbc-6056ae15c8bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9e283f86-e7dc-4b79-ae3a-8622362a86cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_07bbbcc7-f9a0-4e0f-9f5d-783134631d20" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9e283f86-e7dc-4b79-ae3a-8622362a86cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c8de5bdd-8dc4-468f-bd0a-ff55fbf73dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_0900cf51-ddca-467c-b8cc-e92941f6018b" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c8de5bdd-8dc4-468f-bd0a-ff55fbf73dbb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_2361c918-3bb5-4705-90de-e979ac79e555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c8de5bdd-8dc4-468f-bd0a-ff55fbf73dbb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_2361c918-3bb5-4705-90de-e979ac79e555" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2361c918-3bb5-4705-90de-e979ac79e555_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_2361c918-3bb5-4705-90de-e979ac79e555" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2361c918-3bb5-4705-90de-e979ac79e555_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b0035459-f93f-4f4e-9ed6-05b7284965af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_2361c918-3bb5-4705-90de-e979ac79e555" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b0035459-f93f-4f4e-9ed6-05b7284965af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_5203d477-2a0e-49cd-8314-2e1b60d59185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b0035459-f93f-4f4e-9ed6-05b7284965af" xlink:to="loc_us-gaap_CashMember_5203d477-2a0e-49cd-8314-2e1b60d59185" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CashAndMoneyMarketFundsMember_1a6053f0-7139-4323-bbdf-afaac44ca9a9" xlink:href="fldm-20220331.xsd#fldm_CashAndMoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashMember_5203d477-2a0e-49cd-8314-2e1b60d59185" xlink:to="loc_fldm_CashAndMoneyMarketFundsMember_1a6053f0-7139-4323-bbdf-afaac44ca9a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RestrictedCashAndCashEquivalentsMember_f3fc7180-e5a0-4433-a241-141c7a7c91dc" xlink:href="fldm-20220331.xsd#fldm_RestrictedCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashMember_5203d477-2a0e-49cd-8314-2e1b60d59185" xlink:to="loc_fldm_RestrictedCashAndCashEquivalentsMember_f3fc7180-e5a0-4433-a241-141c7a7c91dc" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#FairValueofFinancialInstrumentsScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" xlink:type="extended" id="i5033d8fe06df415fbae80c8704e223f0_FairValueofFinancialInstrumentsScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b4f269d4-c93d-4c55-8484-f7dbb5105418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4587ebcc-e4d3-4f1f-9ecb-85ece23d190d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4f269d4-c93d-4c55-8484-f7dbb5105418" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4587ebcc-e4d3-4f1f-9ecb-85ece23d190d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_fdfda737-fa16-4a1e-8da7-4dfca69f7aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4f269d4-c93d-4c55-8484-f7dbb5105418" xlink:to="loc_us-gaap_DebtInstrumentFairValue_fdfda737-fa16-4a1e-8da7-4dfca69f7aa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_bbf33ad5-7cc3-4fb1-b6f1-735eb329a388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4f269d4-c93d-4c55-8484-f7dbb5105418" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_bbf33ad5-7cc3-4fb1-b6f1-735eb329a388" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e5a0e852-f4cc-40d7-82cd-8d7bf5ad3e65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4f269d4-c93d-4c55-8484-f7dbb5105418" xlink:to="loc_us-gaap_DebtInstrumentTable_e5a0e852-f4cc-40d7-82cd-8d7bf5ad3e65" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e4a3c8c6-f583-4e81-a2c8-5d2a344c68f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e5a0e852-f4cc-40d7-82cd-8d7bf5ad3e65" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e4a3c8c6-f583-4e81-a2c8-5d2a344c68f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e4a3c8c6-f583-4e81-a2c8-5d2a344c68f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e4a3c8c6-f583-4e81-a2c8-5d2a344c68f1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e4a3c8c6-f583-4e81-a2c8-5d2a344c68f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8b334cb0-0240-4834-9fbb-74c700b784bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e4a3c8c6-f583-4e81-a2c8-5d2a344c68f1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8b334cb0-0240-4834-9fbb-74c700b784bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_cacfd3f0-bd35-4386-873d-ea2f1d2d1b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BridgeLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8b334cb0-0240-4834-9fbb-74c700b784bd" xlink:to="loc_us-gaap_BridgeLoanMember_cacfd3f0-bd35-4386-873d-ea2f1d2d1b1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_b2f04e64-d218-47ea-b2f4-f398695cef3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8b334cb0-0240-4834-9fbb-74c700b784bd" xlink:to="loc_us-gaap_ConvertibleDebtMember_b2f04e64-d218-47ea-b2f4-f398695cef3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_155b6146-39c9-4b6c-b30a-a5224c640485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8b334cb0-0240-4834-9fbb-74c700b784bd" xlink:to="loc_us-gaap_SecuredDebtMember_155b6146-39c9-4b6c-b30a-a5224c640485" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_c25799a9-effc-4bc7-a499-eb8055e49fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8b334cb0-0240-4834-9fbb-74c700b784bd" xlink:to="loc_us-gaap_LineOfCreditMember_c25799a9-effc-4bc7-a499-eb8055e49fa0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_da8d03f8-65c7-4d46-bf01-6ce0012e9cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e5a0e852-f4cc-40d7-82cd-8d7bf5ad3e65" xlink:to="loc_us-gaap_DebtInstrumentAxis_da8d03f8-65c7-4d46-bf01-6ce0012e9cc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_da8d03f8-65c7-4d46-bf01-6ce0012e9cc5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_da8d03f8-65c7-4d46-bf01-6ce0012e9cc5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_da8d03f8-65c7-4d46-bf01-6ce0012e9cc5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b999b727-0b77-4e20-afa3-abf278eb985e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_da8d03f8-65c7-4d46-bf01-6ce0012e9cc5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b999b727-0b77-4e20-afa3-abf278eb985e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_eef55f8b-33b3-4e78-9ed4-426f7fe783f1" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b999b727-0b77-4e20-afa3-abf278eb985e" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_eef55f8b-33b3-4e78-9ed4-426f7fe783f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_2cb2338f-cd80-4e3e-be59-73de2367a920" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b999b727-0b77-4e20-afa3-abf278eb985e" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_2cb2338f-cd80-4e3e-be59-73de2367a920" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_113d9202-706b-42ea-ab21-5150f45f0a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e5a0e852-f4cc-40d7-82cd-8d7bf5ad3e65" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_113d9202-706b-42ea-ab21-5150f45f0a3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_113d9202-706b-42ea-ab21-5150f45f0a3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_113d9202-706b-42ea-ab21-5150f45f0a3b" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_113d9202-706b-42ea-ab21-5150f45f0a3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0ae747a4-9061-4ff6-815d-2b44f3a9b249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_113d9202-706b-42ea-ab21-5150f45f0a3b" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0ae747a4-9061-4ff6-815d-2b44f3a9b249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_753f5baf-2318-4597-bcaa-20f73145cd41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0ae747a4-9061-4ff6-815d-2b44f3a9b249" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_753f5baf-2318-4597-bcaa-20f73145cd41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_828ab7d3-31e5-429e-ba30-7d973ef4e2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_753f5baf-2318-4597-bcaa-20f73145cd41" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_828ab7d3-31e5-429e-ba30-7d973ef4e2b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3be6f8ad-e742-4407-b8c3-eea4e86a1d07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_753f5baf-2318-4597-bcaa-20f73145cd41" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3be6f8ad-e742-4407-b8c3-eea4e86a1d07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b8e6bd2f-8992-4eab-b996-65a9269174de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e5a0e852-f4cc-40d7-82cd-8d7bf5ad3e65" xlink:to="loc_us-gaap_CreditFacilityAxis_b8e6bd2f-8992-4eab-b996-65a9269174de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b8e6bd2f-8992-4eab-b996-65a9269174de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b8e6bd2f-8992-4eab-b996-65a9269174de" xlink:to="loc_us-gaap_CreditFacilityDomain_b8e6bd2f-8992-4eab-b996-65a9269174de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a87faf21-ed8f-4d59-9c97-22b60d6b9128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b8e6bd2f-8992-4eab-b996-65a9269174de" xlink:to="loc_us-gaap_CreditFacilityDomain_a87faf21-ed8f-4d59-9c97-22b60d6b9128" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1dfb5a69-5908-4c38-b8b1-9ce64b33a8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a87faf21-ed8f-4d59-9c97-22b60d6b9128" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1dfb5a69-5908-4c38-b8b1-9ce64b33a8f0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended" id="i794728d15f2e4ffcb0fc0303f6bb6d76_ShareholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareholdersEquityLineItems_baa2cbb7-ca98-421a-8f20-6dc695a031ed" xlink:href="fldm-20220331.xsd#fldm_ShareholdersEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_1ec16a2f-d992-4d21-90fa-4eb4fa55dda1" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_fldm_ShareholdersEquityLineItems_baa2cbb7-ca98-421a-8f20-6dc695a031ed" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_1ec16a2f-d992-4d21-90fa-4eb4fa55dda1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareholdersEquityTable_54222148-6e73-4a07-be6b-2bb7feeaa567" xlink:href="fldm-20220331.xsd#fldm_ShareholdersEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_fldm_ShareholdersEquityLineItems_baa2cbb7-ca98-421a-8f20-6dc695a031ed" xlink:to="loc_fldm_ShareholdersEquityTable_54222148-6e73-4a07-be6b-2bb7feeaa567" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0802fb8f-957d-4ec7-b0cb-6505dad1bc32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ShareholdersEquityTable_54222148-6e73-4a07-be6b-2bb7feeaa567" xlink:to="loc_us-gaap_AwardTypeAxis_0802fb8f-957d-4ec7-b0cb-6505dad1bc32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0802fb8f-957d-4ec7-b0cb-6505dad1bc32_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0802fb8f-957d-4ec7-b0cb-6505dad1bc32" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0802fb8f-957d-4ec7-b0cb-6505dad1bc32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f22ceed3-ba8c-4d19-9d4b-d3d6be9abb83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0802fb8f-957d-4ec7-b0cb-6505dad1bc32" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f22ceed3-ba8c-4d19-9d4b-d3d6be9abb83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_6e4f4d61-d13f-4198-a144-971c363b6c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f22ceed3-ba8c-4d19-9d4b-d3d6be9abb83" xlink:to="loc_us-gaap_PerformanceSharesMember_6e4f4d61-d13f-4198-a144-971c363b6c07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_206beeae-f053-43b6-bbe0-f90406c5cdc9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_fldm_ShareholdersEquityTable_54222148-6e73-4a07-be6b-2bb7feeaa567" xlink:to="loc_srt_RangeAxis_206beeae-f053-43b6-bbe0-f90406c5cdc9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_206beeae-f053-43b6-bbe0-f90406c5cdc9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_206beeae-f053-43b6-bbe0-f90406c5cdc9" xlink:to="loc_srt_RangeMember_206beeae-f053-43b6-bbe0-f90406c5cdc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_427ede75-2a4f-46bc-ae47-bb2c2ae4d916" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_206beeae-f053-43b6-bbe0-f90406c5cdc9" xlink:to="loc_srt_RangeMember_427ede75-2a4f-46bc-ae47-bb2c2ae4d916" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f565f3dd-cf53-4bd8-9d45-995e6020d00d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_427ede75-2a4f-46bc-ae47-bb2c2ae4d916" xlink:to="loc_srt_MinimumMember_f565f3dd-cf53-4bd8-9d45-995e6020d00d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_47c4e439-dba5-4f02-a34e-7b15c687041b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_427ede75-2a4f-46bc-ae47-bb2c2ae4d916" xlink:to="loc_srt_MaximumMember_47c4e439-dba5-4f02-a34e-7b15c687041b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#ShareholdersEquityScheduleofStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" xlink:type="extended" id="i3c34f9f3cdbb4c7187792d6979845c5c_ShareholdersEquityScheduleofStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8cc129a3-215b-4219-8213-55e35fb9adde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5dd67ef9-1e6d-4094-8d5a-46d439ff984a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8cc129a3-215b-4219-8213-55e35fb9adde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5dd67ef9-1e6d-4094-8d5a-46d439ff984a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e71b43cd-6b21-4dfe-b553-57ec74cde440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8cc129a3-215b-4219-8213-55e35fb9adde" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e71b43cd-6b21-4dfe-b553-57ec74cde440" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_8ce60905-7da5-4218-895c-872a25ce2e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_8cc129a3-215b-4219-8213-55e35fb9adde" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_8ce60905-7da5-4218-895c-872a25ce2e97" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c6ece7b7-c593-468a-8e31-5b4d00170b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8ce60905-7da5-4218-895c-872a25ce2e97" xlink:to="loc_us-gaap_AwardTypeAxis_c6ece7b7-c593-468a-8e31-5b4d00170b05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c6ece7b7-c593-468a-8e31-5b4d00170b05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c6ece7b7-c593-468a-8e31-5b4d00170b05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c6ece7b7-c593-468a-8e31-5b4d00170b05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b56a56dd-b574-4b2c-a3dc-a666a8a0b5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c6ece7b7-c593-468a-8e31-5b4d00170b05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b56a56dd-b574-4b2c-a3dc-a666a8a0b5a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_741afc7a-ade5-4889-9beb-031a2d433137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b56a56dd-b574-4b2c-a3dc-a666a8a0b5a1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_741afc7a-ade5-4889-9beb-031a2d433137" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RestrictedStockAndPerformanceShareUnitsMember_c95099dd-e2a7-459e-826b-f0ad4b0ef976" xlink:href="fldm-20220331.xsd#fldm_RestrictedStockAndPerformanceShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b56a56dd-b574-4b2c-a3dc-a666a8a0b5a1" xlink:to="loc_fldm_RestrictedStockAndPerformanceShareUnitsMember_c95099dd-e2a7-459e-826b-f0ad4b0ef976" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7557f12c-d15e-4c98-862c-03994f8805ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8ce60905-7da5-4218-895c-872a25ce2e97" xlink:to="loc_us-gaap_PlanNameAxis_7557f12c-d15e-4c98-862c-03994f8805ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7557f12c-d15e-4c98-862c-03994f8805ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_7557f12c-d15e-4c98-862c-03994f8805ab" xlink:to="loc_us-gaap_PlanNameDomain_7557f12c-d15e-4c98-862c-03994f8805ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_06e24101-46b7-44a1-976c-0fbdf50cd3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_7557f12c-d15e-4c98-862c-03994f8805ab" xlink:to="loc_us-gaap_PlanNameDomain_06e24101-46b7-44a1-976c-0fbdf50cd3e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember_ab9cc0f6-64d4-4e4b-8093-3580454f03c3" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndElevenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_06e24101-46b7-44a1-976c-0fbdf50cd3e5" xlink:to="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember_ab9cc0f6-64d4-4e4b-8093-3580454f03c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndTenEquityIncentivePlanMember_90b997da-90e3-4620-8c50-e204c9b8574b" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndTenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_06e24101-46b7-44a1-976c-0fbdf50cd3e5" xlink:to="loc_fldm_TwoThousandAndTenEquityIncentivePlanMember_90b997da-90e3-4620-8c50-e204c9b8574b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_d97c0eac-e737-494a-b93d-fee9c6b36df6" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndSeventeenInducementAwardPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_06e24101-46b7-44a1-976c-0fbdf50cd3e5" xlink:to="loc_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_d97c0eac-e737-494a-b93d-fee9c6b36df6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_585443a9-b12f-4f4e-979b-614ccaf91db6" xlink:href="fldm-20220331.xsd#fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_06e24101-46b7-44a1-976c-0fbdf50cd3e5" xlink:to="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_585443a9-b12f-4f4e-979b-614ccaf91db6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#StockBasedPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/StockBasedPlansNarrativeDetails" xlink:type="extended" id="if2a60f35e6ef46539351737ab901418d_StockBasedPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9e333e1a-c776-4e2d-80bf-eb770a06afc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9e333e1a-c776-4e2d-80bf-eb770a06afc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_a55674ff-e682-4009-b5cc-b4a427c9a182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_a55674ff-e682-4009-b5cc-b4a427c9a182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ed15ae84-b164-4eb6-b749-a368edfd5da4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ed15ae84-b164-4eb6-b749-a368edfd5da4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_8e15005b-eb4b-4e3c-9925-ac5c15a33e57" xlink:href="fldm-20220331.xsd#fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_8e15005b-eb4b-4e3c-9925-ac5c15a33e57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PortionOfStockOptionsVestOnFirstAnniversary_4fe06fbd-78d5-4bf2-903d-83fb063ffb0d" xlink:href="fldm-20220331.xsd#fldm_PortionOfStockOptionsVestOnFirstAnniversary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_fldm_PortionOfStockOptionsVestOnFirstAnniversary_4fe06fbd-78d5-4bf2-903d-83fb063ffb0d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_8a450a9e-9d3f-4060-b0ba-9aeb67ea48fd" xlink:href="fldm-20220331.xsd#fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_8a450a9e-9d3f-4060-b0ba-9aeb67ea48fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_a714907a-539f-4280-964d-40e9ed11f9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_a714907a-539f-4280-964d-40e9ed11f9e6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_68d6a734-ccff-44dd-b0dc-4f1c2150eed5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_68d6a734-ccff-44dd-b0dc-4f1c2150eed5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_1a640f4d-70ad-45be-8922-b5ee34a90638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_1a640f4d-70ad-45be-8922-b5ee34a90638" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_bddcc902-5a13-44d7-9d19-2f22f751f4c7" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_bddcc902-5a13-44d7-9d19-2f22f751f4c7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8eda25d4-643f-4844-98a4-1c12d78e98c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8eda25d4-643f-4844-98a4-1c12d78e98c5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_356d998d-ab6a-4835-b8e9-a2249fa1c4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_356d998d-ab6a-4835-b8e9-a2249fa1c4aa" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EmployeeStockPurchasePlanOfferingPeriod_c6f222ee-a9be-44ac-8ea2-882625728fe5" xlink:href="fldm-20220331.xsd#fldm_EmployeeStockPurchasePlanOfferingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_fldm_EmployeeStockPurchasePlanOfferingPeriod_c6f222ee-a9be-44ac-8ea2-882625728fe5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_a407d550-51d9-4b8f-a045-480d2d28e0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_a407d550-51d9-4b8f-a045-480d2d28e0dd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_e4945959-16dd-4b67-afd8-564578107c41" xlink:href="fldm-20220331.xsd#fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_e4945959-16dd-4b67-afd8-564578107c41" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_746f12d4-2363-4679-a69a-924bc9f174aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_746f12d4-2363-4679-a69a-924bc9f174aa" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bcc9ece4-37af-49f9-bf74-e44a6683214f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:to="loc_us-gaap_AwardTypeAxis_bcc9ece4-37af-49f9-bf74-e44a6683214f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bcc9ece4-37af-49f9-bf74-e44a6683214f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_bcc9ece4-37af-49f9-bf74-e44a6683214f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bcc9ece4-37af-49f9-bf74-e44a6683214f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9b35da5-4fb0-407a-aad9-cf528dddb051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_bcc9ece4-37af-49f9-bf74-e44a6683214f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9b35da5-4fb0-407a-aad9-cf528dddb051" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f744a169-761e-44ca-95e8-040bc06bc04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9b35da5-4fb0-407a-aad9-cf528dddb051" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f744a169-761e-44ca-95e8-040bc06bc04b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_4903455b-b97e-415e-8de6-2cbba4333622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9b35da5-4fb0-407a-aad9-cf528dddb051" xlink:to="loc_us-gaap_StockCompensationPlanMember_4903455b-b97e-415e-8de6-2cbba4333622" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_669f7456-a3e5-450a-baf6-69915d09e4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9b35da5-4fb0-407a-aad9-cf528dddb051" xlink:to="loc_us-gaap_PerformanceSharesMember_669f7456-a3e5-450a-baf6-69915d09e4fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_aa9b23ae-bc4f-46cb-9716-2977a1dc88a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9b35da5-4fb0-407a-aad9-cf528dddb051" xlink:to="loc_us-gaap_EmployeeStockMember_aa9b23ae-bc4f-46cb-9716-2977a1dc88a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_13ff5899-d939-46bb-8a35-ee10417c34b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:to="loc_us-gaap_VestingAxis_13ff5899-d939-46bb-8a35-ee10417c34b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_13ff5899-d939-46bb-8a35-ee10417c34b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_13ff5899-d939-46bb-8a35-ee10417c34b2" xlink:to="loc_us-gaap_VestingDomain_13ff5899-d939-46bb-8a35-ee10417c34b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_bd8530fe-553a-48cd-b844-ead5292eb8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_13ff5899-d939-46bb-8a35-ee10417c34b2" xlink:to="loc_us-gaap_VestingDomain_bd8530fe-553a-48cd-b844-ead5292eb8e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_5f4fde07-ae9f-40b3-a618-fbb5cfed20a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_bd8530fe-553a-48cd-b844-ead5292eb8e3" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_5f4fde07-ae9f-40b3-a618-fbb5cfed20a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ac7cbdb3-dd4f-42f3-87f1-bddadca60ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_bd8530fe-553a-48cd-b844-ead5292eb8e3" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ac7cbdb3-dd4f-42f3-87f1-bddadca60ab7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b9af2baa-9f55-4d79-8efc-fe1a287a9c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:to="loc_us-gaap_PlanNameAxis_b9af2baa-9f55-4d79-8efc-fe1a287a9c4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b9af2baa-9f55-4d79-8efc-fe1a287a9c4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_b9af2baa-9f55-4d79-8efc-fe1a287a9c4c" xlink:to="loc_us-gaap_PlanNameDomain_b9af2baa-9f55-4d79-8efc-fe1a287a9c4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_842a124f-69bc-4d14-8611-ed14dd8d2225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_b9af2baa-9f55-4d79-8efc-fe1a287a9c4c" xlink:to="loc_us-gaap_PlanNameDomain_842a124f-69bc-4d14-8611-ed14dd8d2225" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EquityIncentivePlanTwentyElevenMember_f7755e74-d106-4568-928c-9629851d1519" xlink:href="fldm-20220331.xsd#fldm_EquityIncentivePlanTwentyElevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_842a124f-69bc-4d14-8611-ed14dd8d2225" xlink:to="loc_fldm_EquityIncentivePlanTwentyElevenMember_f7755e74-d106-4568-928c-9629851d1519" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember_ec92ba16-c9cc-4160-a54b-8c282c859049" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndElevenEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_842a124f-69bc-4d14-8611-ed14dd8d2225" xlink:to="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember_ec92ba16-c9cc-4160-a54b-8c282c859049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EquityIncentivePlanMember_e3e3f167-cc0a-42db-84f0-6768e42b9c6d" xlink:href="fldm-20220331.xsd#fldm_EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_842a124f-69bc-4d14-8611-ed14dd8d2225" xlink:to="loc_fldm_EquityIncentivePlanMember_e3e3f167-cc0a-42db-84f0-6768e42b9c6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_a4b612f2-845d-4319-9a26-f144a652f1d9" xlink:href="fldm-20220331.xsd#fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_842a124f-69bc-4d14-8611-ed14dd8d2225" xlink:to="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_a4b612f2-845d-4319-9a26-f144a652f1d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_60e07b28-02ef-4b29-a33c-e8c066d1a9e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:to="loc_srt_RangeAxis_60e07b28-02ef-4b29-a33c-e8c066d1a9e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_60e07b28-02ef-4b29-a33c-e8c066d1a9e3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_60e07b28-02ef-4b29-a33c-e8c066d1a9e3" xlink:to="loc_srt_RangeMember_60e07b28-02ef-4b29-a33c-e8c066d1a9e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_21f48895-ee48-4ff1-8ffe-15d42bd87e97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_60e07b28-02ef-4b29-a33c-e8c066d1a9e3" xlink:to="loc_srt_RangeMember_21f48895-ee48-4ff1-8ffe-15d42bd87e97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a97061ee-d3de-4c58-b580-ffa51876cc4f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_21f48895-ee48-4ff1-8ffe-15d42bd87e97" xlink:to="loc_srt_MinimumMember_a97061ee-d3de-4c58-b580-ffa51876cc4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_21228985-7dd8-413d-9a2e-89ace201bb30" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_21f48895-ee48-4ff1-8ffe-15d42bd87e97" xlink:to="loc_srt_MaximumMember_21228985-7dd8-413d-9a2e-89ace201bb30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_c5d65ae8-47d8-4eba-bce8-c643a49ccadb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:to="loc_srt_TitleOfIndividualAxis_c5d65ae8-47d8-4eba-bce8-c643a49ccadb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c5d65ae8-47d8-4eba-bce8-c643a49ccadb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_c5d65ae8-47d8-4eba-bce8-c643a49ccadb" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_c5d65ae8-47d8-4eba-bce8-c643a49ccadb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_98cf46ba-6ff9-4f3b-adb1-62a87239ab97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_c5d65ae8-47d8-4eba-bce8-c643a49ccadb" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_98cf46ba-6ff9-4f3b-adb1-62a87239ab97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CertainEmployeeMember_b739dc4a-bd96-4d0b-89d6-3c9626233f22" xlink:href="fldm-20220331.xsd#fldm_CertainEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_98cf46ba-6ff9-4f3b-adb1-62a87239ab97" xlink:to="loc_fldm_CertainEmployeeMember_b739dc4a-bd96-4d0b-89d6-3c9626233f22" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#StockBasedPlansRestrictedandPerformanceStockUnitsDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" xlink:type="extended" id="i4da19a436e0546f593d5cf1558d9e9c9_StockBasedPlansRestrictedandPerformanceStockUnitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ed48674-34b5-426a-8509-dfce92a99cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ed48674-34b5-426a-8509-dfce92a99cc4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c146f41e-98e1-4798-ade2-b4606a9ad961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c146f41e-98e1-4798-ade2-b4606a9ad961" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b2381680-211a-4c33-94db-a51e1e006953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b2381680-211a-4c33-94db-a51e1e006953" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod_de3272a5-26eb-41b3-b5fc-fe5d56885fa3" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod_de3272a5-26eb-41b3-b5fc-fe5d56885fa3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ac6c719e-f6c2-4b31-b9cd-b6c029d12676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ac6c719e-f6c2-4b31-b9cd-b6c029d12676" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_743452db-7a37-47c2-8719-3d9d00977202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_743452db-7a37-47c2-8719-3d9d00977202" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0dfbb649-0906-4857-9aaf-c530a7e822c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ed48674-34b5-426a-8509-dfce92a99cc4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c8ccfca5-4d2a-4244-a4ee-0548c399740d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c8ccfca5-4d2a-4244-a4ee-0548c399740d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_db143f3f-c1f3-4a40-843e-142c2c70449c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_db143f3f-c1f3-4a40-843e-142c2c70449c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue_dc8f00c7-d518-49f3-8e70-14cbdde3f1e5" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue_dc8f00c7-d518-49f3-8e70-14cbdde3f1e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d489509d-b995-417d-a2fc-9717f20b28c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d489509d-b995-417d-a2fc-9717f20b28c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9c45421c-5cf9-4400-b7bf-1efdf2f0f66a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9c45421c-5cf9-4400-b7bf-1efdf2f0f66a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8442bd6e-e177-4ebe-b443-5c09dfa4337e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ba7b73c-4eaf-4117-ae34-9f3c9060362a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ed48674-34b5-426a-8509-dfce92a99cc4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ba7b73c-4eaf-4117-ae34-9f3c9060362a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a5d808bb-f599-4f57-b42b-b0800306cd36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ba7b73c-4eaf-4117-ae34-9f3c9060362a" xlink:to="loc_us-gaap_AwardTypeAxis_a5d808bb-f599-4f57-b42b-b0800306cd36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5d808bb-f599-4f57-b42b-b0800306cd36_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a5d808bb-f599-4f57-b42b-b0800306cd36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5d808bb-f599-4f57-b42b-b0800306cd36_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01d26ebc-3984-4d29-80e1-24df9800e666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a5d808bb-f599-4f57-b42b-b0800306cd36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01d26ebc-3984-4d29-80e1-24df9800e666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d5c4ee2e-632d-4f6e-a675-3980d7a1df29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01d26ebc-3984-4d29-80e1-24df9800e666" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d5c4ee2e-632d-4f6e-a675-3980d7a1df29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_4fb38a61-104d-4108-b1ce-bf1a610351bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01d26ebc-3984-4d29-80e1-24df9800e666" xlink:to="loc_us-gaap_PerformanceSharesMember_4fb38a61-104d-4108-b1ce-bf1a610351bb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#StockBasedPlansStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails" xlink:type="extended" id="i2bf14bf1e8d0402bbe0db37700591cc1_StockBasedPlansStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db5c6aa4-99ea-48fd-a590-b79388b5f115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_242f6b2a-f99e-4899-ae3f-f4072ebd55c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db5c6aa4-99ea-48fd-a590-b79388b5f115" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_242f6b2a-f99e-4899-ae3f-f4072ebd55c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_334da2ca-0b56-4ede-9fca-f7a6bad81866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db5c6aa4-99ea-48fd-a590-b79388b5f115" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_334da2ca-0b56-4ede-9fca-f7a6bad81866" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5fd9b65c-d92a-4b7e-89ad-6409196efec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_334da2ca-0b56-4ede-9fca-f7a6bad81866" xlink:to="loc_us-gaap_PlanNameAxis_5fd9b65c-d92a-4b7e-89ad-6409196efec2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5fd9b65c-d92a-4b7e-89ad-6409196efec2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5fd9b65c-d92a-4b7e-89ad-6409196efec2" xlink:to="loc_us-gaap_PlanNameDomain_5fd9b65c-d92a-4b7e-89ad-6409196efec2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_04511784-4b13-44fd-9f1c-dca011bc75bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5fd9b65c-d92a-4b7e-89ad-6409196efec2" xlink:to="loc_us-gaap_PlanNameDomain_04511784-4b13-44fd-9f1c-dca011bc75bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_960f9ce5-497e-4b25-88be-552c2c234515" xlink:href="fldm-20220331.xsd#fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_04511784-4b13-44fd-9f1c-dca011bc75bc" xlink:to="loc_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_960f9ce5-497e-4b25-88be-552c2c234515" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_10a83a84-1b26-4efd-86b2-bfc03b369b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_334da2ca-0b56-4ede-9fca-f7a6bad81866" xlink:to="loc_us-gaap_AwardTypeAxis_10a83a84-1b26-4efd-86b2-bfc03b369b3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10a83a84-1b26-4efd-86b2-bfc03b369b3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_10a83a84-1b26-4efd-86b2-bfc03b369b3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10a83a84-1b26-4efd-86b2-bfc03b369b3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b2cdfb1e-4207-4033-9006-3cff19ac9624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_10a83a84-1b26-4efd-86b2-bfc03b369b3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b2cdfb1e-4207-4033-9006-3cff19ac9624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_224dbd87-31e0-46b3-b2c9-625b7b32d2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b2cdfb1e-4207-4033-9006-3cff19ac9624" xlink:to="loc_us-gaap_EmployeeStockMember_224dbd87-31e0-46b3-b2c9-625b7b32d2d5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/InformationAboutGeographicAreasDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#InformationAboutGeographicAreasDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/InformationAboutGeographicAreasDetails" xlink:type="extended" id="id8e6642feb9a4b15b408d55ba833770a_InformationAboutGeographicAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_3ae73cb3-2cde-4b59-bedf-25bd01848272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_937d3b5d-08e1-46e4-afd5-da9e897be534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_3ae73cb3-2cde-4b59-bedf-25bd01848272" xlink:to="loc_us-gaap_NumberOfReportableSegments_937d3b5d-08e1-46e4-afd5-da9e897be534" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3622606e-c59a-413e-b4f9-7ee945c59bea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_3ae73cb3-2cde-4b59-bedf-25bd01848272" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3622606e-c59a-413e-b4f9-7ee945c59bea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_60828508-aad5-4c06-95f1-f68572a3a726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_3ae73cb3-2cde-4b59-bedf-25bd01848272" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_60828508-aad5-4c06-95f1-f68572a3a726" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_f861ff37-e749-4b08-ba20-06388c8cacf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_3ae73cb3-2cde-4b59-bedf-25bd01848272" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_f861ff37-e749-4b08-ba20-06388c8cacf5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_28744c41-7a17-4e74-9b75-4353141fa009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_f861ff37-e749-4b08-ba20-06388c8cacf5" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_28744c41-7a17-4e74-9b75-4353141fa009" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_28744c41-7a17-4e74-9b75-4353141fa009_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_28744c41-7a17-4e74-9b75-4353141fa009" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_28744c41-7a17-4e74-9b75-4353141fa009_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_939d23a1-9682-4c9c-99e6-5c5d22f88e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_28744c41-7a17-4e74-9b75-4353141fa009" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_939d23a1-9682-4c9c-99e6-5c5d22f88e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_9bdd4731-6b83-48b3-9709-04e04b4bf9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_939d23a1-9682-4c9c-99e6-5c5d22f88e47" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_9bdd4731-6b83-48b3-9709-04e04b4bf9f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2d6f94f2-ebb3-4ec8-9d5e-054e1cf2682d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_f861ff37-e749-4b08-ba20-06388c8cacf5" xlink:to="loc_srt_StatementGeographicalAxis_2d6f94f2-ebb3-4ec8-9d5e-054e1cf2682d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2d6f94f2-ebb3-4ec8-9d5e-054e1cf2682d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_2d6f94f2-ebb3-4ec8-9d5e-054e1cf2682d" xlink:to="loc_srt_SegmentGeographicalDomain_2d6f94f2-ebb3-4ec8-9d5e-054e1cf2682d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_96bb9498-8f34-4c9a-9a41-de9023fe4f83" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_2d6f94f2-ebb3-4ec8-9d5e-054e1cf2682d" xlink:to="loc_srt_SegmentGeographicalDomain_96bb9498-8f34-4c9a-9a41-de9023fe4f83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b8011953-60b0-46cb-9cbd-081e234c9688" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_96bb9498-8f34-4c9a-9a41-de9023fe4f83" xlink:to="loc_country_US_b8011953-60b0-46cb-9cbd-081e234c9688" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_66f4b135-49a8-4f59-8ec0-a206a8a68c3f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_96bb9498-8f34-4c9a-9a41-de9023fe4f83" xlink:to="loc_country_CN_66f4b135-49a8-4f59-8ec0-a206a8a68c3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5eef3622-7a43-4c24-a786-61b7f63c1876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_f861ff37-e749-4b08-ba20-06388c8cacf5" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5eef3622-7a43-4c24-a786-61b7f63c1876" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5eef3622-7a43-4c24-a786-61b7f63c1876_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5eef3622-7a43-4c24-a786-61b7f63c1876" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5eef3622-7a43-4c24-a786-61b7f63c1876_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_998fd879-6820-44a7-9f6b-42538e64089b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5eef3622-7a43-4c24-a786-61b7f63c1876" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_998fd879-6820-44a7-9f6b-42538e64089b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_aae13d2f-09f9-4e1c-8841-eb47b7ad4bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_998fd879-6820-44a7-9f6b-42538e64089b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_aae13d2f-09f9-4e1c-8841-eb47b7ad4bcf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://fluidigm.com/role/SubsequentEventsDetails" xlink:type="extended" id="id14c213f7753403581612c1a5bf6f0dc_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_a1f4e327-5b15-46fc-8d38-88e6b1ec9826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_a1f4e327-5b15-46fc-8d38-88e6b1ec9826" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8c27da7e-ab91-461e-885f-7bad1d48b53f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8c27da7e-ab91-461e-885f-7bad1d48b53f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_341e64a6-cdd5-4a22-a52b-eda70ba9345f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_341e64a6-cdd5-4a22-a52b-eda70ba9345f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_f091491d-4f49-40b2-aa2f-47afb00385a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_f091491d-4f49-40b2-aa2f-47afb00385a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_591e0b9d-c78a-4427-aac5-ae5dd8c1d54c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_591e0b9d-c78a-4427-aac5-ae5dd8c1d54c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_486f8930-7563-4430-90cf-6900e4c9d98f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_486f8930-7563-4430-90cf-6900e4c9d98f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7398c584-380f-42d5-8c4c-5a47be01ded0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7398c584-380f-42d5-8c4c-5a47be01ded0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_94ad8cdb-3d80-4bf5-a4fe-e1cb07075a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_94ad8cdb-3d80-4bf5-a4fe-e1cb07075a44" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1716c861-e2f1-4d3a-8717-89b53a463ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1716c861-e2f1-4d3a-8717-89b53a463ca9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_9b10ac3d-926a-45ab-9dcf-0da404c95bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_SubsequentEventTable_9b10ac3d-926a-45ab-9dcf-0da404c95bfe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_891fc0e6-5141-4734-8e09-c080c382e6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_9b10ac3d-926a-45ab-9dcf-0da404c95bfe" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_891fc0e6-5141-4734-8e09-c080c382e6a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_891fc0e6-5141-4734-8e09-c080c382e6a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_891fc0e6-5141-4734-8e09-c080c382e6a1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_891fc0e6-5141-4734-8e09-c080c382e6a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6a58102f-825e-4662-a3c4-9a9864e55f40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_891fc0e6-5141-4734-8e09-c080c382e6a1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6a58102f-825e-4662-a3c4-9a9864e55f40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_89c49d2e-eef8-4742-886a-af23be1e626b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6a58102f-825e-4662-a3c4-9a9864e55f40" xlink:to="loc_us-gaap_SubsequentEventMember_89c49d2e-eef8-4742-886a-af23be1e626b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2372acc2-3189-4400-972e-2ae0c993f134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_9b10ac3d-926a-45ab-9dcf-0da404c95bfe" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2372acc2-3189-4400-972e-2ae0c993f134" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2372acc2-3189-4400-972e-2ae0c993f134_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2372acc2-3189-4400-972e-2ae0c993f134" xlink:to="loc_us-gaap_ClassOfStockDomain_2372acc2-3189-4400-972e-2ae0c993f134_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3e92d736-ee0c-416a-ad5c-3cd4be528a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2372acc2-3189-4400-972e-2ae0c993f134" xlink:to="loc_us-gaap_ClassOfStockDomain_3e92d736-ee0c-416a-ad5c-3cd4be528a34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_985013f1-9506-428b-8500-5b886761cf45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3e92d736-ee0c-416a-ad5c-3cd4be528a34" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_985013f1-9506-428b-8500-5b886761cf45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f8bac45a-289f-40fb-a3ff-d004a76ebc75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_9b10ac3d-926a-45ab-9dcf-0da404c95bfe" xlink:to="loc_us-gaap_PlanNameAxis_f8bac45a-289f-40fb-a3ff-d004a76ebc75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f8bac45a-289f-40fb-a3ff-d004a76ebc75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_f8bac45a-289f-40fb-a3ff-d004a76ebc75" xlink:to="loc_us-gaap_PlanNameDomain_f8bac45a-289f-40fb-a3ff-d004a76ebc75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7853e0d0-9a15-4c23-a771-780ed3a9590f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_f8bac45a-289f-40fb-a3ff-d004a76ebc75" xlink:to="loc_us-gaap_PlanNameDomain_7853e0d0-9a15-4c23-a771-780ed3a9590f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_A2022InducementEquityIncentivePlanMember_1cfebfee-c49e-4f23-894e-05bb1fb98df6" xlink:href="fldm-20220331.xsd#fldm_A2022InducementEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7853e0d0-9a15-4c23-a771-780ed3a9590f" xlink:to="loc_fldm_A2022InducementEquityIncentivePlanMember_1cfebfee-c49e-4f23-894e-05bb1fb98df6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_664223d2-2751-49f5-aa87-b040555469d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_9b10ac3d-926a-45ab-9dcf-0da404c95bfe" xlink:to="loc_us-gaap_AwardTypeAxis_664223d2-2751-49f5-aa87-b040555469d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_664223d2-2751-49f5-aa87-b040555469d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_664223d2-2751-49f5-aa87-b040555469d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_664223d2-2751-49f5-aa87-b040555469d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27d10353-e153-4149-9dbe-d87d1aaa2721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_664223d2-2751-49f5-aa87-b040555469d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27d10353-e153-4149-9dbe-d87d1aaa2721" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_08a8ede6-ad68-4a19-a78f-ab3d3ccecc24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27d10353-e153-4149-9dbe-d87d1aaa2721" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_08a8ede6-ad68-4a19-a78f-ab3d3ccecc24" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>fldm-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3567094e-7943-4bac-b9e5-feece94f0a52,g:ecd4ac27-903f-4673-9e8a-4f46fd5b8bd9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_fldm_CertainEmployeeMember_85e86aa4-47b2-4ca2-84ce-4de323dd915e_terseLabel_en-US" xlink:label="lab_fldm_CertainEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Employee</link:label>
    <link:label id="lab_fldm_CertainEmployeeMember_label_en-US" xlink:label="lab_fldm_CertainEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Employee [Member]</link:label>
    <link:label id="lab_fldm_CertainEmployeeMember_documentation_en-US" xlink:label="lab_fldm_CertainEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certain Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CertainEmployeeMember" xlink:href="fldm-20220331.xsd#fldm_CertainEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_CertainEmployeeMember" xlink:to="lab_fldm_CertainEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_NonCashRightOfUseAssetsAndLeaseLiabilities_914b37e4-af0d-42ee-9af4-36c9fd8138a6_terseLabel_en-US" xlink:label="lab_fldm_NonCashRightOfUseAssetsAndLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash right-of-use assets and lease liabilities</link:label>
    <link:label id="lab_fldm_NonCashRightOfUseAssetsAndLeaseLiabilities_label_en-US" xlink:label="lab_fldm_NonCashRightOfUseAssetsAndLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Right -of-Use Assets and Lease Liabilities</link:label>
    <link:label id="lab_fldm_NonCashRightOfUseAssetsAndLeaseLiabilities_documentation_en-US" xlink:label="lab_fldm_NonCashRightOfUseAssetsAndLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Cash Right -of-Use Assets and Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_NonCashRightOfUseAssetsAndLeaseLiabilities" xlink:href="fldm-20220331.xsd#fldm_NonCashRightOfUseAssetsAndLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_NonCashRightOfUseAssetsAndLeaseLiabilities" xlink:to="lab_fldm_NonCashRightOfUseAssetsAndLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_125c7f83-fcc9-4dc9-988a-7e6827a2867e_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_e0fb0820-2698-4e76-91c5-5e1cc2bc2dbd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_084a3c0e-d07f-459e-889a-50b10f166b22_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_b2501309-f637-4e63-a8b2-ddb350f9bf86_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_16fe7027-bc25-4f25-b7dc-9ce273ac20c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_48d46d56-6306-4e78-a6ac-2e9c5b4457c3_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_5796c6fd-e2b3-4620-9bf3-56fff28fc1a3_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_f4a59b4c-efeb-4150-a3d1-86f81607bb7b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_5ed0af9c-9114-4491-9fdd-3a549d7fb595_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_97b397de-7592-414c-aa60-7b90dddcc792_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use asset, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_90422d05-ddf3-4256-ba51-d3b09efcbb7f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtCovenantPeriodOneMember_ba29a444-6a3d-4a4b-84a0-50cc4f574921_terseLabel_en-US" xlink:label="lab_fldm_DebtCovenantPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period One</link:label>
    <link:label id="lab_fldm_DebtCovenantPeriodOneMember_label_en-US" xlink:label="lab_fldm_DebtCovenantPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period One [Member]</link:label>
    <link:label id="lab_fldm_DebtCovenantPeriodOneMember_documentation_en-US" xlink:label="lab_fldm_DebtCovenantPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodOneMember" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtCovenantPeriodOneMember" xlink:to="lab_fldm_DebtCovenantPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_fec498d9-28ca-46c3-8d0d-5f0717b70595_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_9c8f1b5c-ef34-4635-8b47-a01d63efba8d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and related benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_fd7c4118-a41f-42bf-bbf4-232f43b4db44_totalLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and related benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_ccf5bc2d-8934-4c13-87d4-a255a50a2b2f_terseLabel_en-US" xlink:label="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option grants exercise price minimum percentage on fair market value</link:label>
    <link:label id="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_label_en-US" xlink:label="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value</link:label>
    <link:label id="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_documentation_en-US" xlink:label="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" xlink:href="fldm-20220331.xsd#fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" xlink:to="lab_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_a710ed44-40c1-47d1-8af5-facb877095bd_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c018ffb0-5dda-4c44-a0ab-160c56821772_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtInstrumentFaceAmountPerInstrument_9943c6da-6867-4462-b2b8-9e656c9ed3fa_terseLabel_en-US" xlink:label="lab_fldm_DebtInstrumentFaceAmountPerInstrument" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, face amount, per instrument</link:label>
    <link:label id="lab_fldm_DebtInstrumentFaceAmountPerInstrument_label_en-US" xlink:label="lab_fldm_DebtInstrumentFaceAmountPerInstrument" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount, Per Instrument</link:label>
    <link:label id="lab_fldm_DebtInstrumentFaceAmountPerInstrument_documentation_en-US" xlink:label="lab_fldm_DebtInstrumentFaceAmountPerInstrument" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount, Per Instrument</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentFaceAmountPerInstrument" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentFaceAmountPerInstrument"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtInstrumentFaceAmountPerInstrument" xlink:to="lab_fldm_DebtInstrumentFaceAmountPerInstrument" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ConsumablesMember_ae16f416-4430-41bb-a8ad-155ae5f1c38e_terseLabel_en-US" xlink:label="lab_fldm_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables</link:label>
    <link:label id="lab_fldm_ConsumablesMember_label_en-US" xlink:label="lab_fldm_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_fldm_ConsumablesMember_documentation_en-US" xlink:label="lab_fldm_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ConsumablesMember" xlink:href="fldm-20220331.xsd#fldm_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ConsumablesMember" xlink:to="lab_fldm_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_9cdef4a1-85b1-40af-9cca-cf57a7fdb0af_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_9fcdf645-5a58-423e-897c-4113a8adfba3_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c55aa85c-ff21-4774-9469-cc68e4cc191f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_2fdecac6-1ae5-4819-80a7-a9d353ec8df8_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3d6f4dce-bfe5-4e90-83e4-9d5fdf42da9b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_InstruNorASMember_da00f6e6-4d5c-45f9-93eb-8b1b5ddb3c9a_terseLabel_en-US" xlink:label="lab_fldm_InstruNorASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">InstruNor AS</link:label>
    <link:label id="lab_fldm_InstruNorASMember_label_en-US" xlink:label="lab_fldm_InstruNorASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">InstruNor AS [Member]</link:label>
    <link:label id="lab_fldm_InstruNorASMember_documentation_en-US" xlink:label="lab_fldm_InstruNorASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">InstruNor AS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember" xlink:href="fldm-20220331.xsd#fldm_InstruNorASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_InstruNorASMember" xlink:to="lab_fldm_InstruNorASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_92b0f6ff-9884-45e6-bb84-5a9707a4911d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_da473ed3-3534-424d-9431-e12256189463_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DeferredGrantRevenueNoncurrent_486f46c4-a4de-477a-b1bd-82cd244f985c_terseLabel_en-US" xlink:label="lab_fldm_DeferredGrantRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred grant income, non-current</link:label>
    <link:label id="lab_fldm_DeferredGrantRevenueNoncurrent_label_en-US" xlink:label="lab_fldm_DeferredGrantRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Grant Revenue, Noncurrent</link:label>
    <link:label id="lab_fldm_DeferredGrantRevenueNoncurrent_documentation_en-US" xlink:label="lab_fldm_DeferredGrantRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Grant Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenueNoncurrent" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DeferredGrantRevenueNoncurrent" xlink:to="lab_fldm_DeferredGrantRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_81743f46-f3ef-4e89-9bcf-eed2448cba3a_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_bd73b0d4-23f4-40b5-801d-f696125c6679_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_193f23b1-1c72-47f2-a48f-4e7c475139eb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_85778667-f7f1-4ded-bdd4-77575f93db73_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cb6c7842-0963-4d1b-8308-657242ad6a80_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9d7c2bfb-42e9-4fed-823a-9c96fc443347_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_5cc25899-e43b-4533-9997-e8512a87d256_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument redemption price</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_InstrumentsMember_5cdb1153-203c-4f01-966e-4bd7214f78ae_terseLabel_en-US" xlink:label="lab_fldm_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments</link:label>
    <link:label id="lab_fldm_InstrumentsMember_label_en-US" xlink:label="lab_fldm_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:label id="lab_fldm_InstrumentsMember_documentation_en-US" xlink:label="lab_fldm_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstrumentsMember" xlink:href="fldm-20220331.xsd#fldm_InstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_InstrumentsMember" xlink:to="lab_fldm_InstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_6bd1462a-dc86-4c09-9185-e9493d9d1cac_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_ec1db20f-fa00-4881-a8a9-8f8bcbe7c28c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_883d58ff-d476-49b4-b1b2-d3d073f34544_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Available-for-Sale Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_VikingMember_976261d3-623e-458a-a91c-3f3706329ac3_terseLabel_en-US" xlink:label="lab_fldm_VikingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking</link:label>
    <link:label id="lab_fldm_VikingMember_label_en-US" xlink:label="lab_fldm_VikingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking [Member]</link:label>
    <link:label id="lab_fldm_VikingMember_documentation_en-US" xlink:label="lab_fldm_VikingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_VikingMember" xlink:href="fldm-20220331.xsd#fldm_VikingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_VikingMember" xlink:to="lab_fldm_VikingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_f215893e-02bf-47b4-8221-577784796687_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued severance and retention bonuses</link:label>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Bonuses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedBonusesCurrent" xlink:to="lab_us-gaap_AccruedBonusesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_1545da14-1f85-44f2-93be-89a14ce010b9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_RestrictedCashAndCashEquivalentsMember_08b30a74-7ba7-4940-b119-3db2a3787e63_terseLabel_en-US" xlink:label="lab_fldm_RestrictedCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-restricted</link:label>
    <link:label id="lab_fldm_RestrictedCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_fldm_RestrictedCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash And Cash Equivalents [Member]</link:label>
    <link:label id="lab_fldm_RestrictedCashAndCashEquivalentsMember_documentation_en-US" xlink:label="lab_fldm_RestrictedCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash And Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RestrictedCashAndCashEquivalentsMember" xlink:href="fldm-20220331.xsd#fldm_RestrictedCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_RestrictedCashAndCashEquivalentsMember" xlink:to="lab_fldm_RestrictedCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_786c5c9e-c11e-459b-ae06-b57099533910_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_828fe000-cf66-4041-83a5-e093ee3006e8_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of developed technology</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_01da32d4-a3db-4b56-a0ae-0c8b8e8db70e_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_b1260183-ce92-456d-9ea9-b517f1fc36b1_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired finite-lived intangible assets, useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_54edb924-f563-4641-a06f-c2860dd74343_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate per annum</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_632332fc-2895-4918-bbea-00ea40e4137d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a6c601b3-576e-428f-ba35-749b23cfd90d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive securities excluded from computations of net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_500baf34-e5b1-44ea-b721-0f84a1531896_terseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Convertible Notes potential make-whole shares</link:label>
    <link:label id="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Nineteen Convertible Notes Potential Make Whole Shares [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Nineteen Convertible Notes Potential Make Whole Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" xlink:to="lab_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_44400a0d-7472-4497-b961-cd1244a242a4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_8c1b1a00-b691-4dc8-89f6-0a6baf0d2600_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod_e65cb1d8-99bc-42c7-aee3-f262c761b25f_terseLabel_en-US" xlink:label="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP, offering period</link:label>
    <link:label id="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod_label_en-US" xlink:label="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan, Offering Period</link:label>
    <link:label id="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod_documentation_en-US" xlink:label="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan, Offering Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EmployeeStockPurchasePlanOfferingPeriod" xlink:href="fldm-20220331.xsd#fldm_EmployeeStockPurchasePlanOfferingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_EmployeeStockPurchasePlanOfferingPeriod" xlink:to="lab_fldm_EmployeeStockPurchasePlanOfferingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_9edefea6-27a2-423a-b1d4-dd3e8ad47b95_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_762c0c89-d4de-4f4d-ba61-fec1ed05d963_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use buildings</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_2129d8a2-abe4-44d2-ae11-19e4e9fd2d57_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee amount</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_258a820b-f765-4c6c-abae-8acd38327852_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_f4186cf1-c726-4999-a081-16b6b85b6bcb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_5a53d3eb-3f27-4a5c-ad85-1c582d2538e9_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember_bc212626-09d9-42d2-b9e2-d0e88ede1b0e_terseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Convertible Notes</link:label>
    <link:label id="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Fourteen Convertible Notes [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Fourteen Convertible Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndFourteenConvertibleNotesMember" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndFourteenConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndFourteenConvertibleNotesMember" xlink:to="lab_fldm_TwoThousandAndFourteenConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_277ab038-6c1c-4b81-80be-6e70497a0876_terseLabel_en-US" xlink:label="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price</link:label>
    <link:label id="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_label_en-US" xlink:label="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price</link:label>
    <link:label id="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_documentation_en-US" xlink:label="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" xlink:to="lab_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_4c42bbeb-f927-4c54-8d94-6ef76c29bca3_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_8dc8fecb-bc04-4de5-971e-6ce729eda23d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating Leased Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfOperatingLeasedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_7cc25f3e-b092-4293-af59-89f37fc7288f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, converted instrument, shares issued</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f057ecc2-9164-4679-aee2-37ed275097e8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_f38e54f1-51be-4e84-ae72-b1b0f4176888_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3024a283-961e-4180-af55-1029164ad7e3_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_d8ba5df5-3879-4df3-8b5a-8b152efc93ee_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_eb2ae8c9-0b0a-45d9-b6dd-173b2456f765_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_272c29fb-7bd7-42f5-8e4c-924a3d1bc2cb_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_982152dc-fb7f-4f01-8736-c5a7798da534_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Contractual Life (in Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract_24f96e5e-0e07-47fd-a8f2-7d4289fee78e_terseLabel_en-US" xlink:label="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term</link:label>
    <link:label id="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract_label_en-US" xlink:label="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Term Of Contract</link:label>
    <link:label id="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract_documentation_en-US" xlink:label="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Term Of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LesseeOperatingLeaseRemainingTermOfContract" xlink:href="fldm-20220331.xsd#fldm_LesseeOperatingLeaseRemainingTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_LesseeOperatingLeaseRemainingTermOfContract" xlink:to="lab_fldm_LesseeOperatingLeaseRemainingTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2fb264e1-e4af-4803-beee-b663857c1f5a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9ba0c72c-1ae1-4786-94da-af503f7f2e21_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue_843a65f4-92fa-4fe9-95c1-36c653cab2ed_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance adjustment for 2018 awards (in usd per share )</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Adjustment in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Adjustment in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_b6f4e530-5b0e-4463-ac44-404ec96cf598_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_fe68dfba-8cdf-4fc7-b880-95b71d7e69f0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either March&#160;31, 2022 or December 31, 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_3abec9bb-03f8-4d05-afe2-da60c5be8b24_terseLabel_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_FinitelivedIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6b3ce7ad-aad1-4027-b4e7-9bfa1c63bd3f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bb9f57f4-0a3f-458a-b207-16777b19e3e3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_dbf9c924-8934-4b4a-80d4-8b139bb86fe4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_68afce6e-e8b0-4927-99dd-cf969acc77a2_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_939f94a7-e5f7-49ce-8d69-2c1aed27104f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_21148962-6abb-4efc-bef4-58eca5dd50d2_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_65d200ea-72ff-4368-a4e9-830d85ee487a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of Bridge Loans</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_93a06ff2-8efb-4b1d-9b69-2cdafd941289_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_f4cebe99-6814-4eef-8a03-2eff3c2e1944_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">China</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_afb4b196-f494-4f24-948e-5b22424bcd02_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e41b6174-7f18-418f-9f06-4fa27cafe00f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock_6e3b62b5-3bee-4291-b50a-387d0f7ab336_terseLabel_en-US" xlink:label="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Balance Sheet Information</link:label>
    <link:label id="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="fldm-20220331.xsd#fldm_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_fldm_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_b7b37723-688e-4ea9-a68d-0577bd8279b5_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_490428a5-08f5-45b7-9970-bdc94838643e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_12501370-2b20-4124-831d-875418aef985_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of performance period</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_6e0dc240-719e-4061-bb03-02732240a788_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee subscription rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_0c70684f-4730-4f5f-a7a6-04c3598335b7_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses_eb38288b-e7a4-4950-b101-23eb79d86334_negatedTerseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative amounts applied against depreciation expense for assets placed in service</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Accumulated Depreciation Expenses</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Accumulated Depreciation Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_7b84bfdf-30e9-48c3-bcf7-082eda532cd0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a4bdc755-f62a-4904-8079-16848d450b0d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_8681854d-a9e8-493e-bccc-06d4a455a101_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NIH Contract</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrimeRateMember_0107d207-7d5c-4a2c-a4c2-f12c34758da3_terseLabel_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate</link:label>
    <link:label id="lab_us-gaap_PrimeRateMember_label_en-US" xlink:label="lab_us-gaap_PrimeRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prime Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrimeRateMember" xlink:to="lab_us-gaap_PrimeRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_SeniorConvertibleNotesdue2034Member_e39fa5ca-2e63-4e7b-8929-af6ae4ed646b_terseLabel_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesdue2034Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes due 2034</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesdue2034Member_d9d631d0-d11e-4068-a6db-c8f45f244968_verboseLabel_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesdue2034Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Notes</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesdue2034Member_14c40c89-b86e-4607-8477-45facc0c7821_netLabel_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesdue2034Member" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2014 Notes</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesdue2034Member_label_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesdue2034Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes due 2034 [Member]</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesdue2034Member_documentation_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesdue2034Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes due 2034 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_SeniorConvertibleNotesdue2034Member" xlink:to="lab_fldm_SeniorConvertibleNotesdue2034Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_94214b98-dcc8-4ef3-af0b-d2c61ea09baa_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_edeadc1f-6855-4fa0-b2ca-f2d02187ae41_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_dc12b4b7-992c-495c-8b7c-682581b78b32_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of convertible preferred stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3cc7c9f2-b858-438a-83ca-82804c7371ed_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3f3be56a-1bd7-4cdb-8e33-3c427da0501a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bc9ee403-a0fb-4d43-9f4b-3b73a5ff0c3e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_0cf40943-6e1c-4b76-a697-f6bdc48e819a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DVSSciencesInc.Member_3127658e-fb8d-4049-be76-fae1eb183b3b_terseLabel_en-US" xlink:label="lab_fldm_DVSSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DVS Sciences, Inc.</link:label>
    <link:label id="lab_fldm_DVSSciencesInc.Member_label_en-US" xlink:label="lab_fldm_DVSSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DVS Sciences, Inc. [Member]</link:label>
    <link:label id="lab_fldm_DVSSciencesInc.Member_documentation_en-US" xlink:label="lab_fldm_DVSSciencesInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DVS Sciences, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DVSSciencesInc.Member" xlink:href="fldm-20220331.xsd#fldm_DVSSciencesInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DVSSciencesInc.Member" xlink:to="lab_fldm_DVSSciencesInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_e8f28977-9bbb-4eaa-b11c-91f6abfe2171_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_3f385acf-82ce-4122-86f5-a695fa9c3243_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2a62855d-5815-405c-be9e-5c2fcedb9ff7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Nonvested and Outstanding Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_EquityIncentivePlanMember_71252f23-71cb-4c70-ad0f-3c3a2cb12921_terseLabel_en-US" xlink:label="lab_fldm_EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan</link:label>
    <link:label id="lab_fldm_EquityIncentivePlanMember_label_en-US" xlink:label="lab_fldm_EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_fldm_EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_fldm_EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EquityIncentivePlanMember" xlink:href="fldm-20220331.xsd#fldm_EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_EquityIncentivePlanMember" xlink:to="lab_fldm_EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_d6de093f-e6f9-4f85-87d2-ac3be7011ac4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_58a6269a-33c5-4ba9-a469-b91789dd5abb_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value per Unit</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e035bab4-cd34-4174-a156-2b63ac9ad31c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities to be issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_CashAndMoneyMarketFundsMember_240fd0c8-e0e6-404e-acf1-31074e1e23b0_terseLabel_en-US" xlink:label="lab_fldm_CashAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and money market funds</link:label>
    <link:label id="lab_fldm_CashAndMoneyMarketFundsMember_label_en-US" xlink:label="lab_fldm_CashAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Money Market Funds [Member]</link:label>
    <link:label id="lab_fldm_CashAndMoneyMarketFundsMember_documentation_en-US" xlink:label="lab_fldm_CashAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Money Market Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CashAndMoneyMarketFundsMember" xlink:href="fldm-20220331.xsd#fldm_CashAndMoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_CashAndMoneyMarketFundsMember" xlink:to="lab_fldm_CashAndMoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebt_e66a312c-0a94-4098-8742-207db7fe34aa_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan, net</link:label>
    <link:label id="lab_us-gaap_SecuredDebt_label_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebt" xlink:to="lab_us-gaap_SecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_ce346dae-ec18-48eb-b14e-36064e1d8480_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash-restricted</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_e2678533-89ff-4a28-ad2c-3eede51b691f_terseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash receipts from milestones achieved</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Amount</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DeferredGrantRevenueCurrent_c9ef4a97-7deb-4fbe-bb98-48fd1bcc2b2b_terseLabel_en-US" xlink:label="lab_fldm_DeferredGrantRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred grant income, current</link:label>
    <link:label id="lab_fldm_DeferredGrantRevenueCurrent_label_en-US" xlink:label="lab_fldm_DeferredGrantRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Grant Revenue, Current</link:label>
    <link:label id="lab_fldm_DeferredGrantRevenueCurrent_documentation_en-US" xlink:label="lab_fldm_DeferredGrantRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Grant Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenueCurrent" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DeferredGrantRevenueCurrent" xlink:to="lab_fldm_DeferredGrantRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures_7a71d0bb-b9df-4444-afc8-fb25ab034b49_terseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future capital expenditures</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Estimated Future Capital Expenditures</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Estimated Future Capital Expenditures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_62c2c277-71f4-48df-be92-001a39869930_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_2a1c5236-b24f-4b01-ad98-6cd207e56afe_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesUnrealizedGainLoss_06dc3f82-ec5d-430a-897c-693ed9c34b87_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on bridge loans</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesUnrealizedGainLoss_5ade30fc-b507-40dd-a255-a6405b209d11_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on Bridge Loans</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_211a9532-4a1d-4046-bb7b-eb3ec52360c1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_a1c1a379-52fc-47c9-aaef-531014da7ec8_terseLabel_en-US" xlink:label="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum employee purchase amount</link:label>
    <link:label id="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_label_en-US" xlink:label="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount</link:label>
    <link:label id="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_documentation_en-US" xlink:label="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" xlink:href="fldm-20220331.xsd#fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" xlink:to="lab_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_afad0af1-a27a-476c-8839-f00db26b0144_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_9cbce8f6-9da9-48b8-ab84-a3695eac2fe2_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_4da53d96-b8ea-4f4f-a48f-71c22436f852_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying value of all Notes</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8fd09aa9-4529-49a3-85d2-e6055362dc13_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_17ddfa56-c28e-4fc4-8f47-72621f1f980c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts_17bfa212-f69a-4b1f-b478-0c510446dafe_terseLabel_en-US" xlink:label="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional advance payments received</link:label>
    <link:label id="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts_label_en-US" xlink:label="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase From Cash Receipts</link:label>
    <link:label id="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts_documentation_en-US" xlink:label="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Increase From Cash Receipts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" xlink:href="fldm-20220331.xsd#fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" xlink:to="lab_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_4d094ebc-65bc-42ce-8b1a-112568c489ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued_8ee2a850-001c-494d-a619-28d166ac70db_terseLabel_en-US" xlink:label="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divisor used to determine number of shares to issue</link:label>
    <link:label id="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued_label_en-US" xlink:label="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Calculation To Determine Shares Issued</link:label>
    <link:label id="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued_documentation_en-US" xlink:label="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Calculation To Determine Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued" xlink:to="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_768a3848-b182-4335-8833-0820f9df4816_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_A2022InducementEquityIncentivePlanMember_b00db4a9-89c0-46e2-be9e-c81d78972ff5_terseLabel_en-US" xlink:label="lab_fldm_A2022InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Inducement Equity Incentive Plan</link:label>
    <link:label id="lab_fldm_A2022InducementEquityIncentivePlanMember_label_en-US" xlink:label="lab_fldm_A2022InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Inducement Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_fldm_A2022InducementEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_fldm_A2022InducementEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Inducement Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_A2022InducementEquityIncentivePlanMember" xlink:href="fldm-20220331.xsd#fldm_A2022InducementEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_A2022InducementEquityIncentivePlanMember" xlink:to="lab_fldm_A2022InducementEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_17759fba-1bd2-4e56-a6ae-251cab91fa65_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_479dd308-596f-4014-9ae0-7858f4870cd5_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_dce6de9a-0ecd-47c1-9af9-6d1eec5913f2_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_f4ec57eb-88e5-4b79-b1fb-2d500d3a798d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_8d890625-4265-4f79-bdd4-3b7ff24cecff_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_LossOnForwardSaleOfStock_a2307a93-a2e8-4480-8474-a5c3c2557b17_negatedTerseLabel_en-US" xlink:label="lab_fldm_LossOnForwardSaleOfStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on forward sale of Series B Preferred Stock</link:label>
    <link:label id="lab_fldm_LossOnForwardSaleOfStock_3e383369-f39b-480b-b28c-24850f751cc9_terseLabel_en-US" xlink:label="lab_fldm_LossOnForwardSaleOfStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on forward sale of Series B Preferred Stock</link:label>
    <link:label id="lab_fldm_LossOnForwardSaleOfStock_label_en-US" xlink:label="lab_fldm_LossOnForwardSaleOfStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss On Forward Sale Of Stock</link:label>
    <link:label id="lab_fldm_LossOnForwardSaleOfStock_documentation_en-US" xlink:label="lab_fldm_LossOnForwardSaleOfStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss On Forward Sale Of Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LossOnForwardSaleOfStock" xlink:href="fldm-20220331.xsd#fldm_LossOnForwardSaleOfStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_LossOnForwardSaleOfStock" xlink:to="lab_fldm_LossOnForwardSaleOfStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_859a57bf-1bf1-49bc-9fa8-2968e4feb04b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_20c56c97-2048-4b1e-ae9d-3efa5655b76f_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_843447f3-1536-4c32-bafa-969c18a096d8_verboseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service revenue</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_9d4dd8b7-59c4-4569-82b9-2cae1fbd571f_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_StockRepurchaseLiability_1a4ba83b-c4e6-4459-9f14-9544fe8a8179_terseLabel_en-US" xlink:label="lab_fldm_StockRepurchaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligation for Series B Preferred Stock</link:label>
    <link:label id="lab_fldm_StockRepurchaseLiability_label_en-US" xlink:label="lab_fldm_StockRepurchaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Liability</link:label>
    <link:label id="lab_fldm_StockRepurchaseLiability_documentation_en-US" xlink:label="lab_fldm_StockRepurchaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_StockRepurchaseLiability" xlink:href="fldm-20220331.xsd#fldm_StockRepurchaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_StockRepurchaseLiability" xlink:to="lab_fldm_StockRepurchaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_14fe17df-d688-4240-8abd-0d4ac874c001_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_f0c4dbd5-7044-40f1-9550-44a32f5eed46_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_a73f6aef-5daf-43f9-95dd-09d6b4dfd44b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_a1e7c37a-7ccc-4d3f-9ba1-a1b78b9b22a6_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2bbbed0c-15cd-4f73-bd94-31987541f083_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_05cff23a-774d-4957-b024-50b29c337204_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_164fa5da-1080-44b5-b67a-1e16a40b5aef_negatedTerseLabel_en-US" xlink:label="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_label_en-US" xlink:label="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Accumulated Amortization</link:label>
    <link:label id="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_documentation_en-US" xlink:label="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="fldm-20220331.xsd#fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="lab_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_8294fd29-5884-4098-ae61-fe25e256779b_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_3e98ab1a-c0a5-43bf-88da-de9cbcc6d0c3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cfda745d-2ca7-42a3-9e1e-98ce1f98e52d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign exchange rate fluctuations on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_a2a2daf3-3860-4f77-a612-774dba33bb63_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate of notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_2a85347d-c191-4caf-8d49-197707e52fa1_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_c443f2d1-3981-4449-99eb-e4589fdc7a32_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance cost</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_910e3ea9-52fb-47bf-8abf-6c4000c29344_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_3ca9355e-120b-49f9-bc4b-3169a936fe80_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_f62bc476-8711-486a-bbda-b4a31fb7c23d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_0157e0e5-6db6-41d2-8bda-937d01d55694_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested awards (in shares)</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_UndisclosedCustomerMember_63f31938-59d2-4096-81d3-14d7012bc698_terseLabel_en-US" xlink:label="lab_fldm_UndisclosedCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undisclosed Customer</link:label>
    <link:label id="lab_fldm_UndisclosedCustomerMember_label_en-US" xlink:label="lab_fldm_UndisclosedCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undisclosed Customer [Member]</link:label>
    <link:label id="lab_fldm_UndisclosedCustomerMember_documentation_en-US" xlink:label="lab_fldm_UndisclosedCustomerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undisclosed Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_UndisclosedCustomerMember" xlink:href="fldm-20220331.xsd#fldm_UndisclosedCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_UndisclosedCustomerMember" xlink:to="lab_fldm_UndisclosedCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_673e9600-803d-47e7-984e-2c2d5c0fb848_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross_3eefcd6a-782a-433e-bac5-1f28d5b188f2_terseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets placed in service, gross</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others , Assets Placed In Service , Gross</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others , Assets Placed In Service , Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_c2a5ebf9-be3f-4206-b07e-2c9ffcac056a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_4c8fd0be-63cc-4f31-b0a6-3a7adb923493_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_7906744b-fbc8-4153-b7f1-13746d2f6702_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_4be7446e-05e8-41bc-a134-3f9a4928f5ae_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_ad4d6a95-902e-4ec9-a871-12010b92a1e9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_cff6a328-d946-47dc-872c-a10848e86ee6_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_2c181925-65ad-4bb5-ba00-fbf7fb0c7d0f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor_14c69292-3b45-4987-8efe-b80b8953962f_terseLabel_en-US" xlink:label="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divisor used to determine number of shares to issue</link:label>
    <link:label id="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor_label_en-US" xlink:label="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Calculation To Determine Shares Issued, Divisor</link:label>
    <link:label id="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor_documentation_en-US" xlink:label="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Calculation To Determine Shares Issued, Divisor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor" xlink:to="lab_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_de3d310c-8541-4284-840a-38e2b6752d0c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_4dc81131-f9d8-41ca-9170-26df21ac7c06_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_b5d24d03-eefc-48d4-87d0-f2f83552d402_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_6a3e2ac6-4b12-46bb-8143-3072bfcabe5e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock: $0.001 par value, 200,000 shares authorized at March&#160;31, 2022 and December&#160;31, 2021; 77,199 and 76,919 shares issued and outstanding at March&#160;31, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_eb6d740b-8c28-4e28-a2d5-0d1820275dce_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_44ff0738-d538-4ce3-b4a6-ce0866dd8ef3_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_4ff2d83c-b686-40df-bad9-2187f156ee00_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_8b928c21-c33a-418a-aeb8-2f96c15a1c86_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Consolidation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne_92554eea-3554-4f75-a89f-a642d699c7c3_verboseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_9a48167f-f059-43b3-ab1d-cbe91f98cbe3_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_5172d2d5-9547-4d8c-a2ac-7d24f7eabf46_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_8ac85cff-b130-4ba3-a823-243322056174_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_e0f0ddf2-2f9c-44cb-b474-d1851b5634b9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_ddb89d3d-6ae7-4168-98e9-85edd2cc4de0_terseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum contract value</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Maximum Contract Value</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Maximum Contract Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_38aa1312-7925-46f7-a981-52c396c25bd8_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b3207c3e-cd9b-416d-a73a-2287a0efbfc5_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_70fa1e18-3678-405e-af45-8d2a24a1e3e7_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowances</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareholdersEquityLineItems_08ba437f-cc28-4b3a-a754-b0778e88624b_terseLabel_en-US" xlink:label="lab_fldm_ShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Line Items]</link:label>
    <link:label id="lab_fldm_ShareholdersEquityLineItems_label_en-US" xlink:label="lab_fldm_ShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Line Items]</link:label>
    <link:label id="lab_fldm_ShareholdersEquityLineItems_documentation_en-US" xlink:label="lab_fldm_ShareholdersEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Shareholders' Equity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareholdersEquityLineItems" xlink:href="fldm-20220331.xsd#fldm_ShareholdersEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareholdersEquityLineItems" xlink:to="lab_fldm_ShareholdersEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses_7c80da25-8efa-47ac-af94-61924752584d_negatedTerseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative amounts applied against operating costs (excluding depreciation)</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Expenses</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod_97ba8e4d-161d-46f8-911f-de5b1afe610d_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance adjustment for 2018 awards (in shares)</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Adjustment in Period</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Adjustment in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareholdersEquityTable_ae7867f3-e0a7-4a6b-a2be-ec89e2a3d694_terseLabel_en-US" xlink:label="lab_fldm_ShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Table]</link:label>
    <link:label id="lab_fldm_ShareholdersEquityTable_label_en-US" xlink:label="lab_fldm_ShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Table]</link:label>
    <link:label id="lab_fldm_ShareholdersEquityTable_documentation_en-US" xlink:label="lab_fldm_ShareholdersEquityTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareholdersEquityTable" xlink:href="fldm-20220331.xsd#fldm_ShareholdersEquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareholdersEquityTable" xlink:to="lab_fldm_ShareholdersEquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_abfc32f3-d01e-45e1-a1b2-1674a3f29795_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt issuance</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_72302f26-3c0d-4e8c-a00f-718987979923_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested awards</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_e832583e-5be1-4fb0-afbc-dfffd00048c8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_8ba1b10a-d455-4b46-b652-1d68b82dd321_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1_63da6614-980b-4dd8-9dd8-a13ad5821df5_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested awards</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term 1</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Weighted Average Remaining Contractual Term 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_3a7ea483-cda1-4fc5-be61-04fe12b111fb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments_6b40cbe4-769e-48c5-9170-f922c7dd57be_terseLabel_en-US" xlink:label="lab_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of installments</link:label>
    <link:label id="lab_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments_label_en-US" xlink:label="lab_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Number Of Installments</link:label>
    <link:label id="lab_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments_documentation_en-US" xlink:label="lab_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Number Of Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments" xlink:to="lab_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_46fcc4d5-9f1a-41b3-a413-658295a3b91d_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, consideration received on transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_3c5a1c1a-90aa-4a9d-bc34-3ebc58c4b082_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DeferredGrantIncomeNoncurrent_285516af-b9bb-4631-8079-434bbbf21cb5_terseLabel_en-US" xlink:label="lab_fldm_DeferredGrantIncomeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred grant income, non-current</link:label>
    <link:label id="lab_fldm_DeferredGrantIncomeNoncurrent_label_en-US" xlink:label="lab_fldm_DeferredGrantIncomeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Grant Income, Noncurrent</link:label>
    <link:label id="lab_fldm_DeferredGrantIncomeNoncurrent_documentation_en-US" xlink:label="lab_fldm_DeferredGrantIncomeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Grant Income, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantIncomeNoncurrent" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantIncomeNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DeferredGrantIncomeNoncurrent" xlink:to="lab_fldm_DeferredGrantIncomeNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8ca3d647-1ef3-44ea-85d6-7bfaa2d9f647_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_323e74a6-6660-43ae-9e8d-654c041b85dd_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_53cebf23-b9da-4f5c-939e-9600fd14d6a2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4ec620ad-a99f-4e80-93eb-9416eaeb59fe_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_9a8cb6bb-49e9-4d9a-bae9-480ff9e4b2ec_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_8f7af5ff-c2be-43a3-b197-b28d0232aa93_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedVacationCurrent_272b7291-6b71-4de6-b47b-3fbb4547e3f1_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedVacationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued vacation</link:label>
    <link:label id="lab_us-gaap_AccruedVacationCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedVacationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Vacation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedVacationCurrent" xlink:to="lab_us-gaap_AccruedVacationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_6ec93ffd-dd55-4098-a811-df1b495cb025_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities To Be Issued Upon Exercise Of Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_94405192-6545-48b3-b4fe-f74ce0343bee_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_e51fe71f-adf9-4379-bea1-965f18f9b44f_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_82a7448b-fa15-478a-ae2d-5b50229c58ce_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_3532cb12-faf3-46b0-b3d9-75372fe9b75e_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_9c5928b6-40f4-4b66-ac07-12c689348453_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_c373f352-1c56-41d4-b53c-75ee6f30c4e6_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome_d39a197b-fae9-4c68-b92e-196f52a59203_negatedTerseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative amounts recognized as non-operating income</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Other Income</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtInstrumentIncrementalPaymentPercent_a4ae6780-cce2-4c53-8b4d-c40cdf9afff9_terseLabel_en-US" xlink:label="lab_fldm_DebtInstrumentIncrementalPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan advances percentage</link:label>
    <link:label id="lab_fldm_DebtInstrumentIncrementalPaymentPercent_label_en-US" xlink:label="lab_fldm_DebtInstrumentIncrementalPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Incremental Payment, Percent</link:label>
    <link:label id="lab_fldm_DebtInstrumentIncrementalPaymentPercent_documentation_en-US" xlink:label="lab_fldm_DebtInstrumentIncrementalPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Incremental Payment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentIncrementalPaymentPercent" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentIncrementalPaymentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtInstrumentIncrementalPaymentPercent" xlink:to="lab_fldm_DebtInstrumentIncrementalPaymentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_fc5194cb-abc0-44ad-bb89-6d624e57ca11_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information About Geographic Areas</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_7be3cf99-a48c-4c25-a629-e862149f0e17_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1b6fe0be-f70c-4af0-b595-476ec77064a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_b6c58498-0e64-4a56-950a-fcad8409af60_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_88bd6a87-824e-4527-a34a-1b0e227b293c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice_fbd34b25-060e-4fe2-9784-1a5598e76753_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested awards (in usd per share)</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_bf9e28ef-f86f-4488-af4f-c185b0d59a1e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_c569f059-23e3-4aa3-8336-0b3b1a4fde3d_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development Agreement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c9384e80-a395-4d8c-aab5-640f27975a89_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_23ae726c-50e5-4361-ab22-57df388b4e58_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_336889e7-6fcf-4e28-a657-39fd81224c8b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_ded2cb2b-9bba-4c31-9556-63506a560003_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_26ea660c-9585-4ac1-8b1d-fa90f85e1533_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_9e545190-85ce-4cd9-a8a0-68ae6df0af3a_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ba682bd7-af7c-47cb-a3cf-6739f2d8648f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_96c4e867-7492-4e0f-aafa-ce8b400395b6_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_d94c6a79-9ace-4bb0-b4c3-ba886e35948a_netLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_SeriesB2ConvertiblePreferredStockMember_7e700666-bceb-4bd6-9613-3913c0470bee_terseLabel_en-US" xlink:label="lab_fldm_SeriesB2ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-2 Convertible Preferred Stock</link:label>
    <link:label id="lab_fldm_SeriesB2ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_fldm_SeriesB2ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-2 Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_fldm_SeriesB2ConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_fldm_SeriesB2ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-2 Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeriesB2ConvertiblePreferredStockMember" xlink:href="fldm-20220331.xsd#fldm_SeriesB2ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_SeriesB2ConvertiblePreferredStockMember" xlink:to="lab_fldm_SeriesB2ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_7d75b550-b78e-450f-ac1e-73c502920dd5_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_cefbb0fb-f361-40e1-9db7-f49b907408bc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_46c4c5f2-83bd-4bfc-8e7d-1ace1b546ca7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and unpaid interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_8360267f-11fa-4cf5-85c0-c883e10e1cea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity of Warranty Accrual</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_PatentsandLicenseAgreementsMember_f90df87d-bc85-41f6-8ef6-4f3fda42d02a_terseLabel_en-US" xlink:label="lab_fldm_PatentsandLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and licenses</link:label>
    <link:label id="lab_fldm_PatentsandLicenseAgreementsMember_24befe62-392e-4153-abc7-7961b0ac5492_verboseLabel_en-US" xlink:label="lab_fldm_PatentsandLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and Licenses Amortization Expense</link:label>
    <link:label id="lab_fldm_PatentsandLicenseAgreementsMember_label_en-US" xlink:label="lab_fldm_PatentsandLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and License Agreements [Member]</link:label>
    <link:label id="lab_fldm_PatentsandLicenseAgreementsMember_documentation_en-US" xlink:label="lab_fldm_PatentsandLicenseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and License Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PatentsandLicenseAgreementsMember" xlink:href="fldm-20220331.xsd#fldm_PatentsandLicenseAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_PatentsandLicenseAgreementsMember" xlink:to="lab_fldm_PatentsandLicenseAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_6163d51d-6db9-403a-911e-5bce17df8f20_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_dea27efb-098b-4f56-9f9c-d976d03b860b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtInstrumentCovenantConvertibleDebtThreshold_acb644da-9624-40d3-ad51-35a8ae7963b5_terseLabel_en-US" xlink:label="lab_fldm_DebtInstrumentCovenantConvertibleDebtThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt</link:label>
    <link:label id="lab_fldm_DebtInstrumentCovenantConvertibleDebtThreshold_label_en-US" xlink:label="lab_fldm_DebtInstrumentCovenantConvertibleDebtThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Convertible Debt Threshold</link:label>
    <link:label id="lab_fldm_DebtInstrumentCovenantConvertibleDebtThreshold_documentation_en-US" xlink:label="lab_fldm_DebtInstrumentCovenantConvertibleDebtThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Convertible Debt Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentCovenantConvertibleDebtThreshold" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentCovenantConvertibleDebtThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtInstrumentCovenantConvertibleDebtThreshold" xlink:to="lab_fldm_DebtInstrumentCovenantConvertibleDebtThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_872f0e3f-a34b-4204-afc2-0dddb63d1d25_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued incentive compensation</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_47649cf0-b747-4e37-9c1e-c59e807642f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty costs incurred</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f0cb2a1d-dd3e-4b33-8320-c2e7fed3f758_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_abd1cf92-aa87-417b-a6fa-1e3a388f78be_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2faf730-3b5c-46d9-a449-78c924c18da0_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockConvertibleConversionRatio_9c07eb9e-407e-475e-a06c-d78a42348d5f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_us-gaap_PreferredStockConvertibleConversionRatio_label_en-US" xlink:label="lab_us-gaap_PreferredStockConvertibleConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockConvertibleConversionRatio" xlink:to="lab_us-gaap_PreferredStockConvertibleConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_303e34c8-563b-4088-a8ec-5200ec4edeed_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ComputerEquipmentAndSoftwareMember_a60fd563-9df5-4ef7-ba8f-5dd79ec524f3_terseLabel_en-US" xlink:label="lab_fldm_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment and software</link:label>
    <link:label id="lab_fldm_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_fldm_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment And Software [Member]</link:label>
    <link:label id="lab_fldm_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_fldm_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment And Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ComputerEquipmentAndSoftwareMember" xlink:href="fldm-20220331.xsd#fldm_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ComputerEquipmentAndSoftwareMember" xlink:to="lab_fldm_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_abdfffe3-2820-4da7-bbb2-a6329d0f7608_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare_31502200-3b91-4a6c-84a7-d35996fc43a9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidation preference (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Liquidation Preference, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:to="lab_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_1fe86ecd-2c75-402c-8b2c-6ef37010ae8e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_333efb75-af8f-4361-802a-4c9efe56a66f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_11c2be36-4ed8-4062-a25c-cd1d19bbfc02_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ff229dcb-12b1-4ecc-b803-9095d1749b3f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1a05ade2-c5cd-4f4e-b748-fde2f196824a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_afb34565-acac-4add-9c5f-5d0b003c1597_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_bd2dc919-bdd0-4c47-8016-40bda6d3859c_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_00e6d090-9d8f-44d1-b54c-03ffb4de9883_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b2b2e2dc-aa28-484d-963b-9f8b3bfe7de1_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_56b9430a-1c67-40fc-b443-5435e6946cba_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_cabb8260-e362-4cc2-b89e-f7bc2ae41df9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_50f5763a-ab6a-49a8-85be-6c5635b9b4c2_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_adf8e597-4d5f-4c72-a5d1-219644057b9d_verboseLabel_en-US" xlink:label="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_f354987b-b9dd-4c5e-89b1-cfdea5bd72e1_terseLabel_en-US" xlink:label="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand Seventeen Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:href="fldm-20220331.xsd#fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:to="lab_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_4e0b9d0a-26c2-4131-a5ab-b84eaae0e163_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_CasdinMember_6f742b1a-178c-4381-b9ad-98f22b61b37d_terseLabel_en-US" xlink:label="lab_fldm_CasdinMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Casdin</link:label>
    <link:label id="lab_fldm_CasdinMember_label_en-US" xlink:label="lab_fldm_CasdinMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Casdin [Member]</link:label>
    <link:label id="lab_fldm_CasdinMember_documentation_en-US" xlink:label="lab_fldm_CasdinMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Casdin</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CasdinMember" xlink:href="fldm-20220331.xsd#fldm_CasdinMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_CasdinMember" xlink:to="lab_fldm_CasdinMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5693fe5f-a3a6-403a-b987-217b50265c20_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3df2851e-f16d-4c51-bbb6-1f905f45b9c6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_49c79ca7-1493-45f5-8e0b-0c072463a8bb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, converted instrument, amount</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_e755badb-db0a-48b5-b0d9-57248070ac96_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_8b7919eb-53bf-451b-b0f4-d8f1cb2052cd_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_377ce187-f572-4cf7-adf9-5d6e10b51e7b_verboseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Inducement Award Plan</link:label>
    <link:label id="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Seventeen Inducement Award Plan [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Seventeen Inducement Award Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndSeventeenInducementAwardPlanMember" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndSeventeenInducementAwardPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndSeventeenInducementAwardPlanMember" xlink:to="lab_fldm_TwoThousandAndSeventeenInducementAwardPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_AccruedBonusesNoncurrent_01f98ed7-875c-4d1c-97ff-2fade8774750_terseLabel_en-US" xlink:label="lab_fldm_AccruedBonusesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued bonuses, noncurrent</link:label>
    <link:label id="lab_fldm_AccruedBonusesNoncurrent_label_en-US" xlink:label="lab_fldm_AccruedBonusesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Bonuses, Noncurrent</link:label>
    <link:label id="lab_fldm_AccruedBonusesNoncurrent_documentation_en-US" xlink:label="lab_fldm_AccruedBonusesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Bonuses, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_AccruedBonusesNoncurrent" xlink:href="fldm-20220331.xsd#fldm_AccruedBonusesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_AccruedBonusesNoncurrent" xlink:to="lab_fldm_AccruedBonusesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_0baf3f1a-2598-478e-a921-95313de9fa74_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in usd per share)</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_bf058a4b-c11f-4dd1-9d5d-bfc6c1bfdc8d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c1a2a7f1-f585-4415-919f-6c882d1b72e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_39dfd87a-683c-4cb9-8c55-bc2b8f9bb076_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_e5e0dd70-49b0-42d2-9498-5dbbc46f2adb_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_66de32b8-aaa2-4005-8202-eabd7f1d2d5d_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_2be10ec7-f9fe-4699-aa9a-431ff3732071_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Par Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_35aaf71f-dfce-4105-b0a0-16e3c5c1b30f_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_56a8ae93-4cd6-4a09-a488-dcda761b3b46_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtCovenantPeriodDomain_5f20fb3b-7a51-4064-a3c2-b354866390ef_terseLabel_en-US" xlink:label="lab_fldm_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_fldm_DebtCovenantPeriodDomain_label_en-US" xlink:label="lab_fldm_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:label id="lab_fldm_DebtCovenantPeriodDomain_documentation_en-US" xlink:label="lab_fldm_DebtCovenantPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodDomain" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtCovenantPeriodDomain" xlink:to="lab_fldm_DebtCovenantPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease_9f8cb729-9ed4-4e3f-8ead-37336388a0f2_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual (release) for current period warranties</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease" xlink:to="lab_us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtCovenantPeriodThreeMember_d81a0d7e-4a07-4101-a1a5-534916290004_terseLabel_en-US" xlink:label="lab_fldm_DebtCovenantPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Period Three</link:label>
    <link:label id="lab_fldm_DebtCovenantPeriodThreeMember_label_en-US" xlink:label="lab_fldm_DebtCovenantPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Period Three [Member]</link:label>
    <link:label id="lab_fldm_DebtCovenantPeriodThreeMember_documentation_en-US" xlink:label="lab_fldm_DebtCovenantPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Period Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodThreeMember" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtCovenantPeriodThreeMember" xlink:to="lab_fldm_DebtCovenantPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_6fe6d7b3-2e6a-4d28-b599-d54725e8d1d1_verboseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_df390c41-947c-4de6-a70c-8f06768dace9_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_dca690e6-44a0-4c98-93b9-d9d6454206d9_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options, restricted stock units and performance awards</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_2543420b-785c-46bd-90f4-9b4a3c63ac11_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_78c0ab72-1546-418b-8ab7-fcd209c5b8c9_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_d33cca46-ae88-45f6-bd71-779d05b2a9e2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c4ca41d4-8d66-44b8-a790-c7e1c317f2c2_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_73bfe084-fb70-42e7-9a50-ed7bbe0d1dd8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tranche Two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_7c46d16f-0cbc-4d0f-ac45-cb2e7907d1a9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_b87b4c8d-e7d1-4dcb-899f-ac8a81e0c89c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred_745014cc-1196-4ce4-8a07-ab9c13a3bf78_terseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures expected to be incurred</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement Contract To Perform For Others Capital Expenditures, To Be Incurred</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement Contract To Perform For Others Capital Expenditures, To Be Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e79ec582-740b-43cb-a933-1f0c4f294c47_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_50338919-53e0-433d-a620-ea63433cdfb2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_6a6b0bb8-faee-471a-913a-1a0fa485bf24_terseLabel_en-US" xlink:label="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of eligible inventory</link:label>
    <link:label id="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_label_en-US" xlink:label="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory</link:label>
    <link:label id="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_documentation_en-US" xlink:label="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" xlink:href="fldm-20220331.xsd#fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" xlink:to="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_bc2f8e82-41b7-4630-b1e0-06f8f1e21331_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of advances under credit agreement</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1d2c88b8-e9d7-46df-b6fb-73edc6722632_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cbe016c2-9037-4951-b6d7-66c86d781eb3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d336c75a-5ad2-4651-a60e-c450794f444d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_SeriesB1ConvertiblePreferredStockMember_223b9939-2033-4f91-82f7-37528c6be80c_terseLabel_en-US" xlink:label="lab_fldm_SeriesB1ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-1 Convertible Preferred Stock</link:label>
    <link:label id="lab_fldm_SeriesB1ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_fldm_SeriesB1ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-1 Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_fldm_SeriesB1ConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_fldm_SeriesB1ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-1 Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeriesB1ConvertiblePreferredStockMember" xlink:href="fldm-20220331.xsd#fldm_SeriesB1ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_SeriesB1ConvertiblePreferredStockMember" xlink:to="lab_fldm_SeriesB1ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_514ad154-1dce-4538-81d7-8bd208de6492_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable (net of allowances of $356 at each of March 31, 2022 and December&#160;31, 2021)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_057ecddb-739d-46d7-b0f2-3bc19a4fa4b5_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_d88f96c8-6190-424a-86a0-2796877db8e6_verboseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_fe139316-2be3-411a-b32f-abd74080f0a0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_b909ed1e-382a-471d-a206-1531db6e2b46_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_211cca09-0a9c-43e4-ab17-ab4bd2d0792d_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_fde06a11-5d47-41cc-b7f2-2f67d3f8e64c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_439e9a67-86cb-4f02-a5b2-05cf762ee815_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_f9857863-2ffa-44be-9990-02f6115e81ad_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_8b91a668-e5ce-4a4d-a491-e62f961aff45_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_c9a64eb9-57da-4748-b7c5-0e3a317481eb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_70353bc0-5326-47ad-958c-f2a4c53b1bd1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_01722ed6-ba4e-4aea-a516-e0051e910eaa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_234eca87-f455-4867-9408-7f2faa9f1179_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_3d963676-0b0c-472b-9fe6-b10acf927dc7_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_0085078a-d035-4c04-9737-7789137bb2c0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_be5b0b4d-2ea5-4a9a-938b-fd3607c16116_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_6bf7aaac-1e43-4eae-bffc-4d21a7cbb016_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_26deecd8-e9aa-4c8b-babc-261abfd8e979_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_8cde87f0-9925-48be-b6a9-ed7d168620c2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtAndEquityIssuanceTextBlock_e4173289-8663-4c7d-94a1-9d5efd300c21_terseLabel_en-US" xlink:label="lab_fldm_DebtAndEquityIssuanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement Issuance</link:label>
    <link:label id="lab_fldm_DebtAndEquityIssuanceTextBlock_label_en-US" xlink:label="lab_fldm_DebtAndEquityIssuanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Issuance [Text Block]</link:label>
    <link:label id="lab_fldm_DebtAndEquityIssuanceTextBlock_documentation_en-US" xlink:label="lab_fldm_DebtAndEquityIssuanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtAndEquityIssuanceTextBlock" xlink:href="fldm-20220331.xsd#fldm_DebtAndEquityIssuanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtAndEquityIssuanceTextBlock" xlink:to="lab_fldm_DebtAndEquityIssuanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_c2d0f878-b646-4b44-ac4e-ddcae65da0e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_081e40d0-0693-44dd-bb50-2bd07eedfada_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_41a6f8c5-e673-4540-ac94-fab1ce0ed7db_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_552725c4-59f8-4a9a-93a0-3329a70838f8_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption, Period Three</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember_6b6c85e1-3ac3-4206-a023-787b5a526548_terseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Convertible Notes</link:label>
    <link:label id="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Nineteen Convertible Notes [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Nineteen Convertible Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineteenConvertibleNotesMember" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndNineteenConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndNineteenConvertibleNotesMember" xlink:to="lab_fldm_TwoThousandAndNineteenConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_14e67f9b-41f5-4377-9a67-00321a64e7ab_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offering related costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_81d609e0-4256-4c53-aa9f-3658553e2e8c_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridge loans</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_726f7738-17e4-4159-afc0-72abc924c0e4_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_e14c5423-e630-46a9-be2d-e15412f5e976_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_dfb95a94-5d32-428d-a56e-a487cd68aeb2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_2f810eb1-e297-4c9e-99c8-5c070205e065_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a11fcb2a-89bc-49f9-a9aa-cbf12b441214_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price per Option</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_33907c31-c7da-469c-890d-04dd21290da3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation, expected revenue</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtCovenantPeriodTwoMember_99c80123-e06c-48db-b580-8082b3b17faa_terseLabel_en-US" xlink:label="lab_fldm_DebtCovenantPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Period Two</link:label>
    <link:label id="lab_fldm_DebtCovenantPeriodTwoMember_label_en-US" xlink:label="lab_fldm_DebtCovenantPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Period Two [Member]</link:label>
    <link:label id="lab_fldm_DebtCovenantPeriodTwoMember_documentation_en-US" xlink:label="lab_fldm_DebtCovenantPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodTwoMember" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtCovenantPeriodTwoMember" xlink:to="lab_fldm_DebtCovenantPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_d345c8d4-1618-4047-af01-aa4a4a0139ef_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_de6be71e-2896-4011-a4ce-3755afb93c7a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock, net of shares withheld for taxes, and other</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet_6fc9071e-cf11-47d6-b2e2-f4d53d51ca35_totalLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of property and equipment, net</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Property and Equipment, Net</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Property and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_2f95194b-c1e0-49f3-a2f0-44f48dfa35a8_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_c431f837-ac48-480a-866b-b41b5dcc90ff_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_29eb26be-0b68-41dc-a89b-edf82f8a5064_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Common Stock Reserved for Future Issuance</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_4652d4e6-c35c-43cc-ad25-a904ea58dd5f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_9a7fadeb-96af-46e9-9126-096d2e278f81_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock, percent</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8e0e59d6-840f-4b1c-9f67-00fc5392bc93_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_f5c8fe8f-7023-413c-b0f7-fa1d0ed4468c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_02836626-43a6-4ffb-a69a-0f5beb690bd9_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, non-current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_0954af18-aee5-4f77-868e-859ae7334c11_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_74b616a4-5381-4175-87f0-ea0f6b043627_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances under revolving credit agreement, current</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_f84c5ad6-bdb4-4d83-be26-17efae6fc310_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_408e4349-1909-4b5a-826a-50ed7c947c5b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3bb29e72-3ae6-49f4-9eef-fb54a668ef00_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_73d19bd8-683b-4b24-b79a-e77fb8d1ce87_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_EquityIncentivePlanTwentyElevenMember_7b993820-bddb-4a83-af18-5fc2e94b9057_terseLabel_en-US" xlink:label="lab_fldm_EquityIncentivePlanTwentyElevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 Equity Incentive Plan</link:label>
    <link:label id="lab_fldm_EquityIncentivePlanTwentyElevenMember_label_en-US" xlink:label="lab_fldm_EquityIncentivePlanTwentyElevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan Twenty Eleven [Member]</link:label>
    <link:label id="lab_fldm_EquityIncentivePlanTwentyElevenMember_documentation_en-US" xlink:label="lab_fldm_EquityIncentivePlanTwentyElevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan Twenty Eleven [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EquityIncentivePlanTwentyElevenMember" xlink:href="fldm-20220331.xsd#fldm_EquityIncentivePlanTwentyElevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_EquityIncentivePlanTwentyElevenMember" xlink:to="lab_fldm_EquityIncentivePlanTwentyElevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_6af98045-e4ac-41b7-a996-f95802847640_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement_656713f7-86d5-4dfe-a91e-8c14d040ade3_terseLabel_en-US" xlink:label="lab_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual payments receivable</link:label>
    <link:label id="lab_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement_label_en-US" xlink:label="lab_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangements, Annual Payments Receivable Under Development Agreement</link:label>
    <link:label id="lab_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement_documentation_en-US" xlink:label="lab_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangements, Annual Payments Receivable Under Development Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement" xlink:href="fldm-20220331.xsd#fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement" xlink:to="lab_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_261ecbbc-b094-4e5d-9967-290e0ac8cfac_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_424a2b83-2110-4700-b9db-5ba2f988703f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_4a6209f7-843e-4121-8e4b-6eae7a6472dc_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_4f064cad-bcb0-47da-91ac-6a3079961cc9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_283f5cca-addf-4d64-93ac-4b9ee870a1bf_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_ed875f81-499e-46f4-8c75-3dc4dce9be9f_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures_85127216-5918-470a-a776-fa647d755a2b_terseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures incurred</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Capital Expenditures</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Capital Expenditures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_8c9d85c4-3a2a-474e-aa41-b1bb34efd0ab_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b3cdaf4b-69ea-4ccb-89fc-b52ed096d2b0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_92eb608a-1ba1-4fa3-9d9a-177f1b03904e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity Under Restricted Stock Units</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_d2d44510-8ea9-4b5d-91ea-e7a0902184ab_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_023836bc-8233-41d8-beb0-ef5f4c309ff6_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_bc1dd7fe-2585-4b2d-917e-701d2657bc58_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Details</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_27edd6b0-febf-404c-88ca-42a36a2ff63a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DeferredGrantRevenue_bf3fb066-9e81-438e-a14c-44738d03aedf_totalLabel_en-US" xlink:label="lab_fldm_DeferredGrantRevenue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred grant income</link:label>
    <link:label id="lab_fldm_DeferredGrantRevenue_label_en-US" xlink:label="lab_fldm_DeferredGrantRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Grant Revenue</link:label>
    <link:label id="lab_fldm_DeferredGrantRevenue_documentation_en-US" xlink:label="lab_fldm_DeferredGrantRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Grant Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenue" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DeferredGrantRevenue" xlink:to="lab_fldm_DeferredGrantRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_7133e96f-de89-4e40-881e-5f2b2de0c971_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DeferredGrantIncomeCurrent_b7bf3c90-2cbc-4f84-966b-b9f6be70ba7b_terseLabel_en-US" xlink:label="lab_fldm_DeferredGrantIncomeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred grant income, current</link:label>
    <link:label id="lab_fldm_DeferredGrantIncomeCurrent_label_en-US" xlink:label="lab_fldm_DeferredGrantIncomeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Grant Income, Current</link:label>
    <link:label id="lab_fldm_DeferredGrantIncomeCurrent_documentation_en-US" xlink:label="lab_fldm_DeferredGrantIncomeCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Grant Income, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantIncomeCurrent" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantIncomeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DeferredGrantIncomeCurrent" xlink:to="lab_fldm_DeferredGrantIncomeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edd1906b-11ec-4d36-8434-a58f0023309b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_6768d74f-4cd0-4718-8ab0-4a5e2519d9c1_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:to="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue_95decfad-3bb2-4f54-9ac2-4813224d45bc_terseLabel_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue_label_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Vested Aggregate Intrinsic Value</link:label>
    <link:label id="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement by Share Based Payment Award, Options, Vested, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" xlink:to="lab_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_08c78a9a-cf28-4182-9add-f4fcaaf6984a_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_d560457c-e1b5-4083-8817-d46d4dc0a94e_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_dcd940a6-cfb6-42db-8a0d-14a36c4e88dc_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8c71f560-48f5-4fe8-801e-8b298c1fa044_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining performance obligation, expected timing of satisfaction</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_d940c0d7-9563-4be0-bc02-fe8a6e42c790_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_44cdec5b-ef97-49ff-a21d-5b88db849ac4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_2c55f158-9330-4bbc-878a-81f1bc251762_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_8e23db06-9a20-45de-9b7d-50d356aea634_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_ffef3268-129b-4770-99fe-9430abf77cfd_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_19523f12-43aa-45c1-be01-c45ac7775c94_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing net loss per share, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_815d311c-458b-4ac2-8ee1-069980bd121e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_21ee79d1-aa74-49a4-8134-026de5adb9f3_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discounts, premiums and issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_4a21133d-1792-4773-b6ad-bc3f3ba749a8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold percentage of stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_c6bc4644-d72a-428c-b5a8-f536665d4b44_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_f04b3b32-a38a-4a2b-9eb3-84b3a232c0c6_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_090ffa78-f78a-4226-989d-fdb9d741f29c_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product revenue</link:label>
    <link:label id="lab_us-gaap_ProductMember_8fef4e6c-69b3-442d-b2c0-5dd38e2039ba_verboseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product revenue</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_1b745e9d-431b-4b52-a539-6908068f49d5_terseLabel_en-US" xlink:label="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of months over which options vest ratably</link:label>
    <link:label id="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_label_en-US" xlink:label="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement</link:label>
    <link:label id="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_documentation_en-US" xlink:label="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" xlink:href="fldm-20220331.xsd#fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" xlink:to="lab_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_fe515cbd-b877-4e7e-903d-4dbd7ddbe5ca_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_03f97e05-67bf-44fe-a797-7e76cf680232_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedPayrollTaxesCurrent_883238cd-582c-4dee-bcf1-f15471e3cc48_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll taxes and other</link:label>
    <link:label id="lab_us-gaap_AccruedPayrollTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Payroll Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedPayrollTaxesCurrent" xlink:to="lab_us-gaap_AccruedPayrollTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_cb6b19d4-5de5-4313-8cca-5e57ca37ad42_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_db44d811-59c0-4435-ab9a-ae50e7224352_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_602434cd-c910-4627-9413-395b6ac53acb_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_BridgeLoansMember_a302c5fa-e178-4d81-9bbf-04b24e238d2a_terseLabel_en-US" xlink:label="lab_fldm_BridgeLoansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridge Loans</link:label>
    <link:label id="lab_fldm_BridgeLoansMember_label_en-US" xlink:label="lab_fldm_BridgeLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridge Loans [Member]</link:label>
    <link:label id="lab_fldm_BridgeLoansMember_documentation_en-US" xlink:label="lab_fldm_BridgeLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridge Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_BridgeLoansMember" xlink:href="fldm-20220331.xsd#fldm_BridgeLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_BridgeLoansMember" xlink:to="lab_fldm_BridgeLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_172e7acd-5510-45ee-afb9-c13b6d67f976_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_d320dead-c8de-411b-bedb-0f8725357f1b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_4eeaccf2-a27e-44b5-becd-109055f616a1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_7b92a334-f2aa-4ce8-a360-d452589204ca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual terms</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_de937f2e-99d1-4fe6-89e4-edcb5bb91a2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_a032eb29-1c94-4fff-94c9-af8092b819fa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_32e23295-c658-4d96-a380-0d499448954b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_db4a70f1-3ca8-4887-b709-c7c9992fa198_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_e6576c17-a3e1-4de8-916b-b33d158c323b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6233649c-0ade-4e58-90da-f5bf66fbd0f1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_02d389a7-c4aa-464d-8a2c-cf68e4c751df_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances under revolving credit agreement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_f31af4af-2ecc-404b-b1c4-514cea8eaf8b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from bridge loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7d498aae-8ef3-4207-ad78-fe68d5f4f5b8_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ee5436b7-7cd0-4b97-918c-398c4f31ecd5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_b133df1a-2cac-42a9-afa0-6c1cd518d7dd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 remainder of the year</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_78c47530-1779-4def-a676-fac5d99d936e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_579ac774-e5f9-4fb3-ba0c-efe4f0301691_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Convertible Preferred Stock Purchase Agreements</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_fabf186b-a90b-470e-acdf-0b71256466b0_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_88f30157-cf28-4e98-905c-5049e68ddf88_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0e06712d-e09a-4ba0-92a9-b09600e30d73_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_78ac3390-5333-48c8-91b1-79fafc7836e9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_d95a9270-41b0-45d8-9e57-bb08641d3ce8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual" xlink:to="lab_us-gaap_ProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_4dc899cd-0aa4-4091-920c-f2edcc8e6f36_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_7e4af52f-2f87-40b3-95b0-68cc6560410e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_75ef4c1c-b698-4278-bd50-084d3c7358db_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember_766fe31f-5887-46ff-9740-975dd688bd6d_terseLabel_en-US" xlink:label="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units at Maximum</link:label>
    <link:label id="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember_label_en-US" xlink:label="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock And Performance Share Units [Member]</link:label>
    <link:label id="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember_documentation_en-US" xlink:label="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock And Performance Share Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RestrictedStockAndPerformanceShareUnitsMember" xlink:href="fldm-20220331.xsd#fldm_RestrictedStockAndPerformanceShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_RestrictedStockAndPerformanceShareUnitsMember" xlink:to="lab_fldm_RestrictedStockAndPerformanceShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_dea367fe-3f71-41bf-8976-ffd7219c8fc6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_ca1af7ab-43ec-4d0a-b5c6-917728e4b6e6_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible preferred stock, value</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:to="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_1e2a74f5-4e6c-4d40-a62f-253ad90a65e7_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_56dd2109-3400-4962-9051-a73e1d2c34df_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_da48611b-af6b-45e0-a17d-34f96c4dbf6f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Expected Timing of Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAbstract_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_45f4506a-e053-44f9-bcfe-0665241be95e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_f529c96b-0e1d-48c8-9313-e2c32f7b40c7_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenue</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_34255b07-1441-4f55-8a74-7adf15df6a2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_PreferredStockFairValueDisclosure_d5365a81-efb7-41c3-8135-ff5d88a742b9_terseLabel_en-US" xlink:label="lab_fldm_PreferredStockFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of preferred stock</link:label>
    <link:label id="lab_fldm_PreferredStockFairValueDisclosure_label_en-US" xlink:label="lab_fldm_PreferredStockFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Fair Value Disclosure</link:label>
    <link:label id="lab_fldm_PreferredStockFairValueDisclosure_documentation_en-US" xlink:label="lab_fldm_PreferredStockFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PreferredStockFairValueDisclosure" xlink:href="fldm-20220331.xsd#fldm_PreferredStockFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_PreferredStockFairValueDisclosure" xlink:to="lab_fldm_PreferredStockFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_8960b389-b90c-4e2d-9feb-27bb6d90935a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BridgeLoanMember_88f9fa32-fe52-472b-a7bf-da58f8d3584d_terseLabel_en-US" xlink:label="lab_us-gaap_BridgeLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridge Loans</link:label>
    <link:label id="lab_us-gaap_BridgeLoanMember_label_en-US" xlink:label="lab_us-gaap_BridgeLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bridge Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BridgeLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BridgeLoanMember" xlink:to="lab_us-gaap_BridgeLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_b93bc634-3b87-4cec-9042-a777fbddd1a6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional awards authorized for issuance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_56ef6904-2437-4c1b-80ff-9d202d6af4c0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_26a188e4-0467-498e-a25d-6c034f45f711_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_eaf0c2fb-91f5-4bb2-9cbd-1c7378037f25_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_9a0fa4ad-9b7c-43f9-8b06-b8c1987fad1a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid_768d950d-f301-4977-bcf1-acb1831cc388_terseLabel_en-US" xlink:label="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset retirement obligations</link:label>
    <link:label id="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid_label_en-US" xlink:label="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligations Incurred But Not Yet Paid</link:label>
    <link:label id="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Retirement Obligations Incurred But Not Yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_AssetRetirementObligationsIncurredButNotYetPaid" xlink:href="fldm-20220331.xsd#fldm_AssetRetirementObligationsIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_AssetRetirementObligationsIncurredButNotYetPaid" xlink:to="lab_fldm_AssetRetirementObligationsIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_eafc2250-007d-437f-8ad0-868ebe541016_terseLabel_en-US" xlink:label="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:label id="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="fldm-20220331.xsd#fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_9760a5ee-a119-42b9-8666-474b194c3dae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Future Intangible Asset Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_87b87e4b-463d-47ca-a0d2-3089f2149127_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_464df9db-8759-4ee3-ab66-ca15d8dc146b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_c1eba3a4-e148-46fd-be4c-3c2ab5dd6091_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_39b92b1f-dc19-4284-97f5-2d96a77fa922_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtCovenantPeriodFourMember_add908ee-484e-425e-b077-63154c9863b7_terseLabel_en-US" xlink:label="lab_fldm_DebtCovenantPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Period Four</link:label>
    <link:label id="lab_fldm_DebtCovenantPeriodFourMember_label_en-US" xlink:label="lab_fldm_DebtCovenantPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Period Four [Member]</link:label>
    <link:label id="lab_fldm_DebtCovenantPeriodFourMember_documentation_en-US" xlink:label="lab_fldm_DebtCovenantPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant, Period Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodFourMember" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtCovenantPeriodFourMember" xlink:to="lab_fldm_DebtCovenantPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_a3cdc4f7-4463-4774-869d-11de8a8996b9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5fb06ee8-58b1-4ef1-a438-970315891c33_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_a557f808-5d34-4866-9dc7-b8ed2283225a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_e7591c79-6c2a-4a9f-8733-dc606ed68613_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_15fda908-efe4-4553-90df-e7400f0c55f1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing base of the credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_InitialConversionPriceOfStock_59ac5827-afc8-4957-b698-ef72fc36b963_terseLabel_en-US" xlink:label="lab_fldm_InitialConversionPriceOfStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price of stock (in usd per share)</link:label>
    <link:label id="lab_fldm_InitialConversionPriceOfStock_label_en-US" xlink:label="lab_fldm_InitialConversionPriceOfStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Conversion Price Of Stock</link:label>
    <link:label id="lab_fldm_InitialConversionPriceOfStock_documentation_en-US" xlink:label="lab_fldm_InitialConversionPriceOfStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Conversion Price Of Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InitialConversionPriceOfStock" xlink:href="fldm-20220331.xsd#fldm_InitialConversionPriceOfStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_InitialConversionPriceOfStock" xlink:to="lab_fldm_InitialConversionPriceOfStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3677d552-53e6-4a27-8905-e5d7804d0642_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3697438b-9b0b-479b-b945-e6abf3c4e841_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_27356339-3fa5-4f4a-b403-b31b14c86d10_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_4a46153c-b173-4ac2-8315-5528a2553f3e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and related benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_a7bdb08b-f023-4aaf-8f0c-5aad6afbc6e7_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_ecf77926-d54b-40f1-9106-7aa3b275ccd2_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_1b2cbd86-c97c-46dc-91f2-e6a77f8a3f72_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_LaboratoryAndManufacturingEquipmentMember_ca61e513-c235-436f-93de-d6169e287086_terseLabel_en-US" xlink:label="lab_fldm_LaboratoryAndManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory and manufacturing equipment</link:label>
    <link:label id="lab_fldm_LaboratoryAndManufacturingEquipmentMember_label_en-US" xlink:label="lab_fldm_LaboratoryAndManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory And Manufacturing Equipment [Member]</link:label>
    <link:label id="lab_fldm_LaboratoryAndManufacturingEquipmentMember_documentation_en-US" xlink:label="lab_fldm_LaboratoryAndManufacturingEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory And Manufacturing Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LaboratoryAndManufacturingEquipmentMember" xlink:href="fldm-20220331.xsd#fldm_LaboratoryAndManufacturingEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_LaboratoryAndManufacturingEquipmentMember" xlink:to="lab_fldm_LaboratoryAndManufacturingEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock_d868e1a8-7be0-4c6f-be38-1a894ac37227_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Research and Development Activity Under NIH Contract</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_fb0e4e8c-0633-48c7-b056-f245b8553920_terseLabel_en-US" xlink:label="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of eligible receivables</link:label>
    <link:label id="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_label_en-US" xlink:label="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables</link:label>
    <link:label id="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_documentation_en-US" xlink:label="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" xlink:href="fldm-20220331.xsd#fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" xlink:to="lab_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_SeniorConvertibleNotesDue2024Member_167986e3-99c1-40b7-80b9-4de6711722bf_terseLabel_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes Due 2024</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesDue2024Member_0576cfa3-139b-4836-98fc-6b3be05457a4_verboseLabel_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Notes</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesDue2024Member_881635bc-0d31-400e-97a4-3a7fe123d6e6_netLabel_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Notes</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesDue2024Member_label_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes Due 2024 [Member]</link:label>
    <link:label id="lab_fldm_SeniorConvertibleNotesDue2024Member_documentation_en-US" xlink:label="lab_fldm_SeniorConvertibleNotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_SeniorConvertibleNotesDue2024Member" xlink:to="lab_fldm_SeniorConvertibleNotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtCovenantPeriodAxis_df555c64-bd64-450a-a012-e80a856b8cb3_terseLabel_en-US" xlink:label="lab_fldm_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_fldm_DebtCovenantPeriodAxis_label_en-US" xlink:label="lab_fldm_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period [Axis]</link:label>
    <link:label id="lab_fldm_DebtCovenantPeriodAxis_documentation_en-US" xlink:label="lab_fldm_DebtCovenantPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Covenant Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodAxis" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtCovenantPeriodAxis" xlink:to="lab_fldm_DebtCovenantPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_ff0f0ee8-4c57-4338-8e77-588f65468a46_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_a6e6b9c2-9f05-41e2-960a-606e293229e9_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_22955e82-2380-4d43-8a94-31c384fa0bcc_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_805cb8b0-e983-4c04-a1b8-820a29ed0066_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_80090664-6b96-4c16-a467-5c5ce86c80f6_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_9b5dae22-0fbd-4b57-967e-85459a281ff2_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_2532502a-16c7-4883-a92b-bb62f3b8f052_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_9af0278a-a384-442f-9418-5e567e7e35b7_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares sold (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_34149881-1204-4527-ba1e-1a583863cf63_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_78ba3d91-38c7-4c27-b163-52373fbe678f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_ba658956-a4ed-4c62-bab5-367d28ac37f8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_fd96f4f0-4ab1-4a16-8278-f2c9da39a355_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_f8bfa752-5ba3-4d42-8597-eb8aaba5f258_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_8f2cc307-2b73-4937-a87b-5e751c10534c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of remaining securities available for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_83d6dd8a-3984-4a97-8494-f57b822e6a7d_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_683d159b-67be-45a1-85e8-dae7abd2cc46_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_399c7213-62a4-47f1-abea-28cbc2577bf8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Amortization Period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_58266bec-3c6e-4218-9efe-5571bf3bfc3f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_9a7431ec-d3cb-4c1c-be5e-283e38a28d71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-Based Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Performance-based Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c056fb3c-e43c-434b-98e8-5adc8d8d46e2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_ca13fb5e-0e5c-4049-8c3a-ce2d1b5a82ee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Compensation and Related Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8b04eb27-5a20-4225-8da5-0d85a242a004_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1e43ce0e-bf01-48a0-8309-36188cf04db0_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing net loss per share, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary_0bd7d558-e8c6-47dd-ab0b-8b27a4f308a0_terseLabel_en-US" xlink:label="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate at which outstanding options vest on the first anniversary of the option grant date</link:label>
    <link:label id="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary_label_en-US" xlink:label="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion Of Stock Options Vest On First Anniversary</link:label>
    <link:label id="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary_documentation_en-US" xlink:label="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion Of Stock Options Vest On First Anniversary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PortionOfStockOptionsVestOnFirstAnniversary" xlink:href="fldm-20220331.xsd#fldm_PortionOfStockOptionsVestOnFirstAnniversary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_PortionOfStockOptionsVestOnFirstAnniversary" xlink:to="lab_fldm_PortionOfStockOptionsVestOnFirstAnniversary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_a82a1cdf-f9d6-40c8-ba35-80551f5ab776_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_ea1bebcf-ed59-4ac6-be51-fb1086cfc7af_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_002ccd9a-5c25-4645-a549-9d587092ad49_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity Under Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2030ad69-5fd9-452b-8276-b3b705ef0557_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6a1c577f-7a2f-4110-8fc8-0691e229e73b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_1b865fd9-0d40-4ed7-a28b-7d57c47e44e8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_471b18d7-b4a4-46da-9dc6-7124afc7f535_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Potential Common Shares Excluded From Computations of Net Loss Per Share Attributed to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_dc336fd9-85c3-4ec9-b665-623167dd29d5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_bf7ca564-a5a0-4ca1-aeb8-782c59f197c9_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_d4209053-bd19-4fff-bd63-3a4119ad078a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dcdceb4e-b5b9-4347-a4ec-645473b22aea_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a607b6b1-d815-41f1-a4fc-95c694cb116a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_f29b83ba-7d6c-4eef-a154-247881d22dcf_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_164cc530-5851-48b4-a8e2-416eb4b86a1c_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ad8282c6-be03-4bd4-916b-bc5a434bbdef_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_c778eae7-70f9-43d6-9061-cb9951956d80_terseLabel_en-US" xlink:label="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units, stock options and performance share units</link:label>
    <link:label id="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_label_en-US" xlink:label="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Performance Share Units And Restricted Stock Units [Member]</link:label>
    <link:label id="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, Performance Share Units And Restricted Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" xlink:href="fldm-20220331.xsd#fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" xlink:to="lab_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f1ea5846-383a-4d56-9adc-e39bc39b2210_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member_44fdf43d-6156-4f9e-a97c-7f166cd8e14d_terseLabel_en-US" xlink:label="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Convertible Senior Notes due 2034</link:label>
    <link:label id="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member_label_en-US" xlink:label="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Convertible Senior Notes Due 2034 [Member]</link:label>
    <link:label id="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member_documentation_en-US" xlink:label="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange Convertible Senior Notes Due 2034 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member" xlink:href="fldm-20220331.xsd#fldm_ExchangeConvertibleSeniorNotesDue2034Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member" xlink:to="lab_fldm_ExchangeConvertibleSeniorNotesDue2034Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9a1888bc-96c7-4ff5-99d2-5d4d2149fc2c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_62dddfd0-54aa-4fd1-8ae0-23ab5a85122e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_5669eeac-fe2d-4b76-9290-9046a550bb71_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_584a5089-79a2-4b24-828d-1ad7ebba68e9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_4a0a2c35-0f40-41fa-9906-b7198cf552fb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_0b935c9a-b6be-44f6-9d00-e6531e379b16_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio_158f0103-6578-40c4-9cdd-61724be4f764_terseLabel_en-US" xlink:label="lab_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted quick ratio</link:label>
    <link:label id="lab_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio_label_en-US" xlink:label="lab_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Minimum Adjusted Quick Ratio</link:label>
    <link:label id="lab_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio_documentation_en-US" xlink:label="lab_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Minimum Adjusted Quick Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio" xlink:to="lab_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c19248fc-1a4a-4a0d-8bd9-bd1a2c629b88_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for taxes related to net share settlement of equity awards and other</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_6d5e7102-f62b-4fd1-acfe-edff40507057_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_57b1dcbf-b2c7-49b6-91f2-918392a23f54_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum ability to borrow under line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_16795edd-2a21-449a-8c1a-c9e72cd1c88d_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_d52fb458-61dd-482a-9e5d-5134700efff4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_OperatingLeaseRightOfUseAssetGross_47c645b3-ac8a-46a0-b38a-967f6807aea5_terseLabel_en-US" xlink:label="lab_fldm_OperatingLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease right-of-use assets, gross</link:label>
    <link:label id="lab_fldm_OperatingLeaseRightOfUseAssetGross_label_en-US" xlink:label="lab_fldm_OperatingLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Gross</link:label>
    <link:label id="lab_fldm_OperatingLeaseRightOfUseAssetGross_documentation_en-US" xlink:label="lab_fldm_OperatingLeaseRightOfUseAssetGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-Of-Use Asset, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetGross" xlink:href="fldm-20220331.xsd#fldm_OperatingLeaseRightOfUseAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_OperatingLeaseRightOfUseAssetGross" xlink:to="lab_fldm_OperatingLeaseRightOfUseAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_3ac8001a-b9ec-417b-8b6f-9964b0da2c69_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLeasedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leased Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems" xlink:to="lab_us-gaap_OperatingLeasedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_ee99bb71-96fc-4b7d-b8b1-9c103a80fba0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_77d3da8f-5621-4ee3-a4b7-06903f685eab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_87a68212-5b7e-48fc-8064-d63b9c9de62c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Changes and Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_e603b773-394e-4074-8637-55fc2eedb727_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized compensation cost related to stock-based compensation arrangements</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_c1ea14b8-2410-4b40-a7d7-96d27d9723aa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross_d80c7b22-0200-40fc-9a06-2c8ed71b7fc1_terseLabel_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction-in-progress</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross_label_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Construction in Progress, Gross</link:label>
    <link:label id="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross_documentation_en-US" xlink:label="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Arrangement, Contract To Perform For Others, Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross" xlink:to="lab_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_be693a1f-be4e-4dc5-bf97-73beac48a859_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_c784d85f-ae2a-4612-acfc-39ea1b6d6da6_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of term fee accretion</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_f6316af5-ee5d-4ce9-b475-4d8b4e2311c0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_6f7bed19-8cbc-481b-b5fa-d08393beee1b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_8222ff3b-9998-4674-8a52-68b71dc8c928_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_3f40d001-466d-4f73-be4c-156ec505ae19_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_0e7017bf-7224-4764-97cf-4a9c2f47b1c8_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguished</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember_3f3d0ba4-6e63-4626-a439-9d318369e3b1_verboseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DVS Sciences Inc. 2010 Equity Incentive Plan</link:label>
    <link:label id="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Ten Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Ten Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndTenEquityIncentivePlanMember" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndTenEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndTenEquityIncentivePlanMember" xlink:to="lab_fldm_TwoThousandAndTenEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_ProceedsFromResearchAndDevelopmentGrant_5b78adf5-6e63-44d4-a5ba-e57ab53df4e3_terseLabel_en-US" xlink:label="lab_fldm_ProceedsFromResearchAndDevelopmentGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from NIH Contract</link:label>
    <link:label id="lab_fldm_ProceedsFromResearchAndDevelopmentGrant_label_en-US" xlink:label="lab_fldm_ProceedsFromResearchAndDevelopmentGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Research and Development Grant</link:label>
    <link:label id="lab_fldm_ProceedsFromResearchAndDevelopmentGrant_documentation_en-US" xlink:label="lab_fldm_ProceedsFromResearchAndDevelopmentGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Research and Development Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ProceedsFromResearchAndDevelopmentGrant" xlink:href="fldm-20220331.xsd#fldm_ProceedsFromResearchAndDevelopmentGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_ProceedsFromResearchAndDevelopmentGrant" xlink:to="lab_fldm_ProceedsFromResearchAndDevelopmentGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_a7848b01-d30e-49e2-8628-6e40d31a1594_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_CollaborationRevenueMember_e5d6e4e4-6041-4512-9c11-1b48b4036b0a_terseLabel_en-US" xlink:label="lab_fldm_CollaborationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development revenue</link:label>
    <link:label id="lab_fldm_CollaborationRevenueMember_d4df9776-154c-4c75-9919-ec4661e79c0b_verboseLabel_en-US" xlink:label="lab_fldm_CollaborationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development revenue</link:label>
    <link:label id="lab_fldm_CollaborationRevenueMember_label_en-US" xlink:label="lab_fldm_CollaborationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Revenue [Member]</link:label>
    <link:label id="lab_fldm_CollaborationRevenueMember_documentation_en-US" xlink:label="lab_fldm_CollaborationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember" xlink:href="fldm-20220331.xsd#fldm_CollaborationRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_CollaborationRevenueMember" xlink:to="lab_fldm_CollaborationRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_bb083e1f-d2b0-4b19-9cf3-a55117aca94c_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction-in-progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseMember_00a15362-68b0-464f-b75a-106c499255bb_verboseLabel_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and royalty revenue</link:label>
    <link:label id="lab_us-gaap_LicenseMember_label_en-US" xlink:label="lab_us-gaap_LicenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseMember" xlink:to="lab_us-gaap_LicenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrantMember_cd37e0eb-8502-46a0-acd3-38d9d0bc3a44_terseLabel_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant revenue</link:label>
    <link:label id="lab_us-gaap_GrantMember_label_en-US" xlink:label="lab_us-gaap_GrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrantMember" xlink:to="lab_us-gaap_GrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3023d9ad-d182-4395-8929-222a1e53d143_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_c0586a73-5135-4006-8cf1-4ce8d3a212c3_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_5d2a13a6-28ae-48b8-a789-200058e55698_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_d0d01f39-4d61-4fda-9414-8e883987f28a_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Amortization Expense</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_75ba1c03-af68-4d6f-b804-d893519ae97f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_57ebe5cf-2f20-4329-9728-fe2628b77b6d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_92afcc5e-6061-4fdd-80ac-4741f6a2672f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_7e2483bd-d40d-4661-9a93-c3a7832f9efa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_a4a9d006-6bdd-4824-9a7b-1cd64286ef87_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_53923069-15c7-4cf3-8bff-5054361bb3be_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_032975eb-2525-4e60-9083-14f28fde8003_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_15538f43-9fa3-44bc-a843-d4b3070d198e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember_be4db72d-21a8-409e-9dcf-3963eeab4824_verboseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 Equity Incentive Plan</link:label>
    <link:label id="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember_f6878e88-0b18-4f5e-87ab-a1d38c4e7f66_terseLabel_en-US" xlink:label="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Eleven Equity Incentive Plan</link:label>
    <link:label id="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember_label_en-US" xlink:label="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Eleven Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Eleven Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndElevenEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember" xlink:to="lab_fldm_TwoThousandAndElevenEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_d0deb7de-9d4f-4766-a1c4-e5751d6ffbda_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for excess and obsolete inventory</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve, Period Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>fldm-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3567094e-7943-4bac-b9e5-feece94f0a52,g:ecd4ac27-903f-4673-9e8a-4f46fd5b8bd9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://fluidigm.com/role/Cover" xlink:type="simple" xlink:href="fldm-20220331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_74821f5d-e783-4ec4-bf57-8fcf51140eb2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_DocumentType_74821f5d-e783-4ec4-bf57-8fcf51140eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_dbd49ce7-6263-4800-bc20-cffba6fc1a2d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_DocumentQuarterlyReport_dbd49ce7-6263-4800-bc20-cffba6fc1a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_c4cda646-9ef8-47fb-b7e5-1e313699c967" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_DocumentPeriodEndDate_c4cda646-9ef8-47fb-b7e5-1e313699c967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_bdfee644-8db5-4963-9714-dc152464b232" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_DocumentTransitionReport_bdfee644-8db5-4963-9714-dc152464b232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_765f59f5-11dd-4323-8015-c1d451835916" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityFileNumber_765f59f5-11dd-4323-8015-c1d451835916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_0b75184b-e2c6-4539-a364-52e5fa6e2689" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityRegistrantName_0b75184b-e2c6-4539-a364-52e5fa6e2689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_9355bef2-8644-468c-8565-51fb2d193277" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_9355bef2-8644-468c-8565-51fb2d193277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bbf4e3e4-25f9-497e-998f-d5dda87eb5f6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityTaxIdentificationNumber_bbf4e3e4-25f9-497e-998f-d5dda87eb5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_c63dea08-09f5-40c6-8629-6eff2a182e70" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityAddressAddressLine1_c63dea08-09f5-40c6-8629-6eff2a182e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_bedb3bdf-1cf5-41a6-a2f8-b807a967f94e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityAddressCityOrTown_bedb3bdf-1cf5-41a6-a2f8-b807a967f94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_fbce03e1-fde6-46b6-82d2-cdc5d96f1d6c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityAddressStateOrProvince_fbce03e1-fde6-46b6-82d2-cdc5d96f1d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c1585a7c-c3da-4e58-97b9-9836076a9d7a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityAddressPostalZipCode_c1585a7c-c3da-4e58-97b9-9836076a9d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_eab7172e-6aec-40bf-a60c-3f7c086e03f3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_CityAreaCode_eab7172e-6aec-40bf-a60c-3f7c086e03f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_7cc30f31-77f0-4f02-9502-645a77cdbc2e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_LocalPhoneNumber_7cc30f31-77f0-4f02-9502-645a77cdbc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b7153fdf-71f1-407d-8114-14b5419f6148" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_Security12bTitle_b7153fdf-71f1-407d-8114-14b5419f6148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_1785ea78-a37e-46b6-92fd-51811be16525" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_TradingSymbol_1785ea78-a37e-46b6-92fd-51811be16525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a2966217-9811-4066-a420-bf550e470457" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_SecurityExchangeName_a2966217-9811-4066-a420-bf550e470457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8f34ce79-38fa-4dfd-9e11-21cb1d08cfb7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityCurrentReportingStatus_8f34ce79-38fa-4dfd-9e11-21cb1d08cfb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_d811911e-4668-4b11-a27d-95e89278e947" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityInteractiveDataCurrent_d811911e-4668-4b11-a27d-95e89278e947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_2217709f-82c8-4482-93b2-3581716845b8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityFilerCategory_2217709f-82c8-4482-93b2-3581716845b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_18b25f61-876a-4538-b004-664255406361" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntitySmallBusiness_18b25f61-876a-4538-b004-664255406361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3816d6f5-83b3-44f1-97cf-bdb5d5a0be4a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityEmergingGrowthCompany_3816d6f5-83b3-44f1-97cf-bdb5d5a0be4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_32110c87-be0c-4afc-89e8-3aeb41969c03" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityShellCompany_32110c87-be0c-4afc-89e8-3aeb41969c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_3e2457e8-dc5b-483a-b098-cce2cc757a8a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_3e2457e8-dc5b-483a-b098-cce2cc757a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f3f43df3-7131-45c0-85b5-d6a66d966bde" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_AmendmentFlag_f3f43df3-7131-45c0-85b5-d6a66d966bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_2c543ef8-5f33-4642-807c-5fd805fbc383" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_DocumentFiscalYearFocus_2c543ef8-5f33-4642-807c-5fd805fbc383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_f4892721-c3e8-4164-9138-a5e92ec1732c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_DocumentFiscalPeriodFocus_f4892721-c3e8-4164-9138-a5e92ec1732c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_bbdb4249-68a3-4ece-9c83-1fded8a943c8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_EntityCentralIndexKey_bbdb4249-68a3-4ece-9c83-1fded8a943c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_8e279a58-3267-4987-9443-d1570b25cf55" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_146daa73-fd23-4ed9-b918-59ca6af0bf8c" xlink:to="loc_dei_CurrentFiscalYearEndDate_8e279a58-3267-4987-9443-d1570b25cf55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="fldm-20220331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_047238c0-55dc-4685-b3d7-483f10b30970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4189893b-a06a-4669-b581-cd40ce736712" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_047238c0-55dc-4685-b3d7-483f10b30970" xlink:to="loc_us-gaap_AssetsAbstract_4189893b-a06a-4669-b581-cd40ce736712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_9e47c792-1d45-4a93-8778-f40012577f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4189893b-a06a-4669-b581-cd40ce736712" xlink:to="loc_us-gaap_AssetsCurrentAbstract_9e47c792-1d45-4a93-8778-f40012577f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9663c07b-18f4-4250-9aa2-b8e611ec39b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9e47c792-1d45-4a93-8778-f40012577f38" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9663c07b-18f4-4250-9aa2-b8e611ec39b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_071b82d1-cde3-4c18-8ea1-0fed59406ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9e47c792-1d45-4a93-8778-f40012577f38" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_071b82d1-cde3-4c18-8ea1-0fed59406ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_18a948c5-69a6-440d-9d17-d394bd807aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9e47c792-1d45-4a93-8778-f40012577f38" xlink:to="loc_us-gaap_InventoryNet_18a948c5-69a6-440d-9d17-d394bd807aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ebaa8e21-a192-40dd-9dc2-b0de010dde2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9e47c792-1d45-4a93-8778-f40012577f38" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ebaa8e21-a192-40dd-9dc2-b0de010dde2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6b593aba-aae8-4865-b550-430cc60cb2cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_9e47c792-1d45-4a93-8778-f40012577f38" xlink:to="loc_us-gaap_AssetsCurrent_6b593aba-aae8-4865-b550-430cc60cb2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b8533711-1b8c-44a2-aa41-b9d8de27906c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4189893b-a06a-4669-b581-cd40ce736712" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b8533711-1b8c-44a2-aa41-b9d8de27906c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7127631e-2849-4bde-8a39-3e6e1116eb13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4189893b-a06a-4669-b581-cd40ce736712" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7127631e-2849-4bde-8a39-3e6e1116eb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_35ae871a-f192-49dc-90ba-974f746ad81b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4189893b-a06a-4669-b581-cd40ce736712" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_35ae871a-f192-49dc-90ba-974f746ad81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f0a64818-bfb9-4206-bd56-d868e4aed17a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4189893b-a06a-4669-b581-cd40ce736712" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f0a64818-bfb9-4206-bd56-d868e4aed17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ec0700af-1032-46c4-8c55-a0a15efa1d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4189893b-a06a-4669-b581-cd40ce736712" xlink:to="loc_us-gaap_Goodwill_ec0700af-1032-46c4-8c55-a0a15efa1d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6efb97d1-fa64-4914-814e-e83aac2cbb69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4189893b-a06a-4669-b581-cd40ce736712" xlink:to="loc_us-gaap_Assets_6efb97d1-fa64-4914-814e-e83aac2cbb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_047238c0-55dc-4685-b3d7-483f10b30970" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_dbe5ecbb-0966-4055-8e9c-061798bf1464" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_dbe5ecbb-0966-4055-8e9c-061798bf1464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6c7a811d-f4b0-416e-8665-1769b9097e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dbe5ecbb-0966-4055-8e9c-061798bf1464" xlink:to="loc_us-gaap_AccountsPayableCurrent_6c7a811d-f4b0-416e-8665-1769b9097e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_27c13f19-2086-42e1-8079-a29504941bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dbe5ecbb-0966-4055-8e9c-061798bf1464" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_27c13f19-2086-42e1-8079-a29504941bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ed2749dc-7544-4cc4-8547-6bf77804d94e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dbe5ecbb-0966-4055-8e9c-061798bf1464" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ed2749dc-7544-4cc4-8547-6bf77804d94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fc1f29b4-8958-4568-8daa-f49540874c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dbe5ecbb-0966-4055-8e9c-061798bf1464" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_fc1f29b4-8958-4568-8daa-f49540874c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenueCurrent_1e14d961-8736-4be3-8e6f-ed5b3373d85c" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantRevenueCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dbe5ecbb-0966-4055-8e9c-061798bf1464" xlink:to="loc_fldm_DeferredGrantRevenueCurrent_1e14d961-8736-4be3-8e6f-ed5b3373d85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f5ec5ba8-0d29-4631-9373-c70c7487f599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dbe5ecbb-0966-4055-8e9c-061798bf1464" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f5ec5ba8-0d29-4631-9373-c70c7487f599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_a1d1ffe6-0562-4c8a-ac62-aa0eff808847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dbe5ecbb-0966-4055-8e9c-061798bf1464" xlink:to="loc_us-gaap_LinesOfCreditCurrent_a1d1ffe6-0562-4c8a-ac62-aa0eff808847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ffec864a-6ede-4093-b20d-028d6e7fdece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_dbe5ecbb-0966-4055-8e9c-061798bf1464" xlink:to="loc_us-gaap_LiabilitiesCurrent_ffec864a-6ede-4093-b20d-028d6e7fdece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_62a5b2a7-0b51-4cd0-a754-d893e6b3693a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_62a5b2a7-0b51-4cd0-a754-d893e6b3693a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_30d525a0-3c2b-4da2-a06d-f975805db89f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_30d525a0-3c2b-4da2-a06d-f975805db89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_200eb69f-02fb-4b46-9486-38c2786300b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_us-gaap_SecuredDebt_200eb69f-02fb-4b46-9486-38c2786300b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_85248ca3-b34e-4978-a643-e0f3383788b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_85248ca3-b34e-4978-a643-e0f3383788b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_102be797-8116-4ce2-b03a-7ec7e8f192bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_102be797-8116-4ce2-b03a-7ec7e8f192bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c968b7b5-f916-486e-80ae-03fd834551c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_c968b7b5-f916-486e-80ae-03fd834551c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenueNoncurrent_3c8644ff-060d-4861-8ace-b0e5ee01c65f" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantRevenueNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_fldm_DeferredGrantRevenueNoncurrent_3c8644ff-060d-4861-8ace-b0e5ee01c65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_StockRepurchaseLiability_352f92b0-8c1e-40ec-a484-6edacdd3af58" xlink:href="fldm-20220331.xsd#fldm_StockRepurchaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_fldm_StockRepurchaseLiability_352f92b0-8c1e-40ec-a484-6edacdd3af58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e44c9202-4776-4729-afa2-1cd0bd8e0d53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e44c9202-4776-4729-afa2-1cd0bd8e0d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4b72861f-4ca5-428c-9fb7-c7bfeb9d1876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_us-gaap_Liabilities_4b72861f-4ca5-428c-9fb7-c7bfeb9d1876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_232f1f6e-a7b1-416d-8bd8-f5a537943093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_us-gaap_CommitmentsAndContingencies_232f1f6e-a7b1-416d-8bd8-f5a537943093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_f34c417c-03d4-46fd-ba56-32509d9495e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_us-gaap_StockholdersEquityAbstract_f34c417c-03d4-46fd-ba56-32509d9495e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_6d0be4d3-8262-436e-a8d6-f1acb9b0a284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f34c417c-03d4-46fd-ba56-32509d9495e0" xlink:to="loc_us-gaap_PreferredStockValue_6d0be4d3-8262-436e-a8d6-f1acb9b0a284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8bb291c9-690c-4830-b6cd-f9e210bcd43b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f34c417c-03d4-46fd-ba56-32509d9495e0" xlink:to="loc_us-gaap_CommonStockValue_8bb291c9-690c-4830-b6cd-f9e210bcd43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_1b4982be-3507-4fec-9cf0-b7b68d79cf08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f34c417c-03d4-46fd-ba56-32509d9495e0" xlink:to="loc_us-gaap_AdditionalPaidInCapital_1b4982be-3507-4fec-9cf0-b7b68d79cf08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a9148c91-a353-423d-a1d0-95e529410434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f34c417c-03d4-46fd-ba56-32509d9495e0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a9148c91-a353-423d-a1d0-95e529410434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0811713f-741d-4ca5-b8db-8d6c0aab7f54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f34c417c-03d4-46fd-ba56-32509d9495e0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0811713f-741d-4ca5-b8db-8d6c0aab7f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_32a1bea1-3034-4f68-bcb5-13a9ff7fa0af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f34c417c-03d4-46fd-ba56-32509d9495e0" xlink:to="loc_us-gaap_StockholdersEquity_32a1bea1-3034-4f68-bcb5-13a9ff7fa0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_44cd8d4f-ddf6-453d-8154-6c1b11e40e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_240b42fc-2f96-4d16-86f3-f9ad6137cf87" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_44cd8d4f-ddf6-453d-8154-6c1b11e40e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="fldm-20220331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_a62e9133-d88e-416b-ac03-9d7f0f0d8ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_20fab346-4f6f-4fa5-a4ab-06d57cbf1de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a62e9133-d88e-416b-ac03-9d7f0f0d8ec3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_20fab346-4f6f-4fa5-a4ab-06d57cbf1de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_769b2296-6f71-4244-845f-b4c37b5b9692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a62e9133-d88e-416b-ac03-9d7f0f0d8ec3" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_769b2296-6f71-4244-845f-b4c37b5b9692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_5865369c-a2b5-43b7-963a-d729d27563e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a62e9133-d88e-416b-ac03-9d7f0f0d8ec3" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_5865369c-a2b5-43b7-963a-d729d27563e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_3706bf20-c76a-4278-9587-81aae80a770a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a62e9133-d88e-416b-ac03-9d7f0f0d8ec3" xlink:to="loc_us-gaap_PreferredStockSharesIssued_3706bf20-c76a-4278-9587-81aae80a770a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_7c2725c9-2f90-4d3e-a19b-34693800b64f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a62e9133-d88e-416b-ac03-9d7f0f0d8ec3" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_7c2725c9-2f90-4d3e-a19b-34693800b64f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1f1fb371-5f1d-446d-9507-bfbbafdc8d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a62e9133-d88e-416b-ac03-9d7f0f0d8ec3" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1f1fb371-5f1d-446d-9507-bfbbafdc8d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_241f29f2-52d7-4f0a-a377-07ddbc65d003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a62e9133-d88e-416b-ac03-9d7f0f0d8ec3" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_241f29f2-52d7-4f0a-a377-07ddbc65d003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_c5e2d811-9012-4d7f-bad3-ed32aada8030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a62e9133-d88e-416b-ac03-9d7f0f0d8ec3" xlink:to="loc_us-gaap_CommonStockSharesIssued_c5e2d811-9012-4d7f-bad3-ed32aada8030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3a338d60-c6bd-4759-bf02-68b645fe2972" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_a62e9133-d88e-416b-ac03-9d7f0f0d8ec3" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3a338d60-c6bd-4759-bf02-68b645fe2972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="fldm-20220331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_9d29c29f-838f-45bc-9192-c277b1aea1d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_292fb449-9104-470a-8d77-f911d476f6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9d29c29f-838f-45bc-9192-c277b1aea1d5" xlink:to="loc_us-gaap_StatementTable_292fb449-9104-470a-8d77-f911d476f6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_70b1daef-ed0b-4918-bedb-88358ded9b13" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_292fb449-9104-470a-8d77-f911d476f6e3" xlink:to="loc_srt_ProductOrServiceAxis_70b1daef-ed0b-4918-bedb-88358ded9b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b9458039-6a62-4e58-9396-7f86973c2f23" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_70b1daef-ed0b-4918-bedb-88358ded9b13" xlink:to="loc_srt_ProductsAndServicesDomain_b9458039-6a62-4e58-9396-7f86973c2f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_251e752e-b4de-4ef5-a737-3f4bbe4e98e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b9458039-6a62-4e58-9396-7f86973c2f23" xlink:to="loc_us-gaap_ProductMember_251e752e-b4de-4ef5-a737-3f4bbe4e98e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_6adc7fc1-190b-411f-98a4-80d351386fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b9458039-6a62-4e58-9396-7f86973c2f23" xlink:to="loc_us-gaap_ServiceMember_6adc7fc1-190b-411f-98a4-80d351386fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember_2cbcbdce-f6f5-44f5-8d52-806dd2424e31" xlink:href="fldm-20220331.xsd#fldm_CollaborationRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b9458039-6a62-4e58-9396-7f86973c2f23" xlink:to="loc_fldm_CollaborationRevenueMember_2cbcbdce-f6f5-44f5-8d52-806dd2424e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_a2ee5384-ce84-402e-9083-06fd7adcf22b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b9458039-6a62-4e58-9396-7f86973c2f23" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_a2ee5384-ce84-402e-9083-06fd7adcf22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cb519662-457a-4f84-95f8-b60807a91ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_292fb449-9104-470a-8d77-f911d476f6e3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cb519662-457a-4f84-95f8-b60807a91ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4576310b-7db9-4b87-a583-1f949960b79c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cb519662-457a-4f84-95f8-b60807a91ef1" xlink:to="loc_us-gaap_ClassOfStockDomain_4576310b-7db9-4b87-a583-1f949960b79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_a55e2fad-f327-4b6f-a2ba-51de17c804d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4576310b-7db9-4b87-a583-1f949960b79c" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_a55e2fad-f327-4b6f-a2ba-51de17c804d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_292fb449-9104-470a-8d77-f911d476f6e3" xlink:to="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_9f7dd129-094e-4d96-9f01-3fc6707e93c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_RevenuesAbstract_9f7dd129-094e-4d96-9f01-3fc6707e93c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_39beba89-e14f-4cb8-88fb-1b6bcc900ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_9f7dd129-094e-4d96-9f01-3fc6707e93c0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_39beba89-e14f-4cb8-88fb-1b6bcc900ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_2b5fe8e1-5a61-4b41-872f-d2d341a93097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_2b5fe8e1-5a61-4b41-872f-d2d341a93097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_631c1382-763b-45e7-b2c9-617007e83e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2b5fe8e1-5a61-4b41-872f-d2d341a93097" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_631c1382-763b-45e7-b2c9-617007e83e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_3c32cb08-c877-4d04-9996-805a49ffdb2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2b5fe8e1-5a61-4b41-872f-d2d341a93097" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_3c32cb08-c877-4d04-9996-805a49ffdb2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_752a8d14-0141-4d6e-ba96-150e8930c097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2b5fe8e1-5a61-4b41-872f-d2d341a93097" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_752a8d14-0141-4d6e-ba96-150e8930c097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b30bdf21-fbdb-4d7c-a685-5254004610fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_2b5fe8e1-5a61-4b41-872f-d2d341a93097" xlink:to="loc_us-gaap_OperatingExpenses_b30bdf21-fbdb-4d7c-a685-5254004610fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3ec68f50-6a1a-4bbb-8209-12c40f582910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_OperatingIncomeLoss_3ec68f50-6a1a-4bbb-8209-12c40f582910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_dd22aa5d-ff73-408b-8f58-11b26209b27a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_InterestExpense_dd22aa5d-ff73-408b-8f58-11b26209b27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LossOnForwardSaleOfStock_94f75f02-4740-4402-9c74-849c8cd645de" xlink:href="fldm-20220331.xsd#fldm_LossOnForwardSaleOfStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_fldm_LossOnForwardSaleOfStock_94f75f02-4740-4402-9c74-849c8cd645de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_3713c787-5722-4660-81bf-ba6eb26d8bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_3713c787-5722-4660-81bf-ba6eb26d8bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ef362548-cf2f-441e-91a2-5527c368afc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ef362548-cf2f-441e-91a2-5527c368afc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1b20265e-8910-43e9-afac-88f601666fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1b20265e-8910-43e9-afac-88f601666fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b8b74e93-df53-4b30-95dd-d9c232f7b813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b8b74e93-df53-4b30-95dd-d9c232f7b813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2d9d6114-04ce-4da2-963f-b4c4f78e863c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_NetIncomeLoss_2d9d6114-04ce-4da2-963f-b4c4f78e863c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_1a6b2107-e5aa-425f-a59f-4af0de51ae0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_EarningsPerShareBasic_1a6b2107-e5aa-425f-a59f-4af0de51ae0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_c46908cc-d088-4e0e-bad7-5c07a4838414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_EarningsPerShareDiluted_c46908cc-d088-4e0e-bad7-5c07a4838414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f95759a9-cc1e-4f00-b063-d8407d7b13d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f95759a9-cc1e-4f00-b063-d8407d7b13d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_757214a4-0291-4375-b6ae-e61f6d65ab9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bf6e3aca-b227-4b19-890d-8f4bbf34e923" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_757214a4-0291-4375-b6ae-e61f6d65ab9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="fldm-20220331.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_05d32ccc-633e-4394-a260-5f20220268d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ec1d82c0-04ec-48c8-b588-373421788f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_05d32ccc-633e-4394-a260-5f20220268d1" xlink:to="loc_us-gaap_NetIncomeLoss_ec1d82c0-04ec-48c8-b588-373421788f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f871aefd-2819-4700-a46b-b031fa2618ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_05d32ccc-633e-4394-a260-5f20220268d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f871aefd-2819-4700-a46b-b031fa2618ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2ce34495-9c87-4a97-b219-0243f6edd087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f871aefd-2819-4700-a46b-b031fa2618ac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2ce34495-9c87-4a97-b219-0243f6edd087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_86805666-41f3-44d1-af2a-bad179dc697c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_05d32ccc-633e-4394-a260-5f20220268d1" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_86805666-41f3-44d1-af2a-bad179dc697c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="fldm-20220331.xsd#CondensedConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_813918a3-17e7-49d8-885b-b4b54936757d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d7960dc0-f64b-40e2-a795-e8237f823089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_813918a3-17e7-49d8-885b-b4b54936757d" xlink:to="loc_us-gaap_StatementTable_d7960dc0-f64b-40e2-a795-e8237f823089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_11fab00f-be82-4f2f-aece-618beb944577" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d7960dc0-f64b-40e2-a795-e8237f823089" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_11fab00f-be82-4f2f-aece-618beb944577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_39c13469-4821-4dbf-8f3b-609799cfd46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_11fab00f-be82-4f2f-aece-618beb944577" xlink:to="loc_us-gaap_EquityComponentDomain_39c13469-4821-4dbf-8f3b-609799cfd46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_dcb6cc49-69da-44c9-968a-a8f03401d8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_39c13469-4821-4dbf-8f3b-609799cfd46b" xlink:to="loc_us-gaap_CommonStockMember_dcb6cc49-69da-44c9-968a-a8f03401d8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_24012558-0554-420a-b188-48bd7ffcd761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_39c13469-4821-4dbf-8f3b-609799cfd46b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_24012558-0554-420a-b188-48bd7ffcd761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8d88393a-3c23-415e-8f6f-523ef9ffecac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_39c13469-4821-4dbf-8f3b-609799cfd46b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_8d88393a-3c23-415e-8f6f-523ef9ffecac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_848648d2-b22c-4c0d-8133-a55f7053ed87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_39c13469-4821-4dbf-8f3b-609799cfd46b" xlink:to="loc_us-gaap_RetainedEarningsMember_848648d2-b22c-4c0d-8133-a55f7053ed87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1d283a01-8f66-489b-b978-0375afc95677" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d7960dc0-f64b-40e2-a795-e8237f823089" xlink:to="loc_us-gaap_StatementLineItems_1d283a01-8f66-489b-b978-0375afc95677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d283a01-8f66-489b-b978-0375afc95677" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3781315c-aff5-4189-ac4e-b5ee96511c51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3781315c-aff5-4189-ac4e-b5ee96511c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7cc9b334-fb2d-41be-bc7c-e774bc1e241d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_StockholdersEquity_7cc9b334-fb2d-41be-bc7c-e774bc1e241d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_64c47a52-8ae9-4029-a998-7bdfec1b6ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_64c47a52-8ae9-4029-a998-7bdfec1b6ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_9dcdb83e-cf94-4e15-b8ba-55511a5ad631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_9dcdb83e-cf94-4e15-b8ba-55511a5ad631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_94886493-8b89-4fcf-9a64-b7eeacef15fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_94886493-8b89-4fcf-9a64-b7eeacef15fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b1ad875a-2ef5-47cc-9c33-125513b5c1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_NetIncomeLoss_b1ad875a-2ef5-47cc-9c33-125513b5c1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e1390ab7-3044-412f-9fc4-e37917e36a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e1390ab7-3044-412f-9fc4-e37917e36a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e04af5f9-0110-4d3f-ac01-6a8b86e82764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e04af5f9-0110-4d3f-ac01-6a8b86e82764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2cb16c6a-9bd8-43c4-acc5-0805c2c9f8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8d05903d-78ff-4f28-986f-d359880250f7" xlink:to="loc_us-gaap_StockholdersEquity_2cb16c6a-9bd8-43c4-acc5-0805c2c9f8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="fldm-20220331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5e78595a-5296-4388-a6ef-c84261a65f80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_19fe0693-106b-4bde-901a-5a580a86adb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5e78595a-5296-4388-a6ef-c84261a65f80" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_19fe0693-106b-4bde-901a-5a580a86adb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5f35b480-2d68-4f77-814a-2f3c5122bf29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_19fe0693-106b-4bde-901a-5a580a86adb1" xlink:to="loc_us-gaap_NetIncomeLoss_5f35b480-2d68-4f77-814a-2f3c5122bf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_72644a90-c584-4370-aed8-4f7b6f93494e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_19fe0693-106b-4bde-901a-5a580a86adb1" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_72644a90-c584-4370-aed8-4f7b6f93494e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LossOnForwardSaleOfStock_de42b4be-72b4-4d29-8ea0-82cfa13bec9f" xlink:href="fldm-20220331.xsd#fldm_LossOnForwardSaleOfStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_72644a90-c584-4370-aed8-4f7b6f93494e" xlink:to="loc_fldm_LossOnForwardSaleOfStock_de42b4be-72b4-4d29-8ea0-82cfa13bec9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_64c2ed87-4418-40e2-821d-e5a67b4c50fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_72644a90-c584-4370-aed8-4f7b6f93494e" xlink:to="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_64c2ed87-4418-40e2-821d-e5a67b4c50fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a372aafd-1988-428a-85c4-6a661d9b5529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_72644a90-c584-4370-aed8-4f7b6f93494e" xlink:to="loc_us-gaap_ShareBasedCompensation_a372aafd-1988-428a-85c4-6a661d9b5529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_4fe35e29-f532-4ccc-aa23-3312107357f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_72644a90-c584-4370-aed8-4f7b6f93494e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_4fe35e29-f532-4ccc-aa23-3312107357f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_4c063a3f-0131-4805-909a-20237eab31a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_72644a90-c584-4370-aed8-4f7b6f93494e" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_4c063a3f-0131-4805-909a-20237eab31a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_654589dc-4809-40f8-ac75-28e45d8ae704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_72644a90-c584-4370-aed8-4f7b6f93494e" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_654589dc-4809-40f8-ac75-28e45d8ae704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_458e6dca-ce94-467f-b322-e8e014452622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_72644a90-c584-4370-aed8-4f7b6f93494e" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_458e6dca-ce94-467f-b322-e8e014452622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_31955bcb-9c67-4497-9392-63aad1e27143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_72644a90-c584-4370-aed8-4f7b6f93494e" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_31955bcb-9c67-4497-9392-63aad1e27143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c1f5a022-5d6e-4c1e-bc87-e8b65287840a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_72644a90-c584-4370-aed8-4f7b6f93494e" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c1f5a022-5d6e-4c1e-bc87-e8b65287840a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e35e1c33-648b-4153-a96e-1eddd1a3b6ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c1f5a022-5d6e-4c1e-bc87-e8b65287840a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e35e1c33-648b-4153-a96e-1eddd1a3b6ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_3b2d0723-c39a-4172-8f6d-19b355953757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c1f5a022-5d6e-4c1e-bc87-e8b65287840a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_3b2d0723-c39a-4172-8f6d-19b355953757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e7517acd-5538-4bb4-9642-beff101ade55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c1f5a022-5d6e-4c1e-bc87-e8b65287840a" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e7517acd-5538-4bb4-9642-beff101ade55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e05966c2-a1f3-49fd-a498-df51888b21a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c1f5a022-5d6e-4c1e-bc87-e8b65287840a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e05966c2-a1f3-49fd-a498-df51888b21a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_35c9d85e-698d-4a89-943d-b5cdc657b347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c1f5a022-5d6e-4c1e-bc87-e8b65287840a" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_35c9d85e-698d-4a89-943d-b5cdc657b347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_6efb2616-a3a5-4a35-9639-d2262fd5e630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c1f5a022-5d6e-4c1e-bc87-e8b65287840a" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_6efb2616-a3a5-4a35-9639-d2262fd5e630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c71e988e-80dc-4fbc-af45-2d6c6e44f350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c1f5a022-5d6e-4c1e-bc87-e8b65287840a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_c71e988e-80dc-4fbc-af45-2d6c6e44f350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_df84a3a2-899d-4fac-91d9-34d85eb30be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_19fe0693-106b-4bde-901a-5a580a86adb1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_df84a3a2-899d-4fac-91d9-34d85eb30be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_34527af5-060b-4706-8ba1-a09250c1403d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5e78595a-5296-4388-a6ef-c84261a65f80" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_34527af5-060b-4706-8ba1-a09250c1403d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ProceedsFromResearchAndDevelopmentGrant_2a1672f7-5314-45f6-acba-c39cab9412f2" xlink:href="fldm-20220331.xsd#fldm_ProceedsFromResearchAndDevelopmentGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_34527af5-060b-4706-8ba1-a09250c1403d" xlink:to="loc_fldm_ProceedsFromResearchAndDevelopmentGrant_2a1672f7-5314-45f6-acba-c39cab9412f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b1e24697-b766-44ed-982d-2fe2fcb86819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_34527af5-060b-4706-8ba1-a09250c1403d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b1e24697-b766-44ed-982d-2fe2fcb86819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5562cefc-bcf7-4441-82cc-52eb92653aee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_34527af5-060b-4706-8ba1-a09250c1403d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5562cefc-bcf7-4441-82cc-52eb92653aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2c7239ba-13a5-4a15-9fc3-17ccd23bb2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5e78595a-5296-4388-a6ef-c84261a65f80" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2c7239ba-13a5-4a15-9fc3-17ccd23bb2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_f48786de-d255-4022-bc81-dec36910729d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2c7239ba-13a5-4a15-9fc3-17ccd23bb2bf" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_f48786de-d255-4022-bc81-dec36910729d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_3d3719c5-fae8-48ff-a2f9-3566ecc8b5a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2c7239ba-13a5-4a15-9fc3-17ccd23bb2bf" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_3d3719c5-fae8-48ff-a2f9-3566ecc8b5a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_837998ad-7a7e-4e4b-98fa-48467fc9e672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2c7239ba-13a5-4a15-9fc3-17ccd23bb2bf" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_837998ad-7a7e-4e4b-98fa-48467fc9e672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_d08b86b4-5a98-430f-b87d-21268dc78e91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2c7239ba-13a5-4a15-9fc3-17ccd23bb2bf" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_d08b86b4-5a98-430f-b87d-21268dc78e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_028100e9-6f92-4cb7-87f1-db480bf7320c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2c7239ba-13a5-4a15-9fc3-17ccd23bb2bf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_028100e9-6f92-4cb7-87f1-db480bf7320c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26e1a1ca-4031-4c2d-8a1e-97afe395c32a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5e78595a-5296-4388-a6ef-c84261a65f80" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_26e1a1ca-4031-4c2d-8a1e-97afe395c32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84cf407c-8c5c-41fc-a9b4-4dc24f5710a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5e78595a-5296-4388-a6ef-c84261a65f80" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_84cf407c-8c5c-41fc-a9b4-4dc24f5710a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a642cc81-5557-4f5d-9e58-f0b5bd487c03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5e78595a-5296-4388-a6ef-c84261a65f80" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a642cc81-5557-4f5d-9e58-f0b5bd487c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_67a0ef7b-a190-4e63-b8e7-71079e06c950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5e78595a-5296-4388-a6ef-c84261a65f80" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_67a0ef7b-a190-4e63-b8e7-71079e06c950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_3cf9d050-7edf-4c1e-bd64-c2f5f062f1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5e78595a-5296-4388-a6ef-c84261a65f80" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_3cf9d050-7edf-4c1e-bd64-c2f5f062f1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_fca81875-183f-4f6b-a236-2e470be8724d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_3cf9d050-7edf-4c1e-bd64-c2f5f062f1fb" xlink:to="loc_us-gaap_InterestPaidNet_fca81875-183f-4f6b-a236-2e470be8724d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_7a76ef9e-b51a-487e-b9b1-d771cc139a42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_3cf9d050-7edf-4c1e-bd64-c2f5f062f1fb" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_7a76ef9e-b51a-487e-b9b1-d771cc139a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_NonCashRightOfUseAssetsAndLeaseLiabilities_299648b0-c1dc-4b4c-bfaa-53cd1752dedd" xlink:href="fldm-20220331.xsd#fldm_NonCashRightOfUseAssetsAndLeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_3cf9d050-7edf-4c1e-bd64-c2f5f062f1fb" xlink:to="loc_fldm_NonCashRightOfUseAssetsAndLeaseLiabilities_299648b0-c1dc-4b4c-bfaa-53cd1752dedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_AssetRetirementObligationsIncurredButNotYetPaid_bfebc87b-5797-4994-a33a-fb95e866bcf7" xlink:href="fldm-20220331.xsd#fldm_AssetRetirementObligationsIncurredButNotYetPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_3cf9d050-7edf-4c1e-bd64-c2f5f062f1fb" xlink:to="loc_fldm_AssetRetirementObligationsIncurredButNotYetPaid_bfebc87b-5797-4994-a33a-fb95e866bcf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DescriptionofBusiness" xlink:type="simple" xlink:href="fldm-20220331.xsd#DescriptionofBusiness"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/DescriptionofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_adbe3e47-ed0e-4e3e-a959-2d0d763aa3fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_805f86ee-92d5-4bb1-ac2f-d8a5da24f492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_adbe3e47-ed0e-4e3e-a959-2d0d763aa3fc" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_805f86ee-92d5-4bb1-ac2f-d8a5da24f492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="fldm-20220331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e9271914-7398-4780-a894-e1e3c9c04e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_484b91d1-21f4-4150-ac71-662949dccb56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e9271914-7398-4780-a894-e1e3c9c04e22" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_484b91d1-21f4-4150-ac71-662949dccb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="fldm-20220331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4aa25241-a1e9-4788-9b27-cf2fa74beb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b296e19e-f5ad-4523-b920-caaa82e56acb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aa25241-a1e9-4788-9b27-cf2fa74beb5e" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b296e19e-f5ad-4523-b920-caaa82e56acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_21f1be1d-ce08-4e5c-8a9b-3cc2b54b7dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aa25241-a1e9-4788-9b27-cf2fa74beb5e" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_21f1be1d-ce08-4e5c-8a9b-3cc2b54b7dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_6086df5f-132e-47d5-8001-a85451b53750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aa25241-a1e9-4788-9b27-cf2fa74beb5e" xlink:to="loc_us-gaap_UseOfEstimates_6086df5f-132e-47d5-8001-a85451b53750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_ade4f04f-61b4-4492-bb80-fd62bfc6bd18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aa25241-a1e9-4788-9b27-cf2fa74beb5e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_ade4f04f-61b4-4492-bb80-fd62bfc6bd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_a35e3344-d875-4719-bef3-a3a03d314f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aa25241-a1e9-4788-9b27-cf2fa74beb5e" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_a35e3344-d875-4719-bef3-a3a03d314f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_6ac6fcad-33c4-4771-83df-beb764a6e553" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aa25241-a1e9-4788-9b27-cf2fa74beb5e" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_6ac6fcad-33c4-4771-83df-beb764a6e553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_dc6d055d-cd9d-4ce0-ba23-e4ad1eda943c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4aa25241-a1e9-4788-9b27-cf2fa74beb5e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_dc6d055d-cd9d-4ce0-ba23-e4ad1eda943c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="fldm-20220331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c15b5703-044e-4565-b114-d64c36893bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1d2fb1e6-c48e-42ef-bf59-777df90f33c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c15b5703-044e-4565-b114-d64c36893bb8" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_1d2fb1e6-c48e-42ef-bf59-777df90f33c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d5327f8a-e296-4ecd-8870-4fbb56b9cd63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c15b5703-044e-4565-b114-d64c36893bb8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d5327f8a-e296-4ecd-8870-4fbb56b9cd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_214cff7b-da4b-4350-8a53-cfc583debb82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_b1481ac0-f7ff-44f0-b469-ff87fcfb7f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_214cff7b-da4b-4350-8a53-cfc583debb82" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_b1481ac0-f7ff-44f0-b469-ff87fcfb7f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f291991f-4254-4a83-91dd-8ab4c8b6f8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_462ea976-d8c5-4155-8972-c79b92052090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f291991f-4254-4a83-91dd-8ab4c8b6f8d9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_462ea976-d8c5-4155-8972-c79b92052090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d033e7bc-a195-48dd-a005-9b30d1ffabe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_462ea976-d8c5-4155-8972-c79b92052090" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d033e7bc-a195-48dd-a005-9b30d1ffabe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_295e1225-f502-4eb1-9f9e-ce285c5afc82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d033e7bc-a195-48dd-a005-9b30d1ffabe0" xlink:to="loc_us-gaap_EquityComponentDomain_295e1225-f502-4eb1-9f9e-ce285c5afc82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_29ffa908-647b-480f-9594-63a5a0db6e13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_295e1225-f502-4eb1-9f9e-ce285c5afc82" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_29ffa908-647b-480f-9594-63a5a0db6e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_83dfb1b8-9d1c-481e-92ab-331e7f761576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_295e1225-f502-4eb1-9f9e-ce285c5afc82" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_83dfb1b8-9d1c-481e-92ab-331e7f761576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1494ca3a-2c60-479c-a8da-07baad4aead8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_295e1225-f502-4eb1-9f9e-ce285c5afc82" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1494ca3a-2c60-479c-a8da-07baad4aead8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_04db14e4-7fb0-41e5-ad18-8a5355a109fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_462ea976-d8c5-4155-8972-c79b92052090" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_04db14e4-7fb0-41e5-ad18-8a5355a109fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_725b66c0-d5d0-435d-a65b-cc8a06eec9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_04db14e4-7fb0-41e5-ad18-8a5355a109fb" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_725b66c0-d5d0-435d-a65b-cc8a06eec9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e00b9b66-d3e6-46d4-8f2e-d88ce01d4a99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_725b66c0-d5d0-435d-a65b-cc8a06eec9ed" xlink:to="loc_us-gaap_StockholdersEquity_e00b9b66-d3e6-46d4-8f2e-d88ce01d4a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2bf19e63-cebc-4ad1-8a3f-d62da0852212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_725b66c0-d5d0-435d-a65b-cc8a06eec9ed" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2bf19e63-cebc-4ad1-8a3f-d62da0852212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7f6f2dd4-7dd4-4515-b252-83d8fcf5991b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_725b66c0-d5d0-435d-a65b-cc8a06eec9ed" xlink:to="loc_us-gaap_StockholdersEquity_7f6f2dd4-7dd4-4515-b252-83d8fcf5991b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9242e3e5-37dd-47f7-a6a6-7f8a412b91e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9cf921a3-45fd-476f-844e-eef4c71b3b33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9242e3e5-37dd-47f7-a6a6-7f8a412b91e7" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9cf921a3-45fd-476f-844e-eef4c71b3b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_56e44c49-b73b-4220-96a1-fc05cbc13e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9cf921a3-45fd-476f-844e-eef4c71b3b33" xlink:to="loc_us-gaap_DebtInstrumentAxis_56e44c49-b73b-4220-96a1-fc05cbc13e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_46fd4681-be2d-4974-976b-5db0f942fd72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_56e44c49-b73b-4220-96a1-fc05cbc13e0e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_46fd4681-be2d-4974-976b-5db0f942fd72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_BridgeLoansMember_b8c33f1e-75ac-43be-aa14-1fac36dda29e" xlink:href="fldm-20220331.xsd#fldm_BridgeLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_46fd4681-be2d-4974-976b-5db0f942fd72" xlink:to="loc_fldm_BridgeLoansMember_b8c33f1e-75ac-43be-aa14-1fac36dda29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineteenConvertibleNotesMember_f70eaa92-be34-468b-a602-ad13489e6e90" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndNineteenConvertibleNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_46fd4681-be2d-4974-976b-5db0f942fd72" xlink:to="loc_fldm_TwoThousandAndNineteenConvertibleNotesMember_f70eaa92-be34-468b-a602-ad13489e6e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_50459d72-b856-42d1-b002-382d35c4ff1d" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_46fd4681-be2d-4974-976b-5db0f942fd72" xlink:to="loc_fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember_50459d72-b856-42d1-b002-382d35c4ff1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndFourteenConvertibleNotesMember_942ecadb-745c-48f2-81aa-8f57ddcad388" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndFourteenConvertibleNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_46fd4681-be2d-4974-976b-5db0f942fd72" xlink:to="loc_fldm_TwoThousandAndFourteenConvertibleNotesMember_942ecadb-745c-48f2-81aa-8f57ddcad388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_473fffb4-05b0-46bc-9c16-e60fb3e703e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9cf921a3-45fd-476f-844e-eef4c71b3b33" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_473fffb4-05b0-46bc-9c16-e60fb3e703e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0d0177b4-da01-47bb-9cad-7516254e0027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_473fffb4-05b0-46bc-9c16-e60fb3e703e3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0d0177b4-da01-47bb-9cad-7516254e0027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_9cd2dced-65d2-4d45-8093-a4fcd16187a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0d0177b4-da01-47bb-9cad-7516254e0027" xlink:to="loc_us-gaap_StockCompensationPlanMember_9cd2dced-65d2-4d45-8093-a4fcd16187a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_7bc4c30e-3615-49ca-98bb-42d1015e6f3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BridgeLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0d0177b4-da01-47bb-9cad-7516254e0027" xlink:to="loc_us-gaap_BridgeLoanMember_7bc4c30e-3615-49ca-98bb-42d1015e6f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_9dfaea47-cce6-4a5b-b1cb-d416eb581fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0d0177b4-da01-47bb-9cad-7516254e0027" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_9dfaea47-cce6-4a5b-b1cb-d416eb581fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_e6c89a42-830f-41eb-a63a-14d59249ffd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0d0177b4-da01-47bb-9cad-7516254e0027" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_e6c89a42-830f-41eb-a63a-14d59249ffd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_03665b31-cbb5-4a95-822c-01866c14a027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9cf921a3-45fd-476f-844e-eef4c71b3b33" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_03665b31-cbb5-4a95-822c-01866c14a027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_223fdc72-9f6e-47da-93c7-6dd1ced680da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_03665b31-cbb5-4a95-822c-01866c14a027" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_223fdc72-9f6e-47da-93c7-6dd1ced680da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/PrivatePlacementIssuance" xlink:type="simple" xlink:href="fldm-20220331.xsd#PrivatePlacementIssuance"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/PrivatePlacementIssuance" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_241049ea-8271-43aa-a9ab-9fbbb3ce6b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtAndEquityIssuanceTextBlock_cab63cc9-1ab6-4712-8f26-6f69781ae0a8" xlink:href="fldm-20220331.xsd#fldm_DebtAndEquityIssuanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_241049ea-8271-43aa-a9ab-9fbbb3ce6b8e" xlink:to="loc_fldm_DebtAndEquityIssuanceTextBlock_cab63cc9-1ab6-4712-8f26-6f69781ae0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/PrivatePlacementIssuanceTables" xlink:type="simple" xlink:href="fldm-20220331.xsd#PrivatePlacementIssuanceTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/PrivatePlacementIssuanceTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f86cb2c2-1a5e-4fcc-a57a-33c35d78dc16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_2e30c0be-11a0-4625-8e9d-a7c1b61b0412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f86cb2c2-1a5e-4fcc-a57a-33c35d78dc16" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_2e30c0be-11a0-4625-8e9d-a7c1b61b0412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#PrivatePlacementIssuanceNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0147f34b-d7ca-48f2-98a8-708fade510fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0147f34b-d7ca-48f2-98a8-708fade510fb" xlink:to="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_78cbb2d8-51ca-4c0f-a542-c222d59140ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_78cbb2d8-51ca-4c0f-a542-c222d59140ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_78331069-3f88-438d-a779-49429b66fc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_78cbb2d8-51ca-4c0f-a542-c222d59140ed" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_78331069-3f88-438d-a779-49429b66fc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_79fba416-18d0-41c8-a46d-d86d280ae8c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BridgeLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_78331069-3f88-438d-a779-49429b66fc74" xlink:to="loc_us-gaap_BridgeLoanMember_79fba416-18d0-41c8-a46d-d86d280ae8c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c078506f-9c0e-4c15-8eca-49fffe87d2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c078506f-9c0e-4c15-8eca-49fffe87d2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8d0a5d0d-937a-4f26-80ff-682056d2932d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c078506f-9c0e-4c15-8eca-49fffe87d2ec" xlink:to="loc_us-gaap_ClassOfStockDomain_8d0a5d0d-937a-4f26-80ff-682056d2932d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_021ce81d-33c6-4d15-88af-eb72161534e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8d0a5d0d-937a-4f26-80ff-682056d2932d" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_021ce81d-33c6-4d15-88af-eb72161534e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_8fc0288a-1468-495c-a412-bde1e2468348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8d0a5d0d-937a-4f26-80ff-682056d2932d" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_8fc0288a-1468-495c-a412-bde1e2468348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeriesB1ConvertiblePreferredStockMember_a4df7f8a-757f-47be-8a46-0b2200d97a28" xlink:href="fldm-20220331.xsd#fldm_SeriesB1ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeriesBPreferredStockMember_8fc0288a-1468-495c-a412-bde1e2468348" xlink:to="loc_fldm_SeriesB1ConvertiblePreferredStockMember_a4df7f8a-757f-47be-8a46-0b2200d97a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeriesB2ConvertiblePreferredStockMember_3a7de038-81ff-4106-ad7b-b63159c09997" xlink:href="fldm-20220331.xsd#fldm_SeriesB2ConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeriesBPreferredStockMember_8fc0288a-1468-495c-a412-bde1e2468348" xlink:to="loc_fldm_SeriesB2ConvertiblePreferredStockMember_3a7de038-81ff-4106-ad7b-b63159c09997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_75853c9e-edd0-458f-b394-746b0b476128" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:to="loc_srt_CounterpartyNameAxis_75853c9e-edd0-458f-b394-746b0b476128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_20f6b34e-dcf0-404b-b07c-ad6e7d5a6b75" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_75853c9e-edd0-458f-b394-746b0b476128" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_20f6b34e-dcf0-404b-b07c-ad6e7d5a6b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CasdinMember_c9349f51-b9e1-4a39-bf68-59119942642d" xlink:href="fldm-20220331.xsd#fldm_CasdinMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_20f6b34e-dcf0-404b-b07c-ad6e7d5a6b75" xlink:to="loc_fldm_CasdinMember_c9349f51-b9e1-4a39-bf68-59119942642d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_VikingMember_1e83fb51-8160-43f4-bec0-7d597f078810" xlink:href="fldm-20220331.xsd#fldm_VikingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_20f6b34e-dcf0-404b-b07c-ad6e7d5a6b75" xlink:to="loc_fldm_VikingMember_1e83fb51-8160-43f4-bec0-7d597f078810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodAxis_29e8e44d-aad5-4652-981e-e68dd102ad27" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:to="loc_fldm_DebtCovenantPeriodAxis_29e8e44d-aad5-4652-981e-e68dd102ad27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodDomain_2275e6d6-8b72-4745-b418-36725f39229b" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_DebtCovenantPeriodAxis_29e8e44d-aad5-4652-981e-e68dd102ad27" xlink:to="loc_fldm_DebtCovenantPeriodDomain_2275e6d6-8b72-4745-b418-36725f39229b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodOneMember_592e47e9-a1e1-4357-b903-ee609432b997" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_DebtCovenantPeriodDomain_2275e6d6-8b72-4745-b418-36725f39229b" xlink:to="loc_fldm_DebtCovenantPeriodOneMember_592e47e9-a1e1-4357-b903-ee609432b997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodTwoMember_316ec36a-6b37-4429-9536-37b9c20044ad" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_DebtCovenantPeriodDomain_2275e6d6-8b72-4745-b418-36725f39229b" xlink:to="loc_fldm_DebtCovenantPeriodTwoMember_316ec36a-6b37-4429-9536-37b9c20044ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodThreeMember_a23d56d5-7be0-4a82-b5cb-901fa466e52f" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_DebtCovenantPeriodDomain_2275e6d6-8b72-4745-b418-36725f39229b" xlink:to="loc_fldm_DebtCovenantPeriodThreeMember_a23d56d5-7be0-4a82-b5cb-901fa466e52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtCovenantPeriodFourMember_91a1dde7-99f0-4718-950c-79cb1d149069" xlink:href="fldm-20220331.xsd#fldm_DebtCovenantPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_DebtCovenantPeriodDomain_2275e6d6-8b72-4745-b418-36725f39229b" xlink:to="loc_fldm_DebtCovenantPeriodFourMember_91a1dde7-99f0-4718-950c-79cb1d149069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_aa3d8550-af51-41d9-8451-e04278f6bb66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_aa3d8550-af51-41d9-8451-e04278f6bb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f70f3b47-533a-4b0a-83c7-f16d27ce8172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_aa3d8550-af51-41d9-8451-e04278f6bb66" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f70f3b47-533a-4b0a-83c7-f16d27ce8172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_7088fac3-3232-4a30-bc77-119cb09179ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f70f3b47-533a-4b0a-83c7-f16d27ce8172" xlink:to="loc_us-gaap_SubsequentEventMember_7088fac3-3232-4a30-bc77-119cb09179ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_65da6bf6-9994-43f6-a00c-c8f78a236e73" xlink:to="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentFaceAmountPerInstrument_280455c0-f787-4d19-a02b-f7ad50800a1b" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentFaceAmountPerInstrument"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_fldm_DebtInstrumentFaceAmountPerInstrument_280455c0-f787-4d19-a02b-f7ad50800a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c3ec5948-5357-4394-8d3b-6576cce2c98c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c3ec5948-5357-4394-8d3b-6576cce2c98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_cea982f3-00c4-480c-b0ab-eb2b69ca1c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_cea982f3-00c4-480c-b0ab-eb2b69ca1c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a6fdc20d-a233-43d1-9d13-df796ed4f27b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_a6fdc20d-a233-43d1-9d13-df796ed4f27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_f114105d-726d-424b-b95b-321f4e94eb89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_f114105d-726d-424b-b95b-321f4e94eb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_3d3ad89b-6ec5-472b-9e0d-295200979638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_3d3ad89b-6ec5-472b-9e0d-295200979638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_430200e2-48fd-4017-bea7-0117b9f413bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_430200e2-48fd-4017-bea7-0117b9f413bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3af056d2-c70a-4800-8274-9272a9c42d58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3af056d2-c70a-4800-8274-9272a9c42d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued_3828e052-61be-4e99-a65e-adf48bc617a6" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued_3828e052-61be-4e99-a65e-adf48bc617a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor_7298d871-865e-419d-950a-f0af33b84e9d" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor_7298d871-865e-419d-950a-f0af33b84e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_483cb89d-d4e8-40e5-a05d-7bfe5cefbae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_SharePrice_483cb89d-d4e8-40e5-a05d-7bfe5cefbae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_999766bb-94ff-4424-9fdf-34b5c46b690d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_DebtInstrumentFairValue_999766bb-94ff-4424-9fdf-34b5c46b690d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_3f111ba9-64dc-4496-9c43-f9de4d80a962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_3f111ba9-64dc-4496-9c43-f9de4d80a962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PreferredStockFairValueDisclosure_8d2750e6-1677-4b9c-b19c-6a488b3d6e84" xlink:href="fldm-20220331.xsd#fldm_PreferredStockFairValueDisclosure"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_fldm_PreferredStockFairValueDisclosure_8d2750e6-1677-4b9c-b19c-6a488b3d6e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_StockRepurchaseLiability_f687c2d4-8577-4c67-b724-b1ef910cc80d" xlink:href="fldm-20220331.xsd#fldm_StockRepurchaseLiability"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_fldm_StockRepurchaseLiability_f687c2d4-8577-4c67-b724-b1ef910cc80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockConvertibleConversionRatio_9d68f19d-2ca4-4876-a939-21207fab9344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockConvertibleConversionRatio"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_PreferredStockConvertibleConversionRatio_9d68f19d-2ca4-4876-a939-21207fab9344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6dfb06bc-9a55-4668-a921-b436598773a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_6dfb06bc-9a55-4668-a921-b436598773a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_68522b0c-25d4-4ba4-8f4e-19cd88c5c149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_68522b0c-25d4-4ba4-8f4e-19cd88c5c149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare_ea52768f-6059-4b6f-820e-f126b573ebb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare_ea52768f-6059-4b6f-820e-f126b573ebb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_71c2ea2b-701e-4c06-9ef9-68d02eced810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17d45fe2-2a77-4ac5-a2b6-010b980faee5" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_71c2ea2b-701e-4c06-9ef9-68d02eced810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6c199f13-0651-4a50-b79b-d5db3fcf7834" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c29a8a59-b11e-4937-bac1-026bead9c1f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6c199f13-0651-4a50-b79b-d5db3fcf7834" xlink:to="loc_us-gaap_DebtInstrumentTable_c29a8a59-b11e-4937-bac1-026bead9c1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_591a4ff9-3789-4709-86e9-a88db16108a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c29a8a59-b11e-4937-bac1-026bead9c1f2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_591a4ff9-3789-4709-86e9-a88db16108a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8fed9d35-790a-4860-9d86-1b70163a17df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_591a4ff9-3789-4709-86e9-a88db16108a7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8fed9d35-790a-4860-9d86-1b70163a17df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_4baa74d5-e6a3-4b2b-90bf-4071e63bb283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BridgeLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8fed9d35-790a-4860-9d86-1b70163a17df" xlink:to="loc_us-gaap_BridgeLoanMember_4baa74d5-e6a3-4b2b-90bf-4071e63bb283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c29a8a59-b11e-4937-bac1-026bead9c1f2" xlink:to="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_cc0e54d7-4c0d-4314-819f-3caa98e2684f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_cc0e54d7-4c0d-4314-819f-3caa98e2684f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_b8ac6177-d04d-409e-9752-f7b07325fc84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_b8ac6177-d04d-409e-9752-f7b07325fc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_5b9dde9f-439c-45ff-97ef-c130d9e4d168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_5b9dde9f-439c-45ff-97ef-c130d9e4d168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_cec54c23-f570-40d4-aafe-7facc79b9aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:to="loc_us-gaap_DebtSecuritiesUnrealizedGainLoss_cec54c23-f570-40d4-aafe-7facc79b9aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_60c65df2-1438-4b54-96c0-be3a02d974d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_dae85e31-e052-4eb8-9bcc-f6236782fef3" xlink:to="loc_us-gaap_DebtInstrumentFairValue_60c65df2-1438-4b54-96c0-be3a02d974d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/NIHContract" xlink:type="simple" xlink:href="fldm-20220331.xsd#NIHContract"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/NIHContract" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_d95961e2-be25-4197-80a2-a6c5c232e738" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_f134dfc5-dbca-4b74-bd4f-755ee054a282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_d95961e2-be25-4197-80a2-a6c5c232e738" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_f134dfc5-dbca-4b74-bd4f-755ee054a282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/NIHContractTables" xlink:type="simple" xlink:href="fldm-20220331.xsd#NIHContractTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/NIHContractTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_da9e61c3-62a7-484d-befb-7d05119fef8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock_3702b9ca-0600-49f6-8b2f-385f4b82ce02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_da9e61c3-62a7-484d-befb-7d05119fef8c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock_3702b9ca-0600-49f6-8b2f-385f4b82ce02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/NIHContractNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#NIHContractNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/NIHContractNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_ed2ac042-6743-41af-b399-319250d8a756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_ba68d5a6-4471-4cca-8ad6-238c4329e89d" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_ed2ac042-6743-41af-b399-319250d8a756" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue_ba68d5a6-4471-4cca-8ad6-238c4329e89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred_935b80ab-4d58-4642-a181-03d5c13a8cde" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_ed2ac042-6743-41af-b399-319250d8a756" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred_935b80ab-4d58-4642-a181-03d5c13a8cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures_928da79d-9216-4b69-a727-4dd66000a8a6" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_ed2ac042-6743-41af-b399-319250d8a756" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures_928da79d-9216-4b69-a727-4dd66000a8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross_04e20885-bb21-4c9b-96ce-144830c131a3" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_ed2ac042-6743-41af-b399-319250d8a756" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross_04e20885-bb21-4c9b-96ce-144830c131a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross_0b511bc5-10a6-4149-b9da-e4bfc6caa34f" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_ed2ac042-6743-41af-b399-319250d8a756" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross_0b511bc5-10a6-4149-b9da-e4bfc6caa34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/NIHContractDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#NIHContractDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/NIHContractDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_9ed4977f-e315-4fdf-82c3-a3bed8e0da68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_33bd18a6-116d-477f-8f74-8aea03ec5c5a" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_9ed4977f-e315-4fdf-82c3-a3bed8e0da68" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount_33bd18a6-116d-477f-8f74-8aea03ec5c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses_d8f578b5-3e38-4c7d-a105-8475715410aa" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_9ed4977f-e315-4fdf-82c3-a3bed8e0da68" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses_d8f578b5-3e38-4c7d-a105-8475715410aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses_2ec77ad7-5a69-48b0-9fc6-22e012b11324" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_9ed4977f-e315-4fdf-82c3-a3bed8e0da68" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses_2ec77ad7-5a69-48b0-9fc6-22e012b11324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome_ba50e3e7-7847-4fb6-8875-9be043724ea4" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_9ed4977f-e315-4fdf-82c3-a3bed8e0da68" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome_ba50e3e7-7847-4fb6-8875-9be043724ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantRevenue_efe030c3-e819-45b5-a4eb-b4059cd2071d" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_9ed4977f-e315-4fdf-82c3-a3bed8e0da68" xlink:to="loc_fldm_DeferredGrantRevenue_efe030c3-e819-45b5-a4eb-b4059cd2071d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross_f883f7eb-7b6f-41d5-ad1c-a25009bd20cd" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_9ed4977f-e315-4fdf-82c3-a3bed8e0da68" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross_f883f7eb-7b6f-41d5-ad1c-a25009bd20cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross_ccd1cb70-67a1-4b2c-a34f-0493ca584700" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_9ed4977f-e315-4fdf-82c3-a3bed8e0da68" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross_ccd1cb70-67a1-4b2c-a34f-0493ca584700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet_340f930d-3bc5-4dcf-a9c2-24208ef8dee9" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_9ed4977f-e315-4fdf-82c3-a3bed8e0da68" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet_340f930d-3bc5-4dcf-a9c2-24208ef8dee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures_b523997b-c9ee-4e1f-827a-1eb36c3f57a8" xlink:href="fldm-20220331.xsd#fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_9ed4977f-e315-4fdf-82c3-a3bed8e0da68" xlink:to="loc_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures_b523997b-c9ee-4e1f-827a-1eb36c3f57a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantIncomeCurrent_52325a3a-2432-417f-80ed-80be670531b6" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantIncomeCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_9ed4977f-e315-4fdf-82c3-a3bed8e0da68" xlink:to="loc_fldm_DeferredGrantIncomeCurrent_52325a3a-2432-417f-80ed-80be670531b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DeferredGrantIncomeNoncurrent_446c14a4-9b6c-40d9-a97e-76adf27866b7" xlink:href="fldm-20220331.xsd#fldm_DeferredGrantIncomeNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_9ed4977f-e315-4fdf-82c3-a3bed8e0da68" xlink:to="loc_fldm_DeferredGrantIncomeNoncurrent_446c14a4-9b6c-40d9-a97e-76adf27866b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DevelopmentAgreement" xlink:type="simple" xlink:href="fldm-20220331.xsd#DevelopmentAgreement"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/DevelopmentAgreement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_04d8d7b8-539f-4482-998f-0e9fb0f6f744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_48db6cb9-685c-4d52-94fe-35a1d6cff7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_04d8d7b8-539f-4482-998f-0e9fb0f6f744" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_48db6cb9-685c-4d52-94fe-35a1d6cff7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DevelopmentAgreementDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#DevelopmentAgreementDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/DevelopmentAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_815096e5-14f7-4e16-bae1-463c4e953b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ac35d96f-dfca-4424-aebb-a745670394ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_815096e5-14f7-4e16-bae1-463c4e953b2a" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ac35d96f-dfca-4424-aebb-a745670394ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5442171a-ef1d-4adf-b3a4-158ce8abc2ee" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ac35d96f-dfca-4424-aebb-a745670394ce" xlink:to="loc_srt_ProductOrServiceAxis_5442171a-ef1d-4adf-b3a4-158ce8abc2ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7888a9af-5715-4aac-bc5c-0e3393c32a94" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5442171a-ef1d-4adf-b3a4-158ce8abc2ee" xlink:to="loc_srt_ProductsAndServicesDomain_7888a9af-5715-4aac-bc5c-0e3393c32a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember_93037097-8abb-4e05-8198-14347b731042" xlink:href="fldm-20220331.xsd#fldm_CollaborationRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7888a9af-5715-4aac-bc5c-0e3393c32a94" xlink:to="loc_fldm_CollaborationRevenueMember_93037097-8abb-4e05-8198-14347b731042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d2e54cd4-8416-48ca-8e51-c4b4b5a2d12d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ac35d96f-dfca-4424-aebb-a745670394ce" xlink:to="loc_srt_CounterpartyNameAxis_d2e54cd4-8416-48ca-8e51-c4b4b5a2d12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_97cdbbe7-53f2-4287-84cb-921bbf447576" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_d2e54cd4-8416-48ca-8e51-c4b4b5a2d12d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_97cdbbe7-53f2-4287-84cb-921bbf447576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_UndisclosedCustomerMember_f3b5fc7e-3607-4225-b7e4-2b1b7fe22b37" xlink:href="fldm-20220331.xsd#fldm_UndisclosedCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_97cdbbe7-53f2-4287-84cb-921bbf447576" xlink:to="loc_fldm_UndisclosedCustomerMember_f3b5fc7e-3607-4225-b7e4-2b1b7fe22b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1605f0f6-d070-470d-a885-a9923e5d8256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_ac35d96f-dfca-4424-aebb-a745670394ce" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1605f0f6-d070-470d-a885-a9923e5d8256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement_6fc3d426-07eb-4889-a52c-4581d5e427f7" xlink:href="fldm-20220331.xsd#fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1605f0f6-d070-470d-a885-a9923e5d8256" xlink:to="loc_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement_6fc3d426-07eb-4889-a52c-4581d5e427f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_36804349-98fe-4b68-bdbb-aff86e24d6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_1605f0f6-d070-470d-a885-a9923e5d8256" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_36804349-98fe-4b68-bdbb-aff86e24d6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/Revenue" xlink:type="simple" xlink:href="fldm-20220331.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5459dac7-f3e4-4bca-88b8-12a1b8370a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_389334c2-9b51-40e1-b6cc-2126e2d2bf67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5459dac7-f3e4-4bca-88b8-12a1b8370a95" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_389334c2-9b51-40e1-b6cc-2126e2d2bf67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenueTables" xlink:type="simple" xlink:href="fldm-20220331.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_89fbc33d-6889-428a-b3bc-300c45148589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_ec0102b2-9de5-417d-afab-12420aefbcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_89fbc33d-6889-428a-b3bc-300c45148589" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_ec0102b2-9de5-417d-afab-12420aefbcd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_b68bd036-fa1d-4b94-b5f8-6382467ebb69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_89fbc33d-6889-428a-b3bc-300c45148589" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_b68bd036-fa1d-4b94-b5f8-6382467ebb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#RevenueScheduleofDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_03e3256b-1c7d-4025-9a2e-1beaeb00faaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_0f36008f-6731-465c-96c6-d7c14ef58a01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_03e3256b-1c7d-4025-9a2e-1beaeb00faaa" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_0f36008f-6731-465c-96c6-d7c14ef58a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a0add2be-5b23-4db6-91b6-f06898647137" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0f36008f-6731-465c-96c6-d7c14ef58a01" xlink:to="loc_srt_StatementGeographicalAxis_a0add2be-5b23-4db6-91b6-f06898647137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f60ef74d-8d73-4148-96ca-87785e264a67" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a0add2be-5b23-4db6-91b6-f06898647137" xlink:to="loc_srt_SegmentGeographicalDomain_f60ef74d-8d73-4148-96ca-87785e264a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_2158db7e-4eda-44c2-8223-aa887f775f2b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AmericasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f60ef74d-8d73-4148-96ca-87785e264a67" xlink:to="loc_srt_AmericasMember_2158db7e-4eda-44c2-8223-aa887f775f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_1db9ffa3-c95b-439f-8fbc-e794335cfd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f60ef74d-8d73-4148-96ca-87785e264a67" xlink:to="loc_us-gaap_EMEAMember_1db9ffa3-c95b-439f-8fbc-e794335cfd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_57bc9e32-a812-4750-8acb-a8bb7dc339e6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f60ef74d-8d73-4148-96ca-87785e264a67" xlink:to="loc_srt_AsiaPacificMember_57bc9e32-a812-4750-8acb-a8bb7dc339e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b913d50c-0c13-4988-a429-dead110c2f95" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0f36008f-6731-465c-96c6-d7c14ef58a01" xlink:to="loc_srt_ProductOrServiceAxis_b913d50c-0c13-4988-a429-dead110c2f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b913d50c-0c13-4988-a429-dead110c2f95" xlink:to="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstrumentsMember_6834f658-89d7-4d24-8b75-f78801cb88d4" xlink:href="fldm-20220331.xsd#fldm_InstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_fldm_InstrumentsMember_6834f658-89d7-4d24-8b75-f78801cb88d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ConsumablesMember_7f5a8123-f59c-4ff5-9591-1aef01805209" xlink:href="fldm-20220331.xsd#fldm_ConsumablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_fldm_ConsumablesMember_7f5a8123-f59c-4ff5-9591-1aef01805209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_65ad2a27-af59-448c-9940-66d18f52ad26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_us-gaap_ProductMember_65ad2a27-af59-448c-9940-66d18f52ad26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_49095d3c-1523-4dc8-844c-d1f7c6e8c9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_us-gaap_ServiceMember_49095d3c-1523-4dc8-844c-d1f7c6e8c9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CollaborationRevenueMember_02e3a1fe-7239-45ce-a24e-5b52b92dc065" xlink:href="fldm-20220331.xsd#fldm_CollaborationRevenueMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_fldm_CollaborationRevenueMember_02e3a1fe-7239-45ce-a24e-5b52b92dc065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_7be950d4-1a57-499d-9530-e492459a344b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_us-gaap_LicenseMember_7be950d4-1a57-499d-9530-e492459a344b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantMember_3a12c567-3649-49bd-87c1-156ae1672ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_us-gaap_GrantMember_3a12c567-3649-49bd-87c1-156ae1672ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_540f8d6d-124e-4140-93d0-a978cb0f9965" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6d1d081a-a2df-47a3-b82e-dcef4ff8cf33" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_540f8d6d-124e-4140-93d0-a978cb0f9965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6a6b67ed-b6bf-4ed7-8565-0b17e72283d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_0f36008f-6731-465c-96c6-d7c14ef58a01" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_6a6b67ed-b6bf-4ed7-8565-0b17e72283d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0980989a-eeb5-48ba-a4ce-51e4e1eab263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6a6b67ed-b6bf-4ed7-8565-0b17e72283d9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0980989a-eeb5-48ba-a4ce-51e4e1eab263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ff8d15d9-e2ef-4509-a0f3-ff22b4298bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_ff9b3809-630e-4bdb-8608-ea329c5b4929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ff8d15d9-e2ef-4509-a0f3-ff22b4298bb0" xlink:to="loc_us-gaap_ContractWithCustomerLiability_ff9b3809-630e-4bdb-8608-ea329c5b4929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_11f56ba7-b918-4b21-835d-35ddb39185d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ff8d15d9-e2ef-4509-a0f3-ff22b4298bb0" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_11f56ba7-b918-4b21-835d-35ddb39185d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts_054c037c-2ad6-45d0-8b77-699a40fe87b2" xlink:href="fldm-20220331.xsd#fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ff8d15d9-e2ef-4509-a0f3-ff22b4298bb0" xlink:to="loc_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts_054c037c-2ad6-45d0-8b77-699a40fe87b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#RevenuePerformanceObligationsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/RevenuePerformanceObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_51ac6381-223f-4c2b-b995-c897a5509c45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f678a352-3bea-4104-beaf-73156840828a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_51ac6381-223f-4c2b-b995-c897a5509c45" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f678a352-3bea-4104-beaf-73156840828a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_3d753c43-c811-43c1-a818-fd20e32812c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f678a352-3bea-4104-beaf-73156840828a" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_3d753c43-c811-43c1-a818-fd20e32812c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1e12abd0-0c4c-4fe4-b89f-411344e0c634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_f678a352-3bea-4104-beaf-73156840828a" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1e12abd0-0c4c-4fe4-b89f-411344e0c634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_4c44e27f-4530-42f9-8103-5ae09a7c9be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1e12abd0-0c4c-4fe4-b89f-411344e0c634" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_4c44e27f-4530-42f9-8103-5ae09a7c9be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_20b8b4a7-a7e2-4727-b085-70f2da069de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_1e12abd0-0c4c-4fe4-b89f-411344e0c634" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_20b8b4a7-a7e2-4727-b085-70f2da069de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/RevenuePerformanceObligationsDetails_1" xlink:type="simple" xlink:href="fldm-20220331.xsd#RevenuePerformanceObligationsDetails_1"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/RevenuePerformanceObligationsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnet" xlink:type="simple" xlink:href="fldm-20220331.xsd#GoodwillandIntangibleAssetsnet"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_62bf509c-5b80-4e3e-9f0b-6a0bc5b90491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_8c37dbd4-6da0-4cfc-b010-8d0f386801b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_62bf509c-5b80-4e3e-9f0b-6a0bc5b90491" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_8c37dbd4-6da0-4cfc-b010-8d0f386801b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables" xlink:type="simple" xlink:href="fldm-20220331.xsd#GoodwillandIntangibleAssetsnetTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3af87560-17df-4af3-b20b-bd7207d7d966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_bd5038e5-b0ce-4159-82fc-98f6639b29fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3af87560-17df-4af3-b20b-bd7207d7d966" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_bd5038e5-b0ce-4159-82fc-98f6639b29fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_6aa6a9e2-01e8-4871-983c-935a771b7fab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3af87560-17df-4af3-b20b-bd7207d7d966" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_6aa6a9e2-01e8-4871-983c-935a771b7fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#GoodwillandIntangibleAssetsnetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e8c8ea83-483e-406e-a854-36b04fb57dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9dd1243f-678b-4fbe-95a0-ddb22d1fb3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e8c8ea83-483e-406e-a854-36b04fb57dae" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9dd1243f-678b-4fbe-95a0-ddb22d1fb3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6d47cc83-2a9c-4abf-b3ba-a7edee4b6b17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9dd1243f-678b-4fbe-95a0-ddb22d1fb3ed" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6d47cc83-2a9c-4abf-b3ba-a7edee4b6b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a3c3cc9-cb34-44fe-8feb-8ef7cbeec18d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6d47cc83-2a9c-4abf-b3ba-a7edee4b6b17" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a3c3cc9-cb34-44fe-8feb-8ef7cbeec18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DVSSciencesInc.Member_7ccaeac2-8548-402e-b31d-62a920a1ca34" xlink:href="fldm-20220331.xsd#fldm_DVSSciencesInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a3c3cc9-cb34-44fe-8feb-8ef7cbeec18d" xlink:to="loc_fldm_DVSSciencesInc.Member_7ccaeac2-8548-402e-b31d-62a920a1ca34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InstruNorASMember_2c439303-c014-44f9-af73-bd4a5fd8f57c" xlink:href="fldm-20220331.xsd#fldm_InstruNorASMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a3c3cc9-cb34-44fe-8feb-8ef7cbeec18d" xlink:to="loc_fldm_InstruNorASMember_2c439303-c014-44f9-af73-bd4a5fd8f57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f0c2dd71-d252-4908-a205-c05f30ea3c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9dd1243f-678b-4fbe-95a0-ddb22d1fb3ed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f0c2dd71-d252-4908-a205-c05f30ea3c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c45bdc98-70ed-42f6-986e-6dffb58e18ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f0c2dd71-d252-4908-a205-c05f30ea3c38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c45bdc98-70ed-42f6-986e-6dffb58e18ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_3dc9a0c8-dc94-4b17-bbfc-0eb0b56eb9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c45bdc98-70ed-42f6-986e-6dffb58e18ff" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_3dc9a0c8-dc94-4b17-bbfc-0eb0b56eb9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_94f37339-f3e4-4b72-9eda-829b063ba08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9dd1243f-678b-4fbe-95a0-ddb22d1fb3ed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_94f37339-f3e4-4b72-9eda-829b063ba08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_04a91dc5-a53c-4989-b7b1-088bfc3cc074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_94f37339-f3e4-4b72-9eda-829b063ba08b" xlink:to="loc_us-gaap_Goodwill_04a91dc5-a53c-4989-b7b1-088bfc3cc074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_40fd4b4f-57f8-468a-92ed-4ec896173e46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinitelivedIntangibleAssetsAcquired1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_94f37339-f3e4-4b72-9eda-829b063ba08b" xlink:to="loc_us-gaap_FinitelivedIntangibleAssetsAcquired1_40fd4b4f-57f8-468a-92ed-4ec896173e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f418b309-01a5-4a26-a991-e5378a9ef176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_94f37339-f3e4-4b72-9eda-829b063ba08b" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_f418b309-01a5-4a26-a991-e5378a9ef176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_14424def-de67-4f95-9669-e292d1055b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_94f37339-f3e4-4b72-9eda-829b063ba08b" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_14424def-de67-4f95-9669-e292d1055b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_61e69073-e930-4063-b5a1-dcafe67d6267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c99c8fa5-305f-4d54-8003-a76413fede81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_61e69073-e930-4063-b5a1-dcafe67d6267" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c99c8fa5-305f-4d54-8003-a76413fede81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1b40003b-b85f-4058-92a8-ef485d31ae44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c99c8fa5-305f-4d54-8003-a76413fede81" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1b40003b-b85f-4058-92a8-ef485d31ae44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21850ba6-2cac-45dd-8da0-20272f678156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_1b40003b-b85f-4058-92a8-ef485d31ae44" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21850ba6-2cac-45dd-8da0-20272f678156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_ae5fcae1-f0b4-4459-9745-3633a96b341f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21850ba6-2cac-45dd-8da0-20272f678156" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_ae5fcae1-f0b4-4459-9745-3633a96b341f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PatentsandLicenseAgreementsMember_3ee08e92-d939-42d3-bd71-bd9f2fd512be" xlink:href="fldm-20220331.xsd#fldm_PatentsandLicenseAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21850ba6-2cac-45dd-8da0-20272f678156" xlink:to="loc_fldm_PatentsandLicenseAgreementsMember_3ee08e92-d939-42d3-bd71-bd9f2fd512be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d321c4f2-71a2-4ef4-b62d-ddba03a36a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_c99c8fa5-305f-4d54-8003-a76413fede81" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d321c4f2-71a2-4ef4-b62d-ddba03a36a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5560428f-8e28-4c46-8ac1-1531785239d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d321c4f2-71a2-4ef4-b62d-ddba03a36a1a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_5560428f-8e28-4c46-8ac1-1531785239d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_02a4b27a-deac-46b3-a03c-c75294ef9e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d321c4f2-71a2-4ef4-b62d-ddba03a36a1a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_02a4b27a-deac-46b3-a03c-c75294ef9e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_22295ae3-ec7b-4715-9759-8a9079171dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d321c4f2-71a2-4ef4-b62d-ddba03a36a1a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_22295ae3-ec7b-4715-9759-8a9079171dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_5156cf76-21c6-4a0b-b47e-663438a40501" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d321c4f2-71a2-4ef4-b62d-ddba03a36a1a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_5156cf76-21c6-4a0b-b47e-663438a40501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5740d867-df27-4bce-955e-a594679f249c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8395be46-da20-4ef0-82bd-85d77d88694a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5740d867-df27-4bce-955e-a594679f249c" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8395be46-da20-4ef0-82bd-85d77d88694a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d0256f37-559e-4030-9b33-21a39ae7555a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8395be46-da20-4ef0-82bd-85d77d88694a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d0256f37-559e-4030-9b33-21a39ae7555a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4402a817-e9f4-49a8-bb27-05395997ef4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d0256f37-559e-4030-9b33-21a39ae7555a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4402a817-e9f4-49a8-bb27-05395997ef4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_81abd028-72d2-4060-8a7f-38601ccf7b90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4402a817-e9f4-49a8-bb27-05395997ef4d" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_81abd028-72d2-4060-8a7f-38601ccf7b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PatentsandLicenseAgreementsMember_1da24183-4c44-4bf3-acae-dd2294db5f8d" xlink:href="fldm-20220331.xsd#fldm_PatentsandLicenseAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4402a817-e9f4-49a8-bb27-05395997ef4d" xlink:to="loc_fldm_PatentsandLicenseAgreementsMember_1da24183-4c44-4bf3-acae-dd2294db5f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8395be46-da20-4ef0-82bd-85d77d88694a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_954f7698-b792-46de-8e34-c8702e0c38ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_954f7698-b792-46de-8e34-c8702e0c38ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b0c609f9-4de2-4c49-a6c2-2fa8c7d23d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b0c609f9-4de2-4c49-a6c2-2fa8c7d23d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2ae11cc6-0b83-4013-a161-78477f9887de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_2ae11cc6-0b83-4013-a161-78477f9887de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_390f30c9-6395-49fc-a2a5-9a37028194e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_390f30c9-6395-49fc-a2a5-9a37028194e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_aaaa2a84-b090-410f-8c4b-b163f9e7ceaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_aaaa2a84-b090-410f-8c4b-b163f9e7ceaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_5c1422c1-1e6d-481d-8ef0-1b456b8b5372" xlink:href="fldm-20220331.xsd#fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_5c1422c1-1e6d-481d-8ef0-1b456b8b5372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_59036526-8ce8-40cd-bdb6-8d024f64bc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_006dc875-db0a-4c70-a80f-6c827db8983a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_59036526-8ce8-40cd-bdb6-8d024f64bc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#BalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0e82ddbc-5d75-4e1f-8de4-bb67574e4396" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_85a510f9-0158-4ad7-9833-9e70ab78830f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_0e82ddbc-5d75-4e1f-8de4-bb67574e4396" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_85a510f9-0158-4ad7-9833-9e70ab78830f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsTables" xlink:type="simple" xlink:href="fldm-20220331.xsd#BalanceSheetDetailsTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ec43df62-145f-4ed4-995a-6564c2c6f088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_73194617-6e44-4528-942d-1ef8ad8a4d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ec43df62-145f-4ed4-995a-6564c2c6f088" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_73194617-6e44-4528-942d-1ef8ad8a4d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_a436e238-debc-44cc-9f7e-78f90905139d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ec43df62-145f-4ed4-995a-6564c2c6f088" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_a436e238-debc-44cc-9f7e-78f90905139d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_35de0fa0-4c49-438c-90bf-2041598e31e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ec43df62-145f-4ed4-995a-6564c2c6f088" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_35de0fa0-4c49-438c-90bf-2041598e31e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_99b720eb-55cf-463e-ac1d-94a4bdeb65bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ec43df62-145f-4ed4-995a-6564c2c6f088" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_99b720eb-55cf-463e-ac1d-94a4bdeb65bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_ab120882-4ef6-4100-8233-b398c6dc363f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ec43df62-145f-4ed4-995a-6564c2c6f088" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_ab120882-4ef6-4100-8233-b398c6dc363f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_ffaffb1a-2471-400a-9824-0ce4fd794a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ec43df62-145f-4ed4-995a-6564c2c6f088" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_ffaffb1a-2471-400a-9824-0ce4fd794a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b835f32b-a70f-4b9e-9483-1174f4c58e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_801796d4-dfea-484c-afa5-fc3edd54d895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b835f32b-a70f-4b9e-9483-1174f4c58e15" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_801796d4-dfea-484c-afa5-fc3edd54d895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_bee976b1-3fd4-473c-ad91-3fd41d946e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b835f32b-a70f-4b9e-9483-1174f4c58e15" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue_bee976b1-3fd4-473c-ad91-3fd41d946e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_632074f1-0710-40f1-855f-ccf0ded7fd75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b835f32b-a70f-4b9e-9483-1174f4c58e15" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_632074f1-0710-40f1-855f-ccf0ded7fd75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_270d72f6-5ccf-4f8f-b043-f7d9a86a19eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b835f32b-a70f-4b9e-9483-1174f4c58e15" xlink:to="loc_us-gaap_RestrictedCashCurrent_270d72f6-5ccf-4f8f-b043-f7d9a86a19eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_a2c53785-46b5-4774-8f10-9464ad994f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_b835f32b-a70f-4b9e-9483-1174f4c58e15" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_a2c53785-46b5-4774-8f10-9464ad994f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#BalanceSheetDetailsInventoriesDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_a4e52715-e10d-4644-a599-ea0291d48a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_2f4e13bf-c725-4f3d-a605-2297e10bc5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_a4e52715-e10d-4644-a599-ea0291d48a4c" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_2f4e13bf-c725-4f3d-a605-2297e10bc5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2e47f362-e3cc-4425-b0dc-6f3542c5fe0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_a4e52715-e10d-4644-a599-ea0291d48a4c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2e47f362-e3cc-4425-b0dc-6f3542c5fe0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_52c544de-76f8-4663-a714-7ea2e86cb531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_a4e52715-e10d-4644-a599-ea0291d48a4c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_52c544de-76f8-4663-a714-7ea2e86cb531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_10bc9182-dc37-4b11-aa77-777e827c2eae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_a4e52715-e10d-4644-a599-ea0291d48a4c" xlink:to="loc_us-gaap_InventoryNet_10bc9182-dc37-4b11-aa77-777e827c2eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#BalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_866ab043-4555-45cb-8622-d7ffa383ca9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4ff21fb7-02d0-4d5d-82bc-1b0e92cf3da9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_866ab043-4555-45cb-8622-d7ffa383ca9f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4ff21fb7-02d0-4d5d-82bc-1b0e92cf3da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_353c7cc2-1b74-43be-b4c1-825328be6270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4ff21fb7-02d0-4d5d-82bc-1b0e92cf3da9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_353c7cc2-1b74-43be-b4c1-825328be6270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca9de6fe-f21b-483c-aa9c-145c37976bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_353c7cc2-1b74-43be-b4c1-825328be6270" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca9de6fe-f21b-483c-aa9c-145c37976bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ComputerEquipmentAndSoftwareMember_e62d8b36-e453-4cf8-8fa2-ab9ba7b992c7" xlink:href="fldm-20220331.xsd#fldm_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca9de6fe-f21b-483c-aa9c-145c37976bb7" xlink:to="loc_fldm_ComputerEquipmentAndSoftwareMember_e62d8b36-e453-4cf8-8fa2-ab9ba7b992c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LaboratoryAndManufacturingEquipmentMember_e7229db2-5d17-48ef-9bbd-3c6dd4ace4ba" xlink:href="fldm-20220331.xsd#fldm_LaboratoryAndManufacturingEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca9de6fe-f21b-483c-aa9c-145c37976bb7" xlink:to="loc_fldm_LaboratoryAndManufacturingEquipmentMember_e7229db2-5d17-48ef-9bbd-3c6dd4ace4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_84535e91-5b3e-4365-a79c-6080b3ea0e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca9de6fe-f21b-483c-aa9c-145c37976bb7" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_84535e91-5b3e-4365-a79c-6080b3ea0e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_ecde8eae-e4a4-45bb-8cfa-f3e945db6e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ca9de6fe-f21b-483c-aa9c-145c37976bb7" xlink:to="loc_us-gaap_OfficeEquipmentMember_ecde8eae-e4a4-45bb-8cfa-f3e945db6e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e1791753-a788-4dc7-89d5-55fc52671caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_4ff21fb7-02d0-4d5d-82bc-1b0e92cf3da9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e1791753-a788-4dc7-89d5-55fc52671caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a0f7a7fc-f8bc-43b3-8b17-673443074173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e1791753-a788-4dc7-89d5-55fc52671caa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a0f7a7fc-f8bc-43b3-8b17-673443074173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b76eff15-04b3-4372-a28d-0c09424e2f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e1791753-a788-4dc7-89d5-55fc52671caa" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_b76eff15-04b3-4372-a28d-0c09424e2f18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_61e902aa-925d-4843-8e85-14a320b6e7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e1791753-a788-4dc7-89d5-55fc52671caa" xlink:to="loc_us-gaap_ConstructionInProgressGross_61e902aa-925d-4843-8e85-14a320b6e7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_55168b7e-ae31-4b12-b986-08fc5d0e8d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_e1791753-a788-4dc7-89d5-55fc52671caa" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_55168b7e-ae31-4b12-b986-08fc5d0e8d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f20207d9-3e3b-49c6-8e0c-c8eaeb8c3b56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_170b3854-b0c2-4ac5-84c6-04cfa9d0634d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f20207d9-3e3b-49c6-8e0c-c8eaeb8c3b56" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_170b3854-b0c2-4ac5-84c6-04cfa9d0634d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent_97b3d1c0-1703-4ca9-bc97-48baf402598a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f20207d9-3e3b-49c6-8e0c-c8eaeb8c3b56" xlink:to="loc_us-gaap_AccruedVacationCurrent_97b3d1c0-1703-4ca9-bc97-48baf402598a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent_5cae8e99-b6b5-4508-aa54-d63ebbb4fe92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f20207d9-3e3b-49c6-8e0c-c8eaeb8c3b56" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrent_5cae8e99-b6b5-4508-aa54-d63ebbb4fe92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent_930fb4af-99b7-4c84-ac3d-cc2a46cea162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f20207d9-3e3b-49c6-8e0c-c8eaeb8c3b56" xlink:to="loc_us-gaap_AccruedBonusesCurrent_930fb4af-99b7-4c84-ac3d-cc2a46cea162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b65e95f7-cb9d-4d1a-9404-3a2497e23e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f20207d9-3e3b-49c6-8e0c-c8eaeb8c3b56" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b65e95f7-cb9d-4d1a-9404-3a2497e23e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_AccruedBonusesNoncurrent_35fa2c7d-9ea7-40db-9a0c-2ef5933c921a" xlink:href="fldm-20220331.xsd#fldm_AccruedBonusesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_f20207d9-3e3b-49c6-8e0c-c8eaeb8c3b56" xlink:to="loc_fldm_AccruedBonusesNoncurrent_35fa2c7d-9ea7-40db-9a0c-2ef5933c921a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#BalanceSheetDetailsWarrantyAccrualDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_54e96603-2855-4e9f-9165-54c59dfd9dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12b82744-8213-4f7d-b131-f4db4e710b89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_54e96603-2855-4e9f-9165-54c59dfd9dd5" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12b82744-8213-4f7d-b131-f4db4e710b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_b6e07d03-5fc6-40da-bdfb-ec187f711213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12b82744-8213-4f7d-b131-f4db4e710b89" xlink:to="loc_us-gaap_ProductWarrantyAccrual_b6e07d03-5fc6-40da-bdfb-ec187f711213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease_7d0b7de2-7d7c-44ff-9131-b39d178041d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12b82744-8213-4f7d-b131-f4db4e710b89" xlink:to="loc_us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease_7d0b7de2-7d7c-44ff-9131-b39d178041d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_1def0d9d-8e60-4911-b125-910310996b14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12b82744-8213-4f7d-b131-f4db4e710b89" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_1def0d9d-8e60-4911-b125-910310996b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_c5ecc34a-8ca0-4fad-8590-c8419ed639c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_12b82744-8213-4f7d-b131-f4db4e710b89" xlink:to="loc_us-gaap_ProductWarrantyAccrual_c5ecc34a-8ca0-4fad-8590-c8419ed639c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/Debt" xlink:type="simple" xlink:href="fldm-20220331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a55198de-b6af-48a6-8bd9-d0265c0b3699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_0a5ddc94-a127-4aca-b76a-45128b40e21b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a55198de-b6af-48a6-8bd9-d0265c0b3699" xlink:to="loc_us-gaap_LongTermDebtTextBlock_0a5ddc94-a127-4aca-b76a-45128b40e21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DebtTables" xlink:type="simple" xlink:href="fldm-20220331.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_aa7c31a0-0509-4fc9-8842-323f00083f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_fcc28074-d6f1-4388-937e-90baea6e1dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_aa7c31a0-0509-4fc9-8842-323f00083f1b" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_fcc28074-d6f1-4388-937e-90baea6e1dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6f288a33-a5fb-488c-aa99-ba0942a90cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6f288a33-a5fb-488c-aa99-ba0942a90cb0" xlink:to="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b6c4f662-d5d3-49cc-b8e0-dd82cea615ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:to="loc_us-gaap_DebtInstrumentAxis_b6c4f662-d5d3-49cc-b8e0-dd82cea615ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f098521a-19b9-40b8-bd1e-3a446a8d327d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b6c4f662-d5d3-49cc-b8e0-dd82cea615ac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f098521a-19b9-40b8-bd1e-3a446a8d327d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_bd0dbdcb-ca26-49fe-9dbf-cab76df86694" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f098521a-19b9-40b8-bd1e-3a446a8d327d" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_bd0dbdcb-ca26-49fe-9dbf-cab76df86694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member_8cbe563f-5ab2-445d-bc1e-e946ad2415c9" xlink:href="fldm-20220331.xsd#fldm_ExchangeConvertibleSeniorNotesDue2034Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f098521a-19b9-40b8-bd1e-3a446a8d327d" xlink:to="loc_fldm_ExchangeConvertibleSeniorNotesDue2034Member_8cbe563f-5ab2-445d-bc1e-e946ad2415c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_261c2fe5-2508-49f6-8e43-a8d5ebfcf555" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f098521a-19b9-40b8-bd1e-3a446a8d327d" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_261c2fe5-2508-49f6-8e43-a8d5ebfcf555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_65504c83-9644-44f6-a504-98e16471d45c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_65504c83-9644-44f6-a504-98e16471d45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_97f35a79-589f-49d4-a8f4-805f4dd40950" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_65504c83-9644-44f6-a504-98e16471d45c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_97f35a79-589f-49d4-a8f4-805f4dd40950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_cc9d090f-bbc6-47e8-bdda-9e544cae6269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BridgeLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_97f35a79-589f-49d4-a8f4-805f4dd40950" xlink:to="loc_us-gaap_BridgeLoanMember_cc9d090f-bbc6-47e8-bdda-9e544cae6269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_39c442ac-a9a4-49b6-8565-a07b71bd3de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_97f35a79-589f-49d4-a8f4-805f4dd40950" xlink:to="loc_us-gaap_ConvertibleDebtMember_39c442ac-a9a4-49b6-8565-a07b71bd3de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_673dcde6-0703-40c8-9413-4510c7592bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_97f35a79-589f-49d4-a8f4-805f4dd40950" xlink:to="loc_us-gaap_LineOfCreditMember_673dcde6-0703-40c8-9413-4510c7592bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_5767566b-85ac-45a2-b78f-b8e770ea75f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_97f35a79-589f-49d4-a8f4-805f4dd40950" xlink:to="loc_us-gaap_SecuredDebtMember_5767566b-85ac-45a2-b78f-b8e770ea75f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3de648df-82ed-4302-a289-bd4a4c57a2f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3de648df-82ed-4302-a289-bd4a4c57a2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_7b89eb88-3525-4d19-a27b-610309402e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_3de648df-82ed-4302-a289-bd4a4c57a2f9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_7b89eb88-3525-4d19-a27b-610309402e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_0e133b52-a5ca-46f1-a7b3-41c09a2eb956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_7b89eb88-3525-4d19-a27b-610309402e3b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_0e133b52-a5ca-46f1-a7b3-41c09a2eb956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_d88aa92d-6ff2-44b8-9ebf-a6d6405c9dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_7b89eb88-3525-4d19-a27b-610309402e3b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_d88aa92d-6ff2-44b8-9ebf-a6d6405c9dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_11bca256-39d0-4c8d-8ad5-232bb320fe96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_7b89eb88-3525-4d19-a27b-610309402e3b" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_11bca256-39d0-4c8d-8ad5-232bb320fe96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b248ceb0-90ff-4cac-9f20-35a2c8c5f7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:to="loc_us-gaap_CreditFacilityAxis_b248ceb0-90ff-4cac-9f20-35a2c8c5f7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_75da6168-9c5b-432c-8fac-de4c63bca989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b248ceb0-90ff-4cac-9f20-35a2c8c5f7f7" xlink:to="loc_us-gaap_CreditFacilityDomain_75da6168-9c5b-432c-8fac-de4c63bca989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_dc22b72f-9e6d-40b0-a569-0ac5109bba06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_75da6168-9c5b-432c-8fac-de4c63bca989" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_dc22b72f-9e6d-40b0-a569-0ac5109bba06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b603e254-b889-4fab-994a-1914e3d734e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:to="loc_srt_RangeAxis_b603e254-b889-4fab-994a-1914e3d734e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d1da3ee7-bd1c-487e-b22b-dd11e2d874d5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b603e254-b889-4fab-994a-1914e3d734e7" xlink:to="loc_srt_RangeMember_d1da3ee7-bd1c-487e-b22b-dd11e2d874d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_8f2f60ae-fd30-47e0-a7e1-8f579eb04ef2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d1da3ee7-bd1c-487e-b22b-dd11e2d874d5" xlink:to="loc_srt_MinimumMember_8f2f60ae-fd30-47e0-a7e1-8f579eb04ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7dbb2907-46ee-4c97-9105-73cbfef3a61a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d1da3ee7-bd1c-487e-b22b-dd11e2d874d5" xlink:to="loc_srt_MaximumMember_7dbb2907-46ee-4c97-9105-73cbfef3a61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_917c2cf5-0f4f-499f-b15e-4760b7db5b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:to="loc_us-gaap_VariableRateAxis_917c2cf5-0f4f-499f-b15e-4760b7db5b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_fe2fbb38-281e-4619-9692-e66b6806d815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_917c2cf5-0f4f-499f-b15e-4760b7db5b94" xlink:to="loc_us-gaap_VariableRateDomain_fe2fbb38-281e-4619-9692-e66b6806d815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_137cd5b4-51b9-445c-9c22-1e7de007a5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_fe2fbb38-281e-4619-9692-e66b6806d815" xlink:to="loc_us-gaap_PrimeRateMember_137cd5b4-51b9-445c-9c22-1e7de007a5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_de7d9ef4-8766-4a40-a460-690231b9c4e9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_17cf57a5-e2ea-4a83-bd24-c56e259000e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_LongTermDebt_17cf57a5-e2ea-4a83-bd24-c56e259000e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_84d74bdc-56ff-4cf9-aa39-3f34abf20ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_84d74bdc-56ff-4cf9-aa39-3f34abf20ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_273d3b7d-740f-438c-8e1e-ca31055a71b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_273d3b7d-740f-438c-8e1e-ca31055a71b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_956b5703-5d01-4cdc-9932-76e40abb10e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_956b5703-5d01-4cdc-9932-76e40abb10e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d3c8d52e-478f-4ac8-811a-2490c5aa4c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d3c8d52e-478f-4ac8-811a-2490c5aa4c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b3608f55-fb0f-4819-b856-9eaaa629a063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b3608f55-fb0f-4819-b856-9eaaa629a063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_61569052-0754-417c-b369-853220ac6d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_61569052-0754-417c-b369-853220ac6d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_8bbd039a-1ac2-48a3-ad8b-b6268e199a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_8bbd039a-1ac2-48a3-ad8b-b6268e199a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4ca5f3ae-cb9b-40b3-890a-161cee1aff41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4ca5f3ae-cb9b-40b3-890a-161cee1aff41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_3853abf8-cda1-4d6d-9bdf-1e5ffdf93c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_3853abf8-cda1-4d6d-9bdf-1e5ffdf93c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_InitialConversionPriceOfStock_013c2e70-7f65-4667-beca-e2da2b36bde1" xlink:href="fldm-20220331.xsd#fldm_InitialConversionPriceOfStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_InitialConversionPriceOfStock_013c2e70-7f65-4667-beca-e2da2b36bde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_9142205c-2ad1-4fa8-b7db-a7ea22e47512" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice_9142205c-2ad1-4fa8-b7db-a7ea22e47512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_50b573de-58cf-4dc8-935e-3821d118811d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_50b573de-58cf-4dc8-935e-3821d118811d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_2b574886-77d5-44b1-9259-17e2b6d5089e" xlink:href="fldm-20220331.xsd#fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables_2b574886-77d5-44b1-9259-17e2b6d5089e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_26f7f83e-397e-48ac-ad62-8cef782b884e" xlink:href="fldm-20220331.xsd#fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory_26f7f83e-397e-48ac-ad62-8cef782b884e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentCovenantConvertibleDebtThreshold_fe467b0c-d787-418f-8f94-e2cb7d508a31" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentCovenantConvertibleDebtThreshold"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_DebtInstrumentCovenantConvertibleDebtThreshold_fe467b0c-d787-418f-8f94-e2cb7d508a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio_5bdfb6a0-e0b8-419d-b875-cd6918e97e0c" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio_5bdfb6a0-e0b8-419d-b875-cd6918e97e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2764a874-545e-453a-96df-2154fb1a0935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2764a874-545e-453a-96df-2154fb1a0935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_afba4730-dbf5-45b1-9335-65d6c5e1d66e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeeAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeeAmount_afba4730-dbf5-45b1-9335-65d6c5e1d66e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_fcf11dfc-8a0b-407f-8ae2-75b6ebf6cf88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_fcf11dfc-8a0b-407f-8ae2-75b6ebf6cf88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_b5452a1f-c1fe-4d8a-ba2f-8d415b38fd33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_us-gaap_LineOfCredit_b5452a1f-c1fe-4d8a-ba2f-8d415b38fd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentIncrementalPaymentPercent_16cc6a77-1d9d-4aac-95d1-4c8ba73f83dd" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentIncrementalPaymentPercent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_DebtInstrumentIncrementalPaymentPercent_16cc6a77-1d9d-4aac-95d1-4c8ba73f83dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments_729d5ea1-2fc8-407a-804c-25c814d9c6e8" xlink:href="fldm-20220331.xsd#fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ee731c12-ffe5-48e0-a233-1fe6518708aa" xlink:to="loc_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments_729d5ea1-2fc8-407a-804c-25c814d9c6e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/DebtScheduleofDebtDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#DebtScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/DebtScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9d036e94-4fce-4f5b-8717-0d55d7ec5f03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_338eb3a3-884a-4aff-8624-6acdb2f1a1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9d036e94-4fce-4f5b-8717-0d55d7ec5f03" xlink:to="loc_us-gaap_DebtInstrumentTable_338eb3a3-884a-4aff-8624-6acdb2f1a1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dfb0ec54-1d2c-40c5-b4ae-3240e6c4c72e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_338eb3a3-884a-4aff-8624-6acdb2f1a1c3" xlink:to="loc_us-gaap_DebtInstrumentAxis_dfb0ec54-1d2c-40c5-b4ae-3240e6c4c72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d72f7cfd-e187-4a2e-b02b-47a38323a04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_dfb0ec54-1d2c-40c5-b4ae-3240e6c4c72e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d72f7cfd-e187-4a2e-b02b-47a38323a04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_cf6c7d95-835d-4f37-9471-4a94cb2fee79" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72f7cfd-e187-4a2e-b02b-47a38323a04b" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_cf6c7d95-835d-4f37-9471-4a94cb2fee79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_f0ab369f-ca6b-41c8-a03c-e64edad0c480" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d72f7cfd-e187-4a2e-b02b-47a38323a04b" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_f0ab369f-ca6b-41c8-a03c-e64edad0c480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fca324e9-bdf9-4d09-adff-798ec71b7175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_338eb3a3-884a-4aff-8624-6acdb2f1a1c3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fca324e9-bdf9-4d09-adff-798ec71b7175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0a383b69-d8d2-40c1-98ed-5a35b6a734e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fca324e9-bdf9-4d09-adff-798ec71b7175" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0a383b69-d8d2-40c1-98ed-5a35b6a734e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_13e40f48-1e85-4e30-8fcf-5ebfb3bd51d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0a383b69-d8d2-40c1-98ed-5a35b6a734e9" xlink:to="loc_us-gaap_ConvertibleDebtMember_13e40f48-1e85-4e30-8fcf-5ebfb3bd51d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c4ac015a-67b5-42c1-8887-a30a65ad1c70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0a383b69-d8d2-40c1-98ed-5a35b6a734e9" xlink:to="loc_us-gaap_SecuredDebtMember_c4ac015a-67b5-42c1-8887-a30a65ad1c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_bee134ce-d728-4286-af02-fad0e30477ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0a383b69-d8d2-40c1-98ed-5a35b6a734e9" xlink:to="loc_us-gaap_LineOfCreditMember_bee134ce-d728-4286-af02-fad0e30477ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c6afd699-17b4-45a2-8cfe-4b268c373025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_338eb3a3-884a-4aff-8624-6acdb2f1a1c3" xlink:to="loc_us-gaap_CreditFacilityAxis_c6afd699-17b4-45a2-8cfe-4b268c373025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d26f5734-ce5d-4ee2-8fd1-4628b49a4114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c6afd699-17b4-45a2-8cfe-4b268c373025" xlink:to="loc_us-gaap_CreditFacilityDomain_d26f5734-ce5d-4ee2-8fd1-4628b49a4114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3441e2f1-dfc8-490a-a505-99ee38af0838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_d26f5734-ce5d-4ee2-8fd1-4628b49a4114" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3441e2f1-dfc8-490a-a505-99ee38af0838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_338eb3a3-884a-4aff-8624-6acdb2f1a1c3" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e03fe8b0-e8dc-4088-991c-7d74489e7e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_e03fe8b0-e8dc-4088-991c-7d74489e7e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_0303e9e4-204e-407c-a9c7-181228465624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_0303e9e4-204e-407c-a9c7-181228465624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_46daad78-581b-49ba-8d4d-e799619959be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_46daad78-581b-49ba-8d4d-e799619959be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_da1daf65-c1d8-4e33-bbe3-ee969aa5ab77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_da1daf65-c1d8-4e33-bbe3-ee969aa5ab77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9354128e-9dd4-4256-94dc-eef61a60c7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_9354128e-9dd4-4256-94dc-eef61a60c7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a1a02e8d-4f0f-434f-b09c-c75eb4e1573a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_LongTermDebt_a1a02e8d-4f0f-434f-b09c-c75eb4e1573a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_541a3aa0-795f-439c-9738-2bbb5d15ab66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c6a43b5e-0478-4321-92d3-0e16a7929a52" xlink:to="loc_us-gaap_LineOfCredit_541a3aa0-795f-439c-9738-2bbb5d15ab66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/Leases" xlink:type="simple" xlink:href="fldm-20220331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_35fdb7d7-2d69-4bcb-b7ae-c773ffa67b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_813fad1a-d2e0-4ff2-a9e6-ab6103299334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_35fdb7d7-2d69-4bcb-b7ae-c773ffa67b44" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_813fad1a-d2e0-4ff2-a9e6-ab6103299334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesTables" xlink:type="simple" xlink:href="fldm-20220331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b12fbf40-73b7-4557-9843-f3984d8ff994" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_AssetsAndLiabilitiesLesseeTableTextBlock_5cbec406-72a0-45be-bbb1-cbd3c42ee0a5" xlink:href="fldm-20220331.xsd#fldm_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b12fbf40-73b7-4557-9843-f3984d8ff994" xlink:to="loc_fldm_AssetsAndLiabilitiesLesseeTableTextBlock_5cbec406-72a0-45be-bbb1-cbd3c42ee0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_faefeddf-7a84-40e9-b4e7-7f32c4e753d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4fca82c7-d5ad-4f16-b7df-8916315ff638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_faefeddf-7a84-40e9-b4e7-7f32c4e753d8" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4fca82c7-d5ad-4f16-b7df-8916315ff638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_580028d7-fab4-4d99-9e6f-419d27264f79" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4fca82c7-d5ad-4f16-b7df-8916315ff638" xlink:to="loc_srt_RangeAxis_580028d7-fab4-4d99-9e6f-419d27264f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7dec1bdc-f72f-4aa1-81a5-b7ecdcd7187d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_580028d7-fab4-4d99-9e6f-419d27264f79" xlink:to="loc_srt_RangeMember_7dec1bdc-f72f-4aa1-81a5-b7ecdcd7187d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7bca25da-78d4-4b0e-8bda-99fa64e00890" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7dec1bdc-f72f-4aa1-81a5-b7ecdcd7187d" xlink:to="loc_srt_MinimumMember_7bca25da-78d4-4b0e-8bda-99fa64e00890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a171d405-68c0-40f1-af7d-43629a6dc7ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7dec1bdc-f72f-4aa1-81a5-b7ecdcd7187d" xlink:to="loc_srt_MaximumMember_a171d405-68c0-40f1-af7d-43629a6dc7ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_a9cd09a2-da38-4021-a1fe-781d4f7f74f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_4fca82c7-d5ad-4f16-b7df-8916315ff638" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_a9cd09a2-da38-4021-a1fe-781d4f7f74f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_LesseeOperatingLeaseRemainingTermOfContract_a5c501bd-f53d-4972-abcd-438d369d09f6" xlink:href="fldm-20220331.xsd#fldm_LesseeOperatingLeaseRemainingTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_a9cd09a2-da38-4021-a1fe-781d4f7f74f3" xlink:to="loc_fldm_LesseeOperatingLeaseRemainingTermOfContract_a5c501bd-f53d-4972-abcd-438d369d09f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_8a54e9b1-f033-4847-9524-fa6d68c08c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_a9cd09a2-da38-4021-a1fe-781d4f7f74f3" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_8a54e9b1-f033-4847-9524-fa6d68c08c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#LeasesSupplementalBalancesheetDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9e74b32e-e665-4c27-83a9-96acce1b85aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b94d6e89-8eb7-4d58-aa05-93da92b66587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOperatingLeasedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9e74b32e-e665-4c27-83a9-96acce1b85aa" xlink:to="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b94d6e89-8eb7-4d58-aa05-93da92b66587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de47d5f8-5333-49d9-ab15-6ddf69728fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b94d6e89-8eb7-4d58-aa05-93da92b66587" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de47d5f8-5333-49d9-ab15-6ddf69728fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f8cc0d4b-1f1f-4255-8b95-9111d1479f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_de47d5f8-5333-49d9-ab15-6ddf69728fa5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f8cc0d4b-1f1f-4255-8b95-9111d1479f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_bfcd50ae-26db-45b0-bd7b-8d9cbf88d222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f8cc0d4b-1f1f-4255-8b95-9111d1479f10" xlink:to="loc_us-gaap_BuildingMember_bfcd50ae-26db-45b0-bd7b-8d9cbf88d222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_3f860d42-f3ed-42fc-acc3-ba1b3950e870" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f8cc0d4b-1f1f-4255-8b95-9111d1479f10" xlink:to="loc_us-gaap_EquipmentMember_3f860d42-f3ed-42fc-acc3-ba1b3950e870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_337ad446-5d8e-4728-b48c-9828ba51d2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f8cc0d4b-1f1f-4255-8b95-9111d1479f10" xlink:to="loc_us-gaap_VehiclesMember_337ad446-5d8e-4728-b48c-9828ba51d2d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfOperatingLeasedAssetsTable_b94d6e89-8eb7-4d58-aa05-93da92b66587" xlink:to="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetGross_76a9fc34-deb7-4fbe-bac9-5c6387c92618" xlink:href="fldm-20220331.xsd#fldm_OperatingLeaseRightOfUseAssetGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_fldm_OperatingLeaseRightOfUseAssetGross_76a9fc34-deb7-4fbe-bac9-5c6387c92618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_e0a36c43-b61b-4f44-abce-824459ebe985" xlink:href="fldm-20220331.xsd#fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization_e0a36c43-b61b-4f44-abce-824459ebe985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ebee5ab2-20be-42fb-a1cb-5fb5ad581d76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ebee5ab2-20be-42fb-a1cb-5fb5ad581d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1491fdbe-980d-498e-8163-84be0298bf38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1491fdbe-980d-498e-8163-84be0298bf38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_68e9668a-0aaa-452e-bebd-19971efb8be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_68e9668a-0aaa-452e-bebd-19971efb8be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4e93c1bc-2176-412c-bae9-87c23bf3f606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_us-gaap_OperatingLeaseLiability_4e93c1bc-2176-412c-bae9-87c23bf3f606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0c4a9c91-a151-46dd-9c1d-835ded7b30e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0c4a9c91-a151-46dd-9c1d-835ded7b30e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1206bcf7-d8a4-4352-85fa-a3a75cea8f60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeasedAssetsLineItems_eff64e06-038f-4f37-bec0-dc43420312f4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1206bcf7-d8a4-4352-85fa-a3a75cea8f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="fldm-20220331.xsd#FairValueofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0e574fad-caba-4c79-abf9-aab8e113cb4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_94f00b22-cd56-4cdc-9e4d-bbd25eff8b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0e574fad-caba-4c79-abf9-aab8e113cb4f" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_94f00b22-cd56-4cdc-9e4d-bbd25eff8b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="fldm-20220331.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_39767d0c-8579-4282-8c9b-80301dff5f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_bbfca0dc-1f49-497e-b1d8-aedec6ecf3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_39767d0c-8579-4282-8c9b-80301dff5f3a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_bbfca0dc-1f49-497e-b1d8-aedec6ecf3b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_4f300d96-55af-4f9a-9694-a17b70785cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_39767d0c-8579-4282-8c9b-80301dff5f3a" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_4f300d96-55af-4f9a-9694-a17b70785cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_46a60d75-afb7-4f35-87f0-e9db78838a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c8de5bdd-8dc4-468f-bd0a-ff55fbf73dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_46a60d75-afb7-4f35-87f0-e9db78838a6d" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c8de5bdd-8dc4-468f-bd0a-ff55fbf73dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_2361c918-3bb5-4705-90de-e979ac79e555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c8de5bdd-8dc4-468f-bd0a-ff55fbf73dbb" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_2361c918-3bb5-4705-90de-e979ac79e555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b0035459-f93f-4f4e-9ed6-05b7284965af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_2361c918-3bb5-4705-90de-e979ac79e555" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b0035459-f93f-4f4e-9ed6-05b7284965af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_5203d477-2a0e-49cd-8314-2e1b60d59185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_b0035459-f93f-4f4e-9ed6-05b7284965af" xlink:to="loc_us-gaap_CashMember_5203d477-2a0e-49cd-8314-2e1b60d59185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CashAndMoneyMarketFundsMember_1a6053f0-7139-4323-bbdf-afaac44ca9a9" xlink:href="fldm-20220331.xsd#fldm_CashAndMoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashMember_5203d477-2a0e-49cd-8314-2e1b60d59185" xlink:to="loc_fldm_CashAndMoneyMarketFundsMember_1a6053f0-7139-4323-bbdf-afaac44ca9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RestrictedCashAndCashEquivalentsMember_f3fc7180-e5a0-4433-a241-141c7a7c91dc" xlink:href="fldm-20220331.xsd#fldm_RestrictedCashAndCashEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashMember_5203d477-2a0e-49cd-8314-2e1b60d59185" xlink:to="loc_fldm_RestrictedCashAndCashEquivalentsMember_f3fc7180-e5a0-4433-a241-141c7a7c91dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_0900cf51-ddca-467c-b8cc-e92941f6018b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable_c8de5bdd-8dc4-468f-bd0a-ff55fbf73dbb" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_0900cf51-ddca-467c-b8cc-e92941f6018b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_07bbbcc7-f9a0-4e0f-9f5d-783134631d20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_0900cf51-ddca-467c-b8cc-e92941f6018b" xlink:to="loc_us-gaap_AssetsAbstract_07bbbcc7-f9a0-4e0f-9f5d-783134631d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6839405f-ef44-4f72-b25a-472f6f239958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_07bbbcc7-f9a0-4e0f-9f5d-783134631d20" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6839405f-ef44-4f72-b25a-472f6f239958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_72c5c34a-8626-4dc4-afbc-6056ae15c8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_07bbbcc7-f9a0-4e0f-9f5d-783134631d20" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_72c5c34a-8626-4dc4-afbc-6056ae15c8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9e283f86-e7dc-4b79-ae3a-8622362a86cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_07bbbcc7-f9a0-4e0f-9f5d-783134631d20" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9e283f86-e7dc-4b79-ae3a-8622362a86cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#FairValueofFinancialInstrumentsScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6888dfcc-4f24-4eb4-930c-3843feaf0a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e5a0e852-f4cc-40d7-82cd-8d7bf5ad3e65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6888dfcc-4f24-4eb4-930c-3843feaf0a6e" xlink:to="loc_us-gaap_DebtInstrumentTable_e5a0e852-f4cc-40d7-82cd-8d7bf5ad3e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e4a3c8c6-f583-4e81-a2c8-5d2a344c68f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e5a0e852-f4cc-40d7-82cd-8d7bf5ad3e65" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e4a3c8c6-f583-4e81-a2c8-5d2a344c68f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8b334cb0-0240-4834-9fbb-74c700b784bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e4a3c8c6-f583-4e81-a2c8-5d2a344c68f1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8b334cb0-0240-4834-9fbb-74c700b784bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BridgeLoanMember_cacfd3f0-bd35-4386-873d-ea2f1d2d1b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BridgeLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8b334cb0-0240-4834-9fbb-74c700b784bd" xlink:to="loc_us-gaap_BridgeLoanMember_cacfd3f0-bd35-4386-873d-ea2f1d2d1b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_b2f04e64-d218-47ea-b2f4-f398695cef3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8b334cb0-0240-4834-9fbb-74c700b784bd" xlink:to="loc_us-gaap_ConvertibleDebtMember_b2f04e64-d218-47ea-b2f4-f398695cef3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_155b6146-39c9-4b6c-b30a-a5224c640485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8b334cb0-0240-4834-9fbb-74c700b784bd" xlink:to="loc_us-gaap_SecuredDebtMember_155b6146-39c9-4b6c-b30a-a5224c640485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_c25799a9-effc-4bc7-a499-eb8055e49fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8b334cb0-0240-4834-9fbb-74c700b784bd" xlink:to="loc_us-gaap_LineOfCreditMember_c25799a9-effc-4bc7-a499-eb8055e49fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_da8d03f8-65c7-4d46-bf01-6ce0012e9cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e5a0e852-f4cc-40d7-82cd-8d7bf5ad3e65" xlink:to="loc_us-gaap_DebtInstrumentAxis_da8d03f8-65c7-4d46-bf01-6ce0012e9cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b999b727-0b77-4e20-afa3-abf278eb985e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_da8d03f8-65c7-4d46-bf01-6ce0012e9cc5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b999b727-0b77-4e20-afa3-abf278eb985e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesdue2034Member_eef55f8b-33b3-4e78-9ed4-426f7fe783f1" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesdue2034Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b999b727-0b77-4e20-afa3-abf278eb985e" xlink:to="loc_fldm_SeniorConvertibleNotesdue2034Member_eef55f8b-33b3-4e78-9ed4-426f7fe783f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SeniorConvertibleNotesDue2024Member_2cb2338f-cd80-4e3e-be59-73de2367a920" xlink:href="fldm-20220331.xsd#fldm_SeniorConvertibleNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b999b727-0b77-4e20-afa3-abf278eb985e" xlink:to="loc_fldm_SeniorConvertibleNotesDue2024Member_2cb2338f-cd80-4e3e-be59-73de2367a920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_113d9202-706b-42ea-ab21-5150f45f0a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e5a0e852-f4cc-40d7-82cd-8d7bf5ad3e65" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_113d9202-706b-42ea-ab21-5150f45f0a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0ae747a4-9061-4ff6-815d-2b44f3a9b249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_113d9202-706b-42ea-ab21-5150f45f0a3b" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0ae747a4-9061-4ff6-815d-2b44f3a9b249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_753f5baf-2318-4597-bcaa-20f73145cd41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_0ae747a4-9061-4ff6-815d-2b44f3a9b249" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_753f5baf-2318-4597-bcaa-20f73145cd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_828ab7d3-31e5-429e-ba30-7d973ef4e2b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_753f5baf-2318-4597-bcaa-20f73145cd41" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_828ab7d3-31e5-429e-ba30-7d973ef4e2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3be6f8ad-e742-4407-b8c3-eea4e86a1d07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_753f5baf-2318-4597-bcaa-20f73145cd41" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_3be6f8ad-e742-4407-b8c3-eea4e86a1d07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b8e6bd2f-8992-4eab-b996-65a9269174de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e5a0e852-f4cc-40d7-82cd-8d7bf5ad3e65" xlink:to="loc_us-gaap_CreditFacilityAxis_b8e6bd2f-8992-4eab-b996-65a9269174de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a87faf21-ed8f-4d59-9c97-22b60d6b9128" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b8e6bd2f-8992-4eab-b996-65a9269174de" xlink:to="loc_us-gaap_CreditFacilityDomain_a87faf21-ed8f-4d59-9c97-22b60d6b9128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_1dfb5a69-5908-4c38-b8b1-9ce64b33a8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a87faf21-ed8f-4d59-9c97-22b60d6b9128" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_1dfb5a69-5908-4c38-b8b1-9ce64b33a8f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b4f269d4-c93d-4c55-8484-f7dbb5105418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e5a0e852-f4cc-40d7-82cd-8d7bf5ad3e65" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b4f269d4-c93d-4c55-8484-f7dbb5105418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_4587ebcc-e4d3-4f1f-9ecb-85ece23d190d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4f269d4-c93d-4c55-8484-f7dbb5105418" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_4587ebcc-e4d3-4f1f-9ecb-85ece23d190d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_fdfda737-fa16-4a1e-8da7-4dfca69f7aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4f269d4-c93d-4c55-8484-f7dbb5105418" xlink:to="loc_us-gaap_DebtInstrumentFairValue_fdfda737-fa16-4a1e-8da7-4dfca69f7aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_bbf33ad5-7cc3-4fb1-b6f1-735eb329a388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b4f269d4-c93d-4c55-8484-f7dbb5105418" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_bbf33ad5-7cc3-4fb1-b6f1-735eb329a388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="fldm-20220331.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7131fd83-a498-4f95-b295-d2aebae03f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4393cf92-733d-4772-81f6-fc352e3e7e86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7131fd83-a498-4f95-b295-d2aebae03f6c" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4393cf92-733d-4772-81f6-fc352e3e7e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="fldm-20220331.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0ecaff0b-8c72-429b-87b3-2bac6e184e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_e24bf243-5b51-4033-b3ce-01695e439c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0ecaff0b-8c72-429b-87b3-2bac6e184e02" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_e24bf243-5b51-4033-b3ce-01695e439c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4be28808-501a-4332-b48c-d3070755d485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareholdersEquityTable_54222148-6e73-4a07-be6b-2bb7feeaa567" xlink:href="fldm-20220331.xsd#fldm_ShareholdersEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4be28808-501a-4332-b48c-d3070755d485" xlink:to="loc_fldm_ShareholdersEquityTable_54222148-6e73-4a07-be6b-2bb7feeaa567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0802fb8f-957d-4ec7-b0cb-6505dad1bc32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityTable_54222148-6e73-4a07-be6b-2bb7feeaa567" xlink:to="loc_us-gaap_AwardTypeAxis_0802fb8f-957d-4ec7-b0cb-6505dad1bc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f22ceed3-ba8c-4d19-9d4b-d3d6be9abb83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0802fb8f-957d-4ec7-b0cb-6505dad1bc32" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f22ceed3-ba8c-4d19-9d4b-d3d6be9abb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_6e4f4d61-d13f-4198-a144-971c363b6c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f22ceed3-ba8c-4d19-9d4b-d3d6be9abb83" xlink:to="loc_us-gaap_PerformanceSharesMember_6e4f4d61-d13f-4198-a144-971c363b6c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_206beeae-f053-43b6-bbe0-f90406c5cdc9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityTable_54222148-6e73-4a07-be6b-2bb7feeaa567" xlink:to="loc_srt_RangeAxis_206beeae-f053-43b6-bbe0-f90406c5cdc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_427ede75-2a4f-46bc-ae47-bb2c2ae4d916" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_206beeae-f053-43b6-bbe0-f90406c5cdc9" xlink:to="loc_srt_RangeMember_427ede75-2a4f-46bc-ae47-bb2c2ae4d916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f565f3dd-cf53-4bd8-9d45-995e6020d00d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_427ede75-2a4f-46bc-ae47-bb2c2ae4d916" xlink:to="loc_srt_MinimumMember_f565f3dd-cf53-4bd8-9d45-995e6020d00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_47c4e439-dba5-4f02-a34e-7b15c687041b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_427ede75-2a4f-46bc-ae47-bb2c2ae4d916" xlink:to="loc_srt_MaximumMember_47c4e439-dba5-4f02-a34e-7b15c687041b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareholdersEquityLineItems_baa2cbb7-ca98-421a-8f20-6dc695a031ed" xlink:href="fldm-20220331.xsd#fldm_ShareholdersEquityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityTable_54222148-6e73-4a07-be6b-2bb7feeaa567" xlink:to="loc_fldm_ShareholdersEquityLineItems_baa2cbb7-ca98-421a-8f20-6dc695a031ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_1ec16a2f-d992-4d21-90fa-4eb4fa55dda1" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_fldm_ShareholdersEquityLineItems_baa2cbb7-ca98-421a-8f20-6dc695a031ed" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_1ec16a2f-d992-4d21-90fa-4eb4fa55dda1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#ShareholdersEquityScheduleofStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a51bcbc8-ba62-493a-a8e3-88a2d7885932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_8ce60905-7da5-4218-895c-872a25ce2e97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a51bcbc8-ba62-493a-a8e3-88a2d7885932" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_8ce60905-7da5-4218-895c-872a25ce2e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c6ece7b7-c593-468a-8e31-5b4d00170b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8ce60905-7da5-4218-895c-872a25ce2e97" xlink:to="loc_us-gaap_AwardTypeAxis_c6ece7b7-c593-468a-8e31-5b4d00170b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b56a56dd-b574-4b2c-a3dc-a666a8a0b5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c6ece7b7-c593-468a-8e31-5b4d00170b05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b56a56dd-b574-4b2c-a3dc-a666a8a0b5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_741afc7a-ade5-4889-9beb-031a2d433137" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b56a56dd-b574-4b2c-a3dc-a666a8a0b5a1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_741afc7a-ade5-4889-9beb-031a2d433137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_RestrictedStockAndPerformanceShareUnitsMember_c95099dd-e2a7-459e-826b-f0ad4b0ef976" xlink:href="fldm-20220331.xsd#fldm_RestrictedStockAndPerformanceShareUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b56a56dd-b574-4b2c-a3dc-a666a8a0b5a1" xlink:to="loc_fldm_RestrictedStockAndPerformanceShareUnitsMember_c95099dd-e2a7-459e-826b-f0ad4b0ef976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7557f12c-d15e-4c98-862c-03994f8805ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8ce60905-7da5-4218-895c-872a25ce2e97" xlink:to="loc_us-gaap_PlanNameAxis_7557f12c-d15e-4c98-862c-03994f8805ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_06e24101-46b7-44a1-976c-0fbdf50cd3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_7557f12c-d15e-4c98-862c-03994f8805ab" xlink:to="loc_us-gaap_PlanNameDomain_06e24101-46b7-44a1-976c-0fbdf50cd3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember_ab9cc0f6-64d4-4e4b-8093-3580454f03c3" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndElevenEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_06e24101-46b7-44a1-976c-0fbdf50cd3e5" xlink:to="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember_ab9cc0f6-64d4-4e4b-8093-3580454f03c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndTenEquityIncentivePlanMember_90b997da-90e3-4620-8c50-e204c9b8574b" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndTenEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_06e24101-46b7-44a1-976c-0fbdf50cd3e5" xlink:to="loc_fldm_TwoThousandAndTenEquityIncentivePlanMember_90b997da-90e3-4620-8c50-e204c9b8574b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_d97c0eac-e737-494a-b93d-fee9c6b36df6" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndSeventeenInducementAwardPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_06e24101-46b7-44a1-976c-0fbdf50cd3e5" xlink:to="loc_fldm_TwoThousandAndSeventeenInducementAwardPlanMember_d97c0eac-e737-494a-b93d-fee9c6b36df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_585443a9-b12f-4f4e-979b-614ccaf91db6" xlink:href="fldm-20220331.xsd#fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_06e24101-46b7-44a1-976c-0fbdf50cd3e5" xlink:to="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_585443a9-b12f-4f4e-979b-614ccaf91db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8cc129a3-215b-4219-8213-55e35fb9adde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8ce60905-7da5-4218-895c-872a25ce2e97" xlink:to="loc_us-gaap_ClassOfStockLineItems_8cc129a3-215b-4219-8213-55e35fb9adde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5dd67ef9-1e6d-4094-8d5a-46d439ff984a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8cc129a3-215b-4219-8213-55e35fb9adde" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_5dd67ef9-1e6d-4094-8d5a-46d439ff984a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e71b43cd-6b21-4dfe-b553-57ec74cde440" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8cc129a3-215b-4219-8213-55e35fb9adde" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e71b43cd-6b21-4dfe-b553-57ec74cde440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlans" xlink:type="simple" xlink:href="fldm-20220331.xsd#StockBasedPlans"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/StockBasedPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f211d293-da21-482f-a433-747a01ee2c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1354e3fa-fcc6-41be-b8d1-32a7c5909414" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f211d293-da21-482f-a433-747a01ee2c29" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1354e3fa-fcc6-41be-b8d1-32a7c5909414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansTables" xlink:type="simple" xlink:href="fldm-20220331.xsd#StockBasedPlansTables"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/StockBasedPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_49fc3dc7-0574-4e1b-badd-351cffa2d1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_fa7d2f36-fbf3-46a6-be41-bfa937f884f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_49fc3dc7-0574-4e1b-badd-351cffa2d1ce" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_fa7d2f36-fbf3-46a6-be41-bfa937f884f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1ed277d1-d223-4bb2-87e4-689c9d722664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_49fc3dc7-0574-4e1b-badd-351cffa2d1ce" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_1ed277d1-d223-4bb2-87e4-689c9d722664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_2ba7b3db-d254-4b07-8527-cbeef2a8ef0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_49fc3dc7-0574-4e1b-badd-351cffa2d1ce" xlink:to="loc_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock_2ba7b3db-d254-4b07-8527-cbeef2a8ef0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_3fbc792a-8d0d-45fa-bfb1-823335682720" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_49fc3dc7-0574-4e1b-badd-351cffa2d1ce" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_3fbc792a-8d0d-45fa-bfb1-823335682720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansNarrativeDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#StockBasedPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/StockBasedPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_327f9706-ea2d-495a-b8e3-e3f0d22e7252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_327f9706-ea2d-495a-b8e3-e3f0d22e7252" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bcc9ece4-37af-49f9-bf74-e44a6683214f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:to="loc_us-gaap_AwardTypeAxis_bcc9ece4-37af-49f9-bf74-e44a6683214f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9b35da5-4fb0-407a-aad9-cf528dddb051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_bcc9ece4-37af-49f9-bf74-e44a6683214f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9b35da5-4fb0-407a-aad9-cf528dddb051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f744a169-761e-44ca-95e8-040bc06bc04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9b35da5-4fb0-407a-aad9-cf528dddb051" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f744a169-761e-44ca-95e8-040bc06bc04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_4903455b-b97e-415e-8de6-2cbba4333622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9b35da5-4fb0-407a-aad9-cf528dddb051" xlink:to="loc_us-gaap_StockCompensationPlanMember_4903455b-b97e-415e-8de6-2cbba4333622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_669f7456-a3e5-450a-baf6-69915d09e4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9b35da5-4fb0-407a-aad9-cf528dddb051" xlink:to="loc_us-gaap_PerformanceSharesMember_669f7456-a3e5-450a-baf6-69915d09e4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_aa9b23ae-bc4f-46cb-9716-2977a1dc88a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d9b35da5-4fb0-407a-aad9-cf528dddb051" xlink:to="loc_us-gaap_EmployeeStockMember_aa9b23ae-bc4f-46cb-9716-2977a1dc88a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_13ff5899-d939-46bb-8a35-ee10417c34b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:to="loc_us-gaap_VestingAxis_13ff5899-d939-46bb-8a35-ee10417c34b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_bd8530fe-553a-48cd-b844-ead5292eb8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_13ff5899-d939-46bb-8a35-ee10417c34b2" xlink:to="loc_us-gaap_VestingDomain_bd8530fe-553a-48cd-b844-ead5292eb8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_5f4fde07-ae9f-40b3-a618-fbb5cfed20a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_bd8530fe-553a-48cd-b844-ead5292eb8e3" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_5f4fde07-ae9f-40b3-a618-fbb5cfed20a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ac7cbdb3-dd4f-42f3-87f1-bddadca60ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_bd8530fe-553a-48cd-b844-ead5292eb8e3" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ac7cbdb3-dd4f-42f3-87f1-bddadca60ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b9af2baa-9f55-4d79-8efc-fe1a287a9c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:to="loc_us-gaap_PlanNameAxis_b9af2baa-9f55-4d79-8efc-fe1a287a9c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_842a124f-69bc-4d14-8611-ed14dd8d2225" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_b9af2baa-9f55-4d79-8efc-fe1a287a9c4c" xlink:to="loc_us-gaap_PlanNameDomain_842a124f-69bc-4d14-8611-ed14dd8d2225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EquityIncentivePlanTwentyElevenMember_f7755e74-d106-4568-928c-9629851d1519" xlink:href="fldm-20220331.xsd#fldm_EquityIncentivePlanTwentyElevenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_842a124f-69bc-4d14-8611-ed14dd8d2225" xlink:to="loc_fldm_EquityIncentivePlanTwentyElevenMember_f7755e74-d106-4568-928c-9629851d1519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember_ec92ba16-c9cc-4160-a54b-8c282c859049" xlink:href="fldm-20220331.xsd#fldm_TwoThousandAndElevenEquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_842a124f-69bc-4d14-8611-ed14dd8d2225" xlink:to="loc_fldm_TwoThousandAndElevenEquityIncentivePlanMember_ec92ba16-c9cc-4160-a54b-8c282c859049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EquityIncentivePlanMember_e3e3f167-cc0a-42db-84f0-6768e42b9c6d" xlink:href="fldm-20220331.xsd#fldm_EquityIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_842a124f-69bc-4d14-8611-ed14dd8d2225" xlink:to="loc_fldm_EquityIncentivePlanMember_e3e3f167-cc0a-42db-84f0-6768e42b9c6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_a4b612f2-845d-4319-9a26-f144a652f1d9" xlink:href="fldm-20220331.xsd#fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_842a124f-69bc-4d14-8611-ed14dd8d2225" xlink:to="loc_fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember_a4b612f2-845d-4319-9a26-f144a652f1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_60e07b28-02ef-4b29-a33c-e8c066d1a9e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:to="loc_srt_RangeAxis_60e07b28-02ef-4b29-a33c-e8c066d1a9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_21f48895-ee48-4ff1-8ffe-15d42bd87e97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_60e07b28-02ef-4b29-a33c-e8c066d1a9e3" xlink:to="loc_srt_RangeMember_21f48895-ee48-4ff1-8ffe-15d42bd87e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a97061ee-d3de-4c58-b580-ffa51876cc4f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_21f48895-ee48-4ff1-8ffe-15d42bd87e97" xlink:to="loc_srt_MinimumMember_a97061ee-d3de-4c58-b580-ffa51876cc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_21228985-7dd8-413d-9a2e-89ace201bb30" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_21f48895-ee48-4ff1-8ffe-15d42bd87e97" xlink:to="loc_srt_MaximumMember_21228985-7dd8-413d-9a2e-89ace201bb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_c5d65ae8-47d8-4eba-bce8-c643a49ccadb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:to="loc_srt_TitleOfIndividualAxis_c5d65ae8-47d8-4eba-bce8-c643a49ccadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_98cf46ba-6ff9-4f3b-adb1-62a87239ab97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_c5d65ae8-47d8-4eba-bce8-c643a49ccadb" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_98cf46ba-6ff9-4f3b-adb1-62a87239ab97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_CertainEmployeeMember_b739dc4a-bd96-4d0b-89d6-3c9626233f22" xlink:href="fldm-20220331.xsd#fldm_CertainEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_98cf46ba-6ff9-4f3b-adb1-62a87239ab97" xlink:to="loc_fldm_CertainEmployeeMember_b739dc4a-bd96-4d0b-89d6-3c9626233f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4c2a6352-0eee-4dfd-b58e-cf6b5aee760a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9e333e1a-c776-4e2d-80bf-eb770a06afc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9e333e1a-c776-4e2d-80bf-eb770a06afc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_a55674ff-e682-4009-b5cc-b4a427c9a182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_a55674ff-e682-4009-b5cc-b4a427c9a182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ed15ae84-b164-4eb6-b749-a368edfd5da4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_ed15ae84-b164-4eb6-b749-a368edfd5da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_8e15005b-eb4b-4e3c-9925-ac5c15a33e57" xlink:href="fldm-20220331.xsd#fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue_8e15005b-eb4b-4e3c-9925-ac5c15a33e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_PortionOfStockOptionsVestOnFirstAnniversary_4fe06fbd-78d5-4bf2-903d-83fb063ffb0d" xlink:href="fldm-20220331.xsd#fldm_PortionOfStockOptionsVestOnFirstAnniversary"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_fldm_PortionOfStockOptionsVestOnFirstAnniversary_4fe06fbd-78d5-4bf2-903d-83fb063ffb0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_8a450a9e-9d3f-4060-b0ba-9aeb67ea48fd" xlink:href="fldm-20220331.xsd#fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement_8a450a9e-9d3f-4060-b0ba-9aeb67ea48fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_a714907a-539f-4280-964d-40e9ed11f9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_a714907a-539f-4280-964d-40e9ed11f9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_68d6a734-ccff-44dd-b0dc-4f1c2150eed5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_68d6a734-ccff-44dd-b0dc-4f1c2150eed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_1a640f4d-70ad-45be-8922-b5ee34a90638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_1a640f4d-70ad-45be-8922-b5ee34a90638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_bddcc902-5a13-44d7-9d19-2f22f751f4c7" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest_bddcc902-5a13-44d7-9d19-2f22f751f4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8eda25d4-643f-4844-98a4-1c12d78e98c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8eda25d4-643f-4844-98a4-1c12d78e98c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_356d998d-ab6a-4835-b8e9-a2249fa1c4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_356d998d-ab6a-4835-b8e9-a2249fa1c4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_EmployeeStockPurchasePlanOfferingPeriod_c6f222ee-a9be-44ac-8ea2-882625728fe5" xlink:href="fldm-20220331.xsd#fldm_EmployeeStockPurchasePlanOfferingPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_fldm_EmployeeStockPurchasePlanOfferingPeriod_c6f222ee-a9be-44ac-8ea2-882625728fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_a407d550-51d9-4b8f-a045-480d2d28e0dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_a407d550-51d9-4b8f-a045-480d2d28e0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_e4945959-16dd-4b67-afd8-564578107c41" xlink:href="fldm-20220331.xsd#fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount_e4945959-16dd-4b67-afd8-564578107c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_746f12d4-2363-4679-a69a-924bc9f174aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6c00ac00-629a-4e69-85ab-c2aaa04dc9fc" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_746f12d4-2363-4679-a69a-924bc9f174aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#StockBasedPlansRestrictedandPerformanceStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cc247968-9883-41ae-81d5-4ca2609c3b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ba7b73c-4eaf-4117-ae34-9f3c9060362a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cc247968-9883-41ae-81d5-4ca2609c3b42" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ba7b73c-4eaf-4117-ae34-9f3c9060362a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a5d808bb-f599-4f57-b42b-b0800306cd36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ba7b73c-4eaf-4117-ae34-9f3c9060362a" xlink:to="loc_us-gaap_AwardTypeAxis_a5d808bb-f599-4f57-b42b-b0800306cd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01d26ebc-3984-4d29-80e1-24df9800e666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a5d808bb-f599-4f57-b42b-b0800306cd36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01d26ebc-3984-4d29-80e1-24df9800e666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d5c4ee2e-632d-4f6e-a675-3980d7a1df29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01d26ebc-3984-4d29-80e1-24df9800e666" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d5c4ee2e-632d-4f6e-a675-3980d7a1df29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_4fb38a61-104d-4108-b1ce-bf1a610351bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_01d26ebc-3984-4d29-80e1-24df9800e666" xlink:to="loc_us-gaap_PerformanceSharesMember_4fb38a61-104d-4108-b1ce-bf1a610351bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ed48674-34b5-426a-8509-dfce92a99cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ba7b73c-4eaf-4117-ae34-9f3c9060362a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ed48674-34b5-426a-8509-dfce92a99cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ed48674-34b5-426a-8509-dfce92a99cc4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c146f41e-98e1-4798-ade2-b4606a9ad961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c146f41e-98e1-4798-ade2-b4606a9ad961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b2381680-211a-4c33-94db-a51e1e006953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b2381680-211a-4c33-94db-a51e1e006953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod_de3272a5-26eb-41b3-b5fc-fe5d56885fa3" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod_de3272a5-26eb-41b3-b5fc-fe5d56885fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ac6c719e-f6c2-4b31-b9cd-b6c029d12676" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_ac6c719e-f6c2-4b31-b9cd-b6c029d12676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_743452db-7a37-47c2-8719-3d9d00977202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_743452db-7a37-47c2-8719-3d9d00977202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0dfbb649-0906-4857-9aaf-c530a7e822c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6ceece24-9f67-474f-8d9d-305c2f04965e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0dfbb649-0906-4857-9aaf-c530a7e822c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ed48674-34b5-426a-8509-dfce92a99cc4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c8ccfca5-4d2a-4244-a4ee-0548c399740d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c8ccfca5-4d2a-4244-a4ee-0548c399740d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_db143f3f-c1f3-4a40-843e-142c2c70449c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_db143f3f-c1f3-4a40-843e-142c2c70449c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue_dc8f00c7-d518-49f3-8e70-14cbdde3f1e5" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue_dc8f00c7-d518-49f3-8e70-14cbdde3f1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d489509d-b995-417d-a2fc-9717f20b28c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d489509d-b995-417d-a2fc-9717f20b28c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9c45421c-5cf9-4400-b7bf-1efdf2f0f66a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9c45421c-5cf9-4400-b7bf-1efdf2f0f66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8442bd6e-e177-4ebe-b443-5c09dfa4337e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_cd142a58-4f89-4124-85c1-02f2816c3600" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8442bd6e-e177-4ebe-b443-5c09dfa4337e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#StockBasedPlansStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b60761e6-57d6-4bfb-a3b1-bc2c5bc7fa1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e3cfcfbe-8fbf-4b8f-b099-6e399908adf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b60761e6-57d6-4bfb-a3b1-bc2c5bc7fa1e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e3cfcfbe-8fbf-4b8f-b099-6e399908adf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_91290f77-1ce4-475f-9a9d-dd6655c1809f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e3cfcfbe-8fbf-4b8f-b099-6e399908adf2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_91290f77-1ce4-475f-9a9d-dd6655c1809f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1d677547-7083-445a-853a-dec97270c335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e3cfcfbe-8fbf-4b8f-b099-6e399908adf2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1d677547-7083-445a-853a-dec97270c335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1b6d4911-036a-471d-8ae1-5da1d135a5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e3cfcfbe-8fbf-4b8f-b099-6e399908adf2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1b6d4911-036a-471d-8ae1-5da1d135a5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4f78f23b-d94c-4d53-bb89-c4797971e900" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e3cfcfbe-8fbf-4b8f-b099-6e399908adf2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_4f78f23b-d94c-4d53-bb89-c4797971e900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9d788690-fc12-436b-bd15-b4c71089030f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e3cfcfbe-8fbf-4b8f-b099-6e399908adf2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9d788690-fc12-436b-bd15-b4c71089030f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2c324699-80f1-4167-8ded-1a7db8ca017c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b60761e6-57d6-4bfb-a3b1-bc2c5bc7fa1e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2c324699-80f1-4167-8ded-1a7db8ca017c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_de560a06-05f7-4339-9bb1-62a641e01ddd" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b60761e6-57d6-4bfb-a3b1-bc2c5bc7fa1e" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber_de560a06-05f7-4339-9bb1-62a641e01ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a6448562-2f29-4b93-b201-792b5c3cd1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b60761e6-57d6-4bfb-a3b1-bc2c5bc7fa1e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a6448562-2f29-4b93-b201-792b5c3cd1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_906016a0-8e9b-4fd8-9da8-6b734b5b8272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a6448562-2f29-4b93-b201-792b5c3cd1d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_906016a0-8e9b-4fd8-9da8-6b734b5b8272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8b423042-c214-4599-a368-1bb6c84b4884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a6448562-2f29-4b93-b201-792b5c3cd1d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8b423042-c214-4599-a368-1bb6c84b4884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_464546c7-f4f4-4dc9-8389-c40b3805e603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a6448562-2f29-4b93-b201-792b5c3cd1d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_464546c7-f4f4-4dc9-8389-c40b3805e603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_9e579bfc-aa20-4317-9cd0-dcc67a7423ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a6448562-2f29-4b93-b201-792b5c3cd1d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_9e579bfc-aa20-4317-9cd0-dcc67a7423ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_82858717-4079-442d-a252-d5cdcfd2ae67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a6448562-2f29-4b93-b201-792b5c3cd1d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_82858717-4079-442d-a252-d5cdcfd2ae67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_f65d8fa9-171d-4c3b-8fa0-8183fb8732de" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b60761e6-57d6-4bfb-a3b1-bc2c5bc7fa1e" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice_f65d8fa9-171d-4c3b-8fa0-8183fb8732de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice_23c1392b-96ec-46d2-ac5f-fee3be27db32" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b60761e6-57d6-4bfb-a3b1-bc2c5bc7fa1e" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice_23c1392b-96ec-46d2-ac5f-fee3be27db32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_02ea3f4c-10b2-4468-913b-ba165ddda167" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b60761e6-57d6-4bfb-a3b1-bc2c5bc7fa1e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_02ea3f4c-10b2-4468-913b-ba165ddda167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_7b5b4d1a-edbe-4fdf-80fd-bbdb7d11a3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_02ea3f4c-10b2-4468-913b-ba165ddda167" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_7b5b4d1a-edbe-4fdf-80fd-bbdb7d11a3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne_3c6dd85f-4111-4407-aba1-f5796d8359f3" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_02ea3f4c-10b2-4468-913b-ba165ddda167" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne_3c6dd85f-4111-4407-aba1-f5796d8359f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1_59affd8c-ab7d-4d1e-97a2-06f589fd6390" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_02ea3f4c-10b2-4468-913b-ba165ddda167" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1_59affd8c-ab7d-4d1e-97a2-06f589fd6390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_bc883ada-5bc3-4319-827c-80f68050ad5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b60761e6-57d6-4bfb-a3b1-bc2c5bc7fa1e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_bc883ada-5bc3-4319-827c-80f68050ad5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6809a055-70e9-4b7c-a378-fac72f7ba844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_bc883ada-5bc3-4319-827c-80f68050ad5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_6809a055-70e9-4b7c-a378-fac72f7ba844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_77ecca32-20cf-421c-bd2f-b744d5ddccb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_bc883ada-5bc3-4319-827c-80f68050ad5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_77ecca32-20cf-421c-bd2f-b744d5ddccb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue_109efa39-58e3-43e1-a3c8-21e3da11af27" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_bc883ada-5bc3-4319-827c-80f68050ad5d" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue_109efa39-58e3-43e1-a3c8-21e3da11af27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_5c4359aa-2a9c-4e6f-a3be-a6e8c7650726" xlink:href="fldm-20220331.xsd#fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract_bc883ada-5bc3-4319-827c-80f68050ad5d" xlink:to="loc_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_5c4359aa-2a9c-4e6f-a3be-a6e8c7650726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_b1d8f5e0-0686-4841-a2c7-44e8bad4314b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b60761e6-57d6-4bfb-a3b1-bc2c5bc7fa1e" xlink:to="loc_us-gaap_SharePrice_b1d8f5e0-0686-4841-a2c7-44e8bad4314b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#StockBasedPlansStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7e68a63d-5866-4271-86c7-f780cd041800" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_334da2ca-0b56-4ede-9fca-f7a6bad81866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7e68a63d-5866-4271-86c7-f780cd041800" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_334da2ca-0b56-4ede-9fca-f7a6bad81866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5fd9b65c-d92a-4b7e-89ad-6409196efec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_334da2ca-0b56-4ede-9fca-f7a6bad81866" xlink:to="loc_us-gaap_PlanNameAxis_5fd9b65c-d92a-4b7e-89ad-6409196efec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_04511784-4b13-44fd-9f1c-dca011bc75bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5fd9b65c-d92a-4b7e-89ad-6409196efec2" xlink:to="loc_us-gaap_PlanNameDomain_04511784-4b13-44fd-9f1c-dca011bc75bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_960f9ce5-497e-4b25-88be-552c2c234515" xlink:href="fldm-20220331.xsd#fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_04511784-4b13-44fd-9f1c-dca011bc75bc" xlink:to="loc_fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember_960f9ce5-497e-4b25-88be-552c2c234515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_10a83a84-1b26-4efd-86b2-bfc03b369b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_334da2ca-0b56-4ede-9fca-f7a6bad81866" xlink:to="loc_us-gaap_AwardTypeAxis_10a83a84-1b26-4efd-86b2-bfc03b369b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b2cdfb1e-4207-4033-9006-3cff19ac9624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_10a83a84-1b26-4efd-86b2-bfc03b369b3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b2cdfb1e-4207-4033-9006-3cff19ac9624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_224dbd87-31e0-46b3-b2c9-625b7b32d2d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b2cdfb1e-4207-4033-9006-3cff19ac9624" xlink:to="loc_us-gaap_EmployeeStockMember_224dbd87-31e0-46b3-b2c9-625b7b32d2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db5c6aa4-99ea-48fd-a590-b79388b5f115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_334da2ca-0b56-4ede-9fca-f7a6bad81866" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db5c6aa4-99ea-48fd-a590-b79388b5f115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_242f6b2a-f99e-4899-ae3f-f4072ebd55c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_db5c6aa4-99ea-48fd-a590-b79388b5f115" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_242f6b2a-f99e-4899-ae3f-f4072ebd55c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/IncomeTaxes" xlink:type="simple" xlink:href="fldm-20220331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_77cf7c15-6cf4-42ed-a4bb-c1b867394238" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_f7496608-a751-4676-b6fd-ed9b20ecd737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_77cf7c15-6cf4-42ed-a4bb-c1b867394238" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_f7496608-a751-4676-b6fd-ed9b20ecd737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_24e06f40-fa8d-45e7-8fb3-9e591030849f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c87e39e3-ea69-4f70-b99c-f6ce49f36221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_24e06f40-fa8d-45e7-8fb3-9e591030849f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c87e39e3-ea69-4f70-b99c-f6ce49f36221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/InformationAboutGeographicAreas" xlink:type="simple" xlink:href="fldm-20220331.xsd#InformationAboutGeographicAreas"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/InformationAboutGeographicAreas" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c9abbe13-cb38-488f-aae9-039bf5f829ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_c509bcf3-3140-40d5-a326-3e3ae1dab9de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c9abbe13-cb38-488f-aae9-039bf5f829ee" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_c509bcf3-3140-40d5-a326-3e3ae1dab9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/InformationAboutGeographicAreasDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#InformationAboutGeographicAreasDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/InformationAboutGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5fdb8488-1316-44b3-967d-fe107dfa4643" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_f861ff37-e749-4b08-ba20-06388c8cacf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5fdb8488-1316-44b3-967d-fe107dfa4643" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_f861ff37-e749-4b08-ba20-06388c8cacf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_28744c41-7a17-4e74-9b75-4353141fa009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_f861ff37-e749-4b08-ba20-06388c8cacf5" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_28744c41-7a17-4e74-9b75-4353141fa009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_939d23a1-9682-4c9c-99e6-5c5d22f88e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_28744c41-7a17-4e74-9b75-4353141fa009" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_939d23a1-9682-4c9c-99e6-5c5d22f88e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_9bdd4731-6b83-48b3-9709-04e04b4bf9f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_939d23a1-9682-4c9c-99e6-5c5d22f88e47" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_9bdd4731-6b83-48b3-9709-04e04b4bf9f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_2d6f94f2-ebb3-4ec8-9d5e-054e1cf2682d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_f861ff37-e749-4b08-ba20-06388c8cacf5" xlink:to="loc_srt_StatementGeographicalAxis_2d6f94f2-ebb3-4ec8-9d5e-054e1cf2682d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_96bb9498-8f34-4c9a-9a41-de9023fe4f83" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_2d6f94f2-ebb3-4ec8-9d5e-054e1cf2682d" xlink:to="loc_srt_SegmentGeographicalDomain_96bb9498-8f34-4c9a-9a41-de9023fe4f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_b8011953-60b0-46cb-9cbd-081e234c9688" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_96bb9498-8f34-4c9a-9a41-de9023fe4f83" xlink:to="loc_country_US_b8011953-60b0-46cb-9cbd-081e234c9688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_66f4b135-49a8-4f59-8ec0-a206a8a68c3f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_96bb9498-8f34-4c9a-9a41-de9023fe4f83" xlink:to="loc_country_CN_66f4b135-49a8-4f59-8ec0-a206a8a68c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5eef3622-7a43-4c24-a786-61b7f63c1876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_f861ff37-e749-4b08-ba20-06388c8cacf5" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5eef3622-7a43-4c24-a786-61b7f63c1876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_998fd879-6820-44a7-9f6b-42538e64089b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5eef3622-7a43-4c24-a786-61b7f63c1876" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_998fd879-6820-44a7-9f6b-42538e64089b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_aae13d2f-09f9-4e1c-8841-eb47b7ad4bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_998fd879-6820-44a7-9f6b-42538e64089b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_aae13d2f-09f9-4e1c-8841-eb47b7ad4bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_3ae73cb3-2cde-4b59-bedf-25bd01848272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_f861ff37-e749-4b08-ba20-06388c8cacf5" xlink:to="loc_us-gaap_ProductInformationLineItems_3ae73cb3-2cde-4b59-bedf-25bd01848272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_937d3b5d-08e1-46e4-afd5-da9e897be534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_3ae73cb3-2cde-4b59-bedf-25bd01848272" xlink:to="loc_us-gaap_NumberOfReportableSegments_937d3b5d-08e1-46e4-afd5-da9e897be534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3622606e-c59a-413e-b4f9-7ee945c59bea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_3ae73cb3-2cde-4b59-bedf-25bd01848272" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3622606e-c59a-413e-b4f9-7ee945c59bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_60828508-aad5-4c06-95f1-f68572a3a726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_3ae73cb3-2cde-4b59-bedf-25bd01848272" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_60828508-aad5-4c06-95f1-f68572a3a726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="fldm-20220331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5d2e4d1e-f674-44c2-80e0-90b1c8594b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2ff50f2f-baa8-45f6-8a87-b60ca281a30f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5d2e4d1e-f674-44c2-80e0-90b1c8594b8e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2ff50f2f-baa8-45f6-8a87-b60ca281a30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SubsequentEvent" xlink:type="simple" xlink:href="fldm-20220331.xsd#SubsequentEvent"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SubsequentEvent" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_9fd5968e-3621-4c3c-8823-b7eaac60883c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_23d5a7c5-ddea-48f7-b9cf-fc6619085825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_9fd5968e-3621-4c3c-8823-b7eaac60883c" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_23d5a7c5-ddea-48f7-b9cf-fc6619085825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://fluidigm.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="fldm-20220331.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://fluidigm.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d5601cf4-40a7-4885-b2f0-8e99594710ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_9b10ac3d-926a-45ab-9dcf-0da404c95bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d5601cf4-40a7-4885-b2f0-8e99594710ee" xlink:to="loc_us-gaap_SubsequentEventTable_9b10ac3d-926a-45ab-9dcf-0da404c95bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_891fc0e6-5141-4734-8e09-c080c382e6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9b10ac3d-926a-45ab-9dcf-0da404c95bfe" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_891fc0e6-5141-4734-8e09-c080c382e6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6a58102f-825e-4662-a3c4-9a9864e55f40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_891fc0e6-5141-4734-8e09-c080c382e6a1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6a58102f-825e-4662-a3c4-9a9864e55f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_89c49d2e-eef8-4742-886a-af23be1e626b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6a58102f-825e-4662-a3c4-9a9864e55f40" xlink:to="loc_us-gaap_SubsequentEventMember_89c49d2e-eef8-4742-886a-af23be1e626b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_2372acc2-3189-4400-972e-2ae0c993f134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9b10ac3d-926a-45ab-9dcf-0da404c95bfe" xlink:to="loc_us-gaap_StatementClassOfStockAxis_2372acc2-3189-4400-972e-2ae0c993f134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3e92d736-ee0c-416a-ad5c-3cd4be528a34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_2372acc2-3189-4400-972e-2ae0c993f134" xlink:to="loc_us-gaap_ClassOfStockDomain_3e92d736-ee0c-416a-ad5c-3cd4be528a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_985013f1-9506-428b-8500-5b886761cf45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3e92d736-ee0c-416a-ad5c-3cd4be528a34" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_985013f1-9506-428b-8500-5b886761cf45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f8bac45a-289f-40fb-a3ff-d004a76ebc75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9b10ac3d-926a-45ab-9dcf-0da404c95bfe" xlink:to="loc_us-gaap_PlanNameAxis_f8bac45a-289f-40fb-a3ff-d004a76ebc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7853e0d0-9a15-4c23-a771-780ed3a9590f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_f8bac45a-289f-40fb-a3ff-d004a76ebc75" xlink:to="loc_us-gaap_PlanNameDomain_7853e0d0-9a15-4c23-a771-780ed3a9590f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_fldm_A2022InducementEquityIncentivePlanMember_1cfebfee-c49e-4f23-894e-05bb1fb98df6" xlink:href="fldm-20220331.xsd#fldm_A2022InducementEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7853e0d0-9a15-4c23-a771-780ed3a9590f" xlink:to="loc_fldm_A2022InducementEquityIncentivePlanMember_1cfebfee-c49e-4f23-894e-05bb1fb98df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_664223d2-2751-49f5-aa87-b040555469d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9b10ac3d-926a-45ab-9dcf-0da404c95bfe" xlink:to="loc_us-gaap_AwardTypeAxis_664223d2-2751-49f5-aa87-b040555469d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27d10353-e153-4149-9dbe-d87d1aaa2721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_664223d2-2751-49f5-aa87-b040555469d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27d10353-e153-4149-9dbe-d87d1aaa2721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_08a8ede6-ad68-4a19-a78f-ab3d3ccecc24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27d10353-e153-4149-9dbe-d87d1aaa2721" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_08a8ede6-ad68-4a19-a78f-ab3d3ccecc24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9b10ac3d-926a-45ab-9dcf-0da404c95bfe" xlink:to="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_a1f4e327-5b15-46fc-8d38-88e6b1ec9826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_a1f4e327-5b15-46fc-8d38-88e6b1ec9826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8c27da7e-ab91-461e-885f-7bad1d48b53f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_8c27da7e-ab91-461e-885f-7bad1d48b53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_341e64a6-cdd5-4a22-a52b-eda70ba9345f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_341e64a6-cdd5-4a22-a52b-eda70ba9345f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_f091491d-4f49-40b2-aa2f-47afb00385a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_f091491d-4f49-40b2-aa2f-47afb00385a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_591e0b9d-c78a-4427-aac5-ae5dd8c1d54c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_591e0b9d-c78a-4427-aac5-ae5dd8c1d54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_486f8930-7563-4430-90cf-6900e4c9d98f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_486f8930-7563-4430-90cf-6900e4c9d98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7398c584-380f-42d5-8c4c-5a47be01ded0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7398c584-380f-42d5-8c4c-5a47be01ded0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_94ad8cdb-3d80-4bf5-a4fe-e1cb07075a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_94ad8cdb-3d80-4bf5-a4fe-e1cb07075a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1716c861-e2f1-4d3a-8717-89b53a463ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_940c2ac5-d81d-41b1-91c1-cc3bb5c6235e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1716c861-e2f1-4d3a-8717-89b53a463ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>fldm-20220331_g1.jpg
<TEXT>
begin 644 fldm-20220331_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /W\HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5XO_ ,%'_P#E'C\>?^R=>(?_ $V7
M%>T5XO\ \%'_ /E'C\>?^R=>(?\ TV7%=.#_ -XAZK\S*O\ PY>C/Y*Z^J?^
M"(W_ "E5^#'_ &&9/_26>OE:OJG_ ((C?\I5?@Q_V&9/_26>OW?-?]QK?X)?
MDS\^P7^\4_\ $OS/ZDZ***_G\_1@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK\^?\ @J;_ ,%]O W["]UJ
M'@SP3#9^/OBA #'-;+*?[,T*3IBZD0Y>0=X4(88PS1\9Z\%@:^+JJCAXW?\
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MJ49NG55I+=,^CA.,X\T'=!1116104444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM.ME\:*^*%T_F[I_UV/G,\H2AB74>TB"BBBOK3Q0K^FO_@WQ\,7OA;_@DO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA_98EVVEK_7S"OVI_P"#43]JW[5H_P 0O@OJ-UE[5U\5:+')*2=C;(+M%!Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<.W>!_M[C[YKP>BBO*G4G-WF[L_2L'@,-@Z?LL+3C"/:*27X!1114'8%%%%
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M_"MO_P#X[7U.2\+U,QH.O":BD[:KT_S/)QV;0PM3V<HWTN?US45_(S_PW?\
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M7YO3PU'V?*V^I_7-7QA_P<)_\H@?B[_W!O\ T]6%?ST?\-W_ !P_Z++\5O\
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M?C+PI9W<OGSP:-K5S8Q328"[V6)U!;  R>< 5T?_  W?\</^BR_%;_PK;_\
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M_P _?_)8_P"1]C_8N#_D_%_YGXG_ /$(WJ__ $7;3O\ PDG_ /DNO'?V_O\
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M]Q:;J=OK.GPW=G<0W5K<()(IH7#QRJ>A5AP1[BOY2J]G_95_X*!?%?\ 8TU
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M+D ;F.!7E-%%?/3G*;YI.[/WG"X2AA:2H8>"C!;)*R04445!T!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %?7'_!$W]FW_ (:'_;R\.3W=MYVB^!U;Q'?;HRT9
M>$@6Z$],F=HVP>JQOZ5\CU^VW_!N[^S=_P *S_91U7Q]>6^S4OB%J!^SLR$,
M+&U+11]?[TIG;W&T\\5Z.5T/:XB*>RU^X^%\1LZ_LW(JTXNTY^Y'UEO]T;L_
M0:BBBOMS^.3\E_\ @ZN_:K_X0_X%>"/A!IUULO/&-\=<U:-"I/V*U^6%'!Y
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M% !1110 4444 %>>_M8? #3_ -JC]FKQO\.]3VK:^+M'N-/$K*&^S2LI\J8
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M %%%% !1110 4444 %?;O["W_!<;XE?LMM::'XO:?XB^"XRL8AO;@_VEI\?
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ML8FM[JVE66&=#R&1U)# ^H-7*]L_'FFG9A1110(**** "BBB@ HHHH ****
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M5L-&]1[S?Q/_ "7DOG=ZA1117$?7!1110 4444 %%%% !1110 4444 %%%%
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M8+[SIH^!V%7\;%2?I%+\VS^@/QM_P7*_9K\&O+''XXNM;GB',>FZ-=R!CC.
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M4C6771_+^OP.+KWK_@F-^U0W[&?[=/P[\>2W#V^D6.IK9ZS^\94;3[@&"X+
M?>"1R&0*1]Z-3U (\%HK[BO1C6I2HSVDFG\SP*=1TYJ<=T?V=12K-&KHP9&
M964Y!![BG5\E?\$0_P!J[_AK?_@G)X$U6[N1<Z_X7A/AC629?,D\^T"HCN<
M[Y+<P2G/>4\GJ?K6OY\Q6'GAZTJ$]XMK[C](I5%4@JD=GJ?$/_!?']F\_&S]
MB"X\1V<!EU?X<WBZQ'M W-:-B*Y7GL%*RG_KA7X0U_55XQ\)V/CWPCJFAZI
MMSINLVDMC=PL,B6*5"CJ?JK$5_,1^T3\&;_]G?XZ^+/ ^I!OM?AC5)[ NPQY
MZ(Y\N4>SIM<>S"OD,^H6FJRZZ']*>"N=>UP=;*YO6F^:/^&6_P!SU_[>.,HH
MHKY\_< HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M44 %%%% !117H?[)WP)NOVFOVDO!G@2UW9\2:I%;3.IYAMP=\\@Z_<B61O\
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M$#GRYH\C<.3@\,I)*D&OW:_X)[_\%-/!'[?7@X#3W70O&MA"'U3P]<2@RQ=
M98&X\V'/\0 *Y 8#(S]=@,TA7]R6DOS]#^7.-_#G%Y))XG#WJ8?OUCY2_P#D
MMO1Z'TE1117JGYJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%9/CKQUH_PR\'ZCX@\0:C::1HND0-<WEY<R;(K>-1DL3_3J20!R:+VU
M948RE)1BKMFAJ&H0:38375U/#;6UNAEEFE<)'$@&2S,>  .I-?D#_P %3_\
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M[Q7XNN%21?!^@^3;@KS'<7<@0.#V_=13K_P/VY_.VOUT_P"#9+1H(? GQ=U
M*?M-S?Z9;NV>-D<=RRC'UD;]/2O1RJ"EBHI_UH?!^)F*E0X;Q,H;M1C_ .!2
M2?X7/U(HHHK[<_CL_ +_ (.D/VJ_^%I?M@Z!\,;"YWZ9\,],$MZBL<'4;T)*
MP8?=.VW6VP>H,D@]17Y@5[=_P4K\:WGQ!_X*$_&S5+UV>:3QMJT";CDI%#=R
M0Q)_P&.-%_X#7B-?OF386.&P-*C'HE][U?XGYUCZSJXB<WW"OUD_X-4_V4O^
M$R^/?C3XOZC:[K+P78C1-)D= 5-]=#,SH>H:.W7:?:[K\FZ_J0_X(K_LH?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "MCP#X^UKX6^,M.\0^'=3O-&UO2)
MA<6=[:R&.6!QW!'MD$=""0<@FL>BFFT[HB<(SBX35T]T?N/_ ,$L_P#@LWH_
M[6,-CX'^(<MEH'Q(5!%;7'$5GXB(S_J^T<^ ,Q]&)RG]Q?O6OY1[:YDLKF.:
M&1XI8F#HZ,59&!R"".00:_6K_@DU_P %MAKYT[X:?&G5$CO<+;:-XJNI-JW&
M!A8+UR>'XPLQ^]D!_F^9OI\MS?FM2KO7H_\ ,_G7C_PN>'YLRR:-X;RIK>/G
M'NNZW7331?J=12 [AD4M?0'X8%%%% !1110 4444 %%%% !1110 4444 %%%
M% !117._%GXL^'O@;\.]5\5^*]5MM&T'1H3/=W<[85!T  ZLS$@*H!+$@ $F
MDVDKLNG3G4FH05V]$ENV'Q9^+/A[X&_#O5?%?BO5;;1M!T:$SW=W.V%0=  .
MK,Q("J 2Q( !)K\'?^"H'_!4_P 0_MX>-)-)TE[[0_AGIDO^@:47VOJ# \7-
MT%.&?^ZG*QCIDDL<W_@IM_P4V\1?M]_$3[/;_:=&^'FC3,='T<OAICR/M5Q@
MX:9@3@<B,$JN269OEFODLSS1UG[*E\/Y_P# /Z?\//#B&5QCF.8J]=[+I#_[
M;SZ;+N%%%%>*?KP4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %?JO_P &R/C+9J/Q>\/22_ZR/2]1@BXXVFZCE;UYW0C\!ZU^
M5%?77_!$'X_P_ ?_ (*!>&H[V40Z=XV@E\,SNSX"O.4>#CN3<10IVQO)SQ@]
MV6U%3Q,)/^KZ'QOB!E\L;P]BJ,%=\O,O^W6I?I8_H"HHHK[H_C$_EV_X+B?
M:Z^ /_!3WXIVLML\%GXHU,^*+&0L2+F.^_?R.N23@3M.GL8S@8Q7R97]&O\
MP7^_X)<W?[=7P*L_&?@NR6X^)7P^AD>"V1"9=<T\Y>2T7'656_>1]<DNHYDR
M/YSKNTET^[E@GBDAGA<QR1R*5>-@<%2#R"#VK]NX9S.&,P4%?WH))KTZ_,^"
MS7"2H5V^CU7]>1[_ /\ !++]E1OVS/V\OAWX'FM_M&C3:DNHZT&BWQ_V?;?O
MYU?D "14\H$_Q2KP>A_JX1!&@50 H&  . *_'/\ X-0_V4_[/\-_$/XSZC:D
M2ZA(OA719)(BI\I-D]VZD\,K.;9<CH87&>HK]C:_/^-,?[?'^RCM35OGN_\
M+Y'TF1X?V>'YWO+7_(*^&?\ @OW^TE_PIG]BEO"UG<&'5_B/>KIBA6 <6<>)
M;EOH<1QGVF-?<U?@W_P7H_:1/QO_ &Y+WP_:3F31_AU:KHL2@C8;H_O+IQWS
MO98SG_GA7Y_FM?V6'=MWI_7R/UGPRR7^T<^I<RO"E[[_ .W=O_)K?*Y\3T44
M5\2?V %%%% !1110 4444 %%%% !1110 5L_#OQWJ/PN\?:)XETB40ZKX?OX
M-1LY#G"RQ2+(A."#C*C/-8U%--IW1$X1G%PFKIZ,_J4^"7Q6T[XZ?"#PSXRT
MEMVG>)M,@U* =T$J!MA_VE)*D=B#745^=_\ P;I_M)-\1OV8M=^'M]<>9?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?V$^_P#>?X+3>X4445X9^R!1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"/7_  4=T_\ ;*^"-KX;UV_1/B5X1M8[?489F"OJT*C:EY&.-V0 ) /NOR0
MZY^RJ_0*-:-6"J0V9_#>;Y5B<MQ<\%BHVG!V]>S7DUJ@HHHK4\T*_#[_ (+H
M_P#!1"#]IOXKQ?#?PI=F;P7X%O)#=W,9!CU?4@"C.I[QP@NBGHQ:1N1L-?6_
M_!;G_@IY!^SWX!N_A9X'U,'Q[XC@,6JW5K+\_A^S=>1N'*W$JG"X^9%R_P I
M,9/XFU\WG./_ .8>G\_\O\S^@/"7@IIK/,;'_KVG_P"E_I'[^S"BBBOFS^@
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M7X&_]#5\5_\ P9Z?_P#(5?H/11_9N&_D0?Z_\1?]!<_P_P C\^/^(;7X&_\
M0U?%?_P9Z?\ _(5'_$-K\#?^AJ^*_P#X,]/_ /D*OT'HH_LW#?R(/]?^(O\
MH+G^'^1^?'_$-K\#?^AJ^*__ (,]/_\ D*C_ (AM?@;_ -#5\5__  9Z?_\
M(5?H/11_9N&_D0?Z_P#$7_07/\/\C\^/^(;7X&_]#5\5_P#P9Z?_ /(5'_$-
MK\#?^AJ^*_\ X,]/_P#D*OT'HH_LW#?R(/\ 7_B+_H+G^'^1^?'_ !#:_ W_
M *&KXK_^#/3_ /Y"H_XAM?@;_P!#5\5__!GI_P#\A5^@]%']FX;^1!_K_P 1
M?]!<_P /\C\^/^(;7X&_]#5\5_\ P9Z?_P#(5'_$-K\#?^AJ^*__ (,]/_\
MD*OT'HH_LW#?R(/]?^(O^@N?X?Y'Y\?\0VOP-_Z&KXK_ /@ST_\ ^0J/^(;7
MX&_]#5\5_P#P9Z?_ /(5?H/11_9N&_D0?Z_\1?\ 07/\/\C\^/\ B&U^!O\
MT-7Q7_\ !GI__P A4?\ $-K\#?\ H:OBO_X,]/\ _D*OT'HH_LW#?R(/]?\
MB+_H+G^'^1^?'_$-K\#?^AJ^*_\ X,]/_P#D*C_B&U^!O_0U?%?_ ,&>G_\
MR%7Z#T4?V;AOY$'^O_$7_07/\/\ (_/C_B&U^!O_ $-7Q7_\&>G_ /R%1_Q#
M:_ W_H:OBO\ ^#/3_P#Y"K]!Z*/[-PW\B#_7_B+_ *"Y_A_D?GQ_Q#:_ W_H
M:OBO_P"#/3__ )"H_P"(;7X&_P#0U?%?_P &>G__ "%7Z#T4?V;AOY$'^O\
MQ%_T%S_#_(_/C_B&U^!O_0U?%?\ \&>G_P#R%1_Q#:_ W_H:OBO_ .#/3_\
MY"K]!Z*/[-PW\B#_ %_XB_Z"Y_A_D?GQ_P 0VOP-_P"AJ^*__@ST_P#^0J/^
M(;7X&_\ 0U?%?_P9Z?\ _(5?H/11_9N&_D0?Z_\ $7_07/\ #_(_/C_B&U^!
MO_0U?%?_ ,&>G_\ R%1_Q#:_ W_H:OBO_P"#/3__ )"K]!Z*/[-PW\B#_7_B
M+_H+G^'^1^?'_$-K\#?^AJ^*_P#X,]/_ /D*C_B&U^!O_0U?%?\ \&>G_P#R
M%7Z#T4?V;AOY$'^O_$7_ $%S_#_(_/C_ (AM?@;_ -#5\5__  9Z?_\ (5'_
M !#:_ W_ *&KXK_^#/3_ /Y"K]!Z*/[-PW\B#_7_ (B_Z"Y_A_D?GQ_Q#:_
MW_H:OBO_ .#/3_\ Y"H_XAM?@;_T-7Q7_P#!GI__ ,A5^@]%']FX;^1!_K_Q
M%_T%S_#_ "/SX_XAM?@;_P!#5\5__!GI_P#\A4?\0VOP-_Z&KXK_ /@ST_\
M^0J_0>BC^S<-_(@_U_XB_P"@N?X?Y'Y\?\0VOP-_Z&KXK_\ @ST__P"0J/\
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M_P#R%7Z#T4?V;AOY$'^O_$7_ $%S_#_(_/C_ (AM?@;_ -#5\5__  9Z?_\
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M (,]/_\ D*OT'HH_LW#?R(/]?^(O^@N?X?Y'Y\?\0VOP-_Z&KXK_ /@ST_\
M^0J/^(;7X&_]#5\5_P#P9Z?_ /(5?H/11_9N&_D0?Z_\1?\ 07/\/\C\^/\
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MW\B#_7_B+_H+G^'^1^?'_$-K\#?^AJ^*_P#X,]/_ /D*C_B&U^!O_0U?%?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHKS;]JG]K;P#^Q?\)KOQG\0]>M]$T>V^2)3\]S?RXR(8(A\
MTDA]!T&22%!(NG3E4DH05V^@I245>6QZ37$_&3]I/X>_L[Z6+SQWXW\*^#[=
MQF-M7U2&T,WLBNP+GV4$U^$/[>__  <I?%C]H6_N]&^%!G^%7A$EHQ<PLDFN
M7R'(R\^"+?L<0892/]:PK\Y_%'BO5/'&OW.JZUJ5_J^J7K;[B\O;A[BXG; &
M7=R68X &2>U?<Y?P+B*B4\7/D\EJ_P#)?B?/XGB"G!\M%<WGLC^D[XA?\'$?
M[*7@*\FMXO'U_P"(9X,AAI.A7DJ$CLLCQI&WU#$<]:\OU?\ X.I_V<]-U&6"
M'PS\7M0C0@+<6^CV CDX!X$EZC^W*CI7\^-%?14^!\NC\3D_FOT1YDN(,2]D
ME\O^"?T0^%/^#HK]FGQ$N;NS^)FA?O1'B^T2!\+Q\_[BXE^49_WN#QTSZM\-
M/^"^/[*/Q/OEM8/BI:Z/=,I?9K.EWFGH ,=9I(A#GGIOSU]*_F(HJ:G N7R^
M&4E\U_D5'B#$K=)_UZG]BOPP^-7@[XVZ&NI^#?%?ASQ7I[C<+G2-2AO8L?[T
M;,!73U_&SX)\>ZY\-?$4&L>'-9U;0-6M3F&^TV[DM;B'_=DC(8?@:_0O]B#_
M (.5_C+^S[?6FE_$P)\6/"JE8WDNRMMK5HGRC*7*KB; W'$RLS$@>8HKY['\
M"XBFN;"S4_)Z/_+\CTL/Q!2D[55R_BC^ANBO'/V+_P!O'X:?M\?#,>)OAUKR
M:@D(5=0TVX7R=0TF1AGRYX<DJ>#A@2C8.UF S7L=?$5:4Z4W3J*S71GO1G&2
MYHNZ"BBBLRCS#XP_MJ_"+]GOQ6FA>.OB7X(\(:S+;K=I8ZOK$%I.\+%E60([
M [248 ],J?2N5_X>D?LW_P#1=?A3_P"%-:?_ !=?C#_P=-?\I(=%_P"Q&L/_
M $KOJ_-JOT/+.#*&*PE/$2J-.2OT/F\7GE2C6E245H?UA_\ #TC]F_\ Z+K\
M*?\ PIK3_P"+H_X>D?LW_P#1=?A3_P"%-:?_ !=?R>45W_Z@X;_G[+[D<W^L
M=7^1']8?_#TC]F__ *+K\*?_  IK3_XNC_AZ1^S?_P!%U^%/_A36G_Q=?R>4
M4?Z@X;_G[+[D'^L=7^1']8?_  ](_9O_ .BZ_"G_ ,*:T_\ BZ/^'I'[-_\
MT77X4_\ A36G_P 77\GE%'^H.&_Y^R^Y!_K'5_D1_6'_ ,/2/V;_ /HNOPI_
M\*:T_P#BZ/\ AZ1^S?\ ]%U^%/\ X4UI_P#%U_)Y11_J#AO^?LON0?ZQU?Y$
M?UA_\/2/V;_^BZ_"G_PIK3_XNC_AZ1^S?_T77X4_^%-:?_%U_)Y11_J#AO\
MG[+[D'^L=7^1']8?_#TC]F__ *+K\*?_  IK3_XNC_AZ1^S?_P!%U^%/_A36
MG_Q=?R>44?Z@X;_G[+[D'^L=7^1']G-O<)=0)+&P>.10RLIR&!Y!%/K-\'?\
MBCI?_7G%_P"@"M*ORUGUH4444 %%%>(?\%'OVIXOV,/V)OB%\0_,1-0T?2WB
MTH,"1)J$Y$%J,#DCSI$+?[*L> ,UI1I2JU(TH;MI+YDSFH1<I;(-=_X*6?L]
M^&-;O--U'XU_#&QU#3YWMKJVG\1VJ2V\J,5=&4OD,K @@]"*J_\ #TC]F_\
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M6T#4XUVI=Z;>26LZC(. \9# 9 []A7UY^S5_P7\_:8_9RN+:*3QM_P )YH\
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MM%-KX3X',Z<WBIM+J<O174?\*0\:?]"AXH_\%4__ ,31_P *0\:?]"AXH_\
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M.^_G(@M1@ Y ED1C_LJW0#-:4:4JM2-*&[:2^9,YJ$7*6R/Y_?\ @O)^U?\
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MR$#.T\F-90.5Y;&>=K<>9XB=#"5*U/>,6U]QMA*<:E:-.6S:/W__ &/?V-/
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MI_P3@_Y1X_ ;_LG7A[_TV6]?R5U_6I_P3@_Y1X_ ;_LG7A[_ --EO7P''_\
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M(Z$$$!@0/Z]:^<O^"FO_  3E\*?\%(/V>KSPQK$4%AXGT]'N/#>NB/,VDW6
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M4[[>S4GIT^U,1D]8S@<9_9^^OH=,LIKFXD2&"W1I99'.%C51DDGT %?R7_\
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M9-(RY#(,,!D9(S@FOH:BBN&M7JUI^TK2<GW;NS>%.,%RP5EY!1116184444
M%?S=?\'*/_*5/Q+_ -@32_\ TF6OZ1:_FZ_X.4?^4J?B7_L":7_Z3+7V/ __
M ",7_A?Z'BY]_NOS1\$4445^OGQ(5_6I_P $X/\ E'C\!O\ LG7A[_TV6]?R
M5U_6I_P3@_Y1X_ ;_LG7A[_TV6]? <?_ .[TO5_D?1\.?Q)^A[11117Y<?6A
M1110 4444 %<Q\:OBSI7P'^#_BCQKKLGE:/X3TJYU:\8 D^5!&TC   DL0N
M "22 !73U^9/_!T+^UB/A'^QKH_PTL+@QZO\4=1'VE4)##3K-DEEY XW3-;+
M@D;E\P<@&N[+,$\7BH8=?:?X=?P,,575&C*J^B/P@^-7Q7U3X[_%_P 3^--;
MD,NK>*]4N=6NSN+ 232-(5&?X1NP!V  KF***_H"$5&*C'9'YPVY.["OO?\
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M_P"P)I?_ *3+7V/ _P#R,7_A?Z'BY]_NOS1\$4445^OGQ(5_6I_P3@_Y1X_
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MG_1K^YM_R_=<>V*^M*^,?^#?")H?^"07PB#*5.-8;!&.#K5^0?Q!K[.K^?\
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MR/4J!WK^GBOQ;B[+XX7'MTU:,US?Y_CK\S[O)L2ZV&7-NM HHHKY@]4****
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MQ+J5K!YNM?#69/%5F0<'R8@4NP3C[OV:25\=VB3TKX'_ .(LOXI_]$N\ ?\
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MBR_BG_T2[P!_X$W?_P 71_Q%E_%/_HEW@#_P)N__ (NOB_\ 4[-?Y%_X$O\
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M[;/[G8ZZ^ Q%%<U2-D>5T445ZAQA117UA_P2._X*)Z7_ ,$^?VAH=6\2>#]
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M+_V[_/[^Y]-DN96MAJK]/\O\C]CZ***_,SZH**** "ORB_X.RO\ DU3X7_\
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M?A6B]%_F[L_0,MPOU>@H/?=^H4445X9WA1110 5_-U_P<H_\I4_$O_8$TO\
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MPZW[$O[=_B"#3;(6O@WQNS>(M \M,0PQRN?.ME[#RIMX"CHC1'O7].U?"O\
MP<$?L,/^V)^PQJ&L:-:-<>,OA@9/$&F+&NZ2ZM@G^F6P !)W1+YBJ!EG@C'<
MU])PKF?U/'1YG[L]'^C^3_"YYF;X3V^'=MUJC^:VBBBOVP^""BBB@ K]-_\
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M<@//(4.3UM1QW/B<09B\%@9UH.TMEZO_ "W^1WY;A5B,0H2VW?H<1_Q"(_\
M5P?_ )8G_P!\:/\ B$1_ZN#_ /+$_P#OC7[/45^7?ZW9M_S]_P#)8_Y'UO\
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MD<?/T["OJ.$<91PV.]I7ERKE>K^1Y6<T:E7#\M-7=T?A=17Z;_\ $*5^T/\
M]#E\&/\ P;:G_P#(%'_$*5^T/_T.7P8_\&VI_P#R!7Z;_K'EG_/Y'R?]EXO^
M1GYD5_6I_P $X/\ E'C\!O\ LG7A[_TV6]?C%_Q"E?M#_P#0Y?!C_P &VI__
M "!7[B?LF?"G4?@/^RM\,_ ^KS65QJW@SPII>A7LMF[/;RSVMG%!(T;,JL4+
M(2I95)&,@'BOC.,\TPF*HTXX>:DTWMZ'NY'A*U&I)U8VT/0:***_/3Z0***P
M?BE#XBN?AIX@C\(MIB>*I--N$T=]2D>.S2\,;"%IF17<1B3:6VJ3@' II7=@
M/YM?^"^W[6'_  U/_P %'?%:6=SY_A_P J^%=-VN2A-NS&Y<#IDW+S#(ZJB=
M<"OBNOT]U#_@U:_:/U>_GNKKQS\'KFZN9&EFFEUG5'DE=CEF9C89)))))ZYJ
M'_B%*_:'_P"AR^#'_@VU/_Y K]JP6<Y5AL/##PK*T4D?"8C XRK4E4<'JS\R
M**_3?_B%*_:'_P"AR^#'_@VU/_Y I]O_ ,&I'[0;7""7QI\&TB+ .R:IJ3,J
M]R!]A&3[9'UKJ_UCRS_G\C'^R\7_ ",^Z/\ @V7_ &6%^"7[!$GCB\M?)UOX
MJ:D^H%WC"R?8+<M!;(>Y!87$HSVG&!W/Z-5S_P )_AII?P8^%WAWPCHD(M]'
M\,:9;Z591@8VPP1K&GXX49]ZZ"OQ?,<9+%8J>(E]IW^73[D?=8:BJ-*--=$%
M%%%<1N%%%% !7QI_P7J_97_X:D_X)M^,TM;8W&N^!@OBO3-J[GW6H;SU ')W
M6SS@ =6V^E?9=17UC#J=E-;7$:307"-%+&XRKJPP01Z$&NC"8F6'KPKPWBT_
MN,ZU-5*;IRV9_&117ZH_$O\ X-4/C1<_$;7Y/"GBWX4P^%GU*X;1H]0U741=
MQV1E;R!,%LF42"/;NPS#.<,>M8O_ !"E?M#_ /0Y?!C_ ,&VI_\ R!7[7'B7
M+&K^V1\&\KQ2=N1GYD5] ?\ !+C]JYOV+_V[?A[XZEN#!H]OJ*Z?K>7VH=/N
M?W-PS>NQ7\T _P 42].H^M_^(4K]H?\ Z'+X,?\ @VU/_P"0*/\ B%*_:'_Z
M'+X,?^#;4_\ Y K/$9YE5:E*C.LK233^9=++\93FIQ@[H_H#BE6:-71@R, R
MLIR"#W%.KS#]B_P!XX^%'[*W@7PM\1[W1M3\9>&]*BTO4+W2[J6YMKSR,Q12
MB26.)V=HEC9]R#YRW+#YCZ?7XG4BHS<4[VZGWD7=)A7\ZG_!SS_RDX;_ +%/
M3?\ T*>OZ*Z_*3_@L9_P0N^+?_!0G]L,_$'P9XB^'6F:,=$M--\G6K^\ANO,
MB,A8[8K65=OSC'S9Z\"OH^$L91PV/]I7ERQY7J_D>9G%&=7#\E-7=T?@]17Z
M;_\ $*5^T/\ ]#E\&/\ P;:G_P#(%'_$*5^T/_T.7P8_\&VI_P#R!7Z?_K'E
MG_/Y'R7]EXO^1GYX?!#_ )+3X0_[#=E_Z/2O[%*_!+X=?\&M?[0/A'X@Z%JU
MSXP^#KV^F:C;W<JQ:KJ1=DCD5R%!L ,X!QDCZU^]M? <:9AAL54I/#S4K)WM
M\CZ3(\-5HPFJL;7L%%%%?$GNA39H4N(6CD571P596&0P/4$4ZB@#^6G_ (+&
M_L0?\,'?MS^)O#-A;F'PGKA&O>',#"I93LW[D<8_<R+)$.^V-2>M?+-?TT?\
M%JO^"5MS_P %-/@MX?@\,7FA:/X_\)7YETV^U9Y8K66UE 6XMY'BCD< [8W4
MA&^:/' <D?F=_P 0I7[0_P#T.7P8_P#!MJ?_ ,@5^OY+Q1A)X.'UJHHS6COU
MMU^?YGQ>/RFM&N_8QO%ZGYD45^F__$*5^T/_ -#E\&/_  ;:G_\ (%'_ !"E
M?M#_ /0Y?!C_ ,&VI_\ R!7K?ZQY9_S^1Q?V7B_Y&?F17Z;_ /!J5_RD.\9?
M]DZO?_3GI='_ !"E?M#_ /0Y?!C_ ,&VI_\ R!7V#_P1._X(G?%3_@F[^U3K
M_CCQQK_P_P!5TG5?"EQH446A7UY/<+/)>6<ZLRS6L2[-MNX)#$Y*\8)(\G/<
M]P%; 5:5*JG)K1'9E^7XF&)A.<&DF?J)1117Y ?:A1110!_*G_P5]_Y2=?&[
M_L:KK^8KYOK]D/V[O^#<+XX?M0?MB?$7X@Z!XI^%5IHWB[6IM2LX=0U._CNH
MXW(P)%2R=0WT8CWKR;_B%*_:'_Z'+X,?^#;4_P#Y K]IR_B#+H86G"=9)J*7
MX'PN)R[$RK3E&#LV_P S\R**_3?_ (A2OVA_^AR^#'_@VU/_ .0*/^(4K]H?
M_H<O@Q_X-M3_ /D"NS_6/+/^?R,/[+Q?\C/S(HK]-_\ B%*_:'_Z'+X,?^#;
M4_\ Y H_XA2OVA_^AR^#'_@VU/\ ^0*/]8\L_P"?R#^R\7_(S\R**_3?_B%*
M_:'_ .AR^#'_ (-M3_\ D"MKPC_P:=_&2];_ (GOQ'^&>FCS /\ 0#?7OR=S
M\\$//M^M3+B7+(J[K+\?\AK*L6W;D9^5U%?MO\*O^#2?P]97'F>-_C)K.IQ'
M;_H^AZ''8LG7/[V:2;/;'[L8P>N>/LG]F[_@A;^S-^S//!=V/P\M/%.K0!<:
MAXIE.K2%E.0XB<?9T;/.Y(E->9BN-LNIK]U>;\E;\[?D==+(<3+X[1_KR/P'
M_8N_X)7_ !M_;RU*'_A!O"%U'H+MB7Q%JVZRTB$<C/G,I,I!&"L*R,,C*@<U
M^Z/_  3._P""%7PQ_P""?TUGXGU(KX^^)<0W+K=] %M]+8C!%G!DB,]O,8M)
MUP5!*U]OVEI%86L<,$4<,,2A$CC4*J*.@ ' %25\-F_%6+QR=->Y#LNOJ^OX
M(^@P644<.^9^]+N_T"BBBOF#U0HHHH YCXU?%G2O@/\ !_Q1XUUV3RM'\)Z5
M<ZM>, 2?*@C:1@  26(7  !))  K^1+XU_%G5?CQ\8?%'C76Y/,U?Q9JMSJU
MV=Q($DTK2%1_LC=@#L !7].__!7']E7XE?ML?L=:C\-/AIJOA?1KWQ%?VW]K
M7.N7EQ;1&QB8S-&AAAE8LTJ0@@@#8'!/.#^2_P#Q"E?M#_\ 0Y?!C_P;:G_\
M@5^@<'8O X2E.KB*BC.3M9]E_F_R/G,[HXBM*,*46TOS/S(HK]-_^(4K]H?_
M *'+X,?^#;4__D"C_B%*_:'_ .AR^#'_ (-M3_\ D"OM?]8\L_Y_(\'^R\7_
M ",_-/0M#N_$VMV>FZ?;R7=_J$Z6UM!&,O-*[!411ZDD ?6OZX?V*OV=K7]D
MW]D_P!\.[98\^%=&@M+IXU $]UMWW$O''SS-(W_ NIK\L/\ @GO_ ,&UGQ,_
M9Z_;'\">._B/XC^&VJ^%O"&H#5I+/1[V]GNI[B%6>VPLMK$FU9Q$[9;HA&.:
M_9^O@N,LYHXN5.CAI<T5J[=]OP7YGT61X&=%2G55F]/D%%%%?#GOA1110 44
M44 ?C%_P=@?LM9C^'/QFL8!D%_"6KNJ<G_67-HQ(_P"WI23ZH,]!7XP5_6?_
M ,%&/V2%_;D_8Q\=?#1);2VU+7K(/I5Q=,R0V]]"ZS6S.RJS*GFHH<JK'8S8
M!Z'\9_\ B%*_:'_Z'+X,?^#;4_\ Y K]0X5X@PU/ JABJBBXMI7[;_YH^3S?
M+:L\1[2C&Z?YGYD45^F__$*5^T/_ -#E\&/_  ;:G_\ (%'_ !"E?M#_ /0Y
M?!C_ ,&VI_\ R!7TO^L>6?\ /Y'E?V7B_P"1FU_P:Q_M9_\ "NOVGO$_PEU&
MY":;\0M/.H:8COP-1LU9F15QUDMC*Q.?^7=1@]OWKK\+OV</^#;S]IS]F?X]
M^$/'^B>,O@R=3\(ZM;ZG%'_;6IH)Q&X+1,?[/.%==R'@\,>*_=&OS/BV>%JX
MSZQA9J2DM;=UI^5CZO)XUH4/9UE:VWH%%%%?+'K'\=?QO_Y+3XO_ .PW>_\
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M.?&WP\?P3+=-)I*Z_?7L&HP0MR(I1%:2HS)G;O#?.%#;5SM'*?\ $*5^T/\
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MP NW^TQ)/K7AXWCO#05L+!R?=Z+_ #_(]"AP]5EK5E9>6I^0'_!.?_@V#O\
M4;JQ\5?M#WHL+5&6:/P?I5R'FFZ';>7*$J@Z@QPEB1_RT4Y%?LM\/OA[H7PH
M\&:=X=\,Z1I^@Z%I$(M[*PL8%A@MHQT554 #^I))K9HK\^S/-\5CY\^(EZ+H
MO1?TSZ3"X.EAX\M)?YA1117F'4%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %?D_\ \'(_PT^+_P (=$T?XV_#+XD_$GP[X>A\K1_$^E:/XDO+
M.SLW9B+:]6*.157>S"%SW;R>,LQ/ZP5@_%+X9:)\:/AQKGA+Q+81:GH'B.RE
MT^_M9/NS0R*589Z@X/!'(.".17H97COJF)C7:NENNZZ_\ Y\70]M2=.]F?R@
M?\/"/CY_T6_XO_\ A9:C_P#'J/\ AX1\?/\ HM_Q?_\ "RU'_P"/5I?\%$OV
M(=>_X)^_M3^(/A[K'G7-E;O]KT3473:-5T^0GR9AVW8!1P.%=''0 GPZOW*A
M2PE:G&K3C%Q:NM$?G]25:G)PDW=>9Z__ ,/"/CY_T6_XO_\ A9:C_P#'J/\
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M+4?_ (]1_P /"/CY_P!%O^+_ /X66H__ !ZO(**/JE#^1?<@]M4_F?WGK_\
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M\/"/CY_T6_XO_P#A9:C_ /'J\@HH^J4/Y%]R#VU3^9_>>O\ _#PCX^?]%O\
MB_\ ^%EJ/_QZC_AX1\?/^BW_ !?_ /"RU'_X]7D%%'U2A_(ON0>VJ?S/[SU_
M_AX1\?/^BW_%_P#\++4?_CU'_#PCX^?]%O\ B_\ ^%EJ/_QZO(**/JE#^1?<
M@]M4_F?WGK__  \(^/G_ $6_XO\ _A9:C_\ 'J/^'A'Q\_Z+?\7_ /PLM1_^
M/5Y!11]4H?R+[D'MJG\S^\]?_P"'A'Q\_P"BW_%__P ++4?_ (]1_P /"/CY
M_P!%O^+_ /X66H__ !ZO(**/JE#^1?<@]M4_F?WGK_\ P\(^/G_1;_B__P"%
MEJ/_ ,>H_P"'A'Q\_P"BW_%__P ++4?_ (]7D%%'U2A_(ON0>VJ?S/[SU_\
MX>$?'S_HM_Q?_P#"RU'_ ./4?\/"/CY_T6_XO_\ A9:C_P#'J\@HH^J4/Y%]
MR#VU3^9_>>O_ /#PCX^?]%O^+_\ X66H_P#QZC_AX1\?/^BW_%__ ,++4?\
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M%'U2A_(ON0>VJ?S/[SU__AX1\?/^BW_%_P#\++4?_CU'_#PCX^?]%O\ B_\
M^%EJ/_QZO(**/JE#^1?<@]M4_F?WGK__  \(^/G_ $6_XO\ _A9:C_\ 'J/^
M'A'Q\_Z+?\7_ /PLM1_^/5Y!11]4H?R+[D'MJG\S^\]?_P"'A'Q\_P"BW_%_
M_P ++4?_ (]1_P /"/CY_P!%O^+_ /X66H__ !ZO(**/JE#^1?<@]M4_F?WG
MK_\ P\(^/G_1;_B__P"%EJ/_ ,>H_P"'A'Q\_P"BW_%__P ++4?_ (]7D%%'
MU2A_(ON0>VJ?S/[SU_\ X>$?'S_HM_Q?_P#"RU'_ ./4?\/"/CY_T6_XO_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *_?;_@WC_X))_\ #-G@6W^-GQ TUH_'WBFSQH=A
M<Q[7T"PD&3(RG[MQ,N,Y&Y(SMX+N*^5O^#>__@C^?VBO%UE\;OB/IH;P%H%S
MN\/Z;<QY7Q!>1MCSF!X-O"Z]""))!C[J,&_>^OS7C'B"]\OP[_Q/_P!M_P _
MN[GU629;;_::J]/\_P#(****_.3Z8**** "BBB@ HHHH *^5_P#@J]_P3$\.
M?\%*_@*VES?9]+\=>'TDN/#.M,O_ ![2D M!+CDP2[5##DJ0K $K@_5%%;X;
M$U,/5C6HNTEL14IQJ0<)JZ9_'/\ %[X2>(O@+\3M<\&^+=*N=%\1^';M[*_L
MYUPT,B^AZ,K##*RDJRLK*2"#7-U_2C_P6F_X(^Z7_P %$?AL?$_A>"VT_P"+
MWARU\O3;IG$46M0*2WV*<].[&-SC:S8)VL<?SA^./!&L?#3QAJ7A_P 0:;>:
M/K>CW#VE[97<1BFM94.&1E/((-?MF19Y2S&CS+2:^)?JO(^#S#+YX6=MXO9F
M51117NGG!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD\HK^L/_ (=;_LW_ /1"OA3_ .$S:?\ Q%'_  ZW_9O_ .B%?"G_ ,)FT_\
MB*/]?L-_SZE]Z#_5RK_.C^3RBOZP_P#AUO\ LW_]$*^%/_A,VG_Q%'_#K?\
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M1_*117Z3_P#!3C_@W4\:_LA:%?\ C7X87M_\1O =D&FO+62%1K6C0JN3)(J
M+<1C!+/&JLH.3'M#./S8K[? 9CA\93]KAY77XKU1X&(PU6A+DJJP4445VG.%
M%%% !17=?LY?LV^-?VLOBSIO@GP#H5WK_B'4R2D$(PD$8QNFE<_+'&N1EV(
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M45?V-?$/X1^%/B[H\NG^*_#/A_Q-83(8Y+;5=.AO(G7^Z5D5@1R:^!OVW/\
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M^U%\,/#D+A[_ $3PS->W0!SY:W-R5C!]_P#1V.,YP1ZC.G!56<<R48[23O\
M=?\ ,G/81>%;>Z:L?E%1117[&?#A7]?O[*'_ ":U\-?^Q5TO_P!)(J_D"K^O
MW]E#_DUKX:_]BKI?_I)%7YWX@?!0]9?H?3\-[U/E^IW]?ST?\'37_*2'1?\
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MB88*L#^AZ@@$<BOF7_@CY_P4SLO^"E7[-G]K7L=EIWC[PO(ECXFTVW;]VLC
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M,HNM0G13MS)K[U8X:%3V=6-1]&G]Q_9=17\@O_#6_P 5O^BF_$+_ ,**\_\
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M\P_B3PY?^#O$5_I&J6D]AJ>EW,EG>6LZ;9;::-BCQL.S*P((]17]E]?ST?\
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M;WJ?+]3OZ_GH_P"#IK_E)#HO_8C6'_I7?5_0O7\]'_!TU_RDAT7_ +$:P_\
M2N^KP>"?^1FO\+/0S[_=?FC\VJ***_8CX@^ZO^#<?X8Q?$3_ (*I>#[N<!HO
M">FZCK6PC(=A;M;IV_A>X5ATY0?0_P!*5?SS?\&M,Z1?\%)-65G56E\#Z@J
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M\E'#(V.5-?9Y%Q=6PEJ.*]^G^*_S7E]QXF89-"M[]+27X,_DQHK[%_X*7?\
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MK.R_+EE4%@@9L>,<9@9X%PYHRJ77+9IM:Z^BM<TR2CB(UU*S4>O8^[*^'/\
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M  40NO&*0.-#^*6G0:I;2X C%U;QQVUS$,<Y&R&4Y_Y^!^'YY5_6'_P44_8
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M-O?&'B3XB:5XU_: TV#P]X7TJ=+J'PI),D][K3*0RK<["R10$XW(29& 92J
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M[U^I.?V^K:]T?!E%%%?KQ\4%%%% !1110 4444 %%%% !1110 4444 %%%%
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M117S9Z84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2KQCIFORNK]#X3PU6AEZIUHN+N]&?,YS5A4Q+E!W5D%%%%?2GE!1110![O\
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MATVS\/\ QGT)_B'I%LBQ)K=@ZV^M1J.\JMB*X.,<DQL>K,Q-?F6?<&U.=U\
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ME2]I[225[;_,_0ZBOSQ_XB=OV8O^>WC_ /\ !"/_ ([1_P 1.W[,7_/;Q_\
M^"$?_':^"_L+,?\ GQ+[F?1?7\-_S\7WH_0ZBOSQ_P"(G;]F+_GMX_\ _!"/
M_CM'_$3M^S%_SV\?_P#@A'_QVC^PLQ_Y\2^YA]?PW_/Q?>C]#J_EM_X+=?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO6OQE_:N_8C^*'[$OC7^P_B5X1U+P[/*S"TNF42V6H*#]Z"="8Y.Q(!W#(W
M'BOT_*\_P>/5J,K2_E>C_P"#\CY/%Y=7P[]]:=UL>4T445[1P!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%>_?L:_\$QOC3^W=J48\ >#;V?1BQ677M0S9Z3!
M@D']^XPY!4@K$'<?W:_8+]AS_@V.^%WP3CL]:^+FH/\ $[Q)&5E.GQ[[70[9
MQSC8")+C![R%48=8J\+,^(L%@;QJ2O+^5:O_ ('S/1PF68C$:Q5EW9^-7['_
M /P3R^+W[=7B,67PY\'ZAJMI'(([K5YQ]FTNQZ9\RX?"9 .=B[G(Z*:_9?\
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M$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM*L8[9';^\^T NQ[LV2?6NNHKXK&YIB\8[XB;EY=/NV/=H82C15J4;!1117
M= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ-!*R.K(Z$JRL,%2.H(KUJ=:G45Z<DUY.YQ3ISAI)6&T445J0%%%% !1110
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M]-/\S\'/@Y_P:?\ Q3\31B3QS\2?!?A)&(Q'IEK/K$RC_:#?9T!^CGZU]?\
MP4_X-=OV>OAZ5F\5W_C;Q_<;0'BN]1&GVF1U*I;*DHS[RGI7Z245X&)XIS.M
MHZME_=T_%:_B>C2RG"4]H7]=3R#X(?L ?!/]F\1MX)^%O@K0;F(!5O(M+CDO
M2!TS<2!I3^+&O7Z**\&I5G4ES5&V_/4]",8Q5HJP4445!04444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/3FOZCJ*]"GQUF$=)1B_D_\ ,YY</X9[-K^O0_DA\3?\$_OCOX-EE75/@O\
M%6Q$+%6>7PI?",X.,A_*VL,]""0>QKSOQ?\ #?Q%\/I0FO:#K6B.SF,+J%C+
M;$L.JX=1R.XK^R*FRQK-&R.H9&!5E89!![&NZ'']5?'13]';]&<\N'(?9F_N
M/XQ:*_L6U_X+^#O%<;KJGA/PUJ2R !UNM+@F#@'(SN4YP0*X'Q+_ ,$[?@#X
MPNY;C4_@E\)KRYG(:2XD\)V'G2$# R_E;CP .O:NN'']-_'1:]'?]$8RX<E]
MFI^'_!/Y)Z*_JNUK_@D+^S'KRRB?X(?#Y/.QN^S::MMC_=\O;MZ=L5Q_B/\
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M^\FI^(8)&C^8CG[-YPZ#/!/!'?(K^D"BN*IQUF$E:,8KY/\ S-X\/X9;MO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
=110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961268493400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-34180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">STANDARD BIOTOOLS INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0513190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2 Tower Place, Ste 2000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South San Francisco,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">266-6000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LAB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,252,135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001162194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961269557576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 29,983<span></span>
</td>
<td class="nump">$ 28,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable (net of allowances of $356 at each of March 31, 2022 and December&#160;31, 2021)</a></td>
<td class="nump">15,422<span></span>
</td>
<td class="nump">18,320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">23,245<span></span>
</td>
<td class="nump">20,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">4,547<span></span>
</td>
<td class="nump">4,470<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">73,197<span></span>
</td>
<td class="nump">72,066<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">27,699<span></span>
</td>
<td class="nump">28,034<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset, net</a></td>
<td class="nump">36,389<span></span>
</td>
<td class="nump">37,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">3,445<span></span>
</td>
<td class="nump">3,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Developed technology, net</a></td>
<td class="nump">24,875<span></span>
</td>
<td class="nump">27,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">106,333<span></span>
</td>
<td class="nump">106,379<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">271,938<span></span>
</td>
<td class="nump">275,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">12,517<span></span>
</td>
<td class="nump">10,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and related benefits</a></td>
<td class="nump">7,964<span></span>
</td>
<td class="nump">4,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">3,209<span></span>
</td>
<td class="nump">3,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current</a></td>
<td class="nump">12,291<span></span>
</td>
<td class="nump">11,947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DeferredGrantRevenueCurrent', window );">Deferred grant income, current</a></td>
<td class="nump">3,603<span></span>
</td>
<td class="nump">3,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">7,589<span></span>
</td>
<td class="nump">8,673<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Advances under revolving credit agreement, current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,838<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">47,173<span></span>
</td>
<td class="nump">49,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Bridge loans</a></td>
<td class="nump">35,655<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible notes, net</a></td>
<td class="nump">54,271<span></span>
</td>
<td class="nump">54,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Term loan, net</a></td>
<td class="nump">10,106<span></span>
</td>
<td class="nump">10,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">3,544<span></span>
</td>
<td class="nump">4,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">36,760<span></span>
</td>
<td class="nump">37,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, non-current</a></td>
<td class="nump">5,793<span></span>
</td>
<td class="nump">5,966<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DeferredGrantRevenueNoncurrent', window );">Deferred grant income, non-current</a></td>
<td class="nump">17,237<span></span>
</td>
<td class="nump">18,116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_StockRepurchaseLiability', window );">Obligation for Series B Preferred Stock</a></td>
<td class="nump">37,792<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,494<span></span>
</td>
<td class="nump">882<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">249,825<span></span>
</td>
<td class="nump">180,618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either March&#160;31, 2022 or December 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $0.001 par value, 200,000 shares authorized at March&#160;31, 2022 and December&#160;31, 2021; 77,199 and 76,919 shares issued and outstanding at March&#160;31, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">835,379<span></span>
</td>
<td class="nump">831,424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,057)<span></span>
</td>
<td class="num">(907)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(812,286)<span></span>
</td>
<td class="num">(735,998)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">22,113<span></span>
</td>
<td class="nump">94,596<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 271,938<span></span>
</td>
<td class="nump">$ 275,214<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DeferredGrantRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Grant Revenue, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DeferredGrantRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DeferredGrantRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Grant Revenue, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DeferredGrantRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_StockRepurchaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_StockRepurchaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961269720168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, net of allowances</a></td>
<td class="nump">$ 356<span></span>
</td>
<td class="nump">$ 356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">77,199,000<span></span>
</td>
<td class="nump">76,919,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">77,199,000<span></span>
</td>
<td class="nump">76,919,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961269620936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 26,504<span></span>
</td>
<td class="nump">$ 32,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">8,865<span></span>
</td>
<td class="nump">10,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">30,875<span></span>
</td>
<td class="nump">27,608<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total costs and expenses</a></td>
<td class="nump">54,007<span></span>
</td>
<td class="nump">52,114<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(27,503)<span></span>
</td>
<td class="num">(19,320)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(1,030)<span></span>
</td>
<td class="num">(887)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_LossOnForwardSaleOfStock', window );">Loss on forward sale of Series B Preferred Stock</a></td>
<td class="num">(37,792)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesUnrealizedGainLoss', window );">Unrealized loss on bridge loans</a></td>
<td class="num">(10,655)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">118<span></span>
</td>
<td class="num">(285)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(76,862)<span></span>
</td>
<td class="num">(20,492)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">574<span></span>
</td>
<td class="nump">1,671<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (76,288)<span></span>
</td>
<td class="num">$ (18,821)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="num">$ (0.99)<span></span>
</td>
<td class="num">$ (0.25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.99)<span></span>
</td>
<td class="num">$ (0.25)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in computing net loss per share, basic (in shares)</a></td>
<td class="nump">77,031<span></span>
</td>
<td class="nump">74,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in computing net loss per share, diluted (in shares)</a></td>
<td class="nump">77,031<span></span>
</td>
<td class="nump">74,707<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_LossOnForwardSaleOfStock', window );">Loss on forward sale of Series B Preferred Stock</a></td>
<td class="num">$ (37,792)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">20,004<span></span>
</td>
<td class="nump">24,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">12,339<span></span>
</td>
<td class="nump">11,663<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">6,144<span></span>
</td>
<td class="nump">6,286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of revenue</a></td>
<td class="nump">1,928<span></span>
</td>
<td class="nump">2,090<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember', window );">Development revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 268<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_LossOnForwardSaleOfStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss On Forward Sale Of Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_LossOnForwardSaleOfStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961272814120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (76,288)<span></span>
</td>
<td class="num">$ (18,821)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(443)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (76,438)<span></span>
</td>
<td class="num">$ (19,264)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271923592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders' Equity - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 139,050<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 815,624<span></span>
</td>
<td class="nump">$ 112<span></span>
</td>
<td class="num">$ (676,761)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other</a></td>
<td class="num">(525)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(525)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">3,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(18,821)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,821)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">(443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(443)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 122,938<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">818,776<span></span>
</td>
<td class="num">(331)<span></span>
</td>
<td class="num">(695,582)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">76,919<span></span>
</td>
<td class="nump">76,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 94,596<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">831,424<span></span>
</td>
<td class="num">(907)<span></span>
</td>
<td class="num">(735,998)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of shares withheld for taxes, and other</a></td>
<td class="num">(87)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">4,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(76,288)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,288)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss, net of tax</a></td>
<td class="num">$ (150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="nump">77,199<span></span>
</td>
<td class="nump">77,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 22,113<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 835,379<span></span>
</td>
<td class="num">$ (1,057)<span></span>
</td>
<td class="num">$ (812,286)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961267239688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (76,288)<span></span>
</td>
<td class="num">$ (18,821)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_LossOnForwardSaleOfStock', window );">Loss on forward sale of Series B Preferred Stock</a></td>
<td class="nump">37,792<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesUnrealizedGainLoss', window );">Unrealized loss on Bridge Loans</a></td>
<td class="nump">10,655<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">4,042<span></span>
</td>
<td class="nump">3,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of developed technology</a></td>
<td class="nump">2,968<span></span>
</td>
<td class="nump">2,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Provision for excess and obsolete inventory</a></td>
<td class="nump">851<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discounts, premiums and issuance costs</a></td>
<td class="nump">211<span></span>
</td>
<td class="nump">132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other non-cash items</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">163<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">2,917<span></span>
</td>
<td class="nump">9,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories, net</a></td>
<td class="num">(3,558)<span></span>
</td>
<td class="num">(2,896)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(2,763)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">1,905<span></span>
</td>
<td class="nump">3,363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Accrued compensation and related benefits</a></td>
<td class="nump">3,037<span></span>
</td>
<td class="num">(5,020)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(1,346)<span></span>
</td>
<td class="num">(4,967)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(15,590)<span></span>
</td>
<td class="num">(12,901)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ProceedsFromResearchAndDevelopmentGrant', window );">Proceeds from NIH Contract</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(868)<span></span>
</td>
<td class="num">(6,923)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(868)<span></span>
</td>
<td class="num">(4,923)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from bridge loans</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of advances under credit agreement</a></td>
<td class="num">(6,838)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(501)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes related to net share settlement of equity awards and other</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(525)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">18,075<span></span>
</td>
<td class="num">(1,026)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign exchange rate fluctuations on cash and cash equivalents</a></td>
<td class="num">(85)<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">1,532<span></span>
</td>
<td class="num">(18,776)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">29,467<span></span>
</td>
<td class="nump">69,536<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">30,999<span></span>
</td>
<td class="nump">50,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes, net of refunds</a></td>
<td class="nump">488<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_NonCashRightOfUseAssetsAndLeaseLiabilities', window );">Non-cash right-of-use assets and lease liabilities</a></td>
<td class="num">(133)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_AssetRetirementObligationsIncurredButNotYetPaid', window );">Asset retirement obligations</a></td>
<td class="nump">$ 722<span></span>
</td>
<td class="nump">$ 324<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_AssetRetirementObligationsIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Retirement Obligations Incurred But Not Yet Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_AssetRetirementObligationsIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_LossOnForwardSaleOfStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss On Forward Sale Of Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_LossOnForwardSaleOfStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_NonCashRightOfUseAssetsAndLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Cash Right -of-Use Assets and Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_NonCashRightOfUseAssetsAndLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ProceedsFromResearchAndDevelopmentGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Research and Development Grant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ProceedsFromResearchAndDevelopmentGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271794872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business</a></td>
<td class="text">Description of BusinessStandard BioTools Inc. (Standard BioTools, the Company, we, our or us), previously known as Fluidigm Corporation, is driven by a bold vision &#8211; unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, we provide reliable and repeatable insights in health and disease using our proprietary mass cytometry and microfluidics technologies that help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022, in connection with the completion of the private placement issuance discussed in Note 3. The Company was founded in 1999 and is headquartered in South San Francisco, California.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271683928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of March&#160;31, 2022, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, Italy, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the audited financial statements and the related notes for the year ended December&#160;31, 2021 included in our annual report on Form 10-K, filed with the SEC on</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March 8, 2022, we disclosed that we had performed an assessment to determine whether there were conditions or events, considered in the aggregate, that raised substantial doubt about our ability to continue as a going concern for at least the twelve-month period following the date the financial statements were issued. We believed that our then-current level of cash and cash equivalents, together with committed financing facilities, were not sufficient to fund ongoing operations for at least the twelve-month period after the financial statements are issued. Since then, we have closed the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$225 million Series B Preferred Equity Financing, as defined in Note 3, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that was previously disclosed in Note 18 to our audited financial statements for the year ended December 31, 2021 as contingent on stockholder approval. The completion of this financing has eliminated the doubt about the Company&#8217;s ability to continue as a going concern. See Note 3 and Note 17 for further discussion. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts in the condensed consolidated financial statements were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders&#8217; equity, total revenue, total costs and expenses, loss from operations or net loss.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Interim Financial Information</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim condensed consolidated financial statements and related disclosures are unaudited, have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the results of operations for the periods presented.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year-end condensed consolidated balance sheet was derived from audited financial statements, but does not include all </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disclosures required by U.S. GAAP. The condensed consolidated results of operations for the three months ended March&#160;31, 2022 are not necessarily indicative of the results to be expected for the full year or for any other year or interim period. The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements and the related notes for the year ended December&#160;31, 2021 included in our annual report on Form 10-K, filed with the SEC on March&#160;8, 2022.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information, including the unknown impact of COVID-19 and the war in Ukraine. Accounting matters that rely on forecasted financial information included, but were not limited to, our inventory, and related reserves, and the carrying value of goodwill and other long-lived assets and liabilities. Actual results could differ materially from these estimates and could have a material adverse effect on our condensed consolidated financial statements. We also use significant judgment in determining the fair value of financial instruments, including the Bridge Loans, forward contracts on Series B Preferred Stock and other debt and equity instruments.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. Income and expense accounts are translated at monthly average exchange rates during the year. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders&#8217; equity. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Private Placement Issuance </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">See Note 3 for a detailed discussion of the transactions, including the accounting treatment, and additional information.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Loss </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) generally consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The component of accumulated other comprehensive loss, net of tax, for the three months ended March&#160;31, 2022 is as follows (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at December 31, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(907)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(907)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at March 31, 2022</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss per Share </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options, restricted stock units and performance awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridge Loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Convertible Preferred Stock Purchase Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Convertible Notes potential make-whole shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,488&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Potentially dilutive securities in the above table include the impact of the Bridge Loans and the Series B Convertible Preferred Stock Purchase Agreements, defined in Note 3.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See Note 3 for further discussion.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Changes and Accounti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ng Pronouncements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Guidance </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2020, the FASB issued ASU 2020-06 Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. The amendment to this ASU reduces the number of accounting models for convertible instruments and allows more contracts to qualify for equity classification, which is expected to result in more convertible instruments being accounted for as a single unit, rather than being bifurcated between debt and equity. The new guidance is effective for fiscal years beginning after December 15, 2021. The Company adopted ASU 2020-06 effective January 1, 2022. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The adoption of ASU 2020-06 did not have an impact on the Company&#8217;s 2014 and 2019 Convertible Notes.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2021, the FASB issued ASU 2021-10 Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. The amendment is effective for annual periods beginning after December 15, 2021. The amendment establishes financial disclosure requirements for business entities that receive government assistance that the entities account for by analogizing to a grant or contribution model because there is no specific authoritative guidance under U.S. GAAP that applies to the transaction. Entities that receive this type of assistance should include the following information in their annual report: (1) the nature of the transaction, (2) the significant terms and conditions, (3) the accounting treatment, (4) the line items on the balance sheet and income statement that are affected along with (5) the respective amounts that have been recorded. The Company adopted ASU 2021-10 effective January 1, 2022. The adoption of ASU 2021-10 did not have a material impact on the Company&#8217;s financial statements. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span></div>None<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271769304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement Issuance<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtAndEquityIssuanceTextBlock', window );">Private Placement Issuance</a></td>
<td class="text">Private Placement Issuance<div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Transactions </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 23, 2022, we entered into (i) a Loan Agreement (the Casdin Bridge Loan Agreement) with Casdin Private Growth Equity Fund II, L.P. and Casdin Partners Master Fund, L.P. (collectively, Casdin) and (ii) a Loan Agreement (the Viking Bridge Loan Agreement, and together with the Casdin Bridge Loan Agreement, the Bridge Loan Agreements) with Viking Global Opportunities Illiquid Investments Sub-Master LP and Viking Global Opportunities Drawdown (Aggregator) LP (collectively, Viking and, together with Casdin, the Purchasers and each, a Purchaser). Each Bridge Loan Agreement provided for a $12.5&#160;million term loan (the Bridge Loans) to the Company. The Bridge Loans were fully drawn on January 24, 2022. The Bridge Loans automatically converted into Series B Preferred Stock, defined below, upon the completion of the Preferred Equity Financ</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ing, defined below.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also on January 23, 2022, we entered into separate Series B Convertible Preferred Stock Purchase Agreements (the Purchase Agreements) with each of Casdin and Viking pursuant to which at the closing of the transactions contemplated thereby, and on the terms and subject to the conditions set forth therein, including the approval of our stockholders, we issued and sold an aggregate of $225 million of convertible preferred stock on April 4, 2022, consisting of: (i) 112,500 shares of the Company&#8217;s Series B-1 Convertible Preferred Stock, par value $0.001 per share (the Series B-1 Preferred Stock), at a purchase </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">price of $1,000 per share to Casdin; and (ii) 112,500 shares of the Company&#8217;s Series B-2 Convertible Preferred Stock, par value $0.001 per share (the Series B-2 Preferred Stock, and together with the Series B-1 Preferred Stock, the Series B Preferred Stock) at a purchase price of $1,000 per share to Viking (the Preferred Equity Financing, and together with the issuance of shares of Series B Preferred Stock in connection with the conversion of the Bridge Loans, the Private Placement Issuance). </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, preferences and privileges of the Series B Preferred Stock are set forth in the Series B-1 Certificate of Designations and Series B-2 Certificate of Designations (collectively, the Series B Certificates of Designations), each as defined in the respective Purchase Agreements. The Series B Preferred Stock ranks senior to our common stock with respect to dividend rights, redemption rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. The holders of Series B Preferred Stock are entitled to participate in all dividends declared on our common stock on an as-converted basis, on the terms and subject to the conditions set forth in the Series B </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certificates of Designations.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors (the Board) called a meeting (Special Meeting) to ask our stockholders to consider, vote upon and approve (i) a proposal to amend the Company&#8217;s Eighth Amended and Restated Certificate of Incorporation (the Charter) to, among other things, increase the number of shares of common stock, par value $0.001 per share, that we are authorized to issue from two hundred million (200,000,000) shares to four hundred million (400,000,000) shares and to change the Company&#8217;s name to Standard BioTools Inc. (the Charter Amendment Proposal); (ii) a proposal to approve, in accordance with Nasdaq Listing Rule 5635, the issuance of (A) the Series B-1 Preferred Stock and the Series B-2 Preferred Stock pursuant to the Purchase Agreements, (B) the Series B-1 Preferred Stock and the Series B-2 Preferred Stock issuable pursuant to the terms of the Bridge Loan Agreements and (C) the common stock issuable upon the conversion of the Series B Preferred Stock (the Private Placement Issuance Proposal); and (iii) a proposal to adjourn the Special Meeting if the Special Meeting were convened and a quorum were present, but there were not sufficient votes to approve the Charter Amendment Proposal and the Private Placement Issuance Proposal (the Adjournment Proposal, and, together with the Private Placement Issuance Proposal and the Charter Amendment Proposal, the Stockholder Proposals). Each of the Private Placement Issuance Proposal and Charter Amendment Proposal were conditioned on the approval of the other proposal, and neither proposal would take effect unless both were approved by our stockholders. Our stockholders approved the Charter Amendment Proposal and Private Placement Issuance Proposal on April 1, 2022. The Private Placement Issuance closed on April 4, 2022. The proceeds of the Private Placement Issuance have been and will be used to fund expenses related to the Private Placement Issuance, as well as working capital, general corporate purposes and potential future merger and acquisition opportunities that we may identify from time to time. </span></div><div style="margin-top:8pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bridge Loans</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to their conversion, the Bridge Loans bore interest (i) from and including the effective date of the Bridge Loan Agreements to but excluding March 1, 2022, at 10%, (ii) from and including March 1, 2022 to but excluding June 1, 2022, at 12%, (iii) from and including June 1, 2022 to but excluding September 1, 2022, at 14%, and (iv) from and including September 1, 2022 and thereafter, at 16%. Interest accrued daily and was payable in kind by adding the accrued interest to the outstanding principal amount. Unless earlier converted, the outstanding principal amount of the Bridge Loans (inclusive of principal and accrued and unpaid interest) was due and payable in cash on the maturity date.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Bridge Loans automatically converted into Series B Preferred Stock upon the issuance of the shares of Series B Preferred Stock pursuant to the Purchase Agreements, in accordance with the terms of the Bridge Loan Agreements. The Bridge Loans converted into a number of shares of Series B Preferred Stock equal to (i) the then outstanding principal amount of the applicable Bridge Loan (including any interest added to the original principal amount thereof) plus accrued and unpaid interest (together, the Conversion Amount) on the Bridge Loans divided by $1,000 multiplied by (ii) the Conversion Price (as defined in the Series B Certificates of Designations) divided by $2.84. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Series B Preferred Stock had not been approved for issuance by our stockholders, or the Purchase Agreements were terminated, then the Bridge Loans would have become convertible, at each lender&#8217;s option, into common stock, par value $0.001 per share, of the Company at an initial conversion rate of 352.1126 shares of common stock per $1,000 of the Conversion Amount, subject to the cap set forth in the Bridge Loan Agreements. Unless earlier converted, the Bridge Loans, inclusive of principal and accrued and unpaid interest, would have become due and payable in cash on the maturity date. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity date of the Bridge Loans was 91 days after the maturity date of the Term Loan Facility as defined in Note 9. The latest possible maturity date of the Bridge Loans was September 30, 2025. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion rate was subject to customary adjustments as set forth in the Bridge Loan Agreements. </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Bridge Loans is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and unpaid interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on Bridge Loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of Bridge Loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Applying the guidance in ASC 825, we elected to record the Bridge Loans at their fair value. The change in fair value of the Bridge Loans from $25.0 million at inception to $35.7 million as of March&#160;31, 2022, including the portion attributable to accrued interest, is reflected as a non-operating unrealized loss on the Bridge Loans in the accompanying consolidated statement of operations. In addition, as required under the fair value option, issuance costs associated with the debt of $0.2 million were recognized in selling, general and administrative expenses in the first quarter of 2022.</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unrealized loss on the Bridge Loans was largely driven by an increase in the price of our common stock from $2.84 per share at inception to $3.59 per share as of March&#160;31, 2022, and, to a lesser extent, to the change in value of the various conversion options under the Approval Scenario, discussed below. We employed a probability&#8208;weighted expected return method in our valuation analysis of the Bridge Loans. Specifically, our analysis contemplated two scenarios: 1) our stockholders approve the transaction (Approval Scenario) and 2) our stockholders do not approve the transaction (Disapproval Scenario). To estimate the fair value of the Bridge Loans pursuant to the Approval Scenario, we employed a Monte Carlo Simulation (MCS) analysis based on the underlying Series B Preferred Stock into which the Bridge Loans were convertible. Given the convertibility of the Series B Preferred Stock into cash or our common stock, our MCS analysis simulated the value of the Series B Preferred Stock using a random&#8208;walk process that incorporated the various provisions of the Series B Preferred Stock discussed below.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Series B Convertible Preferred Stock Purchase Agreements</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Purchase Agreements for the issuance of 225,000 shares of Series B Preferred Stock for $225 million at a future date, have been accounted for as forward sales contracts at fair value in accordance with ASC 480 because the Series B Preferred Stock includes certain contingent redemption features which create an obligation for the Company to repurchase its shares. The fair values of the forward sales contracts were determined using the MCS analysis discussed above. As noted above, given the convertibility of the Series B Preferred Stock into cash or our common stock under several scenarios, the MCS analysis simulated the value of our common stock and the resulting impact on the value of Series B Preferred Stock, given the various provisions discussed below. The fair value of 225,000 shares of Series B Preferred Stock was determined to be $262.8 million as of March&#160;31, 2022. The $37.8 million difference between the fair value of the Series B Preferred Stock of $262.8 million and the par value of $225 million represents the value of the forward sales contracts and is recorded on the condensed consolidated balance sheet in non-current liabilities, while the change in the fair value of the forward sales contracts is</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in non-operating income in the condensed consolidated statement of operations for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March&#160;31, 2022. The increase in the fair value of the Series B Preferred Stock from January 23, 2022 to March 31, 2022 reflects the increase in the price of our common stock since the inception of the contracts through March 31, 2022, and the value of the various conversion rights and key provisions discussed below.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Certificates of Designations contain several conversion rights and other key provisions described below. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Holder Voluntary Conversion Rights </span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B Preferred Stock is convertible at the option of the holders thereof at any time into a number of shares of common stock equal to the Conversion Rate (as defined in the Series B Certificates of Designations), which is initially 294.1176 shares of common stock per share of Series B Preferred Stock, in each case subject to certain adjustments and certain limitations on conversion. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuer Call Provision</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any time after the fifth anniversary of the closing of the Private Placement Issuance, if the last reported sale price of the common stock is greater than 250% of the Conversion Price (as defined in the Series B Certificates of Designations) as of such time for at least 20 consecutive trading days, we may elect to convert all of the outstanding shares of Series B Preferred Stock into shares of common stock. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuer Redemption Provision</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After the seventh anniversary of the closing of the Private Placement Issuance, subject to certain conditions, we may, at our option, redeem all of the outstanding shares of Series B Preferred Stock at a redemption price per share of Series B Preferred Stock, payable in cash, equal to the Liquidation Preference (as defined in the Series B Certificates of Designations). </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change of Control Provisions</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo certain change of control transactions, each holder of outstanding shares of Series B Preferred Stock will have the option, subject to the holder&#8217;s right to convert all or a portion of the shares of Series B Preferred Stock held by such holder into common stock, to require us to purchase all or a portion of such holder&#8217;s outstanding shares of Series B Preferred Stock that have not been converted into common stock at a purchase price per share of Series B Preferred Stock, payable in cash, equal to the greater of (A) the Liquidation Preference of such share of Series B Preferred Stock, and (B) the amount of cash and/or other assets that such holder would have been entitled to receive if such holder had converted such share of Series B Preferred Stock into common stock immediately prior to the change of control transaction (Change of Control Put).</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a change of control in which we are not expected to be the surviving corporation or if the common stock will no longer be listed on a U.S. national securities exchange, we will have a right to redeem, subject to the holder&#8217;s right to convert into common stock prior to such redemption, all of such holder&#8217;s shares of Series B Preferred Stock, or if a holder exercises the Change of Control Put in part, the remainder of such holder&#8217;s shares of Series B Preferred Stock, at a redemption price per share payable in cash, equal to the greater of (A) the Liquidation Preference of such share of Series B Preferred Stock, and (B) the amount of cash and/or other assets that the holder would have received if such holder had converted such share of Series B Preferred Stock into common stock immediately prior to the change of control transaction. </span></div><div style="margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidation Rights </span></div>In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the Series B Preferred Stock has a liquidation preference equal to the greater of (i) the Liquidation Preference (as defined in the Series B Certificates of Designations, currently $3.40) and (ii) the amount per share of Series B Preferred Stock that such holder would have received had all holders of Series B Preferred Stock, immediately prior to such voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, converted all shares of Series B Preferred Stock into common stock pursuant to the terms of the Series B Certificates of Designations (without regard to any limitations on conversion contained therein).<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtAndEquityIssuanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt And Equity Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtAndEquityIssuanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271655480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NIH Contract<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">NIH Contract</a></td>
<td class="text">NIH ContractIn 2020, we were awarded the NIH Contract under the RADx program to support the expansion of our production capacity and throughput capabilities for COVID-19 testing with our microfluidics technology. We completed the required milestones in 2021 and received the total NIH Contract value of $34.0 million. Proceeds from the NIH Contract have been used primarily for capital expenditures to expand production capacity and, to a lesser extent, to offset applicable operating costs. Grant proceeds that exceed the cost of the capital expenditures and expenses that have been and are expected to be incurred are recorded in other non-operating income.<div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity under the NIH Contract as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts from milestones achieved</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,016&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,016&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative amounts applied against operating costs (excluding depreciation)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,526)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,522)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative amounts applied against depreciation expense for assets placed in service</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(703)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative amounts recognized as non-operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets placed in service, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative amounts applied against depreciation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(703)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,852</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,096</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated future capital expenditures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant income, current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant income, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,840&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred grant income, current on the condensed consolidated balance sheet represents amounts expected to be offset against depreciation expense over the next twelve months. Deferred grant income, non-current includes amounts expected to be offset against depreciation expense in later periods. </span></div><div style="margin-top:8pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to spend </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$22.4 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on capital expenditures associated with the NIH Contract. We have incurred $21.4 million of capital expenditures th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rough March&#160;31, 2022, of which $20.4 million has been placed in service, while the remaining $0.9 million is included in construction-in-progress (See Note 8). We expect to place the remaining equipment in service by the end of the first half of 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 730<br> -URI http://asc.fasb.org/subtopic&amp;trid=2197926<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271767064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development Agreement<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Development Agreement</a></td>
<td class="text">Development Agreement<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective March 31, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, we signed an OEM Supply and Development Agreement (Development Agreement) with a customer. Under the Development Agreement, we developed products based on our microfluidics technology. The Development Agreement provided for up-front and periodic milestone payments during the development stage, which was completed in the third quarter of 2021, and on-going annual payments of $0.4&#160;million for sustaining efforts. We recognized $0.1 million and $1.5 million of development revenue from this agreement during the three months ended March&#160;31, 2022 and March&#160;31, 2021, respectively.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271674328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our revenue for the three months ended March&#160;31, 2022 and 2021 based upon geographic area and source in thousands:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Markets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,504&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,794&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Source:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,004&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;License and royalty revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,504&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,794&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unfulfilled Performance Obligations</span></div><div style="margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reported $17.9 million of deferred revenue on our December&#160;31, 2021 consolidated balance sheet. During the three months ended March&#160;31, 2022, $4.1 million of the opening balance was recognized as revenue and $4.3 million of net additional advance payments were received from customers, primarily associated with instrument service contracts. At March&#160;31, 2022, we reported $18.1&#160;million of deferred revenue. </span></div><div style="margin-top:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed as of March&#160;31, 2022 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expected Revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 remainder of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,309&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the practical expedient that permits us not to disclose information about unsatisfied performance obligations for service contracts with an expected term of one year or less.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271783480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, net</a></td>
<td class="text">Goodwill and Intangible Assets, net<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with our acquisition of DVS in February 2014, we recognized goodwill of $104.1 million and $112.0 million of developed technology. In the first quarter of 2020, we recognized $2.2 million (Euro 2.0 million) of goodwill from the InstruNor acquisition and $5.4 million (Euro 4.9 million) of developed technology. As the goodwill and developed technology from the InstruNor acquisition are recorded in the functional currency of our European operations, which is the Euro, these balances are revalued each period and the U.S. dollar value of these assets will fluctuate as foreign exchange rates change. We are amortizing InstruNor developed technology over 8 years.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Qualitative assessment includes assessing significant events and circumstances such as our current results, assumptions regarding future performance, strategic initiatives and overall economic factors, including the ongoing global COVID-19 pandemic and macroeconomic developments to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of our reporting unit or intangible assets is less than their carrying value. If indicators of impairment are identified, a quantitative impairment test is performed.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> There have been no indicators of impairment during the three months ended March&#160;31, 2022.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets also include other patents and licenses, which are included in other non-current assets. Intangibl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e assets, net, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92,517)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,259&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,171)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 years</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89,576)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,257&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,000)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 years</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:7pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization expense for the three months ended March&#160;31, 2022 and 2021 was $3.1 million and $3.2 million, respectively. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the carrying value of intangible assets as of&#160;March&#160;31, 2022, the amortization expense is expected to be as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Technology Amortization Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patents and Licenses Amortization Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 remainder of the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,875&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,963&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961272713576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Details</a></td>
<td class="text">Balance Sheet Details<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term restricted cash of approximately $16&#160;thousand is included in prepaid expenses and other current assets and $1.0&#160;million of non-current restricted cash is included in other non-current assets in the condensed consolidated balance sheet as of March&#160;31, 2022 and December&#160;31, 2021.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventories, net</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,245&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,825&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment, net </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and manufacturing equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,034&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the amounts included in construction-in-progress are related to the NIH Contract (see Note 4).</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Compensation and Related Benefits</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation and related benefits, which is included in current liabilities on the condensed consolidated balance sheet consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued incentive compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued vacation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll taxes and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued severance and retention bonuses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,964&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,920&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term accrued severance and retention bonuses of approximately $0.6&#160;million and $0.1&#160;million are included in non-current other liabilities on our condensed consolidated balance sheet as of March&#160;31, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-bottom:8pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warranties</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued warranty is included in other current liabilities on our condensed consolidated balance sheet. Activity for our warranty accrual for the three months ended March&#160;31, 2022&#160;and 2021 is summarized below (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual (release) for current period warranties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty costs incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,277&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271733496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Debt</a></td>
<td class="text">DebtBridge Loans <div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 3 for a discussion of the $35.7 million Bridge Loans outstanding as of March&#160;31, 2022 as part of the Private Placement Issuance.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">2014 Senior Convertible Notes (2014 Notes) and 2019 Senior Convertible Notes (2019 Notes)</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the components of the 2014 Notes and 2019 Notes are as follows (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;2.75% 2014 Notes due 2034   </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of 2014 Notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;5.25% 2019 Notes due 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,297)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of 2019 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,592&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of all Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,271&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,160&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2014 Senior Convertible Notes (2014 Notes) </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2014, we closed an underwritten public offering of 2014 Notes. In 2019, the outstanding 2014 Notes were largely refinanced with the 2019 Notes, discussed below. The effective interest rate on the 2014 Notes, reflecting the impact of debt discounts and issuance costs, is approximately 3%. The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. Holders may require us to repurchase all or a portion of their 2014 Notes on each of February 6, 2024 and February 6, 2029, at a repurchase price in cash equal to 100% of the principal amount of the 2014 Notes plus accrued and unpaid interest. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As provided by the indenture governing the 2014 Notes, in February 2021, holders of $0.5 million of the 2014 Notes required us to repurchase their notes at 100% of the principal amount plus accrued and unpaid interest. We recorded a loss of $9 thousand on the extinguishment of those notes, representing the difference between the price paid to extinguish the 2014 Notes and their carrying value, including unamortized debt issuance costs. As of March&#160;31, 2022, there was $0.6 million aggregate principal of the 2014 Notes outstanding.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Senior Convertible Notes (2019 Notes)</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, we issued $55.0 million aggregate principal amount of 2019 Notes. Net proceeds of the 2019 Notes issuance were $52.7 million, after deductions for commissions and other debt issuance costs. $51.8 million of the proceeds of the 2019 Notes were used to retire $50.2 million aggregate principal amount of our 2014 Notes, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">leaving $1.1 million of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aggregate principal value of 2014 Notes then outstanding. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Notes bear interest at 5.25% per annum, payable semiannually on June 1 and December 1 of each year, beginning on June 1, 2020. The 2019 Notes will mature on December 1, 2024, unless earlier repurchased or converted pursuant to their terms. The 2019 Notes will be convertible at the option of the holder at any point prior to the close of business on the second scheduled trading day preceding the maturity date. The initial conversion rate of the 2019 Notes is 344.8276 shares of our common stock per $1,000 principal amount of 2019 Notes (which is equivalent to an initial conversion price of approximately $2.90 per share). The conversion rate is subject to adjustment upon the occurrence of certain specified events. Those certain specified events include voluntary conversion of the 2019 Notes prior to our exercise of the Issuer&#8217;s Conversion Option or in connection with a make-whole fundamental change, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2019 Notes. The conversion rate will not be adjusted for any accrued and unpaid interest. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Notes will also be convertible at our option upon certain conditions in accordance with the terms of the indenture governing the 2019 Notes. On or after December 1, 2021 to December 1, 2022, if the price of our common stock has equaled or exceeded 150% of the Conversion Price (as defined in the indenture) then in effect for a specified number of days (Issuer&#8217;s Conversion Option), we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of common stock of the Company, determined in accordance with the terms of the indenture. On or after December 1, 2022, if the price of our common stock has equaled or exceeded 130% of the Conversion Price then in effect for a specified number of days, we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of common stock of the Company, determined in accordance with the terms of the indenture. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offering-related costs for the 2019 Notes were capitalized as debt issuance costs and are recorded as an offset to the carrying value of the 2019 Notes. The effective rate on the 2019 Notes is 6.2%.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revolving Credit Facility and Term Loan, net</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of our term loan and advances under the Credit Facility, and the maximum amount available under the Credit Facility are as follows (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of term fee accretion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of advances under credit agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,838&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, we entered into a revolving credit facility with Silicon Valley Bank (as amended, the Revolving Credit Facility) in an aggregate principal amount of up to the lesser of (i) $15.0 million (Maximum Amount) or (ii) the sum of (a) 85% of our eligible receivables and (b) 50% of our eligible inventory, in each case, subject to certain limitations (Borrowing Base), provided that the amount of eligible inventory that may be counted towards the Borrowing Base shall be subject to a cap as set forth in the Revolving Credit Facility. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2021, we amended our Revolving Credit Facility to extend the maturity date to August 2, 2023 and to provide for a new $10.0&#160;million Term Loan Facility (the Term Loan Facility and, together with the Revolving Credit Facility, the Credit Facility). The stated maturity of the Term Loan Facility is July 1, 2025.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, if the principal amount of our convertible debt exceeds </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.6&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as of June 1, 2024 or if the maturity of our 2019 Notes has not been extended beyond January 1, 2026 by June 1, 2024, then the maturity date of the Term Loan Facility will be June 1, 2024. The Credit Facility is </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">collateralized by substantially all our property, other than intellectual property. The Credit Facility also includes a financial covenant that requires us to maintain a minimum Adjusted Quick Ratio, as defined in the agreement, of at least 1.25 to 1.00.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The interest rate on advances made under the Revolving Credit Facility is the greater of (i) prime rate plus 0.50% or (ii) 5.25%. Interest on any outstanding amounts is due and payable monthly and the principal balance is due at maturity, though loans can be prepaid at any time without penalty. Fees for the Revolving Credit Facility include an annual commitment fee of $112,500 and a quarterly unused line fee based on the Borrowing Base. Total availability under the Revolving Credit Facility as of March&#160;31, 2022 was $8.4 million. There were no borrowings outstanding under the Revolving Credit Facility at</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> March&#160;31, 2022.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March&#160;31, 2022, the Term Loan Facility was fully drawn. The interest rate on the Term Loan Facility is the greater of 4.0% or a floating per annum rate equal to three quarters of one percentage point (0.75%) above the prime rate. Interest on any outstanding term loan advances is due and payable monthly. In addition to the monthly interest payments, a final payment equal to 6.5% of the original principal amount of each advance is due on the earlier of the maturity date or the date the advance is repaid. Principal balances are required to be repaid in twenty-four equal installments beginning on August 1, 2023. The effective interest rate on the Term Loan Facility, reflecting the impact of debt issuance costs, the end-of-term fee and expected timing of principal repayment was 6.3% as of March&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961272686200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating leases for buildings, equipment and vehicles. Existing leases have remaining terms of less than one year to eight years. Some leases contain options to extend the lease, usually for up to five years, and termination options.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands, except for discount rate and lease term):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.636%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use buildings</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,595</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,457</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets, gross</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,286</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,217</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,897)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,098)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets, net</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,389</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,119</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,209</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,053</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,548</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,969</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,601</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate per annum</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271706328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Fair Value of Financial Instruments<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.825%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash- Restricted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-restricted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,983&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash- Restricted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-restricted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,467&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,467&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,451&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents are Level I measurements. There were no transfers between Level I and Level II measurements, and no changes in the valuation techniques used during the three months ended March&#160;31, 2022.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record our Bridge Loans and forward contracts on our Series B Preferred Equity Financing at their fair market values. See Note 3 for a discussion of these transactions and the determination of their fair market value.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our convertible notes, Bridge Loans, and forward sales contracts are not regularly traded and it is difficult to estimate a reliable and accurate market price for these securities. The estimated fair values for these securities represent Level III valuations since a fair value for these securities cannot be determined by using readily observable inputs or measures, such as market prices. Fair values were estimated using pricing models and risk-adjusted value ranges. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of our term loan also represents a Level III valuation since the value cannot be determined by using readily observable inputs or measures, such as market prices. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our term loan was estimated using a discounted cash flows approach and current market interest rate data for similar loans.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the par value, carrying value and the estimated fair value of our debt as of March&#160;31, 2022 and December&#160;31, 2021, respectively (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.825%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridge Loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,578&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,578&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,160&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,481&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances under revolving credit agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271667752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders&#8217; Equity<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Shares Reserved </span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had reserved shares of common</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stock for future issuance under equity compensation plans as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">In thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Exercise Of Options </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units at Maximum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number Of Remaining Securities Available For Future Issuance </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2011 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVS Sciences Inc. 2010 Equity Incentive Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Inducement Award Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Employee Stock Purchase Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,316&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,194&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the securities to be issued upon release of RSUs and PSUs are the maximum number of shares that could be issued for performance share unit awards, which can vest at 0%-200% of the number of awards granted. The number of shares available for future issuance also reflects PSU awards granted at the maximum number of shares that could be issued under these awards.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271811736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Plans<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Plans</a></td>
<td class="text">Stock-Based Plans<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors sets the terms, conditions, and restrictions related to our 2017 Employee Stock Purchase Plan (ESPP) and the grant of stock options, restricted stock units (RSUs) and performance-based awards under our equity incentive plans. Our board of directors determines the number of awards to grant and also sets vesting criteria. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, RSUs vest on a quarterly basis over a period of four years from the date of grant at a rate of 25% on the first anniversary of the grant date and ratably each quarter over the remaining 12 quarters, or ratably over 16 quarters, subject to the employees&#8217; continued employment. We may grant RSUs with different vesting terms from time to time. In the first quarter of 2022, we granted 0.8&#160;million of retention RSUs which vest within one year.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incentive stock options and non-statutory stock options granted under our 2011 Equity Incentive Plan (2011 Plan) have a term of no more than ten years from the date of grant and an exercise price of at least 100% of the fair market value of the underlying common stock on the date of grant. Generally, options vest at a rate of either 25% on the first anniversary of the option grant date and ratably each month over the remaining period of 36 months, or ratably each month over 48 months. We may grant options with different vesting terms from time to time. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For performance-based share awards, our board of directors sets the performance objectives and other vesting provisions in determining the number of shares or value of performance units and performance shares that will be paid out. Such payout will be a function of the extent to which performance objectives or other vesting provisions have been achieved.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2011 Equity Incentive Plan</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January&#160;2011, our board of directors adopted the 2011 Plan under which incentive stock options, non-statutory stock options, RSUs, stock appreciation rights, performance stock units (PSUs), and performance shares may be granted to our employees, directors, and consultants. In April 2019, our board of directors authorized, and in June 2019, our stockholders approved an amendment and restatement of the 2011 Plan to make various changes, including increasing the number of shares reserved for issuance by approximately 5.0 million shares and extending the term of the 2011 Plan until April 2029. In May 2020, our board of directors authorized, and in June 2020, our stockholders approved, an increase of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.4&#160;million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shares reserved for issuance under the 2011 Plan. In April 2021, our board of directors authorized, and in May 2021, our stockholders approved, an additional increase of 4.1&#160;million shares reserved for issuance under the 2011 Plan.</span></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the various plans was as follows:</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units<br/>&#160;(in 000s)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU released</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the unrecognized compensation costs related to outstanding unvested RSUs under our equity incentive plans were $21.8 million. We expect to recognize those costs over a weighted average period of 2.2 years.</span></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">: </span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Options (000s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price<br/>per Option</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average Remaining Contractual Life (in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> in (000s)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.08&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,469&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested awards at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Aggregate intrinsic value as of March&#160;31, 2022 was calculated as the difference between the closing price per share of our common stock on the last trading day of March&#160;31, 2022, which was $3.59, and the exercise price of the options, multiplied by the number of in-the-money options. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the unrecognized compensation costs related to outstanding unvested options under our equity incentive plans were $0.1 million. We expect to recognize those costs over a weighted average period of 0.5 years. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-based Awards:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Stock Units with Market Condition</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted PSU awards to certain executive officers and senior level employees. The number of PSUs ultimately earned under these awards is calculated based on the Total Shareholder Return (TSR) of our common stock as compared to the TSR of a defined group of peer companies during the applicable three-year performance period. The percentage of PSUs that vest will depend on our relative position at the end of the performance period and can range from 0% to 200% of the number of units granted.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the performance of our stock relative to our defined group of peer companies, none of the PSUs awarded in 2019 for the 2019-2021 measurement period were vested. The performance adjustment in the table below reflects that no shares were issued upon vesting of the 2019 PSU awards. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the TSR-based PSUs is as follows: </span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units <br/>(in 000s)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance adjustment for 2019 awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU released</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:3pt"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of&#160;March&#160;31, 2022, the unrecognized compensation costs related to these awards were $3.2 million. We expect to recognize those costs over a weighted average period of 1.6 years. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Stock Units with Performance Conditions</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2019, we granted performance stock units to an employee. The number of performance stock units that ultimately vested under these awards was dependent on the employee achieving certain discrete operational milestones, the last of which was measured at December 31, 2021. In early 2022, it was determined that the operational milestones were not met and the 29&#160;thousand awards that were outstanding on December 31, 2021 were cancelled.</span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2017 Employee Stock Purchase Plan (ESPP)</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ESPP offers U.S. and some non-U.S. employees the right to purchase shares of our common stock. Our ESPP program has a six-month offering period, with a new period commencing on the first trading day on or after May 31 and November 30 of each year. Employees are eligible to participate through payroll deductions of up to 10% of their compensation. Employees may not purchase more than $25 thousand of stock for any calendar year. The purchase price at which shares are sold under the ESPP is 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-based Compensation Expense</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units, stock options and performance share units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,042&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271714104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly provision for income taxes is based on an estimated effective annual income tax rate. Our quarterly provision for income taxes also includes discrete items, such as changes in valuation allowances or adjustments upon finalization of tax returns as well as infrequently occurring items, if any, such as the effects of changes in tax laws or rates, in the interim period in which they occur.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a tax benefit of $0.6 million and $1.7&#160;million for the three months ended March&#160;31, 2022 and 2021, respectively. Lower losses in our foreign operations in the quarter ended March&#160;31, 2022 compared to the quarter ended March&#160;31, 2021 resulted in a lower tax benefit for our foreign operations for the three months ended March&#160;31, 2022 compared to the prior year period.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax benefit for the periods presented in this report differs from the 21% U.S. Federal statutory rate principally because we maintain a valuation allowance for our domestic deferred tax assets, which primarily consist of net-operating loss carryforwards.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recording deferred tax assets is appropriate when realization of these assets is more likely than not. Assessing the realizability of deferred tax assets is dependent upon several factors including historical financial results and future expected financial results. Domestic deferred tax assets have been offset by valuation allowances. Any release of valuation allowances could have the effect of decreasing the income tax provision in the period the valuation allowance is released. We continue to assess the likelihood that we will be able to recover our deferred tax assets, including those for which a valuation allowance is recorded. There can be no assurance that we will generate profits in the future periods enabling us to fully realize our deferred tax assets. The timing of recording a valuation allowance or the reversal of such valuation allowance is subject to objective and subjective factors that cannot be readily predicted in advance.</span></div>Our tax positions are subject to audits by multiple tax jurisdictions. We believe that we have provided adequate reserves for uncertain tax positions for all tax years still open for assessment. For the three months ended March&#160;31, 2022&#160;and 2021, respectively, we did&#160;not recognize any material interest or penalties related to uncertain tax positions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271706888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information About Geographic Areas<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Information About Geographic Areas</a></td>
<td class="text">Information About Geographic Areas<div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in one reporting segment that develops, manufactures and commercializes tools for life science research. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. For purposes of allocating resources and evaluating regional financial performance, our chief executive officer reviews separate sales information for the different regions of the world. Our general and administrative expenses and our research and development expenses are not allocated to any specific region. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary table of our revenue by geographic areas of our customers and by product and services for the three months ended March&#160;31, 2022 and 2021 is included in Note 6 to the condensed consolidated financial statements. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from customers in the United States represented $11.8 million, or 45% of total revenues, and $18.1 million, or 55% of total revenues, for the three months ended March&#160;31, 2022 and 2021, respectively.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from customers in China represented $2.8 million, or 11% of total revenues, and $3.0 million, or 9% of total revenues, for the three months ended March&#160;31, 2022 and 2021, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the exception of China for the three months ended March&#160;31, 2022, no foreign country had revenue in excess of 10% of total revenues during any of the periods presented in this report.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961272691752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we have entered into indemnification provisions under certain of our agreements in the ordinary course of business, typically with business partners, customers, and suppliers. Pursuant to these agreements, we may indemnify, hold harmless, and agree to reimburse the indemnified parties on a case-by-case basis for losses suffered or incurred by the indemnified parties in connection with any patent or other intellectual property infringement claim by any third party with respect to our products. The term of these indemnification provisions is generally perpetual from the time of the execution of the agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is typically not limited to a specific amount. In addition, we have entered into indemnification agreements with our officers, directors, and certain other employees. With certain exceptions, these agreements provide for indemnification for </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related expenses including, among others, attorneys&#8217; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. </span></div><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020, a putative class action complaint alleging violations of the federal securities laws was filed against the Company (also naming our now-former Chief Executive Officer and our Chief Financial Officer as defendants) in the U.S. District Court for the Northern District of California (Reena Saintjermain, et al. v. Fluidigm Corporation, et al). The Court appointed a lead plaintiff and lead counsel in December 2020, and an amended complaint was filed on February 19, 2021. The complaint, as amended, seeks unspecified damages on behalf of a purported class of persons and entities who acquired our common stock between February 7, 2019 and November 5, 2019 and alleges securities laws violations based on statements and alleged omissions made by the Company during such period. The Company filed a motion to dismiss the complaint on April 5, 2021 and, on August 4, 2021, the Court granted defendants&#8217; motion to dismiss with leave to amend. A second amended complaint was filed on September 14, 2021. The Company filed a motion to dismiss the second amended complaint on October 29, 2021 and, on February 14, 2022, the Court granted defendants&#8217; motion and dismissed the second amended complaint with prejudice. On March 15, 2022, plaintiff filed a Notice of Appeal to the U.S. Court of Appeals for the Ninth Circuit. We believe the claims alleged in the complaint lack merit and we intend to defend this action vigorously. </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law, tax, regulatory, distribution arrangements, employee relations and other matters. Periodically, we review the status of each matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we continue to reassess the potential liability related to pending claims and litigation and may revise estimates.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271729528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Event<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Event</a></td>
<td class="text">Subsequent Event<div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, our</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stockholders approved the Charter Amendment Proposal and Private Placement Issuance Proposal discussed in Note 3. The Private Placement Issuance closed on April 4, 2022. On April 4, 2022, we received $225&#160;million, before expenses, and issued 225,000 shares of Series B Preferred Stock pursuant to the Purchase Agreements. The Bridge Loans converted into 30,559 shares of Series B Preferred Stock based on a Conversion Amount, as described in Note 3, of $25.5&#160;million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following stockholder approval of the Charter Amendment Proposal and the Private Placement Issuance Proposal, our name was changed to Standard BioTools Inc. Shortly after the closing of the Private Placement Issuance, we also changed the ticker symbol for our common stock to LAB. Upon the closing of the Private Placement Issuance, Dr. Michael Egholm was appointed as the Company&#8217;s President and Chief Executive Officer and as a member of the Board of Directors. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the closing, we adopted the 2022 Inducement Equity Incentive Plan with an initial reserve of approximately 9.5&#160;million shares. Effective April 4, 2022, we awarded options for 8.1&#160;million shares of our common stock at an exercise price of $3.99 per share and 1.4&#160;million restricted stock units to members of our management team, including Dr. Egholm under the 2022 Inducement Equity Incentive Plan. These awards vest over four years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961267246584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Consolidation</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Consolidation</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of March&#160;31, 2022, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, Italy, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the audited financial statements and the related notes for the year ended December&#160;31, 2021 included in our annual report on Form 10-K, filed with the SEC on</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> March 8, 2022, we disclosed that we had performed an assessment to determine whether there were conditions or events, considered in the aggregate, that raised substantial doubt about our ability to continue as a going concern for at least the twelve-month period following the date the financial statements were issued. We believed that our then-current level of cash and cash equivalents, together with committed financing facilities, were not sufficient to fund ongoing operations for at least the twelve-month period after the financial statements are issued. Since then, we have closed the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$225 million Series B Preferred Equity Financing, as defined in Note 3, </span>that was previously disclosed in Note 18 to our audited financial statements for the year ended December 31, 2021 as contingent on stockholder approval. The completion of this financing has eliminated the doubt about the Company&#8217;s ability to continue as a going concern.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">Certain prior period amounts in the condensed consolidated financial statements were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders&#8217; equity, total revenue, total costs and expenses, loss from operations or net loss.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information, including the unknown impact of COVID-19 and the war in Ukraine. Accounting matters that rely on forecasted financial information included, but were not limited to, our inventory, and related reserves, and the carrying value of goodwill and other long-lived assets and liabilities. Actual results could differ materially from these estimates and could have a material adverse effect on our condensed consolidated financial statements. We also use significant judgment in determining the fair value of financial instruments, including the Bridge Loans, forward contracts on Series B Preferred Stock and other debt and equity instruments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text">Foreign CurrencyAssets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. Income and expense accounts are translated at monthly average exchange rates during the year. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders&#8217; equity.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Loss </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) generally consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss per Share</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Loss per Share </span></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Changes and Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Changes and Accounti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ng Pronouncements</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adoption of New Accounting Guidance </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2020, the FASB issued ASU 2020-06 Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity. The amendment to this ASU reduces the number of accounting models for convertible instruments and allows more contracts to qualify for equity classification, which is expected to result in more convertible instruments being accounted for as a single unit, rather than being bifurcated between debt and equity. The new guidance is effective for fiscal years beginning after December 15, 2021. The Company adopted ASU 2020-06 effective January 1, 2022. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The adoption of ASU 2020-06 did not have an impact on the Company&#8217;s 2014 and 2019 Convertible Notes.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In November 2021, the FASB issued ASU 2021-10 Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. The amendment is effective for annual periods beginning after December 15, 2021. The amendment establishes financial disclosure requirements for business entities that receive government assistance that the entities account for by analogizing to a grant or contribution model because there is no specific authoritative guidance under U.S. GAAP that applies to the transaction. Entities that receive this type of assistance should include the following information in their annual report: (1) the nature of the transaction, (2) the significant terms and conditions, (3) the accounting treatment, (4) the line items on the balance sheet and income statement that are affected along with (5) the respective amounts that have been recorded. The Company adopted ASU 2021-10 effective January 1, 2022. The adoption of ASU 2021-10 did not have a material impact on the Company&#8217;s financial statements. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements</span></div>None.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961272629976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Components of Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The component of accumulated other comprehensive loss, net of tax, for the three months ended March&#160;31, 2022 is as follows (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Investments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at December 31, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(907)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(907)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance at March 31, 2022</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Summary of Potential Common Shares Excluded From Computations of Net Loss Per Share Attributed to Common Stockholders</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options, restricted stock units and performance awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,988&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridge Loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B Convertible Preferred Stock Purchase Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Convertible Notes potential make-whole shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,488&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271672360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement Issuance (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt Instruments</a></td>
<td class="text"><div style="margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Bridge Loans is as follows (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and unpaid interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion amount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on Bridge Loans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of Bridge Loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,655&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271801448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NIH Contract (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock', window );">Summary of Research and Development Activity Under NIH Contract</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity under the NIH Contract as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash receipts from milestones achieved</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,016&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,016&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative amounts applied against operating costs (excluding depreciation)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,526)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,522)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative amounts applied against depreciation expense for assets placed in service</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(703)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative amounts recognized as non-operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,140)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets placed in service, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative amounts applied against depreciation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(703)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,852</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,096</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated future capital expenditures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant income, current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred grant income, non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred grant income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,840&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements. Include also the amount of costs incurred under a research and development arrangement accounted for as a contract to perform research and development for others. Aggregation of similar arrangements by type may be appropriate. Include also the amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others. Aggregation of similar arrangements by type may be appropriate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23221-108380<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961273251384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Summary of Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our revenue for the three months ended March&#160;31, 2022 and 2021 based upon geographic area and source in thousands:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Geographic Markets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,504&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,794&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Source:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,004&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,728&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;License and royalty revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Grant revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,504&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,794&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Summary of Expected Timing of Revenue Recognition</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed as of March&#160;31, 2022 (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expected Revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 remainder of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,190&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,309&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div><div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961273264680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets also include other patents and licenses, which are included in other non-current assets. Intangibl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e assets, net, were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92,517)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,875&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,259&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,171)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 years</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Amortization Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89,576)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and licenses</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,257&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,000)</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0 years</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Future Intangible Asset Amortization Expense</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the carrying value of intangible assets as of&#160;March&#160;31, 2022, the amortization expense is expected to be as follows (in thousands): </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Developed Technology Amortization Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Patents and Licenses Amortization Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 remainder of the year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,905&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,446&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,875&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,963&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961267152696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Summary of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of Restricted Cash</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:8pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,451&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,999&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,592&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,245&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,825&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and software</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,759&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and manufacturing equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,460&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,703)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction-in-progress</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,034&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Compensation and Related Benefits</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued compensation and related benefits, which is included in current liabilities on the condensed consolidated balance sheet consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued incentive compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,779&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued vacation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll taxes and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued severance and retention bonuses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and related benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,964&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,920&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Long-term accrued s<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Activity of Warranty Accrual</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued warranty is included in other current liabilities on our condensed consolidated balance sheet. Activity for our warranty accrual for the three months ended March&#160;31, 2022&#160;and 2021 is summarized below (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrual (release) for current period warranties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty costs incurred</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(236)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,277&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271786136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the components of the 2014 Notes and 2019 Notes are as follows (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;2.75% 2014 Notes due 2034   </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of 2014 Notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;5.25% 2019 Notes due 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,297)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of 2019 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,592&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of all Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,271&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,160&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of our term loan and advances under the Credit Facility, and the maximum amount available under the Credit Facility are as follows (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of term fee accretion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of advances under credit agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,838&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the par value, carrying value and the estimated fair value of our debt as of March&#160;31, 2022 and December&#160;31, 2021, respectively (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.825%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridge Loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,578&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,578&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,160&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,481&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances under revolving credit agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271810056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Balance Sheet Information</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands, except for discount rate and lease term):</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.636%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use buildings</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,595</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,457</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use equipment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use vehicles</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets, gross</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,286</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,217</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,897)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,098)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets, net</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,389</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,119</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,209</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,053</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,760</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,548</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,969</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,601</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in years)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate per annum</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961273260504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Cash and Available-for-Sale Securities</a></td>
<td class="text"><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.443%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.825%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash- Restricted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-restricted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,999&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,983&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash- Restricted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash-restricted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,467&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,467&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,451&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of the components of the 2014 Notes and 2019 Notes are as follows (in thousands): </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;2.75% 2014 Notes due 2034   </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of 2014 Notes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;5.25% 2019 Notes due 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,297)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,408)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of 2019 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,592&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of all Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,271&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,160&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying values of our term loan and advances under the Credit Facility, and the maximum amount available under the Credit Facility are as follows (in thousands):</span></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Term Loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">End of term fee accretion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,049&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Revolving Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value of advances under credit agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,838&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the par value, carrying value and the estimated fair value of our debt as of March&#160;31, 2022 and December&#160;31, 2021, respectively (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.825%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bridge Loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2014 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,578&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,271&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,578&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,160&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,481&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,049&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances under revolving credit agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961271721336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Common Stock Reserved for Future Issuance</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had reserved shares of common</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stock for future issuance under equity compensation plans as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">In thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Exercise Of Options </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units at Maximum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number Of Remaining Securities Available For Future Issuance </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2011 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVS Sciences Inc. 2010 Equity Incentive Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Inducement Award Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Employee Stock Purchase Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,316&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,194&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units, stock options and performance share units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,042&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961273398168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Activity Under Restricted Stock Units</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the various plans was as follows:</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units<br/>&#160;(in 000s)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,141&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU released</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Activity Under Stock Options</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">: </span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Options (000s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price<br/>per Option</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average Remaining Contractual Life (in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> in (000s)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.08&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,469&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested awards at March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______</span></div>(1)Aggregate intrinsic value as of March&#160;31, 2022 was calculated as the difference between the closing price per share of our common stock on the last trading day of March&#160;31, 2022, which was $3.59, and the exercise price of the options, multiplied by the number of in-the-money options.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock', window );">Schedule of Nonvested Performance-Based Units Activity</a></td>
<td class="text"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity under the TSR-based PSUs is as follows: </span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Units <br/>(in 000s)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant Date Fair Value per Unit</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance adjustment for 2019 awards</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU released</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PSU forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had reserved shares of common</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stock for future issuance under equity compensation plans as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">In thousands</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Exercise Of Options </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units at Maximum</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number Of Remaining Securities Available For Future Issuance </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2011 Equity Incentive Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,376&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,561&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DVS Sciences Inc. 2010 Equity Incentive Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Inducement Award Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017 Employee Stock Purchase Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,633&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,316&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,194&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized was as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units, stock options and performance share units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,042&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested performance-based units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961272698920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue', window );">Convertible preferred stock, value</a></td>
<td class="nump">$ 225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961268541240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 94,596<span></span>
</td>
<td class="nump">$ 139,050<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(443)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">22,113<span></span>
</td>
<td class="nump">122,938<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(907)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(1,057)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized Gain (Loss) on Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(907)<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(443)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (1,057)<span></span>
</td>
<td class="num">$ (331)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961356234904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computations of net loss per share (in shares)</a></td>
<td class="nump">103,894<span></span>
</td>
<td class="nump">27,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Stock options, restricted stock units and performance awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computations of net loss per share (in shares)</a></td>
<td class="nump">7,988<span></span>
</td>
<td class="nump">6,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock Purchase Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computations of net loss per share (in shares)</a></td>
<td class="nump">66,176<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_BridgeLoansMember', window );">Bridge Loans | Bridge Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computations of net loss per share (in shares)</a></td>
<td class="nump">8,979<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndNineteenConvertibleNotesMember', window );">2019 Convertible Notes | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computations of net loss per share (in shares)</a></td>
<td class="nump">18,966<span></span>
</td>
<td class="nump">18,966<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember', window );">2019 Convertible Notes potential make-whole shares | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computations of net loss per share (in shares)</a></td>
<td class="nump">1,775<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndFourteenConvertibleNotesMember', window );">2014 Convertible Notes | Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from computations of net loss per share (in shares)</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_BridgeLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_BridgeLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_BridgeLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_BridgeLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndNineteenConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndNineteenConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndFourteenConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_TwoThousandAndFourteenConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961265424552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement Issuance - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 04, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 23, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 03, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.84<span></span>
</td>
<td class="nump">$ 3.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_PreferredStockFairValueDisclosure', window );">Fair value of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 262,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_StockRepurchaseLiability', window );">Obligation for Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,792,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockConvertibleConversionRatio', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294.1176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares) | shares</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock Purchase Agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Series B Convertible Preferred Stock Purchase Agreements | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction</a></td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_PreferredStockFairValueDisclosure', window );">Fair value of preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 262,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_StockRepurchaseLiability', window );">Obligation for Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage of stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare', window );">Liquidation preference (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold (in shares) | shares</a></td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred stock</a></td>
<td class="nump">$ 225,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=fldm_SeriesB1ConvertiblePreferredStockMember', window );">Series B-1 Convertible Preferred Stock | Casdin | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold (in shares) | shares</a></td>
<td class="nump">112,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in usd per share) | $ / shares</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=fldm_SeriesB2ConvertiblePreferredStockMember', window );">Series B-2 Convertible Preferred Stock | Viking | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold (in shares) | shares</a></td>
<td class="nump">112,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in usd per share) | $ / shares</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember', window );">Bridge Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtInstrumentFaceAmountPerInstrument', window );">Debt instrument, face amount, per instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued', window );">Divisor used to determine number of shares to issue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor', window );">Divisor used to determine number of shares to issue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of Bridge Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="nump">$ 35,655,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Offering related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember', window );">Bridge Loans | Debt Covenant Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember', window );">Bridge Loans | Debt Covenant, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember', window );">Bridge Loans | Debt Covenant, Period Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember', window );">Bridge Loans | Debt Covenant, Period Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Calculation To Determine Shares Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Calculation To Determine Shares Issued, Divisor</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtInstrumentFaceAmountPerInstrument">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Face Amount, Per Instrument</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtInstrumentFaceAmountPerInstrument</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_PreferredStockFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Preferred Stock, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_PreferredStockFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_StockRepurchaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_StockRepurchaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share excess of preference in liquidation over convertible debt instrument's if-converted par or stated value of share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockConvertibleConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares issuable upon conversion for each share of preferred stock to be converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockConvertibleConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=fldm_SeriesB1ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=fldm_SeriesB1ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=fldm_CasdinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=fldm_CasdinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=fldm_SeriesB2ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=fldm_SeriesB2ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=fldm_VikingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=fldm_VikingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtCovenantPeriodAxis=fldm_DebtCovenantPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtCovenantPeriodAxis=fldm_DebtCovenantPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtCovenantPeriodAxis=fldm_DebtCovenantPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtCovenantPeriodAxis=fldm_DebtCovenantPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtCovenantPeriodAxis=fldm_DebtCovenantPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtCovenantPeriodAxis=fldm_DebtCovenantPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtCovenantPeriodAxis=fldm_DebtCovenantPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtCovenantPeriodAxis=fldm_DebtCovenantPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961268301016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement Issuance - Schedule of Carrying Value of the Bridge Loans (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 23, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesUnrealizedGainLoss', window );">Unrealized loss on Bridge Loans</a></td>
<td class="nump">$ 10,655<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember', window );">Bridge Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued and unpaid interest</a></td>
<td class="nump">499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion, converted instrument, amount</a></td>
<td class="nump">25,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesUnrealizedGainLoss', window );">Unrealized loss on Bridge Loans</a></td>
<td class="nump">10,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of Bridge Loans</a></td>
<td class="nump">$ 35,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961266999272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NIH Contract - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue', window );">Maximum contract value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred', window );">Capital expenditures expected to be incurred</a></td>
<td class="nump">$ 22,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures', window );">Capital expenditures incurred</a></td>
<td class="nump">21,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross', window );">Assets placed in service, gross</a></td>
<td class="nump">20,425<span></span>
</td>
<td class="nump">16,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross', window );">Construction-in-progress</a></td>
<td class="nump">$ 937<span></span>
</td>
<td class="nump">$ 3,909<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others , Assets Placed In Service , Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development Arrangement, Contract to Perform for Others, Capital Expenditures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement Contract To Perform For Others Capital Expenditures, To Be Incurred</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Construction in Progress, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Maximum Contract Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961269593992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NIH Contract (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount', window );">Cash receipts from milestones achieved</a></td>
<td class="nump">$ 34,016<span></span>
</td>
<td class="nump">$ 34,016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses', window );">Cumulative amounts applied against operating costs (excluding depreciation)</a></td>
<td class="num">(4,526)<span></span>
</td>
<td class="num">(4,522)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses', window );">Cumulative amounts applied against depreciation expense for assets placed in service</a></td>
<td class="num">(1,510)<span></span>
</td>
<td class="num">(703)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome', window );">Cumulative amounts recognized as non-operating income</a></td>
<td class="num">(7,140)<span></span>
</td>
<td class="num">(7,140)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DeferredGrantRevenue', window );">Total deferred grant income</a></td>
<td class="nump">20,840<span></span>
</td>
<td class="nump">21,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross', window );">Assets placed in service, gross</a></td>
<td class="nump">20,425<span></span>
</td>
<td class="nump">16,890<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross', window );">Construction-in-progress</a></td>
<td class="nump">937<span></span>
</td>
<td class="nump">3,909<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet', window );">Carrying value of property and equipment, net</a></td>
<td class="nump">19,852<span></span>
</td>
<td class="nump">20,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures', window );">Estimated future capital expenditures</a></td>
<td class="nump">988<span></span>
</td>
<td class="nump">1,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DeferredGrantIncomeCurrent', window );">Deferred grant income, current</a></td>
<td class="nump">3,603<span></span>
</td>
<td class="nump">3,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DeferredGrantIncomeNoncurrent', window );">Deferred grant income, non-current</a></td>
<td class="nump">$ 17,237<span></span>
</td>
<td class="nump">$ 18,116<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DeferredGrantIncomeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Grant Income, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DeferredGrantIncomeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DeferredGrantIncomeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Grant Income, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DeferredGrantIncomeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DeferredGrantRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Grant Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DeferredGrantRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Accumulated Depreciation Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others , Assets Placed In Service , Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Construction in Progress, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Estimated Future Capital Expenditures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Other Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Contract To Perform For Others, Property and Equipment, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961269597800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development Agreement (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 26,504<span></span>
</td>
<td class="nump">$ 32,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember', window );">Development revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember', window );">Development revenue | Undisclosed Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement', window );">Annual payments receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangements, Annual Payments Receivable Under Development Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=fldm_UndisclosedCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=fldm_UndisclosedCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961265356984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 26,504<span></span>
</td>
<td class="nump">$ 32,794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=fldm_InstrumentsMember', window );">Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">7,523<span></span>
</td>
<td class="nump">7,708<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=fldm_ConsumablesMember', window );">Consumables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">12,481<span></span>
</td>
<td class="nump">17,020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">20,004<span></span>
</td>
<td class="nump">24,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">6,144<span></span>
</td>
<td class="nump">6,286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember', window );">Development revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">1,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember', window );">License and royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">268<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GrantMember', window );">Grant revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">268<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">12,930<span></span>
</td>
<td class="nump">18,523<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">8,609<span></span>
</td>
<td class="nump">9,142<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 4,965<span></span>
</td>
<td class="nump">$ 5,129<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=fldm_InstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=fldm_InstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=fldm_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=fldm_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=fldm_CollaborationRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961267278664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">$ 18.1<span></span>
</td>
<td class="nump">$ 17.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts', window );">Additional advance payments received</a></td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Increase From Cash Receipts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961265401704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Performance Obligations (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation, expected revenue</a></td>
<td class="nump">$ 23,309<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation, expected revenue</a></td>
<td class="nump">$ 10,437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation, expected timing of satisfaction</a></td>
<td class="text">9 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation, expected revenue</a></td>
<td class="nump">$ 7,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation, expected timing of satisfaction</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation, expected revenue</a></td>
<td class="nump">$ 3,678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation, expected timing of satisfaction</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligation, expected revenue</a></td>
<td class="nump">$ 2,190<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Remaining performance obligation, expected timing of satisfaction</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-04-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-01-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961265204536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net - Narrative (Details)<br> $ in Thousands, &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,968<span></span>
</td>
<td class="nump">$ 2,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=fldm_DVSSciencesInc.Member', window );">DVS Sciences, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 104,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=fldm_DVSSciencesInc.Member', window );">DVS Sciences, Inc. | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="nump">$ 112,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember', window );">InstruNor AS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember', window );">InstruNor AS | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinitelivedIntangibleAssetsAcquired1', window );">Finite-lived intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400<span></span>
</td>
<td class="nump">&#8364; 4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Acquired finite-lived intangible assets, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinitelivedIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinitelivedIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=fldm_DVSSciencesInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=fldm_DVSSciencesInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=fldm_InstruNorASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961267212616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 25,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">117,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 117,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(92,517)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89,576)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 24,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted-Average Amortization Period</a></td>
<td class="text">9 years 10 months 24 days<span></span>
</td>
<td class="text">9 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=fldm_PatentsandLicenseAgreementsMember', window );">Patents and licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Amount</a></td>
<td class="nump">$ 11,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(10,171)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 1,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted-Average Amortization Period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=fldm_PatentsandLicenseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=fldm_PatentsandLicenseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961265288456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, net - Future Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2022 remainder of the year</a></td>
<td class="nump">$ 9,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">12,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">2,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">25,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed Technology Amortization Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2022 remainder of the year</a></td>
<td class="nump">8,905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">11,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">2,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">24,875<span></span>
</td>
<td class="nump">$ 27,927<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=fldm_PatentsandLicenseAgreementsMember', window );">Patents and Licenses Amortization Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2022 remainder of the year</a></td>
<td class="nump">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 1,088<span></span>
</td>
<td class="nump">$ 1,257<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=fldm_PatentsandLicenseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=fldm_PatentsandLicenseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961268495048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Summary of Cash and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 29,983<span></span>
</td>
<td class="nump">$ 28,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue', window );">Restricted cash</a></td>
<td class="nump">1,016<span></span>
</td>
<td class="nump">1,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">30,999<span></span>
</td>
<td class="nump">29,467<span></span>
</td>
<td class="nump">$ 50,760<span></span>
</td>
<td class="nump">$ 69,536<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Short-term restricted cash</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Non-current restricted cash</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961269624120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 12,592<span></span>
</td>
<td class="nump">$ 9,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">994<span></span>
</td>
<td class="nump">867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">9,659<span></span>
</td>
<td class="nump">10,613<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories, net</a></td>
<td class="nump">$ 23,245<span></span>
</td>
<td class="nump">$ 20,825<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961268542776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 54,186<span></span>
</td>
<td class="nump">$ 50,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(28,151)<span></span>
</td>
<td class="num">(26,703)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction-in-progress</a></td>
<td class="nump">1,664<span></span>
</td>
<td class="nump">4,549<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">27,699<span></span>
</td>
<td class="nump">28,034<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fldm_ComputerEquipmentAndSoftwareMember', window );">Computer equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">5,777<span></span>
</td>
<td class="nump">5,759<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fldm_LaboratoryAndManufacturingEquipmentMember', window );">Laboratory and manufacturing equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">33,884<span></span>
</td>
<td class="nump">30,260<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">12,460<span></span>
</td>
<td class="nump">12,095<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 2,065<span></span>
</td>
<td class="nump">$ 2,074<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fldm_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=fldm_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=fldm_LaboratoryAndManufacturingEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=fldm_LaboratoryAndManufacturingEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961268410888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details - Accrued Compensation and Related Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Accrued incentive compensation</a></td>
<td class="nump">$ 1,779<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedVacationCurrent', window );">Accrued vacation</a></td>
<td class="nump">3,737<span></span>
</td>
<td class="nump">3,388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Accrued payroll taxes and other</a></td>
<td class="nump">1,547<span></span>
</td>
<td class="nump">1,492<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Accrued severance and retention bonuses</a></td>
<td class="nump">901<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and related benefits</a></td>
<td class="nump">7,964<span></span>
</td>
<td class="nump">4,920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_AccruedBonusesNoncurrent', window );">Accrued bonuses, noncurrent</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_AccruedBonusesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Bonuses, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_AccruedBonusesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedVacationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19396-108361<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedVacationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961267242632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details - Warranty Accrual (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Beginning balance</a></td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 1,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease', window );">Accrual (release) for current period warranties</a></td>
<td class="nump">306<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Warranty costs incurred</a></td>
<td class="num">(264)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Ending balance</a></td>
<td class="nump">$ 1,212<span></span>
</td>
<td class="nump">$ 1,277<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the standard and extended product warranty accrual from changes in estimates attributable to preexisting product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961261649896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 25, 2022</div></th>
<th class="th">
<div>Aug. 02, 2021 </div>
<div>USD ($) </div>
<div>monthly_installment</div>
</th>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Aug. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Feb. 28, 2014</div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,578,000<span></span>
</td>
<td class="nump">$ 72,416,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate of notes</a></td>
<td class="nump">0.3521126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtInstrumentCovenantConvertibleDebtThreshold', window );">Convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments', window );">Number of installments | monthly_installment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum ability to borrow under line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables', window );">Percentage of eligible receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory', window );">Percentage of eligible inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember', window );">Bridge Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,271,000<span></span>
</td>
<td class="nump">54,160,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,578,000<span></span>
</td>
<td class="nump">55,578,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount', window );">Commitment fee amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 112,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Borrowing base of the credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,838,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility | Minimum | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Additional interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility | Maximum | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Additional interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,106,000<span></span>
</td>
<td class="nump">10,049,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio', window );">Adjusted quick ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtInstrumentIncrementalPaymentPercent', window );">Term loan advances percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Additional interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member', window );">Senior Convertible Notes due 2034 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 568,000<span></span>
</td>
<td class="nump">568,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">578,000<span></span>
</td>
<td class="nump">578,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">578,000<span></span>
</td>
<td class="nump">578,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member', window );">Senior Convertible Notes due 2034 | Convertible Debt | Redemption, Period Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt instrument redemption price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_ExchangeConvertibleSeniorNotesDue2034Member', window );">Exchange Convertible Senior Notes due 2034 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate of notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3448276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_InitialConversionPriceOfStock', window );">Initial conversion price of stock (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_ExchangeConvertibleSeniorNotesDue2034Member', window );">Exchange Convertible Senior Notes due 2034 | Convertible Debt | Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice', window );">Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_ExchangeConvertibleSeniorNotesDue2034Member', window );">Exchange Convertible Senior Notes due 2034 | Convertible Debt | Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice', window );">Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member', window );">Senior Convertible Notes Due 2024 | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,703,000<span></span>
</td>
<td class="nump">53,592,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000,000<span></span>
</td>
<td class="nump">$ 55,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Debt extinguished</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtInstrumentCovenantConvertibleDebtThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Convertible Debt Threshold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtInstrumentCovenantConvertibleDebtThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Minimum Adjusted Quick Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtInstrumentIncrementalPaymentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Incremental Payment, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtInstrumentIncrementalPaymentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Number Of Installments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_InitialConversionPriceOfStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Initial Conversion Price Of Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_InitialConversionPriceOfStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_ExchangeConvertibleSeniorNotesDue2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_ExchangeConvertibleSeniorNotesDue2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961266800920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Debt (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Feb. 28, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net carrying value of all Notes</a></td>
<td class="nump">$ 54,271,000<span></span>
</td>
<td class="nump">$ 54,160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount</a></td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">End of term fee accretion</a></td>
<td class="nump">133,000<span></span>
</td>
<td class="nump">79,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized debt issuance cost</a></td>
<td class="num">(27,000)<span></span>
</td>
<td class="num">(30,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net carrying value of all Notes</a></td>
<td class="nump">10,106,000<span></span>
</td>
<td class="nump">10,049,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Line of credit outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,838,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member', window );">2014 Notes | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount</a></td>
<td class="nump">578,000<span></span>
</td>
<td class="nump">578,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="num">(8,000)<span></span>
</td>
<td class="num">(8,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized debt issuance cost</a></td>
<td class="num">(2,000)<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net carrying value of all Notes</a></td>
<td class="nump">568,000<span></span>
</td>
<td class="nump">568,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member', window );">2019 Notes | Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal amount</a></td>
<td class="nump">55,000,000<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Unamortized debt issuance cost</a></td>
<td class="num">(1,297,000)<span></span>
</td>
<td class="num">(1,408,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net carrying value of all Notes</a></td>
<td class="nump">$ 53,703,000<span></span>
</td>
<td class="nump">$ 53,592,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961267328104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_LesseeOperatingLeaseRemainingTermOfContract', window );">Remaining lease term</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_LesseeOperatingLeaseRemainingTermOfContract', window );">Remaining lease term</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_LesseeOperatingLeaseRemainingTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Remaining Term Of Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_LesseeOperatingLeaseRemainingTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961266957208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance sheet (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_OperatingLeaseRightOfUseAssetGross', window );">Total operating lease right-of-use assets, gross</a></td>
<td class="nump">$ 44,286<span></span>
</td>
<td class="nump">$ 44,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="num">(7,897)<span></span>
</td>
<td class="num">(7,098)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Total operating lease right-of-use assets, net</a></td>
<td class="nump">36,389<span></span>
</td>
<td class="nump">37,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">3,209<span></span>
</td>
<td class="nump">3,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">36,760<span></span>
</td>
<td class="nump">37,548<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 39,969<span></span>
</td>
<td class="nump">$ 40,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate per annum</a></td>
<td class="nump">11.70%<span></span>
</td>
<td class="nump">11.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Operating lease right-of-use buildings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_OperatingLeaseRightOfUseAssetGross', window );">Total operating lease right-of-use assets, gross</a></td>
<td class="nump">$ 43,595<span></span>
</td>
<td class="nump">$ 43,457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Operating lease right-of-use equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_OperatingLeaseRightOfUseAssetGross', window );">Total operating lease right-of-use assets, gross</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Operating lease right-of-use vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasedAssetsLineItems', window );"><strong>Operating Leased Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_OperatingLeaseRightOfUseAssetGross', window );">Total operating lease right-of-use assets, gross</a></td>
<td class="nump">$ 609<span></span>
</td>
<td class="nump">$ 676<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset, Accumulated Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_OperatingLeaseRightOfUseAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right-Of-Use Asset, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_OperatingLeaseRightOfUseAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961268511816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">$ 29,983<span></span>
</td>
<td class="nump">$ 28,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">30,999<span></span>
</td>
<td class="nump">29,467<span></span>
</td>
<td class="nump">$ 50,760<span></span>
</td>
<td class="nump">$ 69,536<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">29,983<span></span>
</td>
<td class="nump">28,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Cash-restricted</a></td>
<td class="nump">1,016<span></span>
</td>
<td class="nump">1,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">30,999<span></span>
</td>
<td class="nump">29,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=fldm_CashAndMoneyMarketFundsMember', window );">Cash and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">29,983<span></span>
</td>
<td class="nump">28,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=fldm_RestrictedCashAndCashEquivalentsMember', window );">Cash-restricted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Cash-restricted</a></td>
<td class="nump">$ 1,016<span></span>
</td>
<td class="nump">$ 1,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=fldm_CashAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=fldm_CashAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=fldm_RestrictedCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=fldm_RestrictedCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961261705560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments - Schedule of Debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 23, 2022</div></th>
<th class="th"><div>Aug. 02, 2021</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">$ 90,578,000<span></span>
</td>
<td class="nump">$ 72,416,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">100,032,000<span></span>
</td>
<td class="nump">71,047,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">121,050,000<span></span>
</td>
<td class="nump">99,432,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember', window );">Bridge Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">35,655,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember', window );">Bridge Loans | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">35,655,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember', window );">Bridge Loans | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">35,655,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">55,578,000<span></span>
</td>
<td class="nump">55,578,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">54,271,000<span></span>
</td>
<td class="nump">54,160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">75,599,000<span></span>
</td>
<td class="nump">82,481,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 2014 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">578,000<span></span>
</td>
<td class="nump">578,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 2014 Notes | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">568,000<span></span>
</td>
<td class="nump">568,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 2014 Notes | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">601,000<span></span>
</td>
<td class="nump">601,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 2019 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">55,000,000<span></span>
</td>
<td class="nump">55,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 2019 Notes | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">53,703,000<span></span>
</td>
<td class="nump">53,592,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt | 2019 Notes | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">74,998,000<span></span>
</td>
<td class="nump">81,880,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Par Value</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">10,106,000<span></span>
</td>
<td class="nump">10,049,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Debt | Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt</a></td>
<td class="nump">9,796,000<span></span>
</td>
<td class="nump">10,113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Advances under revolving credit agreement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,838,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Carrying Value | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Advances under revolving credit agreement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,838,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Fair Value | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Advances under revolving credit agreement</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6,838,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_BridgeLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesdue2034Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=fldm_SeniorConvertibleNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961267058632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity - Narrative (Details) - Performance Shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareholdersEquityLineItems', window );"><strong>Shareholders' Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest', window );">Percentage of performance period</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareholdersEquityLineItems', window );"><strong>Shareholders' Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest', window );">Percentage of performance period</a></td>
<td class="nump">200.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareholdersEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Shareholders' Equity [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareholdersEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961266971704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Schedule of Stock Options (Details)<br> shares in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of remaining securities available for future issuance (in shares)</a></td>
<td class="nump">6,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndElevenEquityIncentivePlanMember', window );">2011 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of remaining securities available for future issuance (in shares)</a></td>
<td class="nump">3,561<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndTenEquityIncentivePlanMember', window );">DVS Sciences Inc. 2010 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of remaining securities available for future issuance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndSeventeenInducementAwardPlanMember', window );">2017 Inducement Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of remaining securities available for future issuance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember', window );">2017 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of remaining securities available for future issuance (in shares)</a></td>
<td class="nump">2,633<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Securities To Be Issued Upon Exercise Of Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (in shares)</a></td>
<td class="nump">1,541<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Securities To Be Issued Upon Exercise Of Options | 2011 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (in shares)</a></td>
<td class="nump">1,376<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Securities To Be Issued Upon Exercise Of Options | DVS Sciences Inc. 2010 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (in shares)</a></td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Securities To Be Issued Upon Exercise Of Options | 2017 Inducement Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (in shares)</a></td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Securities To Be Issued Upon Exercise Of Options | 2017 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember', window );">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units at Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (in shares)</a></td>
<td class="nump">7,316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember', window );">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units at Maximum | 2011 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (in shares)</a></td>
<td class="nump">7,259<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember', window );">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units at Maximum | DVS Sciences Inc. 2010 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember', window );">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units at Maximum | 2017 Inducement Award Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (in shares)</a></td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember', window );">Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units at Maximum | 2017 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Securities to be issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndElevenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_TwoThousandAndElevenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndTenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_TwoThousandAndTenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndSeventeenInducementAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_TwoThousandAndSeventeenInducementAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=fldm_RestrictedStockAndPerformanceShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961261953704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Plans - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_EquityIncentivePlanTwentyElevenMember', window );">2011 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional awards authorized for issuance (shares)</a></td>
<td class="nump">4,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndElevenEquityIncentivePlanMember', window );">Two Thousand And Eleven Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Additional awards authorized for issuance (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_EquityIncentivePlanMember', window );">Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation cost related to stock-based compensation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining contractual terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement', window );">Number of months over which options vest ratably</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement', window );">Number of months over which options vest ratably</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation cost related to stock-based compensation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining contractual terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">808,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Awards outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,577,000<span></span>
</td>
<td class="nump">5,141,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_PortionOfStockOptionsVestOnFirstAnniversary', window );">Rate at which outstanding options vest on the first anniversary of the option grant date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Stock options, restricted stock units and performance awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue', window );">Stock option grants exercise price minimum percentage on fair market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized compensation cost related to stock-based compensation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted average remaining contractual terms</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Awards outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">869,000<span></span>
</td>
<td class="nump">1,210,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | Certain Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Awards outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest', window );">Percentage of performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest', window );">Percentage of performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock | 2017 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_EmployeeStockPurchasePlanOfferingPeriod', window );">ESPP, offering period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum employee subscription rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount', window );">Maximum employee purchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_EmployeeStockPurchasePlanOfferingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan, Offering Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_EmployeeStockPurchasePlanOfferingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_PortionOfStockOptionsVestOnFirstAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Portion Of Stock Options Vest On First Anniversary</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_PortionOfStockOptionsVestOnFirstAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_EquityIncentivePlanTwentyElevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_EquityIncentivePlanTwentyElevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_TwoThousandAndElevenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_TwoThousandAndElevenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=fldm_CertainEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=fldm_CertainEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961265329944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Plans - Restricted and Performance Stock Units (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Nonvested and Outstanding Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">5,141,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">808,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares) | shares</a></td>
<td class="num">(302,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(70,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">5,577,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted-Average Grant Date Fair Value per Unit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in usd per share) | $ / shares</a></td>
<td class="nump">$ 5.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">3.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in usd per share) | $ / shares</a></td>
<td class="nump">5.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in usd per share) | $ / shares</a></td>
<td class="nump">5.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in usd per share) | $ / shares</a></td>
<td class="nump">$ 4.94<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Nonvested and Outstanding Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">1,210,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod', window );">Performance adjustment for 2018 awards (in shares) | shares</a></td>
<td class="num">(341,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">869,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted-Average Grant Date Fair Value per Unit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in usd per share) | $ / shares</a></td>
<td class="nump">$ 10.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue', window );">Performance adjustment for 2018 awards (in usd per share ) | $ / shares</a></td>
<td class="nump">16.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in usd per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in usd per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in usd per share) | $ / shares</a></td>
<td class="nump">$ 7.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Adjustment in Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Adjustment in Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961261687688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Plans - Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 23, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">1,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Option exercised (in shares)</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options forfeited (in shares)</a></td>
<td class="num">(47)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">1,542<span></span>
</td>
<td class="nump">1,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Vested (in shares)</a></td>
<td class="nump">1,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber', window );">Unvested awards (in shares)</a></td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price per Option</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in usd per share)</a></td>
<td class="nump">$ 7.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in usd per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in usd per share)</a></td>
<td class="nump">2.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Options forfeited (in usd per share)</a></td>
<td class="nump">14.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in usd per share)</a></td>
<td class="nump">6.87<span></span>
</td>
<td class="nump">$ 7.08<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice', window );">Vested (in usd per share)</a></td>
<td class="nump">6.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice', window );">Unvested awards (in usd per share)</a></td>
<td class="nump">$ 6.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted- Average Remaining Contractual Life (in Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Contractual term</a></td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne', window );">Vested</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1', window );">Unvested awards</a></td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Options exercised</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue', window );">Vested</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue', window );">Unvested awards</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in usd per share)</a></td>
<td class="nump">$ 3.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Weighted Average Remaining Contractual Term 1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement by Share Based Payment Award, Options, Vested, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>fldm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961273199592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Plans - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 4,042<span></span>
</td>
<td class="nump">$ 3,677<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember', window );">Restricted stock units, stock options and performance share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 3,942<span></span>
</td>
<td class="nump">$ 3,473<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961272686200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">$ 574<span></span>
</td>
<td class="nump">$ 1,671<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961272007080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information About Geographic Areas (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reporting segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 26,504<span></span>
</td>
<td class="nump">$ 32,794<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | United States | Revenue from Contract with Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 11,800<span></span>
</td>
<td class="nump">$ 18,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember', window );">Geographic Concentration Risk | China | Revenue from Contract with Customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139961266800280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 04, 2022</div></th>
<th class="th"><div>Jan. 23, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of remaining securities available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,194,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">808,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | 2022 Inducement Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of remaining securities available for future issuance (in shares)</a></td>
<td class="nump">9,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Option granted (in shares)</a></td>
<td class="nump">8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in usd per share)</a></td>
<td class="nump">$ 3.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | 2022 Inducement Equity Incentive Plan | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred stock</a></td>
<td class="nump">$ 225.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold (in shares)</a></td>
<td class="nump">225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted instrument, shares issued</a></td>
<td class="nump">30,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt conversion, converted instrument, amount</a></td>
<td class="nump">$ 25.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=fldm_A2022InducementEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=fldm_A2022InducementEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>fldm-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:fldm="http://fluidigm.com/20220331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fldm-20220331.xsd" xlink:type="simple"/>
    <context id="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8129f3bfc4ec41c9aa6d162ae2eba76a_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i464bfcf84ef44fa0b0e68af70cc3988f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iab920cccfecf44528e9ce52d935fa63a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i96de28bb25374cbaa71d471a786e1db3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if6c770a450054cda9c777968afb1bca3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1a25af0ec36e425db27350cae34291e2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i50ef3b1943a5459d80af3119e547f1cc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8f969efefbfa43cab57d0b0dbba8b692_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i37fe6c7bd98449ef8909d4137b4673a2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i67531e388c0e40cdb02f90448ebfc132_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib0e22c724c524303bf88f4ed321cc50d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ife53191c83774d009455b6219ab8d213_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id512bd02ff5c466b83c1a85dc87fe1ef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3062eea440bb4b8abee952bb6d8f666f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia01ee6541d314637a0cf139b7a3517a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8ee876a5d6724fc3baf62a71ac362565_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3160813ed6ea47239b8b14f10a6a132f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i743f2be8661c4d49bf0e11f2fd7672c6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ief97f0f005454a3ebb73d10c8a6fc288_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic3d0b28316714637ae16364f010efcb3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i671f9af2f29c4f1f929a61c12aba4b42_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieaeae6add4f148cd8e2a749b602bcc59_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7108a12ba20140bf8ddbbf0bd06e0086_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7edfc49d39cd47138bdc5064597c073b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id77c72e5a5f841e093b9ab6998fcfc1f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87fc908e2306474ca6061592bbd313c0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if4e40eb27af64de29a8412568ad4b140_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id803a63fc74c495aa4dd5311fbcac8b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i569592ee5f454ea69635943e7f236859_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0e3525e6da4a471bbb0a4a59a5d15773_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic26f34b391524936ad12d32af015e7a6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic05a8c6dfa64446bad2c73b3c7882945_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i47472db137014a838484b58ca7ec54b1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifdac09bb73da4bc698146a2f6d7842a5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6cd95ac79ec64220ae66aaf7e20ff229_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i28b9b63dddca4cf59ed8ad13d8b810aa_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id618e4076c984ee2b69327451b1b9e70_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i26bb80925b7243dd86ac47e3aa792a15_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6927dcea8afc4590868e910c711eb950_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i32573a3e0127457ab8cd1f21b8706b01_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib7cbdf74105f4c63acc93bf88685787f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1bf7ca99df7546ac8f6f641356b6669f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifb59364bf80942a7b409ac934e71fc8d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if4590fb02726433eac6b072086045564_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0922be352f994b20b3f553c5fd67b357_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1870e9c226e845e4aed6768f8701a354_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:BridgeLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i27af03e024e04f15ba5f16d8c26d2c92_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:BridgeLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6548c4721969408e92076ddc5ec286a8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i033e8053b42848b5b5fc39a8d349706c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia1a5805104194441bb995ef05eee862f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic2fc67f467ba494384ae37dc00e28c5f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i02bbc839aff04cb6b76120a51050ad62_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib249f81dacbc44039cd73fb307a2440a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i969516905a714099b6f6cbab3a226bb5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndFourteenConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia023da1bf6d94cddb5bfc0acd240aef6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:TwoThousandAndFourteenConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i886c80d6b2014617accd5fb486b0da62_I20220123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-23</instant>
        </period>
    </context>
    <context id="i5a6c6bdfb4274d13b3f7a97a1f9a2bcd_D20220404-20220404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <context id="i56ff172b378c40bfa9fb091517220986_D20220404-20220404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:CasdinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fldm:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <context id="ifb221a8d5f7b4664a321c4333783b5a8_I20220404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:CasdinMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fldm:SeriesB1ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-04</instant>
        </period>
    </context>
    <context id="ie16dc5fbce7344098cb3d3224ce907b0_D20220404-20220404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:VikingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fldm:SeriesB2ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <context id="ib2c825e393d44392a0cdda4dde9c896c_I20220404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:VikingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">fldm:SeriesB2ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-04</instant>
        </period>
    </context>
    <context id="ib3c3e7b51c6f444eb205479e022d6700_I20220404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-04</instant>
        </period>
    </context>
    <context id="ic68aad560626482181eb728c71653aff_I20220403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-03</instant>
        </period>
    </context>
    <context id="i77616e0764104572bb6724b63bf8ab85_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="fldm:DebtCovenantPeriodAxis">fldm:DebtCovenantPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2f4791be67494f768846d8731311ee82_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="fldm:DebtCovenantPeriodAxis">fldm:DebtCovenantPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib91f694990c84e7b80102a9d2003a94f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="fldm:DebtCovenantPeriodAxis">fldm:DebtCovenantPeriodThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8289410ad96c48e9a79c0ea4d1093e35_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="fldm:DebtCovenantPeriodAxis">fldm:DebtCovenantPeriodFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibe298cbdde5842d1abc79d95ddf9275c_I20220123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2022-01-23</instant>
        </period>
    </context>
    <context id="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib0ed4fcc32994c51a64df27a56bebe58_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icdfcd99ed0d44886aa6f217791a9b7b2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i17f98442bfed4b7c9e994c9fd18a4bc3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iedc9287f43ef4070913785190e868b4a_D20220123-20220123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-23</startDate>
            <endDate>2022-01-23</endDate>
        </period>
    </context>
    <context id="i4cc0a83a704c446185dfcd2f538f5b2e_D20220123-20220123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-23</startDate>
            <endDate>2022-01-23</endDate>
        </period>
    </context>
    <context id="i2127000202e94f0988bb0ca0fe40e66b_I20220123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-23</instant>
        </period>
    </context>
    <context id="ib0ec30bb1300459287d9f22d16790089_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icbc9e7ab23954ae68df17a0ee7ed1b6f_D20220325-20220325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2022-03-25</startDate>
            <endDate>2022-03-25</endDate>
        </period>
    </context>
    <context id="ia846fcc54289492ea9f2caf7da738fb2_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:UndisclosedCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iafdb8ef4ee9b4330a1afed79e1a6adab_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:UndisclosedCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3c64b4d5135043b2bf9e4a910f74a574_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">fldm:UndisclosedCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:CollaborationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0f8e6499d1bf4299a4a07cd4f748586b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i286841fd19da443ead3fbf7f94d46b19_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i072ebd8279c8453f8cd2f1cb832d29fd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i87071d29b432475bb23956adf7514f92_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2f17be2ff1a047ea95cdaeba288d236a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i24e8ea78bbff495b800d3ede81174994_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5a58b69e2fd947c19feffcbbf475f7fb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:InstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if5517c1a9f7d46acb4b2910a6e65a460_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:InstrumentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5e1af6815ea14d86990d3949065312c1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7dbaa6754bf146218a79d666b5fbe97b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">fldm:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iefe32db1cf564d38b50cdb165fc5cb80_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0afc35aeae144b7e896655ac0045040f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icd77101528ad4efaa4764f0e88507854_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1d2106e31ca44f2b930bd540e5346338_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i335933a56ca64d3d94f51a90d798f76c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3bcb2e193d7c4e4ba7f7c804e5ec66cd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibbe253446f1d4da380bb648d1169a573_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i48119219acbf471d93f5816373e96a28_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-01-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i553dcb7ee7ea4ac9a75e92d924b88f3e_I20140228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:DVSSciencesInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-02-28</instant>
        </period>
    </context>
    <context id="i830df8f0fc5846878354fcf3361da7fb_D20140201-20140228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:DVSSciencesInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-02-01</startDate>
            <endDate>2014-02-28</endDate>
        </period>
    </context>
    <context id="ib03343990d404ba9a12387dbb99c7af4_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i78a77be6f4bb47ae9b4e1a70ef8aba45_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="icd0ea5bfa71e4a248571cf351b4fbc02_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">fldm:InstruNorASMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic84a49a6264541b9a2ad518751a09a27_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic3ccc2277618429ba4dd1bf8f8ac9415_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5c9074a6857a429c8182e81cbd9e260b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4debd5fa9102490ba7555a1193ce7701_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i20d31a7327ed4de3a49655170f642acc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6fa8acd9c9d642edad45d44d1963e783_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icc22933a248246149e4c0d789e039050_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3bf82049acf4414db15019056a8b4a4d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">fldm:PatentsandLicenseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i090e27ef0a04457484fad8f0a7075dd1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i57628b9b4d1948008ccba2dcd4ef1952_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia7f4a8245b6143b2953ff1fa9ffa2409_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:LaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i68ab04d53d1948088109f492c3fb4362_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">fldm:LaboratoryAndManufacturingEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3f99c36bb724482982e5d8102ceeecd7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if0863696f8964c36a94715de8e0f295d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie84a730a5b8e43089afed4061de374a5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i367f8eaf66e547ca84a65357249c487a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i160268d0fa1b4d38bd5ea84554f1559f_I20140228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-02-28</instant>
        </period>
    </context>
    <context id="id7a77d2cffbb466495dfbdb0f232de97_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib879a74c7d314a99bfe67a83c5ae025a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07369311ad5b4af1a043b008ade3c4e7_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="ib6fc6a3e6a134443b3035ae7eef72da4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2ccaab30a9344f92a4d5d4f061f686d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i918712e2e4c4473592c78603409a2035_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i633deee677b14f20aedd746e431d49ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9170739660ea4bfc8eb6c551e60b2612_D20140201-20140228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-02-01</startDate>
            <endDate>2014-02-28</endDate>
        </period>
    </context>
    <context id="i2b39964a5e6c4c19b88ad79540049976_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="i29e7a7788ad04a3d8770310cb3706589_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="ifa7db0e7f6e64bc38b954e286cf01912_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i3b2bc86d58a540e1859dd280a7ab24e4_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="ie91e1a9f5d3646f68aebba6fd62e9508_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i908b5614888049f28cbb80e7a6178f8e_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i812e59424f52454887fd27588f8469d3_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i5874eb1b19274365b89e4f16ba6865fc_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i4690c6ae02014999bb14d18dc8b565b2_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i736e4e930c62488998bc7af6f80cb9a5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i40c95c830e9346709b9e8f6f68d3ca08_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id3bcdcd73f1c405f8f2d59a089c890f3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if7290240890949c08edf84cb715e251f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7138e77d1b41464ba17008df0fb4ab55_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i6637980e82554f3da6571c3ff1c70650_D20180801-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="id87ce5c4623f4d3b9b99a89129d283c5_I20210802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-02</instant>
        </period>
    </context>
    <context id="i6c05f390be1e4fba9543e3eef05cd18a_I20210802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <instant>2021-08-02</instant>
        </period>
    </context>
    <context id="iea73508f9d1047c38f6efe4f293e882e_D20210802-20210802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-02</startDate>
            <endDate>2021-08-02</endDate>
        </period>
    </context>
    <context id="i71f15dd92cc34cc88d928463e4fdea0d_D20180801-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ia9ff2eebee8640b1845873f7c8306421_D20180801-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ia5c8dc8c1e56417a96b944b97cd01027_D20180801-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-01</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i43f34e3da8064d94ba11bd59638ffba3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1ceba926b97e4336840e0087ebe96841_D20210802-20210802">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2021-08-02</startDate>
            <endDate>2021-08-02</endDate>
        </period>
    </context>
    <context id="ia6dab1bdeec84907af3edc92f528486f_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:ExchangeConvertibleSeniorNotesDue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i2946e1733f13418ea3b80b32b99bb663_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9401f96d3b934202bdd9b43f3164dc99_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic6d96d54873a406f8857760fcb97e6dc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2dd1c0dbe46d4ab4b631cf79d9b0e5f0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib8bf776768964321b47a464ab18406e1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if4d100cb233e46569570b3a9160fffaf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieb02155ee72947fe93b3c7c9297367dd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1ab4b34b0e7949c0853287c6a741b50c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i09c9b9a0eec74f1eb1b5c7f46fce7ad2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">fldm:CashAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3cbe9fcdac0241f08b13a6f1500deafa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">fldm:RestrictedCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id2106d7d27e2429382ccfccea124e2d2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia410cf951ff442a7af6415951fac5467_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">fldm:CashAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7656b92dc6c44155b55eebf7f72273b9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">fldm:RestrictedCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53f8932dab17405f952c3ec80f549c94_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iacd8238416414b529e9c11e81b3cb3ea_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i66a0e027243e4b7e8de45f9fb688f73d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i192f9657493242a29365f3d839d90d10_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i35de4e7e785e4aa7b55659c0991572df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:BridgeLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i75ab6b689aa54665b3fe1c022f4f383e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i719deb7dffa9447ea8e3e92416972180_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0ec07d32c39e41fc8f6fae982f6ddbb1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0057b63c6d1d42858acd5f470ced781d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesdue2034Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b6e6c6f6d6d40c09000d22bf80671b7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2947c7abf7fa4f2691d0ca9cde5d6514_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i94d6459171cf40a6843977458759b899_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25222c4b0d624dc4bd5bea0e9e94cbe1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">fldm:SeniorConvertibleNotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i90ccecdd5e034b9e8b3a73afd56dd029_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5621449148c64e2998b4cfe5304b2265_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4d3d07f8af4b4470897c2977833f9255_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53271b8cc303430b9324caf250af4723_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d08369cf4e743e1980090e6f9bd90e3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i744122bb17644424b7a8fd06cb0c7128_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i430bde457f8b49c297f4b7eb59db0e6c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if48c5a23863e4cd8bbe66e032efb7a3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0a2855f667ed4c72a5b8a3fca49072e7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i58112e5c277c4b30a89447743fc62c04_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5bcb085019064514a3ff3a7b73e42196_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9c3dfe2aada444b685f4219ae06fcd20_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b63c6fe97894fe5a0d2c4975b4da0fe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibf2d9ac881dc4deea1d8989f49ab808d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4c347987f267431784a940da9799e057_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i77951f80ba15446c8cd2f0e9ef5ba4f1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1d2a998f16924d858cf125d7c1d814bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i88a9b5eeb2b441ca8c84ceb94e14ff84_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4d77114634a0476587c0c6e236131dd4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i61c25a145cf849d690fe64971fb1219b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id7e1d70fc37c4900b64ff49301b03fd4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia2385c7f15ba43f4afc1f5f66be141ae_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndTenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i03880c5036734260b46d06727e442f92_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndTenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i42f0b198127148778a174350609491d0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndTenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie87e1842c50e4d569dca108ae8ad47ff_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndSeventeenInducementAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1145f4ff09c84a6790d15188392833e4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndSeventeenInducementAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i058640ba016f4fb396b722f5d98c4df8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndSeventeenInducementAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i03c0001f48254fe3bdfc3606ca7946d0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i96a7681635b84887bcccedb27f5cffe1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iec8080f040c148cd9a55c99e106e20ca_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iad71c918ee434181ba0fff19eced37d5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i45fe81b2edc14e8283a89efd8ec7b239_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">fldm:RestrictedStockAndPerformanceShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifbc7c42ab7c948dbb536b605def058fd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id07ffabfcd0b42608b10129b2e59ffd5_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ida95b698f6f541feb12d26c1e08f3545_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9af5c9a4df634b10aa18bac8dd63496d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1f2f332657784dd188961528d24aadfb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i227d5a5fe544411ea37d71f144593da9_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i12d6eaf877364d5dbf2a9fe63b59e9aa_D20190601-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanTwentyElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icefddd7e6aa7456685103922b493fb0b_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandAndElevenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8b311a9055cd4350a32fbf48c1d51dcf_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanTwentyElevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i1b27a08b375d4bd6a7bdb7050cb92f97_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3fa095588fa743319343a18e9698ac0e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i41bfbc4f8008465d885af193c5915937_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1b42cfc93e2b4c79b0b5d4699ce58cae_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib321b7bc2a2347bda69869d595adc12e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i357950952be44c25a149476baf5f1338_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic924218fbf5a4d91b76fd02ad51f0368_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i63b45dc8c7f84841a01e93bde43297e1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">fldm:CertainEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i976dac4ee8d24a6b9937b433c337665a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6f8238e8d8694c059385a480dcb687e1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:TwoThousandSeventeenEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9291755db0804b7e971901deb2d9a94a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i45dc092a669a4531bc189ae9f0583e68_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7f805e7f1d6c46a69b33311aa284f9dd_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id192327cb55c41259f9faa5f5322725c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i890754c6557847938cb71a04d83d4e22_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i6825599028a44895afeda749b0c6a2be_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icd04707bc427433aa0a24baf6c191f0c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i448c3bd9337e456095cdb94a8fa30336_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic3dda181cdd645f793c5612b9ec9660b_D20220404-20220404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <context id="ib980c3b074f94dd4a574cde692cff868_I20220404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:A2022InducementEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-04</instant>
        </period>
    </context>
    <context id="i9b39f3273ab44415baf1d8b96c519c44_D20220404-20220404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:A2022InducementEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <context id="ic5320ad3429740cc9ae7dfdcc463a85f_D20220404-20220404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001162194</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">fldm:A2022InducementEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="monthly_installment">
        <measure>fldm:monthly_installment</measure>
    </unit>
    <unit id="segment">
        <measure>fldm:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80L2ZyYWc6YzBiYzc2NmMyZDI3NGQ2OWJmZjM2MzNiNjk1NjEyNDEvdGFibGU6ZTI1NGYzMmU1M2ZkNGMzMGIxNWFlYzBmOTdjYmQ0MzIvdGFibGVyYW5nZTplMjU0ZjMyZTUzZmQ0YzMwYjE1YWVjMGY5N2NiZDQzMl8zLTEtMS0xLTUzMzU1_05379bb8-84ed-41ca-8d8d-b53de6c2dc42">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80L2ZyYWc6YzBiYzc2NmMyZDI3NGQ2OWJmZjM2MzNiNjk1NjEyNDEvdGFibGU6ZTI1NGYzMmU1M2ZkNGMzMGIxNWFlYzBmOTdjYmQ0MzIvdGFibGVyYW5nZTplMjU0ZjMyZTUzZmQ0YzMwYjE1YWVjMGY5N2NiZDQzMl80LTEtMS0xLTUzMzU1_6e0211d9-e4cd-4a0b-811e-b49d6beabe17">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80L2ZyYWc6YzBiYzc2NmMyZDI3NGQ2OWJmZjM2MzNiNjk1NjEyNDEvdGFibGU6ZTI1NGYzMmU1M2ZkNGMzMGIxNWFlYzBmOTdjYmQ0MzIvdGFibGVyYW5nZTplMjU0ZjMyZTUzZmQ0YzMwYjE1YWVjMGY5N2NiZDQzMl81LTEtMS0xLTUzMzU1_0c063146-b317-4c2d-9b8d-2d679d9f0180">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80L2ZyYWc6YzBiYzc2NmMyZDI3NGQ2OWJmZjM2MzNiNjk1NjEyNDEvdGFibGU6ZTI1NGYzMmU1M2ZkNGMzMGIxNWFlYzBmOTdjYmQ0MzIvdGFibGVyYW5nZTplMjU0ZjMyZTUzZmQ0YzMwYjE1YWVjMGY5N2NiZDQzMl82LTEtMS0xLTUzMzU1_c8273f03-2859-4017-aeca-21a11d66f7c8">0001162194</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80L2ZyYWc6YzBiYzc2NmMyZDI3NGQ2OWJmZjM2MzNiNjk1NjEyNDEvdGFibGU6ZTI1NGYzMmU1M2ZkNGMzMGIxNWFlYzBmOTdjYmQ0MzIvdGFibGVyYW5nZTplMjU0ZjMyZTUzZmQ0YzMwYjE1YWVjMGY5N2NiZDQzMl83LTEtMS0xLTUzMzU1_0e95d181-d52e-4494-9f98-591fecebdc3a">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="icbc9e7ab23954ae68df17a0ee7ed1b6f_D20220325-20220325"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMjQ1L2ZyYWc6NWQyZTQ0MWE3MmRlNDlmNTk0ZDAzMzA1OWFkOWIyZTkvdGV4dHJlZ2lvbjo1ZDJlNDQxYTcyZGU0OWY1OTRkMDMzMDU5YWQ5YjJlOV8xMzE5NDEzOTUzMzUwMQ_4148616a-a732-4a4a-ba06-d429f97bfd2d"
      unitRef="number">0.3521126</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i335933a56ca64d3d94f51a90d798f76c_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80OS9mcmFnOmQ0YmNjM2RmYzE1OTQyODY4ODY0ODJmMDgyNDVjNGUxL3RhYmxlOjc3NTI1NDUyOGNmYjRkYTQ4ZGQ3NzRlZjYzZDJkNjUzL3RhYmxlcmFuZ2U6Nzc1MjU0NTI4Y2ZiNGRhNDhkZDc3NGVmNjNkMmQ2NTNfMS0xLTEtMS01MzM1NQ_76a2a275-ed22-4cda-9695-52b86777e69c">P9M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i3bcb2e193d7c4e4ba7f7c804e5ec66cd_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80OS9mcmFnOmQ0YmNjM2RmYzE1OTQyODY4ODY0ODJmMDgyNDVjNGUxL3RhYmxlOjc3NTI1NDUyOGNmYjRkYTQ4ZGQ3NzRlZjYzZDJkNjUzL3RhYmxlcmFuZ2U6Nzc1MjU0NTI4Y2ZiNGRhNDhkZDc3NGVmNjNkMmQ2NTNfMi0xLTEtMS01MzM1NQ_99a50dc1-526a-4cd0-9e5f-3b7a3d8a45bc">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ibbe253446f1d4da380bb648d1169a573_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80OS9mcmFnOmQ0YmNjM2RmYzE1OTQyODY4ODY0ODJmMDgyNDVjNGUxL3RhYmxlOjc3NTI1NDUyOGNmYjRkYTQ4ZGQ3NzRlZjYzZDJkNjUzL3RhYmxlcmFuZ2U6Nzc1MjU0NTI4Y2ZiNGRhNDhkZDc3NGVmNjNkMmQ2NTNfMy0xLTEtMS01MzM1NQ_1804b613-9221-4991-8d9e-6b2afcff636b">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i48119219acbf471d93f5816373e96a28_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80OS9mcmFnOmQ0YmNjM2RmYzE1OTQyODY4ODY0ODJmMDgyNDVjNGUxL3RhYmxlOjc3NTI1NDUyOGNmYjRkYTQ4ZGQ3NzRlZjYzZDJkNjUzL3RhYmxlcmFuZ2U6Nzc1MjU0NTI4Y2ZiNGRhNDhkZDc3NGVmNjNkMmQ2NTNfNC0xLTEtMS01MzM1NQ_1fdf1408-ebbe-4590-98a7-0140cc981f17"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="ia6dab1bdeec84907af3edc92f528486f_D20191101-20191130"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82MS9mcmFnOmEyMGQxNDk0N2I3ODRkMTliNTE5YmQ2ZGRlMGRiY2M5L3RhYmxlOmE3ZWFmMWVkOTRmYTRlMTliNGNjNDU0MDQ5OTVhYzFlL3RhYmxlcmFuZ2U6YTdlYWYxZWQ5NGZhNGUxOWI0Y2M0NTQwNDk5NWFjMWVfMS0yLTEtMS01MzM1NQ_d1d32980-0465-4bec-9d1f-5202cc3870bd"
      unitRef="number">0.3448276</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzA0_f98e7f03-c8e7-4bb3-ad70-921950185f8d">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzA5_af649969-23f4-48d6-a0e2-646bac97d9bd">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yNTk_e8a06938-920d-49df-81fd-0b5793c41a61">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzEw_92b97755-4c88-4bb1-a90a-4294b9d7c5cb">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzA1_2c74769f-5d51-4754-98a6-3e445856c5a0">001-34180</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzAx_849b3d2c-7eda-4278-8196-59f3efce4cd5">STANDARD BIOTOOLS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ODY4YjBiNDlkYjdhNGFmNzgyMzBkN2QyZWRlN2Y0YmQvdGFibGVyYW5nZTo4NjhiMGI0OWRiN2E0YWY3ODIzMGQ3ZDJlZGU3ZjRiZF8wLTAtMS0xLTUzMzU1_2da19030-bd7d-4e58-9584-8d58f3e68cf9">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ODY4YjBiNDlkYjdhNGFmNzgyMzBkN2QyZWRlN2Y0YmQvdGFibGVyYW5nZTo4NjhiMGI0OWRiN2E0YWY3ODIzMGQ3ZDJlZGU3ZjRiZF8wLTQtMS0xLTUzMzU1_cb016959-1313-4e6f-a223-78480b687678">77-0513190</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ODY4YjBiNDlkYjdhNGFmNzgyMzBkN2QyZWRlN2Y0YmQvdGFibGVyYW5nZTo4NjhiMGI0OWRiN2E0YWY3ODIzMGQ3ZDJlZGU3ZjRiZF8zLTAtMS0xLTUzMzU1_49febf12-5130-4f04-8c6a-261f16327c8c">2 Tower Place, Ste 2000</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ODY4YjBiNDlkYjdhNGFmNzgyMzBkN2QyZWRlN2Y0YmQvdGFibGVyYW5nZTo4NjhiMGI0OWRiN2E0YWY3ODIzMGQ3ZDJlZGU3ZjRiZF8zLTEtMS0xLTUzMzU1_a7b923bc-9263-4f1c-9f40-45e7158c3a15">South San Francisco,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ODY4YjBiNDlkYjdhNGFmNzgyMzBkN2QyZWRlN2Y0YmQvdGFibGVyYW5nZTo4NjhiMGI0OWRiN2E0YWY3ODIzMGQ3ZDJlZGU3ZjRiZF8zLTItMS0xLTUzMzU1_363ddc09-57b5-48bf-bb82-03b6cf87ccec">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ODY4YjBiNDlkYjdhNGFmNzgyMzBkN2QyZWRlN2Y0YmQvdGFibGVyYW5nZTo4NjhiMGI0OWRiN2E0YWY3ODIzMGQ3ZDJlZGU3ZjRiZF8zLTQtMS0xLTUzMzU1_a0c65c87-2e82-4d07-94b7-1bc60ffd2f06">94080</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzEx_6563d650-0185-4c5b-834c-00bf13dd0596">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzAy_83341a07-180b-4966-b4ee-c19264c22d3c">266-6000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ZTI2Mjg3NDIxMTIxNGVmYmE0ZmQzMjJmNDNkNDczYzIvdGFibGVyYW5nZTplMjYyODc0MjExMjE0ZWZiYTRmZDMyMmY0M2Q0NzNjMl8xLTAtMS0xLTUzMzU1_e10ca631-4730-4f41-9526-9bba1d3859f2">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ZTI2Mjg3NDIxMTIxNGVmYmE0ZmQzMjJmNDNkNDczYzIvdGFibGVyYW5nZTplMjYyODc0MjExMjE0ZWZiYTRmZDMyMmY0M2Q0NzNjMl8xLTEtMS0xLTUzMzU1_54bb0105-d726-4ad2-b032-d871b517227b">LAB</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6ZTI2Mjg3NDIxMTIxNGVmYmE0ZmQzMjJmNDNkNDczYzIvdGFibGVyYW5nZTplMjYyODc0MjExMjE0ZWZiYTRmZDMyMmY0M2Q0NzNjMl8xLTItMS0xLTUzMzU1_5db3ec14-5f55-4e7d-a4d8-0c422bb6d8c8">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzA2_a3a144a7-e75a-4be2-8816-4594652d6655">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzAz_129edd63-70e2-4554-a80a-46163f8cb2dd">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6NmIxZTI2YmNmZWY4NGYwODk4NTg1NjA3NzExNTI1N2YvdGFibGVyYW5nZTo2YjFlMjZiY2ZlZjg0ZjA4OTg1ODU2MDc3MTE1MjU3Zl8wLTUtMS0xLTUzMzU1_85a5136c-6fe4-4f65-b624-92ebde5b83a7">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6NmIxZTI2YmNmZWY4NGYwODk4NTg1NjA3NzExNTI1N2YvdGFibGVyYW5nZTo2YjFlMjZiY2ZlZjg0ZjA4OTg1ODU2MDc3MTE1MjU3Zl8xLTctMS0xLTUzMzU1_034fe74a-925d-4c00-8e0a-6c5c90f5a988">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGFibGU6NmIxZTI2YmNmZWY4NGYwODk4NTg1NjA3NzExNTI1N2YvdGFibGVyYW5nZTo2YjFlMjZiY2ZlZjg0ZjA4OTg1ODU2MDc3MTE1MjU3Zl8yLTctMS0xLTUzMzU1_2bbeb246-1669-415d-a7a3-a0e5c1aa433f">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF8yMzA3_8da2605b-dd51-4b41-890b-7df93584fc71">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i8129f3bfc4ec41c9aa6d162ae2eba76a_I20220430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xL2ZyYWc6MDE4ZmNhNjM0ZjM1NDcwYzk2MjViYzI0YTJhZmM0NWQvdGV4dHJlZ2lvbjowMThmY2E2MzRmMzU0NzBjOTYyNWJjMjRhMmFmYzQ1ZF81NDk3NTU4MTQxMzQ1_c71e289b-105c-4dad-bf36-217f9612a4d9"
      unitRef="shares">77252135</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNC0yLTEtMS01MzM1NQ_a9e7d4f0-1310-4ebe-8718-b1129f92b6cb"
      unitRef="usd">29983000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNC00LTEtMS01MzM1NQ_7145249b-e16e-4970-8a4d-5b082a25ec9a"
      unitRef="usd">28451000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNi0wLTEtMS01MzM1NS90ZXh0cmVnaW9uOjllMjM3ODhkYWE2ZTQ2NTNiY2IxNDBkNjNmOTdjY2Y3XzQ1_058abbed-4f6f-4e32-b994-450ab9aa081a"
      unitRef="usd">356000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNi0wLTEtMS01MzM1NS90ZXh0cmVnaW9uOjllMjM3ODhkYWE2ZTQ2NTNiY2IxNDBkNjNmOTdjY2Y3XzQ1_60e0c7fd-01c4-4039-8449-f0be3993f770"
      unitRef="usd">356000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNi0yLTEtMS01MzM1NQ_d6f7b83b-2bc8-4586-b3b1-3f578cce5f63"
      unitRef="usd">15422000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNi00LTEtMS01MzM1NQ_c3818781-9027-4e6d-a197-893b858ac990"
      unitRef="usd">18320000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfOC0yLTEtMS01MzM1NQ_fbe43f6a-fe09-4d93-b1ed-bb1a8fa131d2"
      unitRef="usd">23245000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfOC00LTEtMS01MzM1NQ_a885a7cc-4ca7-4688-b63c-3df403f2472d"
      unitRef="usd">20825000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfOS0yLTEtMS01MzM1NQ_68f2cd22-81b0-4784-bb14-55de392ef384"
      unitRef="usd">4547000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfOS00LTEtMS01MzM1NQ_f42045a7-2619-4711-80c5-7c275fb4606a"
      unitRef="usd">4470000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTAtMi0xLTEtNTMzNTU_60f5af3c-052e-471d-b7c5-d8f688fd7725"
      unitRef="usd">73197000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTAtNC0xLTEtNTMzNTU_573a2be7-341a-4945-a1b1-d12886cfa268"
      unitRef="usd">72066000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTItMi0xLTEtNTMzNTU_d7ed667b-7af2-4890-ae70-7feeb6c9df55"
      unitRef="usd">27699000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTItNC0xLTEtNTMzNTU_293173c1-d325-46c2-93d2-981e51d4176b"
      unitRef="usd">28034000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTMtMi0xLTEtNTMzNTU_3a0a283c-f452-4144-9b78-3789ffec30e6"
      unitRef="usd">36389000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTMtNC0xLTEtNTMzNTU_09170b64-816c-4aed-8fcd-16b99c348bdd"
      unitRef="usd">37119000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTQtMi0xLTEtNTMzNTU_43d2792b-c927-4ee2-b912-fb462242937c"
      unitRef="usd">3445000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTQtNC0xLTEtNTMzNTU_68b0e367-3a0a-4785-9cfd-c2dcafd35b9c"
      unitRef="usd">3689000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTUtMi0xLTEtNTMzNTU_009f180d-da14-49fa-8b9d-235190bcb856"
      unitRef="usd">24875000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTUtNC0xLTEtNTMzNTU_8a46c399-2ad7-4861-93c5-f29dbc8499cf"
      unitRef="usd">27927000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTYtMi0xLTEtNTMzNTU_cc15951c-747a-4c38-bf53-0e1e03ac6958"
      unitRef="usd">106333000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTYtNC0xLTEtNTMzNTU_c1ab8ca6-d256-4ea8-931f-1f77cd1ef9e4"
      unitRef="usd">106379000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTctMi0xLTEtNTMzNTU_a4c818e9-33da-42bc-94e5-9348bccb47ae"
      unitRef="usd">271938000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMTctNC0xLTEtNTMzNTU_5da018f4-26f2-4d61-9c1a-236220e6568e"
      unitRef="usd">275214000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjAtMi0xLTEtNTMzNTU_bbfcd97d-6114-4ee2-bcf9-01e63ff548d5"
      unitRef="usd">12517000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjAtNC0xLTEtNTMzNTU_61571711-916c-49ea-9d2e-59afc39a9edd"
      unitRef="usd">10602000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjEtMi0xLTEtNTMzNTU_ac446e97-a789-4ef5-88f6-085381cfdef9"
      unitRef="usd">7964000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjEtNC0xLTEtNTMzNTU_e2a2527f-f9c3-45b8-bafc-8db5430f48c2"
      unitRef="usd">4920000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjItMi0xLTEtNTMzNTU_c64c47e0-7077-4bc0-83d4-f910b1f0317b"
      unitRef="usd">3209000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjItNC0xLTEtNTMzNTU_f44a55c5-9249-4936-8e78-0613900c8115"
      unitRef="usd">3053000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjMtMi0xLTEtNTQyNjI_01060e84-42d0-47d1-98ec-a0aa9c555ba6"
      unitRef="usd">12291000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjMtNC0xLTEtNTQyNjI_93fc477d-1112-471f-9e05-1f0c5ef70b4f"
      unitRef="usd">11947000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <fldm:DeferredGrantRevenueCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjQtMi0xLTEtNTMzNTU_8f565241-cb45-4dbc-a2e1-d0fbf70a8229"
      unitRef="usd">3603000</fldm:DeferredGrantRevenueCurrent>
    <fldm:DeferredGrantRevenueCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjQtNC0xLTEtNTMzNTU_53c54be8-c986-4af3-a991-7d66084614a8"
      unitRef="usd">3535000</fldm:DeferredGrantRevenueCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjUtMi0xLTEtNTM4Nzg_e0a15c53-2aef-4bf5-84d6-745a27472443"
      unitRef="usd">7589000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjUtNC0xLTEtNTM4Nzg_14d0d84f-09a4-4242-9d3e-24dc35a59c66"
      unitRef="usd">8673000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjYtMi0xLTEtNTM4Nzg_14ae1987-5a04-4245-9a69-0c53f1fb6f32"
      unitRef="usd">0</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjYtNC0xLTEtNTM4Nzg_5e5a6638-442f-4c22-b3ba-f3115b982e07"
      unitRef="usd">6838000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjYtMi0xLTEtNTMzNTU_0ce610e8-1452-4d13-a271-a5446ac2f87c"
      unitRef="usd">47173000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjYtNC0xLTEtNTMzNTU_9cffff07-115c-4558-946c-3d655b6ff11d"
      unitRef="usd">49568000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjgtMi0xLTEtNjk4MzQ_28f2a956-7dfd-4730-aec5-fd132fa5aa1e"
      unitRef="usd">35655000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjgtNC0xLTEtNjk4MzQ_4a130cf8-492b-42d6-ab4b-99613a059ce0"
      unitRef="usd">0</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjktMi0xLTEtNjQ2ODI_13b2ef12-f2eb-4d0c-b6fe-572ac93657ac"
      unitRef="usd">54271000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjktNC0xLTEtNjQ2ODI_4b2f83d9-612a-4d89-a2e3-9f5ae2f1edbc"
      unitRef="usd">54160000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:SecuredDebt
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjctMi0xLTEtNTMzNTU_caea2f8d-60f0-4991-a8f4-11527a7cee29"
      unitRef="usd">10106000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjctNC0xLTEtNTMzNTU_4d109aa4-9afd-4f5f-8c0c-cacaf47bcb36"
      unitRef="usd">10049000</us-gaap:SecuredDebt>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjktMi0xLTEtNTMzNTU_90c0252d-3b8f-4c7b-be75-582b526cbfa3"
      unitRef="usd">3544000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMjktNC0xLTEtNTMzNTU_3fb28373-2b91-4b9e-bac6-cb86b6b968ed"
      unitRef="usd">4329000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzAtMi0xLTEtNTMzNTU_d2d092f8-bcd8-4628-b10b-1f3143218de9"
      unitRef="usd">36760000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzAtNC0xLTEtNTMzNTU_4ef367fe-3b6c-4859-9d8c-81ad8ec3e3ee"
      unitRef="usd">37548000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzEtMi0xLTEtNTMzNTU_8ffb6c53-aaac-4dd1-81d9-aa465e49e285"
      unitRef="usd">5793000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzEtNC0xLTEtNTMzNTU_0c224988-4e8d-4488-977a-db35480e38ac"
      unitRef="usd">5966000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <fldm:DeferredGrantRevenueNoncurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzItMi0xLTEtNTMzNTU_9133fed0-a5ba-42d0-9e27-bce8c31e5ca2"
      unitRef="usd">17237000</fldm:DeferredGrantRevenueNoncurrent>
    <fldm:DeferredGrantRevenueNoncurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzItNC0xLTEtNTMzNTU_4f0c5188-97ed-4955-a275-f32046a3d4f2"
      unitRef="usd">18116000</fldm:DeferredGrantRevenueNoncurrent>
    <fldm:StockRepurchaseLiability
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzUtMi0xLTEtNzE3MDk_c248df7a-0c1d-4676-9a35-76726b92c674"
      unitRef="usd">37792000</fldm:StockRepurchaseLiability>
    <fldm:StockRepurchaseLiability
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzUtNC0xLTEtNzE3MDk_af20bbd9-5eca-45ed-b483-fefe74bbaeae"
      unitRef="usd">0</fldm:StockRepurchaseLiability>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzMtMi0xLTEtNTMzNTU_e5d9490a-1c8d-4efc-9468-4a9bfe5b75d6"
      unitRef="usd">1494000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzMtNC0xLTEtNTMzNTU_0d069cd3-bb49-4ea4-abfb-ef1bc01b58c6"
      unitRef="usd">882000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzQtMi0xLTEtNTMzNTU_dec6eb04-cdc3-47d3-bdfa-2791c6b14a10"
      unitRef="usd">249825000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzQtNC0xLTEtNTMzNTU_39796a92-cad7-44b6-8ad7-968f257effa0"
      unitRef="usd">180618000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzUtMi0xLTEtNTMzNTU_a68864a4-876c-47b9-87df-51faa9b23e94"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzUtNC0xLTEtNTMzNTU_270bfdd7-f8c0-4c8b-b773-bf36e22cc9f1"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M18yMQ_2a9a81de-9b1e-4e9c-81db-a54091470adc"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M18yMQ_602d5241-76fa-451e-8122-ad57c581b4e3"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M18zNQ_2fb81257-fbea-4290-bf52-58d307d0a386"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M18zNQ_bbbfdfdf-2fb7-4c41-8c75-2b4978b620b3"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M181Nw_4d3ff3f0-a598-44d9-a1dd-28e1fb96690f"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M181Nw_940a6441-c03a-4a88-bfa3-24d889d88d1d"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M181Nw_b00c5ed2-67be-4c0e-bc3d-fcc61a01ac8b"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjpkODE4NzczOGM4ODg0ZjZmOGQ0ZjU4ODQyOGI3YmY0M181Nw_cd419518-91f9-40be-8746-146097d345e5"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctMi0xLTEtNTMzNTU_41b9179e-c064-4731-b8fc-05d59307fef9"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzctNC0xLTEtNTMzNTU_fd4a73c6-c6a6-45cf-a781-9026d61348a8"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl8xOA_679f6b3a-2c9f-430e-8411-53e9c6ae52b3"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl8xOA_e827f0c4-e8ee-4d1c-8364-260bfcd9bf14"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl8zMg_1d65f7c1-c0b9-42b1-adbb-2e07200a9cb2"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl8zMg_2949ee37-8cb5-4728-af66-b366ecb502a5"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl84Mg_020383e5-fda4-4e81-9909-076958f26e02"
      unitRef="shares">77199000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl84Mg_1d64a7c4-14d6-4e2b-9fb7-94088c588721"
      unitRef="shares">77199000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl84OQ_a354d478-18af-48a2-a910-b0ca1d788417"
      unitRef="shares">76919000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMC0xLTEtNTMzNTUvdGV4dHJlZ2lvbjoyMTgwNDgzNzQ0OTU0NWNjYThmNzc2MTM1YzQxOGJkZl84OQ_d459342b-3731-43b0-b237-bae0f8b1a8e5"
      unitRef="shares">76919000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtMi0xLTEtNTMzNTU_166ec526-5a7b-4206-bb8d-4c24e7b1ffac"
      unitRef="usd">77000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzgtNC0xLTEtNTMzNTU_4ca0dc6b-6e98-483c-bc0e-3ea986dafbdb"
      unitRef="usd">77000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzktMi0xLTEtNTMzNTU_bc5fb6e9-3c05-489f-bec9-3b7aa0b3c7bb"
      unitRef="usd">835379000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfMzktNC0xLTEtNTMzNTU_3d41b3e8-a8db-4a9d-b046-208aa84fedae"
      unitRef="usd">831424000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDAtMi0xLTEtNTMzNTU_ab53a020-9f03-447b-b541-9f6ba9f8f0be"
      unitRef="usd">-1057000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDAtNC0xLTEtNTMzNTU_a182b23c-1a6e-467e-860f-0b20ec9fada1"
      unitRef="usd">-907000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDEtMi0xLTEtNTMzNTU_169e8215-4df0-4222-9c4c-4f1fa6983b2d"
      unitRef="usd">-812286000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDEtNC0xLTEtNTMzNTU_c89c1c35-ede2-4708-9538-73938f449933"
      unitRef="usd">-735998000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDItMi0xLTEtNTMzNTU_b6f2be07-1588-4fe9-ba5e-0feae0e7553a"
      unitRef="usd">22113000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDItNC0xLTEtNTMzNTU_6479f00f-60d9-40ea-b00d-60dac5b69118"
      unitRef="usd">94596000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDMtMi0xLTEtNTMzNTU_b6078411-f6b0-4977-a731-399c57636bc8"
      unitRef="usd">271938000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xNi9mcmFnOmRkNjk4M2U0ZDdkMjQ0ZmZhMmIzYjk5MGJhOWI0ODBmL3RhYmxlOjk1NjJjNTEyYTQ5YjRmODE5NjllYTlkZjJkNjNlMDRiL3RhYmxlcmFuZ2U6OTU2MmM1MTJhNDliNGY4MTk2OWVhOWRmMmQ2M2UwNGJfNDMtNC0xLTEtNTMzNTU_f4db8ba0-8098-4520-87e2-8736c685dc70"
      unitRef="usd">275214000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i464bfcf84ef44fa0b0e68af70cc3988f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMy0xLTEtMS01MzM1NQ_0101f40a-0511-45fc-8d39-68046d6369dc"
      unitRef="usd">20004000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab920cccfecf44528e9ce52d935fa63a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMy0zLTEtMS01MzM1NQ_81107398-991a-42b4-b104-54676523ac23"
      unitRef="usd">24728000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96de28bb25374cbaa71d471a786e1db3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNC0xLTEtMS01MzM1NQ_f8a274b2-bd3f-4c41-8fe2-9387b2ad315c"
      unitRef="usd">6144000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if6c770a450054cda9c777968afb1bca3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNC0zLTEtMS01MzM1NQ_3cef8098-7a39-48a6-8b84-e37481c00777"
      unitRef="usd">6286000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a25af0ec36e425db27350cae34291e2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNS0xLTEtMS01MzM1NQ_d64fa7a4-3018-4885-90f6-1c692640741f"
      unitRef="usd">88000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i50ef3b1943a5459d80af3119e547f1cc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNS0zLTEtMS01MzM1NQ_1d4853c4-8034-452c-a3b3-a7e4be03d908"
      unitRef="usd">1480000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f969efefbfa43cab57d0b0dbba8b692_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNi0xLTEtMS01MzM1NQ_225947fa-10c8-4b24-b27d-8b78dfc257db"
      unitRef="usd">268000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37fe6c7bd98449ef8909d4137b4673a2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNi0zLTEtMS01MzM1NQ_fc1db5c2-0a35-484b-b1a7-90d6df197d6d"
      unitRef="usd">300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNy0xLTEtMS01MzM1NQ_b8f78f4a-af95-4d0c-8e9a-af7cacd9bc54"
      unitRef="usd">26504000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfNy0zLTEtMS01MzM1NQ_ffd2b899-cc90-44f7-b093-a510d7cf3ab5"
      unitRef="usd">32794000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i464bfcf84ef44fa0b0e68af70cc3988f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfOS0xLTEtMS01MzM1NQ_bc17701a-11a8-47be-9802-fa3f9158e2b9"
      unitRef="usd">12339000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iab920cccfecf44528e9ce52d935fa63a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfOS0zLTEtMS01MzM1NQ_65bcbf6c-a005-4239-a8e0-a1c834006b46"
      unitRef="usd">11663000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i96de28bb25374cbaa71d471a786e1db3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTAtMS0xLTEtNTMzNTU_371beb6e-3156-467f-89de-0473b81f30bd"
      unitRef="usd">1928000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if6c770a450054cda9c777968afb1bca3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTAtMy0xLTEtNTMzNTU_996c5d00-f174-46b7-9c15-f3819d07c676"
      unitRef="usd">2090000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTEtMS0xLTEtNTMzNTU_b0d2d151-0de3-4d2f-a765-b3bf26c933ad"
      unitRef="usd">8865000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTEtMy0xLTEtNTMzNTU_b3b606cf-4a34-4abf-b0f6-c44a140af6b5"
      unitRef="usd">10753000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTItMS0xLTEtNTMzNTU_7caead2d-bb09-4b86-80a6-b5450660cf79"
      unitRef="usd">30875000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTItMy0xLTEtNTMzNTU_19a78c6f-d0e1-421b-a7d0-71610b21c79c"
      unitRef="usd">27608000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTMtMS0xLTEtNTMzNTU_c3a6473a-8c91-4407-924f-e908db63fa29"
      unitRef="usd">54007000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTMtMy0xLTEtNTMzNTU_e3e53020-bf71-4a43-97b6-83b586e23fbd"
      unitRef="usd">52114000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTQtMS0xLTEtNTMzNTU_0c0bff42-a7e2-46b4-8dce-1804979a4b62"
      unitRef="usd">-27503000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTQtMy0xLTEtNTMzNTU_a1ccdf85-3db0-46cb-8102-e845536e4215"
      unitRef="usd">-19320000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTUtMS0xLTEtNTMzNTU_0a5caf12-0827-4d67-abc6-db6923c3039e"
      unitRef="usd">1030000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTUtMy0xLTEtNTMzNTU_38e7bdcc-2f71-4466-a1de-482faee082c5"
      unitRef="usd">887000</us-gaap:InterestExpense>
    <fldm:LossOnForwardSaleOfStock
      contextRef="i67531e388c0e40cdb02f90448ebfc132_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTYtMS0xLTEtNjk4ODI_6c385e16-00e1-43c8-a667-37c2680fae5b"
      unitRef="usd">37792000</fldm:LossOnForwardSaleOfStock>
    <fldm:LossOnForwardSaleOfStock
      contextRef="ib0e22c724c524303bf88f4ed321cc50d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTYtMy0xLTEtNjk4ODI_81895315-6dc0-499a-8595-cf9593d0ed6e"
      unitRef="usd">0</fldm:LossOnForwardSaleOfStock>
    <us-gaap:DebtSecuritiesUnrealizedGainLoss
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTYtMS0xLTEtNTMzNTU_3d371e39-bc89-4d33-b6bd-42cf3fd477f6"
      unitRef="usd">-10655000</us-gaap:DebtSecuritiesUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesUnrealizedGainLoss
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTYtMy0xLTEtNTMzNTU_cd00f9c3-8ccb-4849-b087-8306204bcbd3"
      unitRef="usd">0</us-gaap:DebtSecuritiesUnrealizedGainLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTctMS0xLTEtNTMzNTU_9ffb1855-8eb7-4c58-8d20-37c69d681e0f"
      unitRef="usd">118000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTctMy0xLTEtNTMzNTU_fbf0071f-7f32-46fd-b163-1e9a967725c6"
      unitRef="usd">-285000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTgtMS0xLTEtNTMzNTU_bfbd386b-dc40-48b1-bdb5-abbdcff68b34"
      unitRef="usd">-76862000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTgtMy0xLTEtNTMzNTU_6e234df0-2459-4ac7-9f1d-33a83e6d91fb"
      unitRef="usd">-20492000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTktMS0xLTEtNTMzNTU_e0dcaf5b-27c2-408d-acba-17c9b2609da3"
      unitRef="usd">-574000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMTktMy0xLTEtNTMzNTU_1c1d48f1-3716-4798-bf1d-0c65998fd6aa"
      unitRef="usd">-1671000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjAtMS0xLTEtNTMzNTU_9b63fcfc-0056-42b0-a6fa-1c0ef58816f4"
      unitRef="usd">-76288000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjAtMy0xLTEtNTMzNTU_d2bd70b1-b34a-46d0-8862-59461e71b377"
      unitRef="usd">-18821000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjEtMS0xLTEtNTMzNTU_7fdd9ad7-09f6-4a1f-a2b8-47decff4de7a"
      unitRef="usdPerShare">-0.99</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjEtMS0xLTEtNTMzNTU_a4cfe893-1cf9-4f65-bdda-30291909f1b8"
      unitRef="usdPerShare">-0.99</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjEtMy0xLTEtNTMzNTU_0e5533db-0678-4cbe-97bb-baf0f6f0f0d7"
      unitRef="usdPerShare">-0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjEtMy0xLTEtNTMzNTU_1d459f6b-d79b-43a9-9664-ad82f28c3002"
      unitRef="usdPerShare">-0.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjItMS0xLTEtNTMzNTU_8aa31e36-b66d-4c67-9948-418ff911cb14"
      unitRef="shares">77031000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjItMS0xLTEtNTMzNTU_f3b84bbe-18f9-4dcf-a372-af9637db6322"
      unitRef="shares">77031000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjItMy0xLTEtNTMzNTU_e39ad405-a36c-493f-bced-789fba8fe2bc"
      unitRef="shares">74707000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8xOS9mcmFnOmU0YThlYWNjNTA5ODQ3ODc4ZDQ5ZjcyMDY3M2Y1MWVlL3RhYmxlOjA2MTNhM2Q3NzMzZTQyZTA5OTg5N2I5ODYyMjJmOTI2L3RhYmxlcmFuZ2U6MDYxM2EzZDc3MzNlNDJlMDk5ODk3Yjk4NjIyMmY5MjZfMjItMy0xLTEtNTMzNTU_eac785e3-a9ff-4551-85bd-294556458c4b"
      unitRef="shares">74707000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMi9mcmFnOjYyN2VkNjk2OTJiYTQyMmFiMzlkNWFjY2Q2NTBjNDRlL3RhYmxlOmIzMmZhNGM5NWJkMDQ3MWE5ZTc1MzY1NjViNGQ4ZjJiL3RhYmxlcmFuZ2U6YjMyZmE0Yzk1YmQwNDcxYTllNzUzNjU2NWI0ZDhmMmJfMi0xLTEtMS01MzM1NQ_99fe2176-8447-4e5e-b6dd-7bf4044b0eda"
      unitRef="usd">-76288000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMi9mcmFnOjYyN2VkNjk2OTJiYTQyMmFiMzlkNWFjY2Q2NTBjNDRlL3RhYmxlOmIzMmZhNGM5NWJkMDQ3MWE5ZTc1MzY1NjViNGQ4ZjJiL3RhYmxlcmFuZ2U6YjMyZmE0Yzk1YmQwNDcxYTllNzUzNjU2NWI0ZDhmMmJfMi0zLTEtMS01MzM1NQ_ede6a6a6-069b-46d9-8954-5afc40e17d95"
      unitRef="usd">-18821000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMi9mcmFnOjYyN2VkNjk2OTJiYTQyMmFiMzlkNWFjY2Q2NTBjNDRlL3RhYmxlOmIzMmZhNGM5NWJkMDQ3MWE5ZTc1MzY1NjViNGQ4ZjJiL3RhYmxlcmFuZ2U6YjMyZmE0Yzk1YmQwNDcxYTllNzUzNjU2NWI0ZDhmMmJfNC0xLTEtMS01MzM1NQ_c44ac59f-fcf5-4235-b57d-ed825b067b72"
      unitRef="usd">-150000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMi9mcmFnOjYyN2VkNjk2OTJiYTQyMmFiMzlkNWFjY2Q2NTBjNDRlL3RhYmxlOmIzMmZhNGM5NWJkMDQ3MWE5ZTc1MzY1NjViNGQ4ZjJiL3RhYmxlcmFuZ2U6YjMyZmE0Yzk1YmQwNDcxYTllNzUzNjU2NWI0ZDhmMmJfNC0zLTEtMS01MzM1NQ_df716eb2-7ea3-493c-b2b6-b4ed8cf4dd64"
      unitRef="usd">-443000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMi9mcmFnOjYyN2VkNjk2OTJiYTQyMmFiMzlkNWFjY2Q2NTBjNDRlL3RhYmxlOmIzMmZhNGM5NWJkMDQ3MWE5ZTc1MzY1NjViNGQ4ZjJiL3RhYmxlcmFuZ2U6YjMyZmE0Yzk1YmQwNDcxYTllNzUzNjU2NWI0ZDhmMmJfNy0xLTEtMS01MzM1NQ_18a04ceb-aa85-4d91-b9f2-d18e97615433"
      unitRef="usd">-76438000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMi9mcmFnOjYyN2VkNjk2OTJiYTQyMmFiMzlkNWFjY2Q2NTBjNDRlL3RhYmxlOmIzMmZhNGM5NWJkMDQ3MWE5ZTc1MzY1NjViNGQ4ZjJiL3RhYmxlcmFuZ2U6YjMyZmE0Yzk1YmQwNDcxYTllNzUzNjU2NWI0ZDhmMmJfNy0zLTEtMS01MzM1NQ_5fc571da-2c8c-499b-9344-5841bbe6d550"
      unitRef="usd">-19264000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ife53191c83774d009455b6219ab8d213_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMi0yLTEtMS01MzM1NQ_672070ce-159f-4441-b984-bca7ca1952a2"
      unitRef="shares">76919000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ife53191c83774d009455b6219ab8d213_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMi00LTEtMS01MzM1NQ_53f11ad0-2eb4-4d19-afc7-1db311298990"
      unitRef="usd">77000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id512bd02ff5c466b83c1a85dc87fe1ef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMi02LTEtMS01MzM1NQ_55e53f5a-8fad-4bdd-8f48-4620793cfe73"
      unitRef="usd">831424000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3062eea440bb4b8abee952bb6d8f666f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMi04LTEtMS01MzM1NQ_1f1b0413-d48e-448a-a73d-ed0e1f74e573"
      unitRef="usd">-907000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia01ee6541d314637a0cf139b7a3517a8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMi0xMC0xLTEtNTMzNTU_233466b4-9e55-4f73-9c31-3f5c454e178d"
      unitRef="usd">-735998000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMi0xMi0xLTEtNTMzNTU_e3504f71-4381-4bce-a255-14a230dbc132"
      unitRef="usd">94596000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i8ee876a5d6724fc3baf62a71ac362565_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMy0yLTEtMS01MzM1NQ_b86792fa-2c7e-4892-bd30-1b203e04b0f6"
      unitRef="shares">280000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i3160813ed6ea47239b8b14f10a6a132f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMy02LTEtMS01MzM1NQ_24d3b8dc-a61e-4fa3-b51c-b5ed40d4a6db"
      unitRef="usd">-87000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMy0xMi0xLTEtNTMzNTU_ebcd1b53-837b-401b-b474-9c39d315ddb9"
      unitRef="usd">-87000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3160813ed6ea47239b8b14f10a6a132f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfNS02LTEtMS01MzM1NQ_77ec8587-0af8-45cf-9c1b-b20d88e6d158"
      unitRef="usd">4042000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfNS0xMi0xLTEtNTMzNTU_babf39c4-9a37-40d6-965c-ae8c8d7e5072"
      unitRef="usd">4042000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i743f2be8661c4d49bf0e11f2fd7672c6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfNi0xMC0xLTEtNTMzNTU_040055ec-a2fa-4431-a942-b51bd012f03b"
      unitRef="usd">-76288000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfNi0xMi0xLTEtNTMzNTU_61c66ad6-6b47-4b07-a7da-ff4bb4d77969"
      unitRef="usd">-76288000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ief97f0f005454a3ebb73d10c8a6fc288_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfNy04LTEtMS01MzM1NQ_98383a40-43c6-4bc0-b2fd-6faa10e05506"
      unitRef="usd">-150000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfNy0xMi0xLTEtNTMzNTU_9c028da8-085d-4ca1-8615-39b0a7727621"
      unitRef="usd">-150000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic3d0b28316714637ae16364f010efcb3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfOC0yLTEtMS01MzM1NQ_05fef2f7-af63-495d-a96d-7aa2a62e3a32"
      unitRef="shares">77199000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic3d0b28316714637ae16364f010efcb3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfOC00LTEtMS01MzM1NQ_8eb8b36b-d478-481e-9794-7a867b3c2ed1"
      unitRef="usd">77000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i671f9af2f29c4f1f929a61c12aba4b42_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfOC02LTEtMS01MzM1NQ_775e589e-a65b-4e89-9e06-f54911d9bbd1"
      unitRef="usd">835379000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieaeae6add4f148cd8e2a749b602bcc59_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfOC04LTEtMS01MzM1NQ_201dd665-977c-44b4-9046-35668b1805e2"
      unitRef="usd">-1057000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7108a12ba20140bf8ddbbf0bd06e0086_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfOC0xMC0xLTEtNTMzNTU_ac767018-5ef8-40e8-badc-1ac487e00100"
      unitRef="usd">-812286000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfOC0xMi0xLTEtNTMzNTU_3e494922-f64e-4a49-b171-2494e1a3b1f5"
      unitRef="usd">22113000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7edfc49d39cd47138bdc5064597c073b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjgtMi0xLTEtNTQxMTk_6792f3ba-0016-46c4-aa22-8be5a212f740"
      unitRef="shares">74543000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7edfc49d39cd47138bdc5064597c073b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjgtNC0xLTEtNTQxMTk_690060e5-2c04-4ddf-b538-b03c5cc6f176"
      unitRef="usd">75000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id77c72e5a5f841e093b9ab6998fcfc1f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjgtNi0xLTEtNTQxMTk_e9866cf8-1a52-4a15-9dad-5cb97bcdf72c"
      unitRef="usd">815624000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i87fc908e2306474ca6061592bbd313c0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjgtOC0xLTEtNTQxMTk_a37c4d55-6fb3-4893-8aaa-08a351546307"
      unitRef="usd">112000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if4e40eb27af64de29a8412568ad4b140_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjgtMTAtMS0xLTU0MTE5_49ef7259-c4e2-438d-b6e9-a3eb9e9177ea"
      unitRef="usd">-676761000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id803a63fc74c495aa4dd5311fbcac8b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjgtMTItMS0xLTU0MTE5_06516b9e-dd42-4a6e-8bc8-4088cec25eaf"
      unitRef="usd">139050000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i569592ee5f454ea69635943e7f236859_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjktMi0xLTEtNTQxMTk_91a15c4f-e3c7-481f-a64b-3502c6a4fb0d"
      unitRef="shares">420000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i0e3525e6da4a471bbb0a4a59a5d15773_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjktNi0xLTEtNTQxMTk_a702d9df-a90b-42d4-8960-2fff82095465"
      unitRef="usd">-525000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMjktMTItMS0xLTU0MTE5_7f5075f0-c9c7-4580-abda-12277afdf4bb"
      unitRef="usd">-525000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0e3525e6da4a471bbb0a4a59a5d15773_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzEtNi0xLTEtNTQxMTk_6a011026-dae7-45c4-b021-36be63160ef5"
      unitRef="usd">3677000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzEtMTItMS0xLTU0MTE5_f9215cdb-af16-48c1-919b-2c05bd19d586"
      unitRef="usd">3677000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="ic26f34b391524936ad12d32af015e7a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzItMTAtMS0xLTU0MTE5_8446d1ed-2bce-4174-af5b-bbd620682c95"
      unitRef="usd">-18821000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzItMTItMS0xLTU0MTE5_3b5e8368-09d4-4d62-bc74-f565dbe8297c"
      unitRef="usd">-18821000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic05a8c6dfa64446bad2c73b3c7882945_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzMtOC0xLTEtNTQxMTk_853557db-2bc0-49a8-85d1-d48a4c3aa12d"
      unitRef="usd">-443000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzMtMTItMS0xLTU0MTE5_842153be-d697-4a2a-8396-c953aaecfd1f"
      unitRef="usd">-443000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i47472db137014a838484b58ca7ec54b1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzQtMi0xLTEtNTQxMTk_4db958eb-4594-457f-8332-66c51a74892b"
      unitRef="shares">74963000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i47472db137014a838484b58ca7ec54b1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzQtNC0xLTEtNTQxMTk_9055e11b-5123-4475-abf5-50d24b12bffc"
      unitRef="usd">75000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifdac09bb73da4bc698146a2f6d7842a5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzQtNi0xLTEtNTQxMTk_01a13126-8a36-4d06-b23f-796987dd467d"
      unitRef="usd">818776000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6cd95ac79ec64220ae66aaf7e20ff229_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzQtOC0xLTEtNTQxMTk_eade47ef-5140-4881-9d17-21e16111a59c"
      unitRef="usd">-331000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i28b9b63dddca4cf59ed8ad13d8b810aa_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzQtMTAtMS0xLTU0MTE5_eb081cbb-c130-4479-a101-01fefc527666"
      unitRef="usd">-695582000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id618e4076c984ee2b69327451b1b9e70_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yNS9mcmFnOmI2NzlhYmMyMmM2OTRmMWQ4YjkyZWZmYTI4MzY0N2M3L3RhYmxlOjY0NWZkY2E1NGFlYjQxMzZiZDE3ZTYxOGZkNTlhOThmL3RhYmxlcmFuZ2U6NjQ1ZmRjYTU0YWViNDEzNmJkMTdlNjE4ZmQ1OWE5OGZfMzQtMTItMS0xLTU0MTE5_caec5b7d-e04c-497e-a8ce-b6f4c16b5db1"
      unitRef="usd">122938000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMy0yLTEtMS01MzM1NQ_17a8ceb1-56bc-4f81-8e9b-6705547eb3fb"
      unitRef="usd">-76288000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMy00LTEtMS01MzM1NQ_18f223c3-6b6b-48b1-b208-83aff39e91a3"
      unitRef="usd">-18821000</us-gaap:NetIncomeLoss>
    <fldm:LossOnForwardSaleOfStock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNS0yLTEtMS02OTk2NQ_98d3be75-2f27-45a2-8f78-75566eceac28"
      unitRef="usd">37792000</fldm:LossOnForwardSaleOfStock>
    <fldm:LossOnForwardSaleOfStock
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNS00LTEtMS02OTk2NQ_c54ca4bf-02e3-446a-84cf-46a86f2f4afe"
      unitRef="usd">0</fldm:LossOnForwardSaleOfStock>
    <us-gaap:DebtSecuritiesUnrealizedGainLoss
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNi0yLTEtMS02OTk2NQ_6d686153-ff2e-4ff9-bec9-b61ac9684130"
      unitRef="usd">-10655000</us-gaap:DebtSecuritiesUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesUnrealizedGainLoss
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNi00LTEtMS02OTk2NQ_3d455f0d-0977-40bd-9d41-a9a5f309524d"
      unitRef="usd">0</us-gaap:DebtSecuritiesUnrealizedGainLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNS0yLTEtMS01MzM1NQ_f65bd8db-2ff3-44cc-b119-d48a46f44151"
      unitRef="usd">4042000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNS00LTEtMS01MzM1NQ_05fee469-b37e-453f-858b-c420957fbc2b"
      unitRef="usd">3677000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNi0yLTEtMS01MzM1NQ_b60d7e29-2cd1-4e9d-a250-414112f07b7d"
      unitRef="usd">2968000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNi00LTEtMS01MzM1NQ_cdb5252f-e15b-4102-94f4-6e43d14520e4"
      unitRef="usd">2983000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNy0yLTEtMS01MzM1NQ_a28fa57a-2022-4505-9836-5b1f6b8ba0e8"
      unitRef="usd">1003000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNy00LTEtMS01MzM1NQ_74e2b6f7-f93a-4f9c-9178-7f29146c2997"
      unitRef="usd">934000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfOC0yLTEtMS01NDMzMQ_f57492c6-f634-4f5f-8fe0-ae96609b3d48"
      unitRef="usd">851000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfOC00LTEtMS01NDMzMQ_bf1c1dde-e29b-46ce-92a5-203e49f59a2b"
      unitRef="usd">315000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfOC0yLTEtMS01MzM1NQ_7846ded3-4b30-4410-b293-7ac57c43d0c6"
      unitRef="usd">211000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfOC00LTEtMS01MzM1NQ_568c08f9-cd89-43e2-baf2-321b95ae3d37"
      unitRef="usd">132000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTQtMi0xLTEtNTMzNTU_a88b7ea2-04d7-40ce-aca6-68b791f757d7"
      unitRef="usd">104000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTQtNC0xLTEtNTMzNTU_43afe1c6-63d9-4619-a20e-467edb93a3cd"
      unitRef="usd">163000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTYtMi0xLTEtNTMzNTU_7c815811-642a-4ecc-8bff-e8e3046b18f1"
      unitRef="usd">-2917000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTYtNC0xLTEtNTMzNTU_6c9806e5-3c4b-4d60-acbc-a608f04afa26"
      unitRef="usd">-9843000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTctMi0xLTEtNTMzNTU_d999175c-0244-4bf3-8ebb-9fd4f31a3028"
      unitRef="usd">3558000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTctNC0xLTEtNTMzNTU_50537e7f-dadd-48bd-a591-33165dcf465b"
      unitRef="usd">2896000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTgtMi0xLTEtNTMzNTU_caf027f2-b9c9-4bbb-ab9e-b409bbf76c93"
      unitRef="usd">38000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTgtNC0xLTEtNTMzNTU_1e24040f-5b52-44a2-b134-1d0d1637d3ad"
      unitRef="usd">2763000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTktMi0xLTEtNTMzNTU_700ad20f-303f-4bde-9752-3c005105a399"
      unitRef="usd">1905000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMTktNC0xLTEtNTMzNTU_1e2526d3-2e65-4fb3-a905-b670f6fee8d9"
      unitRef="usd">3363000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjEtMi0xLTEtNTMzNTU_e1fa8a05-6427-42ee-a568-28ca1994ecb5"
      unitRef="usd">3037000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjEtNC0xLTEtNTMzNTU_5d46a6b5-1b63-4b4a-853b-e502e4470ad7"
      unitRef="usd">-5020000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjItMi0xLTEtNTQzOTk_ae43b29e-bd06-42af-aab7-9e4e3718ead3"
      unitRef="usd">155000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjItNC0xLTEtNTQzOTk_fbaacc43-6dc5-4fa8-b9a1-ae489c2c2415"
      unitRef="usd">156000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjItMi0xLTEtNTMzNTU_e4204fb9-ddf0-4648-9511-61572651083b"
      unitRef="usd">-1346000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjItNC0xLTEtNTMzNTU_7e6f531d-e64d-4975-98b8-0d757929c377"
      unitRef="usd">-4967000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjMtMi0xLTEtNTMzNTU_482b1a44-5ba2-49ce-85c4-4b85e19f1e34"
      unitRef="usd">-15590000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjMtNC0xLTEtNTMzNTU_c88f69d0-1fc7-463c-8cfe-7ff547573dce"
      unitRef="usd">-12901000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <fldm:ProceedsFromResearchAndDevelopmentGrant
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjctMi0xLTEtNTMzNTU_7580c7d1-2dba-46b2-8621-a45425104ffa"
      unitRef="usd">0</fldm:ProceedsFromResearchAndDevelopmentGrant>
    <fldm:ProceedsFromResearchAndDevelopmentGrant
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjctNC0xLTEtNTMzNTU_5e0f2bfe-0158-4ddb-9733-ba2671609be1"
      unitRef="usd">2000000</fldm:ProceedsFromResearchAndDevelopmentGrant>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzAtMi0xLTEtNTMzNTU_68b2972a-de62-47f0-bc5b-973f47ce396d"
      unitRef="usd">868000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzAtNC0xLTEtNTMzNTU_05400ac8-973e-4439-a79e-bdc65bd2ab9c"
      unitRef="usd">6923000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzEtMi0xLTEtNTMzNTU_c34c5a0b-1bf7-411a-8a85-39c5041fcdc3"
      unitRef="usd">-868000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzEtNC0xLTEtNTMzNTU_ce4a7e0b-0e87-4fd0-9c39-8bfcd0f009f5"
      unitRef="usd">-4923000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjktMi0xLTEtNjQ2ODg_17a6346a-fbac-4c94-99f6-cae83f918843"
      unitRef="usd">25000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjktNC0xLTEtNjQ2ODg_b43b7736-7ad9-4bb2-b50b-e842f9bbbf4b"
      unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjktMi0xLTEtNjQyNjU_1369a4d6-4b27-45c8-aece-82e4ab285fb2"
      unitRef="usd">6838000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMjktNC0xLTEtNjQyNjU_d71bfda9-d53c-4c85-a0e1-40bb791b11da"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzItMi0xLTEtNjkwOTk_c6bd4b71-e073-4b9e-9cb3-a1e8339781ad"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzItNC0xLTEtNjkwOTk_acd1e263-d21c-4ebe-9966-5a0e074aa66b"
      unitRef="usd">501000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzgtMi0xLTEtNTMzNTU_edb1ffff-ecc4-4273-9121-5bf5d251d3b9"
      unitRef="usd">87000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfMzgtNC0xLTEtNTMzNTU_679181ad-78a3-4eaa-a70f-c719cfb88066"
      unitRef="usd">525000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDItMi0xLTEtNTMzNTU_67bc1e2b-8eb4-445f-8bc7-0e3350bca0b6"
      unitRef="usd">18075000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDItNC0xLTEtNTMzNTU_ab8e003e-b4be-469e-afd2-ed33f43b2a8c"
      unitRef="usd">-1026000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDMtMi0xLTEtNTMzNTU_82580248-1b08-4915-99e0-49ead4f87d91"
      unitRef="usd">-85000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDMtNC0xLTEtNTMzNTU_aa076e40-9f6a-4e8d-95f3-b7ee7b86d2be"
      unitRef="usd">74000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDQtMi0xLTEtNTMzNTU_9539c778-4cf4-4ed9-89bd-0aac4b84a978"
      unitRef="usd">1532000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDQtNC0xLTEtNTMzNTU_fc77fd62-b7bb-48bf-aee6-fdb6c74be710"
      unitRef="usd">-18776000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDUtMi0xLTEtNTMzNTU_acb33f4f-55ab-4ea3-8039-b0a5135c9ecc"
      unitRef="usd">29467000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id803a63fc74c495aa4dd5311fbcac8b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDUtNC0xLTEtNTMzNTU_1a52c606-4ef6-40b4-94f6-e8e2b0988c21"
      unitRef="usd">69536000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDYtMi0xLTEtNTMzNTU_7d50ef3a-6926-4a81-b5aa-14e74d8d8fdf"
      unitRef="usd">30999000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id618e4076c984ee2b69327451b1b9e70_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDYtNC0xLTEtNTMzNTU_d3c26ceb-e23f-4355-8f9e-c79e2aa99d31"
      unitRef="usd">50760000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDktMi0xLTEtNTMzNTU_1b81b9a0-189e-43c5-ab16-34f900271405"
      unitRef="usd">102000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNDktNC0xLTEtNTMzNTU_944eb9e7-97fe-4cdd-a05c-6fe8bcb78785"
      unitRef="usd">44000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNTAtMi0xLTEtNTMzNTU_b8d71798-28a5-45c2-b9d4-12de49539c71"
      unitRef="usd">488000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNTAtNC0xLTEtNTMzNTU_9168be48-77f7-4f28-8c1a-b41be3561318"
      unitRef="usd">1200000</us-gaap:IncomeTaxesPaidNet>
    <fldm:NonCashRightOfUseAssetsAndLeaseLiabilities
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNTEtMi0xLTEtNTMzNTU_5e1d18d3-3f4e-4c01-a656-6a3926e35307"
      unitRef="usd">-133000</fldm:NonCashRightOfUseAssetsAndLeaseLiabilities>
    <fldm:NonCashRightOfUseAssetsAndLeaseLiabilities
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNTEtNC0xLTEtNTMzNTU_14a4fa7a-b87a-456c-8974-0baf77f4e469"
      unitRef="usd">0</fldm:NonCashRightOfUseAssetsAndLeaseLiabilities>
    <fldm:AssetRetirementObligationsIncurredButNotYetPaid
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNTMtMi0xLTEtNTMzNTU_e023fdb8-8e35-4afe-a2da-fe0dd71b7a95"
      unitRef="usd">722000</fldm:AssetRetirementObligationsIncurredButNotYetPaid>
    <fldm:AssetRetirementObligationsIncurredButNotYetPaid
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yOC9mcmFnOjIzMGU3OWE2ZTBhNDQ5ZTg4MTA5OWY1YzM1ZjU2YjljL3RhYmxlOmZiN2NhZDAxMmIzMzQyYzFhYWVjMzZjYjk5ZGIyZDNmL3RhYmxlcmFuZ2U6ZmI3Y2FkMDEyYjMzNDJjMWFhZWMzNmNiOTlkYjJkM2ZfNTMtNC0xLTEtNTMzNTU_71222623-d11f-46e3-9924-397b29008f74"
      unitRef="usd">324000</fldm:AssetRetirementObligationsIncurredButNotYetPaid>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNC9mcmFnOmJlNDMxODJlM2ExZjRkNGQ5OTRkYzczNDhlZDQyMmRkL3RleHRyZWdpb246YmU0MzE4MmUzYTFmNGQ0ZDk5NGRjNzM0OGVkNDIyZGRfODk2_a14828b8-9066-4174-a95f-1703c3035720">Description of BusinessStandard BioTools Inc. (Standard BioTools, the Company, we, our or us), previously known as Fluidigm Corporation, is driven by a bold vision &#x2013; unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, we provide reliable and repeatable insights in health and disease using our proprietary mass cytometry and microfluidics technologies that help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022, in connection with the completion of the private placement issuance discussed in Note 3. The Company was founded in 1999 and is headquartered in South San Francisco, California.</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcxMjQ_d59e8608-5da4-4ea6-835d-080e98512cd7">Summary of Significant Accounting Policies&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation and Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of March&#160;31, 2022, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, Italy, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the audited financial statements and the related notes for the year ended December&#160;31, 2021 included in our annual report on Form 10-K, filed with the SEC on&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; March 8, 2022, we disclosed that we had performed an assessment to determine whether there were conditions or events, considered in the aggregate, that raised substantial doubt about our ability to continue as a going concern for at least the twelve-month period following the date the financial statements were issued. We believed that our then-current level of cash and cash equivalents, together with committed financing facilities, were not sufficient to fund ongoing operations for at least the twelve-month period after the financial statements are issued. Since then, we have closed the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$225 million Series B Preferred Equity Financing, as defined in Note 3, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;that was previously disclosed in Note 18 to our audited financial statements for the year ended December 31, 2021 as contingent on stockholder approval. The completion of this financing has eliminated the doubt about the Company&#x2019;s ability to continue as a going concern. See Note 3 and Note 17 for further discussion. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior period amounts in the condensed consolidated financial statements were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders&#x2019; equity, total revenue, total costs and expenses, loss from operations or net loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unaudited Interim Financial Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim condensed consolidated financial statements and related disclosures are unaudited, have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair statement of the results of operations for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The year-end condensed consolidated balance sheet was derived from audited financial statements, but does not include all &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;disclosures required by U.S. GAAP. The condensed consolidated results of operations for the three months ended March&#160;31, 2022 are not necessarily indicative of the results to be expected for the full year or for any other year or interim period. The accompanying condensed consolidated financial statements should be read in conjunction with the audited financial statements and the related notes for the year ended December&#160;31, 2021 included in our annual report on Form 10-K, filed with the SEC on March&#160;8, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information, including the unknown impact of COVID-19 and the war in Ukraine. Accounting matters that rely on forecasted financial information included, but were not limited to, our inventory, and related reserves, and the carrying value of goodwill and other long-lived assets and liabilities. Actual results could differ materially from these estimates and could have a material adverse effect on our condensed consolidated financial statements. We also use significant judgment in determining the fair value of financial instruments, including the Bridge Loans, forward contracts on Series B Preferred Stock and other debt and equity instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign Currency&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. Income and expense accounts are translated at monthly average exchange rates during the year. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders&#x2019; equity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Private Placement Issuance &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;See Note 3 for a detailed discussion of the transactions, including the accounting treatment, and additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Comprehensive Loss &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) generally consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The component of accumulated other comprehensive loss, net of tax, for the three months ended March&#160;31, 2022 is as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Loss per Share &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options, restricted stock units and performance awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bridge Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Convertible Preferred Stock Purchase Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Convertible Notes potential make-whole shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2014 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Potentially dilutive securities in the above table include the impact of the Bridge Loans and the Series B Convertible Preferred Stock Purchase Agreements, defined in Note 3.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; See Note 3 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Changes and Accounti&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ng Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adoption of New Accounting Guidance &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2020, the FASB issued ASU 2020-06 Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. The amendment to this ASU reduces the number of accounting models for convertible instruments and allows more contracts to qualify for equity classification, which is expected to result in more convertible instruments being accounted for as a single unit, rather than being bifurcated between debt and equity. The new guidance is effective for fiscal years beginning after December 15, 2021. The Company adopted ASU 2020-06 effective January 1, 2022. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The adoption of ASU 2020-06 did not have an impact on the Company&#x2019;s 2014 and 2019 Convertible Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In November 2021, the FASB issued ASU 2021-10 Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. The amendment is effective for annual periods beginning after December 15, 2021. The amendment establishes financial disclosure requirements for business entities that receive government assistance that the entities account for by analogizing to a grant or contribution model because there is no specific authoritative guidance under U.S. GAAP that applies to the transaction. Entities that receive this type of assistance should include the following information in their annual report: (1) the nature of the transaction, (2) the significant terms and conditions, (3) the accounting treatment, (4) the line items on the balance sheet and income statement that are affected along with (5) the respective amounts that have been recorded. The Company adopted ASU 2021-10 effective January 1, 2022. The adoption of ASU 2021-10 did not have a material impact on the Company&#x2019;s financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;None</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcwNjM_db2c8e9c-8c3d-414c-8056-c1d421ac7654">&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation and Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying condensed consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include the accounts of our wholly owned subsidiaries. As of March&#160;31, 2022, we had wholly owned subsidiaries in Singapore, Canada, the Netherlands, Japan, France, Italy, the United Kingdom, China, Germany and Norway. All subsidiaries, except for Singapore, use their local currency as their functional currency. The Singapore subsidiary uses the U.S. dollar as its functional currency. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the audited financial statements and the related notes for the year ended December&#160;31, 2021 included in our annual report on Form 10-K, filed with the SEC on&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; March 8, 2022, we disclosed that we had performed an assessment to determine whether there were conditions or events, considered in the aggregate, that raised substantial doubt about our ability to continue as a going concern for at least the twelve-month period following the date the financial statements were issued. We believed that our then-current level of cash and cash equivalents, together with committed financing facilities, were not sufficient to fund ongoing operations for at least the twelve-month period after the financial statements are issued. Since then, we have closed the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$225 million Series B Preferred Equity Financing, as defined in Note 3, &lt;/span&gt;that was previously disclosed in Note 18 to our audited financial statements for the year ended December 31, 2021 as contingent on stockholder approval. The completion of this financing has eliminated the doubt about the Company&#x2019;s ability to continue as a going concern.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMzg0ODI5MDc3MTcyMA_aab068cd-08a6-42ea-9f44-f04ef82b107f"
      unitRef="usd">225000000</us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcwNjE_760bf02f-a4ab-4207-afee-55a0ba4ea27e">Certain prior period amounts in the condensed consolidated financial statements were reclassified to conform with the current period presentation. These reclassifications were immaterial and did not affect prior period total assets, total liabilities, stockholders&#x2019; equity, total revenue, total costs and expenses, loss from operations or net loss.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcwMzM_6eccfffa-84c0-421e-8611-3167f8480622">&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions believed to be reasonable, which together form the basis for making judgments about the carrying values of assets and liabilities. The full extent to which the COVID-19 pandemic impacts our business, results of operations and financial condition will depend on numerous evolving factors including, but not limited to, the magnitude and duration of the pandemic, the extent to which it will impact worldwide macroeconomic conditions, including the speed of recovery, and governmental and business reactions to the pandemic. We assessed certain accounting matters that generally require consideration of forecasted financial information, including the unknown impact of COVID-19 and the war in Ukraine. Accounting matters that rely on forecasted financial information included, but were not limited to, our inventory, and related reserves, and the carrying value of goodwill and other long-lived assets and liabilities. Actual results could differ materially from these estimates and could have a material adverse effect on our condensed consolidated financial statements. We also use significant judgment in determining the fair value of financial instruments, including the Bridge Loans, forward contracts on Series B Preferred Stock and other debt and equity instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcwOTg_987755de-5d90-46e1-bf8c-eced01fcd3ca">Foreign CurrencyAssets and liabilities of non-U.S. subsidiaries that use the local currency as their functional currency are translated into U.S. dollars at exchange rates in effect on the balance sheet date. Income and expense accounts are translated at monthly average exchange rates during the year. The adjustments resulting from the foreign currency translations are recorded in accumulated other comprehensive loss, a separate component of stockholders&#x2019; equity.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcxMjk_3dec69da-645a-4576-93e5-7d45f7fc5558">&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Comprehensive Loss &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive loss is comprised of net loss and other comprehensive income (loss). Other comprehensive income (loss) generally consists of unrealized gains and losses on our investments and foreign currency translation adjustments. Total comprehensive loss for all periods presented has been disclosed in the condensed consolidated statements of comprehensive loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcxMjA_577b9c12-77c3-44d9-b3a1-8c0d522339b5">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The component of accumulated other comprehensive loss, net of tax, for the three months ended March&#160;31, 2022 is as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i26bb80925b7243dd86ac47e3aa792a15_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMS0yLTEtMS01MzM1NQ_5bba66e1-8adc-4bbb-899a-d74235d65ff2"
      unitRef="usd">-907000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6927dcea8afc4590868e910c711eb950_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMS00LTEtMS01MzM1NQ_43d5e1ae-12dd-4639-8aa3-09da425822f1"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3062eea440bb4b8abee952bb6d8f666f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMS02LTEtMS01MzM1NQ_50ece547-fbcb-4e87-b21e-8981cd149d2c"
      unitRef="usd">-907000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i32573a3e0127457ab8cd1f21b8706b01_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMi0yLTEtMS01MzM1NQ_7bcca162-c83f-4309-a4d2-206509c8f6bc"
      unitRef="usd">-150000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib7cbdf74105f4c63acc93bf88685787f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMi00LTEtMS01MzM1NQ_5fdf373d-abd7-4e3b-ae0b-bb1521c9d351"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMi02LTEtMS01MzM1NQ_b2117c5d-61ff-49bd-b646-caf595cc5470"
      unitRef="usd">-150000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i1bf7ca99df7546ac8f6f641356b6669f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMy0yLTEtMS01MzM1NQ_d9b68cf6-7134-4a9e-a1a6-42a440083b8a"
      unitRef="usd">-1057000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifb59364bf80942a7b409ac934e71fc8d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMy00LTEtMS01MzM1NQ_746c391b-80b6-4461-9c6c-0e41cae5e04e"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ieaeae6add4f148cd8e2a749b602bcc59_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjc3YTg2YmRkNjVhNjQ3MTQ4MzA3NmNkZGJjMTkwNTU5L3RhYmxlcmFuZ2U6NzdhODZiZGQ2NWE2NDcxNDgzMDc2Y2RkYmMxOTA1NTlfMy02LTEtMS01MzM1NQ_f5489075-c5e5-469c-a46b-4b8d2d7f2344"
      unitRef="usd">-1057000</us-gaap:StockholdersEquity>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcwNzY_52690d15-1bee-4025-81c3-9396b307033c">&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Loss per Share &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of shares of common stock outstanding for the period.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcwNTI_afe1f39d-849a-4100-9635-88126e9887c6">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive common shares were excluded from the computations of diluted net loss per share for the periods presented because including them would have been anti-dilutive (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options, restricted stock units and performance awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bridge Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B Convertible Preferred Stock Purchase Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Convertible Notes potential make-whole shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2014 Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if4590fb02726433eac6b072086045564_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfMi0yLTEtMS01MzM1NQ_d9abd94b-3f2f-4d54-9f22-9120a46476a5"
      unitRef="shares">7988000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0922be352f994b20b3f553c5fd67b357_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfMi00LTEtMS01MzM1NQ_11787f76-88f6-450a-99fb-f52178441b77"
      unitRef="shares">6974000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1870e9c226e845e4aed6768f8701a354_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfMy0yLTEtMS02OTU0Mg_5737ee90-f7de-4aeb-9482-9f24792868aa"
      unitRef="shares">8979000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i27af03e024e04f15ba5f16d8c26d2c92_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfMy00LTEtMS02OTU0Mg_86daf7ac-4f04-4e27-89d2-a56de01fc688"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6548c4721969408e92076ddc5ec286a8_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNC0yLTEtMS03ODQ3OQ_c6ac96dd-a348-4e67-aaca-d7b628bf22ea"
      unitRef="shares">66176000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i033e8053b42848b5b5fc39a8d349706c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNC00LTEtMS03ODQ3OQ_36f35aa3-614b-457a-9afd-606d49b232d2"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia1a5805104194441bb995ef05eee862f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfMy0yLTEtMS01MzM1NQ_fd26ae0c-fe8f-427a-9543-ae41242d93d2"
      unitRef="shares">18966000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic2fc67f467ba494384ae37dc00e28c5f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfMy00LTEtMS01MzM1NQ_4568986f-60e0-4b86-8033-3d70dda6ca7f"
      unitRef="shares">18966000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i02bbc839aff04cb6b76120a51050ad62_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNC0yLTEtMS01MzM1NQ_c9504e7b-30b0-4de5-a38a-cfa765a41348"
      unitRef="shares">1775000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib249f81dacbc44039cd73fb307a2440a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNC00LTEtMS01MzM1NQ_1f61151d-ee6a-4992-8f26-b52981822fe0"
      unitRef="shares">1538000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i969516905a714099b6f6cbab3a226bb5_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNS0yLTEtMS01MzM1NQ_c00c42c4-a482-41bb-97c1-7b08487256bb"
      unitRef="shares">10000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia023da1bf6d94cddb5bfc0acd240aef6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNS00LTEtMS01MzM1NQ_01a06216-c250-4292-a370-2ace7e7b600c"
      unitRef="shares">10000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNi0yLTEtMS01MzM1NQ_5942e087-9c38-4cff-ad16-fa1bc038a2b2"
      unitRef="shares">103894000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RhYmxlOjYwZWQxNzY4MzM4ODQxNmZhMzUyMWY1ZTY0YWE4YWIzL3RhYmxlcmFuZ2U6NjBlZDE3NjgzMzg4NDE2ZmEzNTIxZjVlNjRhYThhYjNfNi00LTEtMS01MzM1NQ_f90910d0-dcd1-4b9f-875a-be156b6c897a"
      unitRef="shares">27488000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8zNy9mcmFnOmRkOWFhYTUwMWI2NDRmYzNiNjI2ZDQyNjZmNmM0M2NlL3RleHRyZWdpb246ZGQ5YWFhNTAxYjY0NGZjM2I2MjZkNDI2NmY2YzQzY2VfMjcxMDU_e7dc588a-839d-4267-b3f5-bb2494f498fc">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Changes and Accounti&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ng Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Adoption of New Accounting Guidance &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2020, the FASB issued ASU 2020-06 Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity. The amendment to this ASU reduces the number of accounting models for convertible instruments and allows more contracts to qualify for equity classification, which is expected to result in more convertible instruments being accounted for as a single unit, rather than being bifurcated between debt and equity. The new guidance is effective for fiscal years beginning after December 15, 2021. The Company adopted ASU 2020-06 effective January 1, 2022. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The adoption of ASU 2020-06 did not have an impact on the Company&#x2019;s 2014 and 2019 Convertible Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In November 2021, the FASB issued ASU 2021-10 Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. The amendment is effective for annual periods beginning after December 15, 2021. The amendment establishes financial disclosure requirements for business entities that receive government assistance that the entities account for by analogizing to a grant or contribution model because there is no specific authoritative guidance under U.S. GAAP that applies to the transaction. Entities that receive this type of assistance should include the following information in their annual report: (1) the nature of the transaction, (2) the significant terms and conditions, (3) the accounting treatment, (4) the line items on the balance sheet and income statement that are affected along with (5) the respective amounts that have been recorded. The Company adopted ASU 2021-10 effective January 1, 2022. The adoption of ASU 2021-10 did not have a material impact on the Company&#x2019;s financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;None.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <fldm:DebtAndEquityIssuanceTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM18xMjA5NDYyODAyMjQ3Ng_0937c14b-c83f-4831-ad4f-bddb5a5b1a36">Private Placement Issuance&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Overview of Transactions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 23, 2022, we entered into (i) a Loan Agreement (the Casdin Bridge Loan Agreement) with Casdin Private Growth Equity Fund II, L.P. and Casdin Partners Master Fund, L.P. (collectively, Casdin) and (ii) a Loan Agreement (the Viking Bridge Loan Agreement, and together with the Casdin Bridge Loan Agreement, the Bridge Loan Agreements) with Viking Global Opportunities Illiquid Investments Sub-Master LP and Viking Global Opportunities Drawdown (Aggregator) LP (collectively, Viking and, together with Casdin, the Purchasers and each, a Purchaser). Each Bridge Loan Agreement provided for a $12.5&#160;million term loan (the Bridge Loans) to the Company. The Bridge Loans were fully drawn on January 24, 2022. The Bridge Loans automatically converted into Series B Preferred Stock, defined below, upon the completion of the Preferred Equity Financ&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ing, defined below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also on January 23, 2022, we entered into separate Series B Convertible Preferred Stock Purchase Agreements (the Purchase Agreements) with each of Casdin and Viking pursuant to which at the closing of the transactions contemplated thereby, and on the terms and subject to the conditions set forth therein, including the approval of our stockholders, we issued and sold an aggregate of $225 million of convertible preferred stock on April 4, 2022, consisting of: (i) 112,500 shares of the Company&#x2019;s Series B-1 Convertible Preferred Stock, par value $0.001 per share (the Series B-1 Preferred Stock), at a purchase &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;price of $1,000 per share to Casdin; and (ii) 112,500 shares of the Company&#x2019;s Series B-2 Convertible Preferred Stock, par value $0.001 per share (the Series B-2 Preferred Stock, and together with the Series B-1 Preferred Stock, the Series B Preferred Stock) at a purchase price of $1,000 per share to Viking (the Preferred Equity Financing, and together with the issuance of shares of Series B Preferred Stock in connection with the conversion of the Bridge Loans, the Private Placement Issuance). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The rights, preferences and privileges of the Series B Preferred Stock are set forth in the Series B-1 Certificate of Designations and Series B-2 Certificate of Designations (collectively, the Series B Certificates of Designations), each as defined in the respective Purchase Agreements. The Series B Preferred Stock ranks senior to our common stock with respect to dividend rights, redemption rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. The holders of Series B Preferred Stock are entitled to participate in all dividends declared on our common stock on an as-converted basis, on the terms and subject to the conditions set forth in the Series B &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certificates of Designations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our board of directors (the Board) called a meeting (Special Meeting) to ask our stockholders to consider, vote upon and approve (i) a proposal to amend the Company&#x2019;s Eighth Amended and Restated Certificate of Incorporation (the Charter) to, among other things, increase the number of shares of common stock, par value $0.001 per share, that we are authorized to issue from two hundred million (200,000,000) shares to four hundred million (400,000,000) shares and to change the Company&#x2019;s name to Standard BioTools Inc. (the Charter Amendment Proposal); (ii) a proposal to approve, in accordance with Nasdaq Listing Rule 5635, the issuance of (A) the Series B-1 Preferred Stock and the Series B-2 Preferred Stock pursuant to the Purchase Agreements, (B) the Series B-1 Preferred Stock and the Series B-2 Preferred Stock issuable pursuant to the terms of the Bridge Loan Agreements and (C) the common stock issuable upon the conversion of the Series B Preferred Stock (the Private Placement Issuance Proposal); and (iii) a proposal to adjourn the Special Meeting if the Special Meeting were convened and a quorum were present, but there were not sufficient votes to approve the Charter Amendment Proposal and the Private Placement Issuance Proposal (the Adjournment Proposal, and, together with the Private Placement Issuance Proposal and the Charter Amendment Proposal, the Stockholder Proposals). Each of the Private Placement Issuance Proposal and Charter Amendment Proposal were conditioned on the approval of the other proposal, and neither proposal would take effect unless both were approved by our stockholders. Our stockholders approved the Charter Amendment Proposal and Private Placement Issuance Proposal on April 1, 2022. The Private Placement Issuance closed on April 4, 2022. The proceeds of the Private Placement Issuance have been and will be used to fund expenses related to the Private Placement Issuance, as well as working capital, general corporate purposes and potential future merger and acquisition opportunities that we may identify from time to time. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Bridge Loans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to their conversion, the Bridge Loans bore interest (i) from and including the effective date of the Bridge Loan Agreements to but excluding March 1, 2022, at 10%, (ii) from and including March 1, 2022 to but excluding June 1, 2022, at 12%, (iii) from and including June 1, 2022 to but excluding September 1, 2022, at 14%, and (iv) from and including September 1, 2022 and thereafter, at 16%. Interest accrued daily and was payable in kind by adding the accrued interest to the outstanding principal amount. Unless earlier converted, the outstanding principal amount of the Bridge Loans (inclusive of principal and accrued and unpaid interest) was due and payable in cash on the maturity date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Bridge Loans automatically converted into Series B Preferred Stock upon the issuance of the shares of Series B Preferred Stock pursuant to the Purchase Agreements, in accordance with the terms of the Bridge Loan Agreements. The Bridge Loans converted into a number of shares of Series B Preferred Stock equal to (i) the then outstanding principal amount of the applicable Bridge Loan (including any interest added to the original principal amount thereof) plus accrued and unpaid interest (together, the Conversion Amount) on the Bridge Loans divided by $1,000 multiplied by (ii) the Conversion Price (as defined in the Series B Certificates of Designations) divided by $2.84. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Series B Preferred Stock had not been approved for issuance by our stockholders, or the Purchase Agreements were terminated, then the Bridge Loans would have become convertible, at each lender&#x2019;s option, into common stock, par value $0.001 per share, of the Company at an initial conversion rate of 352.1126 shares of common stock per $1,000 of the Conversion Amount, subject to the cap set forth in the Bridge Loan Agreements. Unless earlier converted, the Bridge Loans, inclusive of principal and accrued and unpaid interest, would have become due and payable in cash on the maturity date. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The maturity date of the Bridge Loans was 91 days after the maturity date of the Term Loan Facility as defined in Note 9. The latest possible maturity date of the Bridge Loans was September 30, 2025. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The conversion rate was subject to customary adjustments as set forth in the Bridge Loan Agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of the Bridge Loans is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued and unpaid interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Conversion amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized loss on Bridge Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of Bridge Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Applying the guidance in ASC 825, we elected to record the Bridge Loans at their fair value. The change in fair value of the Bridge Loans from $25.0 million at inception to $35.7 million as of March&#160;31, 2022, including the portion attributable to accrued interest, is reflected as a non-operating unrealized loss on the Bridge Loans in the accompanying consolidated statement of operations. In addition, as required under the fair value option, issuance costs associated with the debt of $0.2 million were recognized in selling, general and administrative expenses in the first quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unrealized loss on the Bridge Loans was largely driven by an increase in the price of our common stock from $2.84 per share at inception to $3.59 per share as of March&#160;31, 2022, and, to a lesser extent, to the change in value of the various conversion options under the Approval Scenario, discussed below. We employed a probability&#x2010;weighted expected return method in our valuation analysis of the Bridge Loans. Specifically, our analysis contemplated two scenarios: 1) our stockholders approve the transaction (Approval Scenario) and 2) our stockholders do not approve the transaction (Disapproval Scenario). To estimate the fair value of the Bridge Loans pursuant to the Approval Scenario, we employed a Monte Carlo Simulation (MCS) analysis based on the underlying Series B Preferred Stock into which the Bridge Loans were convertible. Given the convertibility of the Series B Preferred Stock into cash or our common stock, our MCS analysis simulated the value of the Series B Preferred Stock using a random&#x2010;walk process that incorporated the various provisions of the Series B Preferred Stock discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Series B Convertible Preferred Stock Purchase Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Purchase Agreements for the issuance of 225,000 shares of Series B Preferred Stock for $225 million at a future date, have been accounted for as forward sales contracts at fair value in accordance with ASC 480 because the Series B Preferred Stock includes certain contingent redemption features which create an obligation for the Company to repurchase its shares. The fair values of the forward sales contracts were determined using the MCS analysis discussed above. As noted above, given the convertibility of the Series B Preferred Stock into cash or our common stock under several scenarios, the MCS analysis simulated the value of our common stock and the resulting impact on the value of Series B Preferred Stock, given the various provisions discussed below. The fair value of 225,000 shares of Series B Preferred Stock was determined to be $262.8 million as of March&#160;31, 2022. The $37.8 million difference between the fair value of the Series B Preferred Stock of $262.8 million and the par value of $225 million represents the value of the forward sales contracts and is recorded on the condensed consolidated balance sheet in non-current liabilities, while the change in the fair value of the forward sales contracts is&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; included in non-operating income in the condensed consolidated statement of operations for the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; March&#160;31, 2022. The increase in the fair value of the Series B Preferred Stock from January 23, 2022 to March 31, 2022 reflects the increase in the price of our common stock since the inception of the contracts through March 31, 2022, and the value of the various conversion rights and key provisions discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series B Certificates of Designations contain several conversion rights and other key provisions described below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Holder Voluntary Conversion Rights &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series B Preferred Stock is convertible at the option of the holders thereof at any time into a number of shares of common stock equal to the Conversion Rate (as defined in the Series B Certificates of Designations), which is initially 294.1176 shares of common stock per share of Series B Preferred Stock, in each case subject to certain adjustments and certain limitations on conversion. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Issuer Call Provision&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At any time after the fifth anniversary of the closing of the Private Placement Issuance, if the last reported sale price of the common stock is greater than 250% of the Conversion Price (as defined in the Series B Certificates of Designations) as of such time for at least 20 consecutive trading days, we may elect to convert all of the outstanding shares of Series B Preferred Stock into shares of common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Issuer Redemption Provision&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After the seventh anniversary of the closing of the Private Placement Issuance, subject to certain conditions, we may, at our option, redeem all of the outstanding shares of Series B Preferred Stock at a redemption price per share of Series B Preferred Stock, payable in cash, equal to the Liquidation Preference (as defined in the Series B Certificates of Designations). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Change of Control Provisions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we undergo certain change of control transactions, each holder of outstanding shares of Series B Preferred Stock will have the option, subject to the holder&#x2019;s right to convert all or a portion of the shares of Series B Preferred Stock held by such holder into common stock, to require us to purchase all or a portion of such holder&#x2019;s outstanding shares of Series B Preferred Stock that have not been converted into common stock at a purchase price per share of Series B Preferred Stock, payable in cash, equal to the greater of (A) the Liquidation Preference of such share of Series B Preferred Stock, and (B) the amount of cash and/or other assets that such holder would have been entitled to receive if such holder had converted such share of Series B Preferred Stock into common stock immediately prior to the change of control transaction (Change of Control Put).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the event of a change of control in which we are not expected to be the surviving corporation or if the common stock will no longer be listed on a U.S. national securities exchange, we will have a right to redeem, subject to the holder&#x2019;s right to convert into common stock prior to such redemption, all of such holder&#x2019;s shares of Series B Preferred Stock, or if a holder exercises the Change of Control Put in part, the remainder of such holder&#x2019;s shares of Series B Preferred Stock, at a redemption price per share payable in cash, equal to the greater of (A) the Liquidation Preference of such share of Series B Preferred Stock, and (B) the amount of cash and/or other assets that the holder would have received if such holder had converted such share of Series B Preferred Stock into common stock immediately prior to the change of control transaction. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liquidation Rights &lt;/span&gt;&lt;/div&gt;In the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, the Series B Preferred Stock has a liquidation preference equal to the greater of (i) the Liquidation Preference (as defined in the Series B Certificates of Designations, currently $3.40) and (ii) the amount per share of Series B Preferred Stock that such holder would have received had all holders of Series B Preferred Stock, immediately prior to such voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company, converted all shares of Series B Preferred Stock into common stock pursuant to the terms of the Series B Certificates of Designations (without regard to any limitations on conversion contained therein).</fldm:DebtAndEquityIssuanceTextBlock>
    <fldm:DebtInstrumentFaceAmountPerInstrument
      contextRef="i886c80d6b2014617accd5fb486b0da62_I20220123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjAz_b9c2ef5c-b61c-45ef-9138-c355f8bffaea"
      unitRef="usd">12500000</fldm:DebtInstrumentFaceAmountPerInstrument>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i5a6c6bdfb4274d13b3f7a97a1f9a2bcd_D20220404-20220404"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjEz_b58b9cb7-0f9a-423e-b710-a21395a2f52a"
      unitRef="usd">225000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i56ff172b378c40bfa9fb091517220986_D20220404-20220404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjIx_b4248fc0-fbda-4d97-9531-0bdbdc26ae09"
      unitRef="shares">112500</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ifb221a8d5f7b4664a321c4333783b5a8_I20220404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjI1_08404dca-6c4f-499d-ab48-af4fe4da43f1"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ifb221a8d5f7b4664a321c4333783b5a8_I20220404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjMx_997e62eb-af97-4774-80bc-8860533680c8"
      unitRef="usdPerShare">1000</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ie16dc5fbce7344098cb3d3224ce907b0_D20220404-20220404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjM1_25c5b8ae-e068-4a8c-b44a-0abcbfc14379"
      unitRef="shares">112500</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib2c825e393d44392a0cdda4dde9c896c_I20220404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjQ0_938cff01-2adf-41ac-8860-c47ad6831765"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ib2c825e393d44392a0cdda4dde9c896c_I20220404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjQ4_bfdf3dbe-b2ea-427e-9415-6f82d13f465b"
      unitRef="usdPerShare">1000</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib3c3e7b51c6f444eb205479e022d6700_I20220404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjUx_e8c18c38-923d-4e9b-81ab-2a16a39a79b3"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic68aad560626482181eb728c71653aff_I20220403"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjU2_50729308-8560-4787-baf6-2e36867755c0"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib3c3e7b51c6f444eb205479e022d6700_I20220404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjYw_308ee6a1-e52e-4543-866d-92e31a7fcc29"
      unitRef="shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i77616e0764104572bb6724b63bf8ab85_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjY0_ff7a0bc5-c511-42d5-aa5f-1361264a5ec8"
      unitRef="number">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2f4791be67494f768846d8731311ee82_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjY3_116d5a35-1c86-4f2b-856b-f3d734bbc304"
      unitRef="number">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib91f694990c84e7b80102a9d2003a94f_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjcx_a61ffeda-5810-472b-b4c9-77fe747b607d"
      unitRef="number">0.14</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8289410ad96c48e9a79c0ea4d1093e35_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjc2_1f88b102-7c00-4c45-beca-174a2a852b8d"
      unitRef="number">0.16</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <fldm:DebtInstrumentConvertibleCalculationToDetermineSharesIssued
      contextRef="i886c80d6b2014617accd5fb486b0da62_I20220123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMjg2_b485df41-db0d-45f1-bc94-b3f2ef669b79"
      unitRef="usd">1000</fldm:DebtInstrumentConvertibleCalculationToDetermineSharesIssued>
    <fldm:DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor
      contextRef="i886c80d6b2014617accd5fb486b0da62_I20220123"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMzAw_0ecc4594-25cd-43ec-8683-ae69b42b224c"
      unitRef="number">2.84</fldm:DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ibe298cbdde5842d1abc79d95ddf9275c_I20220123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMzA0_54452627-7737-4687-aaa0-b47250f4f19a"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM18xMjA5NDYyODAyMjQyMA_3fde1789-3aab-4953-8faf-d6570ef9ebaf">&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of the Bridge Loans is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued and unpaid interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Conversion amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized loss on Bridge Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of Bridge Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl8xLTItMS0xLTc1OTM1_19613c2f-1ad1-4d68-9e39-f3212a3ea041"
      unitRef="usd">25000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib0ed4fcc32994c51a64df27a56bebe58_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl8xLTQtMS0xLTc1OTM1_bb959255-462f-4b3e-b944-8e698d54054e"
      unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl8yLTItMS0xLTc1OTM1_82f2832b-b3c2-4e69-bca5-4524e0844fa2"
      unitRef="usd">499000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="ib0ed4fcc32994c51a64df27a56bebe58_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl8yLTQtMS0xLTc1OTM1_3f07f1a7-54cf-4bbc-843f-7d772a7d1ab0"
      unitRef="usd">0</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="icdfcd99ed0d44886aa6f217791a9b7b2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl8zLTItMS0xLTc1OTM1_92b020ac-f8e2-4351-a5e0-7168900d0a8b"
      unitRef="usd">25499000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="i17f98442bfed4b7c9e994c9fd18a4bc3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl8zLTQtMS0xLTc1OTM1_f1657939-1a9e-4ffd-97a8-90fd2ba54b49"
      unitRef="usd">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtSecuritiesUnrealizedGainLoss
      contextRef="icdfcd99ed0d44886aa6f217791a9b7b2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl80LTItMS0xLTc1OTM1_ed8e4809-eb07-40ac-82fd-999618905b88"
      unitRef="usd">-10156000</us-gaap:DebtSecuritiesUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesUnrealizedGainLoss
      contextRef="i17f98442bfed4b7c9e994c9fd18a4bc3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl80LTQtMS0xLTc1OTM1_a2a77826-4347-409b-b8e1-98f895e071fc"
      unitRef="usd">0</us-gaap:DebtSecuritiesUnrealizedGainLoss>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl81LTItMS0xLTc1OTM1_9ba819c2-4e1f-4e80-a826-db1b40316543"
      unitRef="usd">35655000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib0ed4fcc32994c51a64df27a56bebe58_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGFibGU6OGJkYmFmY2FjODVmNDY4YTg2MzE5YjBjMjk3YjI0MzIvdGFibGVyYW5nZTo4YmRiYWZjYWM4NWY0NjhhODYzMTliMGMyOTdiMjQzMl81LTQtMS0xLTc1OTM1_f48d6830-1949-4bf6-b22b-6c71226be24d"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i886c80d6b2014617accd5fb486b0da62_I20220123"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgzMTE3_ff36dc8b-9694-4d75-aa41-6a95b103e12d"
      unitRef="usd">25000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNTEy_7c0f6df6-a551-46c8-a634-79eb311e7103"
      unitRef="usd">35700000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM18zODQ4MjkwODMxMTMz_2372fd06-17a8-49f7-abdc-b10e660d98c7"
      unitRef="usd">200000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:SharePrice
      contextRef="ibe298cbdde5842d1abc79d95ddf9275c_I20220123"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMzQ0_3d7ce022-0d7b-48dd-8d4c-dcf480fb7721"
      unitRef="usdPerShare">2.84</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMzUy_da53dc0a-7304-4288-a4c5-ab5100605b6f"
      unitRef="usdPerShare">3.59</us-gaap:SharePrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="iedc9287f43ef4070913785190e868b4a_D20220123-20220123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMzYx_c488a0f4-48f8-4c61-9f32-c34d61d3d1bb"
      unitRef="shares">225000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i4cc0a83a704c446185dfcd2f538f5b2e_D20220123-20220123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxMzY2_61ec8612-56e3-4a55-8a9a-f4a896551de1"
      unitRef="usd">225000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="iedc9287f43ef4070913785190e868b4a_D20220123-20220123"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDM5_6d529e01-af7e-4d7b-a6da-d336adaf51b1"
      unitRef="shares">225000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <fldm:PreferredStockFairValueDisclosure
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDU5_04a7ab21-6272-41fb-abf2-e60101a24316"
      unitRef="usd">262800000</fldm:PreferredStockFairValueDisclosure>
    <fldm:StockRepurchaseLiability
      contextRef="i2127000202e94f0988bb0ca0fe40e66b_I20220123"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDg2MjAx_9dd2c49a-4353-4547-8dfb-2c17dcb85352"
      unitRef="usd">37800000</fldm:StockRepurchaseLiability>
    <fldm:PreferredStockFairValueDisclosure
      contextRef="i2127000202e94f0988bb0ca0fe40e66b_I20220123"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDQz_852d5015-bcd4-4e56-a57e-27d26c93a966"
      unitRef="usd">262800000</fldm:PreferredStockFairValueDisclosure>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i4cc0a83a704c446185dfcd2f538f5b2e_D20220123-20220123"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDMw_9e2e0cbb-5219-4c04-a496-4a4eee13c9bd"
      unitRef="usd">225000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:PreferredStockConvertibleConversionRatio
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDc0_f542136f-6f4a-456d-9e37-1082c0a9092a"
      unitRef="number">294.1176</us-gaap:PreferredStockConvertibleConversionRatio>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i67531e388c0e40cdb02f90448ebfc132_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDg1_3fe2ce94-4908-454f-a840-0d3395b3c1d3"
      unitRef="number">2.50</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i67531e388c0e40cdb02f90448ebfc132_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM18xMjA5NDYyODAyMjM1NQ_bc283f98-2514-429e-9c0a-4f4f1ee83b58"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare
      contextRef="ib0ec30bb1300459287d9f22d16790089_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTkzL2ZyYWc6YTNkOWNkODIwN2I4NGM2ZGJlYjRkM2FiMDg4MTRmMzMvdGV4dHJlZ2lvbjphM2Q5Y2Q4MjA3Yjg0YzZkYmViNGQzYWIwODgxNGYzM182MDQ3MzE0MDgxNDcw_0a4a1796-dde6-4f59-8d99-4ff686c0238a"
      unitRef="usdPerShare">3.40</us-gaap:DebtInstrumentConvertibleLiquidationPreferencePerShare>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfMjc4MA_2581e0c7-1b0a-4845-ae6d-81b582b49634">NIH ContractIn 2020, we were awarded the NIH Contract under the RADx program to support the expansion of our production capacity and throughput capabilities for COVID-19 testing with our microfluidics technology. We completed the required milestones in 2021 and received the total NIH Contract value of $34.0 million. Proceeds from the NIH Contract have been used primarily for capital expenditures to expand production capacity and, to a lesser extent, to offset applicable operating costs. Grant proceeds that exceed the cost of the capital expenditures and expenses that have been and are expected to be incurred are recorded in other non-operating income.&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity under the NIH Contract as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash receipts from milestones achieved&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative amounts applied against operating costs (excluding depreciation)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative amounts applied against depreciation expense for assets placed in service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative amounts recognized as non-operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets placed in service, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative amounts applied against depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,852&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,096&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated future capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred grant income, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred grant income, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred grant income, current on the condensed consolidated balance sheet represents amounts expected to be offset against depreciation expense over the next twelve months. Deferred grant income, non-current includes amounts expected to be offset against depreciation expense in later periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expect to spend &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$22.4 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on capital expenditures associated with the NIH Contract. We have incurred $21.4 million of capital expenditures th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rough March&#160;31, 2022, of which $20.4 million has been placed in service, while the remaining $0.9 million is included in construction-in-progress (See Note 8). We expect to place the remaining equipment in service by the end of the first half of 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfNjA0NzMxMzk2MTEzMA_3087972f-a2e3-4baf-acfb-bde3a57f23ad"
      unitRef="usd">34000000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfMjc4MQ_e55ce74a-d0cf-4205-adda-42a2abeb614b">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity under the NIH Contract as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash receipts from milestones achieved&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative amounts applied against operating costs (excluding depreciation)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative amounts applied against depreciation expense for assets placed in service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative amounts recognized as non-operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets placed in service, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative amounts applied against depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,852&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,096&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Estimated future capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred grant income, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred grant income, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred grant income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMS0yLTEtMS01MzM1NQ_234f4e52-039c-45f2-85d1-a7e72a220212"
      unitRef="usd">34016000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMS00LTEtMS01MzM1NQ_dabb5258-73c8-4aea-b14d-e067cfc43bf1"
      unitRef="usd">34016000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMi0yLTEtMS01MzM1NQ_a8022c13-a49c-4365-8cb0-4cc6c65e7979"
      unitRef="usd">4526000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMi00LTEtMS01MzM1NQ_a503763f-d06e-4e7d-9d21-ac7c10a92b88"
      unitRef="usd">4522000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMy0yLTEtMS01MzM1NQ_b6dcf9ec-4d50-4c0d-b6d1-96719a139866"
      unitRef="usd">1510000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMy00LTEtMS01MzM1NQ_bac775ec-2288-4b80-a148-96e80ca58749"
      unitRef="usd">703000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfNC0yLTEtMS01MzM1NQ_9760cf29-cd76-40a2-9d23-3ec52e053c61"
      unitRef="usd">7140000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfNC00LTEtMS01MzM1NQ_f856d0f3-9d12-4c85-b33e-d7b8ea9b2107"
      unitRef="usd">7140000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome>
    <fldm:DeferredGrantRevenue
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfNS0yLTEtMS01NDkwNg_b41ded73-3437-4216-bf9a-7b0cc750fed4"
      unitRef="usd">20840000</fldm:DeferredGrantRevenue>
    <fldm:DeferredGrantRevenue
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfNS00LTEtMS01NDkwNg_960ac113-daa9-4bed-b216-e4c39f441d7a"
      unitRef="usd">21651000</fldm:DeferredGrantRevenue>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfNy0yLTEtMS01MzM1NQ_34739668-bf4d-4de1-bb5a-e638e91a7b8f"
      unitRef="usd">20425000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfNy00LTEtMS01MzM1NQ_63a28e80-b5b6-4c34-b124-8182a6cdf367"
      unitRef="usd">16890000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfOC0yLTEtMS01MzM1NQ_8edf502d-5ef1-4318-86ac-cdf2b3ead824"
      unitRef="usd">937000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfOC00LTEtMS01MzM1NQ_cd7a8617-05cd-4f10-b086-d010dc5b2fd5"
      unitRef="usd">3909000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfOS0yLTEtMS01MzM1NQ_066df34c-b62e-431a-b80d-fac65eaf5bc7"
      unitRef="usd">1510000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfOS00LTEtMS01MzM1NQ_b481f602-c5bd-4c41-b3aa-4da20b5c814c"
      unitRef="usd">703000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTEtMi0xLTEtNTQ5NDA_8971fb18-2edc-43f3-bdd9-66cc330cf7b5"
      unitRef="usd">19852000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTEtNC0xLTEtNTQ5NDA_7a807740-32f4-4cea-9899-c1da5c4ddca4"
      unitRef="usd">20096000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTMtMi0xLTEtNTQ5NDA_d861ade6-fe70-4b93-97ce-6f2232df7d31"
      unitRef="usd">988000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTMtNC0xLTEtNTQ5NDA_7bd65fe6-b1e1-440b-96c8-c69a90f4ce39"
      unitRef="usd">1555000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures>
    <fldm:DeferredGrantRevenue
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTQtMi0xLTEtNTQ5NDA_341cd3f0-5dec-4f2d-a3da-792431163de2"
      unitRef="usd">20840000</fldm:DeferredGrantRevenue>
    <fldm:DeferredGrantRevenue
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTQtNC0xLTEtNTQ5NDA_bfc60530-fbe5-48fe-9ff9-89a22b97f3e8"
      unitRef="usd">21651000</fldm:DeferredGrantRevenue>
    <fldm:DeferredGrantIncomeCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTItMi0xLTEtNTMzNTU_14f218b5-d168-4dc2-a6ad-22a08f0414dc"
      unitRef="usd">3603000</fldm:DeferredGrantIncomeCurrent>
    <fldm:DeferredGrantIncomeCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTItNC0xLTEtNTMzNTU_d0ef1480-6584-4f23-a8c4-93369038e262"
      unitRef="usd">3535000</fldm:DeferredGrantIncomeCurrent>
    <fldm:DeferredGrantIncomeNoncurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTMtMi0xLTEtNTMzNTU_1e745691-9b05-408d-91d1-9813884c10c4"
      unitRef="usd">17237000</fldm:DeferredGrantIncomeNoncurrent>
    <fldm:DeferredGrantIncomeNoncurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTMtNC0xLTEtNTMzNTU_1042096d-6276-4759-98fe-9ffe1ab88b91"
      unitRef="usd">18116000</fldm:DeferredGrantIncomeNoncurrent>
    <fldm:DeferredGrantRevenue
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTQtMi0xLTEtNTMzNTU_ea8f72e1-2b0c-44ff-9ae7-6380e087aa71"
      unitRef="usd">20840000</fldm:DeferredGrantRevenue>
    <fldm:DeferredGrantRevenue
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RhYmxlOmZkMTY5M2YwNDc3NDQ0YzZhMzQ0ZTEyOTE0Y2Q0MmZkL3RhYmxlcmFuZ2U6ZmQxNjkzZjA0Nzc0NDRjNmEzNDRlMTI5MTRjZDQyZmRfMTQtNC0xLTEtNTMzNTU_915defe0-88c0-4e0a-b97a-6277a632ec70"
      unitRef="usd">21651000</fldm:DeferredGrantRevenue>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfMTY0OTI2NzQ0ODQwOA_7d81b745-0a0c-47da-8b97-81b6190cb011"
      unitRef="usd">22400000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfMTY0OTI2NzQ0ODQwMA_87d5d659-2c47-49d8-8148-e66f54462476"
      unitRef="usd">21400000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfMTY0OTI2NzQ0ODM4MQ_dcad5b56-953b-4093-abfc-271756293d82"
      unitRef="usd">20400000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross>
    <fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80MC9mcmFnOjgzNTI0ODJhZGRhNzQwODA5NjE4MTA0OTE4MDFkMTk5L3RleHRyZWdpb246ODM1MjQ4MmFkZGE3NDA4MDk2MTgxMDQ5MTgwMWQxOTlfMTY0OTI2NzQ0ODM5MQ_0a9aa288-80e1-4552-bb31-ffbb2307e27d"
      unitRef="usd">900000</fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80My9mcmFnOjhmZGY3ZGZmZDdiOTQ0MTc5MWM5YTcxM2M3MjdlMjg2L3RleHRyZWdpb246OGZkZjdkZmZkN2I5NDQxNzkxYzlhNzEzYzcyN2UyODZfNzIz_8ccdcacd-f535-46f1-87fb-18e5d77e13ac">Development Agreement&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective March 31, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020, we signed an OEM Supply and Development Agreement (Development Agreement) with a customer. Under the Development Agreement, we developed products based on our microfluidics technology. The Development Agreement provided for up-front and periodic milestone payments during the development stage, which was completed in the third quarter of 2021, and on-going annual payments of $0.4&#160;million for sustaining efforts. We recognized $0.1 million and $1.5 million of development revenue from this agreement during the three months ended March&#160;31, 2022 and March&#160;31, 2021, respectively.&lt;/span&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <fldm:CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement
      contextRef="ia846fcc54289492ea9f2caf7da738fb2_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80My9mcmFnOjhmZGY3ZGZmZDdiOTQ0MTc5MWM5YTcxM2M3MjdlMjg2L3RleHRyZWdpb246OGZkZjdkZmZkN2I5NDQxNzkxYzlhNzEzYzcyN2UyODZfNjA0NzMxMzk1NDMyNw_a95b27e0-8830-4dc9-9e99-25ba67857c41"
      unitRef="usd">400000</fldm:CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iafdb8ef4ee9b4330a1afed79e1a6adab_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80My9mcmFnOjhmZGY3ZGZmZDdiOTQ0MTc5MWM5YTcxM2M3MjdlMjg2L3RleHRyZWdpb246OGZkZjdkZmZkN2I5NDQxNzkxYzlhNzEzYzcyN2UyODZfNDgw_33986b1a-c008-4df2-bbba-99f898341a15"
      unitRef="usd">100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3c64b4d5135043b2bf9e4a910f74a574_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80My9mcmFnOjhmZGY3ZGZmZDdiOTQ0MTc5MWM5YTcxM2M3MjdlMjg2L3RleHRyZWdpb246OGZkZjdkZmZkN2I5NDQxNzkxYzlhNzEzYzcyN2UyODZfMTY0OTI2NzQ0MjUyOQ_d00251d2-bbbf-40f2-94c8-97a5699f104a"
      unitRef="usd">1500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfMTMwOQ_3b5e07cd-7979-4e98-9f2b-95aaf39addb9">Revenue&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our revenue for the three months ended March&#160;31, 2022 and 2021 based upon geographic area and source in thousands:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Markets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Source:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;License and royalty revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unfulfilled Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We reported $17.9 million of deferred revenue on our December&#160;31, 2021 consolidated balance sheet. During the three months ended March&#160;31, 2022, $4.1 million of the opening balance was recognized as revenue and $4.3 million of net additional advance payments were received from customers, primarily associated with instrument service contracts. At March&#160;31, 2022, we reported $18.1&#160;million of deferred revenue. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed as of March&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expected Revenue &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 remainder of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the practical expedient that permits us not to disclose information about unsatisfied performance obligations for service contracts with an expected term of one year or less.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfMTMwNg_6818afed-69ef-4f5a-a416-82a738004b87">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our revenue for the three months ended March&#160;31, 2022 and 2021 based upon geographic area and source in thousands:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Geographic Markets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Source:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Development revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;License and royalty revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Grant revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f8e6499d1bf4299a4a07cd4f748586b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfMy0xLTEtMS01MzM1NQ_5f00690d-69e0-41fe-b05d-1c1d00a71a0a"
      unitRef="usd">12930000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i286841fd19da443ead3fbf7f94d46b19_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfMy0zLTEtMS01MzM1NQ_004b38dd-6e05-4d8e-b354-0c307a5151ef"
      unitRef="usd">18523000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i072ebd8279c8453f8cd2f1cb832d29fd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfNC0xLTEtMS01MzM1NQ_86b60756-311e-4e89-b8de-b0954f066893"
      unitRef="usd">8609000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i87071d29b432475bb23956adf7514f92_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfNC0zLTEtMS01MzM1NQ_51354593-f186-4dbc-9b19-5d28c385e882"
      unitRef="usd">9142000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f17be2ff1a047ea95cdaeba288d236a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfNS0xLTEtMS01MzM1NQ_69f43870-b5c8-47be-913e-71c97b4227e5"
      unitRef="usd">4965000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24e8ea78bbff495b800d3ede81174994_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfNS0zLTEtMS01MzM1NQ_5844f0e8-2bf0-4464-9001-b8eafa5407e3"
      unitRef="usd">5129000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfNi0xLTEtMS01MzM1NQ_9108577a-c265-47af-8889-215deb8c9934"
      unitRef="usd">26504000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjQ0MzU1NmE0ZGQzMDQ1NzM5YTFjZDg3ZmJhNjU4YjMwL3RhYmxlcmFuZ2U6NDQzNTU2YTRkZDMwNDU3MzlhMWNkODdmYmE2NThiMzBfNi0zLTEtMS01MzM1NQ_ab6deab1-4922-489c-a8fc-a832beb1d03b"
      unitRef="usd">32794000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a58b69e2fd947c19feffcbbf475f7fb_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNC0xLTEtMS01MzM1NQ_d44bf5dc-ddc3-4005-96ce-44c1508b58d1"
      unitRef="usd">7523000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5517c1a9f7d46acb4b2910a6e65a460_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNC0zLTEtMS01MzM1NQ_dd39fd10-c231-4327-a93d-bc959fc6a687"
      unitRef="usd">7708000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e1af6815ea14d86990d3949065312c1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNS0xLTEtMS01MzM1NQ_7dbb35ad-881f-4418-9e61-957ea2f07488"
      unitRef="usd">12481000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7dbaa6754bf146218a79d666b5fbe97b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNS0zLTEtMS01MzM1NQ_dceff6f4-0096-409e-8d56-b5b40de2c564"
      unitRef="usd">17020000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i464bfcf84ef44fa0b0e68af70cc3988f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNi0xLTEtMS01MzM1NQ_e20140b4-63cc-4e80-aa0c-d744d7c42740"
      unitRef="usd">20004000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab920cccfecf44528e9ce52d935fa63a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNi0zLTEtMS01MzM1NQ_da20f0ba-19ed-49f0-8b17-93bb0db59c16"
      unitRef="usd">24728000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i96de28bb25374cbaa71d471a786e1db3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNy0xLTEtMS01MzM1NQ_4373b148-cfec-41ad-aee0-c1ecc898dcb6"
      unitRef="usd">6144000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if6c770a450054cda9c777968afb1bca3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfNy0zLTEtMS01MzM1NQ_dc4b6eba-c11f-464d-91c7-502adc1f7859"
      unitRef="usd">6286000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a25af0ec36e425db27350cae34291e2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfOC0xLTEtMS01MzM1NQ_6c7de91c-2dc3-4d68-8c60-d2632fb6fc2a"
      unitRef="usd">88000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i50ef3b1943a5459d80af3119e547f1cc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfOC0zLTEtMS01MzM1NQ_b58b0b5f-dd80-4ad9-9f3c-78ff0e6ab107"
      unitRef="usd">1480000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iefe32db1cf564d38b50cdb165fc5cb80_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTAtMS0xLTEtNTMzNTU_b6710110-dec8-4cf1-85cb-fff40f968c45"
      unitRef="usd">268000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0afc35aeae144b7e896655ac0045040f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTAtMy0xLTEtNTMzNTU_b05dedf9-14d9-462d-a873-7fddcddab08a"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd77101528ad4efaa4764f0e88507854_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTEtMS0xLTEtNTMzNTU_c142075b-7a5e-477b-ab1e-6995da8b1fcb"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d2106e31ca44f2b930bd540e5346338_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTEtMy0xLTEtNTMzNTU_3b240da1-eecf-45dc-8dcf-388039de9871"
      unitRef="usd">300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f969efefbfa43cab57d0b0dbba8b692_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTItMS0xLTEtNTMzNTU_219edf27-8bea-414e-a093-64ebdab1736d"
      unitRef="usd">268000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37fe6c7bd98449ef8909d4137b4673a2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTItMy0xLTEtNTMzNTU_77d6d738-e5c8-40a5-9d0b-a8ee5f0118c5"
      unitRef="usd">300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTMtMS0xLTEtNTMzNTU_932e5c37-cb20-4d60-8651-b5c559c49984"
      unitRef="usd">26504000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOmE3MWRkMTlkMDdkMTRiNTZiODE2ZTNlYTU1MmUxNjMzL3RhYmxlcmFuZ2U6YTcxZGQxOWQwN2QxNGI1NmI4MTZlM2VhNTUyZTE2MzNfMTMtMy0xLTEtNTMzNTU_4deb165a-c722-48af-8755-7f0a1d21cb8c"
      unitRef="usd">32794000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfMjEw_081b4b37-d3bb-44e0-b3fa-e11ce067ed34"
      unitRef="usd">17900000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfMjg5_d251ac50-0dac-4406-a570-7779cb1fa718"
      unitRef="usd">4100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <fldm:ContractWithCustomerLiabilityIncreaseFromCashReceipts
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfMzQ1_3db03207-5e23-425d-b144-37f02a3ae8a4"
      unitRef="usd">4300000</fldm:ContractWithCustomerLiabilityIncreaseFromCashReceipts>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfNDg4_6d3bee36-5588-41ba-baee-bc5b308a1529"
      unitRef="usd">18100000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RleHRyZWdpb246NmVhODNkMjUxYTE4NDJjNWFhOGFmMjg3NmMzMjgxN2RfMTMwNw_4c903dc5-7815-4eeb-903e-2b4b6ebac149">&lt;div style="margin-top:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the expected timing of revenue recognition for unfulfilled performance obligations associated with instrument service contracts that were partially completed as of March&#160;31, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expected Revenue &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 remainder of the year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected revenue includes both billed amounts included in deferred revenue and unbilled amounts that are not reflected in our condensed consolidated financial statements and are subject to change if our customers decide to cancel or modify their contracts. Purchase orders for instrument service contracts can generally be canceled before the service period begins without penalty.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i335933a56ca64d3d94f51a90d798f76c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjlhNjdhM2U4ODNkNTRjYjk4NWRkNTM4OTU2MzlkZTJhL3RhYmxlcmFuZ2U6OWE2N2EzZTg4M2Q1NGNiOTg1ZGQ1Mzg5NTYzOWRlMmFfMS0yLTEtMS01MzM1NQ_67f3d950-f82c-48d8-b7a6-c90fc565b0c1"
      unitRef="usd">10437000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i3bcb2e193d7c4e4ba7f7c804e5ec66cd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjlhNjdhM2U4ODNkNTRjYjk4NWRkNTM4OTU2MzlkZTJhL3RhYmxlcmFuZ2U6OWE2N2EzZTg4M2Q1NGNiOTg1ZGQ1Mzg5NTYzOWRlMmFfMi0yLTEtMS01MzM1NQ_8bb9e701-4b1e-4adc-b602-5f6b800a0627"
      unitRef="usd">7004000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ibbe253446f1d4da380bb648d1169a573_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjlhNjdhM2U4ODNkNTRjYjk4NWRkNTM4OTU2MzlkZTJhL3RhYmxlcmFuZ2U6OWE2N2EzZTg4M2Q1NGNiOTg1ZGQ1Mzg5NTYzOWRlMmFfMy0yLTEtMS01MzM1NQ_522ace0e-b3d7-4300-a253-56ba105d2494"
      unitRef="usd">3678000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i48119219acbf471d93f5816373e96a28_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjlhNjdhM2U4ODNkNTRjYjk4NWRkNTM4OTU2MzlkZTJhL3RhYmxlcmFuZ2U6OWE2N2EzZTg4M2Q1NGNiOTg1ZGQ1Mzg5NTYzOWRlMmFfNC0yLTEtMS01MzM1NQ_83368405-cc7c-46bf-a1be-a0207e9150fd"
      unitRef="usd">2190000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF80Ni9mcmFnOjZlYTgzZDI1MWExODQyYzVhYThhZjI4NzZjMzI4MTdkL3RhYmxlOjlhNjdhM2U4ODNkNTRjYjk4NWRkNTM4OTU2MzlkZTJhL3RhYmxlcmFuZ2U6OWE2N2EzZTg4M2Q1NGNiOTg1ZGQ1Mzg5NTYzOWRlMmFfNS0yLTEtMS01MzM1NQ_b8545828-e10c-447c-85b9-09a0c6f815ae"
      unitRef="usd">23309000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjAyMg_6a371415-72f6-4fd9-97f7-c1d4be5252dd">Goodwill and Intangible Assets, net&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with our acquisition of DVS in February 2014, we recognized goodwill of $104.1 million and $112.0 million of developed technology. In the first quarter of 2020, we recognized $2.2 million (Euro 2.0 million) of goodwill from the InstruNor acquisition and $5.4 million (Euro 4.9 million) of developed technology. As the goodwill and developed technology from the InstruNor acquisition are recorded in the functional currency of our European operations, which is the Euro, these balances are revalued each period and the U.S. dollar value of these assets will fluctuate as foreign exchange rates change. We are amortizing InstruNor developed technology over 8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and intangible assets with indefinite lives are not subject to amortization but are tested for impairment on an annual basis during the fourth quarter or whenever events or changes in circumstances indicate the carrying amount of these assets may not be recoverable. Qualitative assessment includes assessing significant events and circumstances such as our current results, assumptions regarding future performance, strategic initiatives and overall economic factors, including the ongoing global COVID-19 pandemic and macroeconomic developments to determine the existence of potential indicators of impairment and assess if it is more likely than not that the fair value of our reporting unit or intangible assets is less than their carrying value. If indicators of impairment are identified, a quantitative impairment test is performed.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; There have been no indicators of impairment during the three months ended March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets also include other patents and licenses, which are included in other non-current assets. Intangibl&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e assets, net, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:7pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortization expense for the three months ended March&#160;31, 2022 and 2021 was $3.1 million and $3.2 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the carrying value of intangible assets as of&#160;March&#160;31, 2022, the amortization expense is expected to be as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Technology Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Patents and Licenses Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 remainder of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:Goodwill
      contextRef="i553dcb7ee7ea4ac9a75e92d924b88f3e_I20140228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMTI3_052b98aa-7cea-4845-afd3-a3f0206bd12c"
      unitRef="usd">104100000</us-gaap:Goodwill>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i830df8f0fc5846878354fcf3361da7fb_D20140201-20140228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMTQ2_e1de7618-8d86-4a8b-a702-87184d15eaaa"
      unitRef="usd">112000000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:Goodwill
      contextRef="ib03343990d404ba9a12387dbb99c7af4_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjUz_9ee7a0ec-ca22-4fd3-b274-572c017aec3b"
      unitRef="usd">2200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib03343990d404ba9a12387dbb99c7af4_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjYy_125714ec-dc27-4c3d-b5de-c92a647a0a6a"
      unitRef="eur">2000000</us-gaap:Goodwill>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i78a77be6f4bb47ae9b4e1a70ef8aba45_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjgy_f19e1ea4-1e3d-4288-b7f6-4d054a03fbef"
      unitRef="usd">5400000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:FinitelivedIntangibleAssetsAcquired1
      contextRef="i78a77be6f4bb47ae9b4e1a70ef8aba45_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjkx_e6ec9ffb-d33d-45fc-b3af-323bf85418b9"
      unitRef="eur">4900000</us-gaap:FinitelivedIntangibleAssetsAcquired1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="icd0ea5bfa71e4a248571cf351b4fbc02_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMTY0OTI2NzQ0NDU5OQ_4161c267-334f-428f-bb69-f6601bab9083">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjAxMw_7f7f5aac-1d2e-41bc-9b9a-2a6a91a001e7">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets also include other patents and licenses, which are included in other non-current assets. Intangibl&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e assets, net, were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,171)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.020%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Amortization Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMi0yLTEtMS01MzM1NQ_88e69133-641a-4132-b314-7925af843a38"
      unitRef="usd">117392000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMi00LTEtMS01MzM1NQ_2aee1674-cba3-406f-a056-79b9f357e00d"
      unitRef="usd">92517000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMi02LTEtMS01MzM1NQ_efd61c05-dc0f-440d-b3fc-c3a9e8ab9ce2"
      unitRef="usd">24875000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ic3ccc2277618429ba4dd1bf8f8ac9415_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMi04LTEtMS01MzM1NQ_07487f3b-3a48-466a-8462-a7b671ac179a">P9Y10M24D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMy0yLTEtMS01MzM1NQ_7248b528-61c8-4b37-988d-5010ded3ad95"
      unitRef="usd">11259000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMy00LTEtMS01MzM1NQ_211b7ab5-be5b-4e5a-a8c9-252af7c1aab0"
      unitRef="usd">10171000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMy02LTEtMS01MzM1NQ_09534a26-faee-4cf3-9a6b-b89d29248514"
      unitRef="usd">1088000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i4debd5fa9102490ba7555a1193ce7701_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOmI1ZmFiNzQ4Y2JiOTQ0ZTc4NjZlMGM2NTJlMDZkZTE2L3RhYmxlcmFuZ2U6YjVmYWI3NDhjYmI5NDRlNzg2NmUwYzY1MmUwNmRlMTZfMy04LTEtMS01MzM1NQ_11e03150-7fee-4d45-8f77-c17cf5c11ac4">P7Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i20d31a7327ed4de3a49655170f642acc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfMy0yLTEtMS01MzM1NQ_3140b93d-244a-48af-b608-79cad77ec4df"
      unitRef="usd">117503000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i20d31a7327ed4de3a49655170f642acc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfMy00LTEtMS01MzM1NQ_d66024fb-3e77-4733-989a-e6588a398837"
      unitRef="usd">89576000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i20d31a7327ed4de3a49655170f642acc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfMy02LTEtMS01MzM1NQ_22409cbc-ea0e-4ac2-ac59-d0c3a2ccd020"
      unitRef="usd">27927000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i6fa8acd9c9d642edad45d44d1963e783_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfMy04LTEtMS01MzM1NQ_b36f1d48-5ce3-4784-a2ff-f9aa6e1b1eed">P9Y10M24D</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icc22933a248246149e4c0d789e039050_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfNC0yLTEtMS01MzM1NQ_bb9cb650-a4bb-457d-a97a-2218c4c2847c"
      unitRef="usd">11257000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icc22933a248246149e4c0d789e039050_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfNC00LTEtMS01MzM1NQ_84632a15-228d-4b2a-81c5-e4d50c724801"
      unitRef="usd">10000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icc22933a248246149e4c0d789e039050_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfNC02LTEtMS01MzM1NQ_5e6b8cd7-7d4c-4cd7-89da-6e079ec050f6"
      unitRef="usd">1257000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i3bf82049acf4414db15019056a8b4a4d_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjBkY2E5YWVjY2I2ZjRlNzE5N2UyMzE5ZWU5NjQ4ODQyL3RhYmxlcmFuZ2U6MGRjYTlhZWNjYjZmNGU3MTk3ZTIzMTllZTk2NDg4NDJfNC04LTEtMS01MzM1NQ_24d529ee-32bc-4e0e-bf08-bca5e288aab7">P7Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic3ccc2277618429ba4dd1bf8f8ac9415_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMTc2Mg_9ed23460-5c6e-43b1-bad9-896976f9f884"
      unitRef="usd">3100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i6fa8acd9c9d642edad45d44d1963e783_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMTc3MA_b028e871-05e2-4977-b3dc-2a7f83726511"
      unitRef="usd">3200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RleHRyZWdpb246NDIwMzcxN2I4N2RjNGFkYjg2ZDFhMDI3ZjA0ODliNThfMjAxNg_974bdd05-d15a-4af1-b1db-66d90c2f6229">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the carrying value of intangible assets as of&#160;March&#160;31, 2022, the amortization expense is expected to be as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Developed Technology Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Patents and Licenses Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 remainder of the year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMS0xLTEtMS01MzM1NQ_3c7307a7-8667-45f8-a015-2b5464c843e4"
      unitRef="usd">8905000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMS0zLTEtMS01MzM1NQ_f26600c1-af5f-419c-9c17-d5a7fc5b64e0"
      unitRef="usd">508000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMS01LTEtMS01MzM1NQ_67191475-e8a4-40cf-bedc-f6861e7007f0"
      unitRef="usd">9413000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMi0xLTEtMS01MzM1NQ_91591982-a29d-4b3d-b7c3-1ca49f316af0"
      unitRef="usd">11874000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMi0zLTEtMS01MzM1NQ_5d6679c6-000c-4abf-8543-d2f2dcdaf113"
      unitRef="usd">572000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMi01LTEtMS01MzM1NQ_0e76d79c-2f4e-4597-b0b1-da71be716365"
      unitRef="usd">12446000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMy0xLTEtMS01MzM1NQ_4945bfdc-ba8e-4714-a82c-7b22ed70b59b"
      unitRef="usd">2074000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMy0zLTEtMS01MzM1NQ_e6618f06-7023-4a6a-9f56-51a2806f7b1d"
      unitRef="usd">8000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfMy01LTEtMS01MzM1NQ_5190605e-3f3f-4189-ba5e-e88ae2e0d5f9"
      unitRef="usd">2082000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNC0xLTEtMS01MzM1NQ_eb7360ed-848a-424b-8598-4d8def06ea10"
      unitRef="usd">674000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNC0zLTEtMS01MzM1NQ_77af218c-343a-4087-b59d-884f37b7c3ac"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNC01LTEtMS01MzM1NQ_b9fbeab9-1578-4249-babd-9d4bf2387baa"
      unitRef="usd">674000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNS0xLTEtMS01MzM1NQ_059a3dfa-cfa1-43d1-b5a2-5392da5b7021"
      unitRef="usd">674000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNS0zLTEtMS01MzM1NQ_3aa95fda-5fca-418a-ba7b-dd487a85957c"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNS01LTEtMS01MzM1NQ_cc95bee7-b37a-45b8-8dff-b75a7b55a12e"
      unitRef="usd">674000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNi0xLTEtMS01MzM1NQ_135757d9-dd69-4179-a044-1c5321979384"
      unitRef="usd">674000</fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNi0zLTEtMS01MzM1NQ_bdfd4cca-249c-4620-b631-3eaf8dec22bf"
      unitRef="usd">0</fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNi01LTEtMS01MzM1NQ_faee61db-70a5-4f79-8dc0-17c41c5a5aea"
      unitRef="usd">674000</fldm:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic84a49a6264541b9a2ad518751a09a27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNy0xLTEtMS01MzM1NQ_afedbb2c-4a98-4b64-8712-b4e8992b1d0b"
      unitRef="usd">24875000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5c9074a6857a429c8182e81cbd9e260b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNy0zLTEtMS01MzM1NQ_8973c99b-421d-4d6a-91af-e9bc3cd9cf66"
      unitRef="usd">1088000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81Mi9mcmFnOjQyMDM3MTdiODdkYzRhZGI4NmQxYTAyN2YwNDg5YjU4L3RhYmxlOjdhNTA5ZWRiMWMyMTQzODNiZDVmZWNlN2M0NWE0ZWE2L3RhYmxlcmFuZ2U6N2E1MDllZGIxYzIxNDM4M2JkNWZlY2U3YzQ1YTRlYTZfNy01LTEtMS01MzM1NQ_1625bc2e-adf8-46d5-9763-f9059153b238"
      unitRef="usd">25963000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTExNQ_776b39a7-c363-41d8-8870-a8a3f9cf6874">Balance Sheet Details&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents and restricted cash consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term restricted cash of approximately $16&#160;thousand is included in prepaid expenses and other current assets and $1.0&#160;million of non-current restricted cash is included in other non-current assets in the condensed consolidated balance sheet as of March&#160;31, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventories, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment, net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory and manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the amounts included in construction-in-progress are related to the NIH Contract (see Note 4).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accrued Compensation and Related Benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued compensation and related benefits, which is included in current liabilities on the condensed consolidated balance sheet consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued incentive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payroll taxes and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued severance and retention bonuses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and related benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term accrued severance and retention bonuses of approximately $0.6&#160;million and $0.1&#160;million are included in non-current other liabilities on our condensed consolidated balance sheet as of March&#160;31, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Warranties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued warranty is included in other current liabilities on our condensed consolidated balance sheet. Activity for our warranty accrual for the three months ended March&#160;31, 2022&#160;and 2021 is summarized below (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrual (release) for current period warranties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranty costs incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTA5Mw_85037dc6-1be4-4857-8591-294f2f956e4a">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents and restricted cash consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTEyMw_00e76941-7e7b-47bf-aeba-86c930ea3d07">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents and restricted cash consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjY0NDg5MmRmYTEwZDQwYWI5ZjNiNTNlYmM1MTYzOTQ3L3RhYmxlcmFuZ2U6NjQ0ODkyZGZhMTBkNDBhYjlmM2I1M2ViYzUxNjM5NDdfMS0yLTEtMS01MzM1NQ_0fa65923-a902-4a2a-88f2-32c26717a47e"
      unitRef="usd">29983000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjY0NDg5MmRmYTEwZDQwYWI5ZjNiNTNlYmM1MTYzOTQ3L3RhYmxlcmFuZ2U6NjQ0ODkyZGZhMTBkNDBhYjlmM2I1M2ViYzUxNjM5NDdfMS00LTEtMS01MzM1NQ_74bbd9cf-f99d-4279-b214-7b22789c764d"
      unitRef="usd">28451000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjY0NDg5MmRmYTEwZDQwYWI5ZjNiNTNlYmM1MTYzOTQ3L3RhYmxlcmFuZ2U6NjQ0ODkyZGZhMTBkNDBhYjlmM2I1M2ViYzUxNjM5NDdfMi0yLTEtMS01MzM1NQ_6c1b9048-5047-44da-8cf4-1448a8ae2906"
      unitRef="usd">1016000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjY0NDg5MmRmYTEwZDQwYWI5ZjNiNTNlYmM1MTYzOTQ3L3RhYmxlcmFuZ2U6NjQ0ODkyZGZhMTBkNDBhYjlmM2I1M2ViYzUxNjM5NDdfMi00LTEtMS01MzM1NQ_792485c2-6e86-491a-9a95-dd9711e088e3"
      unitRef="usd">1016000</us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjY0NDg5MmRmYTEwZDQwYWI5ZjNiNTNlYmM1MTYzOTQ3L3RhYmxlcmFuZ2U6NjQ0ODkyZGZhMTBkNDBhYjlmM2I1M2ViYzUxNjM5NDdfMy0yLTEtMS01MzM1NQ_abc5b23a-404e-4c6a-baff-62d283edb84a"
      unitRef="usd">30999000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjY0NDg5MmRmYTEwZDQwYWI5ZjNiNTNlYmM1MTYzOTQ3L3RhYmxlcmFuZ2U6NjQ0ODkyZGZhMTBkNDBhYjlmM2I1M2ViYzUxNjM5NDdfMy00LTEtMS01MzM1NQ_b9d061ef-43bf-4a32-bbf9-0e4eedfeb90b"
      unitRef="usd">29467000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfNjA0NzMxMzk1NTc5MQ_22f5b484-f8a4-445d-9f67-ffed0b10599c"
      unitRef="usd">16000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfNjA0NzMxMzk1NTc5MQ_53b41a96-eefd-4ad2-85a1-2c33016dff71"
      unitRef="usd">16000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfNjA0NzMxMzk1NTgwMw_13b24f7b-bf31-47de-83fb-94645e9a53e2"
      unitRef="usd">1000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfNjA0NzMxMzk1NTgwMw_d4963a8d-74d0-4ea8-acf2-2d566d105c84"
      unitRef="usd">1000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTEwMg_ab375fb8-d696-4575-a430-ff281ad30839">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfMS0yLTEtMS01MzM1NQ_c55f9006-7e83-4d71-9784-039e28204a98"
      unitRef="usd">12592000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfMS00LTEtMS01MzM1NQ_aeb60940-56a3-4474-8762-3e6d2dd6121d"
      unitRef="usd">9345000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfMi0yLTEtMS01MzM1NQ_f02aaec9-9465-4098-b291-4e6bfd6b083a"
      unitRef="usd">994000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfMi00LTEtMS01MzM1NQ_d777118d-0a23-48a9-8b2f-d9ef8ea29b8e"
      unitRef="usd">867000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfMy0yLTEtMS01MzM1NQ_11d4cbbe-008c-40db-951f-c215b745a479"
      unitRef="usd">9659000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfMy00LTEtMS01MzM1NQ_58920f1d-df84-488b-97a6-51343c8780db"
      unitRef="usd">10613000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfNC0yLTEtMS01MzM1NQ_c8b12a37-dc94-496d-98ea-c603c726e7f5"
      unitRef="usd">23245000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjhlYjc3MDFmNzgyNjRhYzI4NDc5NDFjMDA3N2Q0NmQ2L3RhYmxlcmFuZ2U6OGViNzcwMWY3ODI2NGFjMjg0Nzk0MWMwMDc3ZDQ2ZDZfNC00LTEtMS01MzM1NQ_3b0bb705-4073-4af1-b2ab-be3d96db3f9e"
      unitRef="usd">20825000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTExMQ_ee9c7d8e-0951-4763-ba7a-cdd8378f9511">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory and manufacturing equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i090e27ef0a04457484fad8f0a7075dd1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfMS0yLTEtMS01MzM1NQ_94a59e22-07f2-4781-a8a9-b1f366d233ba"
      unitRef="usd">5777000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i57628b9b4d1948008ccba2dcd4ef1952_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfMS00LTEtMS01MzM1NQ_1e682ab0-544b-4d3f-b045-ecb1e69024ec"
      unitRef="usd">5759000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia7f4a8245b6143b2953ff1fa9ffa2409_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfMi0yLTEtMS01MzM1NQ_0530abcd-c186-41b0-8e15-647ca6938cb8"
      unitRef="usd">33884000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i68ab04d53d1948088109f492c3fb4362_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfMi00LTEtMS01MzM1NQ_9e8910b6-0c97-46c8-977b-8ae7934cc5e1"
      unitRef="usd">30260000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3f99c36bb724482982e5d8102ceeecd7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfMy0yLTEtMS01MzM1NQ_cf266293-0e6a-4f7a-b48e-b7b799dcac42"
      unitRef="usd">12460000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if0863696f8964c36a94715de8e0f295d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfMy00LTEtMS01MzM1NQ_05e79067-9d4e-4b93-84d2-9ac21aea1682"
      unitRef="usd">12095000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie84a730a5b8e43089afed4061de374a5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNC0yLTEtMS01MzM1NQ_d41b89f1-b1f7-4f5c-b226-c6f65d2dc188"
      unitRef="usd">2065000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i367f8eaf66e547ca84a65357249c487a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNC00LTEtMS01MzM1NQ_a43b005f-a61b-48cf-91b0-abeaf51c981e"
      unitRef="usd">2074000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNS0yLTEtMS01MzM1NQ_3ac8f005-0e59-409a-b1a3-950a4cbb6553"
      unitRef="usd">54186000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNS00LTEtMS01MzM1NQ_6afbd6d3-e923-4710-989a-0f1be9573c35"
      unitRef="usd">50188000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNi0yLTEtMS01MzM1NQ_c5b698c4-7937-43a8-bf7b-0e76d860e748"
      unitRef="usd">28151000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNi00LTEtMS01MzM1NQ_e4a89fc7-97d3-4655-8983-81c1e83ea4ad"
      unitRef="usd">26703000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:ConstructionInProgressGross
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNy0yLTEtMS01MzM1NQ_8ef571eb-1e2c-4a68-88f2-ed171891dedb"
      unitRef="usd">1664000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfNy00LTEtMS01MzM1NQ_aaa52e56-a31f-49be-a12c-99dc42ac1cd0"
      unitRef="usd">4549000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfOC0yLTEtMS01MzM1NQ_e87a2c91-fd02-4156-a754-a41fac7371b9"
      unitRef="usd">27699000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOmI5NTgzODFjMGI4ZjRmZTBhMDAwMWY2NjVmY2RlNzEyL3RhYmxlcmFuZ2U6Yjk1ODM4MWMwYjhmNGZlMGEwMDAxZjY2NWZjZGU3MTJfOC00LTEtMS01MzM1NQ_5eb0889c-2d37-4de4-b0e9-c8bc84650641"
      unitRef="usd">28034000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTA5Ng_0ab9f70a-267f-4095-952d-1f3902007150">&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued compensation and related benefits, which is included in current liabilities on the condensed consolidated balance sheet consisted of the following as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued incentive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued vacation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payroll taxes and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued severance and retention bonuses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and related benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Long-term accrued s</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfMS0yLTEtMS01MzM1NQ_59fd2465-6d73-48e9-bc51-9142575ae136"
      unitRef="usd">1779000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfMS00LTEtMS01MzM1NQ_0a9b3b25-2b34-4cc6-83ae-dfd552b56efb"
      unitRef="usd">14000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfMi0yLTEtMS01MzM1NQ_80eeaaae-52ac-4fcd-a995-6fb8d29b5a58"
      unitRef="usd">3737000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfMi00LTEtMS01MzM1NQ_4a488f00-9978-4b4b-8111-436dba375416"
      unitRef="usd">3388000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfMy0yLTEtMS01MzM1NQ_729a6005-64f7-4028-bec4-633d022ba41c"
      unitRef="usd">1547000</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfMy00LTEtMS01MzM1NQ_94fb30ee-84d9-4d83-8230-511dba58cdc5"
      unitRef="usd">1492000</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfNC0yLTEtMS02NzA0OQ_14538a59-367e-42bb-a318-49b2f01a48c6"
      unitRef="usd">901000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfNC00LTEtMS02NzA0OQ_de7c9054-58d6-4ae1-98c7-df418a23d0ac"
      unitRef="usd">26000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfNC0yLTEtMS01MzM1NQ_9864035c-45ec-4a00-a46f-1548d54266dc"
      unitRef="usd">7964000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjNhYzk2ZDYwMDg2YjQzOGZiMDZlMmJhNjUyMWVjOGVjL3RhYmxlcmFuZ2U6M2FjOTZkNjAwODZiNDM4ZmIwNmUyYmE2NTIxZWM4ZWNfNC00LTEtMS01MzM1NQ_5f4a3c57-34e7-41af-87ff-cdf72114ce18"
      unitRef="usd">4920000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <fldm:AccruedBonusesNoncurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfNjA0NzMxMzk1NDY0OA_fde721ac-96ba-4dd1-a615-f639b69deec4"
      unitRef="usd">600000</fldm:AccruedBonusesNoncurrent>
    <fldm:AccruedBonusesNoncurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfNjA0NzMxMzk1NDcxMA_dbbc8800-83d6-4272-ab1e-5439f0e1ce8f"
      unitRef="usd">100000</fldm:AccruedBonusesNoncurrent>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RleHRyZWdpb246MjRjZDEyMjczZmE3NDQzN2I5NWViMDkzYzViOGJiYTdfMTEwNw_6f879c57-9970-4e63-9eef-0e5c0663f5d3">&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued warranty is included in other current liabilities on our condensed consolidated balance sheet. Activity for our warranty accrual for the three months ended March&#160;31, 2022&#160;and 2021 is summarized below (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrual (release) for current period warranties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranty costs incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrual
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfMi0yLTEtMS01MzM1NQ_7233dbee-7c96-4a72-bf35-0b0ba3a16a98"
      unitRef="usd">1170000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="id803a63fc74c495aa4dd5311fbcac8b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfMi00LTEtMS01MzM1NQ_628adbc4-d941-41b7-b5f9-e2187a04e1a1"
      unitRef="usd">1663000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualPreexistingIncreaseDecrease
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfMy0yLTEtMS01MzM1NQ_c1f5b677-45ff-442d-90d5-e6cd58ff9a35"
      unitRef="usd">306000</us-gaap:ProductWarrantyAccrualPreexistingIncreaseDecrease>
    <us-gaap:ProductWarrantyAccrualPreexistingIncreaseDecrease
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfMy00LTEtMS01MzM1NQ_3921280e-88f0-43ae-8586-4ebbe890cf0c"
      unitRef="usd">-150000</us-gaap:ProductWarrantyAccrualPreexistingIncreaseDecrease>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfNC0yLTEtMS01MzM1NQ_92221b8a-913a-406d-8387-1597df3c5cb0"
      unitRef="usd">264000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfNC00LTEtMS01MzM1NQ_2ce4887b-fa73-422f-ace7-46987b4dad74"
      unitRef="usd">236000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfNS0yLTEtMS01MzM1NQ_ef9b0f7f-bba0-4979-ab82-4f732422746c"
      unitRef="usd">1212000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="id618e4076c984ee2b69327451b1b9e70_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81NS9mcmFnOjI0Y2QxMjI3M2ZhNzQ0MzdiOTVlYjA5M2M1YjhiYmE3L3RhYmxlOjRjYzFjNjdiODgyODRmNmQ4NmVmZDAwZDA1MWU0ZmY0L3RhYmxlcmFuZ2U6NGNjMWM2N2I4ODI4NGY2ZDg2ZWZkMDBkMDUxZTRmZjRfNS00LTEtMS01MzM1NQ_39ae3c0b-e519-4577-990c-3b44934587a6"
      unitRef="usd">1277000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfODM3NA_f8b61600-a63a-4453-8b33-d05ee54a6efe">DebtBridge Loans &lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 3 for a discussion of the $35.7 million Bridge Loans outstanding as of March&#160;31, 2022 as part of the Private Placement Issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;2014 Senior Convertible Notes (2014 Notes) and 2019 Senior Convertible Notes (2019 Notes)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of the components of the 2014 Notes and 2019 Notes are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;2.75% 2014 Notes due 2034   &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying value of 2014 Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;5.25% 2019 Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying value of 2019 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying value of all Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2014 Senior Convertible Notes (2014 Notes) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2014, we closed an underwritten public offering of 2014 Notes. In 2019, the outstanding 2014 Notes were largely refinanced with the 2019 Notes, discussed below. The effective interest rate on the 2014 Notes, reflecting the impact of debt discounts and issuance costs, is approximately 3%. The 2014 Notes will mature on February 1, 2034, unless earlier converted, redeemed, or repurchased in accordance with the terms of the 2014 Notes. Holders may require us to repurchase all or a portion of their 2014 Notes on each of February 6, 2024 and February 6, 2029, at a repurchase price in cash equal to 100% of the principal amount of the 2014 Notes plus accrued and unpaid interest. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As provided by the indenture governing the 2014 Notes, in February 2021, holders of $0.5 million of the 2014 Notes required us to repurchase their notes at 100% of the principal amount plus accrued and unpaid interest. We recorded a loss of $9 thousand on the extinguishment of those notes, representing the difference between the price paid to extinguish the 2014 Notes and their carrying value, including unamortized debt issuance costs. As of March&#160;31, 2022, there was $0.6 million aggregate principal of the 2014 Notes outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2019 Senior Convertible Notes (2019 Notes)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, we issued $55.0 million aggregate principal amount of 2019 Notes. Net proceeds of the 2019 Notes issuance were $52.7 million, after deductions for commissions and other debt issuance costs. $51.8 million of the proceeds of the 2019 Notes were used to retire $50.2 million aggregate principal amount of our 2014 Notes, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;leaving $1.1 million of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; aggregate principal value of 2014 Notes then outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2019 Notes bear interest at 5.25% per annum, payable semiannually on June 1 and December 1 of each year, beginning on June 1, 2020. The 2019 Notes will mature on December 1, 2024, unless earlier repurchased or converted pursuant to their terms. The 2019 Notes will be convertible at the option of the holder at any point prior to the close of business on the second scheduled trading day preceding the maturity date. The initial conversion rate of the 2019 Notes is 344.8276 shares of our common stock per $1,000 principal amount of 2019 Notes (which is equivalent to an initial conversion price of approximately $2.90 per share). The conversion rate is subject to adjustment upon the occurrence of certain specified events. Those certain specified events include voluntary conversion of the 2019 Notes prior to our exercise of the Issuer&#x2019;s Conversion Option or in connection with a make-whole fundamental change, entitling the holders, under certain circumstances, to a make-whole premium in the form of an increase in the conversion rate determined by reference to a make-whole table set forth in the indenture governing the 2019 Notes. The conversion rate will not be adjusted for any accrued and unpaid interest. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2019 Notes will also be convertible at our option upon certain conditions in accordance with the terms of the indenture governing the 2019 Notes. On or after December 1, 2021 to December 1, 2022, if the price of our common stock has equaled or exceeded 150% of the Conversion Price (as defined in the indenture) then in effect for a specified number of days (Issuer&#x2019;s Conversion Option), we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of common stock of the Company, determined in accordance with the terms of the indenture. On or after December 1, 2022, if the price of our common stock has equaled or exceeded 130% of the Conversion Price then in effect for a specified number of days, we may, at our option, elect to convert the 2019 Notes in whole but not in part into shares of common stock of the Company, determined in accordance with the terms of the indenture. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Offering-related costs for the 2019 Notes were capitalized as debt issuance costs and are recorded as an offset to the carrying value of the 2019 Notes. The effective rate on the 2019 Notes is 6.2%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revolving Credit Facility and Term Loan, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of our term loan and advances under the Credit Facility, and the maximum amount available under the Credit Facility are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of term fee accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying value of term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;Revolving Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of advances under credit agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, we entered into a revolving credit facility with Silicon Valley Bank (as amended, the Revolving Credit Facility) in an aggregate principal amount of up to the lesser of (i) $15.0 million (Maximum Amount) or (ii) the sum of (a) 85% of our eligible receivables and (b) 50% of our eligible inventory, in each case, subject to certain limitations (Borrowing Base), provided that the amount of eligible inventory that may be counted towards the Borrowing Base shall be subject to a cap as set forth in the Revolving Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 2, 2021, we amended our Revolving Credit Facility to extend the maturity date to August 2, 2023 and to provide for a new $10.0&#160;million Term Loan Facility (the Term Loan Facility and, together with the Revolving Credit Facility, the Credit Facility). The stated maturity of the Term Loan Facility is July 1, 2025.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;However, if the principal amount of our convertible debt exceeds &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.6&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as of June 1, 2024 or if the maturity of our 2019 Notes has not been extended beyond January 1, 2026 by June 1, 2024, then the maturity date of the Term Loan Facility will be June 1, 2024. The Credit Facility is &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;collateralized by substantially all our property, other than intellectual property. The Credit Facility also includes a financial covenant that requires us to maintain a minimum Adjusted Quick Ratio, as defined in the agreement, of at least 1.25 to 1.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The interest rate on advances made under the Revolving Credit Facility is the greater of (i) prime rate plus 0.50% or (ii) 5.25%. Interest on any outstanding amounts is due and payable monthly and the principal balance is due at maturity, though loans can be prepaid at any time without penalty. Fees for the Revolving Credit Facility include an annual commitment fee of $112,500 and a quarterly unused line fee based on the Borrowing Base. Total availability under the Revolving Credit Facility as of March&#160;31, 2022 was $8.4 million. There were no borrowings outstanding under the Revolving Credit Facility at&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of March&#160;31, 2022, the Term Loan Facility was fully drawn. The interest rate on the Term Loan Facility is the greater of 4.0% or a floating per annum rate equal to three quarters of one percentage point (0.75%) above the prime rate. Interest on any outstanding term loan advances is due and payable monthly. In addition to the monthly interest payments, a final payment equal to 6.5% of the original principal amount of each advance is due on the earlier of the maturity date or the date the advance is repaid. Principal balances are required to be repaid in twenty-four equal installments beginning on August 1, 2023. The effective interest rate on the Term Loan Facility, reflecting the impact of debt issuance costs, the end-of-term fee and expected timing of principal repayment was 6.3% as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMzg0ODI5MDc1NDc2MA_e8f55ea5-6fd3-41c8-8486-4c14cdc62fea"
      unitRef="usd">35700000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMTMxOTQxMzk1OTIzODQ_a67f8666-0757-4cdc-a2bd-bcafde576020">&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of the components of the 2014 Notes and 2019 Notes are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;2.75% 2014 Notes due 2034   &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying value of 2014 Notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;5.25% 2019 Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying value of 2019 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying value of all Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying values of our term loan and advances under the Credit Facility, and the maximum amount available under the Credit Facility are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;End of term fee accretion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying value of term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;Revolving Credit Facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value of advances under credit agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the par value, carrying value and the estimated fair value of our debt as of March&#160;31, 2022 and December&#160;31, 2021, respectively (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.825%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bridge Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2014 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advances under revolving credit agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i160268d0fa1b4d38bd5ea84554f1559f_I20140228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMS0wLTEtMS02NDc0OS90ZXh0cmVnaW9uOjMwNmY4NmYwMjViZTRlNjliN2QyNmFlMDE3OWQ2YjBjXzY_5341d8f7-0957-401d-b3c8-892e7eca8510"
      unitRef="number">0.0275</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id7a77d2cffbb466495dfbdb0f232de97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMi0yLTEtMS02NDc0OQ_54485400-e6ea-40e9-bd81-45dc9b126e49"
      unitRef="usd">578000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib879a74c7d314a99bfe67a83c5ae025a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMi00LTEtMS02NDc0OQ_edc5988d-d57f-4153-bee7-79a92115064e"
      unitRef="usd">578000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="id7a77d2cffbb466495dfbdb0f232de97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMy0yLTEtMS02NDc0OQ_9d11666b-01f6-4534-9bbb-f73f7d01ffa5"
      unitRef="usd">8000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ib879a74c7d314a99bfe67a83c5ae025a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMy00LTEtMS02NDc0OQ_6e7f152e-ec2a-424b-a061-93b81495545e"
      unitRef="usd">8000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="id7a77d2cffbb466495dfbdb0f232de97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfNC0yLTEtMS02NDc0OQ_91e46533-338b-4d44-ad94-8af33a80b3c6"
      unitRef="usd">2000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ib879a74c7d314a99bfe67a83c5ae025a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfNC00LTEtMS02NDc0OQ_3b0b64a2-b79b-48fb-bdbb-0dab55df34e4"
      unitRef="usd">2000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="id7a77d2cffbb466495dfbdb0f232de97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfNS0yLTEtMS03NjIzMQ_7b0298e2-5b10-4608-b68c-b5478a12ead5"
      unitRef="usd">568000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ib879a74c7d314a99bfe67a83c5ae025a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfNS00LTEtMS03NjIzMQ_a01c0b79-e54a-4b2b-9d44-f0b2d3ee5af3"
      unitRef="usd">568000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i07369311ad5b4af1a043b008ade3c4e7_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfNy0wLTEtMS02NDc0OS90ZXh0cmVnaW9uOmEyM2U2ZmRhNmZiYTRkNjM5MWI4ZGUyNGIyZDQwY2JhXzY_1988f466-e82c-4ffe-8194-70db45614724"
      unitRef="number">0.0525</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib6fc6a3e6a134443b3035ae7eef72da4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfOC0yLTEtMS02NDc0OQ_6813bd18-72c0-4a15-a60a-01dbf8dee5ce"
      unitRef="usd">55000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2ccaab30a9344f92a4d5d4f061f686d2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfOC00LTEtMS02NDc0OQ_9029736e-7322-4f3c-8023-6c49604d6a7f"
      unitRef="usd">55000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="ib6fc6a3e6a134443b3035ae7eef72da4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfOS0yLTEtMS02NDc0OQ_28be45d5-ca5a-499f-baa1-26079412e22c"
      unitRef="usd">1297000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i2ccaab30a9344f92a4d5d4f061f686d2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfOS00LTEtMS02NDc0OQ_7d3ec033-1626-461e-8936-d57cb586af0e"
      unitRef="usd">1408000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="ib6fc6a3e6a134443b3035ae7eef72da4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMTAtMi0xLTEtNzYyMzQ_5114cca7-1e92-4bf8-b053-66d7f7d4c141"
      unitRef="usd">53703000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2ccaab30a9344f92a4d5d4f061f686d2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMTAtNC0xLTEtNjQ3NDk_6b6de0c5-f801-4b64-a46c-75ebd5e7b059"
      unitRef="usd">53592000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i918712e2e4c4473592c78603409a2035_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMTEtMi0xLTEtNjQ3NDk_017bf6de-c8d6-41c5-99d2-e3bedbd93c12"
      unitRef="usd">54271000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i633deee677b14f20aedd746e431d49ed_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjIzNWE5YjkxMmNmZDRkY2Q5MzdmNTMwZWEzNDRmYmE1L3RhYmxlcmFuZ2U6MjM1YTliOTEyY2ZkNGRjZDkzN2Y1MzBlYTM0NGZiYTVfMTEtNC0xLTEtNjQ3NDk_069ed106-e29c-4a9d-a77c-362a1e1928fe"
      unitRef="usd">54160000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i160268d0fa1b4d38bd5ea84554f1559f_I20140228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjA0NzMxNDAxMTkyMQ_c6ff3c0a-e1a6-44dd-833b-202745fb710d"
      unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i9170739660ea4bfc8eb6c551e60b2612_D20140201-20140228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfOTk0_e93068ae-18a6-42fd-85cf-2684477c868f"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2b39964a5e6c4c19b88ad79540049976_I20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMTY0OTI2NzQ1MjIwNA_46b8b336-c59b-469e-8e93-b046627402ed"
      unitRef="usd">500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i29e7a7788ad04a3d8770310cb3706589_D20210201-20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMTY0OTI2NzQ1MDg5Ng_14717dfd-dc7e-4f80-8724-362593d24e61"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ifa7db0e7f6e64bc38b954e286cf01912_D20210201-20210228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMTY0OTI2NzQ1MjIxMg_c93bcec8-06c7-473e-a548-942b73cc833e"
      unitRef="usd">-9000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id7a77d2cffbb466495dfbdb0f232de97_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMTY0OTI2NzQ1MjIzOA_b0ca9b49-f959-4be1-aadc-7bfc0069ccec"
      unitRef="usd">600000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i07369311ad5b4af1a043b008ade3c4e7_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMjM2OQ_e6242e6e-18e1-42b7-985b-abce04f4a871"
      unitRef="usd">55000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i3b2bc86d58a540e1859dd280a7ab24e4_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMjQ3NQ_ab3f0c6c-170c-453e-9399-85beb90759bb"
      unitRef="usd">52700000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="ie91e1a9f5d3646f68aebba6fd62e9508_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMjU2Mw_181745f7-d918-4d0e-bc85-0ad9cddb86ba"
      unitRef="usd">51800000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i3b2bc86d58a540e1859dd280a7ab24e4_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMjYyMA_6a403d9f-ca94-40c9-82ed-f111efb0b606"
      unitRef="usd">50200000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i908b5614888049f28cbb80e7a6178f8e_I20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjA0NzMxNDAxMTc0MQ_61db0d1b-bcae-4419-9090-c1fa3b01ce3b"
      unitRef="usd">1100000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i07369311ad5b4af1a043b008ade3c4e7_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMjc3NA_1988f466-e82c-4ffe-8194-70db45614724"
      unitRef="number">0.0525</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <fldm:InitialConversionPriceOfStock
      contextRef="i812e59424f52454887fd27588f8469d3_I20191130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfMzM3MQ_63e16a60-4038-4cf4-8c87-6be14fb120c4"
      unitRef="usdPerShare">2.90</fldm:InitialConversionPriceOfStock>
    <fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice
      contextRef="i5874eb1b19274365b89e4f16ba6865fc_D20191101-20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNDI0MA_ffa35cf3-df89-4dbf-9b3f-21a282ab7b10"
      unitRef="number">1.50</fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice>
    <fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice
      contextRef="i4690c6ae02014999bb14d18dc8b565b2_D20191101-20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNDYwNg_0e671d5a-2c2c-4b15-9d86-56c1e603cc53"
      unitRef="number">1.30</fldm:DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i07369311ad5b4af1a043b008ade3c4e7_I20191130"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNTIxNw_b03f70b5-8b4f-4f9e-a5c6-10e2cfe33adf"
      unitRef="number">0.062</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfMi0yLTEtMS02NDc3OA_6e788a87-a849-4e66-af22-4c5938bbda27"
      unitRef="usd">10000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i40c95c830e9346709b9e8f6f68d3ca08_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfMi00LTEtMS02NDc3OA_dc7e00a7-75ca-45f3-8218-1e971f6e266f"
      unitRef="usd">10000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfMy0yLTEtMS02NDc3OA_2c2728b4-24ab-4b82-86d9-8b72ea1da73d"
      unitRef="usd">-133000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i40c95c830e9346709b9e8f6f68d3ca08_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfMy00LTEtMS02NDc3OA_f17e5f2a-043f-4139-be87-141355f5b68f"
      unitRef="usd">-79000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfNC0yLTEtMS02NDc3OA_6293c08e-4196-4ac9-b396-61df07786f9a"
      unitRef="usd">27000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i40c95c830e9346709b9e8f6f68d3ca08_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfNC00LTEtMS02NDc3OA_2ebf043c-ab54-4502-94de-864bb3817169"
      unitRef="usd">30000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfNS0yLTEtMS03NjIzNw_be5bd232-c725-42ee-a356-d79a3465a73c"
      unitRef="usd">10106000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i40c95c830e9346709b9e8f6f68d3ca08_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfNS00LTEtMS03NjIzNw_579de0e6-88c6-4541-b218-0445977d8c9b"
      unitRef="usd">10049000</us-gaap:LongTermDebt>
    <us-gaap:LineOfCredit
      contextRef="id3bcdcd73f1c405f8f2d59a089c890f3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfOS0yLTEtMS02NDc3OA_aa88b235-df65-4e32-9f1b-a73d755e01dc"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="if7290240890949c08edf84cb715e251f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RhYmxlOjEwNWNlNzM4NmI1NDRjMzNiYmY5Y2Y1ODkyZmJiNjhkL3RhYmxlcmFuZ2U6MTA1Y2U3Mzg2YjU0NGMzM2JiZjljZjU4OTJmYmI2OGRfOS00LTEtMS02NDc3OA_4d4f25f7-7e60-454b-8e5e-5fb4ddd31dfd"
      unitRef="usd">6838000</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i7138e77d1b41464ba17008df0fb4ab55_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNTU2OQ_f11b5c9e-7ad1-477b-bb25-4a92814a5eba"
      unitRef="usd">15000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <fldm:LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables
      contextRef="i6637980e82554f3da6571c3ff1c70650_D20180801-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNTYxMw_cd832a4a-f0e9-4368-8b83-12e60d7072d5"
      unitRef="number">0.85</fldm:LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables>
    <fldm:LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory
      contextRef="i6637980e82554f3da6571c3ff1c70650_D20180801-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNTY1Mg_435a42d6-143c-455a-bc78-200fc83b90ef"
      unitRef="number">0.50</fldm:LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id87ce5c4623f4d3b9b99a89129d283c5_I20210802"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjE5Mw_64f49d45-cb8c-4509-8b3f-d4dc7f460c22"
      unitRef="usd">10000000</us-gaap:DebtInstrumentFaceAmount>
    <fldm:DebtInstrumentCovenantConvertibleDebtThreshold
      contextRef="i6c05f390be1e4fba9543e3eef05cd18a_I20210802"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjQ0NQ_ee5eccd2-19a7-4043-b6cb-30cd92f08dbc"
      unitRef="usd">600000</fldm:DebtInstrumentCovenantConvertibleDebtThreshold>
    <fldm:DebtInstrumentCovenantMinimumAdjustedQuickRatio
      contextRef="iea73508f9d1047c38f6efe4f293e882e_D20210802-20210802"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjkwNg_3c901c17-3442-4eba-9149-6582caee91cf"
      unitRef="number">1.25</fldm:DebtInstrumentCovenantMinimumAdjustedQuickRatio>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i71f15dd92cc34cc88d928463e4fdea0d_D20180801-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNzAyOQ_882d9979-fbdd-47b4-8a84-e1c1626a40dd"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ia9ff2eebee8640b1845873f7c8306421_D20180801-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNzA0MA_65809ec3-beb7-4cb9-b8a6-8d84b2550909"
      unitRef="number">0.0525</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeeAmount
      contextRef="ia5c8dc8c1e56417a96b944b97cd01027_D20180801-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNzI4NQ_75f3a7f7-ef80-42dc-ae85-41427dd4c27e"
      unitRef="usd">112500</us-gaap:LineOfCreditFacilityCommitmentFeeAmount>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="id3bcdcd73f1c405f8f2d59a089c890f3_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjA0NzMxNDAwNzg5OQ_239dcb28-8a31-4e71-ab70-4a29771bcf7d"
      unitRef="usd">8400000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="id3bcdcd73f1c405f8f2d59a089c890f3_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNjA0NzMxNDAwNzQxMg_85e70b9b-19ee-460b-8859-abb933c2a8fe"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNzYzMw_d0ee623c-ca33-49e7-ac76-f6edb3e3ae53"
      unitRef="number">0.040</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i43f34e3da8064d94ba11bd59638ffba3_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNzcxMw_fed061be-e41e-4c43-887a-3bfeb2ebf3ee"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <fldm:DebtInstrumentIncrementalPaymentPercent
      contextRef="iea73508f9d1047c38f6efe4f293e882e_D20210802-20210802"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfNzg4Ng_d230fdd7-1a7a-4562-a8dc-e6cfced1f0d4"
      unitRef="number">0.065</fldm:DebtInstrumentIncrementalPaymentPercent>
    <fldm:DebtInstrumentPeriodicPaymentNumberOfInstallments
      contextRef="i1ceba926b97e4336840e0087ebe96841_D20210802-20210802"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfODA2NQ_03cc9120-3824-49d9-b5d6-22589078c1cb"
      unitRef="monthly_installment">24</fldm:DebtInstrumentPeriodicPaymentNumberOfInstallments>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF81OC9mcmFnOjY0OGZhNWJiZDEwMTQ4ZDM5NTQzNTM3YmJmOWQ1NDllL3RleHRyZWdpb246NjQ4ZmE1YmJkMTAxNDhkMzk1NDM1MzdiYmY5ZDU0OWVfODI5MQ_2becd6d8-c490-4797-832d-b48801c068ec"
      unitRef="number">0.063</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RleHRyZWdpb246MDA3Zjk2ZTZlZWE4NGIyZWI0MjAxYzEyMDNhOWY1YTBfMzg4_7be4ba21-37f7-4907-a673-e7ecd597fc43">Leases&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have operating leases for buildings, equipment and vehicles. Existing leases have remaining terms of less than one year to eight years. Some leases contain options to extend the lease, usually for up to five years, and termination options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands, except for discount rate and lease term):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,595&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,457&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease right-of-use assets, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,286&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,217&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,897)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,098)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease right-of-use assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,389&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,119&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,209&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,053&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,760&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,548&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,969&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,601&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate per annum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <fldm:LesseeOperatingLeaseRemainingTermOfContract
      contextRef="i2946e1733f13418ea3b80b32b99bb663_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RleHRyZWdpb246MDA3Zjk2ZTZlZWE4NGIyZWI0MjAxYzEyMDNhOWY1YTBfMTI5_45f8daa6-ad9f-4247-b299-1eae5cafa6fe">P1Y</fldm:LesseeOperatingLeaseRemainingTermOfContract>
    <fldm:LesseeOperatingLeaseRemainingTermOfContract
      contextRef="i9401f96d3b934202bdd9b43f3164dc99_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RleHRyZWdpb246MDA3Zjk2ZTZlZWE4NGIyZWI0MjAxYzEyMDNhOWY1YTBfNjA0NzMxMzk1MzQyNQ_27e39251-35c2-473c-b65e-8452d31fe5f3">P8Y</fldm:LesseeOperatingLeaseRemainingTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RleHRyZWdpb246MDA3Zjk2ZTZlZWE4NGIyZWI0MjAxYzEyMDNhOWY1YTBfMjA2_a1b04643-f3ef-4d81-919e-0628186f0450">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <fldm:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RleHRyZWdpb246MDA3Zjk2ZTZlZWE4NGIyZWI0MjAxYzEyMDNhOWY1YTBfMzg0_0d910c7e-e9bf-4418-bf56-0b2d4b49330d">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows as of March&#160;31, 2022 and December&#160;31, 2021 (in thousands, except for discount rate and lease term):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,595&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,457&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;676&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease right-of-use assets, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,286&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,217&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,897)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,098)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease right-of-use assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,389&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,119&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,209&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,053&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,760&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,548&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,969&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,601&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate per annum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</fldm:AssetsAndLiabilitiesLesseeTableTextBlock>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="ic6d96d54873a406f8857760fcb97e6dc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMS0yLTEtMS01MzM1NQ_ea4ebbbc-342d-4171-a258-675564c5a377"
      unitRef="usd">43595000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="i2dd1c0dbe46d4ab4b631cf79d9b0e5f0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMS00LTEtMS01MzM1NQ_d7fa786b-aef1-47a3-8da4-b35232e934a4"
      unitRef="usd">43457000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="ib8bf776768964321b47a464ab18406e1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMi0yLTEtMS01MzM1NQ_6fc0e685-34fc-4351-927e-5f042490c4cb"
      unitRef="usd">82000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="if4d100cb233e46569570b3a9160fffaf_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMi00LTEtMS01MzM1NQ_6f7def4e-86e3-4a8e-91c3-a45709a771ae"
      unitRef="usd">84000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="ieb02155ee72947fe93b3c7c9297367dd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMy0yLTEtMS01MzM1NQ_45d4e9b9-4424-472b-8e47-79d22dab91af"
      unitRef="usd">609000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="i1ab4b34b0e7949c0853287c6a741b50c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMy00LTEtMS01MzM1NQ_5851c021-b517-45ea-8147-70d5561b4985"
      unitRef="usd">676000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfNC0yLTEtMS01MzM1NQ_7b75c4c2-f9f8-42d9-b198-8766a1fdeffc"
      unitRef="usd">44286000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetGross
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfNC00LTEtMS01MzM1NQ_952beecd-d3bb-4a72-9524-d4cf796a2829"
      unitRef="usd">44217000</fldm:OperatingLeaseRightOfUseAssetGross>
    <fldm:OperatingLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfNS0yLTEtMS01MzM1NQ_38457eda-238a-422b-b2e7-57500dbfb630"
      unitRef="usd">7897000</fldm:OperatingLeaseRightOfUseAssetAccumulatedAmortization>
    <fldm:OperatingLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfNS00LTEtMS01MzM1NQ_d1d59f39-691d-466b-937a-e52db5581f27"
      unitRef="usd">7098000</fldm:OperatingLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfNi0yLTEtMS01MzM1NQ_2ab299a1-91bb-4265-bca5-2cb8aa70edce"
      unitRef="usd">36389000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfNi00LTEtMS01MzM1NQ_975f9625-98a8-4106-bb7b-9ea8150dd63c"
      unitRef="usd">37119000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfOC0yLTEtMS01MzM1NQ_866ceb4e-4bac-4c18-b10b-f6a10e9088fa"
      unitRef="usd">3209000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfOC00LTEtMS01MzM1NQ_243a2e2e-d3b2-4f88-9e0d-f8f3eca575f2"
      unitRef="usd">3053000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfOS0yLTEtMS01MzM1NQ_640d4e95-b152-4cd0-ae4a-635417913cca"
      unitRef="usd">36760000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfOS00LTEtMS01MzM1NQ_e1e7b1de-8310-499d-ad7e-35cdeec97a2b"
      unitRef="usd">37548000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMTAtMi0xLTEtNTMzNTU_fbf11e96-9cf9-4e54-876d-50b3d0baa3f3"
      unitRef="usd">39969000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMTAtNC0xLTEtNTMzNTU_9b16904a-f41d-4234-96f1-98c925afbde4"
      unitRef="usd">40601000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMTItMi0xLTEtNTMzNTU_10f662a3-eb08-4fed-907d-9f273da9c453">P7Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMTItNC0xLTEtNTMzNTU_554eff6a-959d-4abb-bfb8-69238b5917ff">P7Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMTMtMi0xLTEtNTMzNTU_9eee4e64-dbfb-4798-932b-799165bc23b4"
      unitRef="number">0.117</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82NC9mcmFnOjAwN2Y5NmU2ZWVhODRiMmViNDIwMWMxMjAzYTlmNWEwL3RhYmxlOjhkYjk3ODk0ZGM0MjRiNzg4ZjljZjhkNzIxM2UzNjBmL3RhYmxlcmFuZ2U6OGRiOTc4OTRkYzQyNGI3ODhmOWNmOGQ3MjEzZTM2MGZfMTMtNC0xLTEtNTMzNTU_8fd0273e-b0cf-44c6-bcef-370a0259b4f0"
      unitRef="number">0.117</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RleHRyZWdpb246MTFjMjdiNTNjYzQxNDJkYTg0ZDU0MGFmYWQ3MDlkN2ZfMTQwMQ_2d1ec7d1-f2ee-4b7d-8ab4-7555c4a3c71a">Fair Value of Financial Instruments&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.825%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash- Restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash-restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash- Restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash-restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents are Level I measurements. There were no transfers between Level I and Level II measurements, and no changes in the valuation techniques used during the three months ended March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record our Bridge Loans and forward contracts on our Series B Preferred Equity Financing at their fair market values. See Note 3 for a discussion of these transactions and the determination of their fair market value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our convertible notes, Bridge Loans, and forward sales contracts are not regularly traded and it is difficult to estimate a reliable and accurate market price for these securities. The estimated fair values for these securities represent Level III valuations since a fair value for these securities cannot be determined by using readily observable inputs or measures, such as market prices. Fair values were estimated using pricing models and risk-adjusted value ranges. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of our term loan also represents a Level III valuation since the value cannot be determined by using readily observable inputs or measures, such as market prices. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our term loan was estimated using a discounted cash flows approach and current market interest rate data for similar loans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the par value, carrying value and the estimated fair value of our debt as of March&#160;31, 2022 and December&#160;31, 2021, respectively (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.825%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bridge Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2014 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advances under revolving credit agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RleHRyZWdpb246MTFjMjdiNTNjYzQxNDJkYTg0ZDU0MGFmYWQ3MDlkN2ZfMTQwOA_b2a81c33-d476-4525-a637-2523a266f238">&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our cash and available-for-sale securities that were measured at fair value by significant investment category within the fair value hierarchy (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.825%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash- Restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash-restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash- Restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash-restricted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i09c9b9a0eec74f1eb1b5c7f46fce7ad2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMy0xLTEtMS01MzM1NQ_07f899c6-056f-4cbb-8fbd-3c7d743955ad"
      unitRef="usd">29983000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i09c9b9a0eec74f1eb1b5c7f46fce7ad2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMy03LTEtMS01MzM1NQ_4ec14213-7cbb-4231-b486-a526bd56f4f3"
      unitRef="usd">29983000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i09c9b9a0eec74f1eb1b5c7f46fce7ad2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMy05LTEtMS01MzM1NQ_fa1fe87d-44f8-40e0-be33-b169dbc03c94"
      unitRef="usd">29983000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i3cbe9fcdac0241f08b13a6f1500deafa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNC0xLTEtMS01MzM1NQ_8ae41e6b-4a99-412e-a85f-70fee4c110df"
      unitRef="usd">1016000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i3cbe9fcdac0241f08b13a6f1500deafa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNC03LTEtMS01MzM1NQ_3b128788-7bff-4046-a4bd-a5ee751c7559"
      unitRef="usd">1016000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i3cbe9fcdac0241f08b13a6f1500deafa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNC0xMy0xLTEtNTMzNTU_6b409aca-9eb0-4adf-b4fb-11ff9d37c656"
      unitRef="usd">1016000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id2106d7d27e2429382ccfccea124e2d2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNS0xLTEtMS01MzM1NQ_48e52a07-65ad-4d8f-8136-8de3488c2cad"
      unitRef="usd">30999000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id2106d7d27e2429382ccfccea124e2d2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNS03LTEtMS01MzM1NQ_be9d990e-7a40-4696-8f58-3b1f58e52489"
      unitRef="usd">30999000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id2106d7d27e2429382ccfccea124e2d2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNS05LTEtMS01MzM1NQ_3d8b2e98-7656-4a03-abaf-e6a78f7c6cc1"
      unitRef="usd">29983000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="id2106d7d27e2429382ccfccea124e2d2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfNS0xMy0xLTEtNTMzNTU_89472ef6-ca53-4e41-b02b-759eef035c6d"
      unitRef="usd">1016000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia410cf951ff442a7af6415951fac5467_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTYtMS0xLTEtNTMzNTU_86558552-9c84-420d-8c4c-7073064e2ef3"
      unitRef="usd">28451000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia410cf951ff442a7af6415951fac5467_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTYtNy0xLTEtNTMzNTU_6c3a0311-d77d-4221-866d-0c7ac2594b89"
      unitRef="usd">28451000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia410cf951ff442a7af6415951fac5467_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTYtOS0xLTEtNTMzNTU_acc949d7-840d-4356-b221-990a8110ed9b"
      unitRef="usd">28451000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i7656b92dc6c44155b55eebf7f72273b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTctMS0xLTEtNTMzNTU_c16b108a-666b-4dcb-860d-d8ab636f1736"
      unitRef="usd">1016000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i7656b92dc6c44155b55eebf7f72273b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTctNy0xLTEtNTMzNTU_83df4c2f-c190-459a-9c7f-a35213b82102"
      unitRef="usd">1016000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i7656b92dc6c44155b55eebf7f72273b9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTctMTMtMS0xLTUzMzU1_52d588dc-6f4b-4d2b-8425-7b5d94e5a062"
      unitRef="usd">1016000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i53f8932dab17405f952c3ec80f549c94_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTgtMS0xLTEtNTMzNTU_98f2a114-e9cd-4bcd-9f4f-cd9ac7ee090d"
      unitRef="usd">29467000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i53f8932dab17405f952c3ec80f549c94_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTgtNy0xLTEtNTMzNTU_75655199-e900-4a15-ae8f-c45e3825068c"
      unitRef="usd">29467000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i53f8932dab17405f952c3ec80f549c94_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTgtOS0xLTEtNTMzNTU_3305047f-a7ad-4be3-a4e5-eb676181f19d"
      unitRef="usd">28451000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i53f8932dab17405f952c3ec80f549c94_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOmEzNWMxMzhkNzA5YTQwMGU4NjEwZGFjOTBmYTg4ZWYzL3RhYmxlcmFuZ2U6YTM1YzEzOGQ3MDlhNDAwZTg2MTBkYWM5MGZhODhlZjNfMTgtMTMtMS0xLTUzMzU1_e8c81e85-e8d2-4654-ba92-27cc781eb781"
      unitRef="usd">1016000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi0yLTEtMS02NjU2Ng_765199df-3fda-4075-88c5-37a0b9ad1fcb"
      unitRef="usd">25000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="iacd8238416414b529e9c11e81b3cb3ea_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi00LTEtMS02NjU2Ng_9333e56f-815f-41da-8468-8822769639a7"
      unitRef="usd">35655000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i66a0e027243e4b7e8de45f9fb688f73d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi02LTEtMS02NjU2Ng_de1af30b-0af3-45bd-92c4-041d739fcd3c"
      unitRef="usd">35655000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib0ed4fcc32994c51a64df27a56bebe58_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi04LTEtMS02NjU2Ng_5ceb96f5-eea6-4984-81a9-d2c4c2dfc4d1"
      unitRef="usd">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i192f9657493242a29365f3d839d90d10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi0xMC0xLTEtNjY1NjY_d87a7533-7b07-4184-8e37-10ca18dd9d6d"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i35de4e7e785e4aa7b55659c0991572df_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi0xMi0xLTEtNjY1NjY_1ef36019-16a8-488a-8447-c615f7c16284"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id7a77d2cffbb466495dfbdb0f232de97_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi0xLTEtMS01MzM1NQ_dd9d67e1-9417-4606-a8b6-f96df9aed8eb"
      unitRef="usd">578000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i75ab6b689aa54665b3fe1c022f4f383e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi0zLTEtMS01MzM1NQ_6d204c49-bb44-4cc5-9337-e085f8c6fff1"
      unitRef="usd">568000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i719deb7dffa9447ea8e3e92416972180_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi01LTEtMS01MzM1NQ_ee7d0b5f-c192-4092-be3c-d4fb1fdc8afd"
      unitRef="usd">601000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib879a74c7d314a99bfe67a83c5ae025a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi03LTEtMS01MzM1NQ_e713c4ff-c67e-4446-80c9-727764dabbbf"
      unitRef="usd">578000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i0ec07d32c39e41fc8f6fae982f6ddbb1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi05LTEtMS01MzM1NQ_94229e0c-71b9-4d06-9d96-d43f0e3d5bbb"
      unitRef="usd">568000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i0057b63c6d1d42858acd5f470ced781d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMi0xMS0xLTEtNTMzNTU_6930e9aa-8a27-4d52-9d3c-6cda97ec13f8"
      unitRef="usd">601000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib6fc6a3e6a134443b3035ae7eef72da4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMy0xLTEtMS01MzM1NQ_36b75906-6c9b-4519-ba36-42c86dae4cc4"
      unitRef="usd">55000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i4b6e6c6f6d6d40c09000d22bf80671b7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMy0zLTEtMS01MzM1NQ_437ae7f0-87d1-48a0-8286-3dee3e76d0e5"
      unitRef="usd">53703000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2947c7abf7fa4f2691d0ca9cde5d6514_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMy01LTEtMS01MzM1NQ_7e114ca5-ef42-44b9-a29b-09210ee4d2da"
      unitRef="usd">74998000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2ccaab30a9344f92a4d5d4f061f686d2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMy03LTEtMS01MzM1NQ_d12c591f-e184-4b17-bdde-2ea52bca19ff"
      unitRef="usd">55000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i94d6459171cf40a6843977458759b899_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMy05LTEtMS01MzM1NQ_0c5a68d9-df3d-4cc7-8f5b-ca1f1aaab322"
      unitRef="usd">53592000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i25222c4b0d624dc4bd5bea0e9e94cbe1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMy0xMS0xLTEtNTMzNTU_1acf7536-0fdd-4da4-a6e5-67bbc61ad1c7"
      unitRef="usd">81880000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i918712e2e4c4473592c78603409a2035_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNC0xLTEtMS01MzM1NQ_6c36ff99-05a3-41b9-8289-eedf96421003"
      unitRef="usd">55578000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i90ccecdd5e034b9e8b3a73afd56dd029_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNC0zLTEtMS01MzM1NQ_d4ea0ab2-695c-4497-aa05-64427dab6cc3"
      unitRef="usd">54271000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i5621449148c64e2998b4cfe5304b2265_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNC01LTEtMS01MzM1NQ_e3d532cb-103d-428a-80e3-45cb7acdc66a"
      unitRef="usd">75599000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i633deee677b14f20aedd746e431d49ed_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNC03LTEtMS01MzM1NQ_d36851ac-6876-431f-82a0-21210fdb529a"
      unitRef="usd">55578000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i4d3d07f8af4b4470897c2977833f9255_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNC05LTEtMS01MzM1NQ_12c9f426-c768-4ec3-9253-7df65fed64db"
      unitRef="usd">54160000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i53271b8cc303430b9324caf250af4723_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNC0xMS0xLTEtNTMzNTU_0470fdaa-855e-4c69-a633-d24952aacada"
      unitRef="usd">82481000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i736e4e930c62488998bc7af6f80cb9a5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNi0xLTEtMS01MzM1NQ_95545c38-7441-4244-9707-f8c99ec2369f"
      unitRef="usd">10000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i7d08369cf4e743e1980090e6f9bd90e3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNi0zLTEtMS01MzM1NQ_f9f063a6-816d-4040-b2ce-b96da4e9177e"
      unitRef="usd">10106000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i744122bb17644424b7a8fd06cb0c7128_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNi01LTEtMS01MzM1NQ_44988edb-05e2-4d20-b4c7-65c1a190a6cf"
      unitRef="usd">9796000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i40c95c830e9346709b9e8f6f68d3ca08_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNi03LTEtMS01MzM1NQ_ed935bda-9748-4854-a202-44b1a610b1f5"
      unitRef="usd">10000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i430bde457f8b49c297f4b7eb59db0e6c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNi05LTEtMS01MzM1NQ_5b78b9ae-f31b-4c36-9a00-4efe8ddfaad1"
      unitRef="usd">10049000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if48c5a23863e4cd8bbe66e032efb7a3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfNi0xMS0xLTEtNTMzNTU_eaa4bf00-2a41-431d-ada3-1ac750bfc68c"
      unitRef="usd">10113000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i0a2855f667ed4c72a5b8a3fca49072e7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfOC0xLTEtMS01NTUwMA_59d517ed-450b-43e1-914a-6199b9bcedaa"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i58112e5c277c4b30a89447743fc62c04_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfOC0zLTEtMS01NTUwMA_48ec6030-acea-4cea-8ad4-13a68b908f4b"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i5bcb085019064514a3ff3a7b73e42196_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfOC01LTEtMS01NTUwMA_9f9c9d64-c38f-4d18-b3ff-2cc273835106"
      unitRef="usd">0</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i9c3dfe2aada444b685f4219ae06fcd20_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfOC03LTEtMS01NTUwMA_12a4325f-281f-4957-8f9f-ecb9e2cc1f91"
      unitRef="usd">6838000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i5b63c6fe97894fe5a0d2c4975b4da0fe_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfOC05LTEtMS01NTUwMA_7c6c130d-852f-4e0f-a538-00bcd267bde2"
      unitRef="usd">6838000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="ibf2d9ac881dc4deea1d8989f49ab808d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfOC0xMS0xLTEtNTU1MDA_1bbfbf15-289f-4e2c-b283-2ad8ffb45d9a"
      unitRef="usd">6838000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMTMtMi0xLTEtNzU3NDg_e98bfab6-2e96-4afa-8a40-cd4e7f4bf1c6"
      unitRef="usd">90578000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i4c347987f267431784a940da9799e057_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMTMtNC0xLTEtNzU3NDg_3e2e23ee-f83d-4928-9792-67a3bbbebc0a"
      unitRef="usd">100032000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i77951f80ba15446c8cd2f0e9ef5ba4f1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMTMtNi0xLTEtNzU3NDg_9226f442-6c89-40a4-ba18-b7360d2cfedf"
      unitRef="usd">121050000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMTMtOC0xLTEtNzU3NDg_f829a41e-5744-4e62-bf35-9bca336cbabf"
      unitRef="usd">72416000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i1d2a998f16924d858cf125d7c1d814bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMTMtMTAtMS0xLTc1NzQ4_cff3b7b6-6eca-4a04-be9a-e5caf83a90ee"
      unitRef="usd">71047000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i88a9b5eeb2b441ca8c84ceb94e14ff84_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF82Ny9mcmFnOjExYzI3YjUzY2M0MTQyZGE4NGQ1NDBhZmFkNzA5ZDdmL3RhYmxlOjIwNjk0NDAxODk4YjQ3YWE4OGM5NDJkZTQ2OGM0OWYyL3RhYmxlcmFuZ2U6MjA2OTQ0MDE4OThiNDdhYTg4Yzk0MmRlNDY4YzQ5ZjJfMTMtMTItMS0xLTc1NzQ4_bf2497f5-8643-4052-84bc-c9ac8170b22b"
      unitRef="usd">99432000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RleHRyZWdpb246YzFmZDg5N2RjMmE3NDBhZmI0Y2JjNTcwNzI5M2I2NTdfMTI5Ng_67d0946f-8416-4219-a194-71474adca138">Shareholders&#x2019; Equity&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Shares Reserved &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, we had reserved shares of common&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; stock for future issuance under equity compensation plans as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Securities To Be Issued Upon Exercise Of Options &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units at Maximum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number Of Remaining Securities Available For Future Issuance &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2011 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DVS Sciences Inc. 2010 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017 Inducement Award Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017 Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in the securities to be issued upon release of RSUs and PSUs are the maximum number of shares that could be issued for performance share unit awards, which can vest at 0%-200% of the number of awards granted. The number of shares available for future issuance also reflects PSU awards granted at the maximum number of shares that could be issued under these awards.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RleHRyZWdpb246YzFmZDg5N2RjMmE3NDBhZmI0Y2JjNTcwNzI5M2I2NTdfMTI5Mg_c1292410-6955-464e-88e9-425b2fd00d3d">&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, we had reserved shares of common&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; stock for future issuance under equity compensation plans as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Securities To Be Issued Upon Exercise Of Options &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units at Maximum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number Of Remaining Securities Available For Future Issuance &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2011 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DVS Sciences Inc. 2010 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017 Inducement Award Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017 Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units, stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i4d77114634a0476587c0c6e236131dd4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfMi0yLTEtMS01MzM1NQ_1b6ce137-f106-4530-90a2-28be5eea1d6d"
      unitRef="shares">1376000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i61c25a145cf849d690fe64971fb1219b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfMi00LTEtMS01MzM1NQ_5829b2fc-08be-4791-aadc-a9f42f816d47"
      unitRef="shares">7259000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="id7e1d70fc37c4900b64ff49301b03fd4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfMi02LTEtMS01MzM1NQ_b6113e83-48d6-4478-8840-9e510fa2deb1"
      unitRef="shares">3561000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ia2385c7f15ba43f4afc1f5f66be141ae_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfMy0yLTEtMS01MzM1NQ_5ed18f08-eeed-4557-b51d-2e56e29e3d20"
      unitRef="shares">6000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i03880c5036734260b46d06727e442f92_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfMy00LTEtMS01MzM1NQ_c46e1c8b-7155-47fd-b877-102da96f3c2d"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i42f0b198127148778a174350609491d0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfMy02LTEtMS01MzM1NQ_f7f5f3f7-0324-4a9d-9d89-a38342b3af1c"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ie87e1842c50e4d569dca108ae8ad47ff_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNC0yLTEtMS01MzM1NQ_cb9eb51d-4065-42c8-840d-58e60c5c1c12"
      unitRef="shares">159000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i1145f4ff09c84a6790d15188392833e4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNC00LTEtMS01MzM1NQ_23669f88-ac49-49b3-a010-11d387f23de4"
      unitRef="shares">57000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i058640ba016f4fb396b722f5d98c4df8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNC02LTEtMS01MzM1NQ_be633458-1068-448f-9330-36a797072dde"
      unitRef="shares">0</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i03c0001f48254fe3bdfc3606ca7946d0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNS0yLTEtMS01MzM1NQ_02b9bcf4-37cf-4a30-9d0a-0824b6dd1f76"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i96a7681635b84887bcccedb27f5cffe1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNS00LTEtMS01MzM1NQ_0d0590a3-08e3-4f42-9563-dd99a2ee536b"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="iec8080f040c148cd9a55c99e106e20ca_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNS02LTEtMS01MzM1NQ_508c6af9-8f6d-49d1-be0a-a5bd311db9ab"
      unitRef="shares">2633000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="iad71c918ee434181ba0fff19eced37d5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNi0yLTEtMS01MzM1NQ_a63ea090-529b-49f4-bca1-68b107582b78"
      unitRef="shares">1541000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i45fe81b2edc14e8283a89efd8ec7b239_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNi00LTEtMS01MzM1NQ_77a86a0c-f263-4b74-915e-20ca498a161f"
      unitRef="shares">7316000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RhYmxlOjM3NGFkMGM2ZGVhNDRmNDY4YWJkNWUwYjM3ZGEzODU0L3RhYmxlcmFuZ2U6Mzc0YWQwYzZkZWE0NGY0NjhhYmQ1ZTBiMzdkYTM4NTRfNi02LTEtMS01MzM1NQ_f0becac1-629d-41b3-9540-a21f4ff36ee6"
      unitRef="shares">6194000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest
      contextRef="ifbc7c42ab7c948dbb536b605def058fd_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RleHRyZWdpb246YzFmZDg5N2RjMmE3NDBhZmI0Y2JjNTcwNzI5M2I2NTdfNjU5NzA2OTc2OTQwNA_6d0775b3-cc60-43ea-90e4-cfaccb8ceb44"
      unitRef="number">0</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest
      contextRef="id07ffabfcd0b42608b10129b2e59ffd5_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83MC9mcmFnOmMxZmQ4OTdkYzJhNzQwYWZiNGNiYzU3MDcyOTNiNjU3L3RleHRyZWdpb246YzFmZDg5N2RjMmE3NDBhZmI0Y2JjNTcwNzI5M2I2NTdfNjU5NzA2OTc2OTQwOA_f89f4749-b202-4746-b7f1-78a907d80185"
      unitRef="number">2</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk1OQ_cdaa3385-cb11-49f9-b5b4-f16e40514b25">Stock-Based Plans&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our board of directors sets the terms, conditions, and restrictions related to our 2017 Employee Stock Purchase Plan (ESPP) and the grant of stock options, restricted stock units (RSUs) and performance-based awards under our equity incentive plans. Our board of directors determines the number of awards to grant and also sets vesting criteria. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In general, RSUs vest on a quarterly basis over a period of four years from the date of grant at a rate of 25% on the first anniversary of the grant date and ratably each quarter over the remaining 12 quarters, or ratably over 16 quarters, subject to the employees&#x2019; continued employment. We may grant RSUs with different vesting terms from time to time. In the first quarter of 2022, we granted 0.8&#160;million of retention RSUs which vest within one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incentive stock options and non-statutory stock options granted under our 2011 Equity Incentive Plan (2011 Plan) have a term of no more than ten years from the date of grant and an exercise price of at least 100% of the fair market value of the underlying common stock on the date of grant. Generally, options vest at a rate of either 25% on the first anniversary of the option grant date and ratably each month over the remaining period of 36 months, or ratably each month over 48 months. We may grant options with different vesting terms from time to time. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For performance-based share awards, our board of directors sets the performance objectives and other vesting provisions in determining the number of shares or value of performance units and performance shares that will be paid out. Such payout will be a function of the extent to which performance objectives or other vesting provisions have been achieved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2011 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January&#160;2011, our board of directors adopted the 2011 Plan under which incentive stock options, non-statutory stock options, RSUs, stock appreciation rights, performance stock units (PSUs), and performance shares may be granted to our employees, directors, and consultants. In April 2019, our board of directors authorized, and in June 2019, our stockholders approved an amendment and restatement of the 2011 Plan to make various changes, including increasing the number of shares reserved for issuance by approximately 5.0 million shares and extending the term of the 2011 Plan until April 2029. In May 2020, our board of directors authorized, and in June 2020, our stockholders approved, an increase of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.4&#160;million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; shares reserved for issuance under the 2011 Plan. In April 2021, our board of directors authorized, and in May 2021, our stockholders approved, an additional increase of 4.1&#160;million shares reserved for issuance under the 2011 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the various plans was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units&lt;br/&gt;&#160;(in 000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair Value per Unit&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the unrecognized compensation costs related to outstanding unvested RSUs under our equity incentive plans were $21.8 million. We expect to recognize those costs over a weighted average period of 2.2 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;Options (000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;br/&gt;per Option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average Remaining Contractual Life (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intrinsic &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt; in (000s)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested awards at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Aggregate intrinsic value as of March&#160;31, 2022 was calculated as the difference between the closing price per share of our common stock on the last trading day of March&#160;31, 2022, which was $3.59, and the exercise price of the options, multiplied by the number of in-the-money options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the unrecognized compensation costs related to outstanding unvested options under our equity incentive plans were $0.1 million. We expect to recognize those costs over a weighted average period of 0.5 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance-based Awards:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Stock Units with Market Condition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have granted PSU awards to certain executive officers and senior level employees. The number of PSUs ultimately earned under these awards is calculated based on the Total Shareholder Return (TSR) of our common stock as compared to the TSR of a defined group of peer companies during the applicable three-year performance period. The percentage of PSUs that vest will depend on our relative position at the end of the performance period and can range from 0% to 200% of the number of units granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on the performance of our stock relative to our defined group of peer companies, none of the PSUs awarded in 2019 for the 2019-2021 measurement period were vested. The performance adjustment in the table below reflects that no shares were issued upon vesting of the 2019 PSU awards. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the TSR-based PSUs is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units &lt;br/&gt;(in 000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair Value per Unit&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance adjustment for 2019 awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of&#160;March&#160;31, 2022, the unrecognized compensation costs related to these awards were $3.2 million. We expect to recognize those costs over a weighted average period of 1.6 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance Stock Units with Performance Conditions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2019, we granted performance stock units to an employee. The number of performance stock units that ultimately vested under these awards was dependent on the employee achieving certain discrete operational milestones, the last of which was measured at December 31, 2021. In early 2022, it was determined that the operational milestones were not met and the 29&#160;thousand awards that were outstanding on December 31, 2021 were cancelled.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2017 Employee Stock Purchase Plan (ESPP)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our ESPP offers U.S. and some non-U.S. employees the right to purchase shares of our common stock. Our ESPP program has a six-month offering period, with a new period commencing on the first trading day on or after May 31 and November 30 of each year. Employees are eligible to participate through payroll deductions of up to 10% of their compensation. Employees may not purchase more than $25 thousand of stock for any calendar year. The purchase price at which shares are sold under the ESPP is 85% of the lower of the fair market value of a share of our common stock on the first day of the offering period or the last day of the offering period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units, stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNDMz_1f3a5c61-81e1-4faa-adbe-a7e0ce5f80f1">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNDc5_85241f0e-ca4a-4ca7-9d66-033be5071999"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ida95b698f6f541feb12d26c1e08f3545_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNjA0NzMxMzk2NDQzNQ_89270ba7-e109-4303-b5e7-b3838b0117d9"
      unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ida95b698f6f541feb12d26c1e08f3545_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTQ5NzU1ODE1MTAxOA_e4cc5da0-38be-4c69-8c26-d1097bbbf8ac">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i9af5c9a4df634b10aa18bac8dd63496d_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfODEz_ed0d6b30-a194-4f9c-95b4-061c9b60fded">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <fldm:StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue
      contextRef="i9af5c9a4df634b10aa18bac8dd63496d_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfODcz_1a2a0fb7-3f5d-4a99-a77e-645d21827611"
      unitRef="number">1</fldm:StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue>
    <fldm:PortionOfStockOptionsVestOnFirstAnniversary
      contextRef="ida95b698f6f541feb12d26c1e08f3545_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfOTk4_9fe0b265-a5d4-4491-9f73-f11d5c8037d6"
      unitRef="number">0.25</fldm:PortionOfStockOptionsVestOnFirstAnniversary>
    <fldm:NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement
      contextRef="i1f2f332657784dd188961528d24aadfb_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMTEwMw_03406cda-c77a-4ea5-8465-0ddef1bb7b2b">P36M</fldm:NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement>
    <fldm:NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement
      contextRef="i227d5a5fe544411ea37d71f144593da9_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMTEzNA_7634646c-230b-4f0c-8b02-81b47e53fcf0">P48M</fldm:NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i12d6eaf877364d5dbf2a9fe63b59e9aa_D20190601-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMjExNQ_7cb56aec-fa0f-4847-9b3d-e8a4a70d8174"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="icefddd7e6aa7456685103922b493fb0b_D20200601-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNjA0NzMxMzk2NDQ0Ng_f32e11bd-facb-48ff-a242-f11b3a4d67ee"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i8b311a9055cd4350a32fbf48c1d51dcf_D20210501-20210531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMjQ4MQ_17cc7a13-96dc-43c9-85f1-518fd799f994"
      unitRef="shares">4100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTkzOA_d1b1b964-5d0a-41fd-86b3-91aca1089035">&lt;div style="margin-bottom:8pt;margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the various plans was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units&lt;br/&gt;&#160;(in 000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair Value per Unit&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSU forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1b27a08b375d4bd6a7bdb7050cb92f97_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfMS0yLTEtMS01MzM1NQ_75276d1b-101e-4628-bc4d-732d457d7934"
      unitRef="shares">5141000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1b27a08b375d4bd6a7bdb7050cb92f97_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfMS00LTEtMS01MzM1NQ_2e8564f1-e522-42c1-9695-93d0678a9b15"
      unitRef="usdPerShare">5.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfMi0yLTEtMS01MzM1NQ_42e4c7d0-a2ba-4195-b8a7-21e786b804c4"
      unitRef="shares">808000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfMi00LTEtMS01MzM1NQ_3e93d85f-de24-42af-ab6f-b191ed90f77b"
      unitRef="usdPerShare">3.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfMy0yLTEtMS01MzM1NQ_62bddf8e-1f99-48f1-84c2-c5214c840074"
      unitRef="shares">302000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfMy00LTEtMS01MzM1NQ_3580f983-f89c-4477-9e06-874e5f18ebe0"
      unitRef="usdPerShare">5.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfNC0yLTEtMS01MzM1NQ_e52bcfa3-fbc9-4865-b768-ea389175f383"
      unitRef="shares">70000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfNC00LTEtMS01MzM1NQ_a46618cb-3222-4d86-a604-8d70529e03aa"
      unitRef="usdPerShare">5.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3fa095588fa743319343a18e9698ac0e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfNS0yLTEtMS01MzM1NQ_fa784271-bbd4-46af-8713-3e3149a41e12"
      unitRef="shares">5577000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i3fa095588fa743319343a18e9698ac0e_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjUxMDhmNGYxYWYwMDRhNDhiNDAxNWRkNmJjNGNiYjU0L3RhYmxlcmFuZ2U6NTEwOGY0ZjFhZjAwNGE0OGI0MDE1ZGQ2YmM0Y2JiNTRfNS00LTEtMS01MzM1NQ_55c478e3-c7d8-40b8-b0df-808b62f75c97"
      unitRef="usdPerShare">4.94</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i3fa095588fa743319343a18e9698ac0e_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMjc0Nw_7e276688-7de8-41f7-9616-10b45e85ad8f"
      unitRef="usd">21800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk1MQ_f3798e83-8778-44e5-9d15-6b1f101bf47d">P2Y2M12D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk0NA_2ad0bd13-1034-4c94-9140-301983e64b9e">&lt;div style="margin-bottom:8pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:right"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.098%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;Options (000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;br/&gt;per Option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average Remaining Contractual Life (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Intrinsic &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Value &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt; in (000s)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested awards at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;_______&lt;/span&gt;&lt;/div&gt;(1)Aggregate intrinsic value as of March&#160;31, 2022 was calculated as the difference between the closing price per share of our common stock on the last trading day of March&#160;31, 2022, which was $3.59, and the exercise price of the options, multiplied by the number of in-the-money options.</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMS0yLTEtMS01MzM1NQ_eb435a80-5fce-4bf3-8b96-a53d3991f2c4"
      unitRef="shares">1597000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMS00LTEtMS01MzM1NQ_595c0c67-ba46-4fb3-b7a1-1fcd9b039ae4"
      unitRef="usdPerShare">7.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i41bfbc4f8008465d885af193c5915937_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMS02LTEtMS01MzM1NQ_6a44efeb-2a7a-4b04-b4df-3594122db64b">P5Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMS04LTEtMS01MzM1NQ_a77e0ca3-6d4f-406a-af6e-1cec033dc35e"
      unitRef="usd">82000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMi0yLTEtMS01MzM1NQ_53460431-2ebf-444f-bd89-9a80edbe398d"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMi00LTEtMS01MzM1NQ_f5116cb3-b99f-4b88-92f1-93d0918cc89e"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMy0yLTEtMS01MzM1NQ_2a964858-7b2c-4646-9af2-98b32d31413a"
      unitRef="shares">8000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMy00LTEtMS01MzM1NQ_bee33e38-3624-491a-96a3-0975376e7d8c"
      unitRef="usdPerShare">2.63</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfMy04LTEtMS01MzM1NQ_eb415284-8ea6-4955-8005-ad0ad9629d96"
      unitRef="usd">7000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNC0yLTEtMS01MzM1NQ_d81a098e-8311-4f5e-8e61-bfb3c1ea6fdd"
      unitRef="shares">47000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNC00LTEtMS01MzM1NQ_ac7525e9-8d07-4234-9315-413e07593e96"
      unitRef="usdPerShare">14.84</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNS0yLTEtMS01MzM1NQ_78cf5763-539a-4f71-bb1a-bad8acd825cd"
      unitRef="shares">1542000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNS00LTEtMS01MzM1NQ_7be4b6a1-085f-4ac1-ae79-22d9666789ad"
      unitRef="usdPerShare">6.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNS02LTEtMS01MzM1NQ_d4e2e74c-e938-44f1-a88e-62555661b995">P5Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNS04LTEtMS01MzM1NQ_fe6a5719-9908-44b2-96c8-c7553c8892c0"
      unitRef="usd">35000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNi0yLTEtMS01MzM1NQ_789bd27e-efb2-4906-b6f4-63c6514bdea8"
      unitRef="shares">1469000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNi00LTEtMS01MzM1NQ_54aeed53-df7e-41db-8fdd-ec2303ca1dda"
      unitRef="usdPerShare">6.89</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNi02LTEtMS01MzM1NQ_1fc87896-931a-4c64-b9a7-03e259cc47e7">P5Y4M24D</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNi04LTEtMS01MzM1NQ_f91f8772-6e0c-4053-a1c0-861525a985c7"
      unitRef="usd">35000</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNy0yLTEtMS01MzM1NQ_162b42f3-d1e6-4d0c-b893-d80384e81e4d"
      unitRef="shares">73000</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNy00LTEtMS01MzM1NQ_e5134bc0-bf0c-4a38-a750-e90d8d9a959a"
      unitRef="usdPerShare">6.34</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNy02LTEtMS01MzM1NQ_3e64867c-961e-43a0-82ba-22897de96a19">P8Y4M24D</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjNkYjBmZTAyY2VkYzRjNTA4MWFhYzJlODEzYThkYjM0L3RhYmxlcmFuZ2U6M2RiMGZlMDJjZWRjNGM1MDgxYWFjMmU4MTNhOGRiMzRfNy04LTEtMS01MzM1NQ_fc4c8437-5116-4c2d-a320-5ca0f22c7ac7"
      unitRef="usd">0</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharePrice
      contextRef="i29e61f9e346c4c1e80fed44ed1f1e293_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMzAyMg_ed22d8ec-e707-4b87-b0a3-803463b486cf"
      unitRef="usdPerShare">3.59</us-gaap:SharePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i1b42cfc93e2b4c79b0b5d4699ce58cae_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMzI0MA_decebf7a-5248-4462-835c-f14f4c6fa067"
      unitRef="usd">100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="ib321b7bc2a2347bda69869d595adc12e_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk1NQ_e8ef4238-54d2-4f48-b379-ad1e2d176597">P0Y6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk0MA_6796fdb8-2886-4c9b-ab2d-973ffc54f352">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest
      contextRef="ifbc7c42ab7c948dbb536b605def058fd_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMzg1MQ_21481c74-7e2b-410d-a730-31ed4255d97d"
      unitRef="number">0</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest
      contextRef="id07ffabfcd0b42608b10129b2e59ffd5_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMzg1Nw_0fbffbb9-ecd6-468d-8e6e-e06fb1bb2803"
      unitRef="number">2</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMTIwOTQ2Mjc5MTc2MjQ_c76c9075-d3d5-4efc-9d2e-ee131d7ff9b7"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk1Mw_21935f03-ff02-4c36-b926-8fec074b41b0">&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity under the TSR-based PSUs is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.999%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Units &lt;br/&gt;(in 000s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant Date Fair Value per Unit&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance adjustment for 2019 awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PSU forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i357950952be44c25a149476baf5f1338_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfMS0yLTEtMS01MzM1NQ_2169eb3f-6253-4061-b08a-659ff433099c"
      unitRef="shares">1210000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i357950952be44c25a149476baf5f1338_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfMS00LTEtMS01MzM1NQ_6fab7dee-0afc-428d-8ebd-660e021d93f6"
      unitRef="usdPerShare">10.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfMi0yLTEtMS01MzM1NQ_07480a36-e5cb-47e0-b385-01f82788e2e8"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfMi00LTEtMS01MzM1NQ_88f256b7-779f-43f0-b247-c45721a1a186"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod
      contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfMy0yLTEtMS01MzM1NQ_8c8ce813-7a79-4fa1-a28d-6f50757caa49"
      unitRef="shares">-341000</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod>
    <fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfMy00LTEtMS01MzM1NQ_8813ecb9-edcd-42ee-8701-5f1f63119801"
      unitRef="usdPerShare">16.97</fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfNC0yLTEtMS01MzM1NQ_1d83cb8b-5c3b-4604-accd-037787055be6"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfNC00LTEtMS01MzM1NQ_2e9be8bd-6b3c-4e6f-a962-3162d386f8a1"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfNS0yLTEtMS01MzM1NQ_eb8f2efa-d62a-4b83-ada2-c095c1e85c53"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfNS00LTEtMS01MzM1NQ_5b3ca31b-04a4-4335-a9d4-02a7f6974f30"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ic924218fbf5a4d91b76fd02ad51f0368_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfNi0yLTEtMS01MzM1NQ_a2eb51e1-2fd9-41aa-9301-33ce26121aef"
      unitRef="shares">869000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ic924218fbf5a4d91b76fd02ad51f0368_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjE4ZGY3MDhiYjk4ZTQzNjBhYWRkMTZkMTFiNTA4NjY0L3RhYmxlcmFuZ2U6MThkZjcwOGJiOThlNDM2MGFhZGQxNmQxMWI1MDg2NjRfNi00LTEtMS01MzM1NQ_2a72f24d-1554-4745-9660-2ec8a0cb354f"
      unitRef="usdPerShare">7.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ic924218fbf5a4d91b76fd02ad51f0368_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNDYxMQ_670fa4da-13fc-4936-8da8-2055712e3038"
      unitRef="usd">3200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i9952de5a76e64ec29004ace9ab9527bb_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk0Ng_b1ba583b-4f8d-4d62-a58b-c8944a230453">P1Y7M6D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i63b45dc8c7f84841a01e93bde43297e1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfMTIwOTQ2Mjc5MTcxMDM_5f936d9f-e594-4066-9ffa-fec752729510"
      unitRef="shares">29000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <fldm:EmployeeStockPurchasePlanOfferingPeriod
      contextRef="i976dac4ee8d24a6b9937b433c337665a_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTk0Nw_d2068f8f-42ce-4949-b071-ee80a827ce2b">P6M</fldm:EmployeeStockPurchasePlanOfferingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="i6f8238e8d8694c059385a480dcb687e1_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTUxMQ_ce9e7477-5b48-4925-b8f9-e8ff6d008094"
      unitRef="number">0.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <fldm:SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount
      contextRef="i976dac4ee8d24a6b9937b433c337665a_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTU3NA_bbd3b2ce-918d-423a-9e03-b2ebea4c38a4"
      unitRef="usd">25000</fldm:SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i976dac4ee8d24a6b9937b433c337665a_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RleHRyZWdpb246MmNiMzJkNjQ5YmQwNGVmZmI3MjU0OGFiYTMyZWUxZGNfNTY3MQ_8de4fbcf-f71f-441e-b2ca-34bf32e1eaa9"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9291755db0804b7e971901deb2d9a94a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjA0ZjM5ZDk5ODA3ZDQzMTc4YzU4N2M1ODJlNWM0Njk1L3RhYmxlcmFuZ2U6MDRmMzlkOTk4MDdkNDMxNzhjNTg3YzU4MmU1YzQ2OTVfMi0yLTEtMS01MzM1NQ_040c1b1f-ccae-49ab-8a16-902ae6743c05"
      unitRef="usd">3942000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i45dc092a669a4531bc189ae9f0583e68_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjA0ZjM5ZDk5ODA3ZDQzMTc4YzU4N2M1ODJlNWM0Njk1L3RhYmxlcmFuZ2U6MDRmMzlkOTk4MDdkNDMxNzhjNTg3YzU4MmU1YzQ2OTVfMi00LTEtMS01MzM1NQ_15c0b969-7009-41e0-b60b-dd1e1f18dfeb"
      unitRef="usd">3473000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7f805e7f1d6c46a69b33311aa284f9dd_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjA0ZjM5ZDk5ODA3ZDQzMTc4YzU4N2M1ODJlNWM0Njk1L3RhYmxlcmFuZ2U6MDRmMzlkOTk4MDdkNDMxNzhjNTg3YzU4MmU1YzQ2OTVfMy0yLTEtMS01MzM1NQ_ce91b095-4a5a-4254-86f4-d5c123a67d32"
      unitRef="usd">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id192327cb55c41259f9faa5f5322725c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjA0ZjM5ZDk5ODA3ZDQzMTc4YzU4N2M1ODJlNWM0Njk1L3RhYmxlcmFuZ2U6MDRmMzlkOTk4MDdkNDMxNzhjNTg3YzU4MmU1YzQ2OTVfMy00LTEtMS01MzM1NQ_f5f6d7b7-fcc7-4d01-8113-3f329a24bcb1"
      unitRef="usd">204000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjA0ZjM5ZDk5ODA3ZDQzMTc4YzU4N2M1ODJlNWM0Njk1L3RhYmxlcmFuZ2U6MDRmMzlkOTk4MDdkNDMxNzhjNTg3YzU4MmU1YzQ2OTVfNC0yLTEtMS01MzM1NQ_f389de9d-e31e-4071-b52c-2fa538fbc85f"
      unitRef="usd">4042000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83My9mcmFnOjJjYjMyZDY0OWJkMDRlZmZiNzI1NDhhYmEzMmVlMWRjL3RhYmxlOjA0ZjM5ZDk5ODA3ZDQzMTc4YzU4N2M1ODJlNWM0Njk1L3RhYmxlcmFuZ2U6MDRmMzlkOTk4MDdkNDMxNzhjNTg3YzU4MmU1YzQ2OTVfNC00LTEtMS01MzM1NQ_653a5bde-c022-4743-8bc0-f7858437d6df"
      unitRef="usd">3677000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83Ni9mcmFnOjFjMmJkM2UwYjc5MjQ3YzQ5NjAzNTM0MDZmYmEyYzNkL3RleHRyZWdpb246MWMyYmQzZTBiNzkyNDdjNDk2MDM1MzQwNmZiYTJjM2RfMjgwOQ_5342c03b-5d91-4617-acd8-5420afadbe5f">Income Taxes&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our quarterly provision for income taxes is based on an estimated effective annual income tax rate. Our quarterly provision for income taxes also includes discrete items, such as changes in valuation allowances or adjustments upon finalization of tax returns as well as infrequently occurring items, if any, such as the effects of changes in tax laws or rates, in the interim period in which they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded a tax benefit of $0.6 million and $1.7&#160;million for the three months ended March&#160;31, 2022 and 2021, respectively. Lower losses in our foreign operations in the quarter ended March&#160;31, 2022 compared to the quarter ended March&#160;31, 2021 resulted in a lower tax benefit for our foreign operations for the three months ended March&#160;31, 2022 compared to the prior year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our tax benefit for the periods presented in this report differs from the 21% U.S. Federal statutory rate principally because we maintain a valuation allowance for our domestic deferred tax assets, which primarily consist of net-operating loss carryforwards.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recording deferred tax assets is appropriate when realization of these assets is more likely than not. Assessing the realizability of deferred tax assets is dependent upon several factors including historical financial results and future expected financial results. Domestic deferred tax assets have been offset by valuation allowances. Any release of valuation allowances could have the effect of decreasing the income tax provision in the period the valuation allowance is released. We continue to assess the likelihood that we will be able to recover our deferred tax assets, including those for which a valuation allowance is recorded. There can be no assurance that we will generate profits in the future periods enabling us to fully realize our deferred tax assets. The timing of recording a valuation allowance or the reversal of such valuation allowance is subject to objective and subjective factors that cannot be readily predicted in advance.&lt;/span&gt;&lt;/div&gt;Our tax positions are subject to audits by multiple tax jurisdictions. We believe that we have provided adequate reserves for uncertain tax positions for all tax years still open for assessment. For the three months ended March&#160;31, 2022&#160;and 2021, respectively, we did&#160;not recognize any material interest or penalties related to uncertain tax positions.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83Ni9mcmFnOjFjMmJkM2UwYjc5MjQ3YzQ5NjAzNTM0MDZmYmEyYzNkL3RleHRyZWdpb246MWMyYmQzZTBiNzkyNDdjNDk2MDM1MzQwNmZiYTJjM2RfNDU1_7e2027ed-782d-4793-9f16-93d681766a66"
      unitRef="usd">-600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib0a9110a95a942bf9f38abcebe0f9eae_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83Ni9mcmFnOjFjMmJkM2UwYjc5MjQ3YzQ5NjAzNTM0MDZmYmEyYzNkL3RleHRyZWdpb246MWMyYmQzZTBiNzkyNDdjNDk2MDM1MzQwNmZiYTJjM2RfNDYy_7068966b-3211-4c9a-96b0-0e963e2ab20e"
      unitRef="usd">-1700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTYwNg_f5ed101e-db53-4327-9c89-a7953cba92a2">Information About Geographic Areas&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in one reporting segment that develops, manufactures and commercializes tools for life science research. Our chief executive officer manages our operations and evaluates our financial performance on a consolidated basis. For purposes of allocating resources and evaluating regional financial performance, our chief executive officer reviews separate sales information for the different regions of the world. Our general and administrative expenses and our research and development expenses are not allocated to any specific region. Most of our principal operations, other than manufacturing, and our decision-making functions are located at our corporate headquarters in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary table of our revenue by geographic areas of our customers and by product and services for the three months ended March&#160;31, 2022 and 2021 is included in Note 6 to the condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from customers in the United States represented $11.8 million, or 45% of total revenues, and $18.1 million, or 55% of total revenues, for the three months ended March&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from customers in China represented $2.8 million, or 11% of total revenues, and $3.0 million, or 9% of total revenues, for the three months ended March&#160;31, 2022 and 2021, respectively. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With the exception of China for the three months ended March&#160;31, 2022, no foreign country had revenue in excess of 10% of total revenues during any of the periods presented in this report.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfNTg_9f7c5ec9-b026-48a0-9a20-837a4fb9027d"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i890754c6557847938cb71a04d83d4e22_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfOTc3_e02b2b7d-ba53-49de-9300-f87014b809f5"
      unitRef="usd">11800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i890754c6557847938cb71a04d83d4e22_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfOTg0_5212f1de-1f1b-4d24-b1e2-97449d24cf15"
      unitRef="number">0.45</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6825599028a44895afeda749b0c6a2be_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTAxMA_c65c3a3e-9d1f-458d-b041-01764f00258f"
      unitRef="usd">18100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6825599028a44895afeda749b0c6a2be_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTAxNw_af2452f8-74b6-433a-8c06-a30fb029b3e3"
      unitRef="number">0.55</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd04707bc427433aa0a24baf6c191f0c_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTI2Mw_acd5e346-6d1a-4670-9872-661b9ae8d96a"
      unitRef="usd">2800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icd04707bc427433aa0a24baf6c191f0c_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTI3MA_9113905c-4d97-4111-afa5-1d36fec03a38"
      unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i448c3bd9337e456095cdb94a8fa30336_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTI5Nw_e7e97918-fbd2-43af-94d2-dbb2cf842b8d"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i448c3bd9337e456095cdb94a8fa30336_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF83OS9mcmFnOjlkMjM0NzNkZmQ2NzQ3YjI4NDdkYzdiMjE2Y2IwODlmL3RleHRyZWdpb246OWQyMzQ3M2RmZDY3NDdiMjg0N2RjN2IyMTZjYjA4OWZfMTMwNA_7fff89d7-b571-4f39-a3d5-791868c53739"
      unitRef="number">0.09</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF84Mi9mcmFnOmU3YjdjODI5ZDI2YjQxMzJiZDgxMzAxNTY4ZWZhNDg5L3RleHRyZWdpb246ZTdiN2M4MjlkMjZiNDEzMmJkODEzMDE1NjhlZmE0ODlfMzM3MA_f9ce0d0e-6cbb-4da0-ba54-fa8cb7559ffa">Commitments and Contingencies&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Indemnification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we have entered into indemnification provisions under certain of our agreements in the ordinary course of business, typically with business partners, customers, and suppliers. Pursuant to these agreements, we may indemnify, hold harmless, and agree to reimburse the indemnified parties on a case-by-case basis for losses suffered or incurred by the indemnified parties in connection with any patent or other intellectual property infringement claim by any third party with respect to our products. The term of these indemnification provisions is generally perpetual from the time of the execution of the agreement. The maximum potential amount of future payments we could be required to make under these indemnification provisions is typically not limited to a specific amount. In addition, we have entered into indemnification agreements with our officers, directors, and certain other employees. With certain exceptions, these agreements provide for indemnification for &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;related expenses including, among others, attorneys&#x2019; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020, a putative class action complaint alleging violations of the federal securities laws was filed against the Company (also naming our now-former Chief Executive Officer and our Chief Financial Officer as defendants) in the U.S. District Court for the Northern District of California (Reena Saintjermain, et al. v. Fluidigm Corporation, et al). The Court appointed a lead plaintiff and lead counsel in December 2020, and an amended complaint was filed on February 19, 2021. The complaint, as amended, seeks unspecified damages on behalf of a purported class of persons and entities who acquired our common stock between February 7, 2019 and November 5, 2019 and alleges securities laws violations based on statements and alleged omissions made by the Company during such period. The Company filed a motion to dismiss the complaint on April 5, 2021 and, on August 4, 2021, the Court granted defendants&#x2019; motion to dismiss with leave to amend. A second amended complaint was filed on September 14, 2021. The Company filed a motion to dismiss the second amended complaint on October 29, 2021 and, on February 14, 2022, the Court granted defendants&#x2019; motion and dismissed the second amended complaint with prejudice. On March 15, 2022, plaintiff filed a Notice of Appeal to the U.S. Court of Appeals for the Ninth Circuit. We believe the claims alleged in the complaint lack merit and we intend to defend this action vigorously. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may be subject to various legal proceedings and claims arising in the ordinary course of business. These include disputes and lawsuits related to intellectual property, mergers and acquisitions, licensing, contract law, tax, regulatory, distribution arrangements, employee relations and other matters. Periodically, we review the status of each matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we continue to reassess the potential liability related to pending claims and litigation and may revise estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMjA5NDYyNzkxMjk2Mw_cb5149e1-2db3-4f9a-886f-cfb660507371">Subsequent Event&lt;div style="margin-bottom:8pt;margin-top:3pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2022, our&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; stockholders approved the Charter Amendment Proposal and Private Placement Issuance Proposal discussed in Note 3. The Private Placement Issuance closed on April 4, 2022. On April 4, 2022, we received $225&#160;million, before expenses, and issued 225,000 shares of Series B Preferred Stock pursuant to the Purchase Agreements. The Bridge Loans converted into 30,559 shares of Series B Preferred Stock based on a Conversion Amount, as described in Note 3, of $25.5&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following stockholder approval of the Charter Amendment Proposal and the Private Placement Issuance Proposal, our name was changed to Standard BioTools Inc. Shortly after the closing of the Private Placement Issuance, we also changed the ticker symbol for our common stock to LAB. Upon the closing of the Private Placement Issuance, Dr. Michael Egholm was appointed as the Company&#x2019;s President and Chief Executive Officer and as a member of the Board of Directors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;margin-top:8pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the closing, we adopted the 2022 Inducement Equity Incentive Plan with an initial reserve of approximately 9.5&#160;million shares. Effective April 4, 2022, we awarded options for 8.1&#160;million shares of our common stock at an exercise price of $3.99 per share and 1.4&#160;million restricted stock units to members of our management team, including Dr. Egholm under the 2022 Inducement Equity Incentive Plan. These awards vest over four years.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="ic3dda181cdd645f793c5612b9ec9660b_D20220404-20220404"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDc0Mg_ff195f61-1068-4b38-87bf-0dd7a3715a4f"
      unitRef="usd">225000000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ic3dda181cdd645f793c5612b9ec9660b_D20220404-20220404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDc1Ng_36121433-9867-427f-8d07-d70221b5dcf8"
      unitRef="shares">225000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="ic3dda181cdd645f793c5612b9ec9660b_D20220404-20220404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDc2NQ_c1c48069-d1e4-4fb6-ba01-72791867fe17"
      unitRef="shares">30559</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="ic3dda181cdd645f793c5612b9ec9660b_D20220404-20220404"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDc3Mw_5d3690f6-f8cd-40c1-9f49-20bec00b2da9"
      unitRef="usd">25500000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ib980c3b074f94dd4a574cde692cff868_I20220404"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDc4Nw_65acb1e4-2997-40ab-88d8-46d2943b47e7"
      unitRef="shares">9500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i9b39f3273ab44415baf1d8b96c519c44_D20220404-20220404"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDgwMA_5ac1dd38-d7e6-4d05-aa7a-2b9345886a8c"
      unitRef="shares">8100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i9b39f3273ab44415baf1d8b96c519c44_D20220404-20220404"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDgxMw_e3d3ddee-5354-4bf5-9d8b-9c91bacf9de2"
      unitRef="usdPerShare">3.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ic5320ad3429740cc9ae7dfdcc463a85f_D20220404-20220404"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDgyMA_afeefc0e-dda6-4b53-971b-581c78fa0591"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9b39f3273ab44415baf1d8b96c519c44_D20220404-20220404"
      id="id3VybDovL2RvY3MudjEvZG9jOjNmNTJmNzg4NThiMDQ3M2I5ODNhMjE1MzI5M2QwNGUwL3NlYzozZjUyZjc4ODU4YjA0NzNiOTgzYTIxNTMyOTNkMDRlMF8yMTc4L2ZyYWc6ODlmM2E3NmY0MGVmNDM2YTk2NGEwMzVhNjU2NDZhMTYvdGV4dHJlZ2lvbjo4OWYzYTc2ZjQwZWY0MzZhOTY0YTAzNWE2NTY0NmExNl8xMzE5NDEzOTU0MDg0Ng_baa605dc-c1cc-4fb8-ac89-ca74ed333e99">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>83
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" "S<JE4U=W; T$%  !V%0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;)6875/K-A"&KT]_A2;3BW-F"+;D),"9P(P)T&;*1\"TG=-.+Q1;23S8DBO+
M"?S[KIS$!L99NS<0?^SKQROYW97&&Z5?\I40AKRFB<S/>RMCLN^.DX<KD?+\
M6&5"PI6%TBDW<*B73IYIP:,R*$T<YKHC)^6Q[%V,RW,S?3%6A4EB*6::Y$6:
M<OUV*1*U.>_1WO[$4[Q<&7O"N1AG?"D"87[/9AJ.G$HEBE,A\UA)HL7BO.?3
M[Q./V8#RCC]BL<G?_2;V5>9*O=B#:73><RV12$1HK 2'?VLQ$4EBE8#CWYUH
MKWJF#7S_>Z]^4[X\O,R<YV*BDC_CR*S.>Z<]$HD%+Q+SI#:_BMT+#:U>J)*\
M_$LVVWN'K$?"(C<JW04#01K+[7_^NDO$NX !/1# =@'L4P =' CP=@%>^:);
MLO*UKKCA%V.M-D3;NT'-_BAS4T;#V\32#F-@-%R-(<Y<3-1::-(G^8IKD8\=
M YKVBA/NXB^W\>Q O$?NE#2KG%S+2$0?XQU@J8#8'NB2H8)W7!\3CQX1YC+6
MP#/!P_W,AKM-X1]PO"H_7JGGH?GYVY_G1L.4^P>1'%22@U)R<$#R2H4%? B&
M/+]EHBGC>#AU^X\(Q;"B&':C>"RX-D(G;^1)9$J;)B)<RNA"($2CBFC4C6@F
M=*PB.Z,(S.G&%.%*^SGTTY<O+=/@I&([Z3AFFH.%E0YT.%VXUH(G.9:OTXKI
M%-6YEB8V;^0F3@2Y+]*YT$TLN(;KTKXWH*<NPG-6\9QUX7D2R]A^+)"L>YXV
MCAZN$SS[]U?^TQ6YG#X\/SS<!F1Z/SE& *E;FYW;!7$J0Z5A\+@=QR,2&)AE
M1&DR484T^@W^1XW<+>I7UQCD.T>F72"?^2N91C#GXD4<EJ3(*+=(GISTW2'U
MZ!DVSI35A*P+H1]%4#/RH_T/<@OWD0?9G#M<DI%GM0&GG24\%'9(!#BXB^+6
M%DZ]_X4[L4<PW/!$V8B*RP70#:U(P"6Y@5D>QGFHCC#.NBY0W-D_<U;S<J;5
M.I9A<UYQS8F/H=7%@N(6_QEMIG+#$_)7G!W^6'#%LX&+N@ZMRP;%W;X<3A]Z
MV,,HN,!HB(+4-8+BQGZK0LC);*4D9L@M(FPTZH]:9GY=(2AN[\^Q@>*@%H2R
MK_-O)!!AH2%;C5BXTD2E*3A08%3X<D1^=H^A<I",:[+F22%(!I]NV4)BV'4A
MH7@%@"(;Q7))@K=TKI)&6ES@UK_$6M&Z7C#<T?<)(]>OX8K+I3A8TEJ$[OW@
MRL?:-E:7!]:I/$P*K6U#LNU"RFR!712-+7R+XH_/C?]'LKHLL$YE82JAG=PN
MSVS_QO>HC62X8@M970%8IPI@6R6H\N"J2Z4;OX(6'3\,80$*?8.(MF(87>W[
MK)/O!RE/$G)9Y' Y;QY'7*>ML62UW;-.=G^="KVT4^L74(":!R:0<=F<.%RP
M%:UV>X:;]3Y9*UCYHT"X3"M0[?H,-^S]]_C!((-R.4T>"@-U4I9F]C66NU7V
MM\9E[?8IP_(I=O-E#5T;&S+J#<?.NHFPK@(,]VX?5BY1N7JY2?BR,5FX0&NR
M:F=GN#%7ZZ@;:)N@6/X04$)NX&3S?,?%VI;XM<U[+8W[)ZK= O0@5XO<(\6H
M:J/WNAD]@&F FLI(O)+?1.-L;Y&"?H+2$:-G XRL-GH/M^5][7D_B-AJO46N
MWZ>L[S4FS7FWLV7-J-SPRTEH%VK;3:[J;+6IZ)=;:4Y]^W9'\HY;+\M)(A80
MZAZ?P*>FMYM\VP.CLG*?;*Z,46GY<R5X)+2] :XOE#+[ _N :JOUXC]02P,$
M%     @ LW*I5,9Z(TUP!P  ,A\  !@   !X;"]W;W)K<VAE971S+W-H965T
M,BYX;6RMF5MOXS86Q[\*X0Z*%DC&(JEK)@F0"[;MPV('S73WF9%IFQA)=$G:
MF>RGWT/9D6SQXDR[+XDD'U+_<TB>'WET_2+55[WFW*!O;=/IF]G:F,W5?*[K
M-6^9_B@WO(-?EE*US,"M6LWU1G&VZ!NUS9PD23YOF>AFM]?]L\_J]EIN32,Z
M_EDAO6U;IE[O>2-?;F9X]O;@=[%:&_M@?GN]82O^Q,T?F\\*[N9#+PO1\DX+
MV2'%ES>S.WSUD/8->HM_"_ZBCZZ1=>59RJ_VYK?%S2RQBGC#:V.[8/!OQQ]X
MT]B>0,>?ATYGPSMMP^/KM][_T3L/SCPSS1]D\Q^Q,.N;63E#"[YDV\;\+E]^
MY0>',MM?+1O=_T4O!]MDANJM-K(]- 8%K>CV_]FW0R".&N TT( <&I#W-J"'
M!K1W=*^L=^N1&79[K>0+4M8:>K,7?6SZUN"-Z.PP/AD%OPIH9VX?9+> 0>$+
M!%=:-F+!#-S<LX9U-4=/MF.-+M$?3X_HIP\_HP](=.C+6FXUZQ;Z>FY @^UI
M7A_>=[]_'PF\[Y],?4047R"2$.)I_A!O_LCKH3D^;3X'SP?WR> ^Z?NC(?>W
M2O'.(*8U^'D5Z9$./=*^QS34(]-K!+%!M;W@?V[%CC7P"F^L]EWE?5=VP>UN
M2565]'J^.PZ)QZI,,SQ8G>A,!YUI5.==7<LMR(*U6'/0^-QP]%,'>4,N$6M@
M==OQU_;N \URQ SBK%[;>QA"N'@;P]Y7&!;>/G/UXP\X3SZ]C<_//I?WJK(C
M9W"6VJEPXK+'JJ0D\;N<#2YG49=_ZW8P$%()KB\0N.J3ESDO)I2DV42>QRHI
M2>:7EP_R\JB\SXIOF%@@_FUC5Z3N(RO-FBM(!,?3U*<[=Q2E65I,9'N,TB(0
MU&)07415?Y&&->\06#CO+BBNI@H]5B3)<[_$<I!8G@DL4$^9USZ@=D5N@$,F
M. 5*=W"+O*HF2CU694)3O])J4%I%E?X+=#(CNA5J.+ )*0NA2[F\W,)-']N@
MZLK10W-:3E5[K J,*[]JG(P02>*Z^UG:R>[R_$0X='6B(756F,\J+T-"CVB'
MHT(?^0YV+AL@G.'UNI.-7+T&0WKHZV2,T[)PI'K,BHH4 :TCFC"):OU%RL6+
M:!JO-.(FR"2G=(J.@%T1"N1(.1S'W'[91T:9>H*"*UI.!?KL,H(#"PF/>,/I
MN\C>"/8L&F$@Z<?PCD>(X#A%!G!NV*NEIM=[%Q"89'B:[7QF29Z0@.\C2'"<
M)"!1;6&.U[*U*&'[#3,D/\6;?GOWS#N^%(&1<RE15'DZE>YA214"-!YA@N,T
MF2; H]&[>(.,5[0+#M@N3+.?SRK):$#TB!<<Y\LC7W)09L,+&XPMCRMUP8$)
MJ?!4JL<,5VDHJ8R P7'"#%I7BL'J$!W,D3."?61)G$3CL<IH8$=$1K"0]X"%
M'>;ST6SP*24N,XK,0:#'JLR+P"0@(UE(G"QWB]U^Q[R% Y6R4T$V.SN1:XBV
M ""N%.?[?4<DV,1E23+5[YKDY5%>/=5_=!"*T^9T'W<NTBY6T@(7TTGA,ZNR
M/*1UA ^)P^=>B<4*DH-DG5^>"Q4XPV13<'O, @F,C-@A\6,5G*)WL-<4]CC5
M21,Y:1#WC ,'H6*:"+QF<,H*"!TQ1N(8^\)5VT<P+-!')^#35*#/+$D#.PPR
M0HS$(39D*L.^#?/QU2O491'-TBFQ/%8I)2&9(['(WR#6T8[8*]S#H[S(G17O
M,2NR-+2,1FZ1[^76.;TNE+*B<E:]QZH*G>'(2"[RE\AU3K++)5P0.MV)^<Q*
MC .BZ<@O>H9?SXU8[?=?2ZG0$[?%!W2/X*Q_\.;)R/JKMS;D.0$5<*Z8%H=<
MLT!NH"/+:)QE[G'N# ^HRR2<5M,5Z+$JR\!FEX[@HN\!USF!+HE(6AV7; X2
M/>>E,LEQ8*W1HZK@F;*@;%MA+/_W=9U:=C9I\*X.*8[V9ZO[5WK#:GXSVRBN
MN=KQV2WR%53_#QV=^CRRD,:/8/W47LL&]D/ZQQ]*@HM/??G%O$8+K2/":!QA
MXR+2]DT7Z$/R,4DP',P4VK'&)C2<7"1)@O2:*5M0VYJU5.*_?&'SQMM3H;7=
M7/;5MJW1!BYL.K<53]$OA+[@>5+:) @6\UO1,U"//@RC2\=I>H^:G(9FA">-
MP]-.-\@Y?5RN/'$A22 PUFV?O^$J[R=4%!>XJGJ3(K^H<'4^LM_WB@L@E-[P
M_HM/X]T"4,^A=9KCXS:G@1[Q3^/XOUO YA[2.Z0@6[R]%!VJV49 2O+*=$E>
MPC&IF)Y1O'8X)8&J"!V13^/(OZOK;;O=%P$.I679PKI?VP]S.[NEUOYLY#+]
M$B>9$V*/696$@CRBG\;1?ZQZP9>B%E[64Q?BER4<KLOIEM5G6-"LJ@)I/AUY
MG\9YOX>1#B8^[Q<1E^"$8#S=5GG,JA0V5@')(^S3..P=?O8+\3M=P.XG*E^U
MSVOGJ?;-CSYHVJ_)D"Y6HM.PQ5Y"P^1C 5%0^P^T^QLC-_TWSF=IC&S[RS5G
M(-X:P.]+"6>QPXW];#I\)K_]'U!+ P04    " "S<JE4.1>+!10#  "("@
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M$%UF<1SU(#P0?'0ZD+J ZA9@1T4"),V8$?DY$ZG6\SOPH LI$Z*L GSQXF2
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M([V8HCJDK@:*;\ISWF>N%,_+RS6C"1/&0#]?<J[V _."YE\%T_\!4$L#!!0
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M2:"L =XOI#2[C0W0_.72/U!+ P04    " "S<JE4"^( &LD$  !T%   &
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M?^*J)TJLJT\R=T(ID5?#E%%H^AH SU="J.>)_LK3?FB<_PU02P,$%     @
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M%!Z><\&4]"HMQ)N9==H55E<JX"R#&(U!+?2M45-CG ([K'2-==;1/F(.&^\
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M'3;SPO$9J<YP>"K&OBB:<)< :4X6A?2H4(I/H% @5>G5JO9PF/ -$41E.+'
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ME6H=P?R?E%,@A\"6?AVB)6(+;!V)29V3QU8EK&,CUB7CLNLN"#893*$7B.3
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M SQSJ66%3&S?B):CXB@$K O<JWZS[H)OA=$\=!VC0OL4?D4:B5"&IT3_1\#
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M3B(PW7#M-D[78:!MM"/EA65)_R,TWH&^YUJ[W<8G&/YPB]]02P,$%     @
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M\]O.#SL,T_@9AK1C2+W>09#7\I);?G:BU89I1PTTM_"F>FXH)Z0+RF>K<2K
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M;T.>VJ"=MEUI<%M)1#6>-9+<#'T<D(8.;L+.TH%DYYB-U0F9!=Y:K@680=R
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M:-K!MB'3)591:@V/#DV1*HH4>#!G?Q1Y(:\=GN "'#@B#K$"N3.E0@/E?1[
M@8CT2L'H[0\&N(]$N)U-ZGT1+;.RZ EKLF((:W:L1ID(4.TSPY=4B%\BXR]L
M?I]X#F!L3+H\N(=,K9>=FJ$O<@%SONSS8*<>*?W@>CQKBZ*.$WY@0E?8E%(G
MX*O?/?8'/C'@MB_[0]_>!@V0GUBDFE[N  A/>?R $SV*Y>&^MN'368CM8)$C
M\$)PL%LM*L=N@!O<[L/.10?.]A32R(S6P^#,CNM^E1G/6NMO669RQC)?I?O_
M6\6&;O:Y59FDD.:*BH7MJYD2N=& 0BYRV7&/BC'& )J?M(4\W:.VF;"H3L9'
M#7T?!K7-[D&/VTFI-U&,UO2C0L+@$NP-VA3MQ#N9Z(PR-;'S*X3G,=90&/!P
M8DA$5B,UH>\ ORQ&^L#P':"=5;Y/?EBW!C0CU3D /61J^2!UQ@A\<N_?GC(U
M8O4-:L:C,*@)%]]1!;WT BZ58LA6C+3CR43<WCT]6J(QSF1T:H;3:HZ/'(]N
MPMG3NS/6>7,\V-G7>>(W2-31?HIX*1C>XF]Q=3.<3^;4S+RN5DA(Y!ES#D3%
MR2?U,41->GU^(+>LS^?X^(1K1*?X'36SVHE[:3XS+%/>3VE(0<8[*<. 0^ZI
MCJ':U*Y/];''C2L]0*77[;:N?@I>])HW#@BLKK0>^#JUXA+A2@[$?/:L]EB5
MZ16G3RI4403BTL?@U6(@0N+96Z<-55J%W?%(@+N !.7&L%O@U7DWTSG"W2?>
MJ_O"VF)+&KC'>J229@KAUJ$D;^4]/LZOHD$-YWVLX_9K*VW*#9#8IT_0YTO_
M;N%) $0Q<U36G#0/YX[:/X9A\K%5M7%9-Z?]TT\%5!/CG?*?GNW1G7@L*&J]
MA(QAU!96'G6LW,9M<\X5D>^Y#XI4.ZX4][X-FI]D>-@'-*&F1RU**F^$"*#;
M<RI@]8<J"Y.\>$9CMBWJ<]O-M+T]<;><8PSQF?9PML%PV^DSIUR)+_=UW+;9
M-=I3%O<5*!*S-PL/1W?4OOT@33M]C&^H-NZ>,/3I_-B*I[50MYY=,EZ3AUX"
M?24 <9"S(3?B=+@M5?_4AD&5/(.$./ -]%ID*#_.0% 8KI4SJA-H9%BOZ#^*
M"^?0)"'.A1\A^U8/@<8=-<59F-B586)'KTLYHB6]U/,04Q?Q_ZHT2HJ/%.9#
M<5R--M [9'AV-.R SX^C>,;CS6@TJCOA@X%T ^6Y3+MY\'2X:8\$.)%T66,D
MO"T/)0"/$$<1XUJ 1IZ$T/@]G$X'HR79>U^5^TFW]N\V*$SK<4E.[Q6S79/&
M6\]>R(RS7[W)-8XSY#2]6G.Z@^EAP05W=-SXA F$(YXI8,$(VFLC,S+I.Z7:
MXNJ,'D(7S'4(S7+\,,RWW)2]:2HZ'L?#&3([5RH"U:V%!B!*97BR1>\#>>W"
M3U],#\C"< 5UMJ%:\8=_B:%ZWP#R$',>3>M 9[>P8>)GT._59^^_3?RB\]S!
M86?&J;VQ3'5618&86KDU)QSV-!P>>.4T\@Z(^(,/\)2Y&<5Y:LWXWZT1/K5U
M?)T)NV!U0D.%E0JCJJL1O3(<"+E &->>&+S^O'-W2M8ZWD[[.;^FDJEOINN*
MI(Z!1A_81)Z&IL8#3%;?:<6ZB69-YU18Y'I>U9,6N, (G-6,U4/\,"0LEGVX
M[%W"9UJ"H9:$#[2H4_6&6"U#XQ%>5C@>,82P)#3;0H3=\R670RR(-E!CEK&P
M^U/0D-F]7TV^Z-W;L><\]0[N\*T;*\6DSXOE\[9.AQ'5([I.+I=0C_DWCZVJ
M23YO''+RFVCRK#<ZH[X/$:X['W+DRJ[X<Y725V?^FX[F;O-%S&O_(4B[W'].
M@].@OA+988FMY,T7POI/5/P/5VSXLY!%X5R1\^5:(3%86H#GRP))/OR@ YKO
MA%[]#U!+ P04    " "S<JE4"D#=LX #   Q"   &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6R55EMOVS84_BL'0@<T@&)=+%MV8!M(V@X;L*)!TZT/
M11]HZ=@B2I$J2<5.?WT/J4N<93'6!YNW\WWG3FIU4/J;J1 M'&LAS3JHK&VN
MHL@4%=;,3%2#DDYV2M?,TE+O(]-H9*4'U2)*XW@>U8S+8+/R>[=ZLU*M%5SB
MK0;3UC73#S<HU&$=),&P\9'O*^LVHLVJ87N\0_MW<ZMI%8TL):]1&JXD:-RM
M@^ODZB9S\E[@'XX'<S('Y\E6J6]N\6>Y#F)G$ HLK&-@--SC&Q3"$9$9WWO.
M8%3I@*?S@?UW[SOYLF4&WRCQF9>V6@>+ $K<L5;8C^KP!_;^S!Q?H83Q_W#H
M9!,2+EIC5=V#R8*:RVYDQSX.)X!%_ (@[0&IM[M3Y*U\RRS;K+0Z@';2Q.8F
MWE6/)N.X=$FYLYI..>'LYB\DE\PJLL3E=J*BQ]UTN/0%W!3>*VDK ^]DB>53
M?$0VC(:D@R$WZ5G"]TQ/8)J$D,9I>H9O.CHV]7S3LX[!E^NML9IR__4,9S9R
M9IXS^^5@_1\<?$:HV#T"=91FELL]B.Z >@NV+1<E[9D0\'O+&RI\"TR6<(\5
M+P2:";P[<G,*\V0:7>NY78NZ-J!V=&P,V(I)4!+A 9D&J\#7IU\1U9VJ<: I
M*)%$06:Y/C%>]FB15-NJ%PJA-2T3XL&;VC9.9D?=U-&%WDZGGDOF>ZVG(CUM
MTPATOC!!W2.8+!"ZVX;+[DKINELPBZ6C[8TZ, /,14;0M>&GY!C52%&-1>*U
MOL4"ZRWJ83>!U^2*K51KZ-@%\UA@8[W=)3>%:BFL%'WT:*_,6WYQ]6_VY\P?
MGN8-M(OHI=I=MK08\P>O()N&L^6LFV2S_#SP,=N+%!;9>>&A&& >+V&>S^&3
M<I%5YS#,&+04B;U65!=9%J:+N1^2'*Z+HJW;+OBL5MKR'UU&7N?A8IE?N#%>
M+BY^18^DY+Z"Z3R<+I9NDH=)LGSFEN!LRP6W' E2M%J[")!TF,8>%<:SZ7F0
M5/)R )*V?!X[7;-L\8*Q)V"G8!DNYTY3%H?S.*'F=+ZX,-P3;'_:6(]5XHO+
MU_P%Y),9_?+GP*=E1D90J<FVAB0AZ=_ZX;]NH^CD&J]1[_UCY?J3R+H;?=P=
MW\/K[AEX%.\>4ZKE/:=>%K@C:#S)9T&7K&%A5>,?A:VR],3X:45O.FHG0.<[
MI>RP< K&KX3-3U!+ P04    " "S<JE45?@4B2(&   Q$   &0   'AL+W=O
M<FMS:&5E=',O<VAE970Q."YX;6S-6%MOVS84_BN$5PP;H,22?,^2 $FZ= 7:
M+6C2]F'8 RT=6UPET24IN]ZOWW<H699S:Q^V82\6+^?RG<-S(7VZT>:3S8B<
M^%+DI3WK9<ZM3OI]FV142'NL5U1B9Z%-(1VF9MFW*T,R]4Q%WH_#<-POI"I[
MYZ=^[<:<G^K*Y:JD&R-L5132;"\IUYNS7M3;+;Q3R\SQ0O_\="67=$ON_>K&
M8-9OI:2JH-(J70I#B[/>171R.61Z3_!!T<9VQH(MF6O]B2>OT[->R( HI\2Q
M!(G/FJXHSUD08'QN9/9:E<S8'>^D7WO;8<M<6KK2^4>5NNRL-^V)E!:RRMT[
MO?F%&GM&+"_1N?6_8E/3#L8]D536Z:)A!H)"E?57?FG\T&&8AD\PQ U#[''7
MBCS*E]+)\U.C-\(P-:3QP)OJN0%.E7PHM\Y@5X'/G5]+9<0'F5<D]$)<JU*6
MB9*Y>%U:9RIXW]G3OH,B)N\GC=#+6FC\A-"!>*M+EUGQ<YE2>LC?!\ 69;Q#
M>1D_*_"M-,=B$ 4B#N/X&7F#UNJ!ES?XNM4OE4UR;2M#5OQ^,8?5")0_GM$Q
M;'4,O8[A/^O99X5RBI[8E4SHK(<<M&36U/L63>(N(['0.7)0E4OAY#R'O74F
MJK_ 5QF12)L)6:9"KJ7*F>((27]D94["4E(9Y1287":=V) A49!DOX'!B05C
M6'L,\ZVP:EFJA4IDZ80JUV0=HX &1TMMMHAQEZD2HJC+F"DRTB395OS@-W5E
M <?^>"+>\G(; .*BT,8!=BJNM'7BE='6BO<EBE+N5U^A&#U<?</SCJ^N=O;Z
MP<^?*P48WEF\<"3> ;91B0/KA;7D[,F>I= E;9&'YA/JYJ("2O%"Q+-@-AU@
M\/UWTSB*?SH8M9L/J+PVLU<6!6$T;G=WW\/5>G:G'8Z9SRVH3X\Z1C#,CE2_
M_T(,PF VFSV!L=UL,=9Z7E)"Q9S,[@2B_^T)3(/A*'KJ!':;#ZC^TQ. ;X?C
MR=-14F^V&&L]K=D/E2 1W]":D.Z[A/09?\PICSV?J:46J&NE79"Q8DYN0U2V
M7"RV&1^*"/P6>)-,EDND?I.RG*W2]U1'25:JSQ7V*@L34Q0)+B\@<IDAXE/B
M/D#<!^YE\;'X2'!/HDWJR\^E4>D2MFC@](I1?#82FPED<%&V AJ9\I8,%Z)+
M<8,.3H8K$,>.V^YJ'R"@) $%(LW7ER9,?)F!9VZ![%?M2 Q8B9 B11.HK+]H
MH(*"T5+M,.GO#C4>MBHE1P9MN#:_IGU,R;'XC2NJ1NU#GJ"4PHV.X-&NE<&!
MF5QG;<=8Z<_-P47+*I<FWS(B=B,S*=15"]@+%%G</X33 H&F<$LAF&,H5UR_
MZVJ>H'3S>H-OA7 D;W=MY[ZT^Y!IY:2=TFP?I8<>WX10V7?Q\WH?'&@OJDP8
M3J?$/RH&;8(-G>_="^7H(I7ED^2KIH+U>L[MSINERE7%X6!VX0I7V@JQ)>V!
ME;#HNF.#3X6]>;5X)N1OH5/*FYQ5]M.13/_$[0MD-7#C,^!I#W$L<&PR?I'C
M=(7,K=Y[")(?<U+CHUU6T;_JB[O#=OL \08L]]U3YX:NRK:"+7"'@#6KE=$R
M:8I2A21$%#3Z%(BY[@D?=BFNI?[<K2IPK3!>UP[-X8UD?R&QWB4KV6#EXFK,
ME@EK[+M\?.XH4IH[]@*F]^X/S/V@IP5<JU?D7PGY5Z\@#UOBC=RWM09K/>TT
MO&^A.:B#: 2C( Q#;LZC8#P:=0>/-9"VI75*#Y<ZM,XXC(;U&'2CR91_Q_P[
M#J-'5D ^:\A'-8;1()B$ S$9XI8P[2R.9K&81L%T&C;]L%4R"AJIPR">L)()
M5OP-H[L5C=F^:1P,IY&XVX5C($K$$AI@V#@ @R@<8S +)K/QO9UP.&M(HH&X
M2-=H ]R4T'<,SG6M\S4[.T&O0.F42_0F?R-]WHEP1# =3!]\:RM]? %-V%@2
MA8 QB'F$: I'C&P"HR+&.L'*D!O[#!T>1(\],/J=9UQ!9ND?J]P2D'WUBZY=
M;=_#%_4S<$]>/Z81K4N%^,EI =;P>#+JH:SY!VH]<7KE'X5S[?#$],,,Q84,
M$V!_H7&&S805M/\2G/\-4$L#!!0    ( +-RJ50=R>_YG0,  !H(   9
M>&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;*562W/;-A#^*SO,I+FHHDCJX3B2
M9B3'F>J01B/%Z2'3 T2N1(Q!@ % R_[W70 4+2>QVTXN(A[[??M>:'I4^M:4
MB!;N*R'-+"JMK2_CV.0E5LST58V2;O9*5\S25A]B4VMDA0=5(DX'@W%<,2ZC
M^=2?K?5\JAHKN,2U!M-4%=,/2Q3J.(N2Z'2PX8?2NH-X/JW9 ;=H;^JUIEW<
ML12\0FFXDJ!Q/XL6R>5RZ.2]P!>.1W.V!N?)3JE;MUD5LVC@#$*!N74,C#YW
M>(5"."(RXUO+&74J'?!\?6+_X'TG7W;,X)42?_'"EK/H(H("]ZP1=J..?V#K
MS\CQY4H8_PO'()N2QKPQ5E4MF/85E^'+[MLXG $N!L\ TA:0>KN#(F_E>V;9
M?*K5$;23)C:W\*YZ-!G'I4O*UFJZY82S\VW)-)9*%*C-&[C^UG#[,(TM,;O[
M.&]9EH$E?88E@X]*VM+ M2RP>(J/R:+.K/1DUC)]D? CTWW(DAZD@S1]@2_K
MW,P\7_8,7W ,OBYVQFJJA+]?X!QVG$//.?S%T/UWEM]>7:3)Y%W+!5>JJJAP
MO82!#1K4=UC PH#: T4H+[L0]>"(4+*"^J25,@%%DGF@H5+*;X':&/:-;30"
M-Z9A,D=H*&D:,"@E:6IXPWS/U()) \P03%#[FDM82;"E:@R3A8$MYHWFEI.>
MSPJ6""NB)-TW-6&O[U'GW"!\VL.GVM']"V!#K<J"//EJ-<\M76V]V:0.UJC]
M$'(F^YC C>26S+,4C'M>-17\V50[<L4SN(G$Y>%<Y^*.<<%V H$Z&CZ$,*Q.
M84@'27(*_8H.I)L7L*800-++)F.8]-+16\AZHW$"[[]L89MS)#GCI/L./G@&
M/@:?V?1=]R7A"4D538XTX2PLCDP7K2[2,9H\E;RN:J$>$-MHK!O*O0N5!_S
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M4IEBZC K)&(R3,:)>(;@2::4S&W&3>,I7H^B\Y1? _8J+NTGHSA]SAO&,:]
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M'DAJ:(P^LLT]7&S>ZD&P< Y8V8F\<<B":56'O[[BTZ$Q,(>[T6.AOA"PE3Z
MWTJ+K34YJDUB+T\6Q7-TI;42M:O4DZ/BQ73 *64WJ0E$JLV=0MPI"CR'GQW1
M114+; /%+E?0;@OUAQ\H*+ VYE \B@>K&#58 [6D,.["&<MZV 4JV^F \^1_
M)'S$*##52%*BX9]1[(?.D3V Y>>#_AY1AR($M24=QH)DLG[O5T3E/D*%(OB1
M@:8&;1&H\R&!KJ!" )K@6]%8'OVB/A<?"_66*F"U*B:=^N3#5CC!SEUI.C!W
M"V^E[B.!B(H_:TE+%@[0>\I#A;9!#Y;\/: @,0&U1MD2V)9)!0_X[!G8+Y$G
M$X5 CM*O8_) ;2ZT*G4(6Q@>=*ABH:Z$?'Q[P#8/ MVAB6&<HQ@:XD_EM]W5
M($=[\BUJIJRY!L%PA^GA?"K4.5,LLAO.UFAB;:Q)6S;R@.^*.BZM2[FQ(]U*
M;FN,5A_B.#W8*$J#$U/R);H?J<8JLRP*^^L^\62F.V8__/Q'JE!O'DFR:C1F
MWIJ(0ZYQHM;;@P,)D3J4'*\"S$^.[.#4*GUOJVSS?J[D/& *ZBE/>]/U?I*.
MW3@.%5X>HHYP55!4,F1 "G"@)^X&+<4052F4:;Q8THDY.6"\(%2EUU:D>3PA
M[YF(A_AW7X;4^)A9FSEYF-4"+8^\0GUJ"'4IP1.X=(*M#R+V#9X-.G1L)(].
MG6;26-==PY(#:D;21X9>]]QOF6WT4 ""0>$+QWJH09@ZXC#\<48$)F,$@: B
M'XD'0HW]^BM7%W"\K/+7L]I=\'9': D9N4#+<#KX%6SD*TJ5*7?SLKIET\6A
MI\5\[Z'64MC(<U3HYE)^LTVGTXOW/#_T[L7S<QG#=&,P;RW54%T4+Y[-5,A/
MT+Q)OI-GW]HG/")EV0 O!1; ?>U]VFW8P?1_P-F_4$L#!!0    ( +-RJ53-
MHP@,.P0  &L*   9    >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;+5636_C
M-A#]*P-C>W,M?R3;=.$8<-*O/:0-$NSF4/1 2R.+"$5J22I.^NO[AI(<>Y$$
M+=I>;)&:>?/FS0S%Y<[Y^U Q1WJLC0WGHRK&YD.6A;SB6H6):]CB3>E\K2*6
M?IN%QK,JDE-MLOET^CZKE;:CU3+M7?O5TK71:,O7GD);U\H_7;!QN_/1;#1L
MW.AM%64C6RT;M>5;CI^::X]5MD<I=,TV:&?)<WD^6L\^7)R(?3+XK'D7#IY)
M,MDX=R^+C\7Y:"J$V' >!4'A[X$OV1@! HTO/>9H'U(<#Y\'])]2[LAEHP)?
M.G.GBUB=C\Y&5'"I6A-OW.X7[O,Y%;S<F9!^:=?9+DY'E+<ANKIW!H-:V^Y?
M/?8Z'#B<35]QF/<.\\2["Y18_J"B6BV]VY$7:Z#)0THU>8.<ME*4V^CQ5L,O
MKC[:KK"BT'J#JM'/[+9>-97.:8TRAV46$4>LL[S'O.@PYZ]@+NC*V5@%^M$6
M7!S[9^"W)SD?2%[,WP2\4GY"B]F8YM/Y_ V\Q3[I1<);O()WRUOT5:0;;IR/
MVF[I]_4F1(\6^>,-^),]_$F"/_E/-?VWF'3'A%GU*C)I2\XRAF;(+_09QTI%
M-.T#AK$)8S22;4MDW7H.I&Q!N:MK]KE61O^)K>C07H3(9'3)%'+--A?<P,KG
MU81^:SWEE>:2^)'S5B:,7%GJG+V 8ZP#.=ATQ$"^"\,/RK0@VKTLM5568A*L
M4IH21$86?&QP1A>P+63Z=)@0II&:UC<NB'])RAB7JY0FB $PYZ,HW8LM@B/"
MB['&B<9K>7A^D+, &C8JJ1N4001]4!%1*%9,A2Y+]B)T%S#QDQ<XFDS1R;5E
M"RU,8J@*C+26SDL1^1%G;>C9"Z5!Z+31ERW5\=G2,UD7!Q&@4G2P?J+0<*Z1
M0,]D@ID,4>@(;N,U1&C XKDP$ %,)0]E#QH#ZHWW? I@RG'\;:WN1=:RM7E?
M5? 8&*#%DIX.-4J"5?A:?&F5C^Q%MZ3()ZO%]C9*&TQH/7P6**J-X8$HM&?;
M,FV>H-N^WU7J]]ZD.R0%65C"L/&N:/.8EH']@Y9^&"H4*\],=7<^L9Q/=)44
M'HZ7Y(:'&6GAFIM6;$#Z5X=,WHN\@H/&+*0"Q7&+/K=7D,2D5DCNIL^B]*X^
MX/N2$C*S4G4K6^]FL\D93GUCH#'JX^GD])O44BXB1"].Z.KS;G8VF1T9G[YL
M_,^E&$LC-IP^H.;IK7PN*PAPG,/\JQ1FL]=36$RF1[;?_T\)W.E8)0A^S+E)
M(XPX'?F_C3[&X(DU/OP67=#:B.ZM5+%O6N@A^"&UZFSZ0BY4I %+ ]N?%)A'
M[8I SPJF-M&A/\TG+WV@LH,+ $JQ3=><T)'J[@+[W?U-:MU=()[-NVL8<MQJ
M#+3A$J[3R7>XN/CN:M,MHFO2=6+C(NJ>'F6^V8L!WI<.@](O),#^?KGZ"U!+
M P04    " "S<JE4 ,.]5LH'  "1$@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970R,RYX;6RM6-MNVT@2_96&%AC, (ID*?8FF;4-V,X$.\!.$L0SFX?%/C3)
MHMAQD\WIBV3]_9ZJ)BG9&7NSEQ==^E)UJNK4A3S?.7\7&J*H[EO;A8M9$V/_
MXW(9RH9:'1:NIPX[M?.MCOCK-\O0>]*57&KM<GUR\N=EJTTWNSR7M8_^\MRE
M:$U''[T*J6VUWU^3=;N+V6HV+GPRFR;RPO+RO-<;NJ7X6__1X]]RDE*9EKI@
M7*<\U1>SJ]6/UZ=\7@[\W= N'/U6;$GAW!W_^;FZF)TP(+)41I:@\;6E&[*6
M!0'&[X/,V:22+Q[_'J6_$]MA2Z$#W3C[V52QN9B]GJF*:IUL_.1V?Z7!GC.6
M5SH;Y%/M\MFS]4R5*437#I>!H#5=_M;W@Q^.+KP^>>+">KBP%MQ9D:!\JZ.^
M//=NISR?AC3^(:;*;8 S'0?E-GKL&MR+ES>N;4V$EV-0NJO4C>NBZ3;4E8;"
M^3)"!1]<EH.XZRQN_82XE^H7"&B"^JFKJ'IX?PEH$[[UB.]Z_:S 7[1?J)>K
MN5J?K-?/R'LYV?M2Y+W\;^Q5;TTHK0O)D_K'51&B!VG^^8S6TTGKJ6@]_7]Y
M^7\0IWZ&Z]O.U*;40OQWWK4J(I-4=/(]5SM2C=Z2@@3R5"G38<L\NM=[MS6<
M?$$E;'E5DH](<^5JY9)7>N.),@@LQH:4\Y7ID-JJQ'X@/EBD / AS%7<]Y!L
M[1X,C\VTH7KM8T<>)S+=Y2=;%5+?6X._"_41XI+NHEC0$$0?E(LUK=Y/^/=S
MU3A;P4+?6E'-TN0"W_=DVD+@,>3):'B!D; #N5BH$JG^HMB_X&_.>Q,42J "
M.P*.A%37XCDLF:Y,GG\7^R=%PD&EZ[JA%(D#=+?'=H0)+,3A)HN*J$\XE;1E
M__?P.!M6>PXOFZM*JTW+JOA^;(S/2@:O>@H]KK.='"*(J%*)JJU^!3#$NN68
M9 \^$V[8"C*1EV@!0T\"J!8BL2 F4Q:DZ)[*) *&A2DR62EJE6E3JWK'IAJ(
MT:U+;'2MZA0YU7J]SS1"(,$<A*X@6/)[,NQ5F-+J.QHX^"W8#TSK7%36(%>R
M'*W8.WQM +% LBA=58:E?&-:'-%>7,Y^=C6VA;@5,)?1C1R>4D;"2VUOW9X(
M\?C,5\==NB^I9^&<)H_HG6VK2-CW& NO>;*:[:-[-.H@7"MM0B)NYFQEM\G*
M&5 $L([VX;L_O5ZO7OU%U8 R5U]2M1DRJ>:4S,E',=K,N.RJ\(#G3+YC)AE
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M/[1L BTW^#T;!:#*MU'6(RPZA/0%A G=6!-*3TN3<_Y/_Q'8["FE3Y06Z:N
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M7'%V:BNJ/9@ >2BOVE!VM9K[7-^%"8X#"8&5T3&QJK0QU=J<+JE-DU_6(S$
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M411O8&+:YJ87U4?0MGQ+T F]'EV=7@Y/GO=]HBR+3<EBQX!K[41N;H [)?J
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M]!BY946O/RHK0/=;*<U^8Q4<_D\L_P-02P,$%     @ LW*I5%'SPDNQ!
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M:]P/N?$".*^T=OL7;V"\<6[^!5!+ P04    " "S<JE4+^ACO^$#  !<"0
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MY/NZJKH8LN]&$%DNWI/W3)+<T* I"WM84T-29%#"-F7V-Z[O]P\PS'K@GUW
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MA5$B?TQ@VF/:&<#O:Z7LX\(%J.;'R?]02P,$%     @ LW*I5$JTJ\7V P
MH!$  !D   !X;"]W;W)K<VAE971S+W-H965T,SDN>&ULS5C?CZ,V$/Y7+)YZ
MTNT")@EAE41*LE?UI+M3=&GO'JH^>&$2K 6;VF:S)_6/[QA8R$_:JB^\)-B>
M&7^?OX&Q/3M(]:Q3 $->\TSHN9,:4SRXKHY3R)F^EP4('-E)E3.#3;5W=:&
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M>%!Z]$,]"O01LZWL/4!(-E+2L#^22<VRIVNR"T'WZ=,@:RH$C=*W.X)]PM0
M^?V&2AOS"_6 2?&,T^Q_4$L#!!0    ( +-RJ50<F-IX2P,  (T*   9
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M"V_G567T0E,5:OA:K#&E"(<54@97U^BOJFJ?JF/DQCWNS])@J>":.=:+H&P
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M9$5U;%<=Q0M[D"VYTDO+-C-]U0%A O3W%>=JUS$)FLO3^!]02P,$%     @
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MT.'@DHJAFYG3;*RJ_;-=*TOWQR]+&M.H70!]+Y2RAXT3Z 9_^@=02P,$%
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M^H9/1&J@WZ\Y5X=!ZJ#XG\'@7U!+ P04    " "S<JE4Z]J>69@#  "Y#
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MIM[80SE;TYVP']3A=]8$%#F^3 E3?:-#8QMX*-L9J\H&# I*+NM?^KU)Q F
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M4V_,O,\W*_+ZU1ORBO""W*;BH(Q;-?>UB=3J^>LJJH^GJ* GJK^9/",3^I9
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MJ:J\3,W!%Z6=8)YOA=!/ WNTJH_2R_\!4$L#!!0    ( +-RJ52D9,''Q0(
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MNA/,,%??!< U0.TO&9,?$WTQM%\:R3]02P,$%     @ LW*I5.LW'J%Y @
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MI&1)M65U=Y'VQ2:IN9PYPQF-YGLNOL@=@$*/9<'DPMDI5;UT79GMH"3RBE?
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MFH&XV2A>V9GRGBL]H=KE3G]$@# "^GG.N3ILS)C:?98L_P%02P,$%     @
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M"AXRS%+5STW=,7+K;NRE-'C_NV:!+S0H:X#S:RG-H6,?@?;-'_\'4$L#!!0
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MO6GS^F?ROD?B"@3P-? ]W[>X+\?=;W'6N<-C=U=7H"N#WY7!;^(%9^)]J+!
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M)D.K;X$Y7J \E0]L\P>7"S("8Y8*\P6;TM:Q0)P+R;(2K!1DA!9_]%X&H@:
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MWRF+L\0O2QS>H)T#GA=*V>/&!>A_!^E/4$L#!!0    ( +-RJ52\XEZP>@0
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M::0D.KB[?WA9"C;;3XMBLB<H)A;%Q(WB7*V.@V;7@HF(U[;J+6H"M&)4N.)
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M<$7^"DU^H?C"O/(QXDKQQ'R<,SIA0@^ [Z><J_6%GJ!\D>GL/U!+ P04
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MK$=%$,9 OU]SKAX6QD$U?,[^ 5!+ P04    " "S<JE4]?EX@!X$  "4$
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MN9(!0*C)2LFX[D_LZD F6U!&V!9.J[7IP[65WD@/VH2QWO%:T]K#*'.K6PL
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M0 .&!$'Y'-QY'GGU<\IK_\T>_P502P,$%     @ LW*I5)>*NQS     $P(
M  L   !?<F5L<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2
M!8I%G;^OVJ5QD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4
M+!XUA]) 1-MC0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(
M2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/I
MKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "S<JE4=D:
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MYD'8>#_A!Z;5]MY\@ *1LL<R'+#3JL6C1-&5T$Y4++QS1LDJ<%3L@BNN2\$
M9() )@>$_)P R!2!3 \".8\XX:L ,D,@LP-"=B*9(Y#Y(2%3 %D@D,4A(3,
M>81 'M%"3H0KK=S$=F:6[*)Q4@OG -P;!.X-+=R\J6MNOT6PN5QI&;[&M6?G
M96D:[26 ?(M OJ6%G%GY$'Z9S10OXV/LV=2Y)HZ-</P>80/XB);P:OHQ=D%O
M@^X@$RH58JM,Q(-09M/&ZWQE11LY"(?)9$QLDYL IYO._X=I8TSLC0_&5(]2
M*<9UQ:8A$]*K2,#.G0MIR#\0$Q/'F-@<NXR@3:_81'@N%1Q(QI@PQL3&F(A%
MIWMA7A@3B^&3X$YT(H,)8$QL@$LN+;OCJA%QG+V4.OR)DJO0T9RW30TQ,16,
MJ5VPYE:LC:J$=7^Q]U^:,&^ ;)@!QL0*F'M3WK^^X-'U00,:_K<)-O(GQ"/_
M5)>F%NR6?^WTMP0;^1/BD7^JMU^+&<?YPC2>?1!F9?EF+4MV#B<]"3JA()]1
MU+7T\237CKM1H&$V*,+#T8TE9H:$V SS9N'$ER9*]/U#5Z )IH*$6 5HXM:9
M1"28%!)B*>"8<!J18+Y(B'VQ/\-DKV[Y F)B(DF(10+3S!9,"?<WA,/TD1#K
MXRFEZ^7"U)$0JP/-[;J%"TPD*;%(>G.[OF"FF%I2\DG%HK?GI9A(4F*1;+.]
M7BRT%D6L#C3MZW8\S"0IM4EZTK[>6&(>2:D]\C+_ZR7$%)(2*P0W':Q%I9A"
M4F*%X)@YQ,1DDAZR+O6Y@)B86]*#5:;8:W;%8;T9<TM&[!84<UY"3$PN&;%<
M.NE-C)^U/*X>L5>M#B$FIIN,6#?=+.S)U' <RC#K9,36Z2W[]6.B:R#$UMEE
MB['_K475J%:2$^GX*D"O(";FG8S8.\^8+WOCBUABZLF(U?,,.1.VO4)\LJ\7
M2J[BR1 34T]&K!X\$8=SP0Q33T:L'AP3BCS#U),==%H#19YCZLD/,JT)3_U6
M\! 34T].K)Y]F%,=BS[P$<HQ]>3$ZMF'.;/AJA86IW+,03FQ@_9AAO3--J*"
MF)B#\D,LIP3,_^)0WRGUY>A*_!]86/FM@'),0#FQ@)X(.R9O"P5;4(B)"2@G
M%M!3G>"WH<3LDQ/;YR?CO-EL5)N\<?5S*Q LB^>8?7)B^^"UC<[V$,P^!;%]
M<$SH\@*S3T%LG]X2S',WA9B8?0IB^^S!W#WV$!.S3T&]9/-+K:CSQ$-,S#X%
M==VM!_-&A'XIR[B)"6)B]BG^>.4M_..QC5UONI.+ MT)1EU^VX>Y;8.8F((*
M8@7!Y>)>^128? IB^: +QYV*=8')IZ#>#/!B3;8_DD>8>(Y:\0S;D]W92266
M4HOJ*ES>A?:2JW)F67S9[I3*\KC[8=DH]2ZT7>M/AE>[7<N['==G/P!02P,$
M%     @ LW*I5-MVL'$Q @  B2D  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<\W:2VZC0!2%X:U8+""X[HND%6?4DTRC;  YY8=B&T312K+[MIR!
M?5 />A)Q1JA 7/[1!P(>7_*A'??=J>SV?5E\'@^GLJIVX]C_JNNRWN5C6^ZZ
M/I_.1S;=<&S'\W+8UGV[?F^WN9;E,NKA=D;U]'@[<_'ZU>?_F=AM-OMU_MVM
M_QSS:?S'X/JC&][++N>Q6KRVPS:/JZK^/%QWE_JR27?GR=7B^6U5#<]OJ:KG
M#A((DOF#%()T_B"#()L_R"'(YP\*"(KY@QH(:N8/NH>@^_F#'B#H8?Z@M$09
MEP1)$ZP)M$[(=2+P.B'8B4#LA&0G K,3HIT(U$[(=B)P.R'<B4#NA'0G KL3
MXIT(]!;46PCT%M1;"/26R<,V@=Z">@N!WH)Z"X'>@GH+@=Z">@N!WH)Z"X'>
M@GH+@=Z">@N!WHIZ*X'>BGHK@=Z*>BN!WCIY64*@MZ+>2J"WHMY*H+>BWDJ@
MMZ+>2J"WHMY*H+>BWDJ@MZ'>1J"WH=Y&H+>AWD:@MZ'>1J"W35YV$^AMJ+<1
MZ&VHMQ'H;:BW$>AMJ+<1Z&VHMQ'H[:BW$^CMJ+<3Z.VHMQ/H[:BW$^CMJ+<3
MZ.V3CY4$>COJ[01Z.^KM!'H[ZNT$>COJ[01Z!^H=!'H'ZAT$>@?J'01Z!^H=
M!'H'ZAT$>@?J'01ZQ^1G$P*] _4. KT#]0X"O0/U#@*]&]2[^4F]R_AUR.7:
M\[W&Z_\DU>/YW'R]_&7YO1/O%\T%Y_JVHCS]!5!+ P04    " "S<JE4I,C#
M=_H!  "T*   $P   %M#;VYT96YT7U1Y<&5S72YX;6S-VLM.PS 0!=!?J;)%
MC>LG#]%N@"VPX =,,J51D]BR72A_CY,"$@@J4)&XFT:M[;D3CW16/;][]A0G
MVZ[MX[Q8I>3/&(O5BCH;2^>ISRM+%SJ;\M?PP+RMUO:!F)C-#*M<GZA/TS34
M*!;GE[2TFS9-KK;YY]BX?EX$:F,QN=AM'++FA?6^;2J;\CI[[.M/*=/7A#*?
M'/?$5>/C4=Y0L"\3AI7O U[/W3Q2"$U-DUL;TK7M\BZV;5E,SRW%<G^)+WIT
MRV534>VJ39>/E-$'LG5<$:6N+7=%C_8GIWS#M/OD!^>/9?8%YIVWP?F8)Q;H
M]W%O(QE.3WTN1"$U^U_Q/3&7/OC]:)AV3?4/L_/U/KFP'N<1V?@X_(X_SOB]
M_B_[$"!]2) ^%$@?&J0/ ]+',4@?)R!]G(+TP6<HC:"(RE%(Y2BF<A14.8JJ
M'(55CN(J1X&5H\@J4&05*+(*%%D%BJP"15:!(JM D56@R"I09!4HLDH4626*
MK!)%5HDBJT215:+(*E%DE2BR2A19)8JL"D56A2*K0I%5H<BJ4&15*+(J%%D5
MBJP*15:%(JM&D56CR*I19-4HLFH4636*K!I%5HTBJT:15:/(:E!D-2BR&A19
M#8JL!D56@R*K09'5H,AJ4&0U*+(>_Z>L]\ZM_SA^?):=;?JW?#;^67'Q E!+
M 0(4 Q0    ( +-RJ50'04UB@0   +$    0              "  0    !D
M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ LW*I5.(=(LSO    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
MLW*I5)E<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " "S<JE4U=W; T$%  !V%0  &
M    @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
MLW*I5,9Z(TUP!P  ,A\  !@              ("!A0T  'AL+W=O<FMS:&5E
M=',O<VAE970R+GAM;%!+ 0(4 Q0    ( +-RJ50Y%XL%% ,  (@*   8
M          " @2L5  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M    " "S<JE4?,8W0(L%   V&   &               @(%U&   >&PO=V]R
M:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ LW*I5$!M;2^P @  \08
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M965T.2YX;6Q02P$"% ,4    " "S<JE4U1KO;X@1  "O.P  &0
M    @(%$00  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    (
M +-RJ52AX@R,8P4  %4-   9              " @0-3  !X;"]W;W)K<VAE
M971S+W-H965T,3$N>&UL4$L! A0#%     @ LW*I5#)J<)01 P  [08  !D
M             ("!G5@  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"
M% ,4    " "S<JE4P\HQA&(%   U#   &0              @('E6P  >&PO
M=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( +-RJ529QQZG= 8
M (H/   9              " @7YA  !X;"]W;W)K<VAE971S+W-H965T,30N
M>&UL4$L! A0#%     @ LW*I5*:HA'FP!0  2 \  !D              ("!
M*6@  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " "S<JE4
MO!L[,F\,   S)   &0              @($0;@  >&PO=V]R:W-H965T<R]S
M:&5E=#$V+GAM;%!+ 0(4 Q0    ( +-RJ50*0-VS@ ,  #$(   9
M      " @;9Z  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%
M  @ LW*I5%7X%(DB!@  ,1   !D              ("!;7X  'AL+W=O<FMS
M:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " "S<JE4'<GO^9T#   :"
M&0              @('&A   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+
M 0(4 Q0    ( +-RJ50N9F?:. L  ,(?   9              " @9J(  !X
M;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ LW*I5"0BJUSY
M!   $PP  !D              ("!"90  'AL+W=O<FMS:&5E=',O<VAE970R
M,2YX;6Q02P$"% ,4    " "S<JE4S:,(##L$  !K"@  &0
M@($YF0  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( +-R
MJ50 P[U6R@<  )$2   9              " @:N=  !X;"]W;W)K<VAE971S
M+W-H965T,C,N>&UL4$L! A0#%     @ LW*I5&,&YL!1!   T0D  !D
M         ("!K*4  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
M    " "S<JE4C0V&*#,,   Y(0  &0              @($TJ@  >&PO=V]R
M:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( +-RJ52YH>)], 0  '<)
M   9              " @9ZV  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL
M4$L! A0#%     @ LW*I5)_J^0NV @  J04  !D              ("!!;L
M 'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " "S<JE46JV4
M/Z0#  !;"   &0              @('RO0  >&PO=V]R:W-H965T<R]S:&5E
M=#(X+GAM;%!+ 0(4 Q0    ( +-RJ511\\)+L00  'T*   9
M  " @<W!  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @
MLW*I5"_H8[_A P  7 D  !D              ("!M<8  'AL+W=O<FMS:&5E
M=',O<VAE970S,"YX;6Q02P$"% ,4    " "S<JE4@Y4T:VT%  #,$   &0
M            @('-R@  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4
M Q0    ( +-RJ51/%$LM5 0  !\+   9              " @7'0  !X;"]W
M;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ LW*I5-9WL1,U P
M7P<  !D              ("!_-0  'AL+W=O<FMS:&5E=',O<VAE970S,RYX
M;6Q02P$"% ,4    " "S<JE43+Q'I7X%  # #P  &0              @(%H
MV   >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( +-RJ50#
MBDR3DP,  ,\'   9              " @1W>  !X;"]W;W)K<VAE971S+W-H
M965T,S4N>&UL4$L! A0#%     @ LW*I5 L9R<!!!0  V T  !D
M     ("!Y^$  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4
M" "S<JE4HM?]@@0"  #\ P  &0              @(%?YP  >&PO=V]R:W-H
M965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( +-RJ51;SH3OP0,  $L.   9
M              " @9KI  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L!
M A0#%     @ LW*I5$JTJ\7V P  H!$  !D              ("!DNT  'AL
M+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " "S<JE4M[,4OM0&
M  #O)   &0              @(&_\0  >&PO=V]R:W-H965T<R]S:&5E=#0P
M+GAM;%!+ 0(4 Q0    ( +-RJ50<F-IX2P,  (T*   9              "
M@<KX  !X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ LW*I
M5)9M,?;+ @  1@<  !D              ("!3/P  'AL+W=O<FMS:&5E=',O
M<VAE970T,BYX;6Q02P$"% ,4    " "S<JE47Y"$6,0#  #-"P  &0
M        @(%._P  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0
M   ( +-RJ513U;=.YP(  $@)   9              " @4D# 0!X;"]W;W)K
M<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ LW*I5*LFWT0D!   !10
M !D              ("!9P8! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q0
M2P$"% ,4    " "S<JE4*X-;[GD"   $!@  &0              @('""@$
M>&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( +-RJ51'S6)]
M' ,  /4-   9              " @7(- 0!X;"]W;W)K<VAE971S+W-H965T
M-#<N>&UL4$L! A0#%     @ LW*I5/6G3L_R P  /Q   !D
M ("!Q1 ! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " "S
M<JE4Z]J>69@#  "Y#   &0              @('N% $ >&PO=V]R:W-H965T
M<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( +-RJ521S7*KNP,  %8/   9
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M970U-"YX;6Q02P$"% ,4    " "S<JE4'3LO^[D"   S!P  &0
M    @($,*0$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    (
M +-RJ51W2A7&7@@  "@N   9              " @?PK 0!X;"]W;W)K<VAE
M971S+W-H965T-38N>&UL4$L! A0#%     @ LW*I5%RRC/= !   3!,  !D
M             ("!D30! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"
M% ,4    " "S<JE4C\L,54<"  #9!@  &0              @($(.0$ >&PO
M=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( +-RJ51:6P?.Q ,
M *X.   9              " @88[ 0!X;"]W;W)K<VAE971S+W-H965T-3DN
M>&UL4$L! A0#%     @ LW*I5(^+Z;H: P  UPL  !D              ("!
M@3\! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " "S<JE4
MRF/G _8%  "6(P  &0              @('20@$ >&PO=V]R:W-H965T<R]S
M:&5E=#8Q+GAM;%!+ 0(4 Q0    ( +-RJ51F;C%V.P(  !H&   9
M      " @?]( 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%
M  @ LW*I5+SB7K!Z!   P1D  !D              ("!<4L! 'AL+W=O<FMS
M:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    " "S<JE4IW(D<>P&  #4)
M&0              @($B4 $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+
M 0(4 Q0    ( +-RJ53K)74M)00  *X2   9              " @457 0!X
M;"]W;W)K<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ LW*I5/E^58J7
M!   \1(  !D              ("!H5L! 'AL+W=O<FMS:&5E=',O<VAE970V
M-BYX;6Q02P$"% ,4    " "S<JE4^:BD>.("  #""   &0
M@(%O8 $ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( +-R
MJ50!UGIZ+0(   $%   9              " @8AC 0!X;"]W;W)K<VAE971S
M+W-H965T-C@N>&UL4$L! A0#%     @ LW*I5 %:,:,K P  B H  !D
M         ("![&4! 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4
M    " "S<JE4]?EX@!X$  "4$   &0              @(%.:0$ >&PO=V]R
M:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( +-RJ51^S2>/:@,  -H6
M   -              "  :-M 0!X;"]S='EL97,N>&UL4$L! A0#%     @
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H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !. $X 614  #5\ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>247</ContextCount>
  <ElementCount>325</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>89</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/DescriptionofBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Private Placement Issuance</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/PrivatePlacementIssuance</Role>
      <ShortName>Private Placement Issuance</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - NIH Contract</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/NIHContract</Role>
      <ShortName>NIH Contract</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2116105 - Disclosure - Development Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/DevelopmentAgreement</Role>
      <ShortName>Development Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2118106 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2123107 - Disclosure - Goodwill and Intangible Assets, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/GoodwillandIntangibleAssetsnet</Role>
      <ShortName>Goodwill and Intangible Assets, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2128108 - Disclosure - Balance Sheet Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BalanceSheetDetails</Role>
      <ShortName>Balance Sheet Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2135109 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2139110 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2143111 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/FairValueofFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2147112 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2151113 - Disclosure - Stock-Based Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/StockBasedPlans</Role>
      <ShortName>Stock-Based Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2157114 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2159115 - Disclosure - Information About Geographic Areas</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/InformationAboutGeographicAreas</Role>
      <ShortName>Information About Geographic Areas</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2161116 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2162117 - Disclosure - Subsequent Event</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SubsequentEvent</Role>
      <ShortName>Subsequent Event</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://fluidigm.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Private Placement Issuance (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/PrivatePlacementIssuanceTables</Role>
      <ShortName>Private Placement Issuance (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/PrivatePlacementIssuance</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2313303 - Disclosure - NIH Contract (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/NIHContractTables</Role>
      <ShortName>NIH Contract (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/NIHContract</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2319304 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/Revenue</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2324305 - Disclosure - Goodwill and Intangible Assets, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables</Role>
      <ShortName>Goodwill and Intangible Assets, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/GoodwillandIntangibleAssetsnet</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2329306 - Disclosure - Balance Sheet Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BalanceSheetDetailsTables</Role>
      <ShortName>Balance Sheet Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/BalanceSheetDetails</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/Debt</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2340308 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/Leases</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2344309 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/FairValueofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/FairValueofFinancialInstruments</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2348310 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/ShareholdersEquity</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2352311 - Disclosure - Stock-Based Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/StockBasedPlansTables</Role>
      <ShortName>Stock-Based Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fluidigm.com/role/StockBasedPlans</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Private Placement Issuance - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails</Role>
      <ShortName>Private Placement Issuance - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Private Placement Issuance - Schedule of Carrying Value of the Bridge Loans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails</Role>
      <ShortName>Private Placement Issuance - Schedule of Carrying Value of the Bridge Loans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - NIH Contract - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/NIHContractNarrativeDetails</Role>
      <ShortName>NIH Contract - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - NIH Contract (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/NIHContractDetails</Role>
      <ShortName>NIH Contract (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fluidigm.com/role/NIHContractTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Development Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/DevelopmentAgreementDetails</Role>
      <ShortName>Development Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fluidigm.com/role/DevelopmentAgreement</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2420409 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails</Role>
      <ShortName>Revenue - Schedule of Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2421410 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - Revenue - Performance Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/RevenuePerformanceObligationsDetails</Role>
      <ShortName>Revenue - Performance Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails</Role>
      <ShortName>Goodwill and Intangible Assets, net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2427414 - Disclosure - Goodwill and Intangible Assets, net - Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Intangible Assets, net - Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2430415 - Disclosure - Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails</Role>
      <ShortName>Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2431416 - Disclosure - Balance Sheet Details - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails</Role>
      <ShortName>Balance Sheet Details - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2432417 - Disclosure - Balance Sheet Details - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails</Role>
      <ShortName>Balance Sheet Details - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - Balance Sheet Details - Accrued Compensation and Related Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails</Role>
      <ShortName>Balance Sheet Details - Accrued Compensation and Related Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - Balance Sheet Details - Warranty Accrual (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails</Role>
      <ShortName>Balance Sheet Details - Warranty Accrual (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2437420 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2438421 - Disclosure - Debt - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/DebtScheduleofDebtDetails</Role>
      <ShortName>Debt - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2441422 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2442423 - Disclosure - Leases - Supplemental Balance sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails</Role>
      <ShortName>Leases - Supplemental Balance sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2445424 - Disclosure - Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails</Role>
      <ShortName>Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2446425 - Disclosure - Fair Value of Financial Instruments - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails</Role>
      <ShortName>Fair Value of Financial Instruments - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2449426 - Disclosure - Shareholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/ShareholdersEquityNarrativeDetails</Role>
      <ShortName>Shareholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2450427 - Disclosure - Shareholders' Equity - Schedule of Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails</Role>
      <ShortName>Shareholders' Equity - Schedule of Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2453428 - Disclosure - Stock-Based Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/StockBasedPlansNarrativeDetails</Role>
      <ShortName>Stock-Based Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2454429 - Disclosure - Stock-Based Plans - Restricted and Performance Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails</Role>
      <ShortName>Stock-Based Plans - Restricted and Performance Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2455430 - Disclosure - Stock-Based Plans - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Plans - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2456431 - Disclosure - Stock-Based Plans - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Plans - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2458432 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fluidigm.com/role/IncomeTaxes</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2460433 - Disclosure - Information About Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/InformationAboutGeographicAreasDetails</Role>
      <ShortName>Information About Geographic Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fluidigm.com/role/InformationAboutGeographicAreas</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="fldm-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2463434 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fluidigm.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fluidigm.com/role/SubsequentEvent</ParentRole>
      <Position>70</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="fldm-20220331.htm">fldm-20220331.htm</File>
    <File>exhibit31110q1q2022.htm</File>
    <File>exhibit31210q1q2022.htm</File>
    <File>exhibit32110q1q2022.htm</File>
    <File>exhibit32210q1q2022.htm</File>
    <File>fldm-20220331.xsd</File>
    <File>fldm-20220331_cal.xml</File>
    <File>fldm-20220331_def.xml</File>
    <File>fldm-20220331_lab.xml</File>
    <File>fldm-20220331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fldm-20220331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="700">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>89
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "fldm-20220331.htm": {
   "axisCustom": 1,
   "axisStandard": 25,
   "contextCount": 247,
   "dts": {
    "calculationLink": {
     "local": [
      "fldm-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fldm-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "fldm-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fldm-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fldm-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "fldm-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 538,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 6,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 11
   },
   "keyCustom": 57,
   "keyStandard": 268,
   "memberCustom": 36,
   "memberStandard": 50,
   "nsprefix": "fldm",
   "nsuri": "http://fluidigm.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://fluidigm.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fldm:DebtAndEquityIssuanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Private Placement Issuance",
     "role": "http://fluidigm.com/role/PrivatePlacementIssuance",
     "shortName": "Private Placement Issuance",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fldm:DebtAndEquityIssuanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - NIH Contract",
     "role": "http://fluidigm.com/role/NIHContract",
     "shortName": "NIH Contract",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116105 - Disclosure - Development Agreement",
     "role": "http://fluidigm.com/role/DevelopmentAgreement",
     "shortName": "Development Agreement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118106 - Disclosure - Revenue",
     "role": "http://fluidigm.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123107 - Disclosure - Goodwill and Intangible Assets, net",
     "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnet",
     "shortName": "Goodwill and Intangible Assets, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128108 - Disclosure - Balance Sheet Details",
     "role": "http://fluidigm.com/role/BalanceSheetDetails",
     "shortName": "Balance Sheet Details",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135109 - Disclosure - Debt",
     "role": "http://fluidigm.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139110 - Disclosure - Leases",
     "role": "http://fluidigm.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143111 - Disclosure - Fair Value of Financial Instruments",
     "role": "http://fluidigm.com/role/FairValueofFinancialInstruments",
     "shortName": "Fair Value of Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147112 - Disclosure - Shareholders' Equity",
     "role": "http://fluidigm.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151113 - Disclosure - Stock-Based Plans",
     "role": "http://fluidigm.com/role/StockBasedPlans",
     "shortName": "Stock-Based Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157114 - Disclosure - Income Taxes",
     "role": "http://fluidigm.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2159115 - Disclosure - Information About Geographic Areas",
     "role": "http://fluidigm.com/role/InformationAboutGeographicAreas",
     "shortName": "Information About Geographic Areas",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2161116 - Disclosure - Commitments and Contingencies",
     "role": "http://fluidigm.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2162117 - Disclosure - Subsequent Event",
     "role": "http://fluidigm.com/role/SubsequentEvent",
     "shortName": "Subsequent Event",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Private Placement Issuance (Tables)",
     "role": "http://fluidigm.com/role/PrivatePlacementIssuanceTables",
     "shortName": "Private Placement Issuance (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313303 - Disclosure - NIH Contract (Tables)",
     "role": "http://fluidigm.com/role/NIHContractTables",
     "shortName": "NIH Contract (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319304 - Disclosure - Revenue (Tables)",
     "role": "http://fluidigm.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324305 - Disclosure - Goodwill and Intangible Assets, net (Tables)",
     "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables",
     "shortName": "Goodwill and Intangible Assets, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329306 - Disclosure - Balance Sheet Details (Tables)",
     "role": "http://fluidigm.com/role/BalanceSheetDetailsTables",
     "shortName": "Balance Sheet Details (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - Debt (Tables)",
     "role": "http://fluidigm.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fldm:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340308 - Disclosure - Leases (Tables)",
     "role": "http://fluidigm.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "fldm:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344309 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "role": "http://fluidigm.com/role/FairValueofFinancialInstrumentsTables",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348310 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://fluidigm.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352311 - Disclosure - Stock-Based Plans (Tables)",
     "role": "http://fluidigm.com/role/StockBasedPlansTables",
     "shortName": "Stock-Based Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)",
     "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails",
     "shortName": "Summary of Significant Accounting Policies - Accumulated Other Comprehensive Loss (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i26bb80925b7243dd86ac47e3aa792a15_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)",
     "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails",
     "shortName": "Summary of Significant Accounting Policies - Potential Common Shares Excluded from Computations of Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Private Placement Issuance - Narrative (Details)",
     "role": "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
     "shortName": "Private Placement Issuance - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "ibe298cbdde5842d1abc79d95ddf9275c_I20220123",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesUnrealizedGainLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Private Placement Issuance - Schedule of Carrying Value of the Bridge Loans (Details)",
     "role": "http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails",
     "shortName": "Private Placement Issuance - Schedule of Carrying Value of the Bridge Loans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i9eea7cdcda1e45daaff6b533cd9ab2d6_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InterestPayableCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - NIH Contract - Narrative (Details)",
     "role": "http://fluidigm.com/role/NIHContractNarrativeDetails",
     "shortName": "NIH Contract - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - NIH Contract (Details)",
     "role": "http://fluidigm.com/role/NIHContractDetails",
     "shortName": "NIH Contract (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "fldm:ResearchAndDevelopmentArrangementContractToPerformForOthersAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Development Agreement (Details)",
     "role": "http://fluidigm.com/role/DevelopmentAgreementDetails",
     "shortName": "Development Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "ia846fcc54289492ea9f2caf7da738fb2_I20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "fldm:CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420409 - Disclosure - Revenue - Schedule of Disaggregation of Revenue (Details)",
     "role": "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails",
     "shortName": "Revenue - Schedule of Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i5a58b69e2fd947c19feffcbbf475f7fb_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421410 - Disclosure - Revenue - Narrative (Details)",
     "role": "http://fluidigm.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - Revenue - Performance Obligations (Details)",
     "role": "http://fluidigm.com/role/RevenuePerformanceObligationsDetails",
     "shortName": "Revenue - Performance Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - Goodwill and Intangible Assets, net - Narrative (Details)",
     "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
     "shortName": "Goodwill and Intangible Assets, net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "ic3ccc2277618429ba4dd1bf8f8ac9415_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)",
     "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, net - Schedule of Finite-lived Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "ic84a49a6264541b9a2ad518751a09a27_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "role": "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427414 - Disclosure - Goodwill and Intangible Assets, net - Future Amortization Expense (Details)",
     "role": "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
     "shortName": "Goodwill and Intangible Assets, net - Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430415 - Disclosure - Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)",
     "role": "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails",
     "shortName": "Balance Sheet Details - Summary of Cash and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431416 - Disclosure - Balance Sheet Details - Inventories (Details)",
     "role": "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails",
     "shortName": "Balance Sheet Details - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432417 - Disclosure - Balance Sheet Details - Property and Equipment (Details)",
     "role": "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
     "shortName": "Balance Sheet Details - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WorkersCompensationLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - Balance Sheet Details - Accrued Compensation and Related Benefits (Details)",
     "role": "http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails",
     "shortName": "Balance Sheet Details - Accrued Compensation and Related Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WorkersCompensationLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - Balance Sheet Details - Warranty Accrual (Details)",
     "role": "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails",
     "shortName": "Balance Sheet Details - Warranty Accrual (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437420 - Disclosure - Debt - Narrative (Details)",
     "role": "http://fluidigm.com/role/DebtNarrativeDetails",
     "shortName": "Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i6c05f390be1e4fba9543e3eef05cd18a_I20210802",
      "decimals": "-5",
      "lang": "en-US",
      "name": "fldm:DebtInstrumentCovenantConvertibleDebtThreshold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i918712e2e4c4473592c78603409a2035_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438421 - Disclosure - Debt - Schedule of Debt (Details)",
     "role": "http://fluidigm.com/role/DebtScheduleofDebtDetails",
     "shortName": "Debt - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i736e4e930c62488998bc7af6f80cb9a5_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441422 - Disclosure - Leases - Narrative (Details)",
     "role": "http://fluidigm.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "fldm:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "fldm:OperatingLeaseRightOfUseAssetGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442423 - Disclosure - Leases - Supplemental Balance sheet (Details)",
     "role": "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails",
     "shortName": "Leases - Supplemental Balance sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "fldm:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "fldm:OperatingLeaseRightOfUseAssetGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i7edfc49d39cd47138bdc5064597c073b_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Stockholders' Equity",
     "role": "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
     "shortName": "Condensed Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i7edfc49d39cd47138bdc5064597c073b_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445424 - Disclosure - Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)",
     "role": "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails",
     "shortName": "Fair Value of Financial Instruments - Summary of Investments and Cash Equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "id2106d7d27e2429382ccfccea124e2d2_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446425 - Disclosure - Fair Value of Financial Instruments - Schedule of Debt (Details)",
     "role": "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
     "shortName": "Fair Value of Financial Instruments - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i4c347987f267431784a940da9799e057_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "ifbc7c42ab7c948dbb536b605def058fd_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "fldm:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449426 - Disclosure - Shareholders' Equity - Narrative (Details)",
     "role": "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
     "shortName": "Shareholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450427 - Disclosure - Shareholders' Equity - Schedule of Stock Options (Details)",
     "role": "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
     "shortName": "Shareholders' Equity - Schedule of Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "id7e1d70fc37c4900b64ff49301b03fd4_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i8b311a9055cd4350a32fbf48c1d51dcf_D20210501-20210531",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453428 - Disclosure - Stock-Based Plans - Narrative (Details)",
     "role": "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
     "shortName": "Stock-Based Plans - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i8b311a9055cd4350a32fbf48c1d51dcf_D20210501-20210531",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i1b27a08b375d4bd6a7bdb7050cb92f97_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454429 - Disclosure - Stock-Based Plans - Restricted and Performance Stock Units (Details)",
     "role": "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails",
     "shortName": "Stock-Based Plans - Restricted and Performance Stock Units (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i8c7e2f88ecd44b699576322d8f11e546_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "ia1e4f45acb2a42a08ca6d6eca8cc52a1_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455430 - Disclosure - Stock-Based Plans - Stock Option Activity (Details)",
     "role": "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails",
     "shortName": "Stock-Based Plans - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456431 - Disclosure - Stock-Based Plans - Stock-Based Compensation Expense (Details)",
     "role": "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails",
     "shortName": "Stock-Based Plans - Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458432 - Disclosure - Income Taxes (Details)",
     "role": "http://fluidigm.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460433 - Disclosure - Information About Geographic Areas (Details)",
     "role": "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
     "shortName": "Information About Geographic Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i29e61f9e346c4c1e80fed44ed1f1e293_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463434 - Disclosure - Subsequent Events (Details)",
     "role": "http://fluidigm.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "ib980c3b074f94dd4a574cde692cff868_I20220404",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Description of Business",
     "role": "http://fluidigm.com/role/DescriptionofBusiness",
     "shortName": "Description of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://fluidigm.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fldm-20220331.htm",
      "contextRef": "i75f7bd7b85bb492396437a65fd0a1830_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 89,
   "tag": {
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "China"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://fluidigm.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "fldm_A2022InducementEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2022 Inducement Equity Incentive Plan",
        "label": "2022 Inducement Equity Incentive Plan [Member]",
        "terseLabel": "2022 Inducement Equity Incentive Plan"
       }
      }
     },
     "localname": "A2022InducementEquityIncentivePlanMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_AccruedBonusesNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Bonuses, Noncurrent",
        "label": "Accrued Bonuses, Noncurrent",
        "terseLabel": "Accrued bonuses, noncurrent"
       }
      }
     },
     "localname": "AccruedBonusesNoncurrent",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_AssetRetirementObligationsIncurredButNotYetPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Retirement Obligations Incurred But Not Yet Paid",
        "label": "Asset Retirement Obligations Incurred But Not Yet Paid",
        "terseLabel": "Asset retirement obligations"
       }
      }
     },
     "localname": "AssetRetirementObligationsIncurredButNotYetPaid",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Schedule of Balance Sheet Information"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "fldm_BridgeLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bridge Loans",
        "label": "Bridge Loans [Member]",
        "terseLabel": "Bridge Loans"
       }
      }
     },
     "localname": "BridgeLoansMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_CasdinMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Casdin",
        "label": "Casdin [Member]",
        "terseLabel": "Casdin"
       }
      }
     },
     "localname": "CasdinMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_CashAndMoneyMarketFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Money Market Funds",
        "label": "Cash And Money Market Funds [Member]",
        "terseLabel": "Cash and money market funds"
       }
      }
     },
     "localname": "CashAndMoneyMarketFundsMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_CertainEmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certain Employee [Member]",
        "label": "Certain Employee [Member]",
        "terseLabel": "Certain Employee"
       }
      }
     },
     "localname": "CertainEmployeeMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_CollaborationRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Revenue",
        "label": "Collaboration Revenue [Member]",
        "terseLabel": "Development revenue",
        "verboseLabel": "Development revenue"
       }
      }
     },
     "localname": "CollaborationRevenueMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/DevelopmentAgreementDetails",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangements, Annual Payments Receivable Under Development Agreement",
        "label": "Collaborative Arrangements, Annual Payments Receivable Under Development Agreement",
        "terseLabel": "Annual payments receivable"
       }
      }
     },
     "localname": "CollaborativeArrangementsAnnualPaymentsReceivableUnderDevelopmentAgreement",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/DevelopmentAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer Equipment And Software [Member]",
        "label": "Computer Equipment And Software [Member]",
        "terseLabel": "Computer equipment and software"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumables [Member]",
        "label": "Consumables [Member]",
        "terseLabel": "Consumables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_ContractWithCustomerLiabilityIncreaseFromCashReceipts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Increase From Cash Receipts",
        "label": "Contract With Customer, Liability, Increase From Cash Receipts",
        "terseLabel": "Additional advance payments received"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityIncreaseFromCashReceipts",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_DVSSciencesInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DVS Sciences, Inc. [Member]",
        "label": "DVS Sciences, Inc. [Member]",
        "terseLabel": "DVS Sciences, Inc."
       }
      }
     },
     "localname": "DVSSciencesInc.Member",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_DebtAndEquityIssuanceTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt And Equity Issuance",
        "label": "Debt And Equity Issuance [Text Block]",
        "terseLabel": "Private Placement Issuance"
       }
      }
     },
     "localname": "DebtAndEquityIssuanceTextBlock",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuance"
     ],
     "xbrltype": "textBlockItemType"
    },
    "fldm_DebtCovenantPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period",
        "label": "Debt Covenant Period [Axis]",
        "terseLabel": "Debt Covenant Period [Axis]"
       }
      }
     },
     "localname": "DebtCovenantPeriodAxis",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fldm_DebtCovenantPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period [Domain]",
        "label": "Debt Covenant Period [Domain]",
        "terseLabel": "Debt Covenant Period [Domain]"
       }
      }
     },
     "localname": "DebtCovenantPeriodDomain",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_DebtCovenantPeriodFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant, Period Four",
        "label": "Debt Covenant, Period Four [Member]",
        "terseLabel": "Debt Covenant, Period Four"
       }
      }
     },
     "localname": "DebtCovenantPeriodFourMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_DebtCovenantPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant Period One",
        "label": "Debt Covenant Period One [Member]",
        "terseLabel": "Debt Covenant Period One"
       }
      }
     },
     "localname": "DebtCovenantPeriodOneMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_DebtCovenantPeriodThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant, Period Three",
        "label": "Debt Covenant, Period Three [Member]",
        "terseLabel": "Debt Covenant, Period Three"
       }
      }
     },
     "localname": "DebtCovenantPeriodThreeMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_DebtCovenantPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant, Period Two",
        "label": "Debt Covenant, Period Two [Member]",
        "terseLabel": "Debt Covenant, Period Two"
       }
      }
     },
     "localname": "DebtCovenantPeriodTwoMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssued": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Calculation To Determine Shares Issued",
        "label": "Debt Instrument, Convertible, Calculation To Determine Shares Issued",
        "terseLabel": "Divisor used to determine number of shares to issue"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCalculationToDetermineSharesIssued",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Calculation To Determine Shares Issued, Divisor",
        "label": "Debt Instrument, Convertible, Calculation To Determine Shares Issued, Divisor",
        "terseLabel": "Divisor used to determine number of shares to issue"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCalculationToDetermineSharesIssuedDivisor",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "fldm_DebtInstrumentCovenantConvertibleDebtThreshold": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Convertible Debt Threshold",
        "label": "Debt Instrument, Covenant, Convertible Debt Threshold",
        "terseLabel": "Convertible debt"
       }
      }
     },
     "localname": "DebtInstrumentCovenantConvertibleDebtThreshold",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_DebtInstrumentCovenantMinimumAdjustedQuickRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Minimum Adjusted Quick Ratio",
        "label": "Debt Instrument, Covenant, Minimum Adjusted Quick Ratio",
        "terseLabel": "Adjusted quick ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantMinimumAdjustedQuickRatio",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "fldm_DebtInstrumentFaceAmountPerInstrument": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Face Amount, Per Instrument",
        "label": "Debt Instrument, Face Amount, Per Instrument",
        "terseLabel": "Debt instrument, face amount, per instrument"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmountPerInstrument",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_DebtInstrumentIncrementalPaymentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Incremental Payment, Percent",
        "label": "Debt Instrument, Incremental Payment, Percent",
        "terseLabel": "Term loan advances percentage"
       }
      }
     },
     "localname": "DebtInstrumentIncrementalPaymentPercent",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_DebtInstrumentPeriodicPaymentNumberOfInstallments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment, Number Of Installments",
        "label": "Debt Instrument, Periodic Payment, Number Of Installments",
        "terseLabel": "Number of installments"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentNumberOfInstallments",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "fldm_DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price",
        "label": "Debt Instrument, Redemption Condition, Stock Value Exceeding Percentage of Conversion Price",
        "terseLabel": "Debt redemption conditioned upon common stock value exceeding a percentage of the conversion price"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionConditionStockValueExceedingPercentageofConversionPrice",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_DeferredGrantIncomeCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/NIHContractDetails": {
       "order": 1.0,
       "parentTag": "fldm_DeferredGrantRevenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Grant Income, Current",
        "label": "Deferred Grant Income, Current",
        "terseLabel": "Deferred grant income, current"
       }
      }
     },
     "localname": "DeferredGrantIncomeCurrent",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_DeferredGrantIncomeNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/NIHContractDetails": {
       "order": 2.0,
       "parentTag": "fldm_DeferredGrantRevenue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Grant Income, Noncurrent",
        "label": "Deferred Grant Income, Noncurrent",
        "terseLabel": "Deferred grant income, non-current"
       }
      }
     },
     "localname": "DeferredGrantIncomeNoncurrent",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_DeferredGrantRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/NIHContractDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Grant Revenue",
        "label": "Deferred Grant Revenue",
        "totalLabel": "Total deferred grant income"
       }
      }
     },
     "localname": "DeferredGrantRevenue",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_DeferredGrantRevenueCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Grant Revenue, Current",
        "label": "Deferred Grant Revenue, Current",
        "terseLabel": "Deferred grant income, current"
       }
      }
     },
     "localname": "DeferredGrantRevenueCurrent",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_DeferredGrantRevenueNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Grant Revenue, Noncurrent",
        "label": "Deferred Grant Revenue, Noncurrent",
        "terseLabel": "Deferred grant income, non-current"
       }
      }
     },
     "localname": "DeferredGrantRevenueNoncurrent",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_EmployeeStockPurchasePlanOfferingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan, Offering Period",
        "label": "Employee Stock Purchase Plan, Offering Period",
        "terseLabel": "ESPP, offering period"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanOfferingPeriod",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Incentive Plan [Member]",
        "label": "Equity Incentive Plan [Member]",
        "terseLabel": "Equity Incentive Plan"
       }
      }
     },
     "localname": "EquityIncentivePlanMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_EquityIncentivePlanTwentyElevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Incentive Plan Twenty Eleven [Member]",
        "label": "Equity Incentive Plan Twenty Eleven [Member]",
        "terseLabel": "2011 Equity Incentive Plan"
       }
      }
     },
     "localname": "EquityIncentivePlanTwentyElevenMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_ExchangeConvertibleSeniorNotesDue2034Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exchange Convertible Senior Notes Due 2034 [Member]",
        "label": "Exchange Convertible Senior Notes Due 2034 [Member]",
        "terseLabel": "Exchange Convertible Senior Notes due 2034"
       }
      }
     },
     "localname": "ExchangeConvertibleSeniorNotesDue2034Member",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_InitialConversionPriceOfStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Conversion Price Of Stock",
        "label": "Initial Conversion Price Of Stock",
        "terseLabel": "Initial conversion price of stock (in usd per share)"
       }
      }
     },
     "localname": "InitialConversionPriceOfStock",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "fldm_InstruNorASMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "InstruNor AS [Member]",
        "label": "InstruNor AS [Member]",
        "terseLabel": "InstruNor AS"
       }
      }
     },
     "localname": "InstruNorASMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_InstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments [Member]",
        "label": "Instruments [Member]",
        "terseLabel": "Instruments"
       }
      }
     },
     "localname": "InstrumentsMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_LaboratoryAndManufacturingEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory And Manufacturing Equipment [Member]",
        "label": "Laboratory And Manufacturing Equipment [Member]",
        "terseLabel": "Laboratory and manufacturing equipment"
       }
      }
     },
     "localname": "LaboratoryAndManufacturingEquipmentMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_LesseeOperatingLeaseRemainingTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Remaining Term Of Contract",
        "label": "Lessee, Operating Lease, Remaining Term Of Contract",
        "terseLabel": "Remaining lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingTermOfContract",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Inventory",
        "terseLabel": "Percentage of eligible inventory"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleInventory",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Percentage Of Eligible Receivables",
        "terseLabel": "Percentage of eligible receivables"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleReceivables",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_LossOnForwardSaleOfStock": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss On Forward Sale Of Stock",
        "label": "Loss On Forward Sale Of Stock",
        "negatedTerseLabel": "Loss on forward sale of Series B Preferred Stock",
        "terseLabel": "Loss on forward sale of Series B Preferred Stock"
       }
      }
     },
     "localname": "LossOnForwardSaleOfStock",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_NonCashRightOfUseAssetsAndLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Cash Right -of-Use Assets and Lease Liabilities",
        "label": "Non-Cash Right -of-Use Assets and Lease Liabilities",
        "terseLabel": "Non-cash right-of-use assets and lease liabilities"
       }
      }
     },
     "localname": "NonCashRightOfUseAssetsAndLeaseLiabilities",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement",
        "label": "Number Of Months To Vest Ratably After First Anniversary Of Vesting Commencement",
        "terseLabel": "Number of months over which options vest ratably"
       }
      }
     },
     "localname": "NumberOfMonthsToVestRatablyAfterFirstAnniversaryOfVestingCommencement",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_OperatingLeaseRightOfUseAssetAccumulatedAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset, Accumulated Amortization",
        "label": "Operating Lease, Right-Of-Use Asset, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAccumulatedAmortization",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_OperatingLeaseRightOfUseAssetGross": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Right-Of-Use Asset, Gross",
        "label": "Operating Lease, Right-Of-Use Asset, Gross",
        "terseLabel": "Total operating lease right-of-use assets, gross"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetGross",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options, Performance Share Units And Restricted Stock Units [Member]",
        "label": "Options, Performance Share Units And Restricted Stock Units [Member]",
        "terseLabel": "Restricted stock units, stock options and performance share units"
       }
      }
     },
     "localname": "OptionsPerformanceShareUnitsAndRestrictedStockUnitsMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_PatentsandLicenseAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents and License Agreements [Member]",
        "label": "Patents and License Agreements [Member]",
        "terseLabel": "Patents and licenses",
        "verboseLabel": "Patents and Licenses Amortization Expense"
       }
      }
     },
     "localname": "PatentsandLicenseAgreementsMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_PortionOfStockOptionsVestOnFirstAnniversary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion Of Stock Options Vest On First Anniversary",
        "label": "Portion Of Stock Options Vest On First Anniversary",
        "terseLabel": "Rate at which outstanding options vest on the first anniversary of the option grant date"
       }
      }
     },
     "localname": "PortionOfStockOptionsVestOnFirstAnniversary",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_PreferredStockFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred Stock, Fair Value Disclosure",
        "label": "Preferred Stock, Fair Value Disclosure",
        "terseLabel": "Fair value of preferred stock"
       }
      }
     },
     "localname": "PreferredStockFairValueDisclosure",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ProceedsFromResearchAndDevelopmentGrant": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Research and Development Grant",
        "label": "Proceeds from Research and Development Grant",
        "terseLabel": "Proceeds from NIH Contract"
       }
      }
     },
     "localname": "ProceedsFromResearchAndDevelopmentGrant",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/NIHContractDetails": {
       "order": 3.0,
       "parentTag": "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Accumulated Depreciation Expenses",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Accumulated Depreciation Expenses",
        "negatedTerseLabel": "Cumulative amounts applied against depreciation expense for assets placed in service"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersAccumulatedDepreciationExpenses",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Amount",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Amount",
        "terseLabel": "Cash receipts from milestones achieved"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersAmount",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/NIHContractDetails": {
       "order": 2.0,
       "parentTag": "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others , Assets Placed In Service , Gross",
        "label": "Research And Development Arrangement, Contract To Perform For Others , Assets Placed In Service , Gross",
        "terseLabel": "Assets placed in service, gross"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersAssetsPlacedInServiceGross",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractDetails",
      "http://fluidigm.com/role/NIHContractNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Arrangement, Contract to Perform for Others, Capital Expenditures",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Capital Expenditures",
        "terseLabel": "Capital expenditures incurred"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpenditures",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement Contract To Perform For Others Capital Expenditures, To Be Incurred",
        "label": "Research And Development Arrangement Contract To Perform For Others Capital Expenditures, To Be Incurred",
        "terseLabel": "Capital expenditures expected to be incurred"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersCapitalExpendituresToBeIncurred",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/NIHContractDetails": {
       "order": 1.0,
       "parentTag": "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Construction in Progress, Gross",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Construction in Progress, Gross",
        "terseLabel": "Construction-in-progress"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersConstructionInProgressGross",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractDetails",
      "http://fluidigm.com/role/NIHContractNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Estimated Future Capital Expenditures",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Estimated Future Capital Expenditures",
        "terseLabel": "Estimated future capital expenditures"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersEstimatedFutureCapitalExpenditures",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Expenses",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Expenses",
        "negatedTerseLabel": "Cumulative amounts applied against operating costs (excluding depreciation)"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersExpenses",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Maximum Contract Value",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Maximum Contract Value",
        "terseLabel": "Maximum contract value"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersMaximumContractValue",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Other Income",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Other Income",
        "negatedTerseLabel": "Cumulative amounts recognized as non-operating income"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersOtherIncome",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/NIHContractDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research And Development Arrangement, Contract To Perform For Others, Property and Equipment, Net",
        "label": "Research And Development Arrangement, Contract To Perform For Others, Property and Equipment, Net",
        "totalLabel": "Carrying value of property and equipment, net"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersPropertyAndEquipmentNet",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/NIHContractDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_RestrictedCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Cash And Cash Equivalents [Member]",
        "label": "Restricted Cash And Cash Equivalents [Member]",
        "terseLabel": "Cash-restricted"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_RestrictedStockAndPerformanceShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock And Performance Share Units [Member]",
        "label": "Restricted Stock And Performance Share Units [Member]",
        "terseLabel": "Securities To Be Issued Upon Release Of Restricted Stock and Performance Share Units at Maximum"
       }
      }
     },
     "localname": "RestrictedStockAndPerformanceShareUnitsMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_SeniorConvertibleNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Convertible Notes Due 2024 [Member]",
        "label": "Senior Convertible Notes Due 2024 [Member]",
        "netLabel": "2019 Notes",
        "terseLabel": "Senior Convertible Notes Due 2024",
        "verboseLabel": "2019 Notes"
       }
      }
     },
     "localname": "SeniorConvertibleNotesDue2024Member",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_SeniorConvertibleNotesdue2034Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Convertible Notes due 2034 [Member]",
        "label": "Senior Convertible Notes due 2034 [Member]",
        "netLabel": "2014 Notes",
        "terseLabel": "Senior Convertible Notes due 2034",
        "verboseLabel": "2014 Notes"
       }
      }
     },
     "localname": "SeniorConvertibleNotesdue2034Member",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_SeriesB1ConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B-1 Convertible Preferred Stock",
        "label": "Series B-1 Convertible Preferred Stock [Member]",
        "terseLabel": "Series B-1 Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesB1ConvertiblePreferredStockMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_SeriesB2ConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B-2 Convertible Preferred Stock",
        "label": "Series B-2 Convertible Preferred Stock [Member]",
        "terseLabel": "Series B-2 Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesB2ConvertiblePreferredStockMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Percentage Of Performance Units Expected To Vest",
        "terseLabel": "Percentage of performance period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfPerformanceUnitsExpectedToVest",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Adjustment in Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Adjustment in Period",
        "terseLabel": "Performance adjustment for 2018 awards (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriod",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Adjustment in Period, Weighted Average Grant Date Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Adjustment in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Performance adjustment for 2018 awards (in usd per share )"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceAdjustmentInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value",
        "terseLabel": "Unvested awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number",
        "terseLabel": "Unvested awards (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Exercise Price",
        "terseLabel": "Unvested awards (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageExercisePrice",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expected to Vest, Weighted Average Remaining Contractual Term 1",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Weighted Average Remaining Contractual Term 1",
        "terseLabel": "Unvested awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement by Share Based Payment Award, Options, Vested, Aggregate Intrinsic Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Aggregate Intrinsic Value",
        "terseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAggregateIntrinsicValue",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Exercise Price",
        "terseLabel": "Vested (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageExercisePrice",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "fldm_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested Weighted Average Remaining Contractual Term One",
        "verboseLabel": "Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedWeightedAverageRemainingContractualTermOne",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "fldm_SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Maximum Employee Purchase Amount",
        "terseLabel": "Maximum employee purchase amount"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardMaximumEmployeePurchaseAmount",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_ShareholdersEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Shareholders' Equity [Table]",
        "label": "Shareholders' Equity [Line Items]",
        "terseLabel": "Shareholders' Equity [Line Items]"
       }
      }
     },
     "localname": "ShareholdersEquityLineItems",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fldm_ShareholdersEquityTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholders' Equity [Table]",
        "label": "Shareholders' Equity [Table]",
        "terseLabel": "Shareholders' Equity [Table]"
       }
      }
     },
     "localname": "ShareholdersEquityTable",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "fldm_StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value",
        "label": "Stock Option Grants Exercise Price Minimum Percentage On Fair Market Value",
        "terseLabel": "Stock option grants exercise price minimum percentage on fair market value"
       }
      }
     },
     "localname": "StockOptionGrantsExercisePriceMinimumPercentageOnFairMarketValue",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "fldm_StockRepurchaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Liability",
        "label": "Stock Repurchase Liability",
        "terseLabel": "Obligation for Series B Preferred Stock"
       }
      }
     },
     "localname": "StockRepurchaseLiability",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "fldm_TwoThousandAndElevenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand And Eleven Equity Incentive Plan [Member]",
        "label": "Two Thousand And Eleven Equity Incentive Plan [Member]",
        "terseLabel": "Two Thousand And Eleven Equity Incentive Plan",
        "verboseLabel": "2011 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandAndElevenEquityIncentivePlanMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandAndFourteenConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand And Fourteen Convertible Notes [Member]",
        "label": "Two Thousand And Fourteen Convertible Notes [Member]",
        "terseLabel": "2014 Convertible Notes"
       }
      }
     },
     "localname": "TwoThousandAndFourteenConvertibleNotesMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandAndNineteenConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand And Nineteen Convertible Notes [Member]",
        "label": "Two Thousand And Nineteen Convertible Notes [Member]",
        "terseLabel": "2019 Convertible Notes"
       }
      }
     },
     "localname": "TwoThousandAndNineteenConvertibleNotesMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand And Nineteen Convertible Notes Potential Make Whole Shares [Member]",
        "label": "Two Thousand And Nineteen Convertible Notes Potential Make Whole Shares [Member]",
        "terseLabel": "2019 Convertible Notes potential make-whole shares"
       }
      }
     },
     "localname": "TwoThousandAndNineteenConvertibleNotesPotentialMakeWholeSharesMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandAndSeventeenInducementAwardPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand And Seventeen Inducement Award Plan [Member]",
        "label": "Two Thousand And Seventeen Inducement Award Plan [Member]",
        "verboseLabel": "2017 Inducement Award Plan"
       }
      }
     },
     "localname": "TwoThousandAndSeventeenInducementAwardPlanMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandAndTenEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand And Ten Equity Incentive Plan [Member]",
        "label": "Two Thousand And Ten Equity Incentive Plan [Member]",
        "verboseLabel": "DVS Sciences Inc. 2010 Equity Incentive Plan"
       }
      }
     },
     "localname": "TwoThousandAndTenEquityIncentivePlanMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_TwoThousandSeventeenEmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Seventeen Employee Stock Purchase Plan [Member]",
        "label": "Two Thousand Seventeen Employee Stock Purchase Plan [Member]",
        "terseLabel": "2017 Employee Stock Purchase Plan",
        "verboseLabel": "2017 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "TwoThousandSeventeenEmployeeStockPurchasePlanMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_UndisclosedCustomerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undisclosed Customer",
        "label": "Undisclosed Customer [Member]",
        "terseLabel": "Undisclosed Customer"
       }
      }
     },
     "localname": "UndisclosedCustomerMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/DevelopmentAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "fldm_VikingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Viking",
        "label": "Viking [Member]",
        "terseLabel": "Viking"
       }
      }
     },
     "localname": "VikingMember",
     "nsuri": "http://fluidigm.com/20220331",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AmericasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Americas [Member]",
        "terseLabel": "Americas"
       }
      }
     },
     "localname": "AmericasMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "verboseLabel": "Asia-Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r61",
      "r63",
      "r114",
      "r115",
      "r243",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DevelopmentAgreementDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r242",
      "r273",
      "r326",
      "r328",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r489",
      "r492",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r242",
      "r273",
      "r326",
      "r328",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r489",
      "r492",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r181",
      "r310",
      "r314",
      "r452",
      "r488",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/DevelopmentAgreementDetails",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r181",
      "r310",
      "r314",
      "r452",
      "r488",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/DevelopmentAgreementDetails",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r242",
      "r273",
      "r323",
      "r326",
      "r328",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r489",
      "r492",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r242",
      "r273",
      "r323",
      "r326",
      "r328",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r489",
      "r492",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r62",
      "r63",
      "r114",
      "r115",
      "r243",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DevelopmentAgreementDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r182",
      "r183",
      "r310",
      "r315",
      "r491",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r182",
      "r183",
      "r310",
      "r315",
      "r491",
      "r500",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r187",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r43",
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r23",
      "r188",
      "r189"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable (net of allowances of $356 at each of March 31, 2022 and December\u00a031, 2021)"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedBonusesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r46"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Bonuses, Current",
        "terseLabel": "Accrued severance and retention bonuses"
       }
      }
     },
     "localname": "AccruedBonusesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "auth_ref": [
      "r11",
      "r46"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Payroll Taxes, Current",
        "terseLabel": "Accrued payroll taxes and other"
       }
      }
     },
     "localname": "AccruedPayrollTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedVacationCurrent": {
     "auth_ref": [
      "r10",
      "r46",
      "r322"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Vacation, Current",
        "terseLabel": "Accrued vacation"
       }
      }
     },
     "localname": "AccruedVacationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r41",
      "r214"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r66",
      "r67",
      "r68",
      "r72",
      "r79",
      "r80",
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Unrealized Gain (Loss) on Investments"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r26",
      "r70",
      "r71",
      "r72",
      "r477",
      "r497",
      "r498"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r79",
      "r80",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r69",
      "r72",
      "r79",
      "r80",
      "r81",
      "r118",
      "r119",
      "r120",
      "r394",
      "r493",
      "r494",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "verboseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r65",
      "r72",
      "r79",
      "r80",
      "r81",
      "r394",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation Adjustment"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Acquired finite-lived intangible assets, useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r24",
      "r359",
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r118",
      "r119",
      "r120",
      "r356",
      "r357",
      "r358",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r329",
      "r331",
      "r361",
      "r362"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r331",
      "r353",
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r30",
      "r190",
      "r195"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowances"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r100",
      "r255",
      "r262",
      "r263",
      "r425"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discounts, premiums and issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r100",
      "r201",
      "r209"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of developed technology",
        "verboseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive securities excluded from computations of net loss per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r111",
      "r167",
      "r171",
      "r177",
      "r193",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r391",
      "r395",
      "r411",
      "r437",
      "r439",
      "r458",
      "r474"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS",
        "verboseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r60",
      "r111",
      "r193",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r391",
      "r395",
      "r411",
      "r437",
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r332",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Consolidation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BridgeLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing which is expected to be replaced by a medium to long-term loan. The loan \"bridges\" the gap in time when otherwise no financing would be in place.",
        "label": "Bridge Loan [Member]",
        "terseLabel": "Bridge Loans"
       }
      }
     },
     "localname": "BridgeLoanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Operating lease right-of-use buildings"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r325",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r325",
      "r327",
      "r382",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r3",
      "r117",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Description of Business"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DescriptionofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r407",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r39",
      "r102"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "netLabel": "Cash and Cash Equivalents",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails",
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r96",
      "r102",
      "r106"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r96",
      "r412"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r108",
      "r111",
      "r133",
      "r134",
      "r135",
      "r137",
      "r139",
      "r145",
      "r146",
      "r147",
      "r193",
      "r227",
      "r231",
      "r232",
      "r233",
      "r236",
      "r237",
      "r270",
      "r271",
      "r276",
      "r280",
      "r411",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r385",
      "r386",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Development Agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DevelopmentAgreement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DevelopmentAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r52",
      "r219",
      "r463",
      "r481"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r220",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Number of remaining securities available for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r118",
      "r119",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r22",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r22",
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock: $0.001 par value, 200,000 shares authorized at March\u00a031, 2022 and December\u00a031, 2021; 77,199 and 76,919 shares issued and outstanding at March\u00a031, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r75",
      "r77",
      "r78",
      "r85",
      "r466",
      "r484"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r153",
      "r154",
      "r185",
      "r409",
      "r410",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r153",
      "r154",
      "r185",
      "r409",
      "r410",
      "r499",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r153",
      "r154",
      "r185",
      "r409",
      "r410",
      "r499",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r153",
      "r154",
      "r185",
      "r409",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r153",
      "r154",
      "r185",
      "r409",
      "r410",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r213"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction-in-progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r297",
      "r298",
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r297",
      "r298",
      "r311"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue, current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r297",
      "r298",
      "r311"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 10.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue, non-current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r238",
      "r239",
      "r240",
      "r242",
      "r246",
      "r247",
      "r248",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r260",
      "r261",
      "r262",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Bridge loans"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.",
        "label": "Convertible Debt Securities [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleLongTermNotesPayable": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.",
        "label": "Convertible Notes Payable, Noncurrent",
        "terseLabel": "Convertible notes, net"
       }
      }
     },
     "localname": "ConvertibleLongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r270",
      "r271",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Series B Convertible Preferred Stock Purchase Agreements"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue": {
     "auth_ref": [
      "r21",
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.",
        "label": "Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value",
        "terseLabel": "Convertible preferred stock, value"
       }
      }
     },
     "localname": "ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r87",
      "r452"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Costs and expenses"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "auth_ref": [
      "r104",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "terseLabel": "Debt conversion, converted instrument, amount"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r104",
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Debt conversion, converted instrument, shares issued"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r110",
      "r116",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r260",
      "r261",
      "r262",
      "r263",
      "r427",
      "r459",
      "r460",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Additional interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r19",
      "r257",
      "r460",
      "r473"
     ],
     "calculation": {
      "http://fluidigm.com/role/DebtScheduleofDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Principal amount",
        "verboseLabel": "Long-term debt, principal amount"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r49",
      "r241",
      "r288",
      "r291",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate of notes"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleLiquidationPreferencePerShare": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share excess of preference in liquidation over convertible debt instrument's if-converted par or stated value of share.",
        "label": "Debt Instrument, Convertible, Liquidation Preference, Per Share",
        "terseLabel": "Liquidation preference (in usd per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleLiquidationPreferencePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Threshold percentage of stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r239",
      "r260",
      "r261",
      "r424",
      "r427",
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Par Value",
        "verboseLabel": "Principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r248",
      "r260",
      "r261",
      "r406"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of Bridge Loans",
        "verboseLabel": "Debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r48",
      "r259",
      "r424",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r48",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on notes"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r50",
      "r110",
      "r116",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r260",
      "r261",
      "r262",
      "r263",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "verboseLabel": "Redemption, Period Three"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Debt instrument redemption price"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r50",
      "r110",
      "r116",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r260",
      "r261",
      "r262",
      "r263",
      "r288",
      "r292",
      "r293",
      "r294",
      "r423",
      "r424",
      "r427",
      "r428",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r246",
      "r423",
      "r428"
     ],
     "calculation": {
      "http://fluidigm.com/role/DebtScheduleofDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Unamortized debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r246",
      "r423",
      "r424",
      "r425",
      "r426",
      "r428"
     ],
     "calculation": {
      "http://fluidigm.com/role/DebtScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedLabel": "End of term fee accretion"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Cash and Available-for-Sale Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesUnrealizedGainLoss": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities, Unrealized Gain (Loss)",
        "negatedTerseLabel": "Unrealized loss on Bridge Loans",
        "terseLabel": "Unrealized loss on bridge loans"
       }
      }
     },
     "localname": "DebtSecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Offering related costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r42",
      "r246",
      "r425"
     ],
     "calculation": {
      "http://fluidigm.com/role/DebtScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedTerseLabel": "Unamortized debt issuance cost"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r367",
      "r368"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technology",
        "verboseLabel": "Developed Technology Amortization Expense"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r310",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Summary of Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r332",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Schedule of Stock-Based Compensation Expense",
        "verboseLabel": "Schedule of Common Stock Reserved for Future Issuance"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityTables",
      "http://fluidigm.com/role/StockBasedPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "EMEA"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r86",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r131",
      "r133",
      "r137",
      "r138",
      "r139",
      "r142",
      "r143",
      "r398",
      "r399",
      "r467",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r86",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r133",
      "r137",
      "r138",
      "r139",
      "r142",
      "r143",
      "r398",
      "r399",
      "r467",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share, diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r140",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r412"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of foreign exchange rate fluctuations on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and related benefits",
        "totalLabel": "Accrued compensation and related benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails",
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r354"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized compensation cost related to stock-based compensation arrangements"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock",
        "verboseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "verboseLabel": "Securities To Be Issued Upon Exercise Of Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenuePerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Operating lease right-of-use equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r79",
      "r80",
      "r81",
      "r118",
      "r119",
      "r120",
      "r122",
      "r128",
      "r130",
      "r144",
      "r194",
      "r287",
      "r295",
      "r356",
      "r357",
      "r358",
      "r373",
      "r374",
      "r397",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r493",
      "r494",
      "r495",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r248",
      "r260",
      "r261",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Debt extinguished"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r401",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r248",
      "r260",
      "r261",
      "r400",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r248",
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r208"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2022 remainder of the year"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r210"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r202",
      "r205",
      "r208",
      "r211",
      "r453",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r208",
      "r454"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r202",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r208",
      "r453"
     ],
     "calculation": {
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted-Average Amortization Period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinitelivedIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r203"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.",
        "label": "Finite-lived Intangible Assets Acquired",
        "terseLabel": "Finite-lived intangible assets acquired"
       }
      }
     },
     "localname": "FinitelivedIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r100",
      "r264",
      "r265"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r152",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r198",
      "r199",
      "r439",
      "r457"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrantMember": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award of money not required to be repaid.",
        "label": "Grant [Member]",
        "terseLabel": "Grant revenue"
       }
      }
     },
     "localname": "GrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r83",
      "r167",
      "r170",
      "r173",
      "r176",
      "r179",
      "r455",
      "r464",
      "r469",
      "r486"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r370",
      "r371",
      "r372",
      "r375",
      "r377",
      "r379",
      "r380",
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r113",
      "r129",
      "r130",
      "r166",
      "r369",
      "r376",
      "r378",
      "r487"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r99",
      "r450"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredCompensation": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.",
        "label": "Increase (Decrease) in Deferred Compensation",
        "terseLabel": "Accrued compensation and related benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r200",
      "r206"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Developed technology, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r82",
      "r165",
      "r422",
      "r425",
      "r468"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r95",
      "r97",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r462",
      "r482"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "terseLabel": "Accrued and unpaid interest"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r31",
      "r197"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r57",
      "r58",
      "r59",
      "r196"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory, LIFO Reserve, Period Charge",
        "terseLabel": "Provision for excess and obsolete inventory"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r56",
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails",
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r33",
      "r197"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r32",
      "r197"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r45",
      "r111",
      "r172",
      "r193",
      "r227",
      "r228",
      "r229",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r392",
      "r395",
      "r396",
      "r411",
      "r437",
      "r438"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r29",
      "r111",
      "r193",
      "r411",
      "r439",
      "r461",
      "r479"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r47",
      "r111",
      "r193",
      "r227",
      "r228",
      "r229",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r392",
      "r395",
      "r396",
      "r411",
      "r437",
      "r438",
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicenseMember": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.",
        "label": "License [Member]",
        "verboseLabel": "License and royalty revenue"
       }
      }
     },
     "localname": "LicenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r19",
      "r460",
      "r473"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Line of credit outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeeAmount": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Commitment Fee Amount",
        "terseLabel": "Commitment fee amount"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Borrowing base of the credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum ability to borrow under line of credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r17",
      "r459"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Advances under revolving credit agreement, current"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r19",
      "r247",
      "r258",
      "r260",
      "r261",
      "r460",
      "r475"
     ],
     "calculation": {
      "http://fluidigm.com/role/DebtScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Net carrying value of all Notes",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-term Debt [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r50",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/PrivatePlacementIssuanceScheduleofCarryingValueoftheBridgeLoansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r96",
      "r98",
      "r101"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r73",
      "r76",
      "r81",
      "r84",
      "r101",
      "r111",
      "r121",
      "r123",
      "r124",
      "r125",
      "r126",
      "r129",
      "r130",
      "r136",
      "r167",
      "r170",
      "r173",
      "r176",
      "r179",
      "r193",
      "r227",
      "r228",
      "r229",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r399",
      "r411",
      "r465",
      "r483"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Changes and Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reporting segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "terseLabel": "Office furniture and fixtures"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total costs and expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r167",
      "r170",
      "r173",
      "r176",
      "r179"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r430"
     ],
     "calculation": {
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r430"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current",
        "verboseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r430"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, non-current",
        "verboseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r429"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use asset, net",
        "totalLabel": "Total operating lease right-of-use assets, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "verboseLabel": "Weighted average discount rate per annum"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r432",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Leased Assets [Line Items]",
        "terseLabel": "Operating Leased Assets [Line Items]"
       }
      }
     },
     "localname": "OperatingLeasedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r389",
      "r390",
      "r393"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r74",
      "r77",
      "r389",
      "r390",
      "r393"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive loss, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Payments for taxes related to net share settlement of equity awards and other"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r332",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockConvertibleConversionRatio": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares issuable upon conversion for each share of preferred stock to be converted.",
        "label": "Preferred Stock, Convertible, Conversion Ratio",
        "terseLabel": "Conversion ratio"
       }
      }
     },
     "localname": "PreferredStockConvertibleConversionRatio",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r21",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r21",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r21",
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value, 10,000 shares authorized, no shares issued and outstanding at either March\u00a031, 2022 or December 31, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r7",
      "r37",
      "r38"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from bridge loans"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "auth_ref": [
      "r91"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "terseLabel": "Proceeds from issuance of convertible preferred stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from debt issuance"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Advances under revolving credit agreement"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other revenue"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]",
        "terseLabel": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product revenue",
        "verboseLabel": "Product revenue"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductWarrantyAccrual": {
     "auth_ref": [
      "r223",
      "r224",
      "r462"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.",
        "label": "Standard and Extended Product Warranty Accrual",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "negatedTerseLabel": "Warranty costs incurred"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease": {
     "auth_ref": [
      "r222"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the standard and extended product warranty accrual from changes in estimates attributable to preexisting product warranties.",
        "label": "Standard and Extended Product Warranty Accrual, Increase (Decrease) for Preexisting Warranties",
        "terseLabel": "Accrual (release) for current period warranties"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPreexistingIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsWarrantyAccrualDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r41",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r40",
      "r213"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r14",
      "r15",
      "r215",
      "r439",
      "r470",
      "r480"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r14",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r14",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r94",
      "r110"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedTerseLabel": "Repayment of advances under credit agreement"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock": {
     "auth_ref": [
      "r365",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements. Include also the amount of costs incurred under a research and development arrangement accounted for as a contract to perform research and development for others. Aggregation of similar arrangements by type may be appropriate. Include also the amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others. Aggregation of similar arrangements by type may be appropriate.",
        "label": "Research and Development Arrangement, Contract to Perform for Others [Table Text Block]",
        "terseLabel": "Summary of Research and Development Activity Under NIH Contract"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/NIHContractTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r364",
      "r451",
      "r515"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "verboseLabel": "NIH Contract"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/NIHContract"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r13",
      "r102",
      "r106",
      "r456",
      "r476"
     ],
     "calculation": {
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Cash-restricted"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r13",
      "r102",
      "r106"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Current",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsSummaryofInvestmentsandCashEquivalentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r4",
      "r13",
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Short-term restricted cash"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r9",
      "r16",
      "r106",
      "r501"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Non-current restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsSummaryofCashandCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r25",
      "r295",
      "r359",
      "r439",
      "r478",
      "r496",
      "r498"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r118",
      "r119",
      "r120",
      "r122",
      "r128",
      "r130",
      "r194",
      "r356",
      "r357",
      "r358",
      "r373",
      "r374",
      "r397",
      "r493",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r163",
      "r164",
      "r169",
      "r174",
      "r175",
      "r181",
      "r182",
      "r185",
      "r309",
      "r310",
      "r452"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Sales to customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/DevelopmentAgreementDetails",
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r153",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from Contract with Customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r307",
      "r308",
      "r313",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r305"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Remaining performance obligation, expected revenue"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenuePerformanceObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Remaining performance obligation, expected timing of satisfaction"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenuePerformanceObligationsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenuePerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenuePerformanceObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]",
        "terseLabel": "Summary of Expected Timing of Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Sale of stock, consideration received on transaction"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Shares sold (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock, price per share (in usd per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Compensation and Related Benefits"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r72",
      "r418",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Components of Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Summary of Potential Common Shares Excluded From Computations of Net Loss Per Share Attributed to Common Stockholders"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Summary of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DevelopmentAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r50",
      "r116",
      "r260",
      "r262",
      "r288",
      "r292",
      "r293",
      "r294",
      "r423",
      "r424",
      "r428",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt Instruments"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtTables",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r202",
      "r207",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetFutureAmortizationExpenseDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetNarrativeDetails",
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetScheduleofFinitelivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r202",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r12",
      "r34",
      "r35",
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.",
        "label": "Schedule of Nonvested Performance-based Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Nonvested Performance-Based Units Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of Activity Under Restricted Stock Units"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOperatingLeasedAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of long-lived, depreciable assets that are subject to a operating lease agreements and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Schedule of Operating Leased Assets [Table]",
        "terseLabel": "Schedule of Operating Leased Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeasedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesNarrativeDetails",
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Schedule of Activity of Warranty Accrual"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r41",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r13",
      "r106",
      "r456",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r332",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r337",
      "r348",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Activity Under Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r53",
      "r108",
      "r145",
      "r146",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r276",
      "r280",
      "r285",
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Future Intangible Asset Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/GoodwillandIntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebt": {
     "auth_ref": [
      "r19",
      "r460",
      "r475"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt",
        "terseLabel": "Term loan, net"
       }
      }
     },
     "localname": "SecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails",
      "http://fluidigm.com/role/DebtScheduleofDebtDetails",
      "http://fluidigm.com/role/FairValueofFinancialInstrumentsScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r159",
      "r161",
      "r162",
      "r167",
      "r168",
      "r173",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r184",
      "r185",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Information About Geographic Areas"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/InformationAboutGeographicAreas"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Preferred Stock"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service",
        "verboseLabel": "Service revenue"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/RevenueScheduleofDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Awards outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Nonvested and Outstanding Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in usd per share)",
        "periodStartLabel": "Beginning balance (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Weighted average remaining contractual terms"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Released (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Released (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate",
        "terseLabel": "Maximum employee subscription rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Additional awards authorized for issuance (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Securities to be issued (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted- Average Remaining Contractual Life (in Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r349"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Options forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Option granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r355"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r339",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (in usd per share)",
        "periodStartLabel": "Beginning balance (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price per Option"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r330",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquityNarrativeDetails",
      "http://fluidigm.com/role/ShareholdersEquityScheduleofStockOptionsDetails",
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails",
      "http://fluidigm.com/role/StockBasedPlansStockBasedCompensationExpenseDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Options exercised (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Options forfeited (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Tranche Two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "verboseLabel": "Share price (in usd per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Award vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value per Unit"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansRestrictedandPerformanceStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares",
        "terseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock, percent"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r107",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r108",
      "r111",
      "r133",
      "r134",
      "r135",
      "r137",
      "r139",
      "r145",
      "r146",
      "r147",
      "r193",
      "r227",
      "r231",
      "r232",
      "r233",
      "r236",
      "r237",
      "r270",
      "r271",
      "r276",
      "r280",
      "r287",
      "r411",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r55",
      "r79",
      "r80",
      "r81",
      "r118",
      "r119",
      "r120",
      "r122",
      "r128",
      "r130",
      "r144",
      "r194",
      "r287",
      "r295",
      "r356",
      "r357",
      "r358",
      "r373",
      "r374",
      "r397",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r493",
      "r494",
      "r495",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r118",
      "r119",
      "r120",
      "r144",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Stock options, restricted stock units and performance awards"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPotentialCommonSharesExcludedfromComputationsofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r21",
      "r22",
      "r287",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of shares withheld for taxes, and other (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r21",
      "r22",
      "r287",
      "r295",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Option exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r287",
      "r295"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance of restricted stock, net of shares withheld for taxes, and other"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r22",
      "r27",
      "r28",
      "r111",
      "r191",
      "r193",
      "r411",
      "r439"
     ],
     "calculation": {
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets",
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofStockholdersEquity",
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesAccumulatedOtherComprehensiveLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r109",
      "r271",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r286",
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/ShareholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r420",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r420",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r420",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r420",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/PrivatePlacementIssuanceNarrativeDetails",
      "http://fluidigm.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r440",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SubsequentEvent"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Details"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r151",
      "r155",
      "r156",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Operating lease right-of-use vehicles"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/LeasesSupplementalBalancesheetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/StockBasedPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r132",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in computing net loss per share, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r131",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used in computing net loss per share, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WorkersCompensationLiabilityCurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Workers' Compensation Liability, Current",
        "terseLabel": "Accrued incentive compensation"
       }
      }
     },
     "localname": "WorkersCompensationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://fluidigm.com/role/BalanceSheetDetailsAccruedCompensationandRelatedBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(4))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19396-108361"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "730",
   "Topic": "985",
   "URI": "http://asc.fasb.org/subtopic&trid=2197926"
  },
  "r517": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r518": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r519": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r521": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r522": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r523": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>90
<FILENAME>0001162194-22-000055-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001162194-22-000055-xbrl.zip
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M8<K7OL%;+E;+6+UE%SJ"]9J;[5VV?0*U]8.^XNH^+[0?.E[\!U!+ P04
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MF8QF')-@0B?YX;K*N9'':207'%KG4^D(D6[!%^#V*A5"=0<$KSR5G4)Q=#]
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M4/M5]EUY[+U$7#_+*TUSN7KQ%U!+ P04    " "S<JE4">MU[MH$   Z%0
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M;,+DZ8E3LUN>:[K[;N^B)V*& 9 \\YMH>L?_" -.Q7<"$/1&8?^R'W3"_G
MPTL(WO1[EW#9'W0&0;]SA:]0VAL]B^M8@%S?C,8WG4$(X1"<!MR88S,P8=P+
M-##'J]IE.'H0G3%TNL/KL->%73P;% 7+FG;MZ'$@C\(W/1AW1A>=06]L#'^]
MZGV$3A JAKFV_77+A*4Q@O'=BBX:_SJDRA<A]<OP"[L59 %O^:P,<DXAFC,Z
MA2E+21HQD@"?3EE$!?[#6)(T)B*&"\9#SI,<^FEDPBNE=GK2<%V[%?!%1M*U
M?G):9V5 5<FF:YARH<UG2Y%AS<^5O1U&TTAM&047"EJ3'$C,,U7W42=?$HR.
MY/LCD37*CK([)F)"4IH;P_N$KJ$3225165&PB"PK935P0G,M6JSA-N6KA,8S
M6CXT<QF)8]R#C(1.,76N^?TRYYA;G[_][/MAJ*D8J,CNY-ZIMW)XOR0"5VNR
MAA'-N,"HIW#)Q0(<VWC_0(A/Q2B@N!YB>$=$- ?/*1>[^2ZU"B./S)HN$S0=
MX:0)0V0K)N?:H*"?EDQ0M>-KEFT8@]7R%3D#G-6IOHK/'GA#HZ7 ?@4M].ZC
M.4EG=$L>I^E5"AXNM'.G)]5F"W )_!5;)EQ*OO ]#.71\L<]/OZP%#FQ(#I9
M$9H@J!;C6YVG#86FA"E"98+F*K]E)29) JB&GF"Y0D&&"<^+8O98QM!@K-M2
ME4 U:ID4]. 9%7K.?$N)#8_-0XI"D4!))@G=2B=<Q%08&,J$9#GUMS>MF.59
M0M8^2W5 M%)KGS*J?;Q3%3,BR6;+TYM%(=YTEHVF67.:JKF4V%'*>#OQIN\T
M==]IR?BIK%HW':_QK-@VG6=E?V;6,RNU^C]OM6;:S>I!9BT=B"(8&.X<T_>Z
MY)6V"ANZ^6YV#\Y^FZH8^'G$BV!_^W6I/QBZ2&0L-(T68"U<0[,HA ]4W$3B
M/P[R8JTA_L]0G9Y4<-O3UYVN:@_D@42U%=;2\0>F<6!<5*]V0+(WE5/555MM
MC9#SA,6P=? H(!_(A1_Y_QOY/PI,!R8XT)])EP_]Q;#X3/J1[:_.]AY\'3)+
MMT9?:+P^.VC##TG=TOF")MC"W=$G1V^/E46W5_:C"IE@<5G*YU6>.W5X]AQO
M<RU.%?7YYOD?4$L#!!0    ( +-RJ50F>PA35?," .6M'0 1    9FQD;2TR
M,#(R,#,S,2YH=&WL?5E7&\FVYOO]%6K.[=M5:SEQS -5Y5X8,(=J2[)!V =>
MO&*$! V4!J9?WSM2$F8TV!9(*<OGE"TI,R,C8G][C!T[_OR_YZUFY31T>WFG
M_=<27D9+E?_[YL__E67_>;O]OK+><8-6:/<K:]U@^L%7SO+^8>6S#[WC2NQV
M6I7/G>YQ?FJRK'AFK7-RT<T/#OL5@@BY=;&[0KF02+.02<UHQJQQF=6!9S$$
M%S2+R'#RZF E.,^,(S+3B,:,"4DS'93)6&0B>FZ5]?J57Z&1DRB5XLHB)JG5
MBAJ".26:>L0"2J\][,/H8(3MWHH/^5]+A_W^R<KKU^>VVUSN!;=\T#E]#1=>
M0W?Q/VQI=&M^WL_@ZM7M9V=G5W?G[6;>#FER7O>[IMV+G6[+]&'RH W,,Z0R
MBJ^U<Z.-XK6=[L$W&R$H0R3#9-S(>2^_T<@9+9H@".'7_ZF^WW&'H66RO-WK
MF[8+5Z_N=1C!\O[7P[/T]>B.J]? Q?Q;M]]\P7U=PEKKU^=IRL>-NLZ@W>]>
MW#_OHXO%W(\?&/2R V-.KAZ(IF>+MD<7BILSA*]-\J#??;#;^C5<O1HAS/GQ
MP_U.5\>WWKGSYERDR];TOD[V^4,W8WJ-UN/;>]W^W0'"C_<,+C9]Z^N]S4'N
M\X/6LNNTTKT$T:]WII?Z6P@?=5B\'EXL;EUIFO;!7TNAG>WN+ &#!./?_-D*
M?5-)3V;AGT%^^M?26J?=![;/&A<G,$HW_/;74C^<]U\7!'[]YK_^Z[_^[.?]
M9GB3.IF-^_/GZ^&/?[X>-FT[_N+-GSX_K?3Z%\WPUY+/>R=-<['2[K0#=" _
M7TDWAN[P8^Y]:!<?X7H-9$\W=\/WG_>W0_QK*9<\2NNE5=Q:I@G5@E%I!(\>
M&:PH^K)>= 7#/'Z=H[9II5>'?&45Q)E/(NU=TQPL58:<!\V>]U=B?AY\%DTS
M43;W\*.GGR[L>N?T/=D^W:/5@3_:.-W?U$?UHUJKUOB[5;L\8+7&85Y=_TBK
M9(O7UVN'U:,-7+W<XE7R\:RVN7OVGM::>Y>=R_VCW8O](\?JZ[ML[V@5U2YK
M>;UQ<+G7V#JO-:H7]4;MN+J^W:R^4^@]V;_8^^S$WN7;?._2D5JK>K&_OD5K
MFQ])_?/?K?VC*JG"\[6C8UP[VKBHK6^<^LUWN=W<%?N-+5S;W+NLMG9QE>P?
MUS:KE]5->,?G=]"/MZUZPQ_MM3XBZ./HF4_P+M[>;YPTJT>["-J^V&_L7N[#
M/=#*V1Z,9^_SIZ/JYAZOD5J^O_[QLMI4E^\;&_WJ#CI_#_=6+W?Q%\2IU-:J
M3#&81H:=R917/K.<^B <\8Z1I3?%]/[Y^@:!GY/>8PWV+N\YT]P+IOL.?NDM
M"/P8@=$= HL \@E[G07F@, &V4QA'#(@BQ<V&!M G;Q)1)@:?3] ^QV_H/"3
M*(SOLK!#@F(F,DNQS!CP;*8ML##Q0FJO(\(*+;WYB%^0OAMMT"<7:T#AKFEN
MM7TX_W_A8D';QVA+[M#6*2)I1#0CBNN,(2"P"2"C"3; U$)$Z=32&P1F)18$
M:_:"-%X;=+LW1/1&VZ^#N[$@\V-DIG=9.&CNL<*9YR1DC&F6Z:A5QC6.X&59
M[ZA9>I.!@Y'1A_CX7=>XY(U4!NU\2.'VH&5#=^DFU9UU.DAC@=Z<F2"4CU@:
M%((,'EL11U2GA&?C#TL5'US> AO@KR4YAL#(ME]9#[:_!6Y&MQ#H8(*"6]K/
M;3,,/R8/=3MY28"=!!1X$DT7(1?5HX]XC)+:YX] ,:#HYPU:;6TW:^M->/<Q
MVE]?!<JLXOKG=\?USUMPSS%0_!/S__Z[N4^:I_:H@_?7_X;[/Y[O-=S%_N8N
MJG_>P_7&-KP'4+.^R_<^?^1[1W\WZY_4>?5R@P/2+NM#BI]5/WYAF"F!A<F,
MI 04,S.9-4ADGA&@O;31$P^LO4PYZ&\BQE0?D_F;K$TIUY0:+IP1S%,/;CK'
M1B,OM8I2N"];MSEZ3,[M<!K:@[ -[FG>SML'H)L+:QN<R+IMY@>%P[MQ?A)<
M/_A&WH);ZG$'?NW%8;^&RAS?,-*37[[B!]T6]/%PRO*AOJ-;KO6N74\\VJJ!
M--AN[5UN .4^7M37]Z"-/51?_[M573\ V?#I"-YS_IYN'^ZUSIOU(T=K24:L
M[U[4-VNMO:/MX[W&1[:_^9'6+K>;^T=[EX"*X]K1[N7X&7C78)_LBMJEPTE&
MP/-LC^SGM<WMP]KZX?'^.K2Y^0EZ GUL?22U1BT.94,A(V"\55S[^$4*0PR1
M/ N> %J<-YD6FF><6"6DE$%HM_1&?X_\I]99$K"F7CH6F#4R:1/$ @].".>G
M!)(+4"4+C#R.D?P.1K0V''F' 10@5@ C*-.!QXQ:::A7AG$+&/DN.]#:0#AE
M3$3LF3=4(6L%4Q[,#7B9I N,S#1&+NY@!'P!9@6FF28$9TQK#/Z^#IFPQ$07
MHZ#"?B=&&/B3&HQ/XVQD$EQ-&KG"@DH:-$@M=1TCY[U\I9TW_UH">R$\'V06
MR'@$&;6UN\B(8 DRI+( 3)\QKD%Z*",S!#\ZIQ6.*5#P<\:G$=Y8;'T(3C&-
MI(DT>*=)Y$2!-508GUCCH<N1/E T7\8GJ5Z!8^.BNOGQO+9^C&IDB];7P7!L
M-/-:8X.#BT'V-^'^S>U\CU3Y%3A:&W3_\[M6]?.G8S T6WL-N"<]LPFD7=]%
MT%=>;WPZW+M\U[P-CKV&;^Y]WCO?!Z.TMKE_F$ 'ABV"]@$P,)[U8PYNSA&T
MG<R/BUO@\-A3HA7*$!,\8S:X3'L<0=,@XAQ5$MFAL<H8>*SW&*NO;\:)NR$&
M\!Y=Z-T3WDZ1^I5>L40"L*D40?Z5_L4)D*^7MTZ:*81?_';83:BZ$<E>/N_Y
MA-*;;0S?__6EHS[T.H-N\:U81UD9074(D!_QCL<-A2+\,?Z6^_0]YJ%;*3H4
M[EVB6MOZ?S<=^=L/OQG_=+/UDT+FC;_U^J;;3UYX$=%+RQ((CY_[>NVJF_[:
MK;1P+6]>&7\?O^3UC8FZ=]X4!O>%V@@FI6/8:0,\#T,R@02P,(49:0,&G#W]
MZ1JNC_5',\ RBJX:&EUYV@PDJ5<,OW=H %97(VL%TQMTPYL1 8J+XR;&U\;?
M4QOWSBC10>"H V7",8>#0C%XQL!=CS@0?=T&F[49O8ZI'YS10<'/-Z=LM JZ
MLKNS_MVS:7!@D7$P5HAAQ" %+K(7P1GE'"<&%[,)#O>LS28>!W]^=C;!2-I)
M0+P:GL]/H5O7;RV4N^EWNC\X\7>>3S^NAW8'3+;[FGTJ>]QHXO7-WC]&=R88
M"*6H6(B,18,L"D*9*,&VH5JI. 5Y/AIV.$C&R_"KAY>=GS1SE_>K(1E0%9_#
MU6&>1Z_;7_G0[?B!Z]>[.Z%[FKNP>IZ#N!G;0Z.KPT?_?'UOBU=3=?7B4N@5
M8S4!6KD8'! 0[,6@7> $O T>C:"FH!\>TP\OZ/<P_?#3Z8<G1C\M?"#*6L*I
M9,X: YXB>(M&*A&PMW0N^&_TXSSR7Q1.2F081XBG\*.&KU(G$0H.G3-T+OCO
M9>@W%?[#AG 347!4!$:XMT12CIP!LY)HL"-+S7_)!5Q9ZS2;QG:Z19AH%$N:
M1T[D*("#!7-*#6=<>X5,I!CKP)F,V+E2<^*T*#D5GE11"QUBB#8:1IVQ7'HP
M3+VU1EFAR\V3MVR:U;8?7:[W#T-W'AF3RAA 2UJO%6- 5Z61]@Q3:5,ZM"&E
M9LRIDG,JW&F12:%HH[G1C-BH(U7&NF #BCJ8, 5REF+>A.04!ZJ40X$AYRTB
M42/&5  ''-,R2+4K>[ /<U L+31-KU>/._V..[YC,N:A]_9#$5SN!E_<,H_2
MS:) B).$.4X81=1&I2(+GA*P.3CR)9!N,T[6J7!K#,"M&CM%I60>(<TXMVG&
MC56>8/IR\="?IN;&/X.4==IIG73:\+5WDZ+P>ZO3?B8Z3BI0>X,TGF-B/4C/
MR!T3PBKJL%'<.P6&!@YQ;DBSZGV>3'W3_&!RO]5>,R=YWS1+0B:*! G!,(:L
M919,A! T)]8*KZ(08H[(Y-R@-6BF+86%T9?NZX;#U-IIV&J[3NL9O+1G(9E!
M. 3!&?8I<9Y*@US$5*<\*8ZE47-#LNW0-WD[^ W331DUO9+01X6@I##<"[ W
MHJ/61$&,Q,910;C@930AIZB=IF\\4BR0PC1X 8)2$F U93&+X%T) RY!&5;?
M9E6G39^XDM%(;%!"8,<\TS:B@'$DT4O@7R?FC[C/+U:G3]40M8PHIN4>S@P-
MUDKJ,7+*B.B(4O-'U:G8-],GM*,>6:) 1,NA,12PH()%(&V(SKY@?E&9=>RD
M$I]NA=)PU 8D*=$.M&741!L0LI@8:YAE9&Y(,PT/<')D"@;^)XSW0".FG%<!
MC%70@P(1ZQS7\T.F*7N DR.9Q$@93*PA*;_=1N6]!;O%>B0"0DK,#<E>U .<
M('V"CXYI3[5+:4)46>\X$HQKZ9"DMJ /F@,/_:64$II<6%)*)TG@AD?%<$":
M6FVLT%I%%QV.<T.::2BER9%)R>@T E5$@6TD<T8@@;DFUGJ*J4/S0Z8I*Z7)
MD2RRP%"P1)HHF ]@[ &#$2Z4\<R"FIH;DKVH4IJ@Y%.(&D&C W9BFAO#O.<4
MXVB=<<J*EZ//M&: "PTB) 0>&6?!""THUXP&&0D5"BS=$BX"STI@=BK+ORA0
M3G@0WC #=I:U%L$GK@WWF$M9AK3>6=7JTR>N(R)29JG&G#!-P4/%Q%-B(L(\
M2"/FC[@O')B=#E41-\H)'XU@C EK/''@$5$GE2*:\?FCZO0#LU,A-%CMDGB+
MJ428&4454\QRY8P,CH-!.%REG@/ZOEQJSJ3"$]$;AW2Q)&*8=4(KS(0A47BI
M&#%\;D@SG=2<B<7/G0<SW4D=G&"$(!.$,";*0%",A.CY(=/44W,F13*BK+:"
M>N^=82YR'3RXOYAZ915&QLP-R5XX-6=2]/$"J\"0%$XK%@*Q0E,B&<<66QTD
M>CGZ3 VAPEJ%-.%6$@9 5<(X)@,U1FIB,)^;Y+%K0J61"MXWB_U8J_YHT.NG
MITN23"8TD=X%HTQTJ:R1$BIHC)S$.%C-T3S2JQ;ZN^UN,,W\,H#6/@U#BFV"
MQ'G?Z94E#9 2+JFA >$D8:2QRGD<";9*(F$1GNL4E!=BN>GGGUCIK(^28<0C
M<X(:YW2QNT0H+I6<Q]S *3+J].F-;93.: TTY^ T.15%% Q3+JP00L>Y67J?
MJOZ<W%)\M%S35#T'C![P;:5E2!M@418DCD[Y>:37-/7G!"F7S)UH$9%$,$J#
M<: U)0$+"#'.!2N19%V%%GS>'/3!G]T);M#-^WGH;9R[YL '_Z[;:26J#OH%
MB]7CV*D:%[MZ>W%_ [<V_:4(5&H'WEXT]*%IVO,H@L%[(3:M_$2MF27(TL@Y
M=3QZ(2WELD0AY+D%QG2JQ(!E';0C1 3%>& F "*$BO S-I2726+<K U[K;K(
MVV[N#\+[#FCD1T@X6R#\VN]Y%$DIZ06!JT=80"QB;@V/6'CEB/#$Z3(4SU@@
MKY0R3W"F').  J$94D$3)(7WC@='E#!EVNCR(FBX5F9[_JM> +6#0IQ:EBJ4
M6VYY=%0;Y2G3$HDR%-OZ)< Q%<EAL.$ #HP8D(HQ;*W6/$3$0PA*E&I7ZTN#
M(^G(K[=-2AL^J'D;9YW&86?0,VV_VO:UO!WZ(;2O]:?6Z3_:C5(*,$>B$S(R
M<.P,TXPJL.FI] ZA0!1X? L!ML#HM.4H(M8Z!6HU1L2<%58*3) !P<J1\:),
M%<,6& 6,?NBDDZ=STZR:X_#YL-,,Q>#F4KY:PG14V!MG'6,H[5>3-%J*I"'P
MO0QUR1?8G3YVIU2377,L-.)&8H:TMB(*9XVEAJ0DES*5V?FEL/NN,^C^*O:K
M081Z@VT47C/G/;C@T2'C/ 'A&F*9]C L,#JG]JM2PBGDA4W%! 26QCG/HV5*
M6.2-&)?IP(3.*C3?=]H'_=!M)>(V+D["R\5_;RY\ Q/3"2Q\<R.<L!Y(0"3S
MF%H:I='2I&HJQ#H_4FP,L6S\858I\X1:M3\:<WMZ'P:V%_X9I 2*4_CK+D!N
MW?#\>HC!_Y^HAZ[?^C.G+H@8L2262N52P1"CHT4:<_B-(*U$"2"5BKNO=08P
MJ.X)3-E%S;1NG+I@>CY_C,,G@=OB;:,"RW@!WA< ;[2$8*-\.M.2"<%,*MK-
M* 4P4\O-^(C>!687F+U7+5^'X<_4R<+".S",7)"4@<.IG*6>$L)<T$A:5 (9
M^IU0(<\&E4<8XU-^#+[#_.!Q^C+4$J<(#U13SQC5Q"#P1E,%D*"=TL+-K@Q=
M8':.9*BEC@9I.78B,L8"^)R<21W@'5Y(A$H P_DDC!/*&,\%$D0P1;#"P4JB
MG,2"4Q/C%6%F-@@P@X291#! 2H%%0%(PC!B7Z60&29@5:8^1L8K/[OZ%0BJF
MD,Q:!^8;AO^A&/4UD7GW8KW]V$[O)^-A5H)"$SA%O#U(?7G@7/83^#ANX.FG
MLD>0NM@&(9EF40JEF/!*4DPQ#D'-<&G>'T%5XZRS0-7]^ECC*#33&CG%0#$K
MA!$QVA.$J %DS!D.#KMA(5\>6 4@2H.*,1Z< ::"-E([%,!#P$C30.=,SZ3U
MG040[A<)@:30!GB&7#'BL;%.:J^Y]U$3R=W++0=-:_U%AV"D\\X;'!CW!LQ?
M83FESFMCP4^975:85TBBX%ETCA*MF>/8".8CD88+&RS =/9K8,P$0297VL+Y
M",R@@T>>,:6$,2(2+,&D--I*6Z:4Q^E19OK9*5C&=-@SL1'XRTJG0^(O'3U6
MJ2[<[?*I"P9[E(S?E<!Q@QM_YJPC[S11,C(:(D,2:4REXEBCH(2RS(RYD=!L
MUC,YGC%?8"(<^M6^>(1#K]_Z,T4TG4-&42,1<XP)K'B2O"1RJB*W),P7::=V
M&O5+DY5@(F&6H<T 3C;22EF+G$$Q5= 7PLY^RM7L4'-2+L!5M,W?";0-^MV5
M]>^.L8'5ZBBR%E.$&$\2VNM(P*,24B.DRG2NTHP1>4)NA;-@\4APZ:CFS 2A
M?,32H!!D\-B*\09(2G@V_C #+N]MZ062GS_9;/QZZ\\D-2LFP!OC+(6,- D&
M8.U,E-Y(4$N6C(IH:HIF#=AI"?=#M^,'KE_O G1/<W<C'Z?3;!K;Z18IS-OA
M-+0'/QTN?&35>+?M\YYK=GK!KPUZ_4XK/!:7^ED?$.F,H@EPCXG>*C X0]"6
M48H,-N!&2!W /3?>V!+X@+\H'*;O>%(GF&6>8\H1HQ8<4!V8T1A%R0R7K 3;
M(A;8F=9VVZB"8%J#BHZ,:&V80=)Y!M!17(FRR)TKVVHS= ZZYN0P=Z8YI&:Z
MO K4@U_F<E,444(Q'#W6WC!&@_$TVBBC9IX)B\MP#-/L4' Z/"A)L%X1J9UB
MG$:58A+8646))SKZ\O/@V+_9J&ZLSB,/*HDD!EJ!Z4:8Y+9P@L!NBY)C%DM1
ML&QV*#@5'@2&DS:0&+%!3((3QITWP1JBE"=4F/+S8"%%>[GY8!R\P,TC&Q(6
M5#!261LCT]PJA#P-/BB,)=@X93&$9X:(4^%$;KBR0@,O>LVDPSJ&&!V0% 0K
MF#5EL4B_X<U\W3$]EP9IY!P#W8R.TJ>:[I99 LZH$4%PPP0J"1?.! &GPX$!
MFR@4YL%@YI70&L2H9AH)3C%Q93AJX]%X0KLW:!G;G,\Z&=);8X3DS$;,8$Z5
MD=H+(2R/-FAIR\^!+T? J7!@B(&FTQY=Y()YJBQ'#KX*'AT'OQ"5F@.ODDS@
MEW;ON4_KG$ZE6!,=Y2:8@!FS,B@M!.?&I:5+Q% 9"BW."OVF<ZRNEQ*(PXDR
MGH5H#)."1124XDBJ4I2^?YQ^FUTSGX=(80\L)0+%SC 6B=446<\9"IPR0:F:
M"^Y[">I-A?<HY9I2PX5+B<D4G,#(P9E 7FH5Y=7>ZJD1K7]Q$OS#61ZCU:GM
MT#)Y*MGU(71CI]LR;1?JMID?%$M8&^<GP:6CH/(6W%*/._!K+QJ7KNV,9WE(
M[S^?I^%EWTGM?-U=":1[WC==H?3:!,Y.]@JUSI* -?72L<"LD5$ZA5C@P0GA
MIGZPU=RACHYERZ^,.FL# :7$1,2>>4,5LE8PY0$>VG!)%ZB;,.K8 G5+.5,8
M:P""<2FHBKVFD2LLJ*1!"T/4 G431AU?H&XIYYQZ![YPD,$PX[21/&CB-6%6
MJ4A#0AUF\$8U:\;XU;Z702]OAUYOU?TSR'MY<8#GM6VQGW9V7!Z A+VMMEM^
MSKQ##&*,9$1-@"J*(A]51-%QQ822BG(67:148&]&JRV)*H6O--OD>0>LU _O
M\]-T2B?,QT':U++:ZX5^[^U%U1QUND7B]4TW:ATXL=D!=FD$=]CN-#L'%]OY
MP>&C@?VR@.:Z/S>$S9/\N=L(^YE:6:!(&$UK" R!7:T-)E1)G\['<=)$5F@;
M-(M.^--(.%P,JG6ZJSO/FFN,)E+\) SN5C[)>QU&L%S9V-T>/_[D;1E2&2EM
M$)%9RZ1)V<L!&XE"JJ=CV+!L/!K'6F::S&64'\\*OANQ(/3T6!":8!P6!<-M
M-!('9@A37&)03AQ;%JU#9=H9O4#7S,6)G6*&:9-JM'&&K3;$>(Z5Y-@@^"*G
M[0?-&*AFQ9%PU#E'2"KEIAC1-M7=Q!:,6 5>!<-E.JEDUNDW?1[E3B/)C #)
M;X#83F%%@L+.>AV(0';.>+00NQ],.G8HG9TQ6F)=/>B&\$SI1L\38?+!>A[3
M'B3"-++@ZW-N,-;4!2E1&3*(2D*^Z7,H09Z"Q4^)#![H3D&EBI0!B*)@Q#@W
M^^6$9ET*/TO1(1$-Z$NOG?9 I^"-9]PSYK$6-$AUNUK-W+#HM+7H=/)9P%Y*
MB^K@01$F,-.!.>2ET@%1C3B:,QZ=JA:='(NFHL0$@8?B(F.8>8LYPD N85(=
M(N;GE46GK$6GLP=0HP :-"*#&..2*1:-5_!5(LG!OYE]._=#%Z1IMW_QH0EP
M7VW[C7\&^4EJX^W%UQ)BH^3==+)=Z%[= 7?O=&+_S'2?(9OP>1:SI"#*:IOT
M)5,(*>>L(=ZE;$&L.9E]@5H"<DU.DAH9F0'5QRTH/VJ)YC1&G,[MBJ 340F*
M!SV=7.^'A1(ZW0NXK6K:@[1D/.CF[8.K9TK"9$(9BYCG=,AD2F&D(]/$T6@9
M%7/%9-.FV@2MEJBUH\):21B8FUJ1P#V0CK@0@O,EB*H^B6I76?#!],)AI^FW
M6B?=SFFIPC01*4&%%E%IP8!F1C.)N0\JH @RTL\)@TV/5)/CJJ"8D109;E5@
M%"F=RD,Q)+ /-%7YF3.NJL<(5G_9%!85,JI@HA"!,^D,T$QPRD$0:L>4-'/&
M3R])I,EQ$A:(".51--@6>^L\#T ISEG$G.LX^WEHWZ[.O';ST.])K10_>-3W
M3FCGX+[?.MK;#P)((U:2+#@OC92>N!AM<28JZ+YHO04M2(D/N@0VRP(3$\_-
M5U(;R9ST%#.CM8U!2*.HXR8@PDL@S!>8F+3N0!+,98JQ\=PR4]0*HA8A9< *
M<RP4<@)KC&>O5FN9,+&>,$&>5W?H#./)5&ZU(CIA:! &4\8 #Q2EK=\RA"B)
M-VRA.TJ"B0GJ#N*<,0 $HP$241/#//<L@KL6A1*^!)&K!28FK3LT5A*30$(Z
M>T)2KHF32H#N2[F&:):/A'L.3,P*IPI*?0A@V4F+623(!.\E$X%1[)D.)0B!
MS0Y5)LDK$DPM+40Z,]%&IX(5CG,<!+)$8%*B74DS($BW@P^MDY3;_2%\/<OQ
M:?=.])#/6?$-IK\IBEBJM6"&!^&8P]HJ\"&DY@PAIK44HT,?%KB>30#=/ )B
M0D$HDHY/D3(A 3%#O9(248R<I1()KL:%O,DXW6<!CH70^XD<IR<*O=L _YG"
MH$9ZBX*,(HAT(**R(/ "4<+%%#4A"X#_()(VSMVA:1^$:^\=@NNKFS2?B$J'
MG3APJ+DRJ;X75EQ[3Q0RZ1PJ%HHZ;2D>-[03%X&Y,LBF86CN:0;9K2C>SU3<
MU#BDDL7<4\%$%,H$:XV(7I"@.5(+))4C=#-])&FD+!>8*:7 EH]$.6L5:#TC
ML%11A<4:P4R+HF=9(U"8!*X989$3Q@$:,GHBN0(\,*$]76"B% ;/LV"#*\F"
MQ19K(AD5W"H=6,0"M(]*!9\7FF>*()F"\UEO/W-)Y>FH19!SR(F4.H$PTUI;
MBYG'RKND+;DE"YC_6C!OG'7F$>:2BL""IH!U GI>:V53E2L1%7)6ER%/]]OH
MW@ENT V^1"M\##G-G:((J,*$1-KJH&)R\3QU!JFRK_"]%$4FM[KGJ77>>4DC
M=@SQJ"+Q7 ,IM%,:Q:E7O7V<(FLPX7G_G7%Y$[IUDQ[;X;33/,W;!S=OFI0$
M_C88WN?M4(_#-Y>$/Z,D&A$&U$>::8=4\. 5.2LQ#X3C./O\N4##Y&2#Q%0%
M*3VV##/!K,$2(>4CBI89RPO]B152OQ(:?LY351E2$\J5$51JA8(B:;,$]4:D
M<GQI)ZU+*Y3%J42)-D,3?D&D[[)6"S(]S5J]1=&?L%:]DBYPQP2AD8%:!MM(
M&Z4QT9ZD3/=1&H)"9%8).2NV42(>F02/.3"(J$8VX,"B-9HS&F@($7$'[K)Y
M.8I,:P:"D90C%;7'B$E'P58/$>:":!J4(F&T2JS2&N("G$]=F[U.G$?69J_?
M^C.>,(Z8>Z^)<Y0YIQ1\5$Q0(*4/!OD2:(MT"M-VBJU\/7RWFK?SUJ U*?MM
M'DS')[_QD^GFZ<C&[:NC%[YN.X6[T\_SJ&13E1$2@@U!"88L5HPK\'UEBDD(
M1G!)&<&<+QAAP0C?Q0C<I7B_PX$+AJ71PFK&K);.(XR(+ $CS!-<2XDA1B-E
M 7Q/!;+3ZQ0@P-9S+<!.!'.9EJBR[*2LP_*(G2D=!^H"^%$$A(T,C%*A& H(
M*0D:6<,7/ 6'8E8-^*MC0EKP^V'SXDOAQS6;B=IWC@TI5A_ON7'<]I//$#'"
M&PM<'()33"-I(@W>:1(Y. Q*Q,72<+G29*:_"DLT$P%+2B.F#*M@J%7(4F)3
MWH$09= 2/^Q[EE)&:X9PU"*%("F#EJWWVB9=CT'+.ZU+2K G^4BE))@3'LC%
M&7BRAB$1E>)2"A1=TK+"3_V4YL>EYG>5NGH[R*'5]D%)UE2)]]@A;P,3GAG+
MK*#81:F!J5#@L03UOF>/.I-;X[3*1F 6*5+914IP.CB-": 3!M,4]-:<\4[9
MJOA%YC%"SA)*@7^XT%R"[6 T!O$6HRE!0L(,DF>"E3 MM,9Y"!*L/!F#II8Z
M">Z"EE1(/_63VB=,GD_A,'?-4):2LCAI&\K2-L]A-@^G1$DGC&38<E2"TV!F
MCSH3K%^FG;;:(/"T)8LX;3O@3D8FH@O2C.H2S33OK)G>(1 E_9,(<VJ:\/SU
M<R-&-U0[[7!1-=WCT'\W:/NRL ]U-NCHO'&(,!R1LI@:$3%'R <3S1P0:#OT
M^MT\'6Q^_ZTEH90G& DO/9&!,**I(LY%YX+!A 52=E:Z?D])"&(81BYJCF-D
MC)B4=,\P3]^-XTS(V=<\,RG;)IC:";:TU<0[X1A0AMMDQ($G%"4ADEH]!P2:
MJFR;'*4XC4I3DJ+R,B7H:TX<#4ZAR,&FTZS<E'HQV3;!\VN<5X0JAD&D,<N)
M#MIA'!0&U\?24 *SX)W)NY],<Q#>7E2'ZT*%26UZ^1VJ=+L7>?M@.YQTNL!(
MJZW.H-V_>GP][[EF)SW_,NOI;[NY/PCO.Z9=$C4H!)CWB$C":&!6!N4# PZ.
M5B@5)2V!>_QDJ&ST^GG+]$,]7CVRP,F3'75-HA9<,A#T8"Z!!2MXI%Y1[37R
MN 0AXH5(>2'M0SG(D""#5#PP8R08;H)KA[3&7!)?@H#H0J2\B('/C16@9[0Q
MX' );FD,V('0BBQ21</LJY[92M_XF<HWLRM%9T4!2JQ]L-+':#1C,A@5:- $
M;&PM"59H@=8RHW4B@GQ6H(J"0])3<,)U8#BZ5+[ !*U(%-Y;BV=? 2^@.NN"
M=8*+3(A+*Z@3'GM&%%?&>1Z91"YXJ? O5E)_WM Z X)U<E!E5@3A!(A1X1D"
MCP;PY FQ42$AL5V<^_:"Q3[G5;!.,*M/,^FD24LFAD4B-/;(&>U\X%YPO#AI
MJM1HG0'!.CFH:N8%XQI+[")#1BA&M91IXRO75ND2K/4MH#KK@G5R9@#AA!#'
M+/*", \?/+?!H*"#9LZ&A7]5:K3.@&"=X,E8R+G@O.<!C/]4R=!2(ZF)G@OO
M$=$+&V >1-OD%#$'^C&F,5-.L$!2/5+F8N 4,4N(*'T]TFGC90:$RP1+I7KJ
MD8S*1&89DTAIZ0C8;8K2J GG"STX#\)EDGEB1&*KG*.@C"BR*97 F4@X @1)
M0A=X*;UPF>#JL$>*"@W^8)",!JP50AH%$;7U\&\)JOZ^>,&.D@F6":[-,H8)
ML19+P1@CS$JCHD?"6>0D)FJ!E5(+E0E:+*!U4H(C&"V6Z62LQ)3T:+E.)PV*
M$FPWFUV@S(90F9P"BN #<4.H2C4HG5?6!B' C28A@GRA"ZR46ZA,< ';$,5Y
M%$(&SYPDAEME:'0F%2<B09:@&,FB3MV4ZZ-PA=.9;XY(Z9BER*B49 :&;W2"
M.,06&)I)7;5 ]]/0;<$25QQAC03CF(%TC-1(*T&S OS$ MTOBJ'YT>?3A[9V
MU,= C/$&7$\K%(\)TB8@$9TG:%0M<@3MF387YP':/XLA_'0,W3(@?TH\IO3'
M&+0$K1\#-\@3Q[3DEGF#8EA@:*'\RXMN&XG7QBF%O6,^!(.]TDI'IHU52/D%
MNA?*OZ309HXRJ96,1("KAJ5B1C/DC99:!\1+D ]<LNC>!)<,9"KUHI UF#,F
MG )C+:84KLBM8;$$115GGC^?9Q^Z)T9K%;'0A'G%E8N8<"\=:!7,K)W]J&S)
M6&YR<5*EC+:IA@^QC&%GE%/,!:M9P"Q&58(R,65BN0GN>O%28LP$908Q*;B2
M#CD1"!688N]+L(\@U6:LF5:XEG/:..LT#CN#GFG[5+2Q&4Y#.Y7^Z5]LM5UZ
MXVE(3TW*F%H],UU_3S'5UDFS<Q'"3K_CCNO%<><ED<,".\(-9MP!YVHO-/BI
M GQ6'"T&\MD%*+X;%+=*@A68@&Y\"-W8Z;8,]&#GT'3#;CLO3]5#&;"7*#HJ
M'=,(60&2GFF*L$4T_M*B8U9(E%:X4U%7G.Q>&IF)#L>TFFE!+6-3@BH<CY*H
ML1#MW[6>395"CB,J)&5$(,N$1T(2&1@C49>@5.GS"=8I@W)6( (X0!9KA8G$
M3$FI#):,<B209FF;Z>Q#9+[I$Q0H7L4(<'%@G@OMG<%(F:",9S+&V:?/Q*3J
MY!"QDQ1]/X3V5ML/7.'Z%;TL$2[ C>,13#"DP?<V0J;2?1PK1351Z?B*TN%B
M)D7['  %\>+P88.P +Q8JH65A$3NM7+,QQ)D5/\25*(N35YDBG 6 [4>/"V!
MA#-2)Z.M[%2Z(M$-L?]AT'6'IK<PXK^9ER*,% H+RJUB2DGKG O>$AFYB[$,
MAT;-O*3_:73."E92J7:%(F+(I8V_7AO.G=8!(Q$(<B4H%_Z+$,IXB9W&*@26
MSBG%H)]CC%@'8&TJ?0EV9\^=G 5[.M75)\$#[P0%9K11.D2O@I.6T!(46)C_
M*'2T3CI&C)5.,^6MY518@;@/$>S<Z$N0?OS#Q_O^+&?>IOLST'SZ2;RIBD$T
M-CJ/;(IX*@M8(!JXFNL80:[./D F3,8? N3\'E^LG PD*A#J/B5Y:\VEH(1X
M%3$.G)5I \,# +DE\0OQOKVS.X_$]$9SH&&JBLP9CL%BXHEP." 5*6=SP.T_
M1LPGO_43-)^W#VYM)TUBY2W8TWZMTSJ!1TRRXH8=[(+<.0SU]GSN #'@4FO#
M?!24@>(P!BMKG/(>OFM1!NOB$3@5(+I.U>=QF:9/2AQ)I)0(+J5BWF.EM,"<
M*$^8,3[:$I%RP:,W*C82\(X-N&J<,08JVX"W+''$C'%-01_,/V$;9YUY)"RH
M;A%,5%)2P3SW-A*C8Q#4<AVT,8FP:==I0=CT@:)9)>P],:Q[%J ;9_#Y8IAT
M]+P$Q3I#XFD$'=Y*T00(ZD+TWLL@C)&,"Z$X1E038IFFT:*A"$8C@J8/I2+H
MU%+';G J>C)AA[=.A+#*4HR-1IR##T4Y,I1$FVJL8,^Q=W&T#8R/MH$A/KLB
M>-8X-6U^XD_>_ 2W3D;T6B(- K)*[IGUPDCKK00".IO."BS! <K3=H6?Y_2]
M:)#F7*D( A3L&$T9!8\D:/!XC4,ER.><(;),<)T VV@=BPHAQ03W2G$3@3B.
M:PPVJ)S"+M@?D#(OO\426T9<=)H&, &<U& "@+@16KO E2MI>G)Y$PLM)=A*
MZX@AE(' -R!5A/9<<^,=)J%$CM2TZ#)]ITEK3GS@1HH@6'!$(\2, W?)P@5I
MRQ3F^)57K2B7FH.N)S8P-MR-I9D4UD0>,:6JM ;8"U#O64POIPDC6(%;PPWS
M&@2EB!X1 PY.1%24(&ER)@@RP4V*U#+NG7(R*J88-@@'35,%6$JT+,-!+2^Y
MG-O(^\U0CUMMGY_F?F":US3C6NCV37Z50%42AM12>.-8"$4$7U@-AK8%I\A1
M*H7@ID2*KDR)LO.H;$54A"H $IB[S"%PV<"!8PIY9X629<BG_;41]#Q)UD1C
MR;FW2*%41UQ+K!'VP::*5YJ57+X,\S![]V;^K;;]??&8>>3\9$$@38P0VC!.
ML758:1-TRAVD :RZFY&;!9%_DLC?%6::%)'!0$0\R(B]<$P8H2VE:;W"$,6B
M]G.0Q#'W&MIC32B1SG+N&"9<1QV-X9%30B3AKD1\.@,D?"DN'(!$*>@WZND5
M25K# DM#*36Z.&YC?&W\/35R_Z*C1I(S)SB7BDFPV9R5X 4RKZAG@9 2L'7R
MS';Z,*'I_LW0.>B:D\/<C;TSEVJ"=2]6=G=^WC);ZQ21SVZ1/+*=]X[?7KP-
M;7?8,MWC.\4N0WL0WG4[+7@(GG#]SWG_<&W0ZW=:H3LI4_&>#MWEBJ]S<N?V
M>11S0A'.M49$&<:4YB8&;R33%CEAB+U=+'@!Z06D9U#LWXR;>L0DDM8QDI:L
MC4&&,&NB<%CCB%P)I/3,X>V)/+96FWM(3\=I9,I1ZS6E,C ND.;.6\V,BH8"
M?D4)I/0"TC,+Z>E(:>J]P0H[[P7C4:;<%8&)U<%I(=!XU9@AEHT_S"JDKU"T
MUC2]7CT.-[G>.AVMFX?>VP_=$$.W.PI_3,H(V!G87OAG !W82%'7>W9<W+SA
M^24D@_\_44)>O_5GC@70"H&(1))%S;QGADOF?!":N!C5U6+I#*/HGFC::NKS
MUWHRSUAU</H0NAE1OXZ*GXFH6ZHC)9(:FW9J<+ "L5=6"\>Q=HR52,C\XO"8
MOH1QG!)D/&5$2X:<TR9('[US3%"C>"P1EJ:SSW.!X)=$\.O\?*4;>IU!UX7>
M\.MA,+[HO,]/W_P)?XU3O#F)4BFN+#C.%#0I-00#VC4%3SJ@+\F7^/I,KW_1
M!,2V\G9V&/*#P_X*%2?]/\YRWS]<P0C][Z6;]YGN =S:[YRLZ),4C^V=F/:;
M/VWW-30Z_#QL^\X;TC@RT\P/VBL)$*$[>GA\W76:G>[*OU#QYX\( \^B:>7-
MBY7_TP  ]"JU<%;9[K1,^_^\ZIEV+^O!5,7AC;W\,JQ@ OTNOIX-!R*AG6;>
M#N.!89)&LUO;:FRL5W8:JXV-G9M]GL'>[FRL[6YO-;8V=BJKM?7*QG_6_KU:
MV]RHK-6KU:V=G:UZ;8I#0$\:PF?3.\S;!_U.^U5E?7EMN4(09WJ&NLWN[?:7
M)_V9XC#$DV;_77V[6OD3Q$6[TZX-P-'.764D5;9#3(N;X*U9+ZWBUC)-J!:,
M2B-X] @<.HKNBZ]5VB:I.1_RE?6.&[1&(GAIM-9&/UW8]<[I>[)]ND>K W^T
M<;J_J8_J1[56K?%WJW9YP&J-P[RZ_I%6R1:OK]<.JT<;N'JYQ:ODXUEM<_?L
M/:TU]RX[E_M'NQ?[1X[5UW?9WM$JJEW6\GKCX'*OL75>:U0OZHW:<75]NUE]
MI\[?D_V+O<].5-<WV'ZK=E@[JJ+]HRJNK;NSO<MC4CWZE.]=;J&]QM^'^ZTJ
MJGW^>.HW/S'_[[^;^Z1Y:H\Z9]7&86N/;)#JY7:K>KD+[WM[5&_L7=0^_WU4
M/=H^K+;>M?8N/^+]=^JB>KF*OD2M@HS@1COX-V/6TLQXB3(-6IXC#):$\DMO
M,,H^%D+[*Q7>5.Y@9\((T4\"R&]5TSVNU-OA]P>Q?&*\!P[.FB'V5PA9YM!P
M@>^\G<R7E6SXV],1OMK-3;,"%HGK^%"I[OP<I[X NC\.0*.';O-B>-S.4J7(
MA^C#"\[[*S$_#S[K=P>_( /P+R8*IK70&:&194QYD1D42":8L,9IZ;4%!OB?
M?X&9+?ZXS0-CR#T1-Y\!A0F)O9\#3.4[7SM1=?AQ=W6[L;']?J^RO?&AOMVH
M?-@%JWRUUJ@TZA50]PW0Z15,*_7M"N:_^=\K]7>5QK\W*M<L@2LK8'6MD2ZG
M;7Q/5T0W6)>P9?E=K#M1Z^9=IUOI'X;*/V/VJ@SMWPJ8Q<&_A-KZ4+QO8VB%
MWV1K#[]D+7CG87HL\^8BNPBFFX7V+\;FM<;QEZ ,$IHJT&O(9TS[F"D<?88L
M3[%>AHT OP)4B3NL4/RJDN;\<84W:]9VI_LT'8C5;0V8?IEC_9?JA/3R8@'C
M00483;/WZVG C;,OFE@M)><9<THE$Q!G1B.3,:*9U5XZ[NQ( [*%!EQZT]A>
MK>UL%7KN817X/__" OWQG'IPRCJO?\528Z47NYW6<-B3^KO2[TQO/M1C2$1/
M=[,?\[:OA:786#3/ *W7.JU6WDNARTK,FZ'2'J1XX\IS&C8;1<SR';RM5KSL
MEQ/(J_@+<9))H6/&/<<9DYQE6AF1T< 85UPX;E *QN,L%<I&/V>GY*V#2J_K
M_EI*(? KDGPYP,M')P=+%=/L/W1IU.A7=C@Y_V,$9-OI]SNME>1HGX9N/^4Q
MC-Y;=&%X>1RDI?#@TNMO<P5Y":X@3^.*9T?_=CC(>TF^]M,"Q:_' >=?%-.6
M>N(R&7PR1*0"<UV+C.M(0W2!.<^7WNPT5FOKJ]OKE;=;]4:]_GZGLE5;6WXZ
M.[PTOIYHW/RV<6Y<OT!%I1,KW2LT5$ROTCL)+JVW^4K>KN3]7L4=%K[GP]&O
M:Z/D#XRR;RQ(]]']MM/UH9O!:)OFI!=6QA_^\'GOI&DN5O)VT>?BH1]A>$W
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MQ<%+AR3DT%7-/'(Y.(R!-5H&&UUP-5/.!>47CG3,U#P)=2?=<YYOVVE\MNV
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M_>"WU9+!07K@].K.G>&@ZWMGD(56]H;%[0TO)W@A]MC%R&DN,4=SR Y'.GA
M1&-NE+'<25KY @2>/.[YUZQN@ ?*35VJ W"3@6 !S+  P0,!P1A)M,3[$+5
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M-!4.2^44361'X#HW+BDX4$>+I>! C7%@W.@)41$)CB(%EN587(\<=1(YGI#
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ML5PE!0.)BH/(2&9N:3I52E\6 'OL &8Q 9""D\ (ETQ9["-AQBG+!%%6+P3
M"D];&+I].]S]N:T>92S3:HX,"(%X5 P9SPABF6\+#D3ID Q0)IK&E.J^!>(>
M!\3-@G $>.3">D<MIQ9K;V60X*WV7E!+B@%:$V!KCW>8%3C!&4&<Z?3#>4"6
M)H@CW%*&@_.$T<3;>%,8N18&Z(KJY3SH0>G!8'!>G93V8J,/@V&_[8>0)S[I
MSG4AW-%!7N-K>WAZ"IV0M2@7QX5!LV&[H=&K0HV662AWBM[>C_[@5 -H):T(
M4E$>/7,V2FH5L9Y)*J28HL3,+?B8Y0]A[[R?YNY%>HS>99?E5]=KH1JV\]7V
M0U6!X5FO'Z$]/*]NL"#F](AY,7&2ZK14AL9<;$$E0U<;BEQ@&!&7I >8.QSE
MUC;5D^5 []=,N8Y%%1ZG9E?!;_3W(J9ZBVDFQV$2I28,$A.U7-%D<6M'>"38
M2IN(3;Q_A:\[</AOVSF' L.+A^'QDQ/* W,Z>&0E23 <+4-.$)]^0. X\&1]
MN*UM/8^[L6AV > BIB*F-153/2IAEGURM?ODI(/'^4"<8$@SY1#'Q"''%<_N
M:Q,8$2$X4Y^-LA2<+B.G'+D)&1$5+B)G!Y"?\>PS= >C)D#P+;^&ATZ)6,-M
M\7[LI<:-&8J8BICJYPU?BB_F9VKYH_O-X*3W(P$]YYX?="^SSBN_>(6?NS?@
M\Q7\WWE[T![",?2_M#V,..DK\+T/W>HJ%3TM!X^+XJ6MXPG_C5+@M= *81LU
MXL+'Q$@S-Z4X: TR$*&WMGD3<[J@8\<""@6[BYB*F-9-3*MUXY0M=FVWV G7
MC[,N,N,Y,I8IQ'&0R$CAD07M=5 @<.Y<6;<]=A,">%HP7%JGJT?NUBZG#T5,
M14Q%3$5,14QU$]-,1ZZ<1>I 2TD\#]RXB(&02&-04E$O[W_DFLC%J%9@KA18
M&/;"&/8M:4$XK0,A(%'J'!'*.2,H-U7+H4@N8$(C9JXJJT/U OH-%D6NI2(O
M+7:B*/+R%'G,5$X@+*5-!K)T/)G*#BMD5; H1IZD&I0RTM1+D3?A^+LJAUL=
M?/_<(/HZQV5HOY4C\.+X+6(J8BIB*F):%*6#:%3$,7%[+KAEX)QB@6"OK8P^
M,8#[4[IJ1[NE3W)F>%>]DE_T^OD&=X;#?MN=5XUO3GHO;!^ZP\+S9N%Y%Q-5
M:HQFFEF.$6=>YFQGC%RRN)&,UA(,R9;#<FN;B,GDO9E+.!3-+@!<Q%0[F[H
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MK#.9M(ID/,5"AGE&9.)2DEL.<^]-FJ;B*68]SRP[4$EP?IZ>@7RS +-X("B
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MML=U3M>4]\D-78FLOBB/81Q M^&9F+5GQT,&G0?-ZU<F-SQ1C\;O1N,'%1[
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M$"T-<1!]45FC6O0F@8%RJ$\ U$<Z,XD3P$N'^$MEM/H.$7VF+0[&1P"?P8#
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MT%\N#JU*$VMB1?(D!LK)!! -;H!WZI3&<1:G.O- -+;2Q5RWZ85>337JIC-
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MO:Q-RMT/G+LD@D<A>(: 7@0RTD?$N2<":R=T(&N;:B5*K\J2T1*V!K"5A""
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M2MPP8\!= 3)JY.-M)SB:%#L=./NA+5_)+_<[E>WH8]/%S@#D&5FOY./,)%
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MOP+?LURW_G_[]0&H9GC?_OI/5A\^1M?IV\Y%!:B=#TL'KJM>CJ^V&:Z?I9!
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MI"$VH6B<9WDD1I+%F"JLY]PBK834$E)+2%U$(+*$U/E"ZJBO@4@JG*<1V9!
M395!(*,D0\E@88A@CC(-:JI8-W+.'=86B*E3C";+?V=:K[?ZA8.KF#8R8,C-
M_^<Z_]Z\=Q3)D)DXW5!Y4LA9NUO/-_BM$QLV3_FY&1#RK[O#8(8;@F\^8AT\
M>[]W_T<FS3E9Q+@8PN]NQ^V?>;D%9[(D:%):"^TP5\P9S2P%$@.@")A'?"3$
MVM6'3CHW'?^/(W*=:+^C(CC[FVV<VXONVK_OSG^IM]#(QH_NV?V']] T&4)?
M80;/V/B 8E/U1N6E!T#US\X:L0F48QN_VX9M^?C/28R][7K7-]K=?B=VEV7
M4^V?*WC=P0=T[V?U= ?N?WA2N]S#U4N VOVO#;@'?$>5')R>U ^:']CH@*?J
MZ>?3P^T/%]53?WD([]>V]RYKL,;:MZ^PWN^7!Y=?Z[N?_JP?[(=4W?_PLRC%
MD(X9JY!G (J<!(VT5AA9;5G*^J96?" 4 2ABV,I""LXB"9RP-#)RGS  (=5Y
M9)^WF)AH1P="#7>^4FQ]93OV;+W1'0>DD;E@M\%I<#2/?^_H.A5Q..4 L.;)
M22<(44I3D3U-,@>"IQ[0N$ N^<-V3]8K^6?EP__VZS] &;B:2_(Y=GNP=WFR
M5/'^(F:K[:;\U5NMD/^YM<"EFI[V^LP%]SH_T@(S%;Q$Q$6..!CFN881]M3P
M1),10,9CS/)JQW9#//<<X+L].[CN_ CG7EF&$Z2B GM<N81L=!9IZ0W#T8)(
M5RLY^6Z )S[C11S!D\X-GA3O _%UZ]W\YW".S6!L79Z45XS#NW?LZW;TL>EB
MY\Y;9'3:W6/#[AZ$XI69=B?U!C%Z52:]L0VQ.F/I8+&4S7,LW0P#NIXS5WWF
M(5\OXR^9;LA7P>.5*_:>8MK9TQ-;WMK67<'@U>Z1N<Q*6XH9BE/ZV@JU-$N$
M47GS)#IZJ3$:3W/O+G1CYS=#8T;7[4*?>@&NV\G*\5;OC^',X*]Y9/!J>'"?
MJ$D//;@'.'MUJ\W/S8/]#^>'VWOG!]]VQ.%IK5[;A[4TJZ2Z?W"YN[_'QCRX
MIWMX=_O[Q>&GPY/J_N_?:]N_GQR<-IKP;*1*O]8/+K_\K)U616T[Y!$9%Z,5
MGPE,'+!VD#68(FXI*.$Z4<2HIU(19;D"?*=FW>@7GY'Q1._L-=.4<%?"W8O
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M;O:A>=9H7\0XK'BX55E0&J OI\1=&Z!:<LR$1US$W D%8V2Y3(@(KH/@5,H
M(D*MF[EU0ID'%ZU&EE*)H26&OH[V7&+H(M3LZUS.Q"WS0B'&HT*<V(2T2@GY
MD!2<'O>1Z-R&QM!YS65;)(9.41&;_QX6NQ7*[9W:J"&O<+JA<B736;M;S]?\
M5BB_]1_QIH#I7W>+WH9/BV\^8AT\6[]W_T?&:BD65 ='Q-U2L=L_3SHWI2;'
M$;E.M-^13;#8WVSCW%YTU_Y]M[:LWD(C>SCZ^(.'W/Q_K@,?G?#%(\<S8'I#
M%7$X6<RYYLE))PA12E,AB%92\XD5B$M6;SCYR1ZMM-S\J]TZ1K#CS=Q(>N#V
M'2?BAQW!N9K0GIUUVC\!4GNQ<5'YKY=7IL65($B-T!SQH=3:+3\+^,O5!/\G
ME^[6BO54?U8OOY/:]@'>W3H"H@# MAX9Z2SB(9 \ $>@))EQTH08/; !WKC/
M80(4W;BRY6<Y_2>J >7IS^OT_<_JUE%PSFL-!I!FV5M&%476D8@$9R;A2'S4
M*9_^??[LZ]/OQ#M%S' ENBID+O):1LN9V_W.=.7,3ZE97@>HZIY%GT5KX^*)
M#1+4PAHD?+,= -V\4XOI@/!WIQWZOC=<QL5UW< [[WKPX;QV?B235B;KO<8H
MC'B4#!E03_,('8^E9$D$]N0N!H0^KE;<ZXE^[?X&YT/R&.U?,&#W>[H83,OV
M&Y6MS+VY?PH@>?&QZ^\KU!7;*-[(_0UZ)YT8*TU8^$FW$EMY&1/@8O!7QHRB
MJP$LNMMOPM[#DV?G<Z-]/MKIH/(8;N0C$V6?@[+/P?+V.3!CEZY$R?U^P=+5
M 4M_N&'I7((_2_7]"[6,>#.M#:;L!S'5 [^WC7M_;2!^CR"I6KF1T%!6+U7G
MA_<53"B[:#ZIB^9MNV9KH$>^AS#!Y].#RX^GM5.X;OOX8G?[<[/6W..UYM?F
MX?;6.?Q'JM^^X,/F 1X-$]0^U4ZKWZH4S")8YPZO?3J@A]O']/#;(:SM=_CO
MR\_#_<_-P]//DRH)%64LN!B1\B9GXRB*7&("88>=999(:W3.]25JSF&"Q?<;
M+G&NQ+G9<"YHS*QDR2ONN1'6\A $(R0Y;[UVLL Y7.+<$N#<V!15JFUPGJ-@
M.$&<.(6<2 9%2K2RF$=BR6"XSOB0L"7%N7=3\& ;E5\ZL1%M-_Y:.)6N?%=G
M<-/VM:.K7A8^O"S\/<F'/3L._MV)\6>]VX.-W&GY3C[V[3CXMT3!65!PO#[3
MDR2<5 IQD1+BG 9D<! H2A^$3LG8/$N:X65*OB[9>-[C41VVAA#X(:SAU"63
MF+;.1Q=Q,M'&@H_)%1^327S<A0>&WTJ&?F6&'E5KF*&$:ASSI$"<IQW#;T*#
M(1>=B]I@GW NN!;CQMM;GGRZ4$Z\(GYXP.Y@G$#65D+9-^)%,>VU=!-[D:>Z
M=$O<F@&W)F7X4TJ)TQ89PBSB6 :DF5:("*-"8EYXAW,1V'A^__2X57:(6&)^
MG8,.4O+KR_'KJ)Y!?>1:*P>$DSL#4YJ0]3FO7!IXE0<;% =^9>.&PT+X]3VX
M1CZTPG,C?>7$O7+BWJI6:)8^]!<6 N/MX6,R#B>5D',6C$VC#+).4\238A1D
M@H(CS3YT,$G?S*B]$DI+*%U6* V2Z,BQDMYH'B-UTC!@0D$<<28J/$B[**%T
M":!TW&]G(_/8H2B(05RHG*^./6*.<\.XT,H6DS:HFE<#Y\5#Z5-K-.\O',P9
MWP7UL21H4EH+[3!7S!G-+"6"@3X1,(_X*+?#?C!-/&?VOWXUB>+ \6:C\L*5
M([F2<#]VFMO1]9:E/&3WCRO&/<"[GX!AO_U9/]S^<%[=W^.'VU51V]^[A,^P
M@^:?S=UO>Z2VW6B,EH?43N':Y@<"UWRO[F_]K&V??!_43E5)9OZ#YH$XW/Z"
M=[]]3;O;55;;.DK:26 ?C*S,CB<N&-*.,12PB%%P*V.*HT,Q(T]!6*ZL39QS
M%1U\-S68"JJQ2GZLG"1O\SAI#PCWA0BLN.-O]1[PG9^"Y :\-+$N]?&'O;LY
MPD9IK)?1"8 NDN!/[')^3(A,LLC6-G_OU,-QK/S5AD>H3&#QT1*J\34]^ATC
M:Y(* R!X.%W/N,?8L9"DMTY8'#$G]K&*GR4I'/[G:H8P*[(>;"74N[[?[>9]
M&8X.G:6@T\1HE0\^Y'1-$>" DW2",1^,=33(Q\IY)Z'):M1QOC;65"^/,2@%
MHKKM<QTGK6X=19V$B#:/: @,<>(UTCP'ZCSA<":2I@ADR<3&N+RO7-5PWF&D
M=K_7[=F!#^B!$LQNY<QV>E?D\G>G_L,"0?W=L#YFQVAEI]OM9__1$VLP7U9L
M3H]JA!8Y_X17_HFM.C#+'^U6H8QD#2?S4+?R2_%V\?NOE4&9&3$/7VZ&ER^F
MRK.0ULM4T?GJ;+1?_;F[OU>40^_N[USN;N\=6:F2EE(BK(1"F760I2X@YVT*
M42B)Z=A0:TUDL)I;99G@B6KGI ^!PTO1.*K]BY:#OI:PR"/M/5AP%QD0?MA&
M?]#]83"5NGG6;N4PR-4K-ZQPPPG#/SLQ@\9@)'6WK+A<PB+&LN)R3F6"*U70
M]I(SHE=J(Y9KVO.U?^(5O0;%-@P4O:$OZ#XC !1RV*D1.P ^0:4..%GB>&#:
M!5!,-1<@&XD0)F4[@' @,GW;#MBI?1Q55;*"LM/J@M#,JN1.)I38[7T&!?.?
M7NX8\'?L9/*QQS=I?HBNI@XS]!?N7-:^?1 'I]]_5INUYN'VY^\'=$^ W@)K
MKIX??OMP6=O^W#P _6:LF]MIE1SL-V!='RX.Z.'WVJ?<V>+[98T>P#/]WCC8
MK^+:I\/ZP?[7/,KR_+II\K;'N_\8?/@_)]@WO[;L-]/?/:V>UYH''/X[KYY^
MK1_N?V[43AOU&MV[J#4_-JK;'QBLG1Z<_G[Z/Y<'1X)Q$G12")NL,V$"ZA++
M!HBA4>4J/4%RLLV&$F.VQ[]NJPJAGS4'QBN5$3W@17)DIKC'XSWEGG/W!:QP
M2C&X"A$>,#5;OGYF&Q7;A(WI/4-B37CZU8YRO=%PE+)*!>I3 N-72FY$2"XX
MG"BC(1HU;63_KECY8VC3;!54M#1QIY60(_5;XS&R'-D[$IQK 2>-HHPY[S)/
M> ^:("Z"-XY0&;E9VQ1JQJ&#+Q=I+S%AI3'!:66LXEX%1K@UQJ4HE=7,"QLQ
M%7;:S@ E)LP/$_ ()L3@A=$ZH"!40IP(AER,"L')&3@;@26/"\*$]U O\@4H
MO0W+R6W. I!Y$>694F,J,]"?GH'^,NK*K=/<'IYCB4^SX-/%F,YB B%22H<P
M21(T%<:1<<ZAI%A2 5Y,5JQMCJ-362GR)OCT952(DD^?S:>C>H2,*A%!(XJ>
M@FU!N4,62X(,<YH O HNXM+PZ1ORM(PI$/5A3+^H0)U'I(!.W)<WB#7STPE2
MS$6_'^NM?!!_Y$K@6BP19A:$N3/<<Z@)D,BE8 PQIAWB@7-D@^%(V\28U=BQ
M/-QSO/C@/H1Y?;?%^V.I^8GODJ7FP%*C0ILY["2W%#EE@*5T<@@ #W3M8)T
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M @PO929X1S686T; =54$6:= 1BTU2A'GDP+#JS?XM9O&5135BW7;CP<7BUL
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MEK3_I]<%-0[]M[WNP7^[A]]RN<U_883][?17):A7O<#4_A4#.HN];G$ YW
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MFB&N S@47&FD-0>O(@J"DZ4A.K*VR=:%)*N"#*N0=)M10U__^ZGQR;=CU7P
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M[NW/O#I&0@5CQA,!UW&5KU3">-"A;$>83K>1ERZ)N[A]W&NX;CX^ % 3VCV
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MOD72#5'MK5'J6%1K- -G*U@7#><XGWZ,$<(YZ702@5&[(E'M!>_5E9"R<B9
MPE%_8 ?'$.^=CGT^LKX7X>/US,:-WZK/\J^_-_8M_-56=C]#[&&W<="MME#L
MS7!J;!+>6!Z29-P1;"W1SL(R!?BWD=.W,Q;DVK[Y==3N51=/L<4O&TL!0\_V
M8L!!.H;K/E$\&8],SEQA2;QQ$J<0P]HFV-(YXZ*<.#ALQ!'Q_Q%<7'T, 5/>
MC9MW1^Q.(G3#3D96B-I7JUVU48>"?_(XF^!H'QP?7-J4.,P=1INV]R,.AGU&
M7VI0M/W:0S1MJ<7)*<0 ,#,[BH% 6D4DN0B4:*HD@6B:W+3OD&!"(<[(,]KX
MF:=T]$&%2IW3*L]4-]$:HM?AI)AM--[5N9S.Z?HYO(VV7"_B\MC.[OF<$G?/
M:&-<XO[I]O)#M],ET>MG-P]D*\=)6Q?QX0L6KIT??,^DB!V5 ED1 )&X(<@D
MQ5 B) BO,5-!WC'BKD7DQL ;! Z"W2EA]VQI0))H8@Q&KY3F(1"MC22"ZD"Y
MM2&Y&TQ=)2:C"L-F'D:_WO+\6(]O*SM6X[*RG8:A0JXKROR8V?!-M7'5B[TP
M>6KNO#EIGNQA!EZ>#Q9YI2SBT0JD.0@8#B$FXIQRN6TQDQ/&K9JSJUF6<2&Y
M21@H54%8D:+@G!,2+8BN(HEP+@P#?"G"\,C"<-;:VE/@,$@N/:(,.W!XL$?:
M88HT<5Q%P9)/>&V3ZVN$82P_-C(Z\Z;(5F_CY.W5LJ?A3E1=_#2J>^K>LL]V
MN6RJ6^4F073K@*5;F>C1O!WUNC_;_6IFVX?GVU75C$ZK2H"AG?L0EY]1;Z6-
M[:%=J34X:7<ZN=3@R+9A#,?@47PZ!@4_LJ?PC_-/;2,=']9.P]"2P)KD=8;U
MK#-+U[P9#.S:%ZNB*1?!LP9(:<>?,6S,(17+48\P0TN<E1'P]X>-O^WA,>!H
MG4S,[W:M2-L FA_KG=WS"'D84=<2T9X>G:_?%)K76Y+KPS_:HR-X7+M.=%2%
MG?#1%4&^O%^<*QI_7[].V#-BN8O$^W 3^WQ'8/WBU>I;@!WK'W<&.32J\OE;
M$,!U\IN:ZZ?D_#A$?0M0W+^/#^.E+_4O-6^NWJZ;NX#"O(').PP5R=]HVQU\
ML^K?0W6[F&(8^8']$4'?P1T[[C?\?LX P*C;54EHUC'XK0<AYK5H<=Y_-)<P
MG=<NN=-Z2+_ @1]$L/1S,FK1(*--6BDF>1#!)6K!DY7,"1.-M=G6$X-E9>OS
M+PP_T.;$R&O8"G4QPZC"?-[C*B]M/P+&_"L?-_%.2!L]@ Q.B&NND'$LH*@M
MMPH'351FT-J8C&T;H^V'4:T<R')E)\)(%$>9LW'4&(!NC32,FDKAFJ"P\ ]\
M!W4;?6FJNN6+1QI2;UI/:;K[Y$V$Y],]'U,(045IK>)"2BT(9H92QPU+#M=!
M%Q[J7OZEZ-Z2Z=[87B!N?=M+C$9"7  !\^"GZY20I9SF-(!CE@>I8ES;)!O7
M'<P8*N/3]I2^R>"<E[5>0,$54TMO\#XF=7^(%^0VU;?GDGD5!>92..T8(=9@
M(7S(-->6T>02UYX$08)/E<(1+&J%@U\>;">^*-Q=C=T'WORP1Y3WRA*&C P>
M<>8-TB(1)(A.01F3C %CQS>N.]4]9O%F%_2)6M4'K&C^Y/=C..[$[=3J'N9
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MN;3:ON@LT__/WI<WMXTD>WX5A'=FPXX@V+@/^ZTCU):[Q[,MR6VKI]?^QU$
M"B(L$N  H&3YTV]F5N'@)9&Z"$IX+\9- 06@CJR\*O.7#[>EU[F13E+>.Y+N
MM-\7'4EZ''J@U3@87,-4*W0L-?"9JVHF-VP_#"V7N^A(LN[%D=3K$,]$A[AG
M1](]<IJZ/D+O2;H+'UGR)/EZ[+FNH3I<"U5+ PV"Z:&F>HYN&S;S/3MT[\.3
MU$<K;;5'_ZKJJ3(J07I/+J7[#UG:J QY[W.Z@\_I7ECHVF/ *M"I9Z*;,]%E
M; /=,0++B,'XTKFC6A%PTL#SX4]/,SV+>SJWHA=OW?M* [['O=>'.O4GD$_=
M^33/_'HGU/WQP44G%+=UTPI >PQB5":9Z:G,M365^UKD13[S;9^<4.:=4S_Z
M4*?>"773UNYCFAYFUR^ZHK"NMN>XH>H[.E<MDX'U: 1,-0S/=R/N.TSW7[SU
M[LD5U6L4ST2CZ*(K:JT=M=8[U>-AWP?+6?): 0EX(&I4!(E5K="(5&8:FFJ'
M3(L-(W09>JWN"1SVOH.@?J$"]:VRJ8^^]PS<>]_$_RT4^5S@T*VBKA.6GR5I
M975B+5$Y(RJRS->Z5_'1)(U@V[Q6\<KC\Q6CXBO(/9)T1CM<;#(SM#5?#^ ?
MC5N.Q1B/#-^/HL"$IP+3$QP'G@$5 K>L'3N>Y0:Z!C+,TGPK<'W7-X/0]CW3
ML[DO*[4N?*L6:X\_\/D503V;5F#E9-P\N)JG*4E=\O>"2NJV<BC%7JJ\DLHE
MW +B#V=C1M[+0BE'7(F2..8YQ_3+@)>7G*=T.1QG!?16F:+MI6!A;7*EX;NS
M60Z+,9ED.(-9>*YDXI$Q*TH%E#D<I1*QJS7]&"B7HR0<47?^\6AFZX?CWU9&
MBCT)VW+,__7IZNO?T30P+.=H<@RL^=_GQ]__M+],L"__F7R=?#"/OO^EG?S^
M6_(%OOGU[[]^?/W].#[Z>7!U=/8-]IH1>3Q4N8NX ('GJH'&3-738)+- #3(
M,'[QUAS:RP$* P6$+"U_!;DK2086'Z]F0C@/E,EL7";3<0*4%US1K;2N=@^L
M"RZH0%'\JGIBN+QYUQ>U7N9_;6ZW0V9WL&XW#F@*9FG.P^PLA3>BBMVH/?!'
M418*E::&6V4&NZY6:. Q>0(AYPHN1#B3L#'Y?V=)>04SBL6]DPM8C3%T7[F$
M+7[];EO897I@&6$<^B8W BMT_4 +[,AR?#_DMA<ROD:ELQ<WV?O)=)Q=<?Z9
MYQ= %JN5O.-,#HCTN8+ V]KWW\%D'&?E%PZ=JZ9KLYA,Y]EMZ _:T<$WF 8>
MQ"Y3;</"&'3'4#W3#M58MV(K=&*F.:"#:4-]:3\KL G&\&.H_(U;&E5JI+Z:
M3(%L,]CC@CPS4*@4IEQ*VUYAPKA'<9%D$5+^=0Z*P#3TP U"@QDF2+N(.;[G
M^)'MVRP*=8-OFHMU&YOA/6V3#VE1YC,"JCF![9B?CEAZ8P+F.M=%\<1<%[>F
MP>/3<W(X>CRV#--3;2LR5* [3PU,UU=9!&(ZTEW']HD&[47%5L$Y*X;*LO8[
MK\JU^+_DN98Q=&U4?D%WP3:OB7\"%WQSF43EJ#)L6P]*B:$UC["@R,:S<OTC
M+:L">2S/=R1:6@7OQ02U_AWE56^F0+%JD'-VKK(8.ON:C2_95?'BEWGY"<)S
M80X7AR\&^?9_@OR7MZL^O%*1!7W5M]V(!=RW+. YH-QS#98^\&([,@WVX@8I
M+J\0+(#QD$*<WO@Z ;F3A'-S[ZZ<>U!-::^#E%4ID4 1DNOU%AI*:VPK#;8N
M#E8A^'WE+] ;0*=(RA&J-N>\5( 71K1_]D]% SDW L%5E<E3/G[^JXKL ,$7
M\KP$=H_:;3@CA2J+8U!D\H(4WX*G298K8W[!QPJ7N@[PKM,Y_19>"3H:Z+\@
M'?CX2@'^EL*7A-8&@@<$JOQB,F>B"=*2YA5I10J)LU$VQB<_\7*6I\K+T\^?
M7JTTS-#@ [D(3Y *26_Y_ F;,E#:X@0[@?Z4*5Z:<IZ+YFD"LQM1Z05ZADU!
M;P_1,7*M//=]VXBXS5R'.Q8/#5_3+!9RGP5PPPV"AY3G] _Z_>IR$:M/$BXS
MF&6>/C^)C%HA\%\GC@)/-3P//7-^H++ B%3?->,XM*W8M(T7;\M1SKF*,GA)
M,$];G$#H>(+2X3>*0E3]*FHO1ZQ44*D'-C$> [7!:A(I(Y%68EFII"[&4)$-
MF4:5X;C\+=IP(3 (H@8ESK.)LM:B267PS!R%QD'HAI;! C?T+2\* MMT D>S
M82]HMA='-P3^M'P(=_-8WZA]?JPG]"1NL5_BN_-^[MK248UG1M1'/\_THS^_
M&;KEZ:%KJ2Y8JJJE:Y'*7%-339U'EF';D>]&H&8N&3K_1(ZX'?E$FAO'+(C#
M2 /KV-&\ "C%\ .#VWX<1W9//GM&/L>7W[0XB.,@\%4>1L 3'2]"H%^N<LV)
M ST(#$\S0=?65A&0Y%2-G)^17B05B>']J4)K0W8?2T?ZM:V(M#FSU#J$NE&S
M=7)7Y3>I& ,%IK-V%)+4("T(G@"%"_:1CQ*<;N(?N*=T9<)9,<MI>U1B@7Q;
MPG]4BZ.Z@RSZ/BM*:IZ([M,)CQ+P<78)/8['L!NDN-HNBO16ZL[-#ND'80C7
M5 (FS0A(^'EJ1D>G'RY/3O\TCKZ']M%I"/_]\UOH.J&ON;8:F9&M6CP.53\R
M@"5PW=0C$ %^X+YXFV;+OC-!)X(@$RI@ILRF0$@70C&M2)U(NS$S%CT=#PQ?
M%(YX-!N#9*B]KBT10:1%<N( QG0!5'6*V^44>O#K&/;X,R,/=&4=78*.X9MV
MK)EJ'&L&*,ZFHP:^X:A>S$/-M0)+#[07"@=1.D4'43[C*UQ&N[=TJR5M#$\T
M!Z4#@_@OF)\,:TF,@3D6KV\\;ZE\%ZM<8H+-UFXV"GJ&@8[9M."OJQ]OHJ28
MCMG5ZR2E[M)#;^;E(SJC%@[NZ7OB=N.G&FK"5R6S3^27Y>TAW5H()Q#W7'WH
M^_[:V]I0O^4]VUS_T>N>O*ZSNCYT]'WJK&%L]-J[(M!T!>Q[1=":V!&/$]KE
M+?"!)8<>;9'C6F$5CCSRZ;X$]0B^6BP5L.BG\IJIK,Z&5'DX1%-)VI9RB-$9
MO[$D5RC<C&(H<+[GYO<YY,O5Z-XP)SSD1'OR&%SO2*K<,N[PT\^",VW7MS6P
M50)N6:%A,]WR+=<)6&S'NFEZ=,*OZ\:# ='=:+74"NKS@?Q^;WW]'7I[.$J^
M?#^WOI[^^?/X^Z^C+W]_.C\Z_0K_^RW!*,[C[U^6HS9/1^?0Q\N3W_\-?1N-
MCP^/C*/??QM]_?W/'\>3/W\<_?T!HSB-X^^?XJ-ER&]#=WP>F#&B79JJI6&M
M(\UCJH.N+<LT-=\/$87)T)<](?<,^=VES)$'Y!^=X]-;![-O./@]99KK(Q!O
MQSGO#R-\<\:Y$+I"B@GJ):B6S$,T[&GDXV.SS<6L.B=F@1MQKFHL#E7+(/=Q
M$*F.HW&@@<@W8ZRH!*;.<JA5%]GF<T "1<^;]-'O&OSSR2N9=W22/Z:V>8V/
M_.EE!ST2PUQ&^]1<R].8Z:C<#@/5<KFF!J9GJYH>>X;K>=S@WKUE!W4/#J]'
MXWKBNN$=&=XC*HGS_&X#3?$&AMAKD!LQQ$4-TO-BPW8"5W5=/U8M,P:&:%BN
M&EJV:^@,_M]SNL@0GX/G\N/J0 *,2J S7'%^NVL?YAXJD5M67+\'+;* ,<.O
MQPO J@CGH*:;)U:;_9$XYC*BEQ=Z(?=T4W69ZZM6S'25H>'MQ+;FVF[(F.6_
M>&M:RQ;WYL79NX=ATX-G])KC1IKC+EE;[V^\9]ZWK"WJ)@\Q7#4*(]4R.%<]
M%RC"CO78,77=]S3]Q5O=&?I=JECX7+R*.1]SW%"]6[%W*Z9S"-F]6_$>^>+Q
MNV64U\@SP\ +5#LT ]5R-$ME(7!(S71=8)"V'?!.6M&]6[%W*SXMM^(\O^O=
MBH_$$!<518/[ ??P)#HP0]7B3JPRWS%44W>,R/2<V&-Z%QGBLW K@JH(5!_S
MY+9'T,_;>_AD=<7?*J+HU<7[Y([+T8X\\&*#QTR-'(,AX)FILH@9:JCY-D+*
MV:%M=A&CLO<E]K[$IZ4N2I8W [[=ZXJ/Q V7ZE."BLA,/5"!2"S5,DT;=,7(
M4C6#N;'CNU9L:EWDAL_!K=A*GNEDW?+5A6Z><UY-Z!N6H7MQ$-O,BGP]<)TX
M@JT4V7JLF8YW$QCZ#O)J>F5R<_:Y'-+(#![8.@=1&D>^:NF,J;X)DM4T0VXX
MNJ$S'K]XZ]UW^?([[;S>7]G[*Q]2 ;T=$^Q39)X >USR1#+7B TK4G7;!NW2
MM6S5=QQ--7CH,2T,3-L"]N@.5T L[=@-.5\,8JOR"RV #+/&^U@%GKK%6[H"
MF$F8YF)I[@/8? [_<FN<\EMJ6SU.^8Z!=0Z__#CZ\YOC:C$L&U-U$]/G?--1
MO8AYJJ'9MJL;W-1,#PL/&+O$*=\EKFF/4_ZPJ*C'9]\"/6"VAU$#L1>I5N08
M*OP=J*'G6Q8S3,U"7[ ^=#;#*>\(Y/%]8CRW;]9 ST4GAWVMX#H4D,88NC\
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M5"5D>7X%+R;0J3U<LT\DTPG99GDR4"%D4U#F8#9PVB]'/(4UF]>R!%!=W9Y
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MX].S;W[LAC8/$2/3<%3+8YKJ,T-3/5@**PY\S7"C%V^SE"\[=_**'2ER?86
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M/QPV?U^=GOQ6C8+^4/[?Z?Q=N""'=&C6=P[YN&3*[SQM/BL":EI_GN&.7IB
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M+ @!>)<I,%(2,(2*R@0V5$G!K11 RSD")2'AYT1"T3)F[B47WF:,(I/%G)M
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MYB2'QX <A@J06<''XWD2@G&..4-A"R-D$9\DH5CS#(1K2F\>,Y#5K,P0]VB
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M3K;D8M.$3H:JU)%0I=XWJA2>AVT0QK/)%.?9Y6) V=93! K8;N;G"V>YB@?
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M6YY1/:MMM./SGD>J#M(;.WW+ON63:OD<3G2V13+;VIEVTW/7HH5HUP&&//4
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MP>8W+:V:EGM^L?Y []UR+7;?8=/=LP[OWPR#PO8@V[-ON<MCJ@5%U[#NI\;
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M2 K<,O2B8IQ=JA.X!+-$4Q& F<-+[#?TO\SR*S'VHLS"<U7L4YQ-^+H8"?(
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M.%MGA::DC,#F+<?Y @-_8=:%WU+I/N F'*0Y&."<IHXJ^ \'/X+KF2]CTPP
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M@7KUJPL2FO*H_#310J79@WJ+U&@P!7HL,]%VA10.L2@P 4TD'9RU84H%3\2
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MDI6>^YA'DMNI85S797@A3<."/:%]/R%Q[/SQ><H=&\QKF/96$,AXBCE%A($
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M9P>8GF=GES#1BEK :">,?$G (],<0LA;E_$TX&P>GYSL/SMZ^L3TXS#]5SR
M*.YE 3/Z[I"Z> P)C7G!([;9$:7C;10?B>^-TM. 8S3](!!Z/^9Y=>>CFV N
M@4!VS$A+VA!V&$KQ/>2:"'<#FG1@6XS:)3]1L)W\*.VE YMWK8K=/E4T)-&$
M?>B+-45K6*P9O]J_:@=5O^/3HS*5K[_ZO8*!JPJ7&\/GW6-\B!O<^=L1&,7^
MHAR[C:07 <!TU_+AQQ2>0Q?V\#1<NR^"J+VE!S^B_D%3:AXD<"EC2XBE#ZJ-
M)#<=%LG'+$I&]$!%XEPP5YFMX+2@QXHVI S;C.(-+?]C#=>E\;:DW/5"0HVX
M=;V3CNTKJL*1F#/XB[UGZ@0P>/93VS#I5OM[[3;^H5MV?,V624Q4:*QO6/LM
M6=@M(TIGRE2P+RH\ZTP[EKLAPUYAS69E/:"Q0@CBTGD4H[6(Y);F;BEP"TH?
MAVRQ ,>$+ ^_> W1K/.JSHIJE!5LMJ8&1=X!D$VJ<2MXZ!QESV_/^U<OMJX_
M'9S)LW8&NB@YPH-X^(QDGM*JW'X D^W4@@^G+G;C*G2RH]FS!?[^GS\DCTBB
M.0#FO_/8<ZVO#9*9?G@8AA3\*[Z-XRORJX(;H>!@C(T:C(QV09T_#D]MN.0\
M3%%Y[[.Y\_"WM6/B&#EXM).^386?V74[XDH !(SS#$2SE+!+")\)IG6_IR$O
MVL#?I2_)S)$4>C&[9A'-ZNL?Q4SJSBUO"%6)<'2!)<$A@0L*'2P)AI*_R_!*
M,+KP\57 NZ.10Z!,=$_U&_MW$VPYVBR6_34C/1]Z B+:;&!;8>G_JX7UY9OO
M-+(+EA&=M#>E_J;F!9FE:V, @[T_^5YL!KSK!QGC0\?^:^[DU#J5)VA8B&'2
MV][8#29SA+T$5XK>(+01U2YI'T%^[!.^D<"HX!:=9)0,OF.-"*F38X>Z ^=$
MX)S3[03G;&@>?/5C>DT? P*Q9P69KC9D)Y[WD#@39OH@Y!6_I@+ *IO03EG-
M;C(]Q-OW$1D[NYX^IK(:S!6ROIY19UMR+;"%5(9P?<::^\ 8!S!\Q)<3JM+H
MAO$^<-KAVWBP0' E</3H $3RKX^Y0$>OAKD0Y*"'.@8KI9*TOWBKCZD$Z>2O
M;%1DW/U)*Z#"")[LGWI/*IA;59W/^/N=*3<^5&=6C#.E!+:45=-X6[5&KPX+
M"<L5; #X7G5FHVF]EW%-44E!,9T3;D3_FW]>@\7+>![ IY2[+U;=%'V<8QA8
M[;SA=#D])(K/BHG,JN$X)2OF"K9CM3?%VY,%35Y+D6RP.7W2/8R DAGZ-9N7
M[W>;Q*&?H77/L",,7643KFP(Y:5C."FE23^)<?P@[:$@_YR8PI7E?,L\P^YP
MU-T*;JA\#@KD3,.3_]/FXX_).SPG-DKU.&&%A.6ZL"W[W#;U</_@X ]S7+_Z
M@EUW,U7+[&L>NN+6C73X:C3=> A#&"*+E/HLJ^@F(JM_@V<+AP$S$U#@=KXH
M\A!Q0O\O1)VDBDE#NZ(-U@]\?8(N5*(_-\7,MRI"GU<TY&[!]PTC@AGT[Y5M
MBYZ]*7M-R?LAF^^.3BU<*:HR.@O1+-KF%UDSR3F\\\_\(_4FQJ 0:-\B.3$O
MT(C;34P#J51"4$;W*![(M&41S0V1GX(A<_D])8LV;@?/&C_N>DQ*OT6;1^L5
M0RZ/EN?X(#T]?;Y)L_FJLQ+;)BT?%!718)&2DQ[L?)HQL9P7;A9"KVN7 34$
M N-@KY87&HO0;^\=)B\PXH"5L6S!O718*FO*S/U7CZ[[*N_E^I;R6?FQ@6&4
MDBCMM04F<188$V&6<XS$(<Q*5@">Y>:<LN(_,0B+_RG6Z21ON-9(H7Y<GT28
MJ54"N@5L(3Q\Q#@1_I-[M&6<'H!GD)M,C\#('4M]N_#&]!1[/7=3 #Q_ \%8
MNQ3J_V.$>UDP"I=0C&@O+;FN"KZA"X#W_[B@]IE5V5^WBN.IS5XX)E1DGUH'
M2(#E<:C*PFK6B8?=\::_Y5MXH$* +L<&ZR.8Y]1W=Y,MM6GI(&H<0/WH5@']
M<N/AVZC1V]?IUSB\1/]@=,,__=DP2;AWO!9;N.GKNZ8WFP(^&AL30&U"O!62
M8PF9QW MO>!3RN\Q<8$HK_E._?Q.)GJC\_=8$R]YH]@+N"Z3H^<G^X>'$?ZC
MA_7@KNK7:"ER]R@<,$9,V  JSW:AY@+0.4A98//UDWS(+=+7^->4M ?C"M3P
M6SWK6R;V9T9*.6M/Z8E\BLX!^/BX.5;E%54C>,^;+$0)J1?HA3(]D!.F@6[Z
M/\@_=FB7&!IEH(YNB<S8[#R(WT*X4)HXY?'48SXZ( ?%C5ON@!T 6'!\YG/P
M-^"A11>-90-;2DDWQ1*N"=68&3GWA5<]@ $EXZ:]J.,&)FP'<F#/\=8>JW?!
MD-O:P^4/5$-)O2\]4M>"GM<"6= B=O,OD"Y!+_OMX/.[X?V@,4-/MQS=<3\%
MDUI^ZJAN9]MD]@7[N72?E\NZ,A?"C74T#TQHSZ<H2!1;FADY\Q,<RP1!,99-
M-A;9(QM ,*^4-[V5A)&OXR'^*K@=1X2?[G%B9'+WU&<?N[_)^R]<(>"(, O2
MJ='MY.&[]+5P( 9*"JXM*#!O\;.YY8)18ED"@Y*.[L0_HI'3">Y4'_PAY]=F
MO,X>7W.D_;PW>"6:B8]^X*>%Q(16/OT'XHP8L\5N.ZV%W;FKJH7M#)R,UH/F
MN)5#Z\3^!$N.P@)N-M"!=8[M Y$64O+7'9_DT8#Z:)>/M\YQ/K< %LK&]>=-
ML$GT1B0HC5 DCFC0_LQ!ZVALNA2"5[@OI9S-PK3I:+?U)4<AQU6]J#1GZ/$<
MT>;(CXEC%3D&D:J7Z;HPO?++_OO]1*G.M%P>]UV#F'2_!D65!07$%^RM]=5M
M%(Q<WD.:XV9MD<J*9"KM[I.KQSE2S= B#0F?HEDY)5L[3$2);K]^$#N$BD6H
M/-EJA,I76K5K;H8;+-$MN:R"=K!WE5Q-DP=U-VV?*6ZW=#M#D;UK]*Z3$NGU
MF2%$/6;V12;-M/Z$Y=>>L('@S359HZC0YGC_Y. QG[L\CP[>1B;MM?;B@X2'
M>,6 F@ M@0W21^GP>:=IW[$L!5V%8]TT>A4;0IW:\:@H9J,@7_((;4@$#""B
MK9YP[>%J??B9E%]&\D@1_+S\X^SOKRY!OZ(G5.2@42@RY#[ES%<TW  K%>Y?
M3[^ ]B<8S6R6:WY?8"Y(\X0<+NOC5K[$Y[K*$%_1*3172W8&W'*(H4,(,'K\
M2$G)G#(VG$L!6=B>Y/!(B&N&MC6?_)^_Y,?3TZ/ITV?/3I^-#DZ>'H^>/SO.
MC@Y/CX^>'T\.3MS!_ST\>/Z76W.\G-S#/3+,Z'*^='/!Y>PG_X/GB43_DG?D
M?["82O[[)3<48%HO@MG\G-4?8?'?Y<W'+2QQE='7./H::5X;[O5 2(F&^(R)
MH9>N HS%YZ"[QBQK 9"D_H9G$9V@KG">UA_NK?#E.;^2+%+!'&1<V(K<6V8\
M(*^TTH3*#.RG"&IH"^Z#:3M>YJ7OBRG5S*NX0683F+H1ZREO11[VBMGYX;(@
M18]A=3-@A&+6;<!;::(#="\,T'TNQ_Z#XC3Z45;NA:[<*UTY%.SMD^LSHG<7
M4K<..3L);QUZ=QB^?<\7Q/3QHFR1JTCY9&'CBY4-8$0R*/)OY?YZD62I%\XD
MRNJY$HO0")U>5N#*9LM@^!75& &[^JB KB"F.9+)K";J0D.2GPJP/.X<I:]$
MDY5B?YW7491G@D5QM0PRT/9C>?IUPY0!YEK[2YQD;1TM=,VS65(_*$VZAU,N
M3_JES)=D_614A2H ?1,A]H/RK'X1+Q_NYXNLS"99PMURB-\OHHN<\M6JO0UD
M4+HO&PA)5FMW&]SK](^4#81:@"4 #RADZSH*C7NND($V1Z,-IU75HJZOG/;A
MPA>-\8X74)ATWLJ0]B$;KT)S!=M/P8<1+35G^$)/^>+2EDZYO5"1TLU!+E%0
MV3::.P,KLM$ONL:R*()X9D5+EHSF591-#,,#O ?R%^5H7FFAC<P?M[,CG48R
M3?DF)?+;<BPAS>[YHJAX),SPUQ4]'I85^[!,N!4,&> ;$?^EW'R"@/A=(<!5
M(88/4P)$>%."K!$\IO<;WT#A(("C]0RQ2T.]A11=VF1S"@;E%8S\0R6%=]H/
M R4FKGE&R>J^\L)-9G'OFJQ /V)VH6E[N%:;2D<Q;9GV  'I;1VK9'NXP/J_
M"@%D*WJH?1MB@,%N2HM%75%Q#4+_L9D3:S6V8PJN)>J>P-P,7T[8^?1&HX&B
M2O0'RGP='OS5$CWR*J+J(M,)U1G8Z^PH<\N?2]UIW^Y*;:ARG1E5K5$]WX*E
MX6MM"*KU'K1W3K2:J^TS,H2![S9,@^OK #X0M[W6CA%3+25;HSN1WH!VMB-9
M87T^(B@P$6)7)2@FL:'1_6Q$81%DV=-0L[Z'AS_(($Z7T3#_J@60<&&!WFGK
ME<UT98/TF?M$D;NF37;$T:A[B_JXZ[%[KR(QL0B]S]53H;Q:N0HJQ?M*L85!
MFC?+L?-?T?HZ[4A,T)B:5B"=W9O:/*;K,[UT8URI@<^0-$]9LU&!4W<(U?YF
M$<1*( 6,3$<8 (N?1$=+B;8WU+S^9J%:/K9#.JJ8;%U=-G0GB?H&;O!O0+7^
MB#O]3]WIT+7P/#BP6ZEDK=0/2KR-&G3K'LS!L\Y^VTC_-8[KK/?V\4$M)UZ3
M(><?GXG63C:IL$LRDR>-O7D$#X,1SW)S'MLU/$4;AM8.CZX)K=V]3&X82#O9
MUR0YZ[^WR&,]P;C9-W#07J$Z]677(2;X!TSY@9PZCL5ID]0T\.V$PAJ9/>K<
M%Q=8]/'JDT*!WV!LF@KY)^;SH)#D\S1QO)!21L<T9/  )GKD9T_"ZH[MZB[\
MZMY@57&1MC1^O?EIJ39PS:Y)A_XI(1I/MQ.B$0[75UHXD[U%^MDF.3S.]@Y/
M'SG.S1Z>3N2_0IFRC[Z>C>'PS5U6-K&\"N KG $&D7%FT88_,-''80/PM.BZ
MQ,]LM;#@,>D[U-%76R9C'RW_2+F\N#Y! BS@@"#I&[?S;4=S[",V/ =F1>!8
M2<K#!E]^DBKAW;\DWJ3E#ZFVM*602CX/UEY$6$U)SE<O G*,EA<?1#1V^U8U
MKU,>TNV1WX@)G9#X3-?^Z"&M*T;QYBU'SK2;>UM2LM<W)!EWJ".M:@^4^?B>
MP#/AO#J7^ECY>S"5*E;CF/5L."(#WQ(^N RK FGK*$8\EO(^SC&;SLP3H^#W
MD]"7F\1E5H)D:#2O7*U5V=),' $5X'Z HX3EGKI%=%PHA()R-<Y*STI7E<6*
MPDI5R?'0!D:A5=?9&"ZM2W$V<FRI_1M?3N)JAY&6#J59LE/(JHA2!4OY6SN9
MB:^C%YWZ+MC;:$]Z[TF\"E;G(B?( %P-#57/K9GN?O*#=O%F](LU1K[TRDQO
MO-#77.;X*NF;BON5VMHACB]N.#0*?7A30$L(![>IP*9*WX+G]B+XVN<<&2T\
MQO0-N,=FN=^1I@!!VCZC\@.E8&A_RRA,82+"A<?685C *)M:Y\WJP/>XN773
M'5,2,! '2+4%NQ<XA,)\=-PEJO>#]'9C_R::0?T4(X/H3NI:[NH(;9^0ZK%K
M5@UVG!V\6U#5,= LOERZ)I=>-)E17ZFG04:: 3'^4U9E0K$@VLTC8,W58U.^
M?I#TWKE;[B<_<A\Y3OGR2-0RC'XP;ZG6=,J%E10DI']DPM0F)T#Z46&5Y[)&
M@B5!/.$O?.?8 (=M^+G,CM[ Q)FO5H(GOE\ -?:#2\Q1PPR=4E[BB\ME!#P3
MZH;QP)[$UYX?@;W?=76[:VH?26 /#=%B8=&85WE:9^V$:G,)JA=BATA,30'#
MC2<0#!>9 %CT\-I XB.985?7"(*N^=T45"(MQ^T)N9;#OWWGFEK7]-EZU_0V
MD;73OVR70_O]_6_ \)7P]NS=![YES\_WDS<?_O'J77+^^L<W[WX^^W#^YO7G
MQSJ?W1I&>!\WQTW!S\/]Y"=P= H. 5+M^Q;>A.=E\MXMEMJ*Y^@@I=I(04*.
MBPS1'=(5$^FP\() W>HH\'V95X4:":P@IVZ"B1Z;2"NR*^XZR.3Q&2%"EA8E
MG3PB!JL2)BA-4<OJ:@^];/?9<<>$(?5@(6:@?A][L!%"GE[FW(0.W@]WJ4=,
MO*[H8BW#YVCD(,E^59=YECQZ!W=#EKS'-?C-U5@$EB:(4RGVDTNXEZF;Z&P.
M3_75=_*Y4I+3Z\!]1!I38F@L7#9)>%7SZ90I01Q5N+1EXZ@^T/>-D-WAGNK*
MYQXV):QP9?I<86\E;L'V04($]&WVYOD9*6R6^XC1AQ!WF63SC&BR2KB0+K)B
MRA8&)40(S,Z2@8XLU2/RY>I!-%<7%4B-^/X]]J616U[A+>L'^31E6FE\AN\+
M=6K^2 +GFIY4&?D;J;ML[MSP4_@$KV/ZYCP#LT$:)*@ BH-!CJS'S)C/173!
M[^"VPDBUU> 3?>2%-\&SIYU*KQ9BM ^\H"?:=FSIQ8&:);J)$5:)X R\C"+T
MV#R,PR^X?_O)F?9)ND$FPCD_/+%"L=D<U[X#N[*,EQ5)Z//.K(,8GEBNY TG
M3JTG> B2/%@_45R81>U^:R?YF!NOD%>8')[JB\,ITXF^]LPD9XN%"W4[I"-X
MC/ZST,+X=8[4%2_R>MSFRTX"GS1FCLQA(G4*EO0#+3(X *#6\J5R4:(JX$8*
MO! )]8H3G7N9SZJZ:AO;H'*K+A=F@ %=B=9X6\=]OE(M>^:^MQ@"QBU@CBBL
MCN 5+.B:781K%NWG1;5TU+>A_[$-=[)7U\CSJ'4X;$6UTK#H0$\'B@Y0[!T<
MF#/%NW%\RN.U$$TZR[R8RK8+%'.$@#P8"[4Y)=$4@",5=U@VTPC[P5Q#A)5K
MEXROY'*W\'TJ[C#3Z@ ?#/Y,X?G2]D=P:&'E!7!&05J:51K1!0N/"JU%P,'N
M)^\HMEM(!$#H4[C/JUD2=- $O^('$@!Q+:*1O5M%4M]P +IQRV7! 5=R(+'N
M2BN2F$ H1(ZE+Z]M6R/(V,]/NQ\=WKZBY2$DX@_/]KDXY4=>@<\+0-VOYKAE
M(>NO3F,PY&\G=;;()TATBA%&.M?E95Y7)?>+Y#P-J9 &B>8<*E&P</0<YEJ5
M HLF&.S <4A_E/YV]@?HK/>.&5Y'-QRU=>=J&/Z9_&_5(HX/#[:&6/"@-6[M
MP,:@0Z<MEP%$S7,LRQ']U>:N<@WE4]VC4D9P[BJ4IM(-!A>2L/)3,@5M0+K>
MX5G)X<'>__ *\O FKAG7^8@Z@6!Z2/M7T2!*:GM)"0 \K8XA^+[O8RY<MAWN
M"'XPAW5XC0D(SU/BM%>.FH#,-^R1YE5\R+ND6LZ0H T!UN X8HN23EA--<ZK
M186J#*LPI"=BK[XDVB\?C\LF_#@,!M.(J6V7U]T?P:DALZJE"\S#]WN7 ;%3
MS[V(4466A15%$>H@?SY>/:SI:9I<TZK<T(WR;(P9I$>+.HV$C8)3:>>)@X)+
M(CT@ZGCO%Q.J9=2@I<=7*?4=/M[8]OR+"0,06<&OX%#@0E"K4*$1TK;W*P[/
M*P3L"]3_R4VHJ],'%(]Y'_A7OUSW?\5K[!T)VKM0%X+;^8,7MO-R IY3+>3M
M[QEJMRF0'/M2+/!<EK.]PDV7?SM^TKGD]KZB?4PHI"???SWH<[PVAR?[I[@6
MY!2^^>?YRSUPO[&XSJ&VQ"(RS#50C3GI*TVG1=KA,RH9=IOT&9OTIHV3CZR1
M&5_#57]898,PV<QWC+_$MI.3SBZ2[R6W.ZB"/?DG:UV7T=^X$35#(E::IB#C
MI%EJ2T0J&QLO=UM_YUNOA7R^'%)*Z^  DL$V=LJ3Q1$&W#-;9$6_LZT/]0$:
MXL!JJ<8YIC-8AV3>[><?J6^+?.J29LQ5EPQUEQH2^#'U<Y@O'$97!:IE+&3R
MA)*E&U^4,(D9&:Z,N]CMVAWNVKG66#>.(HV"<)JTL"L33/17"^XM-IT2ZD]J
M$J3VAKO/S)%YCNSX2Z[6E0<T"HV,^  19X=W+&>L*0T36^:B_H?JF952I.LK
M;%X4LQ.2S[VEV6D#YW0L/BY7=*-P4!]YJG4=F0Z\"\UM<2,[I&?,)$*6(\:
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MO3EF)/V()CU/S.3I@\^[V^M[V.M!GER_-R$HL]N,NZQ19B ';8@&759C:F0
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M9!]+6,GTN^KH(0QVL1CXCV/8=D7Y$I0XU/^3G%K,P<F87]=;'MLYAK8Z<_Q
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MIQ.L:E*U/1Y!B@56!*#@6K%EG8]:7X+F*]GQ($HLKZ"&,C7IDR$.*E*M:_B
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MJ_W\$C7@5N$)2U:+9=IA?/_QX"[NH!>)>]R;N'[7O0O)U=E5"Q?[:G Q#GL
MWT[==#A$O7#'MKL$43@]/V-M?6+@Y9QL-QL8QG(Q/W#/38Y2?_D5:[S>X'V.
M<VL*&]LF>+0;([CMCT6__>S]4Q=$LQT>,BP!HM>Y*B:4]QG^;5G-#M:;=L*2
M.^%G]@ES+1/.)#Q,_.!N>S(\HKWL3?L3?05="6:R]05W'(;1@.,L+8X^;.P;
M^3MZC)'Q-D9^O3866I&D+A33:RFQ[JJM,+N&O,EO\B1!HIL+<5./U=8S>3EK
MHETP_5>DY91&K+=FB+8GB(R!I-?[R?ZNR<U,8AL>CD>+9"D9RH1&K">F*F)Q
MJ+D8MU5*CP*$PE)D\*?71!"^*$DX,#P$%5DQ)_J7$ .'55,)I<F<=6I\RD2%
MN^1A=C^9>&9G@+6!:=L)QO%\4W&6ERV\ U!R\O\_P=UBU .&*5O24@U_7K4E
M.D:6N8L1C;;[1NNKTWB'/)=5)89KK0?\2T)%#EPT^+KBEA>TC?H&5&6S@\NX
M0("U+3Z/$D2(R1@QQX5\E;E*S0:/%Y4S+1!G/LS.!^3<Z$QY@S7PQR5P?V$3
ME\R3!NSQ+28*B$/A32PZM8G624L#X,0?/'0[3.&,N 4OFBN\'=40.AXQ'D0X
MM!:W,II9 TNY,XWT-'%E<4,*H+7/,UEVS@PD=G1+-_EOL%+\N+/P$L(3Y1%@
MFAA-:.,%"@\9*WJWT66GD8/D,%U/L>TSZP2S<2DR56J.RYUF&@D8-+D3A>#W
MU66I3"QZV*3]V^.*AM*N2[W*W:)PHZ*!"J^%,+?!$$UO$1GH \#["&F5%"27
MM5-XK1M#NCEY'.V:]A3K7=;4=S<INNHWU!;"T.Y2<8'6GO-4O*ZIT#/+](AO
MS\95 ;[^^);-2_;"79 8:WJS['N*1:X1!YW4TN0 E(7M_:%E\;$<U1J1Z7<G
M_XCVI?_A4%R<ZWIQ>]Z97_Z+SDW_TY3@,N/<[Q*AN %WZB"]( 8D)\U2ZN-?
M-%-I\Z#R7AC4=&I52]&M@7E;;%2@<$-%5"&[87(C< >E.>G15<-V<LM:=0Y<
M&'DN)/ SMJ#>(:2 :^AWDO3X5EI,2=^8PT.\]/AC)<>[FEMF]8.PIW<AZ92F
MQ8TUZ?$(8)S3B]-P\+(&76GI0HW+JM&D#F>0)FU3S$:?+"$.O&DZ,!Y*/Y%V
MBB=R$U@.:5@S#_L#P\CM*^3@PGD=SG#5:9\^T]E",<G.)"/IT]8N>IXN"2V<
ML&J4$):6 OU%XYH@MMBFNQFD:8CRI)>I!8.%(4;R,6-%.NPA)NB,+HLIIXG(
M0HZUA-(C'4,A)U1O4U')VI!B[+0^M2(SG.@)L9DJ>[Y(VC3N6+2J<J311+$V
MVR6$;S:C"5W39Y^A1T>[=(2^V<0%&"/9UVI?SNK@/ZTW:PXX?F"/_<'KLQ\>
MCC'%;>HJV"MEY:AGTI5'U<":]U>D$JZ4_7O<S]M^6/WYI]/1L?@>81S"E@Q^
MY$7)R_]=L:IFV<ET6BX<#9AGC7[P[N3YKP\]Q0!%A,$ )_KV^3")S7MLZ/4F
MDC7D@0]\7QC0Q<HU>LH'8\5XG A_WX!)BC++Q"1%%A:Q#KA/.-H?6S1A-(0K
MOVUPH+&1Q\"$M]:7%L;VWF4LI(K<)Z@\_%HM&3KP'T?'A\?!%"\6+@Y"71;4
MB UT^3;,Z&CD^?(@*V3&,-CE=!,#!B.PHX(%TZG8 _6N@8%Y7Z[6)3@7XNC@
MBFCT'+M*,CJ\$8HP?S.6TN:J;7\H'FB&D\!&N?WZ5#Y_Z/0]5R80#Y'.J:*Z
M1.EQ!3(C)]XYND ,-Q9BG7 J+C;5C):J)UY_ZYC'UQ*@FAR5?[A<N(W&Y^$J
M8?\@WIUTBH^/#Q_I%.>RF'B*;7!,X'BS&EDCC[^*%SC,WD4F3'VBN"3]4Y,7
M-O&,7A*!*2])N"+QA]6I,/J@]2E%](H6#5.0N!2\FS/1<L;AB#LRJ^)B,3:Q
M2,"2.0GG)M;@XZ-<<4G40FW/Z&H;\A[B,:%QBP<^O/V>&20I#C_>Z>+P%Q2T
M(0B#Q0U+X-^E9(#1CCRKP.X&GDQBM-K43BW2M7=*XDA+?!$\W]31V49B3U+Q
MUZS[ZE7MFIAX6D2,1'#]9M5,(Z,E%ZC*\T89N!L)#>1GR6,>9B_YO& C]UUQ
M?7'PO G?(E 'O'211PZ[D:S+5CB_&B.M0X7?A*<XX/OVI423_FW.7[K0@_%/
M\? ,HU&+.T]HX1H&KN[F+#\:K%?+R43\8U54LX-@1U5I!-@;\LT80@<SHG^0
M]!YI684[7A2+N9K_-/XLP);, 6T(EH2&5\XC8EJDGXB X8XE)#X,3@T5XG5-
M\)=5A^C&B(<527<R#3/(5C$<3#[I0,58BU=8UXH2&@57<=!VL+!,[BSGA0^6
M%PS_X?M#OR)\8-[2TZ>!>9\80-'K46ID3H+!S*!AH$\7U28P^\%!*DW;G1^*
M%66SUTR'5U>4CJ/QZ.6X&0*O%3UD>9J%L'@C(LVSPM+T85E5I2D?#<;@,&-<
MHQ"1H"(8XEDIF[BQ\L%(B*US%>KJCZD!O8A9+?$0W</D_;T9 WL8&J4M!;JW
M\FPE#4O(,@@!,1-QZ*W7[.HK<:0Q%<!(U$PLR8 '9N00'U?],QE<Y"$^[:6"
M(UN /&[["Q'63BN"CI*U1\,BE!;-M"J$-&1>L?2G^2(5^C(P)FJ1)R7B_ 4P
M^)2<H'B@=V4I$+B'X^TW9=^+W+Q%Q;I<? =6WZO9S/-QTLM^C;PH%8C:I6B
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M=%-ZBJB*%CZ,THOEK^62SG;:VCJT0TI=;7BG5ZU+(?P%'QK:^-12>+HEN&S
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MZ*0*YFE]@35]'5XA>M2RNJUH@84'LI;#['6S)GN">H*:RW).I)0^9]4?&9]
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M#D+OQ.K6(BU(%+!EBX I(AFC/&^GK [Q#967O.I2!UD#,O8PN?(6MHEJYE2
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MJ]8;@WUR-8>[T)4KBZN=#?4RI> &QM/RTTNO>P]R$Q&IC% "L87TT$>@!26
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MO<,);XS[*EM<R^31 9,6E15PG_R>\XX>@,5'N[;>2"TOB@9:>B7A! *2,3R
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M<X," [GV5"$G/)$"1/ 3VV/GFXH!B@(@%X^ D<-[:8Y[WG]UW5!SP%(KZG2
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M>P0V=ATMR"Q9I-JQ7[DP59IUXZ>U^.J5X-CIY5:J#)5@'WF='\C[.VK?^UE
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MH^.5[+>A6FRAGD8DX':ZZ^)CKKZJTX2/7=*0[V?A[A3/T)=?_A]02P,$%
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M9:60& 3K"*#-R+)*9'ZI/L2X"=HV_% /C1]-Y=&,)F18D9NP',<)OIY-/W[
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M&S@W69%24*+/NK@&U9#"L^THTDP.S9CQBMRX*7WD6[7,72DYAN# 9T8(M.5
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MRV644RF^N R.-E907C'P3!=('(6M'J36O3*XKL(T).=F-U9<MFZ;R*'A_K-
M>DPM"'V!GW$R6YTTG QUQ- )&;V 7 ]@%8T2(JI01RJY1TYZKH^U>RVL(3D_
M;=G13AH-6U=,)C6"B%,:Z(2 /<V'X^EXL:S#_HQK;%@,)R,\@0R1R(LV0_ Q
M@RB%:<PA>^QCI&R';TAN4EO*=)!/PS."M9']DF;A."WGB,!^W\>?89G-\;0#
M#RY^_4K 22#C:9A_>T7SN#KHJ+FNL]4X7TV7.,?%<A2L*40)<OO(E@-5N_P&
MHPSP:'E$'K1P?4(Q'0?5[)SV.\:129&%F#DH6T/#.C"((2$$QY5+-0\X]^DV
ML@',D+;UH7#SRH/>.\JPY0'?:C1K#:*X4[P6]@I1NRI&\HP=XPIJ-5OTIB@O
M^J2Z7@!RR]T?_BU9M(OP&C:[B\M55Z95=M\?TSF&R?A?F'\CQWK%ZZ)$"2D@
M)&6)UUP@>,4]9!$)(2_,(.]"J9N0#<E<&"K%FDJW;5(*C79V7HVNUP%GGF7+
M$S#A29U*5ZWG9  MQUHG$53L<X)W/:XA16&'RK>&DFU3ZE2GZ,WTY6S^)<SS
M^S#!-V45@QQA)(H3NT%S45L,&@^^)'+6G,](XRS&7X@:75'G=-4;;AEV_??:
M MO)IIE2^AV79ZPY*;3/2I$VU%F#JKWLG$0+V08E?0C<A#[5^.=@#-FW\T5A
MKJV9HY:6Q$X[1TR%0<J"9Q:-BZJ/EMZ;;W>_OL_=^7C9SAP&"QJ'+ CHR;[R
M#*=8QK455A9>J5B/DA@H%W4U9@)8YU.H%RT%V\O[V0AH4%Y0:S[M-OWMT][/
M#,YJ'\F2I2TH:R2CMC8"8J&2TA66"^?8*[WYIG#*76+_JS+B]<J]6$U^FCU:
M,Q7IOUP/R840J&GKA61R+4G)":+*@;ZUT0KO5< ^X:0[@!V2RMV52Y=/"OK*
MKOTB.HUV.X$JDH8 %FSM?.)D;2I*J#!'1(:TN#LOH<V'JO>L1%LS9+>)O[]\
MA7-I.BLUUR-MX?);NF<OW#"P1DD,&[*<3C.<;(K:)B?(CG*%%( W$+/1(!$-
M)R5@I.[5>?Q*4&U]*V8M.?M$;#(<:^/WDL$Y88'5GMX!9:(5M6_?ZGXWGE9\
MN*A>[C[O;6-]&\9';C_-[/2XBC9]^S /TP7MCW7^IWGUW8DT\O_0=GE26;F:
MD;>S^>H7R^5\'(^6M5_7A]G;<-R]C7/%4B[DCM2&+5S6AETYDPHMB51GLESW
MJ7?>ZS"'E%O1B[K#Y<T][KIA<?!R,OO2:;<]?7K_77;S0!KMKK4-.KW@[7SV
M>4Q/>_;MCT6]0.C4UGI*=/E\W*'&"_)5T6LRKXRIA5T)/%ESD#36BFV=H^S3
M[V-[C-T/^*2FQ<@%@R C;0O*$_<9,D">D5DGC9=]MN,6!WQ\C^&3'J2Z]8'=
M;:35,N VKR7M+_#X[U?3=:NSJJ%IJ:]F<)2M2MJ["#'(6KC*/7VUZ@?CZG5<
MS"7?YZAX.WQ#VC;W1*<.@FMK&6X8\'IS.-TP1BDQRQ19JH[S6E>H+'CC%'G8
MV;C$(CKLD_R\-<0AY2+LB5I]Q-=195V^+V6D<S%)%0M""U,[/I,!:,-*K89D
MG2?KM8^[L VZ6^8;_!#;7W.I=<XBD"JBPLR!"^-KMK>K4")8AL:9:!.BNLDP
M;YE%\) YT&ZFV^75'Y![^"PL+FR7DOO((KF'5D@&BI4$ <EY1,Q>E)QC3)TZ
M*&S$,Z2&&7O2$PT$TZ[J^+ &%OZU0O"FO!Q/PS312&L142T?>C%>'&NPD4A!
M<444EB'2@),M$$A[ 5/:R<*E$IUZ<&V+<$A]F?=$I"["ZVC$G+>ZSC;;%3HD
M+WR 6B$-JB@/+F=+"P!1J"RCZ!3*N 7((=U@?&\631L1=N38M5WK1]S98FI*
MGHF,=*QA"CPCZZOP0MHUA!!S'RUV2Z!#NC[YWKC63I2=\BR3\<5G&2 ENVJ+
M%R$ZRT$X)V1V2KG8)V7K]F>!^[I->4]DN;L<.JJ>]<V6=7 EB<0R.A ),T%2
M":+6#AP25&F3]:)/"LJUL+:BRH\6E6XGJ(9U2Y_FF,;'4W_&B*O%M8E0UJ]K
M+]Z0,;KH$C"=4JW-TQ +S^ -UTQ[KY+O<P_CE@"WXM,/%I7N(;M.[MS%AIVC
MS$1M_5@@*R')1I,K/T! XN0&8 X81)\SCNMQ;46C'RP"W5!2>P@[GUPM-RHL
M&2MRAA@E!U43!T.A/;?DI# 3HXO;=\SY!-I6'-I7A=N]!YSO(J_V-ZF_?O7R
M36TX,O^,;W$^GN7G!V'^$4?&2]ITA8=H6;V9R@H(9*9!<:0<'5EN.O1BT?7(
MMB+1#Q*Q[B*MCJKHY'[P]1'PQGO"1RP[2ZZ@ "&K4\@3AYB$!ILD[;E<,AO[
MY)_>#>]6?#,_O#W>7+3M^O/2?-3_:[N_SV&"J[.\Q7(^3DO,]1<$\OP/SGSR
M>!5='NY)X<2O7],!;?KX+BSQUU(PU?M[.9F,0@'&($#)FM.')4%B"D5VV<9.
MR<7['6>#*,RV1$7RY9B/#&K!&+$FFGJW4ZR7F]BB>3"Z].DO=M<<N7O.Y1XN
MWS>$@'J0H&6H<!.^NMTN+N +1@1TA7Q#64O&F:C=N2*IU.1%"=(HUZD_XO88
MAY1^]O!)NBL)>I/T]"CQ##YME0BE7B:O9 VRQ@Q!,H3D8K9!")5MGUC4]AB'
ME,CV\$FZ*PG:W2F_&N*;<G;8;Z8[3? H,Y.\J\E\7-8T+(<0:UJ?4BIA3(')
MTL<%[3"8(?7V>4"TOV]:W8<25S9+%76"(&J#5YL(J7"B?FNUL[K(V.?2@+LJ
M\=O/QCOR);^M2G7>E->SZ<</.#^LA0DC74N3$P:P6&I!EZ1A!\LA!UZL5L[K
M3E>K7(7H(92([$JBRUT%&DBGW4VD)UC>X:KM_H?9A_"U9AO4)O\TYI>S^16Y
M>MR*8 -3X!RC?="%FN>B.902I2M<(6(?+MT5\: :$>R):WN1;L,^Z6=6QGB*
M]-?S.>8Q;7(EEIS)RA).$YR(#)SG!$<7GD4B+Z'3C4!70KJEH?U#L*F-?%I>
MHIP0\[HKUF><+^OQX4J7%B&XC#Z1/%T&Y;, 'XHA_EKZ>6*FY#YAQ&M #<E(
MW9?^:22B^PA)F9QT0.>!!:Q7%9$-ZRT3D'-&P:PCNWNOM<4WAJ1N611S5C:;
M[T3X;1YJ^5=@7LEZ^(6E7IE!NX S0I*_P9,0%HWTV]7(;/G"(06#.]'E7,E,
M#SDT-P\_S)XF<O+F>.7%Z:,<<O32TAX@Z]4JV9&>T)S^R,B]Y*5PUTGE;HWQ
M(9B K;C568+=NFC\_NK_KK.>7]3KP29WZI:QX2F[=L6X"=B.W2]6NF!]_KM:
M\2?MYT:>I:1)T!#K9:PJ*0:Q1 5%<IF\QQB-WDH!;WKZ3EO(N0<>9R,_/[DO
MO:9%*&.)1J(ZL[9F;YE 9B$Z:4.)W!E_>]#GWC&$C:*-U,[M!XTFM4WE[ 8P
MM9/L"1ZM0U&)U5)PDZJ7R"!H)!/.^R XLSP(>5<A?W_-$ [>]B/G.TYM&U%O
MMCV>SN<U,ER_7&N_#[.W."^S^>'+V7R5GK)8;REG=Y.: (Q,6\F,@<@J:664
M$+Q;=91UF+/@BFUG.K;'=E]355LJ+>='JXY7->UG]G&.B\5O\]45-%F2(RT0
M$KIZF0/7X!*3Y$7SVC92^F!-[^FZ!M]@].T],_7<*AX %>Y]^1^GIY$]F:H!
M>W+?XO$X@DI!&I\!K:=Y-<&!XU*NODV)W!=VL95Q>TI?#6\P.\L/PNA&1+A_
M0I^]A_A[K<MIDU^,V?EH,C"9?37&/#CE):04>>3%,&3=%?4-& <1G_ZAN-V0
M$]V<YWKG[9?QA#S[?+&>9HK+]^D \]$$9[51 DEL,OZ,ESZW@]/=\.V[.NN]
M)J)1B\OCU[[>]-K*;^ES]CD@9&$M\1L=Q)PB.%\,>7W:&]>G0<WUN'8-)E[S
M].--@F7)- L21+#D]*A 7I7/"#Q&QGF2B+)/R?!-R(9@^G;@SL5885,!-8M!
M7X/JC%(^6TTXTEQHZ:*%$FEO4)HS,I^]!T]V!ZFKVBR[SYWRM\<ZJ)CT_7"K
MA13O:4M]>;0\FN-9U"<&0;=M],8W]MTZ;S?@_6R713B=0Y:0Z_W>JN;E>B44
M&*YC1L^*Y7U2D>YMN]PP_^_P,(QIKN>U#=:")/__R-(EA9T1$]>@0JJ]'3BM
MV)HBJIDKC$>A0]Z_(MP2_ /:=&_#P-LHQAYBWLN^?!GX[Z0+/GS!R6?\._E8
M!V1+2"6]R0&8EN3$V>P@%)1 -D8M9J09Y4.@YD7<0X@9#8Z5.PGWG@A9%\Z'
M+[,1TYQ[80*(J BJXPIJ&UJPM)Z*4R:RT*?T[$YPAU3@,QCZW464]\DZHA&.
M4 :R7Z6$J.MUB\4G<%*RVK<KZRQ**J9/?MD= 0\I?7%8S+NU..^1>R]G1_-1
MYK;4BW' \V1H?ERND50!GHR&%)SQO6I@[H9W2$VT!\6\6PNSS<G*U4 KMG3!
MC7]:EC@_12MM4CHF#B$RA%I' ,$X"Z[V=M9<H9/;I03L &)(#;<[\&FO,NH6
M=WD6)F&:\/T!XCK?[GV=T_FWX_NGPO1BZ>$.(9>[OVS7:$NC8;:ZV'*GTD^#
MA5OT]1+5>K=1*AQBX!8R5Q:#\1YUGVVE8>WPW>;LZ24I/5T^#_/YM_'TXS_"
MY A',>H03:[W:M<+NV.)0/-!YH'$'%,*Z#JU7=X*WI!"+?OCX,4-N+TD&Y;&
M79B!FT#6JQMUC/52XT33(!6X+#((YY$SGCE>S+QK5C!W*Z!#BJ;<'_%Z2G>?
M&_29KL)M-^,-#^ZP\=X$O]$F>]INL!IXS$F1,A)/0N9D:[%$BH0'",D[AR49
MCWVJ9LZB:-;N\EWX\O= IN0X3!:K>UM/NBDN1B(['KW7P).N=R-P ]X: \P+
M<IPMYZE3-=W-V(:T^=V9&U?VM&PCDO:=4?\YF_^YRGI-N+@ S(L8E2FU11FO
M=T75<B>1L-X7EHS!;"SKTV=I"W!#VK#:DZ614-JSI;JSBP/,]7#Z C"CD\TN
M,="F-N+,2H.SPM>;$"*W7FMK^\3OMP WI&A]>[8T$LH^+91U1FDXDU':UE2Y
M[@T=;):M!]3(>+FR>K2R2B@3BW!D Q<,)'4T9)=B!B>XY)I)JVT?K^,Z5 W:
M3&Q^]G%*G--6&"L1;-&"C'],X(I,H+&(>BF+5[9/&[7K<0W)J&G&F0WM)5J)
MIMW]$YOSQ.GK":XOR3@3>;VZ&CMYGG+F$J1CCB8F1S+/L@-.?T3M0RS8QV)N
M-8)!939VX^"]R+M==^]K:M#($A!:N]5A TV-5!F\1@6,P(A0;YR*?;+0=ZQ!
MW)=!U8U2K82R3\.J7OQS=+Z)6*CALM7">(93+./6)S2W>F4'T^ON0VYDB_U*
M$S?[AGCRRC-74:X;!FAEC4)OP H703'#('!#O,F,%15DO8FIRQ*^$5J#;;9.
M_K/9]&CQ?;Q62Q5T\>2D8DW"2!:B8P@R*1O(2PT^=KK=:1.<(=E@;;FR81/<
M41K-=K0:PE@55W]?E:<W9JZ!>>,3,P2'LUI8X.K='8KL1.6+T=J4$'/H0I,M
MP TIP-27-*TEU=*$KVS^1T@K4&LL,2N=Z_U12C%R)[P0X'-.@+3GBL""0=DG
M++D9SY!,H;UHEUWDT9H;;\,WFJ#)A_#U^Q"#29QY*X#SVJ M6P[1U N"K(O!
M*H5:]XE^7(UI2#F;>^'(KG+I9C+7EI??RX[K=SL8PU<_;%<S=TN8C0S8<^VO
M:82)1&(A2$5KFDD#G@E'3G# C+3$A>F3/71U0_+;CZ@^X]7*>ZN.X!_3<.SZ
M8WXQ7JSN)7P[Q\/QT6%U$7E)T0N/4 HG_66)^-'E @)#("\/HW9]C-5;@!Q4
M@_8[T^7R!;9]I-3P=N3CWF#'_7CQ^6QQ4H KI.!,&# F*U"8/0128N"$=3)A
MT;KT"<E< 6A0(;Z&]-A]]AM2X2Q7UWE 3P\K34?<*9EITR0V%E[K\3EX;C6(
MR++PSFB#?4R.ZU -R3#MI#)V$$,G8FQ08J/ ,_.)S.*JJ$!)48#LG4Q6<M$Q
M^,R0];D*]$9HM[1+'XS>:"F1_6@0H:5W-&1PB*XZV&1S%ZG NA*SIR\M[Y,]
ML:L&V5?!SWXTR&W$T,U'>5WOFEJ\/_I$+DC%&"8G4>_%F:CW7?R5[1Z\J^]R
M!_B-_)C3&S=7$-Y55KXI?RR.ZVU&/&E&XD5PVI#_J8V&H),D)S0DDGOV-O5)
M_;\6UDX58-<^^?B@RGI,+NCJ<//:P)87<+E>3L8]+R@8YLANXLV6[QI2G+T=
M%<Z5<S6>\#9U@->"NJJI3W&,U7YX4!OXT!14G4?F,W""2#NC-,64W7GQ$)HM
MW0=56DBEF6%R'NEI['\D,-OD<X;"8LW;R60O^=K\*4NBM@DRVCY>[A6 .HWS
M-(X=N4N%1*N])J/"QT+VH*]^A$<N5-'!]S'3K\<U7*UZ-Z9<M,<:2J7WBCC3
M%]Y'D] +"3:6:H%JA*"T "]="1R1Y;!7L@RK3?\]\.6.LNEFQ+\,X_FJ2FS5
MW+3>YA4FW]V.[\7%Q_?,K'[6M)2ZZ?MW=0GZ3<8@"JZ5SSQ:G2 FZ4%A5,0U
M58"%P%2L3F/HTT+K 11<IY"9\&3'U-(44";5*PE= ,ZEL.@<TNQTFYM_HX+K
MVW#P;@77MY'DW@JN1R)8H:J)K&)MA1N5 4\F,SE>.J:@K%:QUUW*UR,;TCY\
M?]1J*K\M-^N3G]<_(ID(?_O+_P=02P,$%     @ LW*I5(1DJ8LU:   !IX$
M !4   !F;&1M+3(P,C(P,S,Q7V1E9BYX;6SLO5MS6T>2+OH^O\+'\WJR7?=+
MQ_3LD&6[0Q&RI"/)W?L\(>J2)6$W":@!4+;FU^\L7$02!$@ :Q5 0I[PJ$F*
MPOHJ\UM5F96W__I??UQ>?/<9)]/A>/2W[_E?V/??X2B-\W#TX6_?__;^%W#?
M_Z___H__^*__!^!___CVY7<_C=/5)8YFWSV?8)AA_N[WX>SC=__,./W7=V4R
MOOSNG^/)OX:? \!_S__1\_&G+Y/AAX^S[P038OUO)W^5VECF%8+U2H**(4'T
MJ*$@)O2JL*#%__OAKYBR"DE8\$P64,9*\.@"J*),R3JZF/W\0R^&HW_]M?X1
MPQ2_H\6-IO-O__;]Q]GLTU]_^.'WWW__RQ]Q<O&7\>3##X(Q^</JM[]?_OH?
M=W[_=SG_;>Z]_V'^MU]_=3K<](OTL?R'__WKRW?I(UX&&(ZFLS!*UP^@Q^?9
MUW]X$XW^8?&7]*O3X5^G\W__<IS";*Z>!Y?PW=;?J-_!ZM>@_@BX ,G_\L<T
M?__?__'==PO)A4F:C"_P+9;OEE_^]O;%7:3#T>R'/+S\8?D[/X2+"T(\_X39
MET_XM^^GP\M/%[CZV<<)EJWH5TNNH'2%\Y_UTW[HC.DC 9FDJXA /\51)7B/
M&#=]>G?,7S\+,I9P=3'K$?'=S^X5[_@R#/L4\)V/[@'M_(/@$B\C3OJ$>NMS
M;^!<@5Q'6"ZNAGGXX?(O:7SYPQS:\_$HTW(QTQ?3\<4PU[WUW8S^K)OM=%Q>
M$]WFN\#T8>#E(E]"W6Z97+S@_[G/Q]_ 3T09CH;UQR_IV^4S*MX6*\$_9DC_
M-'__W3#_[?NAERX$I9200BOGLW<J8- Q\A1+47&PSX/JDE:+NABG6\^]J-OK
M^"L?+D+$B_E/!U=3^!#"I\'7#R4IX OZ<CJ(Q: ,*4 4="BIR#TXSS(X0A:+
M5.B%O,NFZ8J=)4SCG$_+1Q"O!/\!+V;3U4^J_C@POMRB_W,[EH7"#E_=6_R,
MHRN</HO3V22DV< 7FS,7'N;GLLK>@"\524ET5EOT,K$F:UM'<GMEUV1\-EFM
M<?EF'_CJ5WNE5TW/QCV*=J$_6L#WWXTG&2=_^Y[UI.I?:-WTTLPA_9/,M^=7
MT]GX$B<__Y$NKJKE]VPZ1?HOOP]_#*2/&(/S@%R1Y96B ^=*!!Y-3,DSAC&V
M9,,^8(]/F&X:WDR79NJYRRC>E5'/Q]/9]-DH__S'I[H77\M!1%W0(0<=#*?7
M1G%P5A3((DO%@Y?,VR:TV8;HR6\FO8BZ$05>E[^/Q[FB>X>3S\.$TW?CBSPP
MDB<NG0!K9 2ET=+"DP?#+:-WP4FTJ1D)-F,Z/@WZT=L&,O0@] 9T>(M3I _\
M2+!^HOWL8ORIO@++Q0]DDB)%YB Y2R] 9@K(J3;@F [*EY*CR(U.DWM@G0DI
M^A/]75Z(KKQXAQ?T5Q_^CB.RRB\(XK-\26*NRYX-/^,*I=4BN,P5J9"6KK)!
MB(%0<LW0T>I3JW-C-WQGPI0&RKA+&=F5,DL';O1AM?9!E"SF0OHK,=/>EFV"
M8)P&33XB8\IP5MIL'W>@G D1NHGXKLY5;SI_,4ID]+X<3Z<#B<FXHAF8P ,M
M,$9P@GG@(BE6M!.>MW%(-X!Y\F9D5P$W.!I>C&8XP>G7DRIG(4+0&4JQ$A1S
M!(=0 .=1&,(5A0U-]+T&Y,GKNHM@>]S/ZWWDH!+M]>B7\>3W,,GOP@6^+N]F
MX_2O@5?%ZL($**L8*$5?^605..632]DHG1^\W[SW"4]6C?W)K<%&_1/&V3M,
M5Q.2)4Y_&TTP7 S_!_/?24"+3<5RF:RSH*T@D,8P<#P6LB ,$MVRB]$U>8L?
M0O9D^=!$]'>IH3N?X;./.'DU'HUO'S6K70B+-/5.'U(A*T4ICN!Y$*"UL$D:
M%TI2;8[S>W$]>5KT*/:[I##=#_F5N;&ZWQR.K@CD=93F1RSC"2Y^[WWX Z<_
M_T$&+CU_. J3+W/YT.I2O1D=S]V7U?$VH..+":.19,5I*Y3H(920ZDVH8=P8
M4V(K@Z'9HIX\'1^+PN]RV?;#98*\?+=^)#^Z#&>#Z*(EF4C(1==D%LG ZYPA
M^R2D*#8ZWB8JN 70F7"HFZ#OZM]UU?\KG-WPGD3VV?!Z2Z)2#?G0GNJ-I--6
M)3+1'#HCV]QRWX+QY'5]N%#O:MAWU?#/83*B#6?Z!B?O/H8)_ABFPS3@P43!
MF074@?QDH0L$[>DP#85EU#P@:W/.;(3SY#7>7<@;XA>=@^3KJ'X:7ES-, ^2
M,IZYE" SYT AJY>AF6SLQ&Q03CK%VYBM6P"=G?H/$?0& G2.8/T3:[XJYF>?
MR5#Y@*^NJE3(ZZX8IZ^O9C69LX;A%W0M7EOM@X>4R*)6A3&(S-#)Y!2SV48N
MLV]"B[U@/GFRM%/*!@IUOM'<@G;)\#N@!Y8<=:X"G7;"<[)GK89H @(:7DPV
M.D1?CDFB;4#/E4:]*&8#D3J'P+XN_WV(%S@07I2HE"?/G2E0E@5PV5HHGO.L
MK*F2:9MV.,?1(PUN9(XW5WX'86Y*E/AND0?\UW0QGF+^V_>SR15>_Y"\5OQC
M]O/%_(%_^WZ*'^H7A_)A.ID-WDS&^2K-7D^6Z1[/_AA.!Y9%G@,6P,PB*,\=
M1,R1/&&I7<;LXVXN)SW@!AOHNW4F;$/0(Q?NR=B_AQL'*'/<HU![3*&Y@>=F
M5L]/\YUR)U"#M;*!OC1^%TZ?)\&VHH=KI?>CJ;MJ[TG,1^- ]$H[)CV88 29
MQMJ!E]Z +<YX*Y,HNZ6=/T;=WRH@.8GJ]Y%N@\RY);!?YQ;10&B.5@OR?50F
M$Q:+AF"E!5D/.J1SSJ%H<M3?@G$\@Z]'U8S[DFN#%/SENI9@3,C)EL2!^\IA
MS@MX1]:F8UEJ+ITIJ<V%TBT8YZ#DP^7:XYL\#]@_'U_0C\:+&,<RI7_%O113
MS FA&**=4O2'RUH0+).S4$*AY#NE.FQ_QE/699_B:Y"FM%SL]5KG =<EMB 0
MM70*$M(?BM$&XYF3P$S)EMA8A&A3)G,?JJ=,AMZEWB!!]:L/\OPB3*?+Q)RY
M<9*BYM[4Q6I;J]0)G=>%+!3#'+/!<RR\S<:^#=(3]M/Z%7>#G>$FGB7E=T&T
MC[>V?PG,'4S'==EZ5MIZ_4L_$F]1#G47&0$RDI,A8G/TH**S$#3M4KQXY;UA
MT?I&95!'XL 6U^WH%-A'T U43P?4$*<_OB$5XF12B]$)VNJDTAI%"1F*G-];
MF@)!Q ":9^0V.::R;F7I;P-U@AJ&CCJ[:_3W(O"M?MY__; FFI?T;9/^#G/H
M'\<7]/3IS_^^&LZ^W ;74Y^'#8]IW>_AH96M]7UP(H=L%->UY8^F[9KG;&+1
MC/Z?<VD>[ONPX8&]]W_@63@9Z&USQ1A0SD>(WCI@TNI0DM?&-BI3Z[W_PXM1
MFF"8XD^X^-\7H[L"?$M.V3(%?> RTY[)#-:50GNV(&.>'&H@S]H[QX1FI<W2
M]P3Z*&*5^_!D0_);,\4TN-EZ/KZ\'"\@WHVC2NNXY#I!*-5UY\Y#2 HA:D1O
MZ,5.NHT_=!^JXS.DJ4KOE(CWI(\6EM*=50]L2CY*J:!$D0D1>9<QV01HK8J)
MHU"\36GGMB/Q7'G14?8M2L,KHA?3Z17FGZXF1,\W9->-E]D8;W$ZFPS3;&G=
M/:OK?X6SUX5D47 XNZ+?&1B5E WU*C"@K_= 1&?O'=B8"R8>3<)6URT=H7\#
M7#N:9IO<\&U<P#_"Q17NA-_GE*.3"(G\&5#(-417W1!-FVS09.JN7_FW9>;.
MR+])8K;1:X/JRV?Y_UQ-9W.'Y_WX6<YSU82+-V&87XR>AT_#6;B8OV6UW2=Y
M2I>U?&(94B%!3H<S7%ZG+Q;^%M/XPT+!<QD,O'+.*"_!1;(-5$D%?# *HD4,
M"0O7C3HMM%[9>?/Z4?&B06GI[2*1R$-VY$B!J&%\168,^"1K9UMZ"V74B9<V
M:;,GKKPY)J,.EWB#(M)Y[*^R=H(?Z^7S9[S&-M^BWX<_WHPG<^G/:!./5[,:
M=7H_?D.4'\T&R*5G(5J03-&NS06QMR0%**WG%J4A5[T)83H"/V^*'5.K#:I!
M[W6TD:E0=/'$B5JIFF4A1YOX80)MH :=L*9-U=#N%Q^]N.\B16Z2">!C=J D
MB3^DI($YII-(OCAL4P;SD/O>.><^6V]83@R*49$\$!00K-= NI.VT!_,M5K9
M(\FY[W*)V4&8I\ZYO[.$!;WJ1C4>50MK'L+DO(3(6(%(:Z@;'[W@F! ,=Q&C
M5TJWC@1L@O5(LCWV4O<VYG06>X,+S#5,RUCF+J":)GULA'7BO(_NZENO&^U-
M]D<CAO2)2V7(87*B-E*,A?92&<$P;[U/)2O3)COPB(38-0GD2'S81^1-NB)_
M-;^6"0DY19.2\F!\#J!4\N"-"Q!<85(QGLF$;FT)GBKOHP<5;8]N'2#?!N'/
M+9<MJ]1E D N,ME,6I.+(EB R&MUNXO9EI*R-6T<SWMAG0,1^I-[@UW@64I7
MEU<7-4-EFY.[!.JR<]++ #()"37]I5K;!;206'PIF$*;',&=(9X%69KHHT%(
M]"W.:*V85STR5JB4,\IE4:N?$ZA4"Y^YE!"T+I9IB=FU<38VXSD'2O0@Z:UQ
MQ][2!]]=75Z&R9=Q>3?\,!J680JC&7%Y?%6;JGUX,[X8IB%.[V5WO4S[J:[U
MXJ )4CTCZ)ATV%(>:_F(67,3465)"E>>6.5D,,%[[247TN"@9RS-#YSZL.N[
M'49O"U>HP);(:)]##2%S!RYHJ77@S)<VGLF^2#L?Q:^?O]AT>[RZ8+YYF6V%
MCL8D!EGGVEY09PA&1TC)!680D\=&P<_=01Y_[VW*K3LG=2-UM2CIO7L;CHQ%
M3Y@@2S2@3%9T( D$,BH2DBNB: ,YVV2V9JI[.)%M'[DW,/>[!K)$+-RCD9 P
MDM%!+PN]*[) -B('YK00O$W-_Y,+3QZ+8\?4:*O,RK5<3_)B1*87P]8_E*Z)
M2Z+FUY&!4U+1WO,V!W[_@;H=#Z1%*$(9@<%;VAI<JAG/6H/S5D"R/GK!M&"^
MS?7;/BB/%>0[[E'>2DU/(T"8R8="2V]_X)Y6Y#)M/XQI\%&RS$NASVM#O$<9
M(&Q'AKW"A_LHY6A1HEU _1D^W%M].X6+#I']T8@AO$8NA(:BZ[P7C!Q\\4A&
MA7 ZU1P,U\8N?"KAP_[YL(_(VP8.WD_":'HQS]&]SNY=A3<\K<TS!T;92.MF
M!;SV"HP,.K <#38:.+ ;OL=R/[R7,K=;+WUIHD7T\1HEN277(X%>C#[C N=J
M.-#J?EOF$GETX#,GQ\35:3 B1)"2HRW6<&U-:^;LA/3,.-2_=DX:MN3*JQ1D
M )$,^076TQ;L<@!F8PA9!0RYS9"O)Q>V[(D_/>ICZWW#D<-6;\8S$M,P7"QS
M.N;9RHMA]YC+?';0Y:>KV6)FT'C5JYM>I/K"?!T>T#JTU2O*HX2_VLEU+406
MHE2:EX@V<Y6U]3S$(%!K&55AONP8(NL5;\<-D'#D^OGT?EU/VEMA^>4VEM=E
M?9+%C7L3:8R.DD.*D0S30-:IJP%EQITQB:O 1)N ?5\KZ'R4=,/Q[+*29""$
M+#F1Y^^+0=K6:$?S,EDPF<Y'S,:QW*9/:B_P3W ]?@K^WCFUCJ[Z%L&]]!'S
M59VZVG$YBQLMGXH7/$A0NF2H_0[!*86 6%2R/,HH&PUPZ'4=1[NG?@P\/B$%
M'LL-=YTX^V(TI4?53YM?N6B#2M5TVV@E.;QD3X$W@4-)3*>8N$2&39A\%\O)
MBEU.2(P-(X$[**B!#WD;T:MPB4M':!=<36^YMR$[S45W5\W=2X2.8C\F+92I
M:9J.0\3:@\A;!=Z:"#I'5KP2)=LV=]S'I<,#U]S'8L,^TNZ[0?Z/DV'^@"_'
M8;2Z[HHN25DX@M4A@9*T_8; %? 2DB1#+PC_H!>_^:./;WKW(_)Q;_+JT2:>
MHWG_^_C]Q_'5-(SRLU%^11;6#''T?#SZC)/9D,ZQ5^3&KX 6RS $+VC-4@&M
M/D(P3-3< :F<1X/K21=;%+O/4\]!Y\VDW/?+O!O0KU<[OX9_X3\_DF@7MSO+
M!6BFM"=10'3:T!:726",%B"=R%(G5<IZ[[].-+D?S;=#GQZUTF/NVH8%_#*^
MFMS#?Y($II C6*5KM*0(<#P$<$7;G.EOI','T.?^IYX?37J4<H-.?!U=K!^_
M;/Z N8FEK"RE1 5,U^PV$VM7(VX #2M1HF6RT5C-AHOZTRE^-)1ID-B[&=G-
M/6$'?$V][(<0GL;;?C24V(FJ'?79(C/@(9PL,VXMX<RU89"R,1+.D,E3X49H
MA>RX :\3N_-/EF[[J+%5?_";W2G?7(31R@Y)6>2$&8S. E16&ASS$H(J*7/#
MG0VM9F!O!?58(GR':G!3954/XF\0C[N^#%GBL3&I)!F"-%R3\9L">!?CW%]A
M7*,ILDWCA'4D9\:!3H)NTE#GJU>R<=Z/SR5@4!92JJ5_04>(/$7(BAN,VG'R
MD9KPX %@9T:+/M708A+?-;SJ+E\O?PD/37(^J%KNQDJM8ZI793) S5OR0OER
M!)9L G:^+.FLAO;=-=Y,AI_##.F02_.P>>T+'T8)7X5)'4/[N4MRX<Z?W3$E
M\+ UK"7RR=K2 A&33DR1#GS1PB)35K BZ(>#G9_29Y#PY74C4DOF1D$!(EA+
MFTO2=::;H=>-1>\8[3S89HC>%D"=KCAO?^8O)-%%QA,9_]<_'@C'E-:U@Z9U
MM.3,/00F(GT;LF:.L;!>KKOE;G.GQYWZ4O,P5=^ZT^Q?K"VRRD*](%N:V>1*
MTJ<NF_ GI+<HOQ[-:TU"JC\<)$EOI%<.M-0$5GH%+M?V1MH:.F9%\JZ-B;L7
MS*?-G?:::>$F7X-]=55E1=_,(SB+R28O;F/%X)TH$AA+JE8H)8@L1,!(LJ&3
MG2?5)F%K'Y1G1Z)^]=)DJOU-*_Y-F+R>S&LM%[-P5C=1@V!*3H)E$H*4Q/3,
M:VV2A%RL-YA5$;;5?/M=\)T';QKHHL5,K&MVDSV8KG$5SA5GFEP$83(HH6J?
M>'( I>!%H5<86W7*WX+H/%C1B[P;S*"ZT8)W*U5EEB'7@0$&:P<'2R:61V*N
M\%JPVIW1R#;U@3N .P]V]*V%!D.;[HPB>78U^SB>U K8@9*,(-#2E:OQ7<8M
M1 RVCDNQT1?%96QCV]X#ZNR(T4GJ#<8XW5[NB]$,"=[L+1%WP5XB;J*_"!^(
MNJ$P;7+M^<)"M8X8.%$37(05P2<ELFZS@>R.\3SHTD@G/<Y;VN#>W[AG?!XN
MTM6B.</[\4](\"])+C?-[H%TPB'3 DR=<$LGI*^-X!!"+LK%9+@-:ST/=KI+
MV0O$TR;+455PESKN5-3Y:?AY.!U/!E9XEYWEX"IHQ7T&K^D=*"P4*:.C!>V6
MJ-H=R[=-I$,4<I=/OK,K5"'-C?*!<C*1O9TA*W1UU!%)86Z;QX(Z88D!VS14
MN<;PM"G14:8;KM<Z7].NWR4/)\LAJ-Y;8VI 3-5AA^1Y@2^Y@%11)V6B\:Q-
M?^@M@,Y#\7U(>P,+>BA96US*_#(<U5C7\_%T-OW[I$Y#E>2!\Q@\&)43(?,&
MR/R14'Q&E1T+WK2J6=L"Z5R8T(?$-W"A6U'"[>NYKP3]:3BMM=A7Y&B[+*QF
M:(";NNCH$T1.?YB@G(LR&W1J)_O@P4<];44W$.<&;1]\TSF'-T?U%C]=3=+'
M,,67PQ"'%[6#<C'.)E%;B^N**AERGBUM2I%C\9REY-9W_RU*WO:$,]!M+\+;
MH-+.EY:W27?3YIQ_6;-ZWU;#<^"S<:7:DR*%&I:Q!H*7'@07S)80O51M,H5V
M1?BT6=)4'QN(T_D2<ZNS\IZT/ZU]S:]O2&[>UK^?##]\P,G Y!+9/$D[: W*
M&$?XB0!12:.]LU:N7SXTL1GW!GX>-#NF]C:PK^<;TTWX:[8"IGDZW_M)J%.^
M?PI?IGQ@ZI"!R!((7?O]QU!'8B@$.D?K5 R=N&H3E#L8\K?"N#XTMH%KG>?9
M;T7^<OCOJV%>% 3,MVT<W8A&8M#"TAX-AFE/L&NEGF (A0L3M9488YO*G\/P
MGCG+^M/5!HH=? ][?>J/$V*>U@JH50[IZ[(UMWQ@>1)(0@'+.-9I?.3VD;T(
MQF4F,&%VO,T,A3V!G@>I6FIG YLZW\+>EL&B;MCH'$PLA,1[VD0E?148[:G)
M%>M"'=QGVU2);0!SK&YY[3>8_67[6#K8O1R//M0X0EW/>_HW\Q)*ZU*,(CO0
M/(5*W )!*P%)")&UYXHUFO.W"<VI"O8[:WC<LZ0;),JN8UJ6N.R"JFF1_&9<
MIRF-[ZZW!XC00>C'I(24G!D/LM0QX=)EH$V3;"2O1)TL6))M<^US3"H\4+5^
M/";L+NL&#+A;X>H+.5O< '=U4"!/Y.0KDR$[DX5C 5UJ8S.<OI2X#PT]6$"\
MAWB;C&E=3A!Z?A&FT^4ESYS:B5FG&?E /K%JOW(-#BO)?2D%G<UDQ+8)W6^#
M="ZV0#\R;U$G? //DNN[(&IJ#-S%=.+1:]V4MIZ.VH_$6W06N(N,-JB@,\O@
MI24\11@@/ZF01ROFF8]>BC:.P;$XL.NTM=84V$?0)V@J04I*Z'@&*9.I9:*T
M6A<*8+2"&ZZE:E1P_.B:2G35W9YM)/81? M; 2=#G/ZX$9HKB0D" UP9LHF\
M3F3&< $Q(T=!/Y.J34;Z/:">/!_Z$GC?[6V7N/A#? TJ%UL(H]6VU&89"(Z,
M6V!1",:RMT'LUH)TQP<>7^&]:6C<6+R-*" >PBB#S<BD \=KFB*Y31"RC1"-
MY)I.RYK&N \%'GK@>5&@5_'VZ#!,)S,ZK*YJ.<RG,)E]J0UR%O<AVFF9/ +F
MZLUJ5R#6^G^K3&116</7W_C-QP ]X,810-^M;__;$#QU'[$7R?98WESQ7&>L
M/?LPP84%O 9Q=3.R \A]O,6=:+ SO.,ZCOUH<GPL-?1X0.P'5K!B(EFND%,A
ML*S6:S-+&V6F]R-K>H/L3M[$4^#*%@?SA%391_I]VQ#/PS0/5_>@R4OREC6'
MZ)&#"M(#;9T.M.><MD]AU/KEPA9#X>:G'L\::"CU<1\BZWO@R3^&_QJ./JSF
MZZ*3)1(0Q^M\75D41$P,:"G>%F;=G424+;J[^:EGI[N#1=;W>U=ME>?CSS@*
M\P9@PW&>;S;"HT.E,H20:S:G%N#KC&TT+F?.1,CK3:KO*>.\^_E/W3+K2W0]
M]AS9 NGK;.V'06TVQG;6ZRGLJM[T<+]>.PBQ_?NZ B>L1I,-N&@%**LT1,4=
M2&.%+M(+X7=O@W@\S6ZQ@HZLV#UDUUZAKT>K6?7:"U06/01>#_7:02]Z)@'1
M,*^DB+M>F-SSD.,=K3WJX'ZM'B; OJVBN[C>_SY>7=5P@TF: &0]V%JPZ\%K
M:4#:Z)-@3*FP>Y>$+0\Y0\4>)L#V;VPM6%A1CBR&K UM3#8B&7/!"8@Z1?",
MEZ",02W*H:J]?LPY*O= (?8]6.TNLCKV:]6\G0>>,UHR%JO!;VFI7I.Q:'V*
M/'/EF?$':O?Z*6>HW -%V*(WXU6<XK^OR/S_^7/U 5;9>R'([+1F$*H7K7CV
MX!1]A4P)Z\C-BZ91=Y+-@)ZZB]2GO!MTW-L :\GZ78 US7+:"NU$R4Y]*/!A
M4G20?HN^T5L!%LN*C,J"EC* BBR D\E"X8;\CIJ2T6@*]Y%I\5#^TU%9L8_0
MV[-AE:W+G*OCI$$**>J5*X.8K 7.Z21CGM.!%H[!A),%N_M1U_TD.$#66QVY
MYN-05I,]Q^5YF$R^#$<?YOU:QF7V$6_,*&\P+&7/)S<:I=)E_6N#5KQ4].$I
M1K(656#619-Y5!)CD2FKLG70RIX8VHQAR0&=1EFW/4UTQ4@V;DP)BB%CR3I1
ML!RCMO)EUS$L6XJHEX)=C T9I,10JUQ[U;!,UB%7X+@O(%,(WJ$P3I4C+/8V
MJL=39[P/%QXH7C]<[@TR0%<-<-^$+]5)>'XUF1#&.DQ]/$J+;P;1A=JQU$)F
MJG91]@C>DA2*C<Q*<B+3>K>OGJBQ [CS8$C?6FA@/2UN U:]BI99;'7&QTH2
M"S[S@8X^9R0&*^E3'6==""<62%RR[%%E;MIULMX%X7E0IHD^&E0@W9Z+]]MH
M@N&B]F;_.PGN96UU2/:!5DE(*-K6Z'M6$$)!L&0I)NNCI^^:\>4^9.?#D][D
MW^ F;ULW5,.2T;D(X$HZ\CZT F\2.0PH Q/96SHSCV"//,+>L_V9(H=)N\&(
ME4W7E4GXX(+V$'GMMN*EA1@2:4R8B"'[Q$NKIK./KK-)?RK?7[:/NK.)]CRH
M4CQ(ZSPHRSPX4R/%SN7(#6<NM-DE'GMGD[TTO$MGDWTD?;PV%KN@^K8[F^RE
MM]WZ61PB].-1PA7,/DL-UL^GMA@&/CL#/%K&C0S<YC;VY&/O;-* "?O(^AB=
M350,@4P5#6B")#.F#@!CD5P?9CD:&:-PWUAGD[TT]%!GDWW$V_[^_B?\C!?C
M3W-?=Y7AW>%2_KZ/ZWC3OC/2M>MSRP2:DH05T:NB6>")%<8U>>XN:98']WUP
MUXX!%_33\6+:^;/))(P^S#]]NKR4VO+7-P:^3J_-5VZ8+JP8R*RZF+:.]'1.
M0_!>2-39"=TF*Z//570KC-D.9'05+MZ$+_/O%M.7JP'W&]%@LDF] R*$S$H8
M8!8CO=&TEP<MZLV.XUFC$K;LED[:'Z83E.6?BIZW:W=.H]4&88"WA&ETA;43
MZG-RWR8DHW\.9Q^?7TUGXTN<_/Q'NKBJG9N?3:=(_^7WX8^!-(XIJ3QX.F1J
M<UT',<<(H12R*X3*)K:YZ#T [#?(T&.IMD6FQC+Z6YOQ=I;BPA\.2>KL38%<
M:A>?.EPI8%V15=I8)KU*C:;"][Z68UU&/1H&GY@.I[X J\6,;R;C?)5FKR?O
M</)YF)8.'>'FE@? PC.HD&LM<5# M4OH0DP"=^+T3G76FQ"<ZL+KU(08]ZB8
MGJOTEWCJ^I>(IJM;FQU ]=[)82N<XW=NZ*ZINVKO2<Q'XX!US@4?"FC+-8$+
M"6+2"1A*Z662(OB=,CD>H^[OZ<1P)-7O(]W>.R]<[W3CT=+D6Y5J2"8M\Q9H
M4>1:(-,UP\C54)^RT4K.E-C785Q[QG$K^WO2P!9/KHOX>O3,MG80R0*U2G6R
M7.TQK!P=5PXUAZ2BBCJ(S'?KV?GD&C(]HE._LV)Z[MRU>Z^+74!^\_V<]M+D
M04UZ#E'#R?HY>9O(^<=:"% $*.%H+U2UCE/P&(M25MN=KF^? E?V[>?4GBK[
M2+]OJ^*W45Y,J<6\NB]:GHI%1EV219"&64(E-$2+"D3DT184(LK=;J&W/N*Q
M=@O:2Q_CWH79/JZV-'^N2S!^&D[#!Y+*A[EU-"[+7^@0:]OW$1WC;YU6M!:3
M*]PBRPH#Z48Q9[PQUOF8C1*8=8F#?1_6,7/NUH>_7GWX]<6;"28:BQFBJ9%:
MS$17;32P2 NQ0CB9&\W%? #9*4(6S#OZSY//AY'\ Q<#!#+Q0'-4R$FGPK3)
M#W@2(8M>N=1'&&(?=34(BFV1Q\)U8(4V:U9'2Y(+6/L7I9HQ:R#;Q!46[0+C
MQWROCINGVI(IO8G],5S<?YTP\7<<?YB$3Q^'*5PL:JQ9R%F0ZZNCD*!R-. Y
M_5&8<=X99?FZ!=7!JMX*XV0YJ[TI>=RWL'OVL]XM2'03TJI+P@Z@>O?%M\(Y
MON_=D[K&K61]-"(4P[!8E<%E2^"X<I7OY$E:ZS0*HX+I<2LX+@'N<:B/J?]]
M1-RSWI^1>4-(IDMG3W#M,KEW]52L=XY)@!.TRA"<L\5:743L3=FWGWU<E[HG
M98Q[D60#\_#G7W]^MNK]FZ,O)4A(7L=::%G E9@ K5=2ZE2R;--$Y!K#4]9M
M1XGV_;Y.A^%-2,,R3*L&E#8FCU) <+RV4-,,7$B1OHW1YB2EQ_XN0.\\_BEK
MMKL\>XZ4; P%1\]EKMWK6.*T,N_JQ$[AR7H)F7.61/']#2QX3(DT3:SPSB)N
MH_(-X>)=0'US*3%[:6JGO(A#Q'RTE!B3>6:.!P@BUY%;=.1$)^HL "RJ%)>*
MW.E*\#'J?M^4F/Y5OX]T^PY>79?$K@S&.IVK&.W ^=IP)PM5FZ)J*-8YQE-T
M+J^E/VT)6MWYZ,>2 +.7O,>]":OOKMO/QZ/IU64]A59H;-'56*A=*FH7DU(T
M>.TY\("%<<>T8+NU[+WST4]>==V$U2!]?[G&%8]TR"((6WM)>O+2')D17C$P
MM&!7=&WTWZ;XZQ:,IZSE[G)MT-=GN:Y59:AG7F>9@.OYA4VB;8,<<LB\V&30
M)5_:1$-NP3@')1\NUQZ;\SR4$\D$RL!KDR AB7LZ(2U5U>LZ+:(7.3&C=]R-
M'WM*:8=MN1?Q->BV\Y*6-YJNP-B(7M>N3SQH.N>]SW4( P-47BCM@U1JI_O(
M_?LEW(3QE-7=7:X-6J/_?1*^]MTELHFDC05I%/'-QPR.G'C:5$Q ;JS(C5IB
MW !Q#@H^5*9WU6MZLK&NU_=Z]O%K/IE6K+AL,O"ZJRA.5H&7F4'PUJ7(BO?K
MVW._)M=&5.= @-ZD?I<1MDT6WQN<E/'DLO94?ATOAHN+OBZ]JW?ZW'[R]?;
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M8[(T4<ACB<EL7=*/7][31RS&VFJ9;$J"%F)5-?<0HDJ<%J>E<!&-L&TNF78
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M,' E%:@->Z.,6?/=:@3V+]Y[U,WQ]M+53LWQ]A%T@[2#NVV\D@J)<1W V$B
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MU@G+OQ$YIC__\0EK6?#[\3]P.AMP3-P$VJKS?*O.]*9Z5@)MVE&5H'7.8<?
MXB-8S?'VO%[9=SN*]0CDN!<K>@^-WI'JPJ_02@C!E0.#5H(*U0$D,P,$2;F0
M%QBTL0>^ST>I@6I,F8X2>RQ54',J?TWI9XZ)$LEP\-IF8E^B%; 4R9!D.H?,
M8Y)M)DS<@G%L[[H_I:ZW+SY8N"WRG1_:Z*;;=KKK98QR[<E_(WE@ES4U]<Q;
MK.HTGGT'LJPG7C\633\5%A<A:CUS'?3A$AV_G)RF.ELB2_*8T(<8G?S&V?O
MI<0C)^\^"FX1T[VV_N;05]V #/EP*AL.F=>^8)S,D,"5 F]YDD9&DQK%0[8
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MS6*^"->9CKA_8+W<(+O0V4<!^P56ER^/ONO%+*3%3;CZA#-R$0]&L4)KWK)
M"U]'!.>%@*@1I0J>PK VXZA'98:S6UVCLGXO$#Y>D>[E#]6-.:?DF0 =N*Q;
MDJ5PE'L018AB-2\J]1A5>C9#=<>0A8S!XKWP\W@!^?$>:;>W4;^L[S8=YB!T
M5F!43=9<G5]&"1SPQ$6V#KUK1'Q^+ W/9NV,&CI//.X,\X[91-&[(/@VXYM(
M;;+W+D.(AMSAI(9(^D$00OD2>%)A9+,Y^JKXMDI& 9XGELEA)9I;:\(^ED*K
M>%V3,$F&SC6!",%3J*A42. P"'!.&*&M<&6S0G]+N-3Q \\&;\V\\ 14#N[4
MV=M&J]EA=WK>Q'F:72[7PT58X"0H9K/6##3/'E2= TP&JWV,+(LL'++<:93>
M\3;09S0Z&_R."AI/8/ZPA\Z]:P0VM%JOZ5MFS@DJK[37'GAMY5316 @E.]!&
M:>LXLVF3A'=7\CFX?&<#WK'X^ G<'LR*N+=:=^=/+43X6.X-GEJEQQ.K3*$0
M7H&0IO:46 I6#!G="Q7)S-PV#7>;Z'0VD!\9/)Y _N$/O#]ZIO=NP;_ML%9D
M22.U (84=*E<:M^]0TC%1!T0K6&-@#Z4"L>::G9J-)_$Y>,<F!93\IA0@;2A
M *60'F*Q"I#R!6.<%%R5)J =V\"T8R)AYWBU/AYY,8.I.NCT-EZMTZR' \!R
ME E5>WCZI: X^RCU<GI*B0Q4+<P)@=+,5+1P.>?(]-MXM1[CU48'WCX.;@#:
MC:E+RX?$B]__OJ9!L+6CE^(<:WB]SDL4(VMTP!2+B1GZM3GS8#!6ZAUBC3 5
M:N[Y1ZS60[FM17O><@;T/4/=:^%6GDFE=>5RMR1:'2+C,AJHI*5!22F-:-1D
MMUVH-SP-YK)C\LP93SC7!H*L\P0U"Q!#G2+C/=>9>52-VKE?-\_<(2@:PE4-
MQK<]>+Q:#QT*/@H9$&):<LRD6%GO"-3>VL!S<BZTJ7%\0I@WY!SLH@'[Q]8B
MK1I#EE$CEZ5HYSUD+WT==1+!!:D!D3/%;9(JMCFU[@EQWO<5^WJCP7:R$F6%
M^B["-+UF>"#.:>X']G;.TTX^P+(-XH^'0L7LM&0%06M9:V$28;C6C6'(6GB!
MT6$;5N4CN/F91+J-E_L8]'B7-LM-B_8UVOL^7J]YZ711)2.S$+"V1K$H(1CN
MH,2H4\$L6#@JH_930AX_ECC G=WN5P[V1:L)-#M%_?2OZ3J.23;%3 +F7.,8
M420X6SC$G$-.@0Z]V(A+J+N0KQLV^_FB]=CPZ$,1,03P15/0G*T'AR5!01Z$
ML\$GU2B!'=?8\!-&E7O[HT&^L?FHT4&:\QHRWLL_NT=/[V/<]D/&G1*!"]J7
MC(^)I.(*G.$<D'Z7L\M"B/,8,CZ@I_O8=.CIPD_,//[T+_K]]]N)V'>7]59K
MM HR9P:4-@Z\< F\$=YIGKGF_J'7MQ6N=_FXDP^,[>60:5-KMATF_MS8<TR>
M,,X-))_($-PP"+K./D_"B>2T9ZJ;WU_64/F]_=_.ND=8]VNI),K"C864&(6Y
M(I- JC PUCA4(OIDNHT&>H7^'<9J8Q@('E0T7!1!4NH,2G(//@@#A=<B RT*
MS[U7]HL9"#[$^FYBZ0%#]OEL,;FHZ<DR6C$,F8W" 1-8*N-5G:LH$Z!+S)C,
M@^]V)4@_]5[(1M]MAFL//O8\$[?]+3_@K+@[(=;/FQW$Z).J=0?"\&O^^=SL
M !=L.O$ ^PUX9F^*(WBI[(3U,ELY4*5P<*4@<)WIL,G.=N3^'H<;M^1=PWNQ
MC]D&]MYJ&.GZ4/"6&4Y;2I:Y4E1I5_<5!J4$S9TU*74K+^_DOP<??;S#]R#C
M3X>PW(#)TU*0VU:U.W6$<)2O@:60@:)WF>NY7B< A82"\1@E&\Z%]S_Z!;IP
M;\L-O H_72YJ6/#+=;[\=IEOPM4MG['.ILZ>!F6K0!@#Q$3?)J-D4)2<A=RI
MA+23*Y\4X7PCI<,],N!TTR<%^L?EXLL%7BWM,?]R^<>GZ0?*_A;?U\3I'40=
M/++J*>3QHZ\!W+H+) U\TGJG>49D[U)1A@0UI7C:6F4$$I*#$<%9(7V( T9T
MHX#/CJCOM.CIXXJA[^7>XVQ!,JPO%58G9K32YU1)YK(WM+FR2(=E-B"3-\((
M*<MF1?J6VYHG?_QQXXFFWI@.:LJM\6,K?K8?+1/A(;7X70/%<,1MW3]K6$:W
M/77<H'I3.7 ?E#3(M#)%>YEU*EQKESWZY#>IWKI_ZLDYX#1FY8Q5(%6LC.0F
M@-/,0RX)O0B>-KJ&+#@'R?X"ALU=3*^N?I[.ZO\T,0F1,@X%OAA+IXHJ0/#)
M()E.HC#EC<9Q67HO/4=8NS_L*CC!V+E]872\.K\&0_82IZU6<03OD).BWM%1
MC *B,LP$'^A$'1FKXBN>T'@$K)YLFF,?H)VB2WZHX:Y12,>-8R X#Z"2E.!5
MI@!7<^3(F/'ZJ-7:YSP7^#6MIP-@-CBU7LLYX^LH_EW^WYOYHOZK.YTS2F%%
MT" ,1E \2HAZ69^GLS;.Z;+9"'&*T?3;%7A;.4^LG!>#J :UU^W4_N^E;^[T
M#,DDRSU",4F BI)#]+79P20F?.;"V)'1;_74\&UIG>10.@!F Q;&M->3O%#P
M\KZJ5DFE:TF@#;+Z@_1UI#I(<@ICWEI:$"]L13U2\FU1G611'0:V,1%#]DX2
M62XQ&N6!^5I&[[0%'T*!I"4+%IT0+XY49>=MQ)Z^V&<\[:8X&XQ8R_3B+V&!
ME4YY2:3\+LZ7U%B3E+FB&*D6ASA/01*M%Z<365$403E(DH9UJHK9SRE'U?4%
M[7@#7JN.%TXOZB*HNRTFR:544IU9DT5M+5 *@D($II5+TGNK-KF_7\X^]ZSV
M)UID(T;Y\2]EAX7HBUJF#R_2GC=$CES)(BD(X46""HJ!4Q*!_)M$LDPIWZ9?
M?C0F>%NP)UNP+<'Z2JZ%.Q@EN<)8LI U=W7XK@2'EI%14LRY-OEUY.@:JX9O
M"W3+ AVUUWKA\@7?/G<PA'*>,I8,T7L*.+C-$$1)=>ZB+8)%X=)+NTSK:8*W
M%7RR([8E6%_B)??-#.?/6\$GI97@"72J);R*,8@V%N!8<A&%%6->&K-K'_W?
MUNO)UFLSF+[,F_/G;>!4;>0S",BMK3T6"%$I22:A7:S44>KVQ9;$]ERH>WAP
ML&XZ'8.-5B;R0*4 X;P.D93U[4DFSPR31KQQIHWB3OPD+A\G9UK0V3$7(Q3M
M:Z>.MK1WB B1.<8D,RG+-H4CKXPSK1<2=G*F]?'(2V&;ZJ+3&V?:97_.M%Y@
M.0;MU#Z>?BDH9CS7,L($TCM5GTT\.(8<A,K%DWIHS(F*[$:#WEZ<::,#;Q\'
M'YTS+>ND$ 6"D2*3M2C>#\;J*BO+E;BD"-\$?>? F=;+\[TXT_JXK4&CV3;J
M)%6B=,%PX$R16)PYB#Q1XE@X_2F3FL<V#'ROF^7J$!P-X:JMNU*K[O<?W]ZW
MXH<_ZV]QN,;W3A\S;,][?\TVVMT%.4C1+W29*29B1):CM)8Q[7E*?+/=O=,'
MGKS3/4>=3 B4V7BLC HE0]"^WKIYZ5S4A?.157#^;:A.]W=7RW]#^_R3HJP\
M-1%*%!-%@$(F(@M1;$.I8(&BF!48L]:-:ER[R3?"G798U#U*KX=W6XN.\,&N
M(J14.8@4@$5M0&%&\(6^+3:8&++CKE6:<H;WD(< \S0N'\L]Y -F!EVRCT8G
MR+X6(T:[G"R8P2CFN3=8L%&!P.OBK.F%@UV<-7W\T9[ I(LTY\59T\L_NYE,
M]C%N>Y<SI3FW-8>*7()2M*_ZPDG(%!CG,5D=VY)8C86S9D!/]['IT#/R'A?4
M+?>QY64)I=%/W:&LTE]O6/&I\CLO:<*CT$ ':V5TJQ6O0I)2W8H[]Q;AY-P'
MO1PW/;K5&T3##R^*.0M.!M*?1U&/-=+?4:@.L20FHS0^RC8%#J_LD?*0\&!_
MCS2@2FYR=]=%I[='RCT>*7N!Y1CO//MX^J4\4D:1<HF<]FS!+"A6YP8Q5F>E
MEL)]J!-33S2)<C3H[?5(.3KP]G%P ] ^H$Y:DP,(E2N3 $$"667MED!2>C!"
M1QNER"*WN?%\0I@17F\V]_)T6!>U'Z'\R_4R'EW:*4YO%G_%Z>=9^./+97HW
MPW#(P.2./_G IZ)]Y-]X'<H.C5&B8/2!PGH=%7-9ZTB[37TC"I..GW%@UCV;
MYINTN/=9/ZXV94 K$P&%H%A3 .TA8BY B,F,.^6$;70GMUVH0W>OVQD='\L%
M_C&=+6I0_/OM;>9\XJ7-,NH,;#F_TJ""4+*&'#PZ;R-JV>;@W"[3"1+/@?"P
MN24-9/<&F>9%Y02\P9_)%.^GU\N^B#K<_OW-?#']BK,/?Z:KFWQY_?G=?([T
M'V52?TZD$<(P@Y"T#Y4,IQ;<%P\6T2M-?QBQ3:7W'L*^'@RU]E2#8(GDK+2C
MLZ45+B[G__R-TG[Z@_ 9^<0P)YQF#D(@N*M$I[O7A4,Q3EL19+"BS3O=+JE>
M#UP&LWV+^XN[*YW'VM]>U11G>"G2 EKE2?-:]!,$ V:D<\FED$JC,HOG1#O6
MXVPK7 QK^[&\ICY"^T_?[U)8X:Q227&P@=?^,*O 1TNPEUIRQ4M@K$WEZ ZA
M3G^9.HCWG]MS]O3",8ZB*M@JV>PB6M.;SQW"G>8"<S!'/@>0 [UP9*!XZ;.0
M@8,W3M"QZ5.M>S% D506HCB'JA/AV?@!\LP=X2GPT<?X#7#QX_[AD9#K-\.8
ML[*2@XE.@G)T/GO+/#"%3$45BR^N"3J>%>WX4>U@CIRV],* ^72EB?M]$1;+
ML.:'E"L:0)%-\:H(P$CR*$P.?-;+87/(4Q%DB$[S$#LQ)6X5XW4%'<-9?, ,
M9RG4;4A[7Z3U$==!J,%Y5[>*<WR&U8'<-6UEZX'Y5+<+YTV,7GD'KDA5M\
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M5[U'A5./8#0TU<P%GVORRVL7.>L 9:2HK(=[%ZW'%^=]($&NF<_B7RC'].\
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MOR%G&B=X(39#X"0/WO>%QK.+/7+A,)#]KF'85Q[U6/XM[#K!+W8&WDT%$JG
M5N-XBKVK%B_D.^SU?ZG+D#8X]G5LFRLG28K6L5X0$BRP3?5%!%=(*&2$6VU+
M%J^G]GFLY-$U;NWNGUS- HN0O0TJP(;&M5(BY=I=25*N-$_2ZK->RX'\.?:&
MRYD)U84CI &)\ZEW6$PFNI6&5P[ZM."B8.P,%1 "KY:3S*A 2_7?A>.8H7\\
MCQ\56&> 'QTW+;O!BSRH0!QB7!%VA8:)QA%5]E,-6MB]N2:$.ZO7]9J(JN^C
MB -D$XNBLG+WMQ_/F/K%HW#H/1&*(&HAE'P&&H$FF-$:/FYR+L ;QP(EY,Q;
M5"%Y'%,ZPZHB$TU3J,"CAOCMY8<%?'=T+TK?>@ATS0%28UT^JN;JC]T47^3T
ME->8Q)Y/*]BWOJ(]?GTU,X)8L1([!"7<],?3% A9(P8J1<LYDV;X,69?)S-L
M#]GV,=^J3+89$5<.WT+V#:&=R:W@2?I.!(/S-@;K'=U@C;F"G+!94W!^-M_L
M8J')_/CN^MFW!O(CE^O@!!>:+43V+6!2<(P5G IT.L[+SYYI>Z&,=-WB-M.5
M F_XIU.@J2.M1OB XJ:\@S[H67AS"WPW3"02=7B*"HR,A< U1/X=^_Z&1%,!
M1W $@D==[DVF3\*\?1L'Y\N:>M!0WKK-I8;ZJMH_ZQM-*F*2?SS-!(3X&+^7
ML'*<-,L(S[,>,TS2W3Q62SL;=9QVWSCWVX%^X KB'[#0WB3BP>BVA[7V[&[_
MO*->O>Z9EQ(AO>ZWUS4A9D(?3IY@6N2"9IB&J@OY9RUC9"VN>H$K+*6.!&C8
M:(> H<5U\GP-A:^&"I"\8O_1!GO@@Q,H$AGZ!E1(MLTC15'**>(!H&&*3(#J
M>(-,B97,<O2\/FA!#_6N3O_D4*6[W'R1XQ$7.1-T>AU1X=WIRD]@M.P:)5TL
M?+QFTM07!)>\G6DJ );ZSMZ0?O:-M0A)"=[)<2R-XD-ABU%48*%JI4D!UU&%
M$VT;MQP/JPHTL?GM&I&:2M9>URM,#2K@\OZU6/'4]!8M2M0@P]AE3:CTIZ/U
MJ]IFPS-&2R]\H]6-8Z6=AI)IJ366KD*F$?5F6D*_VB$XTNJ"X3M%_\(R3Z3/
M*PZ"MF?\<XX+M97,$0.Q\_'TK*'@O1$<LLB1@"<X$K4#;A/D<Q];^( [83>P
M.6G330'8EY-C?5$FNF_K)YYY,I0"72L 1.<?TP;F%C5G,8I4_50@?F;J_I2O
MB)%.F.VY5_*1SB+CBGRD*!JQ\":]I@*9/3@:P6">H@(4-9U_,$$?Y1N$"B *
MMU^@-LZ#%^W_FXD[3HM!</HBWXU^ ]_\-U!7*?B7-;NC*+> Z8+?-?.TJA)P
MM!KRG^LI["&\V>?O%>1(:6_4"1(+S."UNO5WJZ[.Q]$:YK!3C_VUX4N9XX-H
MK#F4</6@9A.*72*)8M1^+1+2YJU>$%4>@/%L]0&H5VY40(,#9/Q14](\2E80
M&T$%'B),42GKZPXN+B[/'5ZD0.3$2CJE>SOC=<7B_9:;X,J]*I#2/!1T%^R.
M+7QG[1?77X8[%"4I'%?A&_D-=FQ26FGNZD$,-6OQ/J3[-\*82V(FEU,D8;U[
M;0%L"R@N HQ)CZ\B8K7KN:Z*>''V#(O07K=P%7[@)P=!A;]SEN<,'L$5<#'3
MIV[BGH5<Y;BJ\_;L9D]H^-2$V?6IF*JC"BU/HPY(#DE%?D4>QMVUI];@(GS#
MM;A8CG3:@B*QST?4@#<[@H  ..>M62D0RY@=_4T;\2CSMWY/#)/>[HT<TJ0$
M5#!<Y6CM;1"QW;T\NSN,\6Y7YSXM&A=H^D%3Y#[%>&,0Q @;@W-1@1>-]ZQ]
M^#O2+V"'T(T9E76N%0_@:]ELG[-70;OIB1N# ]F5A8+'(DGVPJ<Q*[Y+B=/0
MW0%3*O!.2O%0_C@@$R6(LC<DJ/!TS/*]E*9<)NC<QUE_NP@U&K8B@@YTO%[V
MKV:#NB\)'QRN_'W8A,&5P$,TD&DX!XW:JF1[L0 XV%RD-_@QK3-M]NQ97%V4
MCJ@'\L4'V]#";#ND?<;13<^?%LL0WV=7E!CP63MRK:9[]X[-(NZZ70IBNA 5
MI#8\[H;[]_SQOT?<1(10#B(G8'V@,ZJ=,233+,*+MI4>I820I,6WNN99 KY6
M .E[-A&RHO3W"@KC10N'G3<Y)&%L!NKU?=GZ>< V=,3#[/N=4@W-N,$H]\2>
ML ZC;RA?N3U0K"A&?5PIL53!*G9/XQ)J:R6ORW$1EKE11XX-V0_?.5";TE=M
M&6--F)YY4-K*'%/4WP9H="$C4*_D"'+>S?!WE]=;6_:L27KC3Z8S-2Z$52Z]
MOD%O73OY:#%@L"@+F2N%:\5'D,MAERECQYV3)/^%\U ;K4"<14.Z:>*/E<];
M@]+W?3MN+T8]3]F3Q+H);,Y^,FU 'U#LMRPX@OZ\,LM/-5V!]YP7W4O:6>H.
MC"4:P)O=FU1@@Y&>=CGKV #08)ZX%C*T5<O]X3Z'1UM/_6B'+>-PTZTQ1:OB
M-\;IN_AE_Y[ZY!OZZKL"8HD#XE]B="5&Q_RDV@MM<B!^,2L;1R_TWO;D$Z79
MKHS8Z$'6#^$W:17BF=^[_Y$[H(;PYNO@N:QC]"8#SC4 [3"FSH"\5[:1<A\U
ML\HP>@%[67/J[<8N F-W]"%B.-'").7K^11E>?4:ML]/[8/;.U.XS1P/=AT]
MCN6/OQ%<<:*W":@Y:_FVIG.C6YYI+!;O7)QV9! >;RZ2-1DO!-/"[ZTFWP_H
M6P3VOBM!TBR?R.0SM^IW..D)_>"W]=.1>+>G)^>^#_$1_?C9640'T-G+ ,,%
M@ G!F0&F6!?$O C;>K7E[_""-HG*QLI/NKRK_D%JP30BR*D)!$.=WW7>X6$I
M/LXZHH\B*/%]?$;^2EXW)DB@N_#QZTTO)S(CI&H)@S3,3[]"J^97\S9UP21>
M4;S^&$A@BA AQ]R5;S-I305>ZCYW/7/]9*9^D[E'OUO4]CQ*G@K,<S5"*9'5
M:53@?0(5V+6&_3&R::('=3ZA65QA2Q#]_. H*Y(K&;/1DU[D0K8@(*@ 9_0Z
M%=BWKMPAB='>Q:]2@3#M _BQ[*0WA=N0"G1Y$I]J><.+CVI(9-H[6XJVR)]:
M\"()>H3HUR'QCE"8C$1(/!"\5VRG);)]0X1KQF;]]9HE+$$D-&5H1_QU?V>O
M$D>EV,M-@Y%!=GDHPO0XF)8L]RAC*&PEW!')$7!M9+NA3PY3DKJ"%G./+_X^
MRQ 7?&7NT[LGS>NLY>PW''>/44:8X]J"VK-F[=V[2?7B>?K%&WL@O1LA5YX)
M72D4S^N5:B0G@^UGH/@B<J;Z>>S&[4L:>NW'V:KN#WI^.'/%/$_[H&VFW/KK
MELI%=I429I0Y>&X,.O&0,(Y_CT.TS]R>\HP-DCX5FW-OH[FIGK'O.:ALJO J
MOHZOR2WF.)T]5[3 TJ^1?][^72O1#Y<WM+/JB< QS2)IB&7*@-8#=:G D6PL
MX;TKK5EF;N7!,6(T"),,K>:%+%*!#9@S%0##=\UIV!4/_L]V"Z<!T7][A@9O
M/(5&SCP51?[HX>_A[-LM*-(6/BER+(&Q7JDBH99#); A?P8DMV#H5,W S*&!
MUT+4,BI#DM!*8>>A I]ND6@14:M$22^2JI&9_]I?<B-1,E%.X/Y58ME$U>+3
MB.[7'S-4.E2SCYMF\_;$K1E;8D_4M(M$V ABNZ<C+^/.%#KF%#?'^KP=N-'>
M4*+M5J_\JU]U'&P30J1ITS5&ND$%RBKN4X'A7X4'*;MN>5=EANT[373[)*;)
M]_]MO'C VT3]4&1^9S4J<%J""BS6D4LS432<9[7G>D2D15@G*;:6TMY,!23F
MJ4 OR? ? JX%-BJ"=1P/1]FC)U8Z0"HC,,D_A)*-%M5'DS7X!S A?_O&&+X]
M<5-X)>BL=LFM26].1H%?Y(WOVUNBJ*KXTUFZ3[^PNHM&%>:?O1![6S*C0R S
MWCW?<RI)E7+"5Y:M\ I%CC2P(!R!CR5<<=ULE-AT(+XDW29X+G6=CPDN^.51
MOE@6W_+P<M6SSOQ=L5@)B656-4CD^.8G1^UBY;$/P[K(+]B#"QB)TR[A,DDW
M:Z,>],>=H9O@\9=<B:>[P!,S(6($+:%P_EU^*U'WQ<C(/1YN CMX^]E4./ =
M?%W#2$PIW/CFX49)'BRD)XPOBL-I  [KPK]%:[EL+%3@Y,Y(@)J_2H(5P=J'
M(OSUII)BKOJ4SD^PAW;'Q:]O7-"61^G2';:O/_O,7XLO-QBX>SA%XT6Y?A.*
MS'P%JIZ)Q%=4X,[BP+\-1QW2;:5"*C#D-8+"QL,I>L@I9JD]*G" NDE#>*@C
M:?BO8_#F8Y%=&,TR;;2B\X_1;&3SPC9U'C>-LDQ6DMG*M)HDBO]9;WWR';.S
M:8I<_[L(EO<OCQQ">E%8X[]EBS$4]<0PY %FJTI.>./AM<%*=^_GNRB'KR>8
M?^9-\XO2YLEE+4*XDDSB-6E!E?*WM,)A3\<"K M$+X=F%'V.7^L4=JI=NF 2
MW8?>1DK$KA 75CH'^& C8#Y%0P&?GD?)IN.*%DJZHFY"5T";1LB[T3K,67FC
M"38@^R^2+!,C!)3H 92=!,K_:FJ^^:I:6(X*T#MF4G:\=RUGBE#A:!Y%=!2"
M4Q'.2T@VJAVKFG%?*MEQ67&J+$%_>WB-3_O$=P  ^(*U^';9JK<'UB,\%@R8
M.<WT[B9UT4#LO=+_P5H-/0T(O?A[TT>'X<2->\^P\.BJ>_N?O6(W_?%$EZ^/
M[)?,G_^*55GL+(L5PDKM*^%M:<$25\GV9O,8WHY@>KSJS?@*A/R6\.:E@8I]
MS9OE#M2V0E[Z5\CB>;ZIT%ZIH6'ND8H_1T)[[\H?3^ZV&]UWW=*929ZE,:>:
M!/!WCG?@*L;6G4G76Y1AK$AD)93'*O-#HHPL7?J4AOH? [$HHFK$CM21*181
MY0D'-O#')2$%KU1E\U].?6LH_>'O&&98\.O]#40&\@?8+I:@+#(_WIQ;/4)Z
MXVJ'D[@;N^0@>Z]RC/.Y1QH=Y.? <9NTSU&[?VT GGNXO 9AN+$#%AAH.-LQ
MV/B@(+, E62SV40CQ[0*D+>MR+?'L9E#PX<^!'&B>6-C#&)>$X/@,@PYIQ1V
M<Z)_\TU(=-?U^P;L)U1<3?GV#_P?K;=D+@?7@2_VWIBV.84L[3!YG?RBF JP
M-_R]^2"CY7_+541(#&4,79/<0@7^H&[SVZCBQ,XD5USTM[X\&IAEU-!Y>-'F
M%A5P[LXK9";ED\MHI&;.-0PM0!G+(BE6T11_@SFZ@7!FE_@MRY\;T.L4#(H+
M^KG_<?R,U+6L.[J-_C(#I9C^4WU[N3D?\E[!!V1$=]<INHA"=.7A5A>V'J\Q
MU#X0&V#Q-&>Z.W5K_\^>VW=K#OR%!TWR'?,G8C:E]NCQM.\(CB YXNBW+*$M
M@=QR)]><[LL6?W]?/R9NK%H4T'IZHW/'\/99R(IA6(#.=Y]ZJQ^C55;$/D.C
M!OB-^?5MKQ3?*6+_IM[UP\OYD/YG%2EC"GG;R,X=L#\&?=K]*T/! AQN,G /
M>>^ %EFI^]KH-I%PT$5"V7SX 8IGPP\9YAF)/*BIBQZ9[E\HE5W\RHI591\+
MU^);O#E5#S9^+\KT7=-"-NQ*9H16R+]=5/OO22"MD9WLH0)!V81D/",N;,2E
M;7*G-<UR#I2?G=2;]![KXJQ[0?J;K23, FAN;D5V*YA5%AI\&IW;'%IY\<6,
M_WJKWNFH4 7QD0/KE-6!]3MSR1U4@(4R!&=3&.#W48-4_ZZ4,;N&'6!Q#R5D
MQ?EE1_@\?\*<SE12CDIU_?.&PLRP@/ZC-,\TIB[GC>_CWM52K0[V6-GTBW]]
MNI-4\8FC7G+WV@T!][S#2+PLN4&=CN@1 *+\P<(R^1]6:E%&AUSN69%E!NP-
MYV^_J=;JKF;JOW.%*'3*CO7VDI]>S9%(]V-'#$7^TO<-DP;LCH/7;K+]2L6N
MG_  C7MFP_S^1AU?" X\?SD9&XII0LTWNF"<%5S9',;/Y>SWOK[TX>RD#OBP
M.V4&V>]*4$G E]"B3(!XJG,N4K",O09G\M!:[=FODT$M)RJLKYV_G[!X-S!/
M?=S%^GV2% ^K.FRDI@<Y9QM>]'TX46=(Y!VJ4JZCV 0?0UB91PL[:J$J2=:%
MCU\E9"3XA/9]+(T2XDCD?2_$SNOVV),7LG_RXEFMVY)=(JG=!OI=VRVH[SN$
M2\F;W\#/P00)P[?[5H6:CDA"!)K"[>S$.W&QKIYY/0:,$CK!% -?282#P%B]
MV(E'E E4#;P5=:+/%1\MO&)L17YYXXSA)M$5/2WE?KV1LXWC,,>F4>JX_B[7
M-U/@REF '4#V$PY%<M2%H(>(193)6JTW!PX"BSP@,] @\I[M^HFF:[04>$\%
MECC!_/!M-BI 2T4BJ*$'WTW^HH":DL!#<7FM,L]L'>WG9]2G9'[%]MY,*)0N
MU:\1]4Y6<&NZ(5]1[&4WMJ##?[\2'Y6)[LJU#<]=-_HD6J\/8]R]^.^AGQ&4
M Y@@EK=%3Y0C[.YH_08)$ K-:SX8)QU7A^3VY:^-Y]=*UNEQ5\],G(4P+ZA_
M5]Q?(7&-4YC\<8;SJ"T!#%28= _;5#8'IO/1>QAJ?K7(JBH'7Z' S1C#M(7F
M+N#7DA$M"/HR:9X.=NI8_J/\5-QBU,QARIK,$=PZMU&W+E1R",Y@OI*)8@3?
MIKV\!?/^?182/?%P8@/-3E%PP%.!^H9HTM7B>ZJG>0+;4VW/=IEXY(2O"=FN
M$=#0L4,2'R/>##JEA.<AA,_=^V9QX-^HB/1P^LHW*A.6/DT?_+;_W6F15E'V
M ]*W\0T27RR>(&(KLU8?D%YX !6=W]L$5[3Y:U6BKB&'P(2;P?COM/CC)\+@
M+8*^X.2L@$<C4WI/8*M-P1[X(M]]'FV-%;ZC"2LP>X-O?H T(3C#!Z']V6J=
M(C3J?* G<.]7A(^8A:V3_XU@J,Z7)[_E6-35FX9)?C")Y)"2U=_1ID.(B?-\
M[91^N*#"P*3.G%PPR3\+04CVJ;]7,W;)!N=;]N'E /%>6_ZAB74.'-PM>\,M
M:95\7F'L;X,0_6L<YB,="C,-5C$88?,V^3"0$6=]9!A,=)US9V3?-.'J*_;K
M&A,FGQ=6)!L4/O_\V2,7306:#<%SM:I*/\]ZBM 'B/\HPW'$G-KPGWGJIO@A
M:.:L!';@=0.N6S1PJTW!DS"T(">PCN8DF<!+'.NBEXL+UQ,4VV>61G,M2L0T
M+#[OZOM8Q#CESZ:=MT.7$97H"%"(\$)L7T+T^5&O3V1_'5R@=)4B13'@%4YI
MBPTG_P@'CSS0/8CV-T_N2_<U!#P>::V&9=$]>@T $"D:#BFFX9"U5X\R[C,G
MBGTR+M=[7G\A,^+JN?_ILOHOI56**$[3T0*F0/GU8G+@'DXZ_0)V]*0<7KC.
M<G>,\XES>#CW;4"(:08B(:X?,*;E8%"TUI/"WHOIO=%[634A(RHW3[@/2A$X
MRCHTQ-/R(8A ND38E?% "U2B6!ONR-) [\NNY;4W()4I#X K!KQ4_DV WDWQ
M\$QJ_M2&:H"2ES?GC.7TA?BK&:]QW7D99D)<VU)']Y'VY$3XW#<H'Q6PU;^E
M](YDXNF<*[^3JE,O\FK$1>UKR_15C4F-8LJ8?ZT37F^F!+D<VZ$<V1S!)P>Y
MG/^+QB<L.Y=DQ@=2QT2&B_F.MHA"\.9F. ?H.CE9AY!F3P68=Z )I_%S?:#8
MU[/U%)* 1C;#K0WQ0.(WGZ#6=DO%ZJR<V<E7EH&+SZS\"RV27MK?&8H;37P2
MJ(G\EA&>8_'&Q!O,VN_.VBI9N.FV_U7$8&"H6*0KF=;6IG$M_Z\\OM5.",&)
M:!+T,8)]_FV3'6G?5JM/-\WCCS%//ES<[KW5M<IH[",TOD0%MMII1)I+6L8;
M0P7>3<+P)SLH5\9D*-##XN)49(!":\UQQ>\?9<IUC_C6P7N@T%""U8W^5T1U
M-K62<C\M/]20-5YG-6_K(M$B $2.)PEYHH0)2:UW:I[ !NBKB86_15I9I9(_
MDD^=\KT 6>+?RJ=]V6F?D?F,QD$*]Q_PNTK^7O@4_T4[&KJ)>73"MF:@5WEV
MALE3'?(3P4VYZA.[(!'E0M*<;W0UP;%7!4SE-J!J'7)<= %N'Z-TWB=T/P$S
MMH!^.95"R P-=;11PC"QI\NGZ\9H, J5O]S8OB:,PA].1S:)XF2S%MC<5TS&
MD#N>^O</>FOXO1,J]_I7"M7*I#NG4W*T^!80!1V24DEJ?Z'Y__)M^R4(#&,'
ME)=T G<0&Z%^OACM [<92;UF/=ETEGV]V[TDM.Z:9&L0VQM>$_T\#WNS3Y+-
M(]\3(H?R"AS[1&I06 ,403:4UHE>CI5B$6V_R[#0&+&IDTI%LS:)16#-JC^4
M>3/PSQ4'9>:))\$[<]ZL$10CJ2U#@D0>Z0QDWGL3Z9]-T#..6)B7"+8QWY*I
M+ PWG-H,YBRHKN T.'6+"P1YR__B#53K77]3A^@.%9#'NES'AH"<;'3R(/J-
MX*W?^'T_WWVPWY7O6Y<=(\T77\Z>\6 =:E+2OK?Z^MXOO*)XX%42@8\T V_N
M@%>YDA2@)%X]LT'IDJA)CE864^Q6>2&]0!UC;[U;[/R>53?X8%OJD K@Z\G?
M-N%VX(G83C"7Y_EBQO>5OCO#EVX1[S:[L=Y*W[UOQ%C/3-$.@,Q'4@$AGRSC
MWU56R8UCBO[YKJZR(H)Y*1#9;;=W\;V&PE6'TZ??KB#5'U='E!_X4T2^[#7<
M"5O*.R=5@O(^( CL&QE;6NI]MVX_R:6KL*<<H[Q@/"#*\_8;NZY$%2P[()QH
M1 5.9<"Z4<\&09<"[$=ERL3WPS'Z9W1N<R2ERLK.Z,X57J]^J..3+5Q%O&AS
MG08?]\F?+Y*C4<^H0"B*/4GY]Y[FL*UJ@H2N:T[O^ ..UR_B'\ K*KV0]LAF
M^0;O\>M54L6I(T,O8X=>*\.?WE8X/CB@M8^&K*)_>PNXU)$GK>A-4;IIC+T+
MCC5"BSB<&3SK8<CSF(/7@5Y4Q+Y!>KM 3?+QZ07ZX8O045/80UJU'0.79^ Z
M-W?FT)$I :SCZ0PH5>WO7>\HP3XZ23L=!CWOM?XO]MX[JLENW1>-%44!48K4
M($6J("+2B:B(@(C4" A1$1 1 R(=$@'I34! 0(E2!<1(5UI FM(B4D*'A-X3
M2@@D>7/#M\=>YXR]OG7/WF>O=>Z]XWY_S#$R&'E?,I]G/K_?[YGEF7?!.WY/
M.>"%D\O(_HU#1UTAWG.]I-Y97[YQ\##^;0H)1\-^YV=ROJ/V:?HZ4_!8(1\W
MD63)9B3(]ZXK4XALXI0IU2ZS>,*X5@ZOI[G\5?_G0I#< XQIT4XX\^>>1/1+
MDIDL&)SH(TI8G-3Y0.G'OMRZ&7R]H]+D@)O;I;%SW\2#]X<M]"&-N2EMO)/:
MZ#<&[L.(;2QZ"MU)_93*N>+V4VLJ?^<0%S1T;S<:TD7+ABQ)3_%$@A^-"X8W
MIWKQGK#>,1L]?:]\(Z/#:KIA](>XU"7I@ZG@"UOHI +E(]\Z'@8>9F&!\D:$
M\037SOXV(/?/5_@))Y.2IN#,B''"[AOWR6CU(Z/P*R=;/"2Z1C.N"O^(NM ]
M5RHBYW\ %HLBFJQ1Y(TC&2#G1_#:,T3L"L!.U*SY\*UN8F8QO?W9$4<S:L0=
MY/YWG:J.C=(P"40OJ@+;S#%RH,T(3=ENYE6O^Y["4]FT[>7G=PHE?QHZH_/+
M:>W2/D?[+M_B@#P-U7>P9RD)-"NZ<N,X-_Y"FZ"=_>.*E(+ B%U)$D1E'=K'
M]#S)&/??PO2Z:+(9O4Y;&M%J31BE"#1O6Z:PB21.Z56?G;I9NS5Q0'"_']P(
M'1<CV_:HZ.4,2Q>+XS,"T2? 5O+JJ4.J6KU06"0UE'H:V8C0YJ=Y7]J%--^9
MHK@05+X?RXBL[1)>^#9]Z_+YY]T2^_0.=)ZMWRJK"S<ICR.,WYD+=N 03/CR
M,,%8)%A59!>WG@"[ K0BB6;H**:B%=J\[0.W!GJ)W?1>'Z3%F%9(\+. DE>_
M2N;>_/BY*)#K/WAS_=_HMIF":JQ65H")I\H"^EJ0E:&G=4)T$[I #TP,:)H@
M6H%#D97J0PN\*E<;A2^]/:1^J4 ]8O7AZKG/JE:!KT,]Z-U;6RV!0C*_BH0?
M/YVG\2JUEZ1Y>H>U]KJESS- RCUHY?=[.?W<?RE-_(<-FK$W - OD \Y0)B(
M6E^TS<*E?%F7)Q!?[X^J?.N3$0'=8UIASYK9G0T,9-.MQ9YH"W\6S<J^(F^:
M$BGA!>CEX)I1554TGC7\Q/);>  $;RQ&8(G[T.GJZJ)]<45M(X0<B5-SF%-L
M2_G1Q-7MLC%%IN^!0H ._5/76GBM^-/: Y-J90(V-L:Q>F;&NSYIB,4O2UP^
M=T_RY7"3S@7,JF@P/8FAQ8_[&#8NK1/*< R06R\SM\C!2-'I');T(H@K/&*B
MTCL&64'S)1R+W@R-+.N]WZF.>,ON$W;"*R0D>$[^LL";2>CK'MV S3GI>F>-
MLNVW\B?#>!(_A ?'\/R4%6>FD3J__ADS(-Q;;31.%;(K Q063J^M5=,:JWJ7
M11&R:?8>R3['YW.#9][X9MKPI<;%$DQN0#RL<H+X=&UYC"FYL&23_H! 7WB9
M*27T([BL[,QQ.5=#73!LS< )[EZ^T>*G9LOA$A'E?PXQA0^XWHTI>R;3&UT^
MMZHW8$/OJ8'H?,R*HGI0IFFI3+@KPCS&4*X"AWS$\(??>99NM*JTW>W/OI)#
MC\+-A H*7T[$AP1K# O[A5"@,'-DXR/DXS*J';)1%R'B,K!1OBL<P@3M(^.Q
M;[EY*AVRY7).)2?"U6\'GEWY%8"&?2/.LBRF!:K#O8NVD-.?ZO7F=O+$1AXX
M2)3V! 37[\U"' /:D<1^,-%4X;#$V#?4%>(9[7-]&^^^5CA<6O07PAG!D[6@
MR(..]1?1$TB*<C[9''(<^1#)23/!5 T5!!CT =@'<\RLQ8HW]L:/R8JFNW-"
MU]Q1.>[:D,6T@.EZ:?^B.09H__*G?(Z5$D5CAZ(=\,=R$UV$<"#Q3VL(90(#
M8-!%!F@XF_R8A&FJ,WX\3*G1^]K;_.E#?9>L]'H>*%A%[X]3&;\^%KZ<.2K=
MYODQW=32B51 8(".+FKO)SD6?%@DH^V+'E4]&[0;43M4/!?9?B/\8$R1M*"@
MNU7_]AI-T)\JC6S21#9>W5(X>6=X1YVC15:7=/#X1Q[E6G!UK4[<IX<6:?%T
MS2@**^9]*>VN^YU'#\3(R0Q05T#:3OW9Z&Q+<]1U[7&"H>'+%$F?W,B0[ _,
MC%*'I02]I 0<_4DUU:4Z(IHG.+3/[!1( !6YXGX?=65. OOO58.$+V]D/X,,
MR>B(!".36.FY3._?QCR>@!A3PHDPDV\[[QU(=I$")>)%3ZIJ=;&@ V1'5HW:
M\(%Z^]@OPB,'B]K\X$0_R*^M4D$]":0C.74V?LAO"O,($C( *>=M6..F2)HT
ME).T4[4SL0R0IM6OEZ_\BUSOKV;5\,NN\R19.HW\+E*W$+/,*,]:1:5#DF%\
M/@;4!NWS_<_/F9Z"%\Q7)=VQ;4;.O.Y1TX,UOH[J0E<QD^]Z5!F2)@T;\4*>
M'+YB_QLA-O3YT\M[,F-YHM],@OI>)0K.I<4KDPXAD!$Y"Q;)*K^ F1\>=QRM
M/ 6?:X^:;09"?XXQ8>N.\#^EG"ET!/.EBL8K0( N5PZD@Z.'D1'UQV(^/1 8
M":'GYK<UT%L:?]YCN3']8_+0HU:C %U=U^MU!A=F\Y:QLBH_SZOE<A1-+12T
M83UG,Q=VP;V2R]G4)P%J]')-(3IZT@@AL'/F-OSB0G@2,C]I^(ZQB-.+)BE_
M1?0=] P2CVM&GP@0)86B(C05/BVJLU?EUU/]1_B&^;*U6G6FA5\*'Q$_H8/N
M1P\> ]B/EY!DAWQLIEZ;.'MW59[6M'#B.>?TP#WCHSEBJ6I-[)#:S.W]+@M$
MJTX9_^1R9#CMP,Y(=(!XZSW?$C6+Q5X 5HG944BIMS7N>RR3&40X!N9^5%F=
MDN;K\G%ANR2R>+4XU^K^.XXS"7VO&G9#H+(C$&'G?$<FF.W_8TK@?Z==\8I)
MGP94 CR)J<LSQ-7M%CMEG%PY&WNCAT1+DX?8O03!1Q=^WW!SBS@F_!W#@YG,
MGB#:0'@1_2N!>.-]&6N' [1>O<F5H2J?<];8Z<[?=D?M3(>_NC5[SRM.SE$[
M15B;3(__C+<[UJFT6/OUT7HOC&OB.Z9K1^%=2OXPC&BB0)%/W9-)9^N)^4T*
M7WQPK3U/@_W'J)O%PCJ-Q]N12!%(0_@CL=DGP164*5+-5!M3C3]: X]14*W#
M6PQ0A')1V8;QLQU.A8>QAWDN"B5?/O#[&[_LM+O/XM?PM95!( >/.-;Q3,:R
MZ?J6\ ;R% ,D,5WO[<?DXKMZN/\^&_^/)H YKBV\".$!Q!]I\_P6V_ TYGQ\
MPKFR(-A#O%1&WKW[PI!V VYSF^B-#WM'-,/KA6N>R9%,S?-Q,@HQJA1JUSU]
M^9:O^)1X9DXZS8Z)"_Y(QS6*#;B2>R(6+G+2&<DNQ];I4!82Z,8O=5@QY.7&
M!/K0"3K$W65Q74:P? R*6]?;T(OEPU5U2L]\\3.%(@FI.]<G_%EWE@#6@C^.
M6@@@&L&< 7"X6HA5N)&KQG4'T!=,M>@1P0.-@]A93OK@<'THNAE+4:>2\_GS
MHQ%"-+Z2-Q?][AH3ZFQ!/S9R)N"/OF&/?Y37/[UP@9]Z-_S 5F>@NH++V.XY
MV$0)Y=;]"/)I7W.;S2V($)/;Z),TXC %/LEF3, T&[%\'Y83G;)B)KKPW#O7
M;/;;1,[<R;Y+[BB- FHA3JC@8=CR%%'VN_"!'BB_T\OGT:XRAUN/9TGU'X\%
M>E_=R9R)1#=@*9?@?^Q$G*,&0&+A]S:>PT/5/1X_3$AVH;[X95T@W(1]+=P%
M0L^G8&2G:I':HJ?OK!SR7F3B%\()1P3 *4F? -QT<&T3N8W^<1,UB"/[X.I%
MEGBP2'CVD419J1G.G_X72S\Y\Y>PL)Q+='/CCG^\N4O+8/KA-<19X=)&P\31
M92>"!/SDXH^<+8W)"K.1]U\?:/V:=$=U*P[&VU^QX*%K&?]6U1 #<%WSDSEU
MK6L*Q&)8+GG+J82FR7Q+K/912L83O]7(*?3QCIBRGPYL8U_);(*Y6#J5>WF<
ME<G#K4!7I@;+\@37\QH5L*^RK$;1<<^UBP;Y^0]<=L:SZI_QS9X)T%?:'H6&
MJ G9/NK.T1)/ISV8(""-,OGHE0 ;I?M*.K0%&<Z['BK_(+S9RU7THPB/].S3
M ^(><5,#-:X:!+UPSV#=O+JLL7M/M8TVC8.6FJ#K-;K/Y452[R DPZ$-RQK(
MZI:*I8/,Q'@::8$B)B\@-T]^88 :F,')#\'+_F: YB7N,T!!1P%E6D&/!? %
MV8MI _;%TR[_8(!^P0$S!F@%NV@#I?1/KG$4"3! /!3''V([3YXJWQ ;GAA3
MNX]EB7\\&:#' !TZ0>'$FW[?F&)I>D=*_/3*90#'GB-XPE+E 8>0(JQ+B_LD
M=HY\KWXC+SYHT(+VQ!R58TH;@;R'"" ;GV$<,8=K2]JFHHN?^H0K+E0KCP;%
M*;U8X6]%'F[UVT9+08CN<]^+S=JL+9FQI=="^$XU"?X]9]HW/MPMJVIW&>UF
M87?ERGX;EJ>7IXL1TCUWU[&*"BX*":MXFN /Y]9>CXR-1 9HQ!125/X_-FEU
M0XCZ3$UB"/ CR;Q$RPH/MZ?*[X0GJ,<L'>_=';79)TQN(VDB[H8#U=">_JW7
MA3*OS.(Z ?M.-^7S=PK?&$QPB1. 6VUS3C3!;U0IY'<*/0B#O_BE?&-K(E1E
MJ;!(7&?&Y6AED]>++5:EXUTC/&UBO3L#Z.5H@MZ+BQAF)L/A.7%LR>NG;[9/
MO#'J9GU0J^6CL['9"<;]=W#K8M3K 2?Z(8Z8>&T%XN'RTXMV)_H_7_R6H[CS
M8*K]56%[45*H)^O2SYT[SURV[ ZV;?S*/&E\IP:MAQEE@)3P7\,Y.DR54VW!
M';LT=OFZ)>!H+-5<9=F)^IRF09JNXH#GW%ET<?H$D)(%C+\>/A;<$#B9\.,A
MJ]YXK/'M(T1KV579GMC'IME:.>E(I89\D][TM]YZ9$^NHHN/YQL37C@XJ!T4
M)KR#22 ;3_S;]E D15(R2-FF)L$#3;$[A8]]F!;P4Y-Z^6/<'&@M<;11&NMK
M+%FP.X!!*=[QQ2\9O-R.=EF%W,@U,0\N$,K,;X808>"A6MH3>H2\II[3OE0H
MQ<.GNMG_\NA ;,1G:&:C03MR*11Q K=E,04^.DC9_JZ>%UYXN4K]:9GSN=A1
MN0L24>92BXC"9N@&)_4:C0]#?P>H4\H:=E_!*RCVYID--<=]Y^,"ONF5Y>&$
M.V6GE19YTC]5SR,-?&3?^=\5>O(9;@U/A^!3&" /'#"NVBZ551] ;_AGGL'?
ME27S,+$@@Z9/?ZG<''^E#A@FOOZ]5D><_2 FH/\,X1BQ?N_UQD;^P:EG7T'0
ME:KEJ\Q@$J+ J=X^+IW$^FPR!^>([BR,XD=/5EA1?&%UW5W.2FP[,N''*->[
M"MK$ "HDP+F(IDXR2JEZO^@]?*DDK_UL15U9VH?,L38^J.F1R83-LW6:/$Y0
MCM4Z^Q%:?#<%T_06HW&K%N(-VTGL88 B/;<F</:[!5F8\YC)MR@B3 O2&MS6
M."'H6/G;\XG<I7'9:W<^K6)UR!6G[]QE@+"Z^[5].:<D-V=_KY^[\EMZ,D7M
M?=K!A)\"A_6Y8L(.NND(+2VY#19Z3G49H3KY&"!V^_4G>OVD7V7S0&?J\UW
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MTW_LGG.@K-,[F5BWT[3]']<R#FQB +9:>HYQ*'#!IPH?N#QM[9/7Z<+_6%'
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MJ.?^K10BXGHV<6/J.NJ)NWI5J'(:E\JX[39/C#\[6WM2(YY%TYZ4A_'Y4<(
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MQ@4V?+B);$Y/H[F3>$V/D,<Y>^;Z>,ZZ8IS3S"/NLPSH&XALN\.PDC3. ^1
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M;:6%J'"+A R?B1.H*V)'YZ9=-<H9"]IHIK=G&EPZ/",R*1BTM7,=,MPT9$R
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M_0#<#K>P2'/Q;R2N@!Y%.[]7J":VFG\1P4:"A6M"\[^.RC^/-1 8+ $VGS1
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M ]3T&^+( .W*8UB1Q+QR!H@PSP"%YR"Z]BZ+0G Q0'@C9P:H!;?NJPM>9!<
M$!VK.D!)/W ->0=)W(P?P@#1Z.\HFG0QA%(-P2^ RY!T7E@HA&)FC21YTC)-
M]'9#PA@@5"GUU7^OFV0/N%OJ;?&2+S[_?M\[UVX7T9L6I0ZC^[8PF9WU-[K#
M:NO#'RN5W 0PT61M.%-AL(E\EA)*XNB\UG<Q\!SA=\C^:^DOIW4>GU<3ZTXX
MABS]Y'- .9??M,CTXH<:9X4TI?27=W-+V;P!5BNJ%L7>IK;7$QR+//[$DTW;
MN[*Z$M7L57"N]F.++9_A](4O(B&_HHK^S/;HF?VKJ[975JWF$O7STSH3]<5X
M?$^_31%?U]=:5*<KN[$+#_>GCL8G,T!W%I\'0SY!_J[[X/]H6<!8*O_?[:&P
M%8=>%Z.J57TU_'KRSCOQ*%WVN'"9R?4C6BW:]5H,4# W,  A#L"(MR"';.UL
M _.;M8_'4&R@"M*)5R4*"YO$$KUY_#T.I&A9H3[++LO0<+SA*<+E'XU]*NNG
M%A_U68@4ZNT5TO-(_]L!$E]X"W;$>W*[08$7><]G@N =5"M1'&$ZM<Q?678H
MM^WUSC!5*&C8S2TPUB\9J8XB>F!I.7C,LEDO<E-Z:>3'A:^.I]%%W4:R*OD)
M36\(,V'9*Z*?$4/(__S("\3\^RA*F/QO#B,(<83@'8Y0I,AT-&>>PEU$GWS$
M_\K>^>-"E;2'JQOWD,##"(.W%TK?"A\1K7(A&0)LCO0:9%D%FC-@'VX-Z1DX
MZP+P;,!R"EF&5Z"2E-=R[>^1!^?J$ .X!B>^)U].%]R?*;317LK?&MW5Y)%^
M(%58M'M?EPOZQO/0!0+^W#W?A_<26G/3WDQ*"28Z;V5,@7>X/(UW-U(9H,L7
M133M_R1H]?Z^GYBD=MDMA2T6IHZ$.&R+36,&U#$_XI<X_N1I6W@C>D0%K[!R
MBA"Y:;R/ID^$QGCZVUC6IW?H#8C49DIQ]_";1C2_9!.5UKJPJ(%;!\/RF*KV
M,926H]$*(]]"(S?G<G&H=#>'X_(G?2+Z7%M@'WI?8F4LB_EOR9KM_G%!1^_"
M_KU%17X2AL9U=5*OR9CW,3]+!.)\@&J/<MU9Q\JZ+W6XE?=?*Y+]LK-599I^
M177\J9LWTAB@0X$,T.MW 4^9>%NXM!.U4X\Q^.ZF+5QQQ,(37)NTT']WQV^(
M?L/\-9=E;/9NTY^]IN=/ W)Z/8HYMFZ[36R08<\N[,4= R3ZGPV\;+I.$Q([
M%/@#\H_M;#U^FAEX$0'[2>^F+8>9E/ERN\HLA7.DC= !5B,'WSK5->JV3TO]
M .RG,A<*A%_)A6Z?88 ^>:HW@H?@X32S/)]2[ J_7;9]@0T#A+4Q?)D&41:W
MV 4NU9Z:HGOC/U>GYX<K%]M<[INR+?#.&]=W48\)>4%ZU?"0G1X:Z$M51C8B
M(<[Q0^V$86E-5P;HZ&P\R%P=&?6!BM@";Y*2OW5?4)I%N;G;V<F^*.&$-O69
M;EDR0$J%\9RF3_M%<5. WF:O+L(5T0PA/EMK9("&A6=[=2D)+@K?89S=5XY%
M_P1ZLVX-J;;\8KT_N3]@VIRO=:,/B'=.?U=9D:_C[>1^:"RWST5.J4DD42TA
MS"(Y_.")9T?0<:TSE+?B],RS[ H;F_Y*HQ\B<ZTU^][U:'&9W'7\C]=]'H;&
MUKIGTY2)*1_0/B'F7WJ>&YT]_*T.4_?N7E5%I%]-S0ENO0+EJ;^C',H<P!Y'
M9\(PW@+Q0YVEZ=BQX'14\YA>9ZV%I)AQV</D1K&\A>'1XUNL4P,84-'*.ONI
M.(UC6^F][C5>50ZXM6^3LVI-3?WDV]#5_R2AV4W\#8L:_XT(F2YCAB(<&PP^
M7>MJC\>P!EA3_ D*)QX[I/3>ZJU8<HG.2/S8W2@&E1NT<%05XL)]QI'FJ-HT
MYWZDDT*<]BG2;%CSX_J3_:Y;AI[CMV\^<&N])$:YN[]XN17S>2(4=K(<'8,Y
M7JM%&&-U]\SV01E5]<LY@-N.]WR*0'R]GS"(^TF2Y/A4>=LMZ;5#_[9>2?(L
MQ-ITUO+1Q-X^1&/S_WGC)K%F[\HV[/)2+JS+Q8.$P7O6=97'<I7H$PPM?,9N
M\=U0>*5SD-/D[Y%Y:><AA1DH$OE,IB4+U#$'_]K=.@3*^ 5Q/2JU(J7^QHZ^
M.YONV6__144!^YLI(?_/:AE;Q&'Z5^UC-*.OZP$:) ]\9HUVOSU;>.3R9XG;
M.F)2I3Q"' >]M),7?MV5Z),5OU5Z?>I9Z=LPX?<X4JQ=+%&!7$O)IEY8/#]*
M86D#Y(CY"9+I(KU;TO:5"34[KYS:7_F%FW+D/L--LBE<J1K'F#.3_<=[!2 A
M9[:5=LE9&%;( V.*.K05.%)7U@.HSO.,*_V^4%)?]W\Q]YY1377MVFBLB"BH
M]!H4%! !!>DEHM)$1%"*M*B(B$B3WK(4I#>E*BH1$0$I$6E20Z\BO0N!T&L2
M2DC/MWC>_>[O>_?SG''.&.?'.3_\)2MKS3GO^RKSGB6K,36@0*RZXT@SI\_,
M03V43#_Z,>PQ9CRF'EZ&:1*$\]+4">>06%OVN34GE]$HF4?UYZ2RGFF80G1-
MZE5$9P\*D/[TB+?>AU*O>VV4P0'R*!'_DZ(21JU N>8 ("LE^OQ%[QY( > )
M>A_BMYIF1N8LCH_DUE N\*IU:GSVWJ!823SV=G:TM"JD?)^*<)B/-QD4PRP.
M0,>W(#D0I7\8T\52:X_ELPC9R?(YJ4LIO.>W[<LZGV?7]@?Y_R29X)G_'D2H
M\O\7JG+GC2/(.IKT#VXY)W/:W%Z]3/#7L' 08+B(0@L#8"\0,#].;*D)+(SF
M/"-W2GQ%0*F_+":P051%-%2P7+N];1B=<%1:%7^(I[:S.^ +$W+WKE\\\!0:
M10=;UH&N1Y.D<MJ8D+$J<,1?P; ]<9>7Q"!G/[80T#]L JS_^+]F0F93*&>I
MH'=J&%;[G>+A]C7(%:]9GN_TNK#(S\:?5U+S46E*N;[_W)<WLT)2W7Z64ZQM
M?3:#+HKS653D4H]N>&!$[KIZVX@]<3QZRW@,(#:17*B/_8X'Z>$G6JK@4040
M>*G>@?6J[X_Y636.1YUQK5&+G1432]^N(@LD+]ZZQ6GNG*7YML/ 4^\NJ/BN
M-/Y?+1A2I^?#G#!LB#88A*9#X&Q5AC_N"])T6TB^Z3^2F%0N[?>2VJ\_?Y?]
MP]SK?6)D;WHMV@TN!#;J*D)MBM35JIR8_:.Z+>M)WR^[@:ME$O/AIU^PUMMN
MWK\<*Q^XC]A&$]JE>G00 &+: .+XD]T+09KX(?/5NW?=$E?-,D3_$+5NLG_C
M>)Q^/\!BOAM1T4 6=R=YQWZK):_/H:=Q2T&NO@G>Y]5.(%9H<!H$Q+QUXX.2
M12A0K:($$+T(F01MO'*8-Q/"L[)I3^>]49RX<MWTRA1UW^@[C9('>J8ZP4[3
M:)*R(_$[ ?'!U8$4_.!S7L/UP2#MAXGZ[/[CB94V 4H<FM()G&]GW#>&5G3E
MNK]XF38.YQ>J5&QJB7ZNZR*!.O[@/GI^G8"U9A/M4I)-6;SF^KFX_'M32OZ=
MD:GPRQGJIU<;%#?A\0CH*N:8AJ%6'-:6TP)/+'[JH1F?XW@V^Q<,IR=Z#';2
MF".^Z2'LI8EAWU<C&TTKH#G&+K<=;%!!,XX)>6P\'MB**69"6F44VNP@PSE]
MBO2+ZU/(R\H>I]@:+@>+1^'E<WI/AD,2EML8K&_ J.;&C]"X8HA>9037Q*BO
M?A'&THY8&;ZZQ0%9XMSZH@S;9E^%QVOWSGI :F<;1SNE1]Q%@QHF&#$ZSA(U
MM>* 1Y2<<=*2*COX=J'XS0L%%V$[GN9O5WHZNSZH.\[_1)X)5PO-,T(0U?W)
M0-J[U7G5T*;!N;T[%#D4*,C/GW_4QIB41&.GKJ>S]AH(14ZDZHB)AOXY:3HR
MR_('V:-'$U9D0J1.]P%KNM^9D/[J%=HX"H1ZDNKB3%MD$$BHA[CZ-KP*6>X-
MKJ<U*)U\YW(A^]T!MOQ^B^=Y_ U"@=$T$-C#3L\:4[@T3,"/S@,?3:=W17QK
M<"B]XSRCQ:*0HQS]WC"OJ\]6CR;%(0#T9F(3:-S&3$@S*!"/7FM%;DOZ98%O
M ?F$H+A&#0!^U6U%C!F7J 9(Y_[]EYM&-&# 3)Q.H:*T8*W6.N1QR )/M [+
MZQO?6=)S!U]]_+PAP2IC)=6GP_WH$)>%GCT^L&7\8[*RTA0/0;BEMO%"L2'/
M>X4ON4VGD\,:#I[0YI;_8$]0Y_H\U;XH693%X(J(@RW=)N@QCH+(A7WR]]<G
MN!F3TZ8L?B ?/]^V,/G;]U\&&E\3<NA'123WC@-C0FA&(E/(+;D:S62J G7_
M?UKD MR1_76<_0W3,?HO62K:I771'^T6EU_J<)E"4"TXDMHJ\<<DK D7DN[=
M,WD<6^O"E>%9QW99W&-\/AI)>>0W"RM)JRAV&G[^QT;_=<-^?O$W$T];/SU*
M#(1(D^7W!#!CL)\QQH24)S1#([\:B#39# E[9;LW=7Z/.#%>--")/'OB>STY
M1L@3;M]@R>$63]RTNF-!KN5=8>C%9& U,Z!OW.2Z\K![5R/4!>F;Z'#MHT0Q
M(8?+]PQM/MK9^&20S*!KN1/\E!>NU%(\\6-^[ECXFZMY*H<-?9#BSV]>BG>_
M1"7 VQ+J8;%5%6LX0D4C0JUW,LD<GYKO\FUBWVEMZ6MG*N,B%^U?F$5X/^0X
MC"["A4%/;:-BP;Q4QZZSNY4^F9(8<-FQYH>A07T5A0RZV%.+,&Y3X7"(CC^O
M;N2\@IZVI J%GNS1Z0]LVW34!DFT*>._C[2RV-J[/4N#">F\)<AHT00ER]4,
M].<JAC=L>A%)-F@"1G- =[5T9V0$KT>+1:^/4$24@AFK6WJ+WEPF\._($WLK
MTD&H@C 4G8&2A%84&PG7E%165S9C=$/XQE#H":'6^K<3PB8CDDU5Q<*KE%'Z
MASJ-)_!2$.J.TJ[@!Z=\8K#=:C)7,>(\$>YD;! @Y,K/Y_/H ;RM!?$;:"A
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MI':(U*03A*-D)3,A/2A:.GPA #ZATK-(XR7_YV-%;FT8O,](3)F,O!<>W9#
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M ^O;$]X'!.W#%>/TYCZ7.Y,G."W&AU-NK:-KD5_O)%S@"@33T3+U/Y:DDLK
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M1C<UJJNC?[H#.!HL_!GDFMKR:;#(QT%!-%@VGHRFP9BDM&BP1-,T"H?>IO
MCH#!E2.BU 47!+V_I=90L5=ZK17BS0R?8$[9COCLTZ(+]_+XL3](&>>9I<=@
MD>'2$V=E4?T3CNE-=?%\D.)KXXBEP?Y[;S1[8F1!O1&Y*EW%MO0.+;O;A?S3
MIR ?QGH8V*;!-'&0\P"Y+!)I,$&L4';BN^N@YI;09A_B!77FWWFG5M]I](G=
M)X$NF*_@V@ -1B3"X8C92@KT]L9.Z&V3O7^=L<+VTSGS3Q%)P>UJY8;3:/\%
M2**DQ$3,NB4H#?5P%WH7>1[QEY[ZH*!@0Q?>7C\E.)RWAJC=H,$ /ZVVKATI
M&HP;ZN)C+QK8@/^UIU7&TSNYK%-(3U8WXVW,>  -1E$5F9RA<M%@D X!YBX(
M2D#B7WOR/\@1_'L^Z2L**%TK:FA0D(V\!L:BH2"*(ED.!]6T_MI/;6B,>L'E
M;>[1L)&;H.-6)NY/\YWSEYYL-#3A-[,HL<L:?\ON;]G]+;N_9?>W[/Z6W=^R
M^UMV?\ON;]G]+;N_9?>W[/XQXRX W^8/ZIOZ4WX].J3E,'+DI$)!T4)ETJU;
MY@V3 E>^>*L6L\LA\=Z2%RFNC0N;>T4,:+!0Y^/%#M3L6MO;#79K7C38P9$N
MGJ:4IY]ZZ5'J?G8[7SVVF/U?U 6=HF.2O$+D6S>UJ(_=F?4F%/0WF]SLQ636
ML?;B!F,)IRIWY5%?;3A)F&B*23$PTJ+@D^WF:-Y7?AR;5U.;,I-V+[E4\>GC
M18U,-NXJ^04.(V3DS0+Q%.^3-;V[LRU7Q25>&VER'H1#0VEPH\$(Z=?W*CK>
M'7KS4^H$-',IA*<IUTF+#1<#?X8XE-C-G3:J5!.]J;I_"'3P9E:?U.X5*ZL)
M=74M=.8]DY7*J'.LH$GBS-11C0."S[&+PS@6J,,I-'!2BR*$$JFB9JD>?,N6
MLR#[:%)"Q6O[7G$&T;TQ(5KBZ$>[-X_/3U\560%D53>-=\)]EW&17S:WU]<V
MU'U5.[<G-V)<37!YZ*1M5DT.LWFQ]O]Z6?7?S72F"1DQO-(J#9\%N4BM:=Y%
M?F'(FH1.PY)*JR\/93/$XPBLGMJP_3JP8\9G3A<[WY-[Z:-5BVZ00! RAW$4
M#M?-_)Z@DZS#4JH2N4N]M88%5R.Y?'0)/'W5#+F($W3SWT+9"G=22-*A<I@(
M%%-WK<KK04MGBU.1SISQX:^J[\7T'^X]<2+A\^G]M4P@@S,-=F#])YJ0@?ZX
MC"'R&1]<B=XX41T977X%3J;! LP.WB3 3YU?%9H,N17_O6\]%2717#7R];SZ
M#&DR>VT91"=MO;#99UL0B#^&I^R=5GZI=FXOX?5]UW% 41>()@H87ASPVK6V
MU.PO^KW7%:?#/,I^1BN^EV3R](E6G?-/?857/^"=*Q0N;I AM@!2:D6TTQ<I
MR>R:6N#AA$\@[LC\C:#=Z_#,;E,:++/$GG4S*:DZF;Z]G.J)&L:7=#U&W,</
MS5@ OI,2;OW*R=L5ODGYBKSZPW2_K"\%*K/[S79\CT]UH-^^3RU%V,.YP29D
M&4LY::W5I]XTYZWB"U>O&,WZ I>6QV;74_H5&8/[4I\2GS[:Y69R7!#0&NQ'
MUR5.U.QL[79%?UN=N83JQGR&@%%Z5?4C--(BU>O_G.;[_]>&Q;L#BHD@@Q@-
M=F2(8(F.QQR5ZT]L&S]3VAII^U!PX(>DZ'$9&4R-A\SD!;YDV<K098E?T!,X
M\#"(=L)RFP?=!Q+?1I"X'CVL:=IQ^^J//&IS=7#MN2!S[=FZPR=T#JG/GW,?
MWZ$,Q/F%;G625BB&-!@$?8B:J@WS4Y;NF^F%/10:K'VO[-74SNW_RQ=+A0"M
M$$^ZMG><5Q?<7Y&F.+2.$_ +%OU$^E[6"3FU[B=,&F<OG-,KO\RB^^3]/HFP
M#4W.>KYCQJRF\ODU.O=^7Q' 4/@6S0\YCWIVOUB"=//2PX9ZJ>YB+R0;X+.T
MB%V<L9*3D<Z:[6@Z\OY-H83$&:$PJS&T+H)DX0Z(+*=!;H(-N!=D2/23*H.\
M]SA_^>KZR%L/#HM>1KW@F(<]-3RCDZX*#,-M\._P!%6V]T%RY(A<(@UVU+DR
M7;TR9U0M=REU].J9HKN7(ZX:MPL-++W@\M<[G_.U+!U(FZ]-#/LJLTUT=)O8
M=##A,+*9F_G?#V__FUMP%81H$!D(U75!DXQP$%T:!H4B5@P!0Z+E8^6^^>7X
M<G,4J>01L/W<[NO="_$\@L=35*4I[)T@0]@$#CCCWDK,O?7"*_&@DSM_O>B
M3YQY8_,$CP9Q671?:$+8P9>/PJCR00<!5J+A4 J1*YK@?F#NJ!/J.&D#-[2X
M=.=+V\D78XG2(B4.CG?T9-D-](.0'.03C1K$!RM;B;Z40LIN,#71]W3'F'.@
M2^$8,I%"]YJ$"9?#[P.0AC_E7/G<9'6ZW7)*/Y95QHF:_L@.OV+"#X/!@B4N
MQ4BL*HST81S^^;ZDWX7+MO?*!4-T+/2T,Z[2,6*Y7HBB7E[6#4H[^VQ[\=T)
M:SE_@GPD+Z0TY#Q_7O'^"R/E.52V[&J2TOR@;D<=O0.N$"'"NRYLP?)*TZMK
M4J]%D+NWEFU"CPJ_]:&F>\/M+'')77(YVRFO/)6G,"?G=N'^PT([)HQ@+()0
MCB==H:IL+I%^=36S1O;W!R!;EF187\E\:)AX_N3V95G^@QG[HGZI\A]X6.FJ
M15GWFVS@;6LRY'&Q@9,/O?3/60A0:QJV&;)NOI/>?U/)_JYJ*#.J+]G1ZR&O
M*JE;SWL$I']!^D0Y0"HM[?/ZK=]#,^'_CBYP[GK38(<&P%8D ]H),VC7$H!/
M5.?SDVA5KL,FK$C:UO7+^4F+Q1SL69^Y%5:=?%0NX;-79\D*,@M!6D /X< H
MLT8,Y90; H@!OJ*/_VB<$(M,51BUKA:<AHL46"2_>U..2.F0V&F"2*\E^(T&
M6[]4SP$Q4UG(J39#5)2EDOJ2!IL-#SH#<5.''AHLJMAP8Y>9!E//W<I!;WAB
MUW*V5;-Q[Q& -VX13X-=D2 :@L<4,!3-!V@N!"$"\;&M94%1#_MX^&SLA>^=
M\8S^ZY51&:M<W+>Z;.+>>$T^,F%1:U1<,4Y&2J\=(P[W=^N1$6DQ$AMA("/$
M=0]]\0LCX"+D$=P4UGYY.-^< J,CILEL%C-,OB)C_CII?^[WGS28Y*;($W7D
M^2CZU8A;Z0SF N8"#*:F/.):US6#':S3;4MZJ6]YS5;& G+:FHGBQ%^=)K?<
M(#D\ZH!H::_[8A]D:S^HF;6:NQ?\Z*[C #%2X^K.;E. =\NW9@CI_,62ENP<
M?.Z\D-013>E-)Y76;F::\^B^L:K"5B;-$F2V[V0\M7Z//GO3;"/R3].%;7('
ME"8)R#"$(VX$K_.#PD1THV_DE:MG^5@3*'"B0T6;UZ&JUO1)-DSQ: S#0KA@
M:LM3#Q/^)K8-/XT\AXW*RT'WC53E$<YG3@7MI1'W"2K]KHV/S,>1KG4!"O@6
M9!DJ/@_HF92?SB$@#MMD6YG/5K1S6_;FJ$:D!*267SH?W_%= R'^P' !OSCY
MNS[?P=TSYA?KCP!(HJOEB+>0BV]_SO5>2S$QZJG@U2.9'0T!D+F:M4\'V84V
M?NG)V_UR=B28!IMZL63KJ;QA)D?M ZAMJZ5$?*2Z,#DXQ6I.F:7TG67.\W1+
MO3..F@_VB>L6'&^@%YQXYQ?6Q)OV&!M>7)B'=$X[>2"4K\8WO",C9.0670*K
M>BONXR=;/3]3I3ZCHP=-C$)>>\%,] .; GQCRJ;+^B0ERR5TU->YKTO^K.R[
MQ6;#2]YO-?RCAX(DL5ZF6IEVOZW'D PG+\6 &6@7*#82&E@D[AH/6NG6,U62
M6.J$[ 0+B9K62H6"GIOSZEVG#$6?;PE^E45&(4@W<(#(0#,>./7]0V7UI]@6
M=;JZYY?M)H+5V9^DJ9WX%/5,857P 9-,):GFZ,6=>WDQY_SF N6V'8<VUH/1
M")&.UKN<I(47"X*SVS(0?7JC^CH[9D<+9& FK5T"2B  $X4@&G_,:<<']WH^
MO;#%/P\_\GYS0%MJ^G9Q'..'=OJD05.>]/GXX_V!FHI;$NDWWL[?C)?O&UE1
MO_]'&X+_Q883_]/XH ^:B=-@RO^F^>9044WHKH+@641?!^Y[XM1J#/@!>J"?
M!BM%4X]BPQ' M6$TF0/=5$2#.=!@.\)(1C3I!>3V)T[38,@/^+5Y9 #K_\KN
MT3*X2FQX&9YN[[I 7CE]WM8!O6XYM,#",P4%TY+#K\M"I2YY)9S^\2#_7=9%
MR#-@W44GE,V?_F)\X/'+K)?0]BNEL4778$LU'9K@'-4/V3&[$B!#-*2XYD 2
M-,/P*FM/14%FP/U ZQF*5N"^E*5[19$)W9(%+QZU2R7Q/M%P:W)[>(?\]$'9
M*Y?57S$*.9=RG5>-S1Q;R]%-]9Q]JLB _F&#E^AW5B>.6TCH^;[JVP<K861H
MU3Z^Q4E5 CO0I,ON0VV;QMU%ZET$/59>UXI=ZPT,Y]7TC)43&9':8T'/H]14
M/_7&'4F^ZKJ@)G:U](>DZ7!K]W#'D/KB]2LEV50.F 21K!JL*U,AF)*\/(9C
MDL7G-J6X;(BY:SX$ILCP)FI@0S^YLW VO3Z-H^BC8FUI\D&?A9!;1]+;L(O3
M?NSS7 E7S$4\RE,C+K->DIC!#QN##$:["+!O4Y%I8B5"G0_\\>DZHMRKT_;M
MO+C6Y9F&\I>"B57!&OE-9 I?>8#4V3D\R1EU]R:QS7VL:T5K-4D3E0)%) 8(
MPI@A+]ANP4F#Q:-X;/"4JR2!)\Y8*?OPJ^4YEPI31&-"I)KM#I2VONM@N19X
M68DRB*W\[* 4=!?A&IDZ,%%G1+ASKL])+_G=!RAT'W[XVX=QCJ&^(TO=X]&N
MTK'*[J%!=%G6"Z!P[Y<S!T08#MCQO4WMZN1W34J[ VL7T*;?7-C<J\9]1YV7
M<JI;LCPQ7O%CD"89\45VSC1%QSG;7 FVN*W;Z1'1]?476^2ALU7D4JLMAC0L
M'A?X$;^SH4+R][ZG1QWNJ1FD,!5G@8>!;GE10*N9L"_9(!4!!Y;05D@&G",:
M1CG4?:>$9!A:*T%4T=88$4S);7*Z,&_0<B#EN\[43/IBX>2\7\C*;K6R?R>X
M;^ER)&?=' B'L(0E!FRH/XOZAF%%J<]YFOOA/X,<Y+NUK\Q,N[-JA#:%JI/?
M^ C]S@I<A$9QNUXPZ-I/K#<FE'L5H&^.X=5>=]U]<;;,M75JB67D;4C**+?&
MY\/T\K,$OQD&4ZM/44K^R_6!B,_3V*:-UU@#*WP8XF!^<=ODP&=6'M17)(>W
M]"&_%8TZTDK4>MZ(6F['AO&6_=7CYB+WW\WK)OT8$$"Z,K1Z&(=5.X:=_E1O
M?A]B3.;"FIQ46QKLKW8J\;E+=L??4:PL-DU^<[5R._,9W=EGTB]3A_LIAO_"
MW#DIFY".>*"X '=")843/H&."!+)<K;A)6V^I*9NZBOJE^NY6KK+ZGQ,VKP:
M(K[LZZ/$_TRL[N%4K:'>^>)9XS!]B87[<ZBWSQ??^5FXO'F36:%ND!TC,=<E
M^I]5ZXKP$9@C% UR6ELU,IPBD8.'-*5_AJM?@<OHN$/5D[40^MO[1#-A!Y)A
MIW"N--AM=T!^LA'%\6,1HC^)U1G@R8&[^TU)_2E>/YPK_!N&Y.:B'3SPG?87
M/64FI]4-G%_9>@)X-BF;+_=I,*QL)4-(4;3/V[*5'Q39XD1# #$Q9M,J48AD
M F*FAXD'DO2Y7LJ^B?$_\I[[ -P(V8]M2!SB([I#W/>#'Q]Q):Q6_-WEXW)C
MIWA.)45>]=^_XD/P;,Y4'L@V:^TCTR''C'J^(TD(XY%(%N>5+M+>$?WCW/VR
MSFFEEE9-4G4M-64W6L0Y_%X9,'Y0#3TL%&9DMBE/9B7"P]7/SJ[.@1*DKDB*
MOJT,SU1%G]>L^PEO<,Z<\Q%_.L"W"0%FF&L]$^I'@/5T+FE<$3":Z+]!9I+J
M<1J03N#2,Q7KX-_WG'%?LNZ%B9H'0;X1!6>MKO"KKGAOBP&RO!0U4_'UW&\
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M5BIQ_%Z>>!HCBX\>?/29['>C!N/,U,TU$FB5%NX>2%%&.88)BEB-K\OM58)
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MF(>PB_>QXX$+P'CP3TO0$ X;]R.)PL^N1]6OPVUMIP2C:^MJ? 93;E]\1XJ
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MYO6FRQ=O:?99][XJLCJX,@U@+6<XLW1F4U6@F4E)W'C&,M2^_R4D2U.3FA/
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MTJ),,GF19H(NS=*3Y)/"NGG0IZ,;!;N>V#&ZM\AX.N7K>H\[@N.GLD7FZ7]
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M5>56Z/GI]NLP\9HEU7.U'X6J8J7WV94QR3^U6."7YKY#:*_)3!@GECAA0(#
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M:Q>6OXT[%QW3++$6'^]X?5([U8'/Z;2AU\.[]0.XEAE6GRX7MM3YLKZT]U=
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M_!PLWB4RB-$U(Z2PY?9,PXO;[96K-!%>$&0UG9<H-FN_T8@< 7:%\I P-"9
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M)<9]B,^S^K9)E5MZ<780^,J''E$7MXLM:Q_QD+S%>BJS4(7^R_2='T R\/W
MAT[G:MQ1/VW&!?;__W/&@5&P+A3NGG<"J/9E(1^./L+;93".)]U^6,&EH#5<
MAT**5SMW1YH] #B#')<;]Z6R)!+M</<UM#RP2Q^/ 5Q-AOS6]Q$B)#O6B6[5
M<8:4>?JF2--HJ[*V7\2X<V%-[G=WJ!9EQX"P72TA">LW'1X\SC.(! B--).Y
M^K 'FR/8&\ZXY=:CJ#(WH7"-"GL?@J=L=Q&T+[KMR9F<N/J?*T4HYV.  XJH
M[());_F\H;0=-^:!U^CD\'RW&BL@3#=X--^'-<H6V?'4%WZ,_(M@)!K<Q?%&
M7]L+9;LWM.<I:1*OZ^'LY)5&(/Q4OZK_ZFJ2@[0^2K4_$,4?VW0%MJ5M2YX[
MM#J"2AC=2OH!"CK</.#Q,V;M:[?1:T846T^N$B[XO*G8K,BS^A1&?\J"&_ Q
M^&2W7?,]PO_R>-%_1OM,3&VW"8CW$ZR0 P]M5-O)4Q58^G,6F#5Y&8++\D^7
M%_^)MUB3FGI(O\R[20-_NK]0'LHG@75+8HC,6)LW1U_:SAZ1.I+_:QD8//+F
M!NZZ9KJ>8,SDR*$,R1G>R@EW!8Y7V4'69CGA/(&/QWD]0]KUD)M..BDV#YDD
M7@/D;>ZTG<=UH3Z[2Z_NS,IT8SSYM0,)Z8?;A[F6TI+MHR.RX$6J 3Y:#VZ&
MJ &2.5(),$JUS=I!ASUS[9\F(__Z+ ANU4Z=DAWOG>K^H<B+7D%_.?$&Y#VJ
M>ILLL(IWPAC6#S?S>#1 .GY<E%]W5+-3L(Q_><JN*>.Y1@Q[;@\D)!V?>(;+
M=1CVVSXDE!1*T [@2GE\Q8,M*,C[ )A>!3;&0] #<<UGB=_MF+MR^<>@TN6Z
M*:/!%?%IJ>R,@N%U@NFBF"B=#8\,9&E\OG@_KU_@IN)&6ZQ4*?M_ O?X/]3\
M4$PP%F+M?'&<XQ\H/Z;"M]/FU\*SRK_E!0U9_%W8SZS< 4ZO-#(S[MYX]/>E
MKF'M$]^'X#7@QLFQZ :R);%"O*80#[$;TA9PW8X.U9[^4ECV4Z.$8?:V-;#C
MR0N-8C[D"&)\CLJPC>,B7+Q0F\N+\VRNP-HZ%%,Y60(3=$UGZ>=NM1C0!/(7
MJ1R/15^1&RV.2 &32:,^;Q3Y2PC?LU0.L#6I; !>1Y:BQ-$D7A2PBGXSC9!.
MH/)YGPTTP[Q/K,4ZATC-RNO;\%U_FA7__N)ISAM-_LC18\ XDLK21N0E*11^
M*9XW<M.6(>:*EO_U>![Y-P_JL/'];/X5M6. _5]"E_3>I5BB4%_<#6)CIU&*
M5O[1CX'\M@5BL/I4QLEF6+KTPBG73+\++RUQ-C:VHK%\HO$&0G?H3I<F LY\
MY-'B!O_*_?A?,':G>J$.1![TP"1SF_>GP.6V!OHXOV@UDD2%D_"PZ]SL _2F
M%QW_<WUZI<-!DA6-Q%<< QBH5XU\/I/E\*R5N#[SU"5;QK 1OY07AFT_V_PD
M50<R>P%\)I#AJ]*H<YF/<8G$H#HJY&6W%E1&H'?$R?<P@5(&1T= JJ(W2F6]
M+^.< I=U(B1))FW/)M\P9SM7M,5%HL,-XUSY#[\R(A.]-L6'MA;# PNB A]U
M7WYQ!9P0UFK&)AHQB:J,Q0],NE 923@70GN-#YX7,Q>MJ?=R\-#H<S5J8I\O
M?= K3UH^?O<5D8"L;,$OWB'5]0;L)B9M!<.D<'@A+=X*?ML>1(\2#PE.,H&W
M?K87'&/I/&@#OFF(BE2X$+B'Y&R3D_D>?'6ZX\+M!_ ?0L7T)=V@''C5,ID#
M3'A+>:])2O# C!8B77$O_"$LQX".R6'D0<9C.JNQV3M#^SP$*UFQ/KR-^>?4
MC3UXXC% .E<8BN0RP":,I17WOC,OC/GX/GDD^<][9\?P O^SYA[3FKC_ZAS9
M_]*:DRD?4.CDN2JY32_/91RBW>Z%\"5TN%*H(UVZX]=C@$"/]IP2?/VM[R8D
M[QCP?8PL '=[]A4"=28FR/21RR<-7F-WYL\*O1WS_72-[=8%'JWG(]CYNFBY
M-C?+/)1S&5GY,&=/?MK8.TH](!@8=^/V4._GV-];MTH_]SP.!DBO(R9TJ0R^
M)'WJ:(*GOR,Z)(EA105X?81L9GOO%9+O2<R[ 5'1!?G;#^<KX#JH[\MD+G-T
MP(:G$&?@&<QH6*'[\XLZ90-L4_[Z9[= J^87WIV^J6$1CKM.=RZD$.H%2I*@
M3 MK!/61TP\KI]MQ>Y;5BW!QJLMB\48&#8JJH-+$IZ-'29W>G.[' (Y]GL.L
M^U4SA6YW7["R=BGTQ#MI/S[-V+N'')R+@- H $F#:*PH=YIH?A.7EA(=,%%5
MQK>9/$4:J#J]$5+Y!&&S_AD9V[7TH<FI^9*7O9WV9M++*,X$'G?3$PW>XO=?
MGHCZ?S01-=*=?V2M8H:-7>\Y!C S8[JC-'4#+G%3_WA *M>8&+HNK%U*96M=
M1P,G0526NT1_[*JLG#9?(*E#FZ4NN;8(4=;64)%"DSJ)YWU%M]/<V/8HCGD_
M-$5\$MK@I_.-:M:W@H6J<0^EX9Q7J/ @\E_J( 3GS;NI@F-9RNUKLX2P^]5%
M@";),L&RB#.J0)>W!L^M$I_3GNL;2QSJFCTU!A,(#+>3[ B6K?CH_C:^QZ7$
MNL?#!VCZZP6@_=/F).J[S1),BLR+B^XZ!K UI\[+,0>&= 8_B: ; P_E-<7A
MK+E?A7:&VK,EW> 8XC(VZG<]!E@<BFAYB13L%TK\\ <E9DH?Z5,^HM!3VQ.(
M>=M'TZL"(O6X7;,ZSR5O-O=KHK39;;\;\]CB&/!4R>09N -T$B0<9GLC(N3V
M!28 O8,;BQ5EM;ZVW^?FU_@6,<,&S!&L\1GKHT_MOGL4+\FW6%WU+AN82;$8
M7!C]B7\PX1L,3-D#_X4(P]%OX56(C?6E'JS<:YATYF_)J]Z*@;S@VDF%W?1J
M^6=F]."IX3,1G=#Y #=91, UKL[+"FU+:F+)=YN>L3*]#3HK,K+G=T/10]9=
MP<S>6*&OY&ZABEO1CSLK>;'3O_YWSU/\Q]N/1K0<F<MWOGM3^;'W6?)5?!K2
M0YY1K#FE8V*\3NN&K_9/$\J!M07R_KN@TAZ]H$9>)M^L*AX*&T<>RE3[#,WR
M2H\!_$U^9: D34?T,0 PI5ZRX]F^SOO9Y,'/*-4ZPH>E9@P%<9)F8GMB"J/;
M[HLMPD,Z0E9Z&V6+X00-F79$FJ!#0I)%D)# X32$=_&=HODR? 9,]H/$K [V
M^%BH6.Z#<NW8;C7CM9'>Q:LU 3:1E*DWZ)J:R,+,IUH\ICK70E\A:6[-!404
M/09LJI$,LH(VJ2+3@;I&=79SDR)7/[C=R<V(#*M7V[#DU%H_ A$E27)054J6
M7[XS&G@F$-R* \G#GZPFVVHNAV4(/U3(!LAWY-(7!OCO$']K5<A<K_J[&TQE
MFBM9'\2,R[CW4C.!;X&5<+) $.:'Z-0LU(J87K)N5I;?G($I<ZZ,2+06P#IL
MK9GP6\VKKNAHPL*H_4"<T=PKQ/?K49 S9 7<8F(AW=VU]+<YNJ9G=WQ\U(*X
M@7H.6F5S4LC4+I? #<OW:\J-SYH7/VT\:'%<.0:P2I_L>F[*+_]_SR+^8TUZ
MH%F1VC-W'NZZ;B+=C6 C7\1.A_8H&5\5C,E3[3+3MUOQF;FCM*)H<>M%Q%)$
M)9=AF<+N]CR<+&A(4H!:["[]V9OC)FLWO8_/JC*V6XSV40,U-' !4!N?'JB?
M9SJDGP\@"SAA9Z[;F>#6L<UAY0E3'ROQK#FRN:V!A_=P&1'*"A&+GR6%U<>V
M>'BV'.NR%#[A1CR#U@_7GEOT?JU6";?/A!GL<N'3J0P72>9D?K=9DZC_ULZ5
MOB6=M>&?6:F5FL-8YH8F9DK*E%'NV+0X+4IF:FE&9D;D-IC[ J6I18[.:V.^
MKI1IC.62IFEC2H@*KHR56I*!H&%:"(GZ0UD&Y[K>OV ^S)?WP_EXSG.NYWK.
M<^[[>>YSXMUV-%S?LO6\25NZ]SQ>_L[WY;P2(&2D-(LA$U"28O/5HZ$\UJ:$
MK(ZEO,D*P_9BY&^YV=B--E4.3-9;_T6D+[)F0U]G4?+8U7UQS8L-J6!D\-D0
MXN.G9J/43/Z'$S%UGL=?S\I83G4ZKXGTNYA<*;0[5E_N*[N@!-(.J*+"N/R%
MX1RM;ET7DEUHV?+:5B?W9Z$7[]/Q@Y#OT%969==*BJ1W>%29(6L%!0Z>W2$:
M:15KT!KRS<TS%4:SOFZ5EV\QB7/3=?&ZC#/;/OOMR>51M8GJ@U5T,$.TER7H
M)LECP4K5I9@/CI[(B1?Y=\UMG/4LH6]IJF ]PD^S(.>B77^<GX8+=$D8423Q
MJZ]H?![';;/H&N'C<8V>T>_3^ 92JRL5C@*CDQ*!,9;]H#,Q-"JS0?I9^FZB
M*I\W\1+:AV&"ETD+2N V5(3FY& T(VLMQ% 5!EL.8*=*)T4+;P)C!OU"#QIM
MBO=SH$F0DZ<Z_SS&G&%.'VMX2COEE 8?H024'DZ*]DQT+O&A.. L@QN]#U]U
M_^>H.,F#CGDWQQOM/M1$U)+M7NT73;2-!9.]1/+A3KN:I<#^TS9;C856!@*'
MZAG?#&1B8T&A]\V*K_K7!J;K&@D&1%H[IPG;V<,?%XVG.(9M%ZYX-3T9"[21
M<+MAN&<<.2;J$>$.Z*]R;FF*SV@(AX^XW;Y>],ZV Q?7[/0L@R'6V#);LKCI
MB/-BG0UU\U1CN].0U%GA[VQ^CT=IA$Y)R;_%^,\5=.2"2#AW-#/T>7'71V?Q
M$FGJYN4S$9[MA6$_I[Z%Y:E]L=2@N%&]4BQ6Y;**/LSZZV&Z-TU-AQ\-!@2E
M?AK93UZR"^)#W>\G^]_!Y$2#.,]C&#BB2Z'B7]#./AX.VK\U(P7Z)&'V;*[7
MT-XVCS-O+:=LPR/*>-CE[6O04YBC,F/5PG#%6Y1Q2'/!,1#%BW :B5-GC1X*
MV%-^]Y>IR++]-DZRQT=-U)@LB2I]4[.*-.@1UN$NS@^FE]>1KF_A>#7DC%@R
M3M@ J&/OZS;J,88Y(FO+&;:L.NE[,*Y( 6-+WLA8-%8Z6813 ETHR!&8F-5)
M7@<>-<CV>!3 JC[Q4'Z?@W4GY!":%E;%W""2O9@$)OE%Z7- -F/)R#VA=D&/
M,G8IUN9>;U[V2F^2_V=+?>[%!(I]S<,GH?)QE'X=+VEO0XFEZP-B$-H,-%\!
M4B#RXLX(+CFC?<.?D1?5_+[9VCDB?C*QQYOAT+SN-@()3JORB[4<\'XN6W#5
M[-[M1UH%<^O^;0SWC\<U-Q0(Y\Z1%O-H/+)6 K;SJ5>F8\AP3 OBN\,6N$TP
MO[47^!I-,6]]3N'C#[0+^C%Z1&XVID'0I0G+/:6:R?9&P#[K':WX8=)4^V&G
MQ[B)\Z48*S<CL:Y"FR0O=,%"M.T0I@E'639CEUL%:J/901[[/&89WI@'$O^'
M'@Z,4PH3'*)8EH/C/IT'[[?SOT%X5C)#](01V",B=Z/U/N_2^7%FV=CI>O!\
MR@O23[MEQEQ)I,X1EV0&582C=)DX6;D9@)5<V^ ;TB.4L'A*Y+:%7[ ,J*"-
M(/0^GV]G.Q"L!!"(F0+IN<DRSYL%[V1G9?P$MD*[6/Z[S#K"XMWG\QO%<#/+
MD#<I!XPCK !N:F6PB;C'1+<IT9^$XF9AFJ)NZ@V,TLB;^Z9*H/5![SF008?-
M_5+!FV97Q[H9)Y+$6CP2;&)I0+VK!.S+SJ$RD_=1ZPY*S<7[52R!3TT/S8]%
MIRD!_?!#NWS+,!LPFH,Z>Z"]8W1739AI]\NY+B6@+3LL6CY9M)A><R5G,&3C
M[V?ZPH_K/,GR9@KA*]L?]1D.&%G\?NF";W[F 8WZVFF\W%<\A!YB2[ N+='0
MRU%"5'8 ?&7+J&(CZ-R%_V.F#"(:J6@ 3"(;6W;HJ#$'IQQI:UJ@WZW^9D@
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MA7P2JB!D/O1Y$FA7707::<?&ADPX2B(_)-(I\^WH*%-CORI5J.&3U^UV'$W
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M)$0*">VEQ3Y4DOM2>)$@=M4_CC]^:D2P3<.=E\T%,I.:"9<*KO1_L%ITQT3
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M1^N.=HBC@#')H"(F6,8C!+$@2"_K*HEY0!BG5OE_'<:>VJI=BE\5LULKX-A
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M(681U7_X42 5-UW5G4IB'QED:A_JWAG]CM[C43CMC(E+01KX\W7&Q[U:=0L
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MS*BR;38)B2*()E!&*M%?/Y<0BYC @/O4%+#U/>1<X7MWB*E]^7O+<:<FY$>
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M?<J6+ZF0XLVWG[4Q=+NX+2LJF:TX7J0O9>1V4]0-*^$1:K@P"O0?A(801R*
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M/,9U460I6Q6E(58LP2=:D5)O)3B[(=@K/5D./2I5N<&Q3UN.=U]>_K/^6*A
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M,?<CZG/L=%# ;MBI.;.EU,;[^J2?NL[3*4-=;_6<:=E%A\H5EC-@M]CUC^O
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M274 **R<J,6XXXJ(V@-Q)!WJ\%7/0MGNA* )3DVRPJQ@,N6*$$ 1YCIZ3#)
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M[5 9)M \/>3;Q)R][I\-/_N_-;66VUTI\?=5R>5,,9$BIO>N<1YKHE(R :3
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M_SCXI&?3D[L/7V[7ZU7)7M;FP??+[]0D"M6-5>[IS]T-=9)+FN<QU^\[UEL
MRB' # J@*(D5SB3,4J<WWV'LJ5&",3W:M=VTG&RLW_01TAY<==[A,C5V7#(0
MX .33&"LW7NQN*,6MD&+P_CC=FUQ!^:HE8O'(SR)3HC2!$2F%K@47Q8?Z'.Y
MIO-.CU!F*(,D!CCC4@<U@@"*:0QR3&4N5$Q52IVHK6^TR9'9QMC(6 O*1=3:
MZTA8O1!;4E0HX(8FI;.8#:!G: 5*6,[I'7%<EK%Q_HA7K+[DVR&B,C(RYA_F
MX/65SC5A5;?K3MF]UG&?,9KCA(D"4%5P@ HC!9!R!?(B)2H1.$?8L2^$Q:A3
M8Q9C;5T<5I\'R*W=KHTA;! G.4<2YP4H$$D DK$"E"H*N,0,:;=)QG*WTZO@
MF(]SF#4JZH(@GM." $+-RLF,3#?B*6 4XURF&4&8SA9R/3;B&U6_]5AHUW_X
M-"S:=HMH\-_MP(OI60AO(KJ.+%O*>'0\<4 I<)\3FY%'[F[B ,9Q3Q.7+_N4
M'LE5*:OWR8?E0E/HVJ2U?=<3(E<K*7:5L0M9Q'&>YX!QR309B1R0'*8@)3#E
M,2IBRR9K+H-.;<UMS([>@R3:L3S:F.ZB0>X$?C\W#07IT)<=5FA>COG]874I
M<@D/[U@5*M?]:!VK2=Q@ZB\%L7S6B'4<;M[M%V$X?M=O _5UN7C03/ADU-KN
M]2/:^Y!"%!G+,AT_%MA4IYOXG4,)BI1G<4*26(C,9<=T>IBIT;6Q$A@S(V/G
M360L];QC.H.K7<QX/5H#,[$?4,Y183\.0</ ,T.-&O?UNWL8Z%WXM!\=_)"O
M<O$B?TCS+!TMMOJ[1O;UCLW+ATW-0EW>53[IC]RIW_5_K13EYN]^7]/5^N.F
M&X54>A.J&% F1PW%$@(B6 $4(HS$!8HQXRXT$M:\J=%/Z]U-M/$OVG$PVGJX
M4T#4.&FN77;=O(EJ1Z./ODTQ O\.[&CO[69W8+I\FXEUIMMA\ ]*TX%-')7>
MAX'W<%D8:!3?:@[-F[):?Z>_S(UB*WQRNQ F+:U5Y4$Y1SQ3"< I$P QQ0&6
MA0!0OTN09?JO:>%6P7%QS*D1_RWGJQ<C#;(0T<OBF98B*ELO7,LR+N-MQ\6!
M41R88#MKH];<D$45UC@$+J2X/.[(Q1/60!P73-A_-8 JIWCAZW]1DP2[_K71
M7*H%]'9:+*=YG.2% A JDSBI,I-M$ ..<2JACE.Y=,HQ<#5@:@RTJ])YJY>!
M5U.HI/_<N1'5%.6:A. \+7;<-"380Q]A[JNA&N.W&&_,;U4[A^G,[(O><$*>
M-D:\G:"G T2]PIXNS_&XEOFN([;%NM(AQ->2FU3_325[U1Y>*Q(+A75DQ;A)
M&84JUX&6_A^D4B4H2D2<6'&>W7!38[C6X#K&FC<F6]X*6\*;(":5S!.0FGY[
M"&:IZ3=1@(+DD,649X@D=BD/X0$>)]=A%^+6Z&I/X>1B%8H/[A9774&Q''B%
M. 'B5I2B\KG<N@RAP[564"A'NM"Z%E*W&RUKA'KOLBX_9;Q;+&N/]NZO[+_E
M*6=M6L'I'<2F-V>C\=]2S"R'>2HR*$ N& $H3BD@$$J0,2YAH1="E;C)6?<.
M-[75KFF66+:=)MK"R=]NHH5TE53N1]DN8 ^'W<#DV\"V:^FF6T=K;,B&'5:H
MA)54[A]R7$EE*_>/))7MOA5*?*8>;BOCO%4HGPE)DT(J!F*"F8ZAC5R^(AP(
M4N0B3AG.8W:=\,S9L:=)-COR[==JR9Q'W?;P<A L!S_$/*DATZ"[(_9N@7,
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M]-("[J+M< O*1A>&')6([-P_Y"#+;WG23_N8^^4M_\]+N9)G.VS.5,Q90J$
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MH63QF/&RDNQ]VLM$<OB:;S;]JW[J<O7K!_WS[WK?N"KIO*J;"?R0E5R]ZC"
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M 9CB.8=,"8Z=[A;.#S6U8&#7TGT1R_]]K5B@8Z9H&,R&7H3MQ0,'20R]#-+
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M"9,PEKP BB@)4$Z(!I=0@%*H5%JD25PXZ:>' '04\5&ZNM#(QPU'.TX.@<[
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MI.-7=G_;?^;(G=]..G3<]>WTQZXX?3H6/#.[HGN];^*/\O[/9;=S29F2,49
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MPM1[:67[K/&NI!R]V[MP<OVN7V1WR[GIXEO]D%R6KZ;$\9M<?V@Z$LTRB*B
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M8"PI]="6&]$%J[=U?+6ZSWL*3K5R4Q5:NBG@[\".-:<VK=,1;+J@U]3F7>X
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M< V[CW$9IV'WSKC3:-A]#(1UP^X37_76>3ZOSK0C^Q,G.,WS) <HI?I_E&*
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M$A. )(IU) 8ER%2B-Y@RYJ1PZAMV8;RIA5^M:9$>Z\FQ!] %8.TBK8!P#<R
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M*=:=QV0@0;H3 [Z1WMQYU\_+R?5\)X0\0OWH6<*S3,$, Y*F>C-K6C3C E.
MH8*,)QDL\L1?!^%^BJF"N[]^DU %3.E==%"\7[7OA&-6]BF([:CC2N!&9(PK
M,+M2U^!^L#S!4^.\H5+!?5\^8-]'?46@6"7_\V(4Y?1N;?UU4R& 99(*%N>
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M*FQQKQ(EYC]8RH(0+@NGD#1_T6.;_E^4V"RK MW@<0%>*?!^M;(=W7_[;A/
MU:P*!WC08&]D<T%GW=J6G?4A)*@L!6P-_LI^3I\V3QY]T/Q&L)M>XHY+=%_B
M".K[#JA[-)SS ]JC&5TTP =J5!<6>+^.=KVPZ^QVY_?&X3KA];+TH$M>OS?T
M+ QL)=2<^,80Y;;^9'VV?ZR(+5-9=5AYMUAJ-5W;&D]FN6-Y46H%<UVF]C!9
M0T)M_)V699920;3P.BJZ6:.Q+4'6EFIZ5:=*NRG8W'PW_:6:"W#;8?>;FDE@
MAMOV3['77G8E6E1I(KUO#F\?9;<=[*!C%_T<W%)DXR[4UC2>\OY&\I11ZS+!
M38NJEF$!BP2'PCAL9>";M1JV'' H$$]J  =[<>! QX^+N?E1J2>;$?6P_+S[
MN5)V65>FKPKX301+F2X9ARA7 B*9,,BQ*"!-RS(C"O%">1[^WZS3V#B]'=KW
M?1?:UU#Z#ZMQH-!(CV%SO6$8=#"B7T5<#+$T+-RVR,PBL+?IKB;V9=/RY*XN
M+#I ,*8_RL,$;'KH-8Z@3G\@G0,_>[S:_WCV[7P]73^_KBJ?S=[/I?KYO]7S
M)%49*Y'&$*G"4B]*("OL;0O.F:0)*[ J78]GSTH8&Y'62H)&2U"I"8R>[L>S
MYX&\?CQ[,SR1J<T;&:_CV4[K>Q_/GG_K8,>SG4:UCV>[/QBJ3*F:BV]/;/G/
MIO(_+J3,TH3"'"4)1+3(;.AQ"EF9JU1F(D=^M;2N"1S;5#]3?'.G<<]V"U<Q
M=_:)@B$9W^&Y <0 A4S/(Q.YFNF1T!<N:7H>@NMU32\\=U-DQJYA6.N(\('/
MIE]W2;EVN_DX?3(?>=!?S&]7F@G[MT?KT>R;!4B&2&%;Q#-=F)T?5L;S2$MI
MR$K30B#)=>'%3H'U&QN9?=D\F:%\MJ<\N^SYV@K[J\9X\_]B\75>]=CH%4$2
M;'3=>/ %QRSZG5-EV;:F07.6M[OXV%MW=VXXVR:"WRLC092V$Y$&($8@33 =
M7R(.)S3 %\)X@HOINU2LE'GHV_U<OC&*S1;?J\YCOL%I72\9U52O%:WN35JJ
M1@I=<T$E\/SK%#GP='(Q_W1V.#W5LT*@V=K)Z6RSGOY0^^"/MS_%;".5K"L2
M/GW?U'?M#_HM6]H)NC(SM#JC_S"=J_=K];2:(*P13@H&58)SB(P;!+G0"B9%
M@3.4<D6Q5Z1K*,7&Y@FU[0*M<)NM9=O"G#O;*I^IL<ZNPDW8P>_60E"9Z+D+
M##;D;DSX$@,9F3,''4/_$GN! 0];@2^4<L,6Z L,Z4G]OM#OORFE=)\34143
M;"*_-,ZHH&:SFZA4-HFE>9I#E8D\TR5'B7 Z:W<1-C;2KLN.]LIQZL34C4%#
M(169%;<YCZT,I[NF8&OX\BTNF,1(@CPO\"52(3M-OY 0V?U,SY"XOFV<ZXO!
M=D;\Y\5L]FZQM'^<Y"C#F"<E3!%*(=(80\)*!$LF=8JE+ECF5=,^CIIC(ZJ/
M&SNBUMUHU/8,?(LSEFXT]_(C%)D@*^TAM^J#MHF@92/@SZ#]N<;.;:1<8^I!
M<0_PNS47-/8&Y-BX Q(VGBZ.JL,&V46%^R3R+JZT'CD[AU$E9QKD3B3."\Q(
M"I7F)42IR"%)<PRUQI+8U2'CU#E/YZJXL7%[U='YQ[8=]E$8G4?"QW6<N_DZ
M/'K1'=.C2+>SO;&#(NB1)A,4R8%28VY$U"\7QAF@SOR7ZV\9+N?%V:*#/!?W
MIWKO_K^KY?KYDQEJNU-X^Z_-M#IJWM^+$EHD/"<4<IH(B%0F(=6*PZSDO) T
MH3EFGF< 5T2.C82_B&]*;F85!6^UKTO_;%6OTAF\SPBN(>]\4A 0S_CG!96R
M=Z!2]Q#%J/?&[C"%/D*X)G;H@P1'&,X<)[@^V8^+7E6-W#XLV+PY*2-$4\WR
M#&J%,XC*C$-6<@TEPT03F6."O+J&' L8&\_4^H$/_IWL3J!SHXY; (E,%"TL
M(IPD7C(\Z-0_$3+H1+]DXO&TOOBY@4\&ZU.L!WTO914,QF9U0MC]9OUML9S^
MMY(33G,NBAS!G-N2#4()2!.4&5(H2\VEE"GS2Z.-I^O8J&6O*6#6@A5@.UVK
M1-KI-@/WEW[9LQ&'/?))8MC!'/]QXOZXN/6EJ$T&>YM'<*+H/C#C.%9TT/?/
M<;;H#GRP T8/D8$WNF;C-L&%TH592F"&<KNPI!R2Q!8$DN8[(@NFD?!J,M E
M;&PKP\&&5NTWM-Y=DCH1S@J6$J(03%!A$*9$099A"0N1Y$@CK,LTG:P7:S8;
M&.&=R#\[PC<>%GCB]I+'!-V'+>$.!EJ0#',D8 6.XS"@9;KS,4#[F7X<_6!>
M;!:,^=>F4=YJHIA.1*8YI*E-^.4\@U1P"5-1YB5)\E)GV(<V3B2,C2L>K0P@
M%JMU7358-7KZ$<4ID&[L<!,\D2EAIQMX>PT3;PJX:'?0>7\J9=#)?M'(XQE^
M^8,]I[4-._HP97PZJT(</QI]-TO;:WI"6:(98A)27@J(<DTAX4D!.1$I):5F
M9DOOXWA=%C4VMZN.D9LOYK!1$,SV:GO.]LOX.D[[(*C%GO\58"TMJ^(EC9X!
MJ> J%F$YX;*X8<GAJMDG+'']B1[Q(%73W,]J/5U6V\5])MCJ??UZ^6JS_KA8
M_T.M/[&IG)0%D10G$MJ6969?498V R6%3/"4Y*D0.2'.T2&>PL=&*97Z8+G3
M'RSV!G@$.O@.03?'Q 8V,NO4F.Y5;Z7!KL!6>6"T-V2T!D9_8 V(B+9'D$E$
MU <*.0F,OE\(2D_X.@-2?-\Y7'A*3VL/@E7ZOJ/'.G&YX_HV9;C=>/U>&_ZU
M7=;?F:^FW52*++,%_9-2&J>SU) PF4!2$,451FF2.ETCW:K(V-:/1[.@&VR,
M* _^NF4@'%:.@>"-O(K45L#*#+"W U2&M,HIM&VY Y4UP)H#K#T##8K' C/0
MX RTV,0=)+^U)P"RG>O0+>\?;DT*@,+!^A3B?3VC(IH(PH6^K,/JW<96MVVK
MT!S '!6JH661,*P49&E*H8U_-TM744!4(IY2)'+)O++N0RHWMC6M';KY=K6>
M/C$[A6MC3B;YP=3>'C-ZQD&$'&C'P(<7&K[8D0ZMD>NDYM7==CS/#5_4F-(8
MT(>-90BIX+#!"Q&@/8E6B"'CM@7B0;]1?/U^OEHO*Y]GU8K#+SDI%>(0%;G9
MMI2"09;(#.8)H3I+$4TSKUS\ZR+'3.8?%O.OT A] E9[T%*_'V%W .]'PV'@
M')!<+R,Y"'=>QRL*(W:(?1&>NP[#)?9R>+(?)QV^]L.^ZE.!I*:20U)BXW\J
ME4/&C?\I6(HED2)%A5>6_@4Y8V.?H]EQ0S&F2\"Z$4T N"*S2R^DO GD"@Y!
M6>.2K$&IXHK!Q_QP[>-]"R5^K\,V5P_:KAR/9N&PDB8B59SE#$&5(F+[*4K(
M%1(P%QGCMJ5B0M/)7'VU&[!'GQJYY^4Y?=UI_74_D1KOJ[]3UZZLL]W**HW&
MOM5M+^#L1A(WP394$<JMBJ=>2,CJD]U !*X[>4'8P!4GNTT^K35YY?/^G3L>
ME\P6B?CR_,07LTE..<UXJJ'Q#>R!%4&0EAK#3-*"E:5F-,M<.W8<O'EL+D*C
M'*BU<^_/<0A7]PR_"83(4]K1?J\N'&=M[=U]X_!M@W7=.&M$N]O&^0_TN!BU
M$_?UXH>:LVUG97M\W62%,BEI0I2"B"#SGPPKR).RA$6>8B0H*7+N=(1P5=+8
M)F;ED6Z5O=MV\_:\5>N$UN$N,Q1@0WCO9['JTVFX$S2/N\90X UTF=CC"^=W
M0^B"1^<58.<+AKOC<['CX!+/Z8' .6)_62Y6JPG+A11(EQ"A(H>H+!$D!94P
M3:4BC%!:N%6B<A,W-@J]E,7TU2H;*(^IQMEMAQ,.O<A\>B67Z2^=^(7+9CJ
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M0"11#@FCR" K<H(T2[@0_D5O;M+)9SX,5\JF7OBL7U!%'S:Z-KFC!WX#8&O
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M?KB?+_11K>T1RJ?EXL=4*OGJ^;>5)9WW525'6U^\CO.<JM5$9Y23G#-8RD)
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M9+H@EFTTY"1!4!*:XY0R14OM=<5W4=382+S:YMDC_.J'EK*]O+T.B!TO^H(
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M9W55Z*#['5<(CG<ASL]=8IWV*'XP/_W'_]C^QOS'[EW^XW_\/U!+ P04
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M9_@6UQ<7U\SRZ$2N^P[)7$QD*3H,!(B"67O%#&;51D,]0M4X73G:P6HP"72
MIM?S;T3U8OF#EC#AU35T28/QP8!2+(//W$*67L5<ZW)"&^UTG8IQ&G:T0\O>
M'.X '>^7^#5,\\OO7ZOC0JKTW?H+.:?7>33!& (YE1P")P;1BNJ2$JE/EI%Q
M^A+%8Q=#^X-F"^+&Z?+1#DM#RZ,#B-TDWD3M98@!0JBA3&?(X]!T("O)4C(L
M19%*>PM[G)8@#0^LO7F\/T 6ZS ;2 <MON)R_>/]+! [YKE:<E^KYUKU:71:
M2LLYT*%+'JHBLRT$Q2'Z['*-=+%'BR\/43X/4]6#O3.(8S88ZSO0,^]H):%F
M K_!L,(/M=WGN_)74J*571-B@C62(PBG/-!1C.""]"#1(.?<8.2/W5KNCZ-'
MR>K!%!H$2,,QOP<D79VY;Q?S=*Y5I29M:GF LCEVZ<@%STC)>JN*529DQV,;
M!-U'3@^&SS#(.9C9'2#F-?%^_GE*CN+Y2G#]\GN:G=9LG]\7B_S'=#:;%!:,
M<N0NQA)I%PAF(&9M(#OC4 4D-Z&-';T-=3U81(/@:7!1= "O2[HQ,<M8*,"9
MI&UAD@+R-37Q*7"-)? L'\OUWA]".\%D\/R;!C#9BZ4=0.&,!1.#!%R;.10"
M,NE'3E1SA8!.AI!$BM$\UD+O4#=JG.9HS6XF=F)G!Q[3FVF(T]ET/<45&>V;
M)-,OBQDQ?54-^/6/2]8(Q:(2)8$HWH#*O+9F*A**#]EP:5-QCU61[0^3;2D<
MUY-J?D?:1% =:*%KZ[H=QL@1-=*& >8-K821*G7H$S##K7>Q<&7:7% \3-.X
MMUYM,/ PT X12 ?0NKA[>1]^U(N7RYA6LL%QGJ&HR&H*)+F0QFC@UOCH:0^B
M:I._<C\]W4#J(&D_<.UU .L[ -#+DZ^SQ0_$#SBK^5=W>341-G'2W9Y$[HA'
M GE-MO80A-=,><7IN&^"I9^2-NYQV A6PPJD X3=#'9=K.?'Y?U,%G83L;"Z
M=M5-U:/0RH*)Q5K'5'Z\F>10H<;;=(T;:VR$K0%%T0&PGB_F&Y;\;;K^\OQT
MM5Z<X/+.FDKB1?A(*_':@=+&@<LAD';V6C%G51)M3L)MJ!LW+-D(9(.+942H
MU<SHR8OS=_Y>F\A_P&\X/[T\[3ERVA:;"GA)C(HHB5&F &8=I;0R.WWKPNUN
MLO7/7C)NL'%@E S*T0Z4$%F!R]-[C^E"O-$Q.&!9>/*$)0=/]$.R+%GE;-&^
M4=#I(9+&#4>V,\,'$$ '2'I3>VJ\*\_IS=/+]+G ,R\%#3!M!!W)+D!(IEXM
M,RS%,><>;6QT2'S@+C7CQC$;X>=@MG<!G;O@+YB<40$,9B26> E1L Q,N&S0
MEHRIC5F]I]H9O*:P.6P.8GD'87&RT[[A<EWO_EY@7%^[3C8BZ"B"!18U)_1G
M!H%< LC.2S11&B_;7+T^2%(WGGZ[F.0PXNA &5U;R)O%_/,G7)Z\7:SQ(DXV
MD2QKH0,#F40D)M5$*68R,<EJQW2.SK?):?P)8=UX_$?!V,&BZ0!IF\ZGF.MV
MF=#S,1I?2-L6(CW669#*&9 N">N,9.S1'G\'5&Q>$=&-.]\.0?NRO .T7#B=
M=<C7"7X*WZ\QK"9P.BV42X$.;:FP3FUR$(R2@*Q(Z:1U+K:YBOL)8=VX_^U0
M-:1H.D#: V'6:T<Z9R*B];9V9R=F):SU"#* Q631U2R^V"9/^Z>D=1,C:(>V
M8<73 =X>C;A>6U;RQD4;-7&I+LO5JTD6$)@LV4FE-4]M(E);$MA-?*&I!3:X
MJ'J,CU]/3JY.L2ID)AARAFDI'%Q(2#N*O&]D/!E]R][?(42^(WB.$648'CQ#
M<WELP&S8\P&_GB[3E^L:>"(U<45$!B[59N,,$P3E5 VHA)2S#$6[K:#RT!O&
M&2MY/) ,PMD.3K1-F<-U(_ *Z*A4\B1Q4-82;ZSP$ HYJCQE%K-#<F$;E28]
M2--(,RF/:S0-(Y$.L'5M$1,5K2!56<C&"QJ4< E\B1:2C06CS]S9-KE-UX@8
M:5[E6 F7._&\BS#YR<ET7=.>*W^J_4:> \Y378J0HO!"MEFPD==<OPR.$ ]%
M!RVM5Y+Y-KKH$:)&FFUY9"MZ&)ETH(T>X5"=S:.X363TYSIOOF2(01N00C.?
MO?(:6S6A.Z@ 8?B9F<<-<0XCD0ZP]?[BO9LEG75W,KE.7,@2G*@WV[)N%)<-
M%!Y2])$%X=I$.>\A9NR6?\/(^6Y/DH.8W@%NKG7C/Z/?Q2@\3QZ,KZ,;G&00
M3:KW0B@XBRDKV::8^S8E8Q= -4',0>SN "[/<M[4@(79^S#-K^?/P]<I65\3
M'I5W(B)(S2RH0CZG3X768J-QV=;/&[6'O)^@<2]X&X%G".;W@*&43D].-Q4/
M&T^S#HU9XA><KZ;?\.Q:Z,UB52^#WI5/X?LD>*Y<\AR"U)*<")DA\,SJ1#HM
MO.),R6:-_78A=-PKX5:8:RBL#K#X ==A.L?\,BSGY%>LKBWW!99IFJXGS'%N
MN2Q@%<]GCFQT.0(=ZHF%$&W1;>#W<]K&O2YNA+B!1=(!R.XR:B)%X+'VQI1,
M$H.*<1!3U,!E\*78$EAHDQAUEY9Q;X$;@>A EG<0B_J9_SM1*F6758&<BZD#
M&>O\=ZW )!XY1\50YR80^AEEV[EZ3SLW:E#I#(:VH\Z:>+^1QA=<3Q/9VS>6
M,M3@B9NO.,(4BD?6=,R1%,$(]%Q*R,YAC6M&"(E)\-D65EAVF-K$FH\RDF(V
M6_Q16?YJL7RQ.(WK<CJ[VU;ZL@":E1"E,E5A%_I 1WU0(0(S6=L4"\_8J+)J
M%S+'CFX-C*D[3D SD75@G=T,XI$&>+?<,#1O C3O<;F94CFI+1V$H(/"%,O)
ML5$*G-(%HDK21AV]\6T:A&]'W]C1LL8(;""D[J!W-@WUV>GZRV(Y_0?FB79&
M2^,3!$%VJI+1@C<R0+;"9V&UD=@FJ/8X76/'UHX*M8.$TBG$7J]6I[02:9F)
M13!(FXGNPCKPVM5$V-H=FP5K6;/N]0_0-'8(;01H[2&,3F%U?8ZS3<(*G7SU
MK1CY5A)K3_X(9!9XZ1B+1K6);_R$L+$C9B, ;%^Q=("R:[=E#Q[YO/ 2)9WV
MNM18H#*9-@ZSM7]M#"4GETVK$L.?$C=V:*TQVH863U^(NW/R"U7[V!0!6M0F
MEX4%"-):8#;GF(S.1$]KI.UEBS4KHS@FP@X21X_(.C_XDT:1'>?@&1>DDBUY
M*R%+P"Q%"#DX)ELUK;J7H'%K*XZ/J#W$T".:KI_R,DA)>I5L21-)YUKM2=TR
M <;1^:X+"F\;35I\A*IQRS&.CZM]!?)D!D]?LG2U*.=EEO33P2X"'GA\FTN
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M35NYN[1TXC(?)N3;\=S#.-X!9DAG3G'UV\V4@ OEJ36*$C(4*2PMQ92:SA1
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MS<XK#TF+,NV9S&!=J8/$A0/O2(MFJ;US3&A6VJ!H1T([<>?VQ,7=0H!F0NH
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M:@>%11VS<C:Q-A65[0^&9CEV?0)])U%V,\WJL"4;&Q@6&R%PS\BC-I)\$;1
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MS]&V\0R.D>E[8.K<Q@?UJ7C!@ZP3A"N'3 %7\_D0BTJ61QEE[YF275]*[X+
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MB/IQ .W!]P[ <U,UO[FL#^<V*UU0@ A$O I)0Q#1D+Q9](Z5@(TRE1X@:"L
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M9(F!8+4%<3TIJ6'0-;1$.@#965^PBQO:\U!9K?2]X-S9WN$3'7W.2+M%29]
MZ5)H75@@<<FR1Y6Y:5>OL0V%?59C'ZK,!I=-)YC[B+1AINLIKOXZ7V*8U6JG
MW\G\?%,3VA(FK9*04+2M#;2S@A *@BTA)>NCIZ^:8>TQROJLOCX48X/)8G=L
M^3-LS?%S+3_ZU,@6NTJY-2P9G8L KJ0C?T0K\"8QB"@#$]F3KW*,2\/=LIV/
MGFDVG 6V'^=[O&MY^_I_D 8^BYGO<6%R_<\/OO5XD):!KBX^$%'$_2]DV;S
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M,=>Q,T_V1,L !5J[B*[C),VW87E6 7=X,N:=1PV5=/DXC4=.KJ0C,W.=/:!
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MVX\@8B<$FK-#X$EUT[>[K-U2VC-IM#!D1W7R/TL98HZFKOT1JA@5DVNS[6^
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MWN,T$'(>;7,ZD1H[@&QEXIIR39%D5M:"" PIITNU5,,5".21SB)-TFSG('N
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M67>'ENM0)#A;0B&-8JXS0S.EVCZ1?0E1G]*9Z+EH]#+A"6I&?H-ZI(:W N8
M<7< F8_X?7[QG0[UA\S<U"ES71%A/&C/R"TGZ<A;1DX<H5%1RN!*FRK?5K)Z
M M$A6G_T^F H%72 IX=.^=WM"[*H"IE35I"\S,1&71>GG()B<XR:,ZTV-U8U
M*>6\V^OI:+--"FUK@(=)O3OPD"'@58HQ4=I9C/7!H:)T0M6-@QY3!*<QH9"9
M>]:F!>XYBGHJ\QRH[JT0.E#V'6+H.A&8E%QRL-)""=R "AS)LD*MF99$[K78
M$$[A@&X)ZJGTTP9!ATB^BQ>_'Q;SA)B7OY#8:GM/W=%01;2\:<JI,UWIY,T:
M;-ULJPJ=Q]$4#E9JC%+X(%T;,+U(6D^%GV%@-:PV>AR&^L<7$NZ7^07I9EG?
M\JU^/*1VMQ=M3WS*T>_57J)LH-=H5Q]]^][(<LE+=K*VN+DZW%9#%/1+%@%C
M0":+24VLZR$=1_?8KN;IWP^$5ZOA=S=2]Z;Y2B]3H?S3RFH>U@IPO!@H26J!
M$BVZ-BNA=B9QW'CG"'P\ZL5MHI3S\"J'+QMX]K,:>)B&*P4V<,0PA5(8A;*)
ME*M$'<QMHP010S+(G4+69IKYL'[F#KSORUJ</]7506_G7[_A;'EMHXLP^[RN
MDB]_^G'W=SZ$'^M.PK_"(M\!'X6*12@).M9E5 0"B#(A\6&\1C*+)!IM%AB6
MD:Y\UCY8>Q18CZC@/A<[/?8:OX=%W6[U'8^8";##IS;P=]LI;^/Y5$3A''.@
M&0^@I!00E4N0);/,:IU;/?89QO-=]1H^?7),M!)"<.7 H*5L(-0*'YI(EA9M
M00Q!&_L2$K9]05=N91]%/NS4'$!Z'=SV7'FVF\?#S#%1HBO@M:60#1,1SU($
MHYG.(?.89)N3ZP$9XP!D.*UNSF\[6,0=X./PX_*.[5G^<!%F]]JCBQ#U1H).
MS4"FIC+WX+.*9'391/0A1B>;P*P%-R./ACL<7)N)W=B:[@#M'W!1YHNO899P
MS>K-N%N#JJAL.&1>!VYSRIH#5PJ\Y4D:&4UJU*ST#$'C8FY\I&S>< Z@MA'1
MMURL)A^K[*ZV"3#B%P-"89J.&J(28D0&Q3/%3-(IIYWZUNE3[^&,_K2)L0=?
M.TXU9? S]W!1]J#_:]@J83&CU2""(MB:F""@(NZC2()^ESW?Z39S=P2,Z56.
M4-FFT@^0W\AJ_VTZFWZ]_'HS55T;763.D$IE/F97?: &[S4:)EAFNU7I=U+\
M@Z\>6?6'*&X^A!3'5G_X^Q[ARB95;X\@QZ!!%28@2(5@(]?).,L4W^DMW&[J
MO__5XWC_P=1_L!1'?WS]Z.A[=U?R#4$D.NH@A5JD$3R *X*!R<EX'9CDN.$,
M=KZ&>;=7$]?@Q>[!3_U!9=D%)K9%U\\%UU=,WYN&^G[U!1>?OH39^V_U(Y84
M)J>JW\_XOMP+F?\YFZZ6/__]#>LXW$_S/W&YFG!,W 11(*^[>C.Y#\]*6,^N
M+$'KG,..+_X[X*:K^Z0#0?D(Z>>$D/.H[MX-#U[7N*]%,F@Y9/M7-*B-[,%3
MFT))T#RFF!RE]89@XF6 X%""<T%DZYSVC6Z4!VY%N=TEO9;C3S_>7H3E\NK$
M<HG"2L\TV%P#CCJ^SGF=P%D1A$XHT+>Y'-I"5%<UEGTP\/P2[^,$W\'EXL.K
MVKJY'FWU_L1^75A$WA\E!QT5)2C<LLC:5! [*+4,KMRM%9=])-T!3)K<KD9M
M*'"FG#AJJR@G%I1:R4R_&&.""RSJS7CNOQ67G2HN>X'K%!67?33= =I_ID!J
M_@/Q7GAR\Z)9\5"2I;,BU\?OSGGP$2-07$S'AJ(@2S9Z(/X<2:^PZK(76C:?
MC0^BNE$?+&RLO%QS4H6T44]:YS\W@T2]9MZ3Q%#4)QC:(SAA(A06LHH,B[?F
MI<1@_Z\=][%+-]!KK*\._.&-D-:'B]7:%DZ"R5PCJ.1=74.4R(Z\5\4YID.;
MX6CWJ1@9>HU"Q(/EW!%&;D8E&12*DQ*5H3A$J<"!,$W4EYB+9BE+;)-)]!25
M':[/9X!Q@'#'OCG^]-?\TY?YY3+,,CG%GR_P.\YNKOSJM=[T.U;NKAUCB#XE
M5@P854>-HHK@&,6P4CNFM"I,)KG30;;7U_:!DD.4.S^)I,</AQ[R]FD;8YY%
M[\GY@F=8DQ_!P"7-Z*AE9'31T<$>#X#0MN\<>2)3$_P,)N/>P/-'M8L5XNS7
M6;Y,>!L5WF,O>YL8A@18'S@KKP+$^L2U(/IDHC2Y[!9.[_O-X[[S;0.D@>7=
M%9QN>7N0=GZX7*0OE'3<XU [K90,'B(7!5112++T$0Q7*87B>8Y[(VK7+Q]W
MGE<#4#61>A<S"M9YQ'56<5>3=2GQ^MX=!-=U\BWWE"UR"5JCU"7ZD%O-AGN*
MG'%]5*O4ZWC)=Y"#'5R#__VRVLOU.\3EF\O5E_EB^G\Q3W3.QF+QP-%D4,PK
M<+GN7#=925^*=RJ,<T6_+RLCCQ<['E[[WM,WU74'8">VO\YG:XF^#=^FJW!Q
MQ=%'TNSB.^9?YHM?+E=UCO-R>5EOX29H>50R93!U;KC*!2%J3>*VF*Q*&95J
M,_=N;U+'32B&!VM;7779R;,^G=:V1_'(89TZ&Q]Q?"?.-IH&ZK2Y_ZK]OF/Z
MB!>A+K:?+U?+M>[C/;]TMY2Z",ZS\!)RJ&IW%+8%)274L>N,(XHDVNQ'.([N
M(8<];/WV^]Y\>??VGTNM4)8 )24#BD>R%I>)21%LTIY<.5?CBNUIPD<>N'<Z
MK&X;_M!:X6?@'H^88?/D!PWM*AM.KSD2A,J7)'.RP-8%2^01(IW$(#5/I021
M>6JT3&]4AWF7!OY>UU(MZ1LW*K#K<NN;M)I^O^GBO[.>$FP611HHL=3KRV @
MHN(02_#2%N=4:=/_>1399^TL]\'I\^V6K97=05IS[X+CR0SO?LOT,QQSS,):
M.@VR$/6M613@+"HPSB>?K1#&M(D&CJ=]Y/FI/6#\)&KO"NBW5GVO968M@&UF
M+6*P4>9(W.K:J<,L."TLI(A81'!8&@V//H[ND2>Y]@#PYNKN -Q##W>3)2;K
M10"760:E*?*/=2*N$U)*;9RPF^M+SWAZ7[O=,N/!?TQ G$$".,B@OQ<^<NBD
M\"0C_HZ$K!2V>,L,(,$3E-<$D_K*"27Y2R'0"MU^ZN>8Z>$1MK:N*:HD@I%:
M $/$>@]=6X,=0BHFZH!H#6M4 !N*A;-.&_?![[XA=1L0=!!\/'P,%%/RF"@/
MD#84$F'Q=%+0^85*!6.<%%R5)@CN\TW?*:&P]07@/GKI %1-GEMD'Z5>-VN4
MR$"Q^CHG9%^'Y B7<XY,__<%X"$O /<"URE> .ZCZ0[0_M3]XL<__GDSS,G6
MQC7CP1I.3D"E %ZC Z983,S0_V^V& \$VZUDO<*7@'NAYM$"OJ%4V $>KUHG
M[@GV7I>C\DPJK>N*2TNLU-<E+J.!.L>E%B2E:339?PM1K_!IX#%8'$I]'2#Q
MV;&F=>>7T@:"K,]K-:-(/=3G)=YSG9E'5=JL]SEF&FV[-M7>$#B$VCI WX..
M[YN73,%'(0-"3.L)?2G66;ID0-[:P'-RKM$.P">(&?=^LSO4':NN#A!7YXI-
M9Y_74367I6CG/60O?7W!$,$%J0&1,\5MDBJV.6GO$='-R^<1$^E#==(/G&[&
M#62G)2L(6LL RB42@E.4IH6LA1=8[[I: JJ'Q/5@93X-B@,DVP$LGK&FM;F0
M19'5O9_=3*35196,S$) 3PZ410G!< <E1IT*9L'"21=5/$5D%Y Z! J[W84<
MK9>S@-RGO^8W9W:R*69B*.=Z9HLBP=G"(>8<<@KDJF.C:8*[$SGNP7A*R!VF
MEPX@]V >1O2AB!@"^*(IN,S6@\.2H" /PMG@DVJ4,.X[1^84CQE'C*8.UDI'
MB+JV.Z=$X(),P?BXWM>BP!G. >EW.;LLA/@/FSJSESZW3YW91[AC3YUY8G3%
MI[_H]S^NQJ+<7@);K=$JR)P94-HX\,(E\$9XIWGFFF^\-GKF5?Y.7]<'*@Y1
MYKRI9,?&RGYS<S!YLB=N(/E$@N.&0=!U>$X23B2G/5.[86;X"46GFC!S,';:
M27IL#&WA0J(LW%A(B5$H*#(QH H#8XU#):)/9K>-&<=AXU1#8X;T*P=(<&P<
M'#*E)*AHN"B"N-(9E*Q+YH(P4'@MUFM1>-[;HYSE;)@A_$H3J?>PAFT=S1F&
MS$;A@ DL=3RIAR!E G2)&9-Y\+O=%S98P]>NJ#%JDG2X_'L S376!2]UWG&]
M1U4.5"D<7"D(7&?RG]G9'9=!G./NOKU4]LSNOGWD-_;RM@=;YT+MG>4$]BQS
MG3FJ744\@U*"YLZ:E';K_3S7W7U[*>[9W7W[2'%L]3_8.B>X$([R+;!T?%($
M+7,]XQ"<#PD%XS'*G5X-G>ONOH/5?[ 41U;_I^FJ'I2_SO+T^S1?AHNK=1 Z
M&SK?B'9;&< 8(";Z8S)*!D7)5<C#K7!\DH2=X*!?;P1QO%YZ ]:_IJLOZS<<
M]4'RE^FW3_.?*6];_;@.Y;U+11EBR)3BR?)D!&*&@Q'!62%]B -&''L2-][1
M-  ,MH%J0)V,G4>_Q<6*:+Y)XJX]<;32YU2GPV9OR/Q8)"><#<CDC3!"RK+9
MZ?I,IOSDQW>$BR$U.1]4K!W4? Z>?/CN=I:=28P%^G^2F*_;(8T'IT,$<N\A
M,)63;]2L>CSM.Z'4O,ZC="0$G#/FU[]<-R=\P,5TGOF$,EXID0=(UI*]H\C@
M6"R T5H6F DEC?3J:@\N.G_M,C "AS* 8^'0BRG$EWF/VWC_./W\975OL_ D
M:&TL98B Q@E0C'ER1RE!5$$)FWS@KM$CFA;L=/[\Y@3&,2I SME*?O[[VW1Q
M]49I[1\FF'G-3A1$;NK4DV@@6E5O48U#.K9U#HVFB0W%0N=/@3JUAJ. ,';^
M>&]<VO\0IW51/)GR=(D?%M.$U]>[]Q;+SWX)T\5O8?%O7/T9+BYQXI!KQG2D
M4U!%8E8F\%YH"$DG$@,=F-KNE&H>2TGG+XK:@/?T.AP;L!_FB\KH]=3UZT%_
M]2PBMJ:+Y>K-;#;]3E\5%C\FJB S)6:P+FM0L0CP3%+4)DMD1A;Z=;>6DCV^
M=.0;W!%AV$HS8R/N9@_$;_/9ZLORT[RR]#&L*#G_\:;0=VPR][Y<AT9UF#_.
MKC8Y35RH;T8]@L^R/GHP#"*+ 7R@\\%B4*[LAL5!R!GY<F1$E)Y>F[T$N<?L
M0'F3\[3^)S?[*.YM0PF6*U\?NVI97_,(Q\ ;5?>BH*=(B!>/IEW8VX:IG<S#
MOC+SZ TL'=C-;6\<+KY/KP<"/)+,[9C6M1#(I:S"Q?U_7T>W_3Y?_2]<?<0T
M_SQ;"\*X;(*5"E*B5%FINDF;Y02J\"0H&D/,;1Y@-&-I)YMQK]1F^@!*!Q9S
ML!YNVIJ7J\7ENBKR?O4%%Y^^A-EU)/G^<K5<A5FFH_A?6"^=2(YT1E-"\Q%K
ML6]]1,_6TQ OP\4G7)!*>3"*%?(OEH4Z_#769A0A(&I$J8*G4+/-Q(NNQ+"3
M9?I7:IE=:6(O0(Z=][23W+V[B')OWLYZ\MC/?W_#.HOL*C*?Q)Q3\DR #EQ6
M]V<IY.8>1!&B6,V+2CM>+W7 S6ZE./;*++$;\>\%IE=]EEY=$_YZ<V'M, >A
MLP*C:C9;'^![RG"!)RZR=>A=:A.,GHK#W0SOOT7P$^+H5=O7;:1_E1)/I#;9
M>Y<A1%/'7$A=IW-["$(H7P)/*G2V'7A?%G>SL%==2>\.26,'D,^^+'Q?B)C;
MQII),G3^"D0(/M81LR&!PR# .6&$ML(5U#O%>#M^X6Y8?6UU[F8J.6=/?OV
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M?10,4[:RS7/F;52-ZW&&PL>F*QE,#YT[D",JO$]\RI#NI&5]=AMJA$)FZ"B
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MJHQ<UZJ\]%G(P,GJG "5*'_POK:Y)YV%*,ZA:G,GM(6H<6$UF.)? M2!6N@
M4'?!Q2.F;OJ,8L[*2@XFUD7KKKIURRC@I#Q8116++VWN5E\DK3-P'0J">4N-
MC BQY6(U^8/TL2[WW'$5+J[L+YOB51& D>A7F.I&)8W M$*>BB#![32.A;[E
M'J3H3YMPVDI&+QU@0QY[P\E];/!<19KW6;BQ+Q.C5]Z!*U)5^PK@ _GRC)X)
M65 5MU,ZLAMXGB-C'/\SH'KG0\MZ1,"D^26YRA^3?_XQB8YQ[K4$PV)MLDD1
M?(H9F.,H)'%@W+83:XGI__D\__[_7G_B%4"N_[#&QQH9=]\W(@R&4=K\* EV
MH/.WOT^,*;7UNG9#!P>J: \.$P-REB:X8%R2VVHU^^G\[>_CG!OM=+ZG!#L(
M7)^([7_"6?KR-2S^??6D W%=.*$ 7Y$G3$)!L,Z X=$6(Q-WMLW+OY<HZZ6I
M[$2I]N%:Z1)E-]S<&)UW)3OK@0Y6\I0J6/#%1%!"2X=&,>?;/,9_B;+.DJ.C
M</ BR(Y02@<@^XC?<7:)OY 4;\9[_FNZ^O+V<KF:?\7%==87 G)9!RLQ7\@L
M*9H#5X<.8%0VVI!53&VZ$78BKS>X'8.(>6OU=("YQ\[_W6WCI0QH9:+T0:1<
M7Y91)! Q%Q Z9L:=:K9A>PM1(P_4:7IH#J6+#F#U^V4UAO?EJCI4)7,=KRXG
M7MHLHZY)!-96.22/7[*&'#PZ;R-JV>99U?,TC?R$="BUSYOHH ,TO>!Y?_X[
M75RN9SPMETC_ES^%OR<UJ##,("1-"9#B$B$J\L@6T2M-/XS89I7J <2.>_O8
M"G^MM=;%NZA'$<<'7-0?A,_()X;5[8VU*SB0<:G$#'A=.!3CM!5!AD=CZUHE
M!?>H&C?M; 6VP?308R_3V_G7K]/5VG6'6:[&1&9#D>WTL.<>VS[NZ*ZEG6D=
MJ%7IWO>]V?B^)YIV=1:XWHU0C%44_R<!CB$#SR)/3GL579M&P[W(/-XI[?!E
M=ZU^HA3-2AW5&^J-GRX&7' 6HF$I",>#9&TRROWH'#NU;(6SQZZLF?9Z=&Y_
M7,8E_I]+^IB?*5Y8'>+0-C_B^*F!VV@:JL?RX7?<S4KS%(E[XQ H&.)UM6V]
M01 2HL40$IUE3K:9RO0<14?W6&Y\[CWLRJR#391XY*NGG01;GPJ49 SWS&DG
M&O56/D?2R/UO0V#B44_E(.(_ ]=Q3%/W<Q\UM"MIV[;]''RR-HROGSRR8.MC
M 0U1% 8.O:?#R'+6ZE'):5S*U=V;CYR%)#-X80C..D3PF>#,<E!,):]C.0F7
M/31G#X&$%QS)_D+OX"IIDX>;-E#G>4FLMN9Q10[62D4B81X2<RQ))]"$-N\>
MGR&H*_@<H.D7H'.(V/M$SW5AR03M.*,HG(Y,!&6,J.L;%/C@G5&H=5%M!C0_
M2U)?"#I(X2^#Z #I]P>CZ\JA\TEYRAL!L5 B9Q7EC(XL+10A(W(TPC2:Y_\4
M.=W!YQ!5;P?0 7+O 3PW/9]O+\)R^;ZLQXI=]7Q**T)*@O3K?%VYR\!;XDL$
M9,E[67BCRMJS)(W<5CWX*3:(Z#O T'WZK^U*HA?92D-6P!(H7@T@ZP0R9151
M"Q<:@><Q+?]_>5>RVT8.1._YEP+(YGX)X,Q, @,!8L19C@*78BQ@1@JZ)2.?
MGZ(L!7&\0"TW+<IST<$RH%I>+21K.;+KF4;)?U[J/4WB#6#F$OLY#F\N=C__
M^SA#9Q7CQ#\XQ<IX?QN _L) !?*D1I<#1Z5[G(>).O)U\1/U?:=C?QKA-X"C
M6_/6LPT^DA.&SKI,9]+-#IZ<(3$FO=%8)F;7*3$:N]6@7B'NU%'J8 $W!(ZM
MR1BK!+)$?M;S\G#;"?#&<#"681+>*5?I9:JEX<F'Z_/Q!05CA'OL!05GY;+V
M?)'6<1.:=_OIR@O__!H+8UMG2-X.R380**>GXP&E\&"=+'U/(? <G$UYOTV!
M^_YB&]@X1*7+VO)MP)_<'CRNM>PZD3KH-E/Z7%;@-T^E3#*EE-0NU<EQQV\;
MJ%?".G6X.5S$#>"CRK#PSB3.A!* G#XDEXZD&1"2I2^\]YVI-$/OI2\.& 6N
MYU@<,$;3#:#]OBTR'R\_;UT[L]YB0DVG$FU!>NY**TX&'T02,2*=?.MXQT?)
M:GQ\=774W"FJG4J%#>#QCUCT_E<EJ),L=KX4)EB>2$*!#K<\<HA1A#(-O!/J
M65YRWX]J.U$G$[,G$7P# +KHEQ$Q#:7&_'P8UF5O5ME/N;C&?C4G*=V^,)EY
MGB6*SH *)3_6.8)-PH*UJ /'Z&RE@NR1A#;U^'(@.NXV-U5350-(O/2;_1R%
M]%W?S28N#(573.>+3Q0R!A^+#F<V4@CP!LDON])^PY'84AE,\(DG:8-Z=$C!
M$]S;""J;>KN9!H/5E-0  /_&L+JQIH&HW]I5X8GRA77)2G[GE,^$Y*BEUQ!3
M:8GP70=>=0&06&;!.R%5'0B.H[.IJ]EI0%A14:< P[/_RJ@1/LO,4>);I)=+
MHRP+Q)?O,DCC<R#"K*I4<+4OA4U=TSP3] Y13@.@*QT3R\7&K__EO\]7_M\;
M&Z+#$O;7F-XN^[?KU;K'7>(Q4XXC"RY!-):29TEYAB]"]:A2LI$G)>O4V(\F
MM:F3QS0PK*NN!O!X\-*K[1;@=_2/J^%\<8']?)G>]<MAF$FKLW6"@5&Z;!86
MI9F(CGO:,89TW$O.5LH9IV=F+TSKD\+TL55^"JA_\*[L7AE\Q?FW*XI.9Q2D
M_#?\YP?V<3[0,7%.#L$(9Z.R$H1E%)8Z2HULE!&4ER8@XPE3I7+;YV-R+RLQ
M+\M*C@214[">AR2S>ZO=Y7##A]45]I^N_.)>F9'^/(7,%$ DRT"&\H@B,P+R
M&)AAAN1SI+76$W&XE]W8EV4WQP#'*1O-YN,+#J6U^H9U/N.&ZV@U!^PR!YF$
M!VNX >N"$EYJ$7V==0Q3<K$7^-W_ _Q/57+]EM?M%^4C$/6O7_T$4$L! A0#
M%     @ LW*I5+<J?F"-"   0RD  !<              ( !     &5X:&EB
M:70S,3$Q,'$Q<3(P,C(N:'1M4$L! A0#%     @ LW*I5!)ID%2B"   M"X
M !<              ( !P@@  &5X:&EB:70S,3(Q,'$Q<3(P,C(N:'1M4$L!
M A0#%     @ LW*I5,R2.TKR!   MQ4  !<              ( !F1$  &5X
M:&EB:70S,C$Q,'$Q<3(P,C(N:'1M4$L! A0#%     @ LW*I5 GK=>[:!
M.A4  !<              ( !P!8  &5X:&EB:70S,C(Q,'$Q<3(P,C(N:'1M
M4$L! A0#%     @ LW*I5"9["%-5\P( Y:T= !$              ( !SQL
M &9L9&TM,C R,C S,S$N:'1M4$L! A0#%     @ LW*I5,OV-PQ]%   ZN@
M !$              ( !4P\# &9L9&TM,C R,C S,S$N>'-D4$L! A0#%
M  @ LW*I5) V[N11'@  Y"@! !4              ( !_R,# &9L9&TM,C R
M,C S,S%?8V%L+GAM;%!+ 0(4 Q0    ( +-RJ52$9*F+-6@   :>!  5
M          "  8-" P!F;&1M+3(P,C(P,S,Q7V1E9BYX;6Q02P$"% ,4
M" "S<JE4[T[S?%]6 0 ]L0$ %               @ 'KJ@, 9FQD;2TR,#(R
M,#,S,5]G,2YJ<&=02P$"% ,4    " "S<JE4,AT;LA;^  !ASPH %0
M        @ %\ 04 9FQD;2TR,#(R,#,S,5]L86(N>&UL4$L! A0#%     @
MLW*I5*Y#Z\2TH0  -6X' !4              ( !Q?\% &9L9&TM,C R,C S
@,S%?<')E+GAM;%!+!08     "P + . "  "LH08    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
